Unnamed: 0,Unnamed: 1,Unnamed: 2,Unnamed: 3,April,May,June,July,August,September,October,November,December,January,February,March,Total
District,,,,,,,,,,,,,,,,
Amritsar,1.1,Total number of pregnant women Registered for ANC,TOTAL,4087.0,4278.0,3444.0,3741.0,3309.0,2920.0,2813.0,2934.0,2964.0,3684.0,4316.0,4016.0,42506.0
Amritsar,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,2643.0,2701.0,2263.0,2404.0,2152.0,1851.0,1841.0,2062.0,2171.0,2687.0,3116.0,2811.0,28702.0
Amritsar,1.2,Number of Pregnant women registered under JSY,TOTAL,2407.0,2505.0,2052.0,2298.0,1965.0,1775.0,1756.0,1779.0,1875.0,2213.0,2439.0,2298.0,25362.0
Amritsar,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,2989.0,3274.0,3553.0,3575.0,3473.0,3305.0,3097.0,3057.0,2845.0,2974.0,2937.0,2962.0,38041.0
Amritsar,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,4283.0,4416.0,3636.0,3972.0,3563.0,3057.0,2927.0,2980.0,3085.0,3604.0,4106.0,3925.0,43554.0
Amritsar,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,3995.0,4119.0,4031.0,3636.0,3668.0,3340.0,2977.0,2850.0,2905.0,2915.0,3327.0,3763.0,41526.0
Amritsar,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,2920.0,3369.0,3263.0,2781.0,2626.0,2484.0,1689.0,1479.0,1286.0,1330.0,1341.0,2012.0,26580.0
Amritsar,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,203.0,99.0,114.0,128.0,95.0,113.0,118.0,149.0,131.0,118.0,93.0,42.0,1403.0
Amritsar,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,2.0,0.0,0.0,1.0,0.0,0.0,0.0,2.0,2.0,4.0,1.0,0.0,12.0
Amritsar,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,5578.0,4395.0,3706.0,5193.0,3575.0,3099.0,2439.0,2709.0,2210.0,3571.0,2782.0,2793.0,42050.0
Amritsar,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,148.0,86.0,79.0,147.0,247.0,220.0,106.0,144.0,62.0,80.0,81.0,137.0,1537.0
Amritsar,1.8,Number of pregnancy test kits used at SC level,TOTAL,1348.0,1003.0,826.0,431.0,240.0,269.0,179.0,191.0,327.0,411.0,506.0,335.0,6066.0
Amritsar,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,42.0,22.0,30.0,80.0,48.0,41.0,67.0,245.0,285.0,296.0,196.0,191.0,1543.0
Amritsar,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,285.0,279.0,250.0,311.0,404.0,416.0,369.0,137.0,84.0,95.0,85.0,125.0,2840.0
Amritsar,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,327.0,301.0,280.0,391.0,452.0,457.0,436.0,382.0,369.0,391.0,281.0,316.0,4383.0
Amritsar,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,247.0,228.0,257.0,291.0,410.0,396.0,375.0,344.0,298.0,298.0,189.0,226.0,3559.0
Amritsar,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,77.0,103.0,57.0,85.0,106.0,84.0,108.0,81.0,98.0,68.0,66.0,48.0,981.0
Amritsar,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,1002.0,1183.0,1373.0,1920.0,2058.0,2116.0,2111.0,1853.0,1762.0,1656.0,1319.0,1305.0,19658.0
Amritsar,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,569.0,726.0,821.0,1092.0,1238.0,924.0,958.0,788.0,815.0,610.0,567.0,587.0,9695.0
Amritsar,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,520.0,568.0,540.0,1107.0,1071.0,1095.0,1097.0,1257.0,1176.0,998.0,888.0,880.0,11197.0
Amritsar,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Amritsar,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Amritsar,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,941.0,990.0,1070.0,1440.0,1577.0,1586.0,1639.0,1569.0,1487.0,1533.0,1233.0,1147.0,16212.0
Amritsar,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,39.0,24.0,19.0,25.0,52.0,44.0,44.0,40.0,26.0,21.0,24.0,11.0,369.0
Amritsar,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Amritsar,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Amritsar,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,5.0,6.0
Amritsar,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,24.0,28.0,34.0,45.0,60.0,53.0,56.0,61.0,46.0,35.0,23.0,35.0,500.0
Amritsar,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,317.0,314.0,355.0,499.0,458.0,538.0,565.0,504.0,499.0,462.0,346.0,381.0,5238.0
Amritsar,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Amritsar,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,341.0,342.0,389.0,544.0,518.0,591.0,621.0,565.0,545.0,497.0,370.0,421.0,5744.0
Amritsar,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,261.0,277.0,353.0,441.0,461.0,451.0,511.0,439.0,485.0,604.0,469.0,370.0,5122.0
Amritsar,4.1.1.a,Number of male live births,TOTAL,1192.0,1383.0,1432.0,1935.0,2068.0,2098.0,2161.0,1932.0,1868.0,1804.0,1491.0,1434.0,20798.0
Amritsar,4.1.1.b,Number of female live births,TOTAL,1043.0,1068.0,1218.0,1738.0,1928.0,1965.0,1928.0,1814.0,1694.0,1702.0,1284.0,1269.0,18651.0
Amritsar,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,2235.0,2451.0,2650.0,3673.0,3996.0,4063.0,4089.0,3746.0,3562.0,3506.0,2775.0,2703.0,39449.0
Amritsar,4.1.2,Number of still births,TOTAL,61.0,57.0,93.0,116.0,119.0,126.0,127.0,78.0,87.0,106.0,73.0,88.0,1131.0
Amritsar,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,145.0,195.0,149.0,175.0,121.0,111.0,122.0,139.0,104.0,135.0,127.0,130.0,1653.0
Amritsar,4.2.1,Number of Newborns weighed at birth,TOTAL,2234.0,2431.0,2610.0,3655.0,3996.0,4056.0,3998.0,3683.0,3371.0,3491.0,2769.0,2698.0,38992.0
Amritsar,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,126.0,155.0,220.0,197.0,155.0,182.0,161.0,237.0,176.0,148.0,113.0,103.0,1973.0
Amritsar,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,2134.0,2347.0,2402.0,2731.0,3577.0,3326.0,3436.0,3074.0,2911.0,2925.0,2457.0,2543.0,33863.0
Amritsar,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,31.0,30.0,34.0,75.0,65.0,63.0,61.0,97.0,105.0,87.0,82.0,17.0,747.0
Amritsar,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,58.0,71.0,62.0,95.0,117.0,130.0,106.0,87.0,93.0,87.0,61.0,50.0,1017.0
Amritsar,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,280.0,379.0,361.0,520.0,450.0,483.0,1305.0,962.0,1156.0,795.0,693.0,533.0,7917.0
Amritsar,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Amritsar,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,369.0,480.0,457.0,690.0,632.0,676.0,1472.0,1146.0,1354.0,969.0,836.0,600.0,9681.0
Amritsar,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,0.0,0.0,27.0,54.0,18.0,84.0,166.0,249.0,107.0,110.0,75.0,17.0,907.0
Amritsar,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,226.0,263.0,295.0,507.0,501.0,528.0,610.0,497.0,550.0,617.0,418.0,272.0,5284.0
Amritsar,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,7.0,14.0,20.0,79.0,51.0,33.0,36.0,35.0,31.0,26.0,15.0,13.0,360.0
Amritsar,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,221.0,372.0,322.0,512.0,317.0,296.0,405.0,475.0,600.0,672.0,354.0,271.0,4817.0
Amritsar,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,131.0,189.0,149.0,215.0,146.0,132.0,133.0,271.0,294.0,355.0,300.0,349.0,2664.0
Amritsar,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,1767.0,1788.0,2171.0,3089.0,3437.0,4067.0,4103.0,3673.0,3339.0,3505.0,2445.0,2584.0,35968.0
Amritsar,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,1076.0,1075.0,1219.0,2275.0,2383.0,3055.0,3191.0,2682.0,2916.0,3005.0,2062.0,1947.0,26886.0
Amritsar,6.3,PNC maternal complications attended,TOTAL,0.0,3.0,2.0,10.0,12.0,16.0,0.0,0.0,2.0,1.0,1.0,2.0,49.0
Amritsar,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,48.0,41.0,43.0,47.0,34.0,18.0,10.0,23.0,24.0,23.0,29.0,27.0,367.0
Amritsar,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,0.0,1.0,0.0,2.0,0.0,0.0,1.0,0.0,0.0,0.0,6.0,0.0,10.0
Amritsar,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,48.0,42.0,43.0,49.0,34.0,18.0,11.0,23.0,24.0,23.0,35.0,27.0,377.0
Amritsar,7.2,Number of MTPs conducted at Private Facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,2.0,0.0,4.0,1.0,0.0,0.0,0.0,7.0
Amritsar,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,120.0,78.0,297.0,58.0,137.0,231.0,77.0,89.0,116.0,317.0,32.0,152.0,1704.0
Amritsar,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,1008.0,832.0,599.0,557.0,574.0,535.0,361.0,598.0,556.0,577.0,277.0,205.0,6679.0
Amritsar,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,1128.0,910.0,896.0,615.0,711.0,766.0,438.0,687.0,672.0,894.0,309.0,357.0,8383.0
Amritsar,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Amritsar,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,21.0,12.0,42.0,33.0,47.0,24.0,11.0,28.0,11.0,15.0,19.0,26.0,289.0
Amritsar,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,22.0,16.0,13.0,33.0,19.0,20.0,11.0,19.0,5.0,20.0,22.0,5.0,205.0
Amritsar,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,17.0,18.0,37.0,32.0,24.0,30.0,20.0,18.0,12.0,17.0,8.0,7.0,240.0
Amritsar,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Amritsar,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,60.0,46.0,92.0,98.0,90.0,74.0,42.0,65.0,28.0,52.0,49.0,38.0,734.0
Amritsar,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Amritsar,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,50.0,34.0,71.0,20.0,62.0,54.0,34.0,61.0,28.0,15.0,58.0,35.0,522.0
Amritsar,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,0.0,40.0,16.0,13.0,0.0,27.0,10.0,43.0,0.0,0.0,14.0,63.0,226.0
Amritsar,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,130.0,88.0,134.0,146.0,65.0,72.0,55.0,77.0,47.0,40.0,70.0,91.0,1015.0
Amritsar,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Amritsar,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,180.0,162.0,221.0,179.0,127.0,153.0,99.0,181.0,75.0,55.0,142.0,189.0,1763.0
Amritsar,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Amritsar,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,69.0,40.0,77.0,71.0,60.0,31.0,34.0,47.0,37.0,21.0,46.0,85.0,618.0
Amritsar,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,115.0,68.0,108.0,162.0,92.0,59.0,57.0,46.0,11.0,78.0,106.0,78.0,980.0
Amritsar,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,39.0,22.0,107.0,36.0,32.0,29.0,32.0,42.0,9.0,14.0,29.0,35.0,426.0
Amritsar,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Amritsar,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,223.0,130.0,292.0,269.0,184.0,119.0,123.0,135.0,57.0,113.0,181.0,198.0,2024.0
Amritsar,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Amritsar,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Amritsar,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,1.0,8.0,5.0,11.0,8.0,15.0,9.0,11.0,8.0,7.0,6.0,3.0,92.0
Amritsar,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,43.0,53.0,46.0,89.0,79.0,78.0,139.0,69.0,72.0,68.0,67.0,78.0,881.0
Amritsar,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Amritsar,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,44.0,61.0,51.0,100.0,87.0,93.0,148.0,80.0,80.0,75.0,73.0,81.0,973.0
Amritsar,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Amritsar,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,646.0,749.0,667.0,942.0,816.0,1099.0,2255.0,1253.0,1066.0,1095.0,963.0,1855.0,13406.0
Amritsar,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,30.0,10.0,29.0,49.0,58.0,58.0,79.0,127.0,97.0,109.0,108.0,64.0,818.0
Amritsar,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,9.0,12.0,8.0,5.0,14.0,39.0,45.0,47.0,45.0,42.0,26.0,32.0,324.0
Amritsar,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,85.0,82.0,94.0,159.0,179.0,277.0,303.0,282.0,269.0,265.0,242.0,282.0,2519.0
Amritsar,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Amritsar,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,770.0,853.0,798.0,1155.0,1067.0,1473.0,2682.0,1709.0,1477.0,1511.0,1339.0,2233.0,17067.0
Amritsar,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,67.0,73.0,87.0,128.0,191.0,335.0,396.0,404.0,371.0,363.0,329.0,315.0,3059.0
Amritsar,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,0.0,0.0,15.0,0.0,0.0,1.0,35.0,0.0,37.0,7.0,0.0,0.0,95.0
Amritsar,9.06,Number of IUCD removals,TOTAL,117.0,106.0,130.0,120.0,174.0,191.0,216.0,334.0,307.0,299.0,278.0,386.0,2658.0
Amritsar,9.07,Number of Oral Pills cycles distributed,TOTAL,6968.0,5980.0,8142.0,5435.0,5634.0,6451.0,6316.0,6992.0,6954.0,7884.0,6605.0,6808.0,80169.0
Amritsar,9.08,Number of Condom pieces distributed,TOTAL,151524.0,151281.0,156419.0,138127.0,142249.0,149668.0,151047.0,157358.0,158192.0,188117.0,177761.0,171049.0,1892792.0
Amritsar,9.09,Number of Centchroman (weekly) pills given,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Amritsar,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,212.0,90.0,111.0,194.0,108.0,215.0,174.0,137.0,115.0,95.0,76.0,47.0,1574.0
Amritsar,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Amritsar,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0.0,0.0,0.0,0.0,4.0,9.0,0.0,1.0,0.0,0.0,0.0,0.0,14.0
Amritsar,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Amritsar,9.11.2.b,Number of failures following female sterilization,TOTAL,1.0,0.0,1.0,1.0,1.0,5.0,1.0,0.0,0.0,0.0,0.0,0.0,10.0
Amritsar,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Amritsar,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Amritsar,9.12,Number of Institutions having NSV trained doctors,TOTAL,4.0,6.0,8.0,7.0,6.0,7.0,6.0,5.0,6.0,5.0,6.0,5.0,-1.0
Amritsar,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,2904.0,3111.0,3108.0,4099.0,4350.0,4301.0,4659.0,4266.0,3774.0,3698.0,3421.0,3041.0,44732.0
Amritsar,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,3222.0,3135.0,2519.0,2967.0,3101.0,3489.0,4060.0,4113.0,3620.0,3208.0,516.0,182.0,34132.0
Amritsar,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,3430.0,3519.0,2707.0,2800.0,2709.0,2849.0,3535.0,3718.0,3847.0,3449.0,3155.0,1019.0,36737.0
Amritsar,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,3448.0,3662.0,3072.0,3108.0,2803.0,2815.0,3200.0,3462.0,4309.0,3600.0,3264.0,2872.0,39615.0
Amritsar,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,445.0,3466.0,3113.0,7024.0
Amritsar,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,156.0,2693.0,2849.0
Amritsar,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,28.0,490.0,518.0
Amritsar,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,1831.0,2095.0,2305.0,3070.0,3067.0,3080.0,3187.0,2780.0,2436.0,2357.0,2027.0,1909.0,30144.0
Amritsar,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,3212.0,3146.0,2520.0,2985.0,3107.0,3510.0,4006.0,4074.0,3475.0,3288.0,3276.0,2561.0,39160.0
Amritsar,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,3414.0,3537.0,2703.0,2801.0,2719.0,2857.0,3477.0,3695.0,3762.0,3486.0,3183.0,3153.0,38787.0
Amritsar,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,3437.0,3681.0,3074.0,3122.0,2810.0,2821.0,3156.0,3414.0,3534.0,3616.0,3230.0,3171.0,39066.0
Amritsar,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,915.0,1051.0,1396.0,1471.0,1723.0,1765.0,1873.0,1663.0,1587.0,1209.0,694.0,874.0,16221.0
Amritsar,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,3189.0,3145.0,2538.0,2968.0,3121.0,3496.0,4054.0,4182.0,3606.0,3196.0,458.0,169.0,34122.0
Amritsar,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,3390.0,3513.0,2706.0,2831.0,2737.0,2873.0,3537.0,3723.0,3819.0,3453.0,2577.0,915.0,36074.0
Amritsar,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,3434.0,3706.0,3085.0,3112.0,2811.0,2859.0,3194.0,3484.0,3557.0,3591.0,2768.0,2294.0,37895.0
Amritsar,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,3302.0,4050.0,3376.0,4091.0,3730.0,3432.0,3818.0,3290.0,2879.0,2511.0,2633.0,2580.0,39692.0
Amritsar,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,3468.0,3641.0,3140.0,3386.0,2990.0,2629.0,2723.0,3058.0,3065.0,3105.0,3256.0,3192.0,37653.0
Amritsar,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Amritsar,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1754.0,2143.0,1850.0,2143.0,2008.0,1796.0,2048.0,1668.0,1473.0,1338.0,1393.0,1385.0,20999.0
Amritsar,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1545.0,1884.0,1518.0,1916.0,1699.0,1586.0,1752.0,1527.0,1348.0,1168.0,1232.0,1195.0,18370.0
Amritsar,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,3299.0,4027.0,3368.0,4059.0,3707.0,3382.0,3800.0,3195.0,2821.0,2506.0,2625.0,2580.0,39369.0
Amritsar,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,3579.0,3654.0,3090.0,3460.0,3036.0,2700.0,2771.0,3061.0,3088.0,3121.0,3315.0,3284.0,38159.0
Amritsar,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,3558.0,3704.0,3107.0,3463.0,3050.0,2698.0,2746.0,3024.0,2997.0,3105.0,3327.0,3266.0,38045.0
Amritsar,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Amritsar,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,10.0,20.0,19.0,27.0,11.0,3.0,6.0,14.0,28.0,6.0,7.0,4.0,155.0
Amritsar,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,12.0,17.0,21.0,35.0,13.0,3.0,3.0,14.0,28.0,5.0,7.0,2.0,160.0
Amritsar,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,22.0,37.0,40.0,62.0,24.0,6.0,9.0,28.0,56.0,11.0,14.0,6.0,315.0
Amritsar,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,2418.0,2536.0,2568.0,3379.0,3222.0,2784.0,2711.0,3250.0,2711.0,2396.0,2648.0,2898.0,33521.0
Amritsar,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,2038.0,2467.0,2225.0,4202.0,3745.0,2899.0,2476.0,3287.0,2445.0,2055.0,2249.0,2910.0,32998.0
Amritsar,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,2347.0,2568.0,1662.0,2872.0,2298.0,1879.0,1806.0,2675.0,1678.0,1661.0,1962.0,2278.0,25686.0
Amritsar,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Amritsar,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Amritsar,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Amritsar,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,1841.0,1772.0,1646.0,1883.0,1643.0,1611.0,1782.0,1598.0,1726.0,1544.0,1610.0,1548.0,20204.0
Amritsar,10.4.2,Number of Immunisation sessions held during the month,TOTAL,1705.0,1745.0,1600.0,1813.0,1600.0,1498.0,1641.0,1564.0,1651.0,1496.0,1546.0,1362.0,19221.0
Amritsar,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,991.0,934.0,926.0,1108.0,958.0,903.0,985.0,956.0,1052.0,952.0,964.0,836.0,11565.0
Amritsar,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Amritsar,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,2321.0,2621.0,2422.0,3638.0,3632.0,3193.0,3809.0,3062.0,2549.0,2109.0,2265.0,2255.0,33876.0
Amritsar,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,1602.0,1009.0,882.0,1198.0,1320.0,1400.0,1393.0,1428.0,1356.0,1108.0,1126.0,1151.0,14973.0
Amritsar,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,1492.0,1172.0,1196.0,1594.0,1602.0,1610.0,1552.0,1684.0,1491.0,1390.0,1557.0,1801.0,18141.0
Amritsar,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Amritsar,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Amritsar,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Amritsar,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Amritsar,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Amritsar,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,1.0,0.0,3.0
Amritsar,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,188.0,278.0,351.0,468.0,242.0,241.0,115.0,198.0,191.0,318.0,402.0,372.0,3364.0
Amritsar,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,2.0
Amritsar,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,0.0,6.0,170.0,0.0,0.0,87.0,0.0,0.0,55.0,215.0,218.0,18.0,769.0
Amritsar,13.1,Number of Patients operated for cataract,TOTAL,2616.0,2289.0,1818.0,1618.0,1537.0,1640.0,1788.0,1906.0,1448.0,1501.0,1606.0,1727.0,21494.0
Amritsar,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,2616.0,2286.0,1816.0,1614.0,1534.0,1638.0,1781.0,1901.0,1446.0,1497.0,1604.0,1725.0,21458.0
Amritsar,13.3,Number of School children detected with Refractive errors,TOTAL,449.0,474.0,43.0,978.0,387.0,302.0,299.0,648.0,248.0,229.0,538.0,277.0,4872.0
Amritsar,13.4,Number of children provided free glasses,TOTAL,409.0,444.0,41.0,433.0,358.0,280.0,256.0,451.0,168.0,242.0,188.0,200.0,3470.0
Amritsar,13.5,Number of eyes collected through eye donation,TOTAL,2.0,8.0,4.0,2.0,4.0,4.0,5.0,7.0,8.0,7.0,10.0,8.0,69.0
Amritsar,13.6,Number of eyes utilised for corneal transplant,TOTAL,2.0,8.0,4.0,2.0,4.0,4.0,5.0,7.0,8.0,7.0,10.0,8.0,69.0
Amritsar,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,7.0,7.0,7.0,7.0,7.0,7.0,7.0,7.0,7.0,7.0,7.0,7.0,-1.0
Amritsar,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,19.0,18.0,18.0,19.0,19.0,19.0,18.0,19.0,18.0,19.0,18.0,19.0,-1.0
Amritsar,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,846.0,791.0,867.0,838.0,801.0,775.0,780.0,830.0,780.0,779.0,798.0,714.0,-1.0
Amritsar,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,9.0,7.0,7.0,7.0,6.0,8.0,8.0,7.0,7.0,7.0,7.0,7.0,-1.0
Amritsar,14.05,Number of RKS meetings held during the month,TOTAL,28.0,27.0,28.0,28.0,26.0,28.0,26.0,24.0,29.0,27.0,30.0,29.0,330.0
Amritsar,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,9.0,7.0,8.0,9.0,8.0,9.0,9.0,9.0,8.0,8.0,9.0,11.0,-1.0
Amritsar,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,55.0,39.0,59.0,75.0,18.0,80.0,76.0,62.0,78.0,89.0,54.0,54.0,739.0
Amritsar,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,2.0,2.0,4.0,3.0,3.0,3.0,3.0,2.0,3.0,2.0,2.0,3.0,-1.0
Amritsar,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,5.0,5.0,5.0,3.0,3.0,3.0,3.0,3.0,3.0,3.0,3.0,3.0,-1.0
Amritsar,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,425.0,421.0,796.0,524.0,606.0,576.0,458.0,524.0,424.0,385.0,392.0,390.0,5921.0
Amritsar,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,695.0,786.0,776.0,1521.0,1239.0,781.0,924.0,609.0,603.0,582.0,392.0,547.0,9455.0
Amritsar,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,479.0,420.0,830.0,416.0,565.0,515.0,390.0,470.0,341.0,348.0,344.0,634.0,5752.0
Amritsar,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,2307.0,2478.0,2589.0,2826.0,3320.0,2976.0,2954.0,2507.0,2349.0,2234.0,2278.0,1914.0,30732.0
Amritsar,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,904.0,841.0,1626.0,940.0,1171.0,1091.0,848.0,994.0,765.0,733.0,736.0,1024.0,11673.0
Amritsar,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,3002.0,3264.0,3365.0,4347.0,4559.0,3757.0,3878.0,3116.0,2952.0,2816.0,2670.0,2461.0,40187.0
Amritsar,14.10.2.a,Number of death cases of Inpatient males,TOTAL,5.0,3.0,0.0,2.0,2.0,1.0,1.0,0.0,4.0,4.0,4.0,2.0,28.0
Amritsar,14.10.2.b,Number of death cases of Inpatient females,TOTAL,2.0,3.0,1.0,0.0,0.0,4.0,2.0,5.0,1.0,1.0,3.0,0.0,22.0
Amritsar,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,7.0,6.0,1.0,2.0,2.0,5.0,3.0,5.0,5.0,5.0,7.0,2.0,50.0
Amritsar,14.11,In-Patient Head Count at midnight,TOTAL,4072.0,3030.0,5102.0,7698.0,8828.0,7419.0,5807.0,7216.0,5650.0,6206.0,5623.0,2547.0,69198.0
Amritsar,14.12.1,OPD attendance (All),TOTAL,109087.0,118898.0,131419.0,120766.0,126858.0,115589.0,104250.0,110359.0,118910.0,101368.0,105579.0,111039.0,1374122.0
Amritsar,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,593.0,669.0,611.0,400.0,763.0,867.0,781.0,797.0,641.0,696.0,390.0,649.0,7857.0
Amritsar,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,4.0,9.0,15.0,13.0,6.0,34.0,8.0,7.0,0.0,2.0,4.0,3.0,105.0
Amritsar,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,1706.0,2034.0,2173.0,742.0,1233.0,1336.0,935.0,808.0,886.0,906.0,665.0,1848.0,15272.0
Amritsar,14.14.a,Number of patients given AYUSH treatment,TOTAL,6046.0,6227.0,7219.0,8836.0,10273.0,9466.0,8962.0,8898.0,9287.0,8351.0,7204.0,8867.0,99636.0
Amritsar,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,2873.0,3920.0,3106.0,4274.0,3691.0,4065.0,3660.0,3816.0,3718.0,3608.0,2684.0,3387.0,42802.0
Amritsar,14.14.c,Number of Adolescents counselled,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Amritsar,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,14050.0,17536.0,15258.0,12547.0,14319.0,27565.0,11228.0,10819.0,9568.0,11259.0,12061.0,13180.0,169390.0
Amritsar,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,739.0,608.0,800.0,647.0,821.0,588.0,796.0,584.0,473.0,696.0,685.0,650.0,8087.0
Amritsar,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,714.0,706.0,714.0,855.0,811.0,770.0,666.0,691.0,941.0,726.0,663.0,527.0,8784.0
Amritsar,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,27.0,17.0,23.0,25.0,29.0,17.0,19.0,13.0,15.0,7.0,25.0,13.0,230.0
Amritsar,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,1154.0,1226.0,1361.0,853.0,1375.0,1293.0,967.0,957.0,805.0,924.0,921.0,650.0,12486.0
Amritsar,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,8.0,8.0,8.0,7.0,7.0,6.0,4.0,7.0,5.0,4.0,3.0,2.0,69.0
Amritsar,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,3394.0,3619.0,2570.0,2551.0,3104.0,2351.0,1767.0,2393.0,2163.0,2288.0,2192.0,1854.0,30246.0
Amritsar,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,6.0,3.0,3.0,2.0,3.0,5.0,2.0,3.0,1.0,6.0,1.0,2.0,37.0
Amritsar,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,5262.0,5551.0,4645.0,4259.0,5290.0,4414.0,3400.0,4041.0,3909.0,3938.0,3776.0,3031.0,51516.0
Amritsar,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,41.0,28.0,34.0,34.0,39.0,28.0,25.0,23.0,21.0,17.0,29.0,17.0,336.0
Amritsar,15.2,Number of Widal tests conducted,Number tested,1188.0,1348.0,1521.0,1710.0,1843.0,1729.0,1314.0,1115.0,762.0,825.0,1445.0,1318.0,16118.0
Amritsar,15.3.a,Number of VDRL tests conducted on males,Number tested,117.0,169.0,354.0,210.0,193.0,121.0,170.0,191.0,218.0,164.0,215.0,127.0,2249.0
Amritsar,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,369.0,485.0,191.0,207.0,244.0,142.0,266.0,418.0,211.0,285.0,331.0,170.0,3319.0
Amritsar,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,2474.0,2728.0,2122.0,2684.0,2297.0,2175.0,1666.0,2276.0,1827.0,2278.0,2536.0,2538.0,27601.0
Amritsar,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,2960.0,3382.0,2667.0,3101.0,2734.0,2438.0,2102.0,2885.0,2256.0,2727.0,3082.0,2835.0,33169.0
Amritsar,15.4.1,Number of blood smears examined for Malaria,TOTAL,15195.0,19532.0,17108.0,15616.0,12845.0,14183.0,17751.0,21671.0,14318.0,9498.0,10923.0,12890.0,181530.0
Amritsar,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,4.0,3.0,4.0,1.0,3.0,6.0,3.0,1.0,0.0,0.0,0.0,0.0,25.0
Amritsar,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Amritsar,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,22460.0,11660.0,15760.0,31000.0,39910.0,32610.0,31530.0,37780.0,19180.0,16690.0,16850.0,11450.0,286880.0
Amritsar,16.1.1,Stock position of DPT vaccines,2. Stocks Received,10000.0,25000.0,35000.0,30000.0,10000.0,20000.0,20000.0,0.0,15000.0,20000.0,10000.0,20000.0,215000.0
Amritsar,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Amritsar,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,20800.0,20900.0,19760.0,21090.0,17300.0,21080.0,13750.0,18600.0,17490.0,19840.0,15400.0,10050.0,216060.0
Amritsar,16.1.1,Stock position of DPT vaccines,5. Total Stock,11660.0,15760.0,31000.0,39910.0,32610.0,31530.0,37780.0,19180.0,16690.0,16850.0,11450.0,21400.0,285820.0
Amritsar,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,18150.0,22750.0,40900.0
Amritsar,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,30000.0,10000.0,5000.0,45000.0
Amritsar,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,,,,,,,,,,,,,
Amritsar,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,11850.0,5400.0,7150.0,24400.0
Amritsar,16.1.1A,Stock Position of Pentavalent,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,18150.0,22750.0,20600.0,61500.0
Amritsar,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,17540.0,14840.0,13940.0,15400.0,19700.0,22400.0,3080.0,15220.0,18920.0,18080.0,1700.0,7320.0,168140.0
Amritsar,16.1.2,Stock position of OPV vaccines,2. Stocks Received,20000.0,30000.0,30000.0,30000.0,25000.0,5000.0,30000.0,24000.0,25000.0,10000.0,21920.0,36200.0,287120.0
Amritsar,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,,,,,,,,,,,,,
Amritsar,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,22700.0,30900.0,28540.0,25700.0,22300.0,24320.0,17860.0,20300.0,25840.0,26380.0,16300.0,18000.0,279140.0
Amritsar,16.1.2,Stock position of OPV vaccines,5. Total Stock,14840.0,13940.0,15400.0,19700.0,22400.0,3080.0,15220.0,18920.0,18080.0,1700.0,7320.0,25520.0,176120.0
Amritsar,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,17200.0,13650.0,12950.0,28500.0,39520.0,31620.0,36520.0,32320.0,15270.0,16870.0,19560.0,16840.0,280820.0
Amritsar,16.1.3,Stock position of TT vaccines,2. Stocks Received,10000.0,20000.0,30000.0,30000.0,10000.0,20000.0,5000.0,0.0,15000.0,20000.0,10000.0,10000.0,180000.0
Amritsar,16.1.3,Stock position of TT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Amritsar,16.1.3,Stock position of TT vaccines,4. Stock Distributed,13550.0,20700.0,14450.0,18980.0,17900.0,15100.0,9200.0,17050.0,13400.0,17310.0,12720.0,3300.0,173660.0
Amritsar,16.1.3,Stock position of TT vaccines,5. Total Stock,13650.0,12950.0,28500.0,39520.0,31620.0,36520.0,32320.0,15270.0,16870.0,19560.0,16840.0,23540.0,287160.0
Amritsar,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Amritsar,16.1.4,Stock position of DT vaccines,2. Stocks Received,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Amritsar,16.1.4,Stock position of DT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Amritsar,16.1.4,Stock position of DT vaccines,4. Stock Distributed,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Amritsar,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Amritsar,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,12120.0,9970.0,11420.0,10850.0,13730.0,11990.0,14470.0,12880.0,10160.0,10960.0,11120.0,9870.0,139540.0
Amritsar,16.1.5,Stock position of BCG vaccines,2. Stocks Received,5000.0,10000.0,7000.0,10000.0,5000.0,10000.0,5000.0,5000.0,8000.0,8000.0,5000.0,8000.0,86000.0
Amritsar,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,,,,,,,,,,,,,
Amritsar,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,7150.0,8550.0,7570.0,7120.0,6740.0,7520.0,6590.0,7720.0,7200.0,7840.0,6250.0,5450.0,85700.0
Amritsar,16.1.5,Stock position of BCG vaccines,5. Total Stock,9970.0,11420.0,10850.0,13730.0,11990.0,14470.0,12880.0,10160.0,10960.0,11120.0,9870.0,12420.0,139840.0
Amritsar,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,6960.0,10160.0,10350.0,16330.0,16170.0,13460.0,3910.0,6370.0,7530.0,9840.0,10020.0,6120.0,117220.0
Amritsar,16.1.6,Stock position of Measles vaccines,2. Stocks Received,10000.0,10000.0,15000.0,10000.0,5000.0,1000.0,9000.0,10000.0,10000.0,10000.0,5000.0,10000.0,105000.0
Amritsar,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,,,,,,,,,,,,,
Amritsar,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,6800.0,9810.0,9020.0,10160.0,7710.0,10550.0,6540.0,8840.0,7690.0,9820.0,8900.0,6000.0,101840.0
Amritsar,16.1.6,Stock position of Measles vaccines,5. Total Stock,10160.0,10350.0,16330.0,16170.0,13460.0,3910.0,6370.0,7530.0,9840.0,10020.0,6120.0,10120.0,120380.0
Amritsar,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,0.0,0.0,0.0,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Amritsar,16.1.7,Stock position of JE vaccines,2. Stocks Received,0.0,0.0,0.0,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Amritsar,16.1.7,Stock position of JE vaccines,3. Unusable Stock,,,,,,,,,,,,,
Amritsar,16.1.7,Stock position of JE vaccines,4. Stock Distributed,0.0,0.0,0.0,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Amritsar,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Amritsar,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,17720.0,15720.0,15670.0,20310.0,32990.0,28730.0,14960.0,22540.0,5990.0,12060.0,260.0,1200.0,188150.0
Amritsar,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,15000.0,20000.0,20000.0,30000.0,10000.0,5000.0,20000.0,0.0,15000.0,2000.0,5000.0,20000.0,162000.0
Amritsar,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,,,,,,,,,,,,,
Amritsar,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,17000.0,20050.0,15360.0,17320.0,14260.0,18770.0,12420.0,16550.0,8930.0,13800.0,4060.0,3310.0,161830.0
Amritsar,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,15720.0,15670.0,20310.0,32990.0,28730.0,14960.0,22540.0,5990.0,12060.0,260.0,1200.0,17890.0,188320.0
Amritsar,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,5847.0,5147.0,4147.0,3097.0,3097.0,,,,,,,,21335.0
Amritsar,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,,,,,,,,0.0
Amritsar,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Amritsar,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,700.0,1000.0,1050.0,0.0,1200.0,,,,,,,,3950.0
Amritsar,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,5147.0,4147.0,3097.0,3097.0,1897.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,17385.0
Amritsar,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,149580.0,95580.0,35580.0,0.0,0.0,,,,,,,,280740.0
Amritsar,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,800000.0,,,,,,,,800000.0
Amritsar,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Amritsar,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,54000.0,60000.0,35580.0,0.0,700000.0,,,,,,,,849580.0
Amritsar,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,95580.0,35580.0,0.0,0.0,100000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,231160.0
Amritsar,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,,,,,,,,0.0
Amritsar,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,,,,,,,,0.0
Amritsar,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Amritsar,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,,,,,,,,0.0
Amritsar,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Amritsar,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,,,,,,,,0.0
Amritsar,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,1500.0,,,,,,,,1500.0
Amritsar,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Amritsar,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,0.0,1400.0,,,,,,,,1400.0
Amritsar,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,100.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,100.0
Amritsar,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,5000.0,4500.0,4500.0,4500.0,4500.0,,,,,,,,23000.0
Amritsar,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,,,,,,,,0.0
Amritsar,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Amritsar,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,500.0,0.0,0.0,0.0,0.0,,,,,,,,500.0
Amritsar,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,4500.0,4500.0,4500.0,4500.0,4500.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,22500.0
Amritsar,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,0.0,0.0,,,,,,,,,,,0.0
Amritsar,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,0.0,0.0,,,,,,,,,,,0.0
Amritsar,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,,,,,,,,,,,,,
Amritsar,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,0.0,0.0,,,,,,,,,,,0.0
Amritsar,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Amritsar,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,0.0,0.0,,,,,,,,,,,0.0
Amritsar,16.3.02,Stock Position of Gloves,2. Stocks Received,0.0,0.0,,,,,,,,,,,0.0
Amritsar,16.3.02,Stock Position of Gloves,3. Unusable Stock,,,,,,,,,,,,,
Amritsar,16.3.02,Stock Position of Gloves,4. Stock Distributed,0.0,0.0,,,,,,,,,,,0.0
Amritsar,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Amritsar,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,0.0,0.0,,,,,,,,,,,0.0
Amritsar,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,0.0,0.0,,,,,,,,,,,0.0
Amritsar,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,,,,,,,,,,,,,
Amritsar,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,0.0,0.0,,,,,,,,,,,0.0
Amritsar,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Amritsar,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,0.0,0.0,,,,,,,,,,,0.0
Amritsar,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,0.0,0.0,,,,,,,,,,,0.0
Amritsar,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,,,,,,,,,,,,,
Amritsar,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,0.0,0.0,,,,,,,,,,,0.0
Amritsar,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Amritsar,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,0.0,0.0,,,,,,,,,,,0.0
Amritsar,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,0.0,0.0,,,,,,,,,,,0.0
Amritsar,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,,,,,,,,,,,,,
Amritsar,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,0.0,0.0,,,,,,,,,,,0.0
Amritsar,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Amritsar,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,0.0,0.0,,,,,,,,,,,0.0
Amritsar,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,0.0,0.0,,,,,,,,,,,0.0
Amritsar,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,,,,,,,,,,,,,
Amritsar,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,0.0,0.0,,,,,,,,,,,0.0
Amritsar,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Amritsar,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,0.0,0.0,,,,,,,,,,,0.0
Amritsar,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,0.0,0.0,,,,,,,,,,,0.0
Amritsar,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,,,,,,,,,,,,,
Amritsar,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,0.0,0.0,,,,,,,,,,,0.0
Amritsar,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Amritsar,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,0.0,0.0,,,,,,,,,,,0.0
Amritsar,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,0.0,0.0,,,,,,,,,,,0.0
Amritsar,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,,,,,,,,,,,,,
Amritsar,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,0.0,0.0,,,,,,,,,,,0.0
Amritsar,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Amritsar,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,0.0,0.0,,,,,,,,,,,0.0
Amritsar,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,0.0,0.0,,,,,,,,,,,0.0
Amritsar,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,,,,,,,,,,,,,
Amritsar,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,0.0,0.0,,,,,,,,,,,0.0
Amritsar,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Amritsar,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,0.0,0.0,,,,,,,,,,,0.0
Amritsar,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,0.0,0.0,,,,,,,,,,,0.0
Amritsar,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,,,,,,,,,,,,,
Amritsar,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,0.0,0.0,,,,,,,,,,,0.0
Amritsar,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Amritsar,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,0.0,0.0,,,,,,,,,,,0.0
Amritsar,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,0.0,0.0,,,,,,,,,,,0.0
Amritsar,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,,,,,,,,,,,,,
Amritsar,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,0.0,0.0,,,,,,,,,,,0.0
Amritsar,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Amritsar,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,4010.0,4310.0,4110.0,310.0,110.0,3510.0,2210.0,8410.0,4510.0,1460.0,10.0,7810.0,40770.0
Amritsar,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,4000.0,4000.0,0.0,0.0,4000.0,2000.0,10000.0,0.0,0.0,0.0,10000.0,10000.0,44000.0
Amritsar,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,,
Amritsar,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,3700.0,4200.0,3800.0,200.0,600.0,3300.0,3800.0,3900.0,3050.0,1450.0,2200.0,3300.0,33500.0
Amritsar,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,4310.0,4110.0,310.0,110.0,3510.0,2210.0,8410.0,4510.0,1460.0,10.0,7810.0,14510.0,51270.0
Amritsar,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,66800.0,125800.0,107400.0,67000.0,38600.0,32600.0,30600.0,6600.0,24600.0,19600.0,44200.0,5800.0,569600.0
Amritsar,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,100000.0,50000.0,0.0,0.0,20000.0,40000.0,0.0,40000.0,20000.0,40000.0,0.0,20000.0,330000.0
Amritsar,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,,
Amritsar,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,41000.0,68400.0,40400.0,28400.0,26000.0,42000.0,24000.0,22000.0,25000.0,15400.0,38400.0,4600.0,375600.0
Amritsar,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,125800.0,107400.0,67000.0,38600.0,32600.0,30600.0,6600.0,24600.0,19600.0,44200.0,5800.0,21200.0,524000.0
Amritsar,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,3200.0,2300.0,6400.0,5000.0,3700.0,4600.0,3400.0,10700.0,9000.0,7800.0,7000.0,10100.0,73200.0
Amritsar,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,0.0,4800.0,0.0,0.0,2400.0,0.0,9600.0,0.0,0.0,0.0,4800.0,2400.0,24000.0
Amritsar,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,,,,,,,,,,,,,
Amritsar,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,900.0,700.0,1400.0,1300.0,1500.0,1200.0,2300.0,1700.0,1200.0,800.0,1700.0,900.0,15600.0
Amritsar,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,2300.0,6400.0,5000.0,3700.0,4600.0,3400.0,10700.0,9000.0,7800.0,7000.0,10100.0,11600.0,81600.0
Amritsar,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,2.0,5.0,1.0,2.0,,,,1.0,,,,,11.0
Amritsar,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Amritsar,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Amritsar,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,,,,,,,,,,,,
Amritsar,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,,1.0,,1.0,1.0,,1.0,,,2.0,1.0,,7.0
Amritsar,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,1.0,,,,,,1.0
Amritsar,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,,1.0,,1.0,1.0,,2.0,,,2.0,1.0,,8.0
Amritsar,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,,,,,,1.0,2.0,2.0,1.0,1.0,,1.0,8.0
Amritsar,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,2.0,,1.0,1.0,,,,,,,4.0
Amritsar,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,,,2.0,,1.0,2.0,2.0,2.0,1.0,1.0,,1.0,12.0
Amritsar,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,8.0,6.0,9.0,15.0,10.0,13.0,11.0,12.0,9.0,8.0,5.0,3.0,109.0
Amritsar,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,3.0,8.0,6.0,,9.0,3.0,6.0,4.0,2.0,1.0,,2.0,44.0
Amritsar,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,11.0,14.0,15.0,15.0,19.0,16.0,17.0,16.0,11.0,9.0,5.0,5.0,153.0
Amritsar,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,1.0,1.0,,2.0,,,,2.0,5.0,3.0,4.0,,18.0
Amritsar,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,1.0,,,,,,1.0,,2.0,,4.0
Amritsar,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,1.0,1.0,1.0,2.0,,,,2.0,6.0,3.0,6.0,,22.0
Amritsar,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,4.0,3.0,2.0,3.0,3.0,5.0,5.0,1.0,,,1.0,,27.0
Amritsar,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,2.0,1.0,,,,,,,1.0,,,4.0
Amritsar,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,4.0,5.0,3.0,3.0,3.0,5.0,5.0,1.0,,1.0,1.0,,31.0
Amritsar,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,5.0,1.0,3.0,2.0,3.0,1.0,3.0,2.0,1.0,1.0,22.0
Amritsar,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,1.0,2.0,,3.0,2.0,,1.0,2.0,3.0,,14.0
Amritsar,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,,6.0,3.0,3.0,5.0,5.0,1.0,4.0,4.0,4.0,1.0,36.0
Amritsar,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,1.0,,,,,,,,1.0
Amritsar,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Amritsar,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,1.0,,,,,,,,1.0
Amritsar,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,3.0,7.0,16.0,6.0,5.0,3.0,13.0,3.0,,1.0,3.0,7.0,67.0
Amritsar,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,5.0,11.0,5.0,,4.0,3.0,8.0,8.0,1.0,7.0,5.0,2.0,59.0
Amritsar,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,8.0,18.0,21.0,6.0,9.0,6.0,21.0,11.0,1.0,8.0,8.0,9.0,126.0
Amritsar,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,1.0,1.0,,,,,1.0,,1.0,,4.0
Amritsar,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,3.0,1.0,3.0,1.0,3.0,1.0,3.0,1.0,1.0,1.0,18.0
Amritsar,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,3.0,2.0,2.0,5.0,1.0,2.0,4.0,2.0,,21.0
Amritsar,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,4.0,5.0,5.0,3.0,8.0,2.0,6.0,5.0,4.0,1.0,43.0
Amritsar,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,1.0,,,,1.0,,,,,,2.0
Amritsar,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,4.0,10.0,11.0,13.0,8.0,6.0,6.0,7.0,8.0,9.0,11.0,7.0,100.0
Amritsar,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,7.0,2.0,7.0,3.0,2.0,2.0,3.0,4.0,2.0,6.0,5.0,6.0,49.0
Amritsar,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,11.0,12.0,19.0,16.0,10.0,8.0,10.0,11.0,10.0,15.0,16.0,13.0,151.0
Amritsar,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,1.0,2.0,,,,,,,,2.0,5.0
Amritsar,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,,,7.0,2.0,7.0,2.0,6.0,2.0,5.0,2.0,3.0,3.0,39.0
Amritsar,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,,,4.0,6.0,2.0,1.0,7.0,2.0,2.0,3.0,1.0,4.0,32.0
Amritsar,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,,,12.0,10.0,9.0,3.0,13.0,4.0,7.0,5.0,4.0,9.0,76.0
Amritsar,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
Amritsar,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,,,,1.0,,,,1.0
Amritsar,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
Amritsar,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,,,,,,1.0,,,,1.0
Amritsar,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,1.0,4.0,,3.0,4.0,1.0,2.0,1.0,2.0,1.0,2.0,21.0
Amritsar,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,15.0,15.0,18.0,17.0,13.0,19.0,27.0,13.0,11.0,20.0,33.0,12.0,213.0
Amritsar,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,46.0,41.0,85.0,29.0,39.0,45.0,41.0,35.0,52.0,71.0,67.0,28.0,579.0
Amritsar,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,61.0,57.0,107.0,46.0,55.0,68.0,69.0,50.0,64.0,93.0,101.0,42.0,813.0
Amritsar,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
Amritsar,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,2.0,3.0,3.0,,2.0,,1.0,1.0,1.0,1.0,14.0
Amritsar,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,1.0,,,,,,1.0
Amritsar,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,2.0,3.0,3.0,,3.0,,1.0,1.0,1.0,1.0,15.0
Amritsar,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,1.0,2.0,1.0,1.0,,1.0,3.0,,2.0,,3.0,14.0
Amritsar,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,81.0,98.0,108.0,98.0,106.0,88.0,108.0,107.0,109.0,146.0,124.0,102.0,1275.0
Amritsar,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,156.0,199.0,237.0,198.0,189.0,169.0,201.0,185.0,215.0,287.0,219.0,188.0,2443.0
Amritsar,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,237.0,298.0,347.0,297.0,296.0,257.0,310.0,295.0,324.0,435.0,343.0,293.0,3732.0
Amritsar,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,1.0,,,,,,,,,1.0
Amritsar,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,4.0,4.0,2.0,4.0,,3.0,3.0,3.0,2.0,2.0,2.0,,29.0
Amritsar,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,6.0,1.0,5.0,3.0,4.0,3.0,6.0,3.0,2.0,10.0,3.0,7.0,53.0
Amritsar,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,10.0,5.0,7.0,8.0,4.0,6.0,9.0,6.0,4.0,12.0,5.0,7.0,83.0
Amritsar,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Amritsar,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,1.0,1.0,1.0,,,,,,,,,,3.0
Amritsar,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Amritsar,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,1.0,1.0,1.0,,,,,,,,,,3.0
Amritsar,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Amritsar,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,,,,,,,,
Amritsar,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Amritsar,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,,,,,,,,
Amritsar,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Amritsar,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,1.0,2.0,3.0,3.0,2.0,2.0,1.0,4.0,1.0,1.0,1.0,,21.0
Amritsar,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Amritsar,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,1.0,2.0,3.0,3.0,2.0,2.0,1.0,4.0,1.0,1.0,1.0,,21.0
Amritsar,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Amritsar,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,1.0,,,,,,,2.0,4.0,,7.0
Amritsar,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Amritsar,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,1.0,,,,,,,2.0,4.0,,7.0
Amritsar,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Amritsar,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,1.0,1.0,,,,,,1.0,,3.0
Amritsar,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Amritsar,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,1.0,1.0,,,,,,1.0,,3.0
Amritsar,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Amritsar,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,3.0,3.0,5.0,8.0,7.0,6.0,6.0,5.0,7.0,1.0,13.0,1.0,65.0
Amritsar,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Amritsar,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,3.0,3.0,5.0,8.0,7.0,6.0,6.0,5.0,7.0,1.0,13.0,1.0,65.0
Amritsar,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,,5.0,3.0,1.0,2.0,2.0,3.0,3.0,,4.0,3.0,26.0
Amritsar,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,,,50.0,54.0,37.0,33.0,36.0,38.0,37.0,37.0,22.0,31.0,375.0
Amritsar,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,,,20.0,7.0,8.0,7.0,6.0,9.0,11.0,5.0,5.0,5.0,83.0
Amritsar,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,,,75.0,64.0,46.0,42.0,44.0,50.0,51.0,42.0,31.0,39.0,484.0
Amritsar,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,1.0,,,,1.0,,,,,,,2.0
Amritsar,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,2.0,8.0,7.0,9.0,14.0,2.0,7.0,3.0,5.0,1.0,5.0,5.0,68.0
Amritsar,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,1.0,4.0,,,1.0,,3.0,,,,,,9.0
Amritsar,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,3.0,13.0,7.0,9.0,15.0,3.0,10.0,3.0,5.0,1.0,5.0,5.0,79.0
Amritsar,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,,,1.0,,,,,,,1.0
Amritsar,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,1.0,,3.0,3.0,5.0,1.0,,,,,1.0,14.0
Amritsar,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,1.0,1.0,4.0,1.0,1.0,1.0,,,,,9.0
Amritsar,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,,1.0,1.0,4.0,7.0,7.0,2.0,1.0,,,,1.0,24.0
Amritsar,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,,,,,,,,,,,
Amritsar,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,2.0,2.0,8.0,1.0,3.0,2.0,2.0,2.0,4.0,,2.0,4.0,32.0
Amritsar,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,5.0,3.0,12.0,1.0,3.0,6.0,9.0,6.0,2.0,1.0,3.0,10.0,61.0
Amritsar,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,7.0,5.0,20.0,2.0,6.0,8.0,11.0,8.0,6.0,1.0,5.0,14.0,93.0
Amritsar,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,1.0,1.0,,4.0,1.0,2.0,2.0,,,3.0,1.0,,15.0
Amritsar,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,23.0,33.0,27.0,39.0,33.0,42.0,31.0,43.0,42.0,40.0,36.0,31.0,420.0
Amritsar,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,45.0,38.0,70.0,48.0,65.0,74.0,47.0,64.0,68.0,95.0,56.0,58.0,728.0
Amritsar,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,69.0,72.0,97.0,91.0,99.0,118.0,80.0,107.0,110.0,138.0,93.0,89.0,1163.0
Amritsar,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,3.0,3.0,2.0,1.0,3.0,6.0,3.0,2.0,2.0,3.0,1.0,2.0,31.0
Amritsar,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,49.0,64.0,55.0,64.0,63.0,34.0,59.0,23.0,40.0,40.0,60.0,50.0,601.0
Amritsar,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,160.0,190.0,236.0,172.0,196.0,182.0,215.0,152.0,143.0,149.0,139.0,120.0,2054.0
Amritsar,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,212.0,257.0,293.0,237.0,262.0,222.0,277.0,177.0,185.0,192.0,200.0,172.0,2686.0
Barnala,1.1,Total number of pregnant women Registered for ANC,TOTAL,874.0,945.0,764.0,756.0,747.0,648.0,579.0,572.0,608.0,743.0,707.0,728.0,8671.0
Barnala,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,569.0,638.0,564.0,539.0,550.0,483.0,483.0,434.0,496.0,602.0,577.0,591.0,6526.0
Barnala,1.2,Number of Pregnant women registered under JSY,TOTAL,339.0,378.0,312.0,267.0,305.0,253.0,205.0,237.0,271.0,319.0,291.0,300.0,3477.0
Barnala,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,575.0,778.0,714.0,754.0,732.0,707.0,656.0,620.0,592.0,558.0,524.0,528.0,7738.0
Barnala,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,833.0,926.0,731.0,736.0,699.0,610.0,533.0,571.0,556.0,657.0,648.0,684.0,8184.0
Barnala,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,858.0,839.0,764.0,737.0,727.0,631.0,603.0,558.0,536.0,542.0,581.0,613.0,7989.0
Barnala,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,731.0,825.0,757.0,726.0,701.0,680.0,684.0,636.0,525.0,487.0,525.0,548.0,7825.0
Barnala,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,16.0,9.0,13.0,6.0,7.0,12.0,3.0,3.0,11.0,13.0,10.0,6.0,109.0
Barnala,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,0.0,0.0,0.0,,1.0,,0.0,4.0,2.0,2.0,1.0,2.0,12.0
Barnala,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,727.0,851.0,729.0,657.0,715.0,538.0,518.0,502.0,559.0,593.0,584.0,510.0,7483.0
Barnala,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,8.0,8.0,9.0,12.0,10.0,6.0,7.0,9.0,8.0,11.0,9.0,1.0,98.0
Barnala,1.8,Number of pregnancy test kits used at SC level,TOTAL,227.0,447.0,376.0,328.0,482.0,358.0,323.0,219.0,297.0,259.0,277.0,287.0,3880.0
Barnala,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,6.0,22.0,13.0,19.0,27.0,25.0,16.0,30.0,31.0,23.0,9.0,15.0,236.0
Barnala,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,2.0,3.0,14.0,4.0,4.0,2.0,3.0,5.0,2.0,3.0,3.0,2.0,47.0
Barnala,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,8.0,25.0,27.0,23.0,31.0,27.0,19.0,35.0,33.0,26.0,12.0,17.0,283.0
Barnala,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,1.0,17.0,12.0,14.0,28.0,25.0,18.0,33.0,27.0,22.0,4.0,13.0,214.0
Barnala,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Barnala,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,295.0,307.0,374.0,454.0,483.0,496.0,514.0,440.0,496.0,469.0,359.0,369.0,5056.0
Barnala,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,242.0,253.0,328.0,402.0,346.0,295.0,296.0,276.0,311.0,38.0,164.0,188.0,3139.0
Barnala,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,96.0,92.0,121.0,145.0,144.0,107.0,82.0,99.0,102.0,69.0,140.0,81.0,1278.0
Barnala,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Barnala,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Barnala,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,178.0,140.0,215.0,250.0,313.0,332.0,264.0,278.0,298.0,264.0,200.0,115.0,2847.0
Barnala,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,5.0,,3.0,5.0,5.0,1.0,2.0,1.0,1.0,,3.0,26.0
Barnala,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,,,,,0.0,0.0,0.0,,,,0.0
Barnala,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,,,,,0.0,0.0,0.0,,,,0.0
Barnala,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Barnala,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,0.0,0.0,2.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0
Barnala,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,43.0,54.0,44.0,52.0,77.0,78.0,78.0,60.0,63.0,66.0,62.0,59.0,736.0
Barnala,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Barnala,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,43.0,54.0,46.0,52.0,77.0,78.0,78.0,60.0,63.0,66.0,62.0,59.0,738.0
Barnala,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,27.0,19.0,36.0,25.0,41.0,54.0,37.0,51.0,47.0,10.0,15.0,17.0,379.0
Barnala,4.1.1.a,Number of male live births,TOTAL,270.0,268.0,328.0,395.0,442.0,446.0,437.0,388.0,440.0,413.0,320.0,242.0,4389.0
Barnala,4.1.1.b,Number of female live births,TOTAL,205.0,202.0,289.0,324.0,383.0,405.0,355.0,360.0,386.0,342.0,247.0,255.0,3753.0
Barnala,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,475.0,470.0,617.0,719.0,825.0,851.0,792.0,748.0,826.0,755.0,567.0,497.0,8142.0
Barnala,4.1.2,Number of still births,TOTAL,7.0,3.0,5.0,12.0,5.0,6.0,6.0,9.0,6.0,6.0,7.0,5.0,77.0
Barnala,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,43.0,48.0,30.0,21.0,27.0,29.0,31.0,30.0,16.0,25.0,13.0,22.0,335.0
Barnala,4.2.1,Number of Newborns weighed at birth,TOTAL,468.0,463.0,614.0,717.0,821.0,849.0,790.0,734.0,826.0,754.0,562.0,497.0,8095.0
Barnala,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,50.0,42.0,49.0,73.0,36.0,104.0,49.0,46.0,33.0,52.0,19.0,29.0,582.0
Barnala,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,399.0,393.0,534.0,639.0,704.0,715.0,670.0,627.0,715.0,677.0,562.0,424.0,7059.0
Barnala,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Barnala,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Barnala,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,10.0,13.0,28.0,33.0,41.0,35.0,28.0,49.0,50.0,62.0,54.0,36.0,439.0
Barnala,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Barnala,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,10.0,13.0,28.0,33.0,41.0,35.0,28.0,49.0,50.0,62.0,54.0,36.0,439.0
Barnala,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,0.0,0.0,,,,,,0.0,,,0.0,,0.0
Barnala,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,5.0,9.0,6.0,12.0,7.0,5.0,8.0,19.0,25.0,34.0,12.0,13.0,155.0
Barnala,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,6.0,7.0,1.0,0.0,0.0,0.0,1.0,3.0,2.0,9.0,3.0,5.0,37.0
Barnala,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,7.0,12.0,0.0,0.0,0.0,3.0,6.0,7.0,8.0,10.0,21.0,16.0,90.0
Barnala,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,2.0,8.0,27.0,32.0,40.0,34.0,26.0,49.0,50.0,62.0,54.0,36.0,420.0
Barnala,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,412.0,387.0,523.0,659.0,649.0,632.0,318.0,341.0,346.0,287.0,217.0,253.0,5024.0
Barnala,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,70.0,73.0,82.0,77.0,173.0,223.0,218.0,145.0,189.0,214.0,188.0,165.0,1817.0
Barnala,6.3,PNC maternal complications attended,TOTAL,1.0,0.0,1.0,2.0,4.0,1.0,1.0,0.0,0.0,0.0,0.0,2.0,12.0
Barnala,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,2.0,7.0,3.0,1.0,3.0,6.0,1.0,1.0,3.0,1.0,1.0,0.0,29.0
Barnala,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Barnala,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,2.0,7.0,3.0,1.0,3.0,6.0,1.0,1.0,3.0,1.0,1.0,0.0,29.0
Barnala,7.2,Number of MTPs conducted at Private Facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Barnala,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,25.0,19.0,16.0,72.0,58.0,48.0,34.0,0.0,15.0,1.0,3.0,5.0,296.0
Barnala,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,152.0,98.0,57.0,119.0,58.0,51.0,52.0,19.0,46.0,27.0,36.0,83.0,798.0
Barnala,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,177.0,117.0,73.0,191.0,116.0,99.0,86.0,19.0,61.0,28.0,39.0,88.0,1094.0
Barnala,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Barnala,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Barnala,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Barnala,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,3.0,2.0,0.0,,,,,11.0,8.0,0.0,,,24.0
Barnala,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Barnala,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,3.0,2.0,0.0,0.0,0.0,0.0,0.0,11.0,8.0,0.0,0.0,0.0,24.0
Barnala,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,0.0,0.0,,,,,,,,,,,0.0
Barnala,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,12.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,12.0
Barnala,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,13.0,136.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,149.0
Barnala,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,8.0,,,,,,,,,8.0
Barnala,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Barnala,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,13.0,136.0,0.0,20.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,169.0
Barnala,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,0.0,0.0,,,,,,,,,,,0.0
Barnala,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,3.0,11.0,0.0,0.0,0.0,0.0,0.0,0.0,14.0
Barnala,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,42.0,118.0,197.0,69.0,69.0,30.0,7.0,5.0,13.0,10.0,21.0,11.0,592.0
Barnala,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,22.0,56.0,114.0,24.0,44.0,24.0,8.0,18.0,11.0,7.0,13.0,23.0,364.0
Barnala,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Barnala,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,64.0,174.0,311.0,93.0,116.0,65.0,15.0,23.0,24.0,17.0,34.0,34.0,970.0
Barnala,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,0.0,0.0,,,,,,,,,,,0.0
Barnala,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0
Barnala,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,4.0,4.0
Barnala,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,11.0,11.0,0.0,10.0,10.0,17.0,7.0,7.0,5.0,11.0,10.0,5.0,104.0
Barnala,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Barnala,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,11.0,11.0,0.0,10.0,10.0,19.0,7.0,7.0,5.0,11.0,10.0,9.0,110.0
Barnala,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,0.0,0.0,,,,,,,,,,,0.0
Barnala,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,293.0,289.0,270.0,416.0,280.0,308.0,286.0,268.0,224.0,231.0,234.0,178.0,3277.0
Barnala,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,3.0,0.0,0.0,3.0,0.0,12.0,29.0,12.0,23.0,15.0,19.0,6.0,122.0
Barnala,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,8.0,13.0,14.0,8.0,11.0,39.0,32.0,20.0,36.0,39.0,30.0,8.0,258.0
Barnala,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,102.0,133.0,157.0,210.0,104.0,138.0,150.0,124.0,101.0,135.0,159.0,174.0,1687.0
Barnala,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Barnala,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,406.0,435.0,441.0,637.0,395.0,497.0,497.0,424.0,384.0,420.0,442.0,366.0,5344.0
Barnala,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,30.0,62.0,62.0,41.0,40.0,125.0,137.0,95.0,77.0,87.0,132.0,115.0,1003.0
Barnala,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,0.0,0.0,,,,,,,,,,,0.0
Barnala,9.06,Number of IUCD removals,TOTAL,67.0,43.0,66.0,52.0,46.0,58.0,57.0,36.0,55.0,41.0,39.0,30.0,590.0
Barnala,9.07,Number of Oral Pills cycles distributed,TOTAL,1792.0,1644.0,1805.0,1197.0,1886.0,2433.0,1511.0,1718.0,2052.0,1683.0,2068.0,1536.0,21325.0
Barnala,9.08,Number of Condom pieces distributed,TOTAL,49595.0,50356.0,47885.0,37005.0,42977.0,34011.0,42527.0,36765.0,27246.0,33849.0,41924.0,34580.0,478720.0
Barnala,9.09,Number of Centchroman (weekly) pills given,TOTAL,0.0,0.0,2.0,0.0,2.0,0.0,2.0,0.0,0.0,0.0,6.0,0.0,12.0
Barnala,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,9.0,72.0,4.0,10.0,21.0,36.0,23.0,15.0,20.0,22.0,15.0,13.0,260.0
Barnala,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Barnala,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Barnala,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Barnala,9.11.2.b,Number of failures following female sterilization,TOTAL,0.0,0.0,0.0,0.0,2.0,0.0,0.0,2.0,0.0,0.0,0.0,0.0,4.0
Barnala,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Barnala,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Barnala,9.12,Number of Institutions having NSV trained doctors,TOTAL,,,1.0,,,,,,,,,,-1.0
Barnala,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,537.0,566.0,520.0,697.0,795.0,753.0,793.0,713.0,840.0,673.0,598.0,583.0,8068.0
Barnala,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,633.0,642.0,495.0,575.0,627.0,655.0,787.0,819.0,740.0,499.0,72.0,10.0,6554.0
Barnala,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,709.0,689.0,568.0,572.0,604.0,603.0,667.0,744.0,768.0,718.0,490.0,114.0,7246.0
Barnala,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,707.0,806.0,635.0,663.0,626.0,554.0,626.0,660.0,722.0,719.0,633.0,454.0,7805.0
Barnala,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,281.0,645.0,572.0,1498.0
Barnala,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,155.0,563.0,718.0
Barnala,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,6.0,196.0,202.0
Barnala,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,341.0,349.0,315.0,157.0,417.0,402.0,494.0,437.0,414.0,483.0,385.0,410.0,4604.0
Barnala,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,633.0,642.0,493.0,575.0,627.0,655.0,787.0,818.0,730.0,661.0,655.0,563.0,7839.0
Barnala,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,709.0,689.0,568.0,572.0,604.0,603.0,667.0,746.0,757.0,718.0,608.0,670.0,7911.0
Barnala,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,707.0,806.0,633.0,661.0,626.0,554.0,626.0,660.0,722.0,719.0,632.0,630.0,7976.0
Barnala,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,290.0,98.0,272.0,342.0,371.0,370.0,464.0,384.0,142.0,423.0,372.0,416.0,3944.0
Barnala,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,633.0,642.0,495.0,576.0,626.0,654.0,786.0,825.0,733.0,502.0,80.0,8.0,6560.0
Barnala,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,709.0,689.0,564.0,569.0,603.0,603.0,669.0,751.0,770.0,718.0,490.0,109.0,7244.0
Barnala,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,707.0,806.0,635.0,663.0,624.0,554.0,626.0,660.0,725.0,719.0,633.0,436.0,7788.0
Barnala,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,651.0,779.0,714.0,756.0,721.0,732.0,697.0,698.0,580.0,546.0,486.0,477.0,7837.0
Barnala,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,820.0,815.0,612.0,673.0,641.0,599.0,586.0,611.0,632.0,641.0,677.0,618.0,7925.0
Barnala,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Barnala,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,339.0,400.0,351.0,360.0,336.0,320.0,318.0,337.0,238.0,233.0,210.0,183.0,3625.0
Barnala,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,258.0,344.0,300.0,309.0,261.0,298.0,296.0,271.0,204.0,215.0,178.0,169.0,3103.0
Barnala,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,597.0,744.0,651.0,669.0,597.0,618.0,614.0,608.0,442.0,448.0,388.0,352.0,6728.0
Barnala,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,820.0,815.0,612.0,673.0,642.0,599.0,586.0,611.0,632.0,641.0,671.0,613.0,7915.0
Barnala,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,820.0,815.0,612.0,673.0,642.0,599.0,586.0,611.0,632.0,641.0,671.0,613.0,7915.0
Barnala,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Barnala,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,7.0,12.0,102.0,35.0,9.0,7.0,9.0,2.0,19.0,27.0,19.0,22.0,270.0
Barnala,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,6.0,9.0,83.0,26.0,10.0,12.0,9.0,3.0,19.0,23.0,20.0,23.0,243.0
Barnala,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,13.0,21.0,185.0,61.0,19.0,19.0,18.0,5.0,38.0,50.0,39.0,45.0,513.0
Barnala,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,271.0,1730.0,454.0,688.0,769.0,515.0,416.0,474.0,354.0,298.0,271.0,311.0,6551.0
Barnala,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,298.0,2934.0,284.0,847.0,924.0,549.0,436.0,495.0,379.0,195.0,211.0,195.0,7747.0
Barnala,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,169.0,2180.0,188.0,581.0,698.0,330.0,474.0,328.0,295.0,172.0,179.0,140.0,5734.0
Barnala,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Barnala,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Barnala,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Barnala,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,314.0,313.0,315.0,307.0,309.0,321.0,319.0,317.0,322.0,315.0,301.0,259.0,3712.0
Barnala,10.4.2,Number of Immunisation sessions held during the month,TOTAL,313.0,313.0,315.0,307.0,309.0,321.0,316.0,316.0,319.0,313.0,293.0,234.0,3669.0
Barnala,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,295.0,278.0,280.0,266.0,274.0,282.0,277.0,270.0,276.0,277.0,250.0,213.0,3238.0
Barnala,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Barnala,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,651.0,779.0,696.0,745.0,736.0,700.0,676.0,693.0,560.0,344.0,441.0,606.0,7627.0
Barnala,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,2306.0,2628.0,2311.0,2387.0,2285.0,2240.0,2263.0,2269.0,2008.0,1208.0,2158.0,1815.0,25878.0
Barnala,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,1538.0,2290.0,2002.0,1951.0,1866.0,1723.0,1878.0,1821.0,1701.0,904.0,1639.0,1304.0,20617.0
Barnala,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Barnala,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Barnala,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Barnala,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Barnala,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Barnala,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Barnala,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Barnala,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Barnala,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Barnala,13.1,Number of Patients operated for cataract,TOTAL,583.0,278.0,197.0,208.0,243.0,378.0,460.0,645.0,265.0,271.0,283.0,432.0,4243.0
Barnala,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,578.0,273.0,193.0,203.0,242.0,377.0,459.0,643.0,265.0,270.0,281.0,432.0,4216.0
Barnala,13.3,Number of School children detected with Refractive errors,TOTAL,92.0,150.0,0.0,340.0,303.0,299.0,432.0,434.0,205.0,169.0,42.0,0.0,2466.0
Barnala,13.4,Number of children provided free glasses,TOTAL,0.0,0.0,228.0,0.0,407.0,405.0,394.0,538.0,10.0,149.0,316.0,0.0,2447.0
Barnala,13.5,Number of eyes collected through eye donation,TOTAL,6.0,2.0,2.0,2.0,0.0,0.0,0.0,0.0,0.0,0.0,4.0,2.0,18.0
Barnala,13.6,Number of eyes utilised for corneal transplant,TOTAL,6.0,2.0,2.0,2.0,0.0,0.0,0.0,0.0,0.0,0.0,4.0,2.0,18.0
Barnala,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,,,1.0,2.0,2.0,2.0,2.0,1.0,2.0,1.0,,1.0,-1.0
Barnala,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,,,1.0,3.0,2.0,3.0,3.0,2.0,1.0,2.0,1.0,1.0,-1.0
Barnala,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,183.0,180.0,194.0,198.0,183.0,186.0,184.0,184.0,180.0,179.0,186.0,148.0,-1.0
Barnala,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,3.0,3.0,2.0,2.0,3.0,3.0,2.0,1.0,2.0,2.0,1.0,1.0,-1.0
Barnala,14.05,Number of RKS meetings held during the month,TOTAL,0.0,0.0,1.0,1.0,1.0,1.0,2.0,,0.0,,1.0,1.0,8.0
Barnala,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,,,2.0,4.0,1.0,2.0,1.0,1.0,,,,,-1.0
Barnala,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,142.0,150.0,206.0,120.0,110.0,88.0,128.0,130.0,107.0,71.0,112.0,120.0,1484.0
Barnala,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,,,,1.0,1.0,1.0,1.0,1.0,,,,,-1.0
Barnala,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,5.0,5.0,1.0,,,,,,,,,,-1.0
Barnala,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,213.0,252.0,247.0,293.0,260.0,274.0,333.0,224.0,233.0,243.0,226.0,201.0,2999.0
Barnala,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,534.0,694.0,867.0,708.0,679.0,648.0,667.0,585.0,523.0,536.0,523.0,596.0,7560.0
Barnala,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,149.0,157.0,184.0,219.0,247.0,262.0,272.0,246.0,246.0,244.0,180.0,204.0,2610.0
Barnala,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,900.0,1203.0,1251.0,1108.0,1072.0,1006.0,915.0,912.0,881.0,859.0,741.0,916.0,11764.0
Barnala,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,362.0,409.0,431.0,512.0,507.0,536.0,605.0,470.0,479.0,487.0,406.0,405.0,5609.0
Barnala,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,1434.0,1897.0,2118.0,1816.0,1751.0,1654.0,1582.0,1497.0,1404.0,1395.0,1264.0,1512.0,19324.0
Barnala,14.10.2.a,Number of death cases of Inpatient males,TOTAL,3.0,4.0,6.0,5.0,10.0,10.0,15.0,9.0,13.0,11.0,5.0,8.0,99.0
Barnala,14.10.2.b,Number of death cases of Inpatient females,TOTAL,3.0,4.0,2.0,4.0,5.0,4.0,6.0,3.0,4.0,7.0,10.0,3.0,55.0
Barnala,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,6.0,8.0,8.0,9.0,15.0,14.0,21.0,12.0,17.0,18.0,15.0,11.0,154.0
Barnala,14.11,In-Patient Head Count at midnight,TOTAL,1142.0,1026.0,1198.0,1141.0,991.0,901.0,817.0,924.0,305.0,608.0,654.0,654.0,10361.0
Barnala,14.12.1,OPD attendance (All),TOTAL,44768.0,50229.0,43526.0,57721.0,59361.0,48944.0,39246.0,42163.0,43700.0,36637.0,38706.0,37846.0,542847.0
Barnala,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,203.0,300.0,305.0,296.0,267.0,255.0,183.0,165.0,158.0,154.0,154.0,198.0,2638.0
Barnala,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Barnala,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,213.0,834.0,249.0,947.0,867.0,917.0,764.0,850.0,806.0,867.0,707.0,747.0,8768.0
Barnala,14.14.a,Number of patients given AYUSH treatment,TOTAL,2376.0,2577.0,2677.0,2861.0,2862.0,2618.0,1772.0,2659.0,1934.0,970.0,1758.0,,25064.0
Barnala,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,758.0,812.0,746.0,599.0,1355.0,501.0,399.0,484.0,459.0,336.0,334.0,317.0,7100.0
Barnala,14.14.c,Number of Adolescents counselled,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Barnala,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,4273.0,4013.0,3789.0,3889.0,3376.0,3428.0,2734.0,2600.0,2817.0,2719.0,3523.0,2665.0,39826.0
Barnala,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,491.0,563.0,491.0,451.0,533.0,460.0,323.0,318.0,337.0,450.0,312.0,443.0,5172.0
Barnala,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,177.0,84.0,336.0,163.0,183.0,153.0,138.0,130.0,144.0,103.0,86.0,76.0,1773.0
Barnala,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,7.0,0.0,5.0,5.0,4.0,3.0,2.0,2.0,2.0,4.0,2.0,0.0,36.0
Barnala,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,309.0,193.0,392.0,312.0,317.0,300.0,191.0,263.0,260.0,185.0,174.0,84.0,2980.0
Barnala,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,3.0,0.0,1.0,2.0,2.0,4.0,1.0,1.0,2.0,2.0,1.0,1.0,20.0
Barnala,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,657.0,373.0,383.0,486.0,504.0,487.0,383.0,556.0,547.0,477.0,474.0,313.0,5640.0
Barnala,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,0.0,1.0,1.0,1.0,0.0,0.0,2.0,1.0,0.0,0.0,0.0,0.0,6.0
Barnala,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,1143.0,650.0,1111.0,961.0,1004.0,940.0,712.0,949.0,951.0,765.0,734.0,473.0,10393.0
Barnala,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,10.0,1.0,7.0,8.0,6.0,7.0,5.0,4.0,4.0,6.0,3.0,1.0,62.0
Barnala,15.2,Number of Widal tests conducted,Number tested,152.0,233.0,202.0,212.0,165.0,225.0,257.0,288.0,121.0,149.0,235.0,229.0,2468.0
Barnala,15.3.a,Number of VDRL tests conducted on males,Number tested,350.0,329.0,289.0,47.0,19.0,12.0,32.0,25.0,36.0,16.0,9.0,21.0,1185.0
Barnala,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,150.0,144.0,105.0,142.0,107.0,49.0,98.0,103.0,93.0,63.0,239.0,61.0,1354.0
Barnala,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,362.0,488.0,251.0,455.0,477.0,216.0,407.0,455.0,510.0,524.0,348.0,425.0,4918.0
Barnala,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,862.0,961.0,645.0,644.0,603.0,277.0,537.0,583.0,639.0,603.0,596.0,507.0,7457.0
Barnala,15.4.1,Number of blood smears examined for Malaria,TOTAL,9648.0,10131.0,9076.0,6443.0,4343.0,4350.0,5306.0,4022.0,4209.0,3620.0,5047.0,3807.0,70002.0
Barnala,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Barnala,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Barnala,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,7000.0,11500.0,5500.0,2500.0,10000.0,,10130.0,8570.0,8400.0,10350.0,6210.0,8000.0,88160.0
Barnala,16.1.1,Stock position of DPT vaccines,2. Stocks Received,8000.0,,,11000.0,,,,2000.0,4000.0,,3000.0,,28000.0
Barnala,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Barnala,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,3500.0,6000.0,3000.0,3500.0,4360.0,,1560.0,2170.0,2050.0,4140.0,1210.0,3350.0,34840.0
Barnala,16.1.1,Stock position of DPT vaccines,5. Total Stock,11500.0,5500.0,2500.0,10000.0,5640.0,0.0,8570.0,8400.0,10350.0,6210.0,8000.0,4650.0,81320.0
Barnala,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,,,,,,,,,,,7870.0,7800.0,15670.0
Barnala,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,,,,,,,,,,,,,
Barnala,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,,,,,,,,,,,,,
Barnala,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,,,,,,,,,,,70.0,2430.0,2500.0
Barnala,16.1.1A,Stock Position of Pentavalent,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,7800.0,5370.0,13170.0
Barnala,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,12500.0,16500.0,11000.0,5500.0,13500.0,,2080.0,10000.0,10900.0,5100.0,7040.0,9900.0,104020.0
Barnala,16.1.2,Stock position of OPV vaccines,2. Stocks Received,10000.0,,,14000.0,,,10000.0,4000.0,95000.0,95700.0,95000.0,,323700.0
Barnala,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,,,,,,,,,,,,,
Barnala,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,6000.0,5500.0,5500.0,6000.0,6600.0,,2080.0,3100.0,100800.0,93760.0,92140.0,1500.0,322980.0
Barnala,16.1.2,Stock position of OPV vaccines,5. Total Stock,16500.0,11000.0,5500.0,13500.0,6900.0,0.0,10000.0,10900.0,5100.0,7040.0,9900.0,8400.0,104740.0
Barnala,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,10000.0,13500.0,8000.0,3500.0,9800.0,,9600.0,8200.0,8500.0,9580.0,6690.0,8500.0,95870.0
Barnala,16.1.3,Stock position of TT vaccines,2. Stocks Received,6000.0,,,11000.0,,,,2000.0,3000.0,,3000.0,,25000.0
Barnala,16.1.3,Stock position of TT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Barnala,16.1.3,Stock position of TT vaccines,4. Stock Distributed,2500.0,5500.0,4500.0,4700.0,4460.0,,1400.0,1700.0,1920.0,2890.0,1190.0,2710.0,33470.0
Barnala,16.1.3,Stock position of TT vaccines,5. Total Stock,13500.0,8000.0,3500.0,9800.0,5340.0,0.0,8200.0,8500.0,9580.0,6690.0,8500.0,5790.0,87400.0
Barnala,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Barnala,16.1.4,Stock position of DT vaccines,2. Stocks Received,,,,,,,,,,,,,
Barnala,16.1.4,Stock position of DT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Barnala,16.1.4,Stock position of DT vaccines,4. Stock Distributed,,,,,,,,,,,,,
Barnala,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Barnala,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,5500.0,8500.0,6000.0,4000.0,5500.0,,6530.0,6670.0,7250.0,8800.0,5800.0,7000.0,71550.0
Barnala,16.1.5,Stock position of BCG vaccines,2. Stocks Received,5000.0,,,3000.0,,,1000.0,2000.0,3000.0,,2000.0,,16000.0
Barnala,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,,,,,,,,,,,,,
Barnala,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,2000.0,2500.0,2000.0,1500.0,1290.0,,860.0,1420.0,1450.0,3000.0,800.0,2080.0,18900.0
Barnala,16.1.5,Stock position of BCG vaccines,5. Total Stock,8500.0,6000.0,4000.0,5500.0,4210.0,0.0,6670.0,7250.0,8800.0,5800.0,7000.0,4920.0,68650.0
Barnala,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,4750.0,8000.0,5750.0,4250.0,3250.0,,480.0,2530.0,4250.0,7750.0,5160.0,7480.0,53650.0
Barnala,16.1.6,Stock position of Measles vaccines,2. Stocks Received,5000.0,,,1000.0,,,3000.0,3000.0,5000.0,,3000.0,,20000.0
Barnala,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,,,,,,,,,,,,,
Barnala,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,1750.0,2250.0,1500.0,2000.0,1660.0,,950.0,1280.0,1500.0,2590.0,680.0,2725.0,18885.0
Barnala,16.1.6,Stock position of Measles vaccines,5. Total Stock,8000.0,5750.0,4250.0,3250.0,1590.0,0.0,2530.0,4250.0,7750.0,5160.0,7480.0,4755.0,54765.0
Barnala,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Barnala,16.1.7,Stock position of JE vaccines,2. Stocks Received,,,,,,,,,,,,,
Barnala,16.1.7,Stock position of JE vaccines,3. Unusable Stock,,,,,,,,,,,,,
Barnala,16.1.7,Stock position of JE vaccines,4. Stock Distributed,,,,,,,,,,,,,
Barnala,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Barnala,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,7500.0,10500.0,6600.0,3700.0,9300.0,,6090.0,7470.0,7500.0,9030.0,4910.0,6920.0,79520.0
Barnala,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,6000.0,,,9000.0,,,3000.0,2000.0,4000.0,,3000.0,,27000.0
Barnala,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,,,,,,,,,,,,,
Barnala,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,3000.0,3900.0,2900.0,3400.0,3160.0,,1620.0,1970.0,2470.0,4120.0,990.0,3090.0,30620.0
Barnala,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,10500.0,6600.0,3700.0,9300.0,6140.0,0.0,7470.0,7500.0,9030.0,4910.0,6920.0,3830.0,75900.0
Barnala,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,2148.0,2148.0,6348.0,6348.0,5748.0,,5748.0,4548.0,4548.0,4548.0,4548.0,3348.0,50028.0
Barnala,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,,4200.0,,,,,,,,,,,4200.0
Barnala,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Barnala,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,,,,600.0,,,1200.0,,,,1200.0,600.0,3600.0
Barnala,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,2148.0,6348.0,6348.0,5748.0,5748.0,0.0,4548.0,4548.0,4548.0,4548.0,3348.0,2748.0,50628.0
Barnala,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,39600.0,27600.0,15600.0,3600.0,,,84000.0,65000.0,59000.0,103000.0,103000.0,101000.0,601400.0
Barnala,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,,,,,,,,,54000.0,,54000.0,120000.0,228000.0
Barnala,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Barnala,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,12000.0,12000.0,12000.0,3600.0,,,19000.0,6000.0,10000.0,,56000.0,41000.0,171600.0
Barnala,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,27600.0,15600.0,3600.0,0.0,0.0,0.0,65000.0,59000.0,103000.0,103000.0,101000.0,180000.0,657800.0
Barnala,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,6395.0,695.0,695.0,695.0,695.0,4495.0,13670.0
Barnala,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,8600.0,,,,,,7400.0,,16000.0
Barnala,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Barnala,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,2205.0,,5700.0,,,,3600.0,3895.0,15400.0
Barnala,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,6395.0,0.0,695.0,695.0,695.0,695.0,4495.0,600.0,14270.0
Barnala,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,190.0,30.0,30.0,30.0,30.0,280.0,590.0
Barnala,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,269.0,,,,,,500.0,,769.0
Barnala,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Barnala,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,79.0,,160.0,,,,250.0,250.0,739.0
Barnala,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,190.0,0.0,30.0,30.0,30.0,30.0,280.0,30.0,620.0
Barnala,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,,,500.0,500.0,500.0,,500.0,500.0,500.0,500.0,500.0,500.0,4500.0
Barnala,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,,500.0,,,,,,,,,,,500.0
Barnala,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Barnala,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Barnala,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0.0,500.0,500.0,500.0,500.0,0.0,500.0,500.0,500.0,500.0,500.0,500.0,5000.0
Barnala,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,,,,,,,,,,,,,
Barnala,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,,,,,,,,,,,,,
Barnala,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,,,,,,,,,,,,,
Barnala,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,,,,,,,,,,,,,
Barnala,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Barnala,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,,,,,,,,,,,572.0,254.0,826.0
Barnala,16.3.02,Stock Position of Gloves,2. Stocks Received,,,,,,,,,,750.0,,3622.0,4372.0
Barnala,16.3.02,Stock Position of Gloves,3. Unusable Stock,,,,,,,,,,,,,
Barnala,16.3.02,Stock Position of Gloves,4. Stock Distributed,,,,,,,,,,178.0,318.0,3726.0,4222.0
Barnala,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,572.0,254.0,150.0,976.0
Barnala,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,,,,,,,,,,,,,
Barnala,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,,,,,,,,,,,,,
Barnala,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,,,,,,,,,,,,,
Barnala,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,,,,,,,,,,,,,
Barnala,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Barnala,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
Barnala,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,,,,,,,,,,,,,
Barnala,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,,,,,,,,,,,,,
Barnala,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,,,,,,,,,,,,,
Barnala,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Barnala,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,,,,,,,,,,,,,
Barnala,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,,,,,,,,,,,,,
Barnala,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,,,,,,,,,,,,,
Barnala,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,,,,,,,,,,,,,
Barnala,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Barnala,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,,,,,,,,,,,,,
Barnala,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,,,,,,,,,,,,,
Barnala,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,,,,,,,,,,,,,
Barnala,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,,,,,,,,,,,,,
Barnala,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Barnala,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
Barnala,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,,,,,,,,,,,,,
Barnala,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,,,,,,,,,,,,,
Barnala,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,,,,,,,,,,,,,
Barnala,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Barnala,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,,,,,,,,,,,,,
Barnala,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,,,,,,,,,,,,,
Barnala,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,,,,,,,,,,,,,
Barnala,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,,,,,,,,,,,,,
Barnala,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Barnala,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,,,,,,,,,,,,,
Barnala,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,,,,,,,,,,,,,
Barnala,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,,,,,,,,,,,,,
Barnala,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,,,,,,,,,,,,,
Barnala,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Barnala,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,,,,,,,,,,,,,
Barnala,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,,,,,,,,,,,,,
Barnala,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,,,,,,,,,,,,,
Barnala,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,,,,,,,,,,,,,
Barnala,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Barnala,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,,,,,,,,,,,,,
Barnala,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,,,,,,,,,,,,,
Barnala,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,,,,,,,,,,,,,
Barnala,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,,,,,,,,,,,,,
Barnala,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Barnala,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,3400.0,4200.0,3000.0,2000.0,2400.0,1100.0,100.0,2080.0,1280.0,2300.0,1380.0,3380.0,26620.0
Barnala,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,2000.0,,,2000.0,,,2000.0,,2000.0,,2000.0,,10000.0
Barnala,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,,
Barnala,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,1200.0,1200.0,1000.0,1600.0,1300.0,1000.0,20.0,800.0,980.0,920.0,,2400.0,12420.0
Barnala,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,4200.0,3000.0,2000.0,2400.0,1100.0,100.0,2080.0,1280.0,2300.0,1380.0,3380.0,980.0,24200.0
Barnala,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,34000.0,34000.0,34000.0,92000.0,103600.0,99000.0,94200.0,93000.0,92400.0,88600.0,84200.0,83600.0,932600.0
Barnala,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,,,60000.0,20000.0,,,,,,,,,80000.0
Barnala,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,,
Barnala,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,0.0,,2000.0,8400.0,4600.0,4800.0,1200.0,600.0,3800.0,4400.0,600.0,5000.0,35400.0
Barnala,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,34000.0,34000.0,92000.0,103600.0,99000.0,94200.0,93000.0,92400.0,88600.0,84200.0,83600.0,78600.0,977200.0
Barnala,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,3700.0,3200.0,,0.0,3600.0,3000.0,1410.0,1180.0,960.0,200.0,60.0,2460.0,19770.0
Barnala,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,,,,4800.0,,,,,,,2400.0,,7200.0
Barnala,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,,,,,,,,,,,,,
Barnala,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,500.0,800.0,,1200.0,600.0,1590.0,230.0,200.0,760.0,140.0,,1300.0,7320.0
Barnala,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,3200.0,2400.0,0.0,3600.0,3000.0,1410.0,1180.0,980.0,200.0,60.0,2460.0,1160.0,19650.0
Barnala,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,,,,,,,,,,,,,
Barnala,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Barnala,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Barnala,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,,,,,,,,,,,,
Barnala,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Barnala,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Barnala,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,,,,,,,,,,,,,
Barnala,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Barnala,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Barnala,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,,,,,,,,,,,,,
Barnala,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,,,,,,,,,1.0,,1.0,1.0,3.0
Barnala,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,1.0,,,,,,,,1.0,,,2.0
Barnala,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,,1.0,,,,,,,1.0,1.0,1.0,1.0,5.0
Barnala,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,,,,,,,,1.0,1.0,1.0,,3.0
Barnala,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,,,,,,,,,1.0,1.0
Barnala,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,,,,,,,,,1.0,1.0,1.0,1.0,4.0
Barnala,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,,,,,,
Barnala,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
Barnala,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,,,,,,,,,
Barnala,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,1.0,,,,,1.0,,,,,2.0
Barnala,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,,,,,,,,,,
Barnala,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,,1.0,,,,,1.0,,,,,2.0
Barnala,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Barnala,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Barnala,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Barnala,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,,,,,,1.0,,,2.0,,1.0,,4.0
Barnala,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,,,,,,,,,1.0,,,1.0,2.0
Barnala,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,,,,,,1.0,,,3.0,,1.0,1.0,6.0
Barnala,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
Barnala,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,,,,,,,,,
Barnala,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,,1.0,,,,,,,1.0
Barnala,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,,,,1.0,,,,,,,1.0
Barnala,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
Barnala,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,,,,1.0,1.0,,2.0,1.0,1.0,2.0,1.0,,9.0
Barnala,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,,1.0,,,2.0,,2.0,2.0,2.0,1.0,1.0,,11.0
Barnala,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,,1.0,,1.0,3.0,,4.0,3.0,3.0,3.0,2.0,,20.0
Barnala,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,,,,,,
Barnala,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,,,1.0,3.0,2.0,2.0,,,,,1.0,,9.0
Barnala,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,,,2.0,1.0,3.0,3.0,,,,,,2.0,11.0
Barnala,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,,,3.0,4.0,5.0,5.0,,,,,1.0,2.0,20.0
Barnala,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
Barnala,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,,,,,,,,
Barnala,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
Barnala,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,,,,,,,,,,
Barnala,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,,,,,,,,,,
Barnala,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,,,,,,,,,1.0,,,,1.0
Barnala,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,,,,,,,,,,,,,
Barnala,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,,,,,,,,,1.0,,,,1.0
Barnala,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
Barnala,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,,,,,,,1.0,,,,1.0
Barnala,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,,,,
Barnala,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,,,,,,,1.0,,,,1.0
Barnala,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,,,1.0,,,,,,1.0
Barnala,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,6.0,3.0,6.0,12.0,20.0,15.0,21.0,13.0,19.0,12.0,18.0,24.0,169.0
Barnala,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,12.0,12.0,17.0,21.0,32.0,41.0,32.0,28.0,32.0,29.0,26.0,29.0,311.0
Barnala,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,18.0,15.0,23.0,33.0,52.0,56.0,54.0,41.0,51.0,41.0,44.0,53.0,481.0
Barnala,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,,,,,,,
Barnala,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,,,,,,1.0,,,,,,,1.0
Barnala,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,,,1.0,,,,,,,,,,1.0
Barnala,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,,,1.0,,,1.0,,,,,,,2.0
Barnala,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Barnala,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
Barnala,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Barnala,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
Barnala,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Barnala,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,,,,,,,,
Barnala,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Barnala,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,,,,,,,,
Barnala,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Barnala,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,,,,,1.0,,,,,1.0
Barnala,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Barnala,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,,,,,,1.0,,,,,1.0
Barnala,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Barnala,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,,,,,,,,,,,
Barnala,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Barnala,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,,,,,,,,,,,
Barnala,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Barnala,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,1.0,,,,,,,,,,1.0
Barnala,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Barnala,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,1.0,,,,,,,,,,1.0
Barnala,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Barnala,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,,,,,,,1.0,,,,,,1.0
Barnala,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Barnala,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,,,,,,,1.0,,,,,,1.0
Barnala,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,,,,,1.0,,,,,,,1.0
Barnala,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,,,6.0,13.0,6.0,7.0,3.0,3.0,3.0,2.0,10.0,2.0,55.0
Barnala,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,,,,3.0,1.0,,,1.0,,,,1.0,6.0
Barnala,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,,,6.0,16.0,7.0,8.0,3.0,4.0,3.0,2.0,10.0,3.0,62.0
Barnala,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,,,,,,,,,
Barnala,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,,,,4.0,5.0,4.0,4.0,1.0,4.0,1.0,4.0,5.0,32.0
Barnala,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,,2.0,2.0,,1.0,,,1.0,,,,6.0
Barnala,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,,,2.0,6.0,5.0,5.0,4.0,1.0,5.0,1.0,4.0,5.0,38.0
Barnala,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,,,,,,,,,,
Barnala,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,,,,,,,,,,,,
Barnala,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,,,,,,,,,,,
Barnala,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,,,,,,,,,,,,,
Barnala,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,,,,,,1.0,,,,,1.0
Barnala,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,,1.0,,,,2.0,3.0,,1.0,1.0,,,8.0
Barnala,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,1.0,1.0,,2.0,2.0,5.0,6.0,5.0,2.0,,4.0,2.0,30.0
Barnala,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,1.0,2.0,,2.0,2.0,7.0,9.0,6.0,3.0,1.0,4.0,2.0,39.0
Barnala,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,,,,,,1.0,,,,,,1.0
Barnala,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,2.0,3.0,3.0,11.0,11.0,16.0,10.0,9.0,16.0,7.0,8.0,15.0,111.0
Barnala,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,7.0,7.0,8.0,18.0,13.0,26.0,14.0,12.0,17.0,10.0,8.0,11.0,151.0
Barnala,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,9.0,10.0,11.0,29.0,24.0,42.0,25.0,21.0,33.0,17.0,16.0,26.0,263.0
Barnala,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,,,,1.0,,1.0,3.0,3.0,,,2.0,,10.0
Barnala,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,3.0,5.0,1.0,7.0,10.0,11.0,19.0,20.0,11.0,1.0,20.0,11.0,119.0
Barnala,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,20.0,25.0,30.0,53.0,49.0,43.0,48.0,51.0,55.0,22.0,42.0,29.0,467.0
Barnala,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,23.0,30.0,31.0,61.0,59.0,55.0,70.0,74.0,66.0,23.0,64.0,40.0,596.0
Bathinda,1.1,Total number of pregnant women Registered for ANC,TOTAL,2302.0,2136.0,2015.0,1967.0,2065.0,1900.0,1372.0,1686.0,1728.0,2065.0,2032.0,1803.0,23071.0
Bathinda,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,1786.0,1611.0,1565.0,1483.0,1624.0,1495.0,1011.0,1271.0,1328.0,1671.0,1598.0,1437.0,17880.0
Bathinda,1.2,Number of Pregnant women registered under JSY,TOTAL,1099.0,1093.0,1006.0,1014.0,976.0,851.0,687.0,898.0,990.0,1067.0,1052.0,923.0,11656.0
Bathinda,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,1582.0,1654.0,1782.0,1730.0,2078.0,1929.0,1635.0,1604.0,1571.0,1876.0,2008.0,1824.0,21273.0
Bathinda,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,2029.0,2060.0,1841.0,1967.0,1904.0,1845.0,1382.0,1656.0,1700.0,1907.0,1991.0,1883.0,22165.0
Bathinda,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,2198.0,2224.0,2231.0,2051.0,2015.0,1853.0,1633.0,1579.0,1565.0,1756.0,1758.0,1820.0,22683.0
Bathinda,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,1718.0,1805.0,1832.0,1604.0,1306.0,1246.0,1167.0,1044.0,1146.0,1218.0,1368.0,1519.0,16973.0
Bathinda,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,12.0,43.0,20.0,17.0,27.0,23.0,42.0,42.0,52.0,58.0,58.0,30.0,424.0
Bathinda,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,0.0,1.0,1.0,1.0,5.0,2.0,0.0,0.0,1.0,0.0,1.0,0.0,12.0
Bathinda,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,2176.0,1615.0,1823.0,1596.0,1408.0,1031.0,943.0,1130.0,1151.0,1342.0,1432.0,1266.0,16913.0
Bathinda,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,28.0,33.0,23.0,25.0,34.0,37.0,33.0,30.0,29.0,33.0,36.0,33.0,374.0
Bathinda,1.8,Number of pregnancy test kits used at SC level,TOTAL,427.0,730.0,514.0,575.0,656.0,533.0,486.0,641.0,498.0,785.0,842.0,785.0,7472.0
Bathinda,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,76.0,82.0,70.0,64.0,84.0,74.0,55.0,79.0,88.0,85.0,64.0,38.0,859.0
Bathinda,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,68.0,77.0,97.0,89.0,116.0,112.0,124.0,111.0,89.0,77.0,95.0,88.0,1143.0
Bathinda,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,144.0,159.0,167.0,153.0,200.0,186.0,179.0,190.0,177.0,162.0,159.0,126.0,2002.0
Bathinda,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,87.0,71.0,98.0,125.0,139.0,138.0,130.0,150.0,162.0,141.0,132.0,99.0,1472.0
Bathinda,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,6.0,3.0,1.0,4.0,2.0,1.0,1.0,0.0,0.0,0.0,0.0,0.0,18.0
Bathinda,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,712.0,821.0,823.0,1054.0,1212.0,1178.0,1145.0,1067.0,1065.0,1021.0,859.0,869.0,11826.0
Bathinda,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,459.0,530.0,504.0,641.0,587.0,662.0,500.0,592.0,555.0,499.0,408.0,337.0,6274.0
Bathinda,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,578.0,515.0,406.0,278.0,757.0,459.0,557.0,627.0,713.0,609.0,486.0,387.0,6372.0
Bathinda,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bathinda,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bathinda,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,579.0,603.0,735.0,801.0,872.0,778.0,890.0,979.0,924.0,839.0,783.0,706.0,9489.0
Bathinda,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bathinda,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bathinda,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bathinda,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0.0,2.0,0.0,2.0,0.0,1.0,2.0,0.0,2.0,0.0,0.0,0.0,9.0
Bathinda,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,47.0,34.0,40.0,42.0,52.0,51.0,53.0,52.0,37.0,36.0,31.0,34.0,509.0
Bathinda,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,138.0,200.0,184.0,245.0,275.0,265.0,278.0,220.0,229.0,261.0,208.0,199.0,2702.0
Bathinda,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Bathinda,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,185.0,236.0,224.0,289.0,327.0,317.0,333.0,272.0,268.0,297.0,239.0,233.0,3220.0
Bathinda,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,204.0,199.0,202.0,229.0,252.0,310.0,279.0,328.0,262.0,329.0,227.0,235.0,3056.0
Bathinda,4.1.1.a,Number of male live births,TOTAL,739.0,823.0,918.0,1024.0,1194.0,1142.0,1149.0,1168.0,1100.0,1067.0,931.0,886.0,12141.0
Bathinda,4.1.1.b,Number of female live births,TOTAL,685.0,751.0,774.0,961.0,1077.0,974.0,1063.0,1051.0,1047.0,944.0,856.0,805.0,10988.0
Bathinda,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,1424.0,1574.0,1692.0,1985.0,2271.0,2116.0,2212.0,2219.0,2147.0,2011.0,1787.0,1691.0,23129.0
Bathinda,4.1.2,Number of still births,TOTAL,18.0,21.0,42.0,41.0,35.0,41.0,28.0,35.0,42.0,38.0,30.0,24.0,395.0
Bathinda,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,98.0,141.0,165.0,161.0,136.0,74.0,92.0,118.0,118.0,152.0,66.0,87.0,1408.0
Bathinda,4.2.1,Number of Newborns weighed at birth,TOTAL,1401.0,1566.0,1681.0,1344.0,2244.0,2100.0,2198.0,2200.0,1671.0,1995.0,1771.0,1681.0,21852.0
Bathinda,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,211.0,235.0,364.0,174.0,201.0,170.0,207.0,231.0,149.0,260.0,260.0,336.0,2798.0
Bathinda,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,1258.0,1512.0,1610.0,1257.0,1570.0,1488.0,1826.0,1906.0,1591.0,1703.0,1348.0,1191.0,18260.0
Bathinda,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,0.0,0.0,0.0,2.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0
Bathinda,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,4.0,3.0,5.0,2.0,5.0,5.0,4.0,5.0,13.0,9.0,3.0,8.0,66.0
Bathinda,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,56.0,78.0,112.0,75.0,56.0,72.0,63.0,71.0,70.0,119.0,63.0,42.0,877.0
Bathinda,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Bathinda,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,60.0,81.0,117.0,79.0,61.0,77.0,67.0,76.0,83.0,128.0,66.0,50.0,945.0
Bathinda,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,65.0,0.0,35.0,10.0,45.0,155.0
Bathinda,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,24.0,18.0,84.0,28.0,0.0,27.0,30.0,90.0,0.0,150.0,25.0,61.0,537.0
Bathinda,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,3.0,8.0,13.0,4.0,3.0,7.0,2.0,27.0,0.0,15.0,0.0,0.0,82.0
Bathinda,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,8.0,3.0,58.0,58.0,0.0,32.0,31.0,35.0,9.0,67.0,25.0,66.0,392.0
Bathinda,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,55.0,80.0,64.0,77.0,57.0,75.0,53.0,76.0,83.0,51.0,66.0,50.0,787.0
Bathinda,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,565.0,713.0,678.0,1042.0,1380.0,1905.0,2002.0,2042.0,1873.0,1161.0,1450.0,1498.0,16309.0
Bathinda,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,594.0,833.0,827.0,1079.0,1127.0,1738.0,1998.0,2047.0,2130.0,1877.0,1687.0,1669.0,17606.0
Bathinda,6.3,PNC maternal complications attended,TOTAL,0.0,2.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,9.0,0.0,12.0
Bathinda,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,56.0,59.0,39.0,56.0,57.0,22.0,36.0,38.0,34.0,48.0,69.0,65.0,579.0
Bathinda,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,13.0,9.0,12.0,22.0,22.0,17.0,15.0,10.0,14.0,20.0,15.0,12.0,181.0
Bathinda,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,69.0,68.0,51.0,78.0,79.0,39.0,51.0,48.0,48.0,68.0,84.0,77.0,760.0
Bathinda,7.2,Number of MTPs conducted at Private Facilities,TOTAL,188.0,228.0,249.0,249.0,194.0,144.0,140.0,166.0,140.0,140.0,198.0,210.0,2246.0
Bathinda,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,78.0,70.0,63.0,7.0,60.0,51.0,33.0,19.0,128.0,21.0,6.0,21.0,557.0
Bathinda,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,218.0,314.0,218.0,139.0,188.0,174.0,310.0,230.0,240.0,50.0,193.0,245.0,2519.0
Bathinda,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,296.0,384.0,281.0,146.0,248.0,225.0,343.0,249.0,368.0,71.0,199.0,266.0,3076.0
Bathinda,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bathinda,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bathinda,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,5.0,16.0,6.0,27.0,13.0,5.0,3.0,2.0,6.0,8.0,7.0,6.0,104.0
Bathinda,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,5.0,9.0,11.0,9.0,4.0,4.0,3.0,7.0,7.0,0.0,0.0,4.0,63.0
Bathinda,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Bathinda,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,10.0,25.0,17.0,36.0,17.0,9.0,6.0,9.0,13.0,8.0,7.0,10.0,167.0
Bathinda,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bathinda,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bathinda,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bathinda,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bathinda,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Bathinda,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bathinda,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0
Bathinda,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,4.0,6.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,10.0
Bathinda,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,68.0,240.0,378.0,162.0,137.0,57.0,30.0,17.0,44.0,21.0,36.0,58.0,1248.0
Bathinda,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,78.0,185.0,380.0,152.0,108.0,35.0,10.0,13.0,29.0,17.0,39.0,45.0,1091.0
Bathinda,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Bathinda,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,150.0,431.0,758.0,314.0,245.0,92.0,40.0,30.0,73.0,38.0,75.0,103.0,2349.0
Bathinda,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,0.0,0.0,0.0,1.0,3.0,2.0,2.0,1.0,1.0,2.0,0.0,1.0,13.0
Bathinda,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bathinda,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,21.0,3.0,3.0,4.0,3.0,1.0,2.0,3.0,2.0,0.0,0.0,2.0,44.0
Bathinda,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,13.0,20.0,1.0,0.0,19.0,39.0,42.0,23.0,43.0,41.0,2.0,20.0,263.0
Bathinda,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Bathinda,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,34.0,23.0,4.0,4.0,22.0,40.0,44.0,26.0,45.0,41.0,2.0,22.0,307.0
Bathinda,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bathinda,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,981.0,892.0,956.0,1172.0,879.0,909.0,832.0,828.0,835.0,863.0,789.0,688.0,10624.0
Bathinda,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,1.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,2.0,0.0,0.0,18.0,23.0
Bathinda,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,27.0,39.0,40.0,44.0,28.0,24.0,24.0,37.0,31.0,31.0,31.0,27.0,383.0
Bathinda,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,123.0,62.0,126.0,131.0,175.0,201.0,226.0,394.0,274.0,280.0,88.0,300.0,2380.0
Bathinda,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Bathinda,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,1132.0,993.0,1122.0,1347.0,1082.0,1134.0,1082.0,1261.0,1142.0,1174.0,908.0,1033.0,13410.0
Bathinda,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,50.0,43.0,45.0,65.0,55.0,102.0,197.0,266.0,241.0,265.0,64.0,254.0,1647.0
Bathinda,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,0.0,27.0,0.0,0.0,27.0,24.0,26.0,25.0,26.0,26.0,0.0,23.0,204.0
Bathinda,9.06,Number of IUCD removals,TOTAL,175.0,163.0,156.0,132.0,114.0,102.0,112.0,123.0,104.0,106.0,119.0,99.0,1505.0
Bathinda,9.07,Number of Oral Pills cycles distributed,TOTAL,3190.0,2726.0,2582.0,2816.0,2331.0,3606.0,3467.0,3115.0,2915.0,3123.0,3351.0,3070.0,36292.0
Bathinda,9.08,Number of Condom pieces distributed,TOTAL,103243.0,87631.0,102443.0,95309.0,86592.0,99122.0,87206.0,82772.0,86210.0,91624.0,93044.0,102651.0,1117847.0
Bathinda,9.09,Number of Centchroman (weekly) pills given,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bathinda,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,18.0,16.0,14.0,22.0,43.0,105.0,159.0,237.0,224.0,217.0,184.0,139.0,1378.0
Bathinda,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bathinda,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bathinda,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Bathinda,9.11.2.b,Number of failures following female sterilization,TOTAL,3.0,1.0,3.0,1.0,4.0,2.0,0.0,1.0,2.0,1.0,1.0,0.0,19.0
Bathinda,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bathinda,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bathinda,9.12,Number of Institutions having NSV trained doctors,TOTAL,,1.0,,5.0,3.0,1.0,3.0,2.0,2.0,1.0,1.0,3.0,-1.0
Bathinda,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,1435.0,1425.0,1582.0,2067.0,1952.0,2272.0,2151.0,2086.0,1909.0,1816.0,1758.0,1687.0,22140.0
Bathinda,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,1750.0,1608.0,1375.0,1541.0,1649.0,1907.0,2000.0,2172.0,1762.0,1366.0,236.0,118.0,17484.0
Bathinda,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,1848.0,1698.0,1628.0,1619.0,1475.0,1559.0,1607.0,1954.0,2002.0,1598.0,1550.0,467.0,19005.0
Bathinda,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,1823.0,1834.0,1852.0,1620.0,1477.0,1497.0,1474.0,1596.0,1817.0,1816.0,1767.0,1246.0,19819.0
Bathinda,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,354.0,2049.0,1607.0,4010.0
Bathinda,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,9.0,163.0,1497.0,1669.0
Bathinda,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,37.0,361.0,398.0
Bathinda,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,819.0,816.0,935.0,1306.0,1414.0,1521.0,1510.0,1302.0,1201.0,1187.0,1192.0,1102.0,14305.0
Bathinda,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,1750.0,1608.0,1375.0,1541.0,1649.0,1907.0,2000.0,2172.0,1762.0,1717.0,2285.0,1725.0,21491.0
Bathinda,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,1848.0,1698.0,1628.0,1619.0,1475.0,1559.0,1607.0,1954.0,2002.0,1607.0,1713.0,1959.0,20669.0
Bathinda,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,1823.0,1834.0,1852.0,1620.0,1477.0,1497.0,1474.0,1596.0,1817.0,1816.0,1804.0,1613.0,20223.0
Bathinda,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,633.0,682.0,861.0,1192.0,1285.0,1431.0,1352.0,1128.0,1143.0,1076.0,990.0,987.0,12760.0
Bathinda,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,1730.0,1595.0,1366.0,1535.0,1646.0,1893.0,2002.0,2161.0,1765.0,1366.0,211.0,119.0,17389.0
Bathinda,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,1845.0,1698.0,1626.0,1620.0,1480.0,1564.0,1606.0,1932.0,2006.0,1581.0,1539.0,470.0,18967.0
Bathinda,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,1865.0,1818.0,1852.0,1618.0,1473.0,1503.0,1477.0,1602.0,1815.0,1807.0,1760.0,1239.0,19829.0
Bathinda,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,1649.0,1926.0,2072.0,1915.0,1915.0,1877.0,1702.0,1851.0,1598.0,1425.0,1357.0,1430.0,20717.0
Bathinda,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,1873.0,1826.0,1900.0,1872.0,1554.0,1507.0,1219.0,1483.0,1559.0,1541.0,1772.0,1657.0,19763.0
Bathinda,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bathinda,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,877.0,1063.0,1103.0,1016.0,1048.0,947.0,896.0,1024.0,864.0,736.0,738.0,774.0,11086.0
Bathinda,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,772.0,853.0,965.0,892.0,860.0,925.0,802.0,827.0,735.0,689.0,619.0,656.0,9595.0
Bathinda,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,1649.0,1916.0,2068.0,1908.0,1908.0,1872.0,1698.0,1851.0,1599.0,1425.0,1357.0,1430.0,20681.0
Bathinda,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,1845.0,1832.0,1863.0,1885.0,1586.0,1535.0,1261.0,1503.0,1483.0,1586.0,1752.0,1659.0,19790.0
Bathinda,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,1845.0,1832.0,1863.0,1885.0,1586.0,1535.0,1261.0,1503.0,1483.0,1586.0,1752.0,1659.0,19790.0
Bathinda,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bathinda,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bathinda,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bathinda,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bathinda,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,590.0,1116.0,1199.0,3923.0,2023.0,1772.0,1123.0,1402.0,641.0,695.0,608.0,653.0,15745.0
Bathinda,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,389.0,1329.0,854.0,3639.0,2423.0,2198.0,1079.0,1213.0,431.0,501.0,247.0,372.0,14675.0
Bathinda,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,184.0,888.0,334.0,3116.0,2081.0,1320.0,782.0,1362.0,480.0,232.0,144.0,204.0,11127.0
Bathinda,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bathinda,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bathinda,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Bathinda,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,778.0,701.0,822.0,787.0,765.0,753.0,760.0,761.0,765.0,744.0,764.0,737.0,9137.0
Bathinda,10.4.2,Number of Immunisation sessions held during the month,TOTAL,751.0,687.0,803.0,774.0,749.0,733.0,731.0,744.0,747.0,733.0,747.0,651.0,8850.0
Bathinda,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,562.0,522.0,590.0,578.0,569.0,535.0,545.0,566.0,557.0,562.0,550.0,501.0,6637.0
Bathinda,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bathinda,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,1595.0,1865.0,1999.0,1868.0,1859.0,1656.0,1484.0,1533.0,1496.0,1250.0,1304.0,1217.0,19126.0
Bathinda,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,1239.0,1115.0,1261.0,1200.0,1138.0,1177.0,1160.0,1291.0,1273.0,1072.0,1254.0,1081.0,14261.0
Bathinda,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,1199.0,1223.0,1436.0,1852.0,1250.0,1688.0,1266.0,1426.0,1397.0,1116.0,1287.0,1173.0,16313.0
Bathinda,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Bathinda,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bathinda,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bathinda,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bathinda,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bathinda,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bathinda,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,3.0,26.0,3.0,19.0,0.0,5.0,14.0,10.0,15.0,3.0,8.0,1.0,107.0
Bathinda,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,2.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0
Bathinda,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,0.0,3.0,0.0,7.0,0.0,0.0,0.0,0.0,0.0,0.0,3.0,0.0,13.0
Bathinda,13.1,Number of Patients operated for cataract,TOTAL,1198.0,950.0,736.0,703.0,1171.0,1312.0,1568.0,1760.0,1241.0,962.0,1534.0,1847.0,14982.0
Bathinda,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,1198.0,950.0,736.0,703.0,1171.0,1312.0,1568.0,1760.0,1241.0,962.0,1534.0,1847.0,14982.0
Bathinda,13.3,Number of School children detected with Refractive errors,TOTAL,35.0,146.0,51.0,482.0,174.0,47.0,47.0,776.0,172.0,47.0,137.0,44.0,2158.0
Bathinda,13.4,Number of children provided free glasses,TOTAL,35.0,146.0,51.0,238.0,89.0,47.0,47.0,776.0,172.0,47.0,137.0,44.0,1829.0
Bathinda,13.5,Number of eyes collected through eye donation,TOTAL,2.0,0.0,4.0,2.0,4.0,2.0,2.0,2.0,2.0,4.0,4.0,0.0,28.0
Bathinda,13.6,Number of eyes utilised for corneal transplant,TOTAL,2.0,0.0,4.0,2.0,4.0,2.0,2.0,2.0,2.0,4.0,4.0,0.0,28.0
Bathinda,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,,2.0,,6.0,10.0,7.0,6.0,5.0,5.0,6.0,9.0,8.0,-1.0
Bathinda,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,,,,2.0,2.0,3.0,3.0,1.0,2.0,3.0,3.0,1.0,-1.0
Bathinda,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,318.0,305.0,306.0,290.0,312.0,331.0,326.0,338.0,367.0,349.0,346.0,294.0,-1.0
Bathinda,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,3.0,3.0,1.0,6.0,11.0,8.0,7.0,6.0,6.0,6.0,9.0,8.0,-1.0
Bathinda,14.05,Number of RKS meetings held during the month,TOTAL,2.0,5.0,0.0,3.0,2.0,0.0,6.0,3.0,3.0,6.0,0.0,2.0,32.0
Bathinda,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,1.0,1.0,,6.0,8.0,7.0,5.0,4.0,6.0,5.0,7.0,6.0,-1.0
Bathinda,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,99.0,121.0,168.0,152.0,273.0,297.0,219.0,374.0,269.0,217.0,203.0,113.0,2505.0
Bathinda,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,,2.0,,5.0,6.0,4.0,3.0,2.0,1.0,2.0,5.0,3.0,-1.0
Bathinda,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,1.0,10.0,12.0,0.0,0.0,0.0,0.0,0.0,0.0,5.0,0.0,1.0,-1.0
Bathinda,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,528.0,317.0,392.0,357.0,909.0,292.0,231.0,289.0,1533.0,676.0,518.0,178.0,6220.0
Bathinda,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,4277.0,1661.0,1541.0,1314.0,944.0,1130.0,1257.0,948.0,984.0,3220.0,2960.0,1606.0,21842.0
Bathinda,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,422.0,248.0,311.0,260.0,811.0,230.0,204.0,319.0,1245.0,652.0,976.0,158.0,5836.0
Bathinda,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,2135.0,2692.0,3010.0,2582.0,2177.0,1667.0,1569.0,3058.0,4615.0,5116.0,4233.0,1945.0,34799.0
Bathinda,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,950.0,565.0,703.0,617.0,1720.0,522.0,435.0,608.0,2778.0,1328.0,1494.0,336.0,12056.0
Bathinda,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,6412.0,4353.0,4551.0,3896.0,3121.0,2797.0,2826.0,4006.0,5599.0,8336.0,7193.0,3551.0,56641.0
Bathinda,14.10.2.a,Number of death cases of Inpatient males,TOTAL,26.0,21.0,29.0,29.0,25.0,11.0,23.0,22.0,17.0,19.0,15.0,41.0,278.0
Bathinda,14.10.2.b,Number of death cases of Inpatient females,TOTAL,12.0,13.0,16.0,15.0,11.0,6.0,10.0,3.0,14.0,8.0,10.0,19.0,137.0
Bathinda,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,38.0,34.0,45.0,44.0,36.0,17.0,33.0,25.0,31.0,27.0,25.0,60.0,415.0
Bathinda,14.11,In-Patient Head Count at midnight,TOTAL,4238.0,5070.0,5035.0,4740.0,4457.0,3897.0,5195.0,3534.0,3269.0,4277.0,4363.0,4881.0,52956.0
Bathinda,14.12.1,OPD attendance (All),TOTAL,91386.0,107748.0,108484.0,102710.0,98122.0,87613.0,75515.0,83213.0,84587.0,82001.0,84744.0,86672.0,1092795.0
Bathinda,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,994.0,604.0,663.0,620.0,1054.0,448.0,425.0,568.0,770.0,547.0,525.0,401.0,7619.0
Bathinda,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,22.0,37.0,1.0,4.0,14.0,1.0,8.0,0.0,9.0,62.0,0.0,16.0,174.0
Bathinda,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,556.0,1353.0,1430.0,1242.0,955.0,1270.0,1208.0,1176.0,606.0,1055.0,1097.0,1160.0,13108.0
Bathinda,14.14.a,Number of patients given AYUSH treatment,TOTAL,1523.0,2439.0,1879.0,2958.0,2451.0,3161.0,2591.0,3540.0,2528.0,3360.0,3432.0,1850.0,31712.0
Bathinda,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,785.0,2444.0,2375.0,2284.0,2171.0,1884.0,2196.0,2042.0,1881.0,1746.0,1881.0,2187.0,23876.0
Bathinda,14.14.c,Number of Adolescents counselled,TOTAL,0.0,4.0,6.0,0.0,16.0,10.0,4.0,9.0,6.0,6.0,0.0,0.0,61.0
Bathinda,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,8057.0,8915.0,8840.0,8808.0,7350.0,6332.0,5198.0,6044.0,5930.0,6930.0,6291.0,5790.0,84485.0
Bathinda,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,915.0,493.0,270.0,204.0,117.0,127.0,181.0,123.0,197.0,203.0,167.0,185.0,3182.0
Bathinda,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,856.0,760.0,1138.0,711.0,691.0,528.0,428.0,579.0,468.0,450.0,447.0,423.0,7479.0
Bathinda,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,42.0,47.0,32.0,22.0,19.0,12.0,8.0,16.0,18.0,8.0,15.0,4.0,243.0
Bathinda,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,940.0,838.0,1150.0,578.0,543.0,503.0,482.0,411.0,347.0,465.0,463.0,599.0,7319.0
Bathinda,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,23.0,18.0,18.0,7.0,6.0,4.0,3.0,5.0,8.0,4.0,9.0,1.0,106.0
Bathinda,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,1926.0,1985.0,1701.0,1448.0,1320.0,1192.0,1224.0,1847.0,1335.0,1399.0,1136.0,983.0,17496.0
Bathinda,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,4.0,5.0,2.0,1.0,2.0,1.0,1.0,2.0,1.0,3.0,1.0,37.0,60.0
Bathinda,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,3722.0,3583.0,3989.0,2737.0,2554.0,2223.0,2134.0,2837.0,2150.0,2314.0,2046.0,2005.0,32294.0
Bathinda,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,69.0,70.0,52.0,30.0,27.0,17.0,12.0,23.0,27.0,15.0,25.0,42.0,409.0
Bathinda,15.2,Number of Widal tests conducted,Number tested,1937.0,891.0,838.0,707.0,790.0,875.0,671.0,518.0,385.0,397.0,976.0,837.0,9822.0
Bathinda,15.3.a,Number of VDRL tests conducted on males,Number tested,20.0,30.0,51.0,20.0,16.0,99.0,58.0,216.0,17.0,99.0,235.0,330.0,1191.0
Bathinda,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,79.0,55.0,62.0,53.0,43.0,81.0,179.0,192.0,35.0,78.0,153.0,311.0,1321.0
Bathinda,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,1014.0,1246.0,922.0,1175.0,946.0,743.0,902.0,971.0,952.0,1045.0,1247.0,850.0,12013.0
Bathinda,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,1113.0,1331.0,1035.0,1248.0,1005.0,923.0,1139.0,1379.0,1004.0,1222.0,1635.0,1491.0,14525.0
Bathinda,15.4.1,Number of blood smears examined for Malaria,TOTAL,6385.0,5472.0,8555.0,7886.0,6604.0,5288.0,3797.0,3108.0,6231.0,4106.0,6541.0,5103.0,69076.0
Bathinda,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,2.0,6.0,26.0,51.0,51.0,11.0,15.0,6.0,1.0,3.0,0.0,2.0,174.0
Bathinda,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bathinda,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,20290.0,10440.0,30190.0,16540.0,590.0,15700.0,17450.0,88150.0,97800.0,15900.0,10350.0,10590.0,333990.0
Bathinda,16.1.1,Stock position of DPT vaccines,2. Stocks Received,0.0,30000.0,0.0,0.0,23850.0,8000.0,80000.0,16000.0,0.0,0.0,8000.0,0.0,165850.0
Bathinda,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bathinda,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,9850.0,10250.0,13650.0,15950.0,8740.0,6250.0,9300.0,6350.0,81900.0,5550.0,7760.0,4550.0,180100.0
Bathinda,16.1.1,Stock position of DPT vaccines,5. Total Stock,10440.0,30190.0,16540.0,590.0,15700.0,17450.0,88150.0,97800.0,15900.0,10350.0,10590.0,6040.0,319740.0
Bathinda,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,6400.0,10500.0,16900.0
Bathinda,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,25000.0,5000.0,0.0,30000.0
Bathinda,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bathinda,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,18600.0,900.0,1300.0,20800.0
Bathinda,16.1.1A,Stock Position of Pentavalent,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,6400.0,10500.0,9200.0,26100.0
Bathinda,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,39660.0,27040.0,42440.0,23740.0,5140.0,8240.0,440.0,1500.0,16000.0,11020.0,10520.0,14420.0,200160.0
Bathinda,16.1.2,Stock position of OPV vaccines,2. Stocks Received,0.0,30000.0,0.0,0.0,15000.0,5000.0,17000.0,24000.0,15000.0,5000.0,10000.0,4200.0,125200.0
Bathinda,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bathinda,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,12620.0,14600.0,18700.0,18600.0,11900.0,12800.0,15940.0,9500.0,19980.0,5500.0,6100.0,3800.0,150040.0
Bathinda,16.1.2,Stock position of OPV vaccines,5. Total Stock,27040.0,42440.0,23740.0,5140.0,8240.0,440.0,1500.0,16000.0,11020.0,10520.0,14420.0,14820.0,175320.0
Bathinda,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,21220.0,12420.0,28520.0,16820.0,2220.0,16560.0,17750.0,17050.0,18600.0,18900.0,14450.0,16650.0,201160.0
Bathinda,16.1.3,Stock position of TT vaccines,2. Stocks Received,0.0,24000.0,0.0,0.0,24000.0,8000.0,8000.0,8000.0,8000.0,0.0,8000.0,0.0,88000.0
Bathinda,16.1.3,Stock position of TT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bathinda,16.1.3,Stock position of TT vaccines,4. Stock Distributed,8800.0,7900.0,11700.0,14600.0,9660.0,6810.0,8700.0,6450.0,7700.0,4450.0,5800.0,2600.0,95170.0
Bathinda,16.1.3,Stock position of TT vaccines,5. Total Stock,12420.0,28520.0,16820.0,2220.0,16560.0,17750.0,17050.0,18600.0,18900.0,14450.0,16650.0,14050.0,193990.0
Bathinda,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,17750.0,17050.0,18600.0,0.0,0.0,0.0,53400.0
Bathinda,16.1.4,Stock position of DT vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,8000.0,8000.0,8000.0,0.0,0.0,0.0,24000.0
Bathinda,16.1.4,Stock position of DT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bathinda,16.1.4,Stock position of DT vaccines,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,8700.0,6450.0,7700.0,0.0,0.0,0.0,22850.0
Bathinda,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,17050.0,18600.0,18900.0,0.0,0.0,0.0,54550.0
Bathinda,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,12650.0,6150.0,10780.0,4250.0,100.0,9150.0,14340.0,17150.0,11400.0,13750.0,9600.0,13450.0,122770.0
Bathinda,16.1.5,Stock position of BCG vaccines,2. Stocks Received,0.0,10000.0,0.0,0.0,15000.0,10000.0,10000.0,0.0,10000.0,0.0,10000.0,0.0,65000.0
Bathinda,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bathinda,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,6500.0,5370.0,6530.0,4150.0,5950.0,4810.0,7190.0,5750.0,7650.0,4150.0,6150.0,3400.0,67600.0
Bathinda,16.1.5,Stock position of BCG vaccines,5. Total Stock,6150.0,10780.0,4250.0,100.0,9150.0,14340.0,17150.0,11400.0,13750.0,9600.0,13450.0,10050.0,120170.0
Bathinda,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,11050.0,5950.0,21330.0,6810.0,1685.0,2575.0,555.0,900.0,7400.0,12125.0,8300.0,7980.0,86660.0
Bathinda,16.1.6,Stock position of Measles vaccines,2. Stocks Received,0.0,20000.0,0.0,0.0,4000.0,2000.0,5000.0,10000.0,10000.0,0.0,5000.0,0.0,56000.0
Bathinda,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bathinda,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,5100.0,4620.0,14520.0,5125.0,3110.0,4020.0,4655.0,3500.0,5275.0,3825.0,5320.0,2475.0,61545.0
Bathinda,16.1.6,Stock position of Measles vaccines,5. Total Stock,5950.0,21330.0,6810.0,1685.0,2575.0,555.0,900.0,7400.0,12125.0,8300.0,7980.0,5505.0,81115.0
Bathinda,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bathinda,16.1.7,Stock position of JE vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bathinda,16.1.7,Stock position of JE vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bathinda,16.1.7,Stock position of JE vaccines,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bathinda,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bathinda,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,16800.0,7500.0,28620.0,18070.0,9870.0,12270.0,12270.0,8870.0,6570.0,9420.0,4920.0,6120.0,141300.0
Bathinda,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,0.0,30000.0,0.0,0.0,10000.0,0.0,11000.0,4000.0,10000.0,0.0,8000.0,0.0,73000.0
Bathinda,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bathinda,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,9300.0,8880.0,10550.0,8200.0,7600.0,0.0,14400.0,6300.0,7150.0,4500.0,6800.0,2450.0,86130.0
Bathinda,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,7500.0,28620.0,18070.0,9870.0,12270.0,12270.0,8870.0,6570.0,9420.0,4920.0,6120.0,3670.0,128170.0
Bathinda,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,3710.0,3000.0,12600.0,12500.0,12500.0,12500.0,12500.0,12400.0,9550.0,8950.0,1300.0,2250.0,103760.0
Bathinda,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,0.0,10176.0,0.0,0.0,0.0,0.0,0.0,0.0,600.0,0.0,6350.0,0.0,17126.0
Bathinda,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bathinda,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,710.0,576.0,100.0,0.0,0.0,0.0,100.0,2850.0,1200.0,7650.0,5400.0,0.0,18586.0
Bathinda,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,3000.0,12600.0,12500.0,12500.0,12500.0,12500.0,12400.0,9550.0,8950.0,1300.0,2250.0,2250.0,102300.0
Bathinda,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,73600.0,37600.0,7000.0,2000.0,0.0,49600.0,0.0,0.0,0.0,0.0,15101.0,0.0,184901.0
Bathinda,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,99600.0,0.0,0.0,0.0,0.0,31101.0,0.0,0.0,130701.0
Bathinda,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bathinda,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,36000.0,30600.0,5000.0,2000.0,50000.0,49600.0,0.0,0.0,0.0,16000.0,15101.0,0.0,204301.0
Bathinda,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,37600.0,7000.0,2000.0,0.0,49600.0,0.0,0.0,0.0,0.0,15101.0,0.0,0.0,111301.0
Bathinda,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,3300.0,100.0,0.0,0.0,0.0,0.0,300.0,3700.0
Bathinda,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,13000.0,0.0,0.0,0.0,0.0,0.0,11500.0,0.0,24500.0
Bathinda,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bathinda,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,0.0,9700.0,3200.0,100.0,0.0,,0.0,11200.0,200.0,24400.0
Bathinda,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,3300.0,100.0,0.0,0.0,0.0,0.0,300.0,100.0,3800.0
Bathinda,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bathinda,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bathinda,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bathinda,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bathinda,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bathinda,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bathinda,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bathinda,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bathinda,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bathinda,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bathinda,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bathinda,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bathinda,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bathinda,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bathinda,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bathinda,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bathinda,16.3.02,Stock Position of Gloves,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bathinda,16.3.02,Stock Position of Gloves,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bathinda,16.3.02,Stock Position of Gloves,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bathinda,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bathinda,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bathinda,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bathinda,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bathinda,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bathinda,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bathinda,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bathinda,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bathinda,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bathinda,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bathinda,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bathinda,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bathinda,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bathinda,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bathinda,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bathinda,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bathinda,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bathinda,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bathinda,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bathinda,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bathinda,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bathinda,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bathinda,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bathinda,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bathinda,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bathinda,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bathinda,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bathinda,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bathinda,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bathinda,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bathinda,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bathinda,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bathinda,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bathinda,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bathinda,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bathinda,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bathinda,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bathinda,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bathinda,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bathinda,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bathinda,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bathinda,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bathinda,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bathinda,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bathinda,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bathinda,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bathinda,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,10000.0,6400.0,2400.0,1400.0,600.0,5600.0,3800.0,7400.0,5200.0,4400.0,2450.0,1250.0,50900.0
Bathinda,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,0.0,0.0,0.0,0.0,6000.0,0.0,6000.0,0.0,1000.0,0.0,0.0,0.0,13000.0
Bathinda,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bathinda,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,3600.0,4000.0,1000.0,800.0,1000.0,1800.0,2400.0,2200.0,1800.0,1950.0,1200.0,450.0,22200.0
Bathinda,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,6400.0,2400.0,1400.0,600.0,5600.0,3800.0,7400.0,5200.0,4400.0,2450.0,1250.0,800.0,41700.0
Bathinda,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,46400.0,38200.0,32200.0,108200.0,106000.0,72200.0,128200.0,70200.0,44200.0,50200.0,43000.0,139000.0,878000.0
Bathinda,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,0.0,0.0,100000.0,0.0,0.0,60000.0,0.0,0.0,40000.0,0.0,100000.0,0.0,300000.0
Bathinda,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0
Bathinda,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,8200.0,6000.0,24000.0,2200.0,33800.0,4000.0,58000.0,26000.0,34000.0,7200.0,4000.0,18080.0,225480.0
Bathinda,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,38200.0,32200.0,108200.0,106000.0,72200.0,128200.0,70200.0,44200.0,50200.0,43000.0,139000.0,120920.0,952520.0
Bathinda,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,4400.0,2400.0,5600.0,5200.0,7600.0,7200.0,6000.0,38400.0
Bathinda,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,0.0,0.0,0.0,0.0,4800.0,0.0,4800.0,0.0,2400.0,0.0,0.0,0.0,12000.0
Bathinda,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bathinda,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,0.0,0.0,0.0,0.0,400.0,2000.0,1600.0,400.0,0.0,400.0,1200.0,600.0,6600.0
Bathinda,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,0.0,0.0,0.0,0.0,4400.0,2400.0,5600.0,5200.0,7600.0,7200.0,6000.0,5400.0,43800.0
Bathinda,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,4.0,3.0,2.0,1.0,,3.0,1.0,1.0,,,,,15.0
Bathinda,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Bathinda,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Bathinda,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,,,,,,,,,,,,
Bathinda,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,,,,,,1.0,,1.0,2.0,,,1.0,5.0
Bathinda,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Bathinda,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,,,,,,1.0,,1.0,2.0,,,1.0,5.0
Bathinda,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,,,,1.0,1.0,1.0,1.0,1.0,1.0,1.0,,,7.0
Bathinda,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,1.0,,,1.0,,,1.0,,,,3.0
Bathinda,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,,,1.0,1.0,1.0,2.0,1.0,1.0,2.0,1.0,,,10.0
Bathinda,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,5.0,3.0,5.0,8.0,4.0,12.0,3.0,2.0,5.0,2.0,1.0,7.0,57.0
Bathinda,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,1.0,3.0,2.0,,2.0,1.0,2.0,1.0,1.0,2.0,,2.0,17.0
Bathinda,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,6.0,6.0,7.0,8.0,6.0,13.0,5.0,3.0,6.0,4.0,1.0,9.0,74.0
Bathinda,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,1.0,1.0,,,5.0,,1.0,3.0,1.0,2.0,,14.0
Bathinda,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,1.0,,,,1.0,,1.0,,1.0,1.0,1.0,,6.0
Bathinda,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,1.0,1.0,1.0,,1.0,5.0,1.0,1.0,4.0,2.0,3.0,,20.0
Bathinda,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,1.0,,,2.0,4.0,,,7.0
Bathinda,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,1.0,,,,,,1.0,1.0,,,3.0
Bathinda,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,1.0,,,1.0,,,3.0,5.0,,,10.0
Bathinda,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,2.0,2.0,4.0,1.0,,,1.0,2.0,,,12.0
Bathinda,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,,,1.0,1.0,,,,,,2.0
Bathinda,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,,2.0,2.0,4.0,2.0,1.0,,1.0,2.0,,,14.0
Bathinda,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Bathinda,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Bathinda,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Bathinda,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,2.0,5.0,4.0,,2.0,3.0,4.0,3.0,3.0,2.0,4.0,2.0,34.0
Bathinda,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,4.0,3.0,2.0,1.0,3.0,2.0,2.0,3.0,,,2.0,1.0,23.0
Bathinda,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,6.0,8.0,6.0,1.0,5.0,5.0,6.0,6.0,3.0,2.0,6.0,3.0,57.0
Bathinda,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,1.0,,,,,,,,,,,,1.0
Bathinda,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,,,,,,,,,
Bathinda,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,1.0,1.0,,,,1.0,,,,,,3.0
Bathinda,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,1.0,1.0,1.0,,,,1.0,,,,,,4.0
Bathinda,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,1.0,,1.0,,,2.0
Bathinda,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,6.0,4.0,10.0,2.0,3.0,5.0,6.0,4.0,7.0,6.0,5.0,3.0,61.0
Bathinda,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,1.0,5.0,3.0,4.0,4.0,3.0,3.0,3.0,5.0,4.0,3.0,3.0,41.0
Bathinda,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,7.0,9.0,13.0,6.0,7.0,8.0,9.0,8.0,12.0,11.0,8.0,6.0,104.0
Bathinda,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,,,,,,
Bathinda,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,,,1.0,,2.0,2.0,1.0,5.0,,7.0,3.0,2.0,23.0
Bathinda,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,,,4.0,3.0,1.0,4.0,2.0,4.0,4.0,7.0,4.0,5.0,38.0
Bathinda,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,,,5.0,3.0,3.0,6.0,3.0,9.0,4.0,14.0,7.0,7.0,61.0
Bathinda,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
Bathinda,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,1.0,,,,,,,,,,,,1.0
Bathinda,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
Bathinda,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,1.0,,,,,,,,,,,,1.0
Bathinda,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,1.0,,,1.0,1.0,,,,,,,,3.0
Bathinda,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,4.0,5.0,1.0,1.0,10.0,2.0,1.0,,3.0,,,2.0,29.0
Bathinda,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,3.0,5.0,4.0,1.0,7.0,1.0,1.0,,5.0,3.0,2.0,,32.0
Bathinda,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,8.0,10.0,5.0,3.0,18.0,3.0,2.0,,8.0,3.0,2.0,2.0,64.0
Bathinda,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
Bathinda,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,1.0,,,,2.0,,,,,1.0,1.0,5.0
Bathinda,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,1.0,,,,,,,,,1.0
Bathinda,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,1.0,,1.0,,2.0,,,,,1.0,1.0,6.0
Bathinda,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,1.0,1.0,1.0,1.0,,,,,,,,,4.0
Bathinda,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,43.0,42.0,61.0,46.0,56.0,27.0,56.0,51.0,49.0,51.0,54.0,36.0,572.0
Bathinda,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,65.0,56.0,90.0,62.0,76.0,54.0,82.0,86.0,81.0,104.0,78.0,63.0,897.0
Bathinda,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,109.0,99.0,152.0,109.0,132.0,81.0,138.0,137.0,130.0,155.0,132.0,99.0,1473.0
Bathinda,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,,,1.0,,1.0,,2.0
Bathinda,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,1.0,,,2.0,7.0,,1.0,1.0,1.0,2.0,1.0,4.0,20.0
Bathinda,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,1.0,3.0,4.0,3.0,5.0,4.0,3.0,4.0,3.0,2.0,4.0,3.0,39.0
Bathinda,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,2.0,3.0,4.0,5.0,12.0,4.0,4.0,5.0,5.0,4.0,6.0,7.0,61.0
Bathinda,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Bathinda,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,2.0,,,,,2.0
Bathinda,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Bathinda,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,2.0,,,,,2.0
Bathinda,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Bathinda,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,,,,,,,,
Bathinda,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Bathinda,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,,,,,,,,
Bathinda,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Bathinda,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,2.0,1.0,1.0,1.0,,,,,,5.0
Bathinda,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Bathinda,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,,2.0,1.0,1.0,1.0,,,,,,5.0
Bathinda,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Bathinda,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,1.0,1.0,1.0,,,,,1.0,,,,4.0
Bathinda,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Bathinda,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,1.0,1.0,1.0,,,,,1.0,,,,4.0
Bathinda,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Bathinda,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,1.0,,,,,,,,,,1.0
Bathinda,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Bathinda,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,1.0,,,,,,,,,,1.0
Bathinda,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Bathinda,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,1.0,,,3.0,3.0,1.0,1.0,1.0,,1.0,1.0,,12.0
Bathinda,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Bathinda,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,1.0,,,3.0,3.0,1.0,1.0,1.0,,1.0,1.0,,12.0
Bathinda,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,,1.0,1.0,1.0,1.0,1.0,2.0,1.0,1.0,1.0,1.0,11.0
Bathinda,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,15.0,18.0,10.0,22.0,22.0,32.0,30.0,23.0,20.0,20.0,10.0,14.0,236.0
Bathinda,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,7.0,4.0,4.0,11.0,4.0,8.0,9.0,6.0,6.0,4.0,2.0,5.0,70.0
Bathinda,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,22.0,22.0,15.0,34.0,27.0,41.0,40.0,31.0,27.0,25.0,13.0,20.0,317.0
Bathinda,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,1.0,,,,,,,,,1.0
Bathinda,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,8.0,12.0,13.0,15.0,16.0,12.0,7.0,5.0,7.0,8.0,10.0,12.0,125.0
Bathinda,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,,1.0,1.0,1.0,2.0,1.0,1.0,3.0,1.0,1.0,,12.0
Bathinda,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,8.0,12.0,14.0,17.0,17.0,14.0,8.0,6.0,10.0,9.0,11.0,12.0,138.0
Bathinda,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,,,,,,,,,,
Bathinda,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,1.0,1.0,2.0,3.0,2.0,2.0,,1.0,,,1.0,13.0
Bathinda,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,1.0,1.0,,,,,1.0,,,,,,3.0
Bathinda,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,1.0,2.0,1.0,2.0,3.0,2.0,3.0,,1.0,,,1.0,16.0
Bathinda,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,1.0,,,,,,,,,,1.0
Bathinda,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,1.0,3.0,1.0,3.0,,1.0,,1.0,,1.0,5.0,1.0,17.0
Bathinda,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,4.0,,1.0,6.0,3.0,1.0,1.0,1.0,1.0,5.0,1.0,3.0,27.0
Bathinda,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,5.0,3.0,3.0,9.0,3.0,2.0,1.0,2.0,1.0,6.0,6.0,4.0,45.0
Bathinda,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,1.0,1.0,1.0,,2.0,,2.0,,,1.0,,8.0
Bathinda,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,14.0,13.0,15.0,20.0,22.0,11.0,20.0,22.0,18.0,21.0,18.0,16.0,210.0
Bathinda,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,22.0,23.0,39.0,24.0,33.0,25.0,41.0,29.0,37.0,41.0,38.0,34.0,386.0
Bathinda,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,36.0,37.0,55.0,45.0,55.0,38.0,61.0,53.0,55.0,62.0,57.0,50.0,604.0
Bathinda,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,3.0,2.0,3.0,3.0,2.0,,1.0,3.0,2.0,,,1.0,20.0
Bathinda,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,33.0,23.0,30.0,33.0,12.0,19.0,32.0,22.0,29.0,37.0,25.0,18.0,313.0
Bathinda,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,128.0,139.0,238.0,136.0,155.0,129.0,174.0,148.0,178.0,237.0,124.0,98.0,1884.0
Bathinda,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,164.0,164.0,271.0,172.0,169.0,148.0,207.0,173.0,209.0,274.0,149.0,117.0,2217.0
Faridkot,1.1,Total number of pregnant women Registered for ANC,TOTAL,1039.0,1159.0,839.0,929.0,925.0,732.0,648.0,768.0,800.0,932.0,991.0,905.0,10667.0
Faridkot,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,772.0,826.0,649.0,687.0,677.0,527.0,454.0,537.0,611.0,733.0,780.0,684.0,7937.0
Faridkot,1.2,Number of Pregnant women registered under JSY,TOTAL,508.0,602.0,423.0,458.0,367.0,322.0,287.0,367.0,443.0,502.0,565.0,458.0,5302.0
Faridkot,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,948.0,859.0,969.0,995.0,832.0,868.0,824.0,776.0,773.0,755.0,855.0,855.0,10309.0
Faridkot,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,963.0,1018.0,811.0,873.0,864.0,712.0,590.0,699.0,737.0,802.0,905.0,827.0,9801.0
Faridkot,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,920.0,946.0,957.0,824.0,838.0,844.0,679.0,639.0,695.0,732.0,806.0,839.0,9719.0
Faridkot,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,886.0,975.0,903.0,930.0,798.0,688.0,755.0,540.0,597.0,516.0,778.0,764.0,9130.0
Faridkot,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,11.0,24.0,15.0,12.0,7.0,10.0,8.0,12.0,13.0,11.0,9.0,11.0,143.0
Faridkot,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,4.0,3.0,3.0,5.0,10.0,5.0,4.0,5.0,2.0,9.0,3.0,3.0,56.0
Faridkot,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,898.0,1022.0,1110.0,908.0,646.0,977.0,938.0,1000.0,994.0,1132.0,1069.0,923.0,11617.0
Faridkot,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,4.0,16.0,15.0,13.0,6.0,3.0,8.0,7.0,4.0,8.0,6.0,3.0,93.0
Faridkot,1.8,Number of pregnancy test kits used at SC level,TOTAL,256.0,277.0,216.0,195.0,244.0,265.0,239.0,295.0,266.0,259.0,226.0,233.0,2971.0
Faridkot,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,10.0,16.0,6.0,9.0,6.0,9.0,6.0,15.0,8.0,10.0,13.0,7.0,115.0
Faridkot,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,37.0,28.0,34.0,36.0,59.0,40.0,44.0,40.0,47.0,41.0,35.0,29.0,470.0
Faridkot,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,47.0,44.0,40.0,45.0,65.0,49.0,50.0,55.0,55.0,51.0,48.0,36.0,585.0
Faridkot,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,45.0,24.0,27.0,32.0,51.0,38.0,38.0,44.0,35.0,39.0,31.0,25.0,429.0
Faridkot,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,1.0,1.0,0.0,0.0,3.0,2.0,4.0,2.0,2.0,1.0,0.0,0.0,16.0
Faridkot,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,407.0,500.0,523.0,699.0,754.0,795.0,693.0,659.0,684.0,640.0,554.0,519.0,7427.0
Faridkot,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,311.0,355.0,399.0,510.0,527.0,576.0,501.0,399.0,408.0,408.0,371.0,304.0,5069.0
Faridkot,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,226.0,199.0,183.0,220.0,267.0,282.0,277.0,348.0,322.0,239.0,219.0,196.0,2978.0
Faridkot,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Faridkot,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Faridkot,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,152.0,161.0,206.0,252.0,297.0,245.0,276.0,273.0,245.0,262.0,214.0,185.0,2768.0
Faridkot,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,0.0,0.0,0.0,,,,,,,,0.0
Faridkot,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,0.0,0.0,0.0,,,,,,,,0.0
Faridkot,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,,,,,,,,0.0
Faridkot,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Faridkot,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Faridkot,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,110.0,108.0,105.0,163.0,167.0,177.0,153.0,145.0,181.0,164.0,122.0,155.0,1750.0
Faridkot,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Faridkot,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,110.0,108.0,105.0,163.0,167.0,177.0,153.0,145.0,181.0,164.0,122.0,155.0,1750.0
Faridkot,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,44.0,51.0,64.0,74.0,97.0,72.0,73.0,77.0,67.0,102.0,68.0,62.0,851.0
Faridkot,4.1.1.a,Number of male live births,TOTAL,314.0,346.0,397.0,501.0,600.0,565.0,528.0,505.0,544.0,486.0,412.0,363.0,5561.0
Faridkot,4.1.1.b,Number of female live births,TOTAL,282.0,342.0,358.0,470.0,517.0,518.0,484.0,469.0,427.0,452.0,388.0,365.0,5072.0
Faridkot,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,596.0,688.0,755.0,971.0,1117.0,1083.0,1012.0,974.0,971.0,938.0,800.0,728.0,10633.0
Faridkot,4.1.2,Number of still births,TOTAL,15.0,28.0,26.0,35.0,14.0,23.0,26.0,24.0,19.0,24.0,21.0,19.0,274.0
Faridkot,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,159.0,148.0,151.0,144.0,113.0,89.0,91.0,104.0,85.0,123.0,122.0,115.0,1444.0
Faridkot,4.2.1,Number of Newborns weighed at birth,TOTAL,523.0,675.0,647.0,571.0,797.0,979.0,983.0,966.0,962.0,927.0,790.0,719.0,9539.0
Faridkot,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,53.0,77.0,108.0,104.0,127.0,111.0,123.0,90.0,94.0,78.0,41.0,85.0,1091.0
Faridkot,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,523.0,677.0,634.0,570.0,788.0,720.0,751.0,755.0,726.0,661.0,647.0,552.0,8004.0
Faridkot,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,6.0,5.0,5.0,6.0,5.0,4.0,4.0,8.0,6.0,7.0,5.0,4.0,65.0
Faridkot,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,0.0,1.0,0.0,0.0,0.0,2.0,0.0,1.0,0.0,0.0,0.0,0.0,4.0
Faridkot,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,83.0,65.0,101.0,135.0,172.0,121.0,49.0,28.0,60.0,43.0,120.0,89.0,1066.0
Faridkot,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Faridkot,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,89.0,71.0,106.0,141.0,177.0,127.0,53.0,37.0,66.0,50.0,125.0,93.0,1135.0
Faridkot,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,,,,,,68.0,62.0,130.0
Faridkot,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,56.0,19.0,56.0,122.0,125.0,83.0,5.0,7.0,23.0,18.0,124.0,122.0,760.0
Faridkot,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,5.0,3.0,46.0,7.0,13.0,10.0,5.0,6.0,2.0,12.0,5.0,10.0,124.0
Faridkot,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,43.0,18.0,55.0,79.0,76.0,60.0,20.0,6.0,13.0,12.0,104.0,63.0,549.0
Faridkot,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,24.0,46.0,42.0,60.0,46.0,35.0,24.0,18.0,39.0,28.0,139.0,25.0,526.0
Faridkot,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,564.0,687.0,524.0,705.0,1079.0,1074.0,1008.0,968.0,947.0,946.0,797.0,736.0,10035.0
Faridkot,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,596.0,595.0,454.0,779.0,1016.0,937.0,897.0,914.0,912.0,802.0,788.0,671.0,9361.0
Faridkot,6.3,PNC maternal complications attended,TOTAL,0.0,26.0,4.0,10.0,6.0,3.0,4.0,3.0,2.0,1.0,2.0,4.0,65.0
Faridkot,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,35.0,32.0,27.0,23.0,21.0,12.0,8.0,12.0,8.0,20.0,15.0,12.0,225.0
Faridkot,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,0.0,5.0,0.0,3.0,1.0,1.0,2.0,2.0,0.0,0.0,0.0,2.0,16.0
Faridkot,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,35.0,37.0,27.0,26.0,22.0,13.0,10.0,14.0,8.0,20.0,15.0,14.0,241.0
Faridkot,7.2,Number of MTPs conducted at Private Facilities,TOTAL,93.0,75.0,80.0,91.0,62.0,54.0,49.0,55.0,58.0,76.0,66.0,69.0,828.0
Faridkot,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,93.0,30.0,115.0,11.0,33.0,27.0,20.0,23.0,23.0,18.0,28.0,16.0,437.0
Faridkot,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,194.0,191.0,190.0,146.0,187.0,190.0,94.0,155.0,126.0,137.0,104.0,92.0,1806.0
Faridkot,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,287.0,221.0,305.0,157.0,220.0,217.0,114.0,178.0,149.0,155.0,132.0,108.0,2243.0
Faridkot,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Faridkot,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Faridkot,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,1.0
Faridkot,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,3.0,1.0,3.0,7.0,2.0,1.0,2.0,7.0,1.0,2.0,2.0,2.0,33.0
Faridkot,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Faridkot,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,3.0,1.0,4.0,7.0,2.0,1.0,2.0,7.0,1.0,2.0,2.0,2.0,34.0
Faridkot,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,,,,,,,,0.0
Faridkot,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Faridkot,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Faridkot,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Faridkot,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Faridkot,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Faridkot,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,,,,,,,,0.0
Faridkot,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Faridkot,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,0.0,0.0,22.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,22.0
Faridkot,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,160.0,169.0,270.0,130.0,137.0,108.0,31.0,53.0,35.0,52.0,119.0,103.0,1367.0
Faridkot,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Faridkot,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,160.0,169.0,292.0,130.0,137.0,108.0,31.0,53.0,35.0,52.0,119.0,103.0,1389.0
Faridkot,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,3.0,7.0,20.0,10.0,17.0,6.0,2.0,4.0,2.0,4.0,0.0,7.0,82.0
Faridkot,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Faridkot,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Faridkot,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,19.0,23.0,22.0,28.0,34.0,37.0,35.0,35.0,25.0,20.0,29.0,42.0,349.0
Faridkot,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Faridkot,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,19.0,23.0,22.0,28.0,34.0,37.0,35.0,35.0,25.0,20.0,29.0,42.0,349.0
Faridkot,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,2.0,0.0,3.0,0.0,0.0,,,,,2.0,1.0,0.0,8.0
Faridkot,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,234.0,239.0,227.0,241.0,181.0,237.0,230.0,226.0,220.0,223.0,215.0,214.0,2687.0
Faridkot,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,2.0,2.0,2.0,0.0,2.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,8.0
Faridkot,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,4.0,3.0,6.0,2.0,0.0,0.0,2.0,0.0,0.0,1.0,0.0,,18.0
Faridkot,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,117.0,140.0,105.0,163.0,137.0,153.0,134.0,150.0,164.0,230.0,231.0,186.0,1910.0
Faridkot,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Faridkot,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,357.0,384.0,340.0,406.0,320.0,390.0,366.0,376.0,384.0,454.0,446.0,400.0,4623.0
Faridkot,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,0.0,3.0,0.0,6.0,8.0,30.0,52.0,34.0,63.0,119.0,137.0,112.0,564.0
Faridkot,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,62.0,27.0,64.0,57.0,68.0,69.0,58.0,66.0,60.0,70.0,66.0,65.0,732.0
Faridkot,9.06,Number of IUCD removals,TOTAL,57.0,43.0,42.0,28.0,19.0,34.0,24.0,23.0,30.0,19.0,55.0,34.0,408.0
Faridkot,9.07,Number of Oral Pills cycles distributed,TOTAL,3264.0,1360.0,1917.0,1968.0,1614.0,3297.0,1963.0,1969.0,1988.0,1702.0,2340.0,1954.0,25336.0
Faridkot,9.08,Number of Condom pieces distributed,TOTAL,56506.0,46906.0,51071.0,52482.0,50442.0,45316.0,49176.0,52876.0,57236.0,53296.0,59301.0,47121.0,621729.0
Faridkot,9.09,Number of Centchroman (weekly) pills given,TOTAL,2.0,3.0,0.0,0.0,0.0,0.0,6.0,3.0,0.0,0.0,0.0,0.0,14.0
Faridkot,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,91.0,88.0,66.0,120.0,79.0,74.0,94.0,99.0,93.0,98.0,123.0,22.0,1047.0
Faridkot,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Faridkot,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Faridkot,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Faridkot,9.11.2.b,Number of failures following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,2.0,0.0,3.0
Faridkot,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Faridkot,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Faridkot,9.12,Number of Institutions having NSV trained doctors,TOTAL,,,,3.0,3.0,3.0,3.0,3.0,3.0,2.0,3.0,4.0,-1.0
Faridkot,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,763.0,763.0,793.0,879.0,1061.0,1095.0,1000.0,1051.0,962.0,901.0,882.0,755.0,10905.0
Faridkot,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,768.0,790.0,669.0,685.0,776.0,781.0,801.0,907.0,716.0,358.0,29.0,10.0,7290.0
Faridkot,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,831.0,811.0,697.0,739.0,710.0,703.0,727.0,810.0,832.0,762.0,574.0,185.0,8381.0
Faridkot,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,818.0,852.0,747.0,831.0,744.0,665.0,676.0,770.0,756.0,789.0,667.0,468.0,8783.0
Faridkot,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,591.0,755.0,715.0,2061.0
Faridkot,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,7.0,289.0,734.0,1030.0
Faridkot,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,14.0,258.0,272.0
Faridkot,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,539.0,549.0,645.0,727.0,853.0,926.0,854.0,826.0,843.0,786.0,725.0,636.0,8909.0
Faridkot,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,768.0,790.0,669.0,685.0,776.0,781.0,801.0,907.0,716.0,949.0,784.0,725.0,9351.0
Faridkot,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,831.0,811.0,697.0,739.0,710.0,703.0,727.0,810.0,832.0,764.0,863.0,923.0,9410.0
Faridkot,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,818.0,852.0,747.0,831.0,744.0,665.0,676.0,770.0,756.0,789.0,681.0,751.0,9080.0
Faridkot,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,242.0,329.0,349.0,564.0,696.0,783.0,699.0,636.0,666.0,664.0,561.0,501.0,6690.0
Faridkot,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,768.0,760.0,669.0,685.0,776.0,781.0,801.0,907.0,716.0,358.0,6.0,3.0,7230.0
Faridkot,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,831.0,791.0,697.0,739.0,710.0,703.0,727.0,810.0,832.0,762.0,574.0,182.0,8358.0
Faridkot,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,818.0,842.0,747.0,835.0,744.0,665.0,675.0,770.0,756.0,789.0,667.0,462.0,8770.0
Faridkot,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,761.0,805.0,763.0,853.0,851.0,809.0,726.0,771.0,689.0,650.0,610.0,601.0,8889.0
Faridkot,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,739.0,798.0,725.0,792.0,700.0,617.0,559.0,686.0,650.0,643.0,703.0,706.0,8318.0
Faridkot,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Faridkot,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,418.0,428.0,421.0,466.0,455.0,438.0,379.0,412.0,372.0,350.0,314.0,318.0,4771.0
Faridkot,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,331.0,363.0,335.0,375.0,386.0,362.0,345.0,344.0,310.0,286.0,279.0,277.0,3993.0
Faridkot,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,749.0,791.0,756.0,841.0,841.0,800.0,724.0,756.0,682.0,636.0,593.0,595.0,8764.0
Faridkot,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,754.0,804.0,749.0,800.0,710.0,613.0,564.0,688.0,656.0,645.0,704.0,706.0,8393.0
Faridkot,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,754.0,804.0,749.0,800.0,710.0,613.0,564.0,688.0,656.0,645.0,704.0,706.0,8393.0
Faridkot,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Faridkot,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,8.0,8.0,6.0,9.0,6.0,6.0,2.0,15.0,5.0,5.0,6.0,2.0,78.0
Faridkot,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,4.0,6.0,1.0,3.0,4.0,3.0,0.0,0.0,2.0,9.0,11.0,4.0,47.0
Faridkot,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,12.0,14.0,7.0,12.0,10.0,9.0,2.0,15.0,7.0,14.0,17.0,6.0,125.0
Faridkot,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,248.0,2128.0,409.0,892.0,774.0,461.0,291.0,371.0,442.0,617.0,432.0,290.0,7355.0
Faridkot,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,108.0,3307.0,236.0,952.0,1075.0,482.0,212.0,197.0,366.0,604.0,374.0,123.0,8036.0
Faridkot,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,96.0,3064.0,135.0,637.0,649.0,273.0,84.0,129.0,369.0,684.0,556.0,83.0,6759.0
Faridkot,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,2.0
Faridkot,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Faridkot,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,108.0,94.0,76.0,34.0,53.0,44.0,39.0,38.0,60.0,63.0,28.0,93.0,730.0
Faridkot,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,352.0,353.0,327.0,322.0,318.0,319.0,325.0,321.0,324.0,326.0,335.0,324.0,3946.0
Faridkot,10.4.2,Number of Immunisation sessions held during the month,TOTAL,350.0,356.0,323.0,319.0,318.0,312.0,316.0,314.0,321.0,323.0,327.0,296.0,3875.0
Faridkot,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,274.0,267.0,259.0,241.0,241.0,228.0,248.0,254.0,254.0,256.0,256.0,230.0,3008.0
Faridkot,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Faridkot,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,774.0,823.0,767.0,818.0,851.0,802.0,700.0,730.0,635.0,466.0,587.0,620.0,8573.0
Faridkot,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,921.0,862.0,885.0,546.0,472.0,545.0,479.0,407.0,491.0,495.0,536.0,591.0,7230.0
Faridkot,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,667.0,818.0,582.0,586.0,497.0,484.0,383.0,453.0,484.0,273.0,429.0,436.0,6092.0
Faridkot,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Faridkot,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Faridkot,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Faridkot,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Faridkot,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Faridkot,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Faridkot,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,21.0,39.0,32.0,0.0,16.0,0.0,0.0,0.0,0.0,5.0,0.0,0.0,113.0
Faridkot,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Faridkot,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,0.0,22.0,1.0,0.0,11.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,36.0
Faridkot,13.1,Number of Patients operated for cataract,TOTAL,1138.0,795.0,484.0,376.0,453.0,850.0,872.0,1027.0,706.0,353.0,887.0,1620.0,9561.0
Faridkot,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,1138.0,795.0,484.0,376.0,453.0,850.0,872.0,1027.0,706.0,353.0,887.0,1620.0,9561.0
Faridkot,13.3,Number of School children detected with Refractive errors,TOTAL,5.0,45.0,21.0,63.0,138.0,166.0,127.0,146.0,71.0,158.0,44.0,26.0,1010.0
Faridkot,13.4,Number of children provided free glasses,TOTAL,1.0,3.0,21.0,63.0,138.0,166.0,127.0,146.0,71.0,158.0,44.0,26.0,964.0
Faridkot,13.5,Number of eyes collected through eye donation,TOTAL,6.0,4.0,6.0,4.0,4.0,4.0,2.0,2.0,6.0,2.0,6.0,2.0,48.0
Faridkot,13.6,Number of eyes utilised for corneal transplant,TOTAL,6.0,4.0,6.0,4.0,3.0,3.0,2.0,2.0,4.0,2.0,6.0,2.0,44.0
Faridkot,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,,,,6.0,6.0,5.0,5.0,5.0,5.0,5.0,5.0,4.0,-1.0
Faridkot,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,,,,3.0,3.0,2.0,2.0,3.0,2.0,1.0,2.0,2.0,-1.0
Faridkot,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,209.0,219.0,223.0,223.0,199.0,208.0,226.0,203.0,203.0,202.0,200.0,189.0,-1.0
Faridkot,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,,,,5.0,5.0,4.0,4.0,4.0,4.0,4.0,4.0,3.0,-1.0
Faridkot,14.05,Number of RKS meetings held during the month,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,1.0,0.0,2.0
Faridkot,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,,,,3.0,3.0,3.0,3.0,2.0,3.0,4.0,3.0,2.0,-1.0
Faridkot,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,30.0,30.0,33.0,58.0,33.0,37.0,66.0,46.0,56.0,10.0,19.0,17.0,435.0
Faridkot,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,,,,4.0,4.0,4.0,3.0,4.0,4.0,4.0,4.0,4.0,-1.0
Faridkot,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,6.0,6.0,6.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,2.0,1.0,-1.0
Faridkot,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,145.0,167.0,135.0,232.0,272.0,266.0,107.0,202.0,212.0,133.0,99.0,96.0,2066.0
Faridkot,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,245.0,280.0,466.0,305.0,365.0,334.0,297.0,223.0,142.0,186.0,175.0,180.0,3198.0
Faridkot,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,122.0,152.0,108.0,220.0,213.0,247.0,111.0,203.0,160.0,110.0,85.0,85.0,1816.0
Faridkot,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,1047.0,1367.0,1301.0,1397.0,1536.0,1516.0,908.0,1114.0,992.0,1102.0,1070.0,1074.0,14424.0
Faridkot,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,267.0,319.0,243.0,452.0,485.0,513.0,218.0,405.0,372.0,243.0,184.0,181.0,3882.0
Faridkot,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,1292.0,1647.0,1767.0,1702.0,1901.0,1850.0,1205.0,1337.0,1134.0,1288.0,1245.0,1254.0,17622.0
Faridkot,14.10.2.a,Number of death cases of Inpatient males,TOTAL,4.0,4.0,6.0,4.0,2.0,3.0,4.0,0.0,3.0,3.0,4.0,4.0,41.0
Faridkot,14.10.2.b,Number of death cases of Inpatient females,TOTAL,5.0,2.0,3.0,2.0,1.0,3.0,3.0,1.0,1.0,1.0,2.0,0.0,24.0
Faridkot,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,9.0,6.0,9.0,6.0,3.0,6.0,7.0,1.0,4.0,4.0,6.0,4.0,65.0
Faridkot,14.11,In-Patient Head Count at midnight,TOTAL,3878.0,4870.0,5529.0,3950.0,3622.0,3199.0,2647.0,3449.0,3461.0,2936.0,3020.0,3820.0,44381.0
Faridkot,14.12.1,OPD attendance (All),TOTAL,31678.0,37288.0,34309.0,43963.0,36408.0,34903.0,30120.0,30794.0,31091.0,29207.0,33622.0,36467.0,409850.0
Faridkot,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,230.0,241.0,244.0,186.0,190.0,332.0,266.0,315.0,245.0,240.0,210.0,183.0,2882.0
Faridkot,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,59.0,55.0,58.0,28.0,21.0,13.0,7.0,7.0,8.0,6.0,13.0,18.0,293.0
Faridkot,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,242.0,627.0,660.0,216.0,212.0,774.0,452.0,358.0,617.0,529.0,551.0,631.0,5869.0
Faridkot,14.14.a,Number of patients given AYUSH treatment,TOTAL,2938.0,3155.0,3527.0,3240.0,3021.0,1464.0,1681.0,1924.0,2608.0,2732.0,2320.0,850.0,29460.0
Faridkot,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,1073.0,1206.0,1164.0,1134.0,1300.0,643.0,777.0,1003.0,1068.0,748.0,378.0,752.0,11246.0
Faridkot,14.14.c,Number of Adolescents counselled,TOTAL,373.0,34.0,55.0,113.0,194.0,0.0,0.0,197.0,1044.0,421.0,303.0,300.0,3034.0
Faridkot,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,3817.0,4772.0,4468.0,4661.0,4251.0,3094.0,3280.0,4259.0,4141.0,3012.0,3646.0,3938.0,47339.0
Faridkot,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,45.0,53.0,59.0,83.0,65.0,50.0,47.0,47.0,28.0,24.0,43.0,24.0,568.0
Faridkot,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,167.0,209.0,247.0,311.0,249.0,171.0,210.0,144.0,174.0,142.0,90.0,161.0,2275.0
Faridkot,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,1.0,1.0,6.0,7.0,9.0,5.0,0.0,2.0,2.0,1.0,3.0,46.0,83.0
Faridkot,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,263.0,244.0,467.0,405.0,381.0,425.0,238.0,296.0,188.0,244.0,293.0,340.0,3784.0
Faridkot,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,2.0,3.0,4.0,6.0,0.0,1.0,0.0,2.0,1.0,0.0,0.0,2.0,21.0
Faridkot,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,709.0,958.0,633.0,571.0,633.0,508.0,435.0,494.0,470.0,640.0,517.0,576.0,7144.0
Faridkot,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,0.0,3.0,0.0,0.0,1.0,4.0,0.0,8.0,22.0,1.0,0.0,0.0,39.0
Faridkot,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,1139.0,1411.0,1347.0,1287.0,1263.0,1104.0,883.0,934.0,832.0,1026.0,900.0,1077.0,13203.0
Faridkot,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,3.0,7.0,10.0,13.0,10.0,10.0,0.0,12.0,25.0,2.0,3.0,48.0,143.0
Faridkot,15.2,Number of Widal tests conducted,Number tested,289.0,258.0,216.0,200.0,214.0,136.0,272.0,287.0,186.0,121.0,182.0,231.0,2592.0
Faridkot,15.3.a,Number of VDRL tests conducted on males,Number tested,79.0,12.0,74.0,430.0,88.0,0.0,48.0,48.0,44.0,30.0,21.0,77.0,951.0
Faridkot,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,71.0,149.0,62.0,108.0,50.0,51.0,121.0,96.0,103.0,64.0,136.0,144.0,1155.0
Faridkot,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,607.0,989.0,394.0,509.0,295.0,51.0,318.0,368.0,425.0,449.0,376.0,463.0,5244.0
Faridkot,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,757.0,1150.0,530.0,1047.0,433.0,102.0,487.0,512.0,572.0,543.0,533.0,684.0,7350.0
Faridkot,15.4.1,Number of blood smears examined for Malaria,TOTAL,4600.0,3451.0,4065.0,2414.0,3492.0,1833.0,2151.0,4172.0,3103.0,2408.0,3214.0,3201.0,38104.0
Faridkot,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,2.0,0.0,2.0,8.0,10.0,15.0,3.0,2.0,2.0,0.0,0.0,0.0,44.0
Faridkot,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Faridkot,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,8500.0,5000.0,2500.0,5000.0,1500.0,500.0,5000.0,11000.0,9500.0,9500.0,7000.0,7000.0,72000.0
Faridkot,16.1.1,Stock position of DPT vaccines,2. Stocks Received,0.0,6000.0,5000.0,0.0,5000.0,7000.0,10000.0,4000.0,2000.0,0.0,3000.0,5000.0,47000.0
Faridkot,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Faridkot,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,3500.0,8500.0,2500.0,3500.0,6000.0,2500.0,4000.0,5500.0,2000.0,2500.0,3000.0,3000.0,46500.0
Faridkot,16.1.1,Stock position of DPT vaccines,5. Total Stock,5000.0,2500.0,5000.0,1500.0,500.0,5000.0,11000.0,9500.0,9500.0,7000.0,7000.0,9000.0,72500.0
Faridkot,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,,,,,,,,,,0.0,5000.0,9500.0,14500.0
Faridkot,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,,,,,,,,,,10000.0,5000.0,0.0,15000.0
Faridkot,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,,,,,,,,,,0.0,0.0,0.0,0.0
Faridkot,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,,,,,,,,,,5000.0,500.0,2500.0,8000.0
Faridkot,16.1.1A,Stock Position of Pentavalent,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,5000.0,9500.0,7000.0,21500.0
Faridkot,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,9500.0,4500.0,5000.0,6000.0,500.0,1500.0,1500.0,2500.0,500.0,96000.0,100.0,4980.0,132580.0
Faridkot,16.1.2,Stock position of OPV vaccines,2. Stocks Received,0.0,8000.0,6000.0,0.0,10000.0,6000.0,8000.0,5000.0,100000.0,0.0,102000.0,9000.0,254000.0
Faridkot,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Faridkot,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,5000.0,7500.0,5000.0,5500.0,9000.0,6000.0,7000.0,7000.0,4500.0,95900.0,97120.0,6100.0,255620.0
Faridkot,16.1.2,Stock position of OPV vaccines,5. Total Stock,4500.0,5000.0,6000.0,500.0,1500.0,1500.0,2500.0,500.0,96000.0,100.0,4980.0,7880.0,130960.0
Faridkot,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,8500.0,5000.0,2500.0,3500.0,1000.0,5000.0,12000.0,10000.0,9000.0,10000.0,8000.0,8000.0,82500.0
Faridkot,16.1.3,Stock position of TT vaccines,2. Stocks Received,0.0,6000.0,5000.0,0.0,10000.0,10000.0,2000.0,2000.0,3000.0,0.0,3000.0,5000.0,46000.0
Faridkot,16.1.3,Stock position of TT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Faridkot,16.1.3,Stock position of TT vaccines,4. Stock Distributed,3500.0,8500.0,4000.0,2500.0,6000.0,3000.0,4000.0,3000.0,2000.0,2000.0,3000.0,3500.0,45000.0
Faridkot,16.1.3,Stock position of TT vaccines,5. Total Stock,5000.0,2500.0,3500.0,1000.0,5000.0,12000.0,10000.0,9000.0,10000.0,8000.0,8000.0,9500.0,83500.0
Faridkot,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Faridkot,16.1.4,Stock position of DT vaccines,2. Stocks Received,,,,,,,,,,,,,
Faridkot,16.1.4,Stock position of DT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Faridkot,16.1.4,Stock position of DT vaccines,4. Stock Distributed,,,,,,,,,,,,,
Faridkot,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Faridkot,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,4500.0,2500.0,2500.0,4000.0,1000.0,3000.0,5500.0,9500.0,7500.0,8500.0,7000.0,9000.0,64500.0
Faridkot,16.1.5,Stock position of BCG vaccines,2. Stocks Received,0.0,3000.0,3000.0,0.0,5000.0,5000.0,8000.0,2000.0,2000.0,0.0,4000.0,4000.0,36000.0
Faridkot,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Faridkot,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,2000.0,3000.0,1500.0,3000.0,3000.0,2500.0,4000.0,4000.0,1000.0,1500.0,2000.0,4000.0,31500.0
Faridkot,16.1.5,Stock position of BCG vaccines,5. Total Stock,2500.0,2500.0,4000.0,1000.0,3000.0,5500.0,9500.0,7500.0,8500.0,7000.0,9000.0,9000.0,69000.0
Faridkot,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,5000.0,4000.0,2000.0,2500.0,1000.0,1000.0,1000.0,1000.0,2250.0,3250.0,2000.0,4250.0,29250.0
Faridkot,16.1.6,Stock position of Measles vaccines,2. Stocks Received,0.0,1000.0,2000.0,0.0,3000.0,2000.0,2000.0,3000.0,3000.0,0.0,4000.0,8000.0,28000.0
Faridkot,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Faridkot,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,1000.0,3000.0,1500.0,1500.0,3000.0,2000.0,2000.0,1750.0,2000.0,1250.0,3000.0,2750.0,24750.0
Faridkot,16.1.6,Stock position of Measles vaccines,5. Total Stock,4000.0,2000.0,2500.0,1000.0,1000.0,1000.0,1000.0,2250.0,3250.0,2000.0,3000.0,9500.0,32500.0
Faridkot,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Faridkot,16.1.7,Stock position of JE vaccines,2. Stocks Received,,,,,,,,,,,,,
Faridkot,16.1.7,Stock position of JE vaccines,3. Unusable Stock,,,,,,,,,,,,,
Faridkot,16.1.7,Stock position of JE vaccines,4. Stock Distributed,,,,,,,,,,,,,
Faridkot,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Faridkot,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,4000.0,1000.0,2400.0,2400.0,1700.0,0.0,2000.0,2500.0,2500.0,5500.0,3000.0,4000.0,31000.0
Faridkot,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,0.0,6000.0,0.0,0.0,3000.0,5000.0,4500.0,5000.0,5000.0,0.0,4000.0,3000.0,35500.0
Faridkot,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Faridkot,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,3000.0,4600.0,0.0,700.0,4700.0,3000.0,4000.0,5000.0,2000.0,2500.0,3000.0,3000.0,35500.0
Faridkot,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,1000.0,2400.0,2400.0,1700.0,0.0,2000.0,2500.0,2500.0,5500.0,3000.0,4000.0,4000.0,31000.0
Faridkot,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,,,0.0,4788.0,1788.0,1788.0,588.0,,,,,,8952.0
Faridkot,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,,,4788.0,0.0,0.0,0.0,0.0,,,,,,4788.0
Faridkot,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,,,0.0,0.0,0.0,0.0,0.0,,,,,,0.0
Faridkot,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,,,0.0,3000.0,0.0,1200.0,588.0,,,,,,4788.0
Faridkot,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,0.0,0.0,4788.0,1788.0,1788.0,588.0,0.0,0.0,0.0,0.0,0.0,0.0,8952.0
Faridkot,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,,,,,,0.0,72000.0,18000.0,18000.0,30000.0,6000.0,,144000.0
Faridkot,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,,,,,,72000.0,0.0,0.0,42000.0,0.0,0.0,,114000.0
Faridkot,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,,,,,,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Faridkot,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,,,,,,0.0,54000.0,18000.0,30000.0,24000.0,6000.0,,132000.0
Faridkot,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,72000.0,18000.0,0.0,30000.0,6000.0,0.0,0.0,126000.0
Faridkot,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,0.0,3800.0,9700.0,,,,,,0.0,13500.0
Faridkot,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,,,,3800.0,11300.0,0.0,,,,,,6500.0,21600.0
Faridkot,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,0.0,0.0,0.0,,,,,,0.0,0.0
Faridkot,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,0.0,5400.0,9700.0,,,,,,4500.0,19600.0
Faridkot,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,3800.0,9700.0,0.0,0.0,0.0,0.0,0.0,0.0,2000.0,15500.0
Faridkot,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,0.0,150.0,,,0.0,50.0,,,,0.0,200.0
Faridkot,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,,,150.0,0.0,,,150.0,0.0,,,,250.0,550.0
Faridkot,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,,,0.0,0.0,,,0.0,0.0,,,,0.0,0.0
Faridkot,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,,,0.0,150.0,,,100.0,50.0,,,,100.0,400.0
Faridkot,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,150.0,0.0,0.0,0.0,50.0,0.0,0.0,0.0,0.0,150.0,350.0
Faridkot,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,,,0.0,100.0,100.0,100.0,100.0,100.0,100.0,100.0,100.0,100.0,900.0
Faridkot,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,,,100.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,100.0
Faridkot,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Faridkot,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Faridkot,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0.0,0.0,100.0,100.0,100.0,100.0,100.0,100.0,100.0,100.0,100.0,100.0,1000.0
Faridkot,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,,,,,,,,,,,,,
Faridkot,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,,,,,,,,,,,,,
Faridkot,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,,,,,,,,,,,,,
Faridkot,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,,,,,,,,,,,,,
Faridkot,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Faridkot,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,,,0.0,1000.0,400.0,,,,,,,0.0,1400.0
Faridkot,16.3.02,Stock Position of Gloves,2. Stocks Received,,,1500.0,0.0,0.0,,,,,,,3600.0,5100.0
Faridkot,16.3.02,Stock Position of Gloves,3. Unusable Stock,,,0.0,0.0,0.0,,,,,,,0.0,0.0
Faridkot,16.3.02,Stock Position of Gloves,4. Stock Distributed,,,500.0,600.0,400.0,,,,,,,200.0,1700.0
Faridkot,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,0.0,1000.0,400.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3400.0,4800.0
Faridkot,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,,,,,,,,,,,,,
Faridkot,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,,,,,,,,,,,,,
Faridkot,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,,,,,,,,,,,,,
Faridkot,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,,,,,,,,,,,,,
Faridkot,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Faridkot,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
Faridkot,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,,,,,,,,,,,,,
Faridkot,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,,,,,,,,,,,,,
Faridkot,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,,,,,,,,,,,,,
Faridkot,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Faridkot,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,,,,,,,,,,,,,
Faridkot,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,,,,,,,,,,,,,
Faridkot,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,,,,,,,,,,,,,
Faridkot,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,,,,,,,,,,,,,
Faridkot,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Faridkot,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,,,,,,,,,,,,,
Faridkot,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,,,,,,,,,,,,,
Faridkot,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,,,,,,,,,,,,,
Faridkot,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,,,,,,,,,,,,,
Faridkot,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Faridkot,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
Faridkot,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,,,,,,,,,,,,,
Faridkot,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,,,,,,,,,,,,,
Faridkot,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,,,,,,,,,,,,,
Faridkot,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Faridkot,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,,,,,,,,0.0,9088.0,588.0,,0.0,9676.0
Faridkot,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,,,,,,,,31788.0,0.0,0.0,,31788.0,63576.0
Faridkot,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,,,,,,,,0.0,0.0,0.0,,0.0,0.0
Faridkot,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,,,,,,,,22700.0,8500.0,588.0,,5504.0,37292.0
Faridkot,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,9088.0,588.0,0.0,0.0,26284.0,35960.0
Faridkot,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,,,,,,,,,,,,,
Faridkot,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,,,,,,,,,,,,,
Faridkot,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,,,,,,,,,,,,,
Faridkot,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,,,,,,,,,,,,,
Faridkot,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Faridkot,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,,,,,,,,,,,,,
Faridkot,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,,,,,,,,,,,,,
Faridkot,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,,,,,,,,,,,,,
Faridkot,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,,,,,,,,,,,,,
Faridkot,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Faridkot,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,,,,,,,,,,,,,
Faridkot,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,,,,,,,,,,,,,
Faridkot,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,,,,,,,,,,,,,
Faridkot,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,,,,,,,,,,,,,
Faridkot,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Faridkot,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,0.0,1200.0,0.0,0.0,0.0,200.0,1400.0,1400.0,400.0,1400.0,200.0,0.0,6200.0
Faridkot,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,2000.0,0.0,0.0,0.0,2000.0,2000.0,2000.0,0.0,2000.0,0.0,0.0,2000.0,12000.0
Faridkot,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Faridkot,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,800.0,1200.0,0.0,0.0,1800.0,800.0,2000.0,1000.0,1000.0,1200.0,200.0,600.0,10600.0
Faridkot,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,1200.0,0.0,0.0,0.0,200.0,1400.0,1400.0,400.0,1400.0,200.0,0.0,1400.0,7600.0
Faridkot,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,2000.0,40000.0,28000.0,28000.0,24000.0,18000.0,18000.0,18000.0,4000.0,24000.0,14000.0,12000.0,230000.0
Faridkot,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,80000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,20000.0,0.0,0.0,0.0,100000.0
Faridkot,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Faridkot,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,42000.0,12000.0,0.0,4000.0,6000.0,0.0,0.0,14000.0,0.0,10000.0,2000.0,10000.0,100000.0
Faridkot,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,40000.0,28000.0,28000.0,24000.0,18000.0,18000.0,18000.0,4000.0,24000.0,14000.0,12000.0,2000.0,230000.0
Faridkot,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,200.0,1600.0,600.0,300.0,0.0,1000.0,,0.0,0.0,2400.0,1800.0,600.0,8500.0
Faridkot,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,2400.0,0.0,0.0,0.0,2400.0,0.0,,0.0,2400.0,0.0,0.0,2400.0,9600.0
Faridkot,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Faridkot,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,1000.0,1000.0,300.0,300.0,1400.0,1000.0,,0.0,0.0,600.0,1200.0,800.0,7600.0
Faridkot,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,1600.0,600.0,300.0,0.0,1000.0,0.0,0.0,0.0,2400.0,1800.0,600.0,2200.0,10500.0
Faridkot,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,,1.0,,,,,,,1.0,,,,2.0
Faridkot,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,2.0,2.0,,,1.0,2.0,,3.0,,1.0,1.0,12.0
Faridkot,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,1.0,,2.0,1.0,,,,1.0,,,1.0,6.0
Faridkot,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,3.0,2.0,2.0,1.0,1.0,2.0,,4.0,,1.0,2.0,18.0
Faridkot,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,,,1.0,,,2.0,,,,,,1.0,4.0
Faridkot,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,1.0,,,,,,,,,,,1.0
Faridkot,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,,1.0,1.0,,,2.0,,,,,,1.0,5.0
Faridkot,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,,,,,,1.0,,,3.0,3.0,,,7.0
Faridkot,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Faridkot,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,,,,,,1.0,,,3.0,3.0,,,7.0
Faridkot,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,,1.0,1.0,3.0,,1.0,,,1.0,,,1.0,8.0
Faridkot,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,,,1.0,,,,,,,,,1.0
Faridkot,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,,1.0,1.0,4.0,,1.0,,,1.0,,,1.0,9.0
Faridkot,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,,,,,,,1.0,2.0,1.0,1.0,,5.0
Faridkot,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,,,,,,,2.0,,,2.0
Faridkot,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,,,,,,,,1.0,2.0,3.0,1.0,,7.0
Faridkot,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,,,,,,
Faridkot,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
Faridkot,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,,,,,,,,,
Faridkot,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,,,,,,,,,,,
Faridkot,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,,,,,,,,,,
Faridkot,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,,,,,,,,,,,,
Faridkot,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Faridkot,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,1.0,,,,,,,,,,,,1.0
Faridkot,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,1.0,,,,,,,,,,,,1.0
Faridkot,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,,,,,4.0,1.0,,,1.0,1.0,,1.0,8.0
Faridkot,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,1.0,,,,3.0,,1.0,,,,,,5.0
Faridkot,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,1.0,,,,7.0,1.0,1.0,,1.0,1.0,,1.0,13.0
Faridkot,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
Faridkot,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,,,,,,,,,
Faridkot,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,,,,,,,,,
Faridkot,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,,,,,,,,,,,
Faridkot,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,1.0,,,,,,,,1.0,,1.0,,3.0
Faridkot,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,2.0,1.0,,1.0,,,,,,,1.0,,5.0
Faridkot,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,1.0,2.0,,1.0,,1.0,1.0,2.0,,1.0,2.0,,11.0
Faridkot,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,4.0,3.0,,2.0,,1.0,1.0,2.0,1.0,1.0,4.0,,19.0
Faridkot,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,,,,,,
Faridkot,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,,,,,,1.0,1.0,,,1.0,,,3.0
Faridkot,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,,,,,,1.0,3.0,,,1.0,1.0,1.0,7.0
Faridkot,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,,,,,,2.0,4.0,,,2.0,1.0,1.0,10.0
Faridkot,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
Faridkot,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,,,,,,,,
Faridkot,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
Faridkot,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,,,,,,,,,,
Faridkot,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,1.0,,1.0,,,,1.0,,,1.0,,4.0
Faridkot,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,5.0,6.0,1.0,,3.0,,2.0,2.0,4.0,2.0,4.0,1.0,30.0
Faridkot,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,20.0,21.0,2.0,,13.0,10.0,27.0,20.0,25.0,28.0,18.0,18.0,202.0
Faridkot,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,25.0,28.0,3.0,1.0,16.0,10.0,29.0,23.0,29.0,30.0,23.0,19.0,236.0
Faridkot,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
Faridkot,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,1.0,,1.0,,,,,,,,,,2.0
Faridkot,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,,,,
Faridkot,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,1.0,,1.0,,,,,,,,,,2.0
Faridkot,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,,,,,,,,,
Faridkot,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,10.0,14.0,2.0,,6.0,7.0,13.0,10.0,20.0,17.0,8.0,12.0,119.0
Faridkot,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,16.0,34.0,7.0,2.0,20.0,21.0,23.0,25.0,39.0,44.0,31.0,35.0,297.0
Faridkot,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,26.0,48.0,9.0,2.0,26.0,28.0,36.0,35.0,59.0,61.0,39.0,47.0,416.0
Faridkot,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,,,,,,,
Faridkot,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,,1.0,,,,1.0,,,,,,,2.0
Faridkot,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,,1.0,,,1.0,,,,5.0,1.0,,,8.0
Faridkot,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,,2.0,,,1.0,1.0,,,5.0,1.0,,,10.0
Faridkot,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Faridkot,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
Faridkot,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Faridkot,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
Faridkot,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Faridkot,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,,,,,,,,
Faridkot,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Faridkot,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,,,,,,,,
Faridkot,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Faridkot,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,,,,1.0,,,,,,1.0
Faridkot,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Faridkot,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,,,,,1.0,,,,,,1.0
Faridkot,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Faridkot,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,,1.0,,,,,,,,,1.0
Faridkot,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Faridkot,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,,1.0,,,,,,,,,1.0
Faridkot,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Faridkot,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,,,,,,,
Faridkot,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Faridkot,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,,,,,,,
Faridkot,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Faridkot,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,1.0,2.0,3.0,,1.0,1.0,1.0,,1.0,,,2.0,12.0
Faridkot,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Faridkot,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,1.0,2.0,3.0,,1.0,1.0,1.0,,1.0,,,2.0,12.0
Faridkot,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,,1.0,,,,,,,,,,1.0
Faridkot,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,,6.0,4.0,,,5.0,4.0,4.0,4.0,4.0,1.0,5.0,37.0
Faridkot,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,,2.0,,,2.0,,1.0,3.0,1.0,,2.0,1.0,12.0
Faridkot,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,,8.0,5.0,,2.0,5.0,5.0,7.0,5.0,4.0,3.0,6.0,50.0
Faridkot,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,,,,,,,,,
Faridkot,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,1.0,1.0,,,3.0,1.0,2.0,1.0,2.0,1.0,1.0,,13.0
Faridkot,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,1.0,1.0,,,,,,,,,,2.0
Faridkot,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,1.0,2.0,1.0,,3.0,1.0,2.0,1.0,2.0,1.0,1.0,,15.0
Faridkot,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,,,,,,,,,,
Faridkot,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,,,,,1.0,1.0,1.0,,1.0,,,4.0
Faridkot,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,,,1.0,,,,,,,,1.0
Faridkot,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,,,,,1.0,1.0,1.0,1.0,,1.0,,,5.0
Faridkot,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,2.0,,,1.0,1.0,,,,,,,4.0
Faridkot,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,1.0,1.0,,,1.0,3.0,,,2.0,1.0,,,9.0
Faridkot,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,1.0,2.0,1.0,3.0,8.0,2.0,,,5.0,1.0,,,23.0
Faridkot,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,2.0,5.0,1.0,3.0,10.0,6.0,,,7.0,2.0,,,36.0
Faridkot,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,,,,,,,,,,,,
Faridkot,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,1.0,7.0,3.0,1.0,2.0,3.0,,4.0,4.0,3.0,,5.0,33.0
Faridkot,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,2.0,8.0,3.0,1.0,,5.0,2.0,8.0,16.0,7.0,6.0,10.0,68.0
Faridkot,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,3.0,15.0,6.0,2.0,2.0,8.0,2.0,12.0,20.0,10.0,6.0,15.0,101.0
Faridkot,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,1.0,,,,,,,,,,,,1.0
Faridkot,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,1.0,8.0,,5.0,4.0,17.0,6.0,5.0,6.0,7.0,,3.0,62.0
Faridkot,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,4.0,27.0,9.0,8.0,25.0,54.0,42.0,50.0,56.0,66.0,3.0,28.0,372.0
Faridkot,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,6.0,35.0,9.0,13.0,29.0,71.0,48.0,55.0,62.0,73.0,3.0,31.0,435.0
Fatehgarh Sahib,1.1,Total number of pregnant women Registered for ANC,TOTAL,974.0,965.0,739.0,831.0,907.0,755.0,702.0,713.0,726.0,865.0,904.0,731.0,9812.0
Fatehgarh Sahib,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,617.0,594.0,482.0,513.0,550.0,461.0,402.0,514.0,474.0,659.0,624.0,480.0,6370.0
Fatehgarh Sahib,1.2,Number of Pregnant women registered under JSY,TOTAL,254.0,243.0,163.0,161.0,205.0,157.0,142.0,218.0,193.0,255.0,257.0,237.0,2485.0
Fatehgarh Sahib,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,860.0,871.0,825.0,914.0,836.0,831.0,721.0,684.0,693.0,803.0,724.0,684.0,9446.0
Fatehgarh Sahib,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,896.0,939.0,714.0,788.0,798.0,736.0,659.0,697.0,706.0,856.0,844.0,704.0,9337.0
Fatehgarh Sahib,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,935.0,908.0,832.0,787.0,727.0,786.0,735.0,621.0,662.0,771.0,798.0,737.0,9299.0
Fatehgarh Sahib,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,883.0,905.0,886.0,918.0,816.0,739.0,651.0,746.0,683.0,783.0,721.0,686.0,9417.0
Fatehgarh Sahib,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,14.0,10.0,17.0,10.0,12.0,10.0,6.0,6.0,6.0,15.0,4.0,6.0,116.0
Fatehgarh Sahib,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Fatehgarh Sahib,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,574.0,553.0,498.0,485.0,544.0,449.0,331.0,500.0,394.0,576.0,612.0,533.0,6049.0
Fatehgarh Sahib,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,6.0,7.0,11.0,9.0,15.0,22.0,9.0,14.0,23.0,10.0,12.0,16.0,154.0
Fatehgarh Sahib,1.8,Number of pregnancy test kits used at SC level,TOTAL,417.0,426.0,363.0,423.0,463.0,346.0,295.0,288.0,315.0,463.0,513.0,376.0,4688.0
Fatehgarh Sahib,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,2.0,3.0,6.0,2.0,7.0,6.0,1.0,5.0,3.0,0.0,4.0,0.0,39.0
Fatehgarh Sahib,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,28.0,43.0,54.0,43.0,62.0,66.0,49.0,43.0,53.0,57.0,22.0,21.0,541.0
Fatehgarh Sahib,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,30.0,46.0,60.0,45.0,69.0,72.0,50.0,48.0,56.0,57.0,26.0,21.0,580.0
Fatehgarh Sahib,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,1.0,2.0,11.0,8.0,27.0,8.0,10.0,35.0,33.0,44.0,17.0,15.0,211.0
Fatehgarh Sahib,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,9.0,3.0,0.0,1.0,0.0,0.0,0.0,1.0,0.0,1.0,0.0,0.0,15.0
Fatehgarh Sahib,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,211.0,235.0,265.0,346.0,404.0,399.0,358.0,326.0,310.0,321.0,258.0,224.0,3657.0
Fatehgarh Sahib,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,82.0,88.0,92.0,176.0,121.0,175.0,68.0,75.0,136.0,42.0,49.0,76.0,1180.0
Fatehgarh Sahib,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,5.0,66.0,32.0,32.0,71.0,30.0,41.0,48.0,41.0,32.0,13.0,18.0,429.0
Fatehgarh Sahib,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Fatehgarh Sahib,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Fatehgarh Sahib,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,206.0,227.0,206.0,278.0,300.0,322.0,294.0,318.0,288.0,273.0,261.0,231.0,3204.0
Fatehgarh Sahib,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,0.0,,0.0,,,,,,,,0.0
Fatehgarh Sahib,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,0.0,,0.0,,,,,,,,0.0
Fatehgarh Sahib,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,,0.0,,,,,,,,0.0
Fatehgarh Sahib,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,,,,,,,,0.0
Fatehgarh Sahib,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,45.0,38.0,34.0,46.0,53.0,44.0,59.0,41.0,40.0,38.0,32.0,25.0,495.0
Fatehgarh Sahib,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,31.0,17.0,24.0,38.0,42.0,52.0,43.0,41.0,44.0,36.0,32.0,29.0,429.0
Fatehgarh Sahib,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Fatehgarh Sahib,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,76.0,55.0,58.0,84.0,95.0,96.0,102.0,82.0,84.0,74.0,64.0,54.0,924.0
Fatehgarh Sahib,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,65.0,64.0,70.0,102.0,125.0,118.0,104.0,101.0,111.0,98.0,84.0,73.0,1115.0
Fatehgarh Sahib,4.1.1.a,Number of male live births,TOTAL,227.0,274.0,292.0,369.0,412.0,426.0,375.0,358.0,358.0,339.0,285.0,251.0,3966.0
Fatehgarh Sahib,4.1.1.b,Number of female live births,TOTAL,220.0,233.0,238.0,295.0,359.0,368.0,327.0,336.0,294.0,308.0,260.0,224.0,3462.0
Fatehgarh Sahib,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,447.0,507.0,530.0,664.0,771.0,794.0,702.0,694.0,652.0,647.0,545.0,475.0,7428.0
Fatehgarh Sahib,4.1.2,Number of still births,TOTAL,0.0,2.0,1.0,8.0,3.0,3.0,2.0,2.0,4.0,5.0,2.0,1.0,33.0
Fatehgarh Sahib,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,62.0,43.0,111.0,110.0,97.0,91.0,61.0,75.0,67.0,64.0,57.0,57.0,895.0
Fatehgarh Sahib,4.2.1,Number of Newborns weighed at birth,TOTAL,423.0,487.0,521.0,655.0,764.0,789.0,698.0,687.0,648.0,641.0,542.0,472.0,7327.0
Fatehgarh Sahib,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,9.0,13.0,19.0,42.0,10.0,30.0,32.0,29.0,17.0,18.0,14.0,22.0,255.0
Fatehgarh Sahib,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,391.0,449.0,473.0,625.0,730.0,759.0,657.0,660.0,639.0,575.0,501.0,432.0,6891.0
Fatehgarh Sahib,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,1.0,2.0,4.0,6.0,5.0,4.0,2.0,6.0,5.0,,2.0,2.0,39.0
Fatehgarh Sahib,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,44.0,39.0,38.0,25.0,33.0,40.0,56.0,41.0,47.0,38.0,15.0,18.0,434.0
Fatehgarh Sahib,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,29.0,23.0,21.0,30.0,34.0,46.0,42.0,42.0,44.0,31.0,32.0,29.0,403.0
Fatehgarh Sahib,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Fatehgarh Sahib,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,74.0,64.0,63.0,61.0,72.0,90.0,100.0,89.0,96.0,69.0,49.0,49.0,876.0
Fatehgarh Sahib,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,0.0,0.0,0.0,,0.0,,,,,,,,0.0
Fatehgarh Sahib,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,58.0,50.0,51.0,44.0,57.0,88.0,95.0,68.0,84.0,67.0,40.0,41.0,743.0
Fatehgarh Sahib,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,0.0,0.0,0.0,2.0,1.0,4.0,3.0,6.0,0.0,0.0,0.0,0.0,16.0
Fatehgarh Sahib,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,10.0,7.0,6.0,11.0,6.0,0.0,0.0,3.0,0.0,0.0,1.0,0.0,44.0
Fatehgarh Sahib,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,6.0,7.0,3.0,4.0,8.0,6.0,2.0,6.0,7.0,2.0,6.0,6.0,63.0
Fatehgarh Sahib,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,445.0,628.0,515.0,634.0,829.0,822.0,766.0,687.0,647.0,798.0,752.0,452.0,7975.0
Fatehgarh Sahib,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,376.0,511.0,471.0,633.0,736.0,812.0,709.0,675.0,568.0,713.0,565.0,420.0,7189.0
Fatehgarh Sahib,6.3,PNC maternal complications attended,TOTAL,0.0,4.0,0.0,1.0,0.0,0.0,,,,,,,5.0
Fatehgarh Sahib,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,11.0,6.0,14.0,18.0,9.0,9.0,0.0,7.0,4.0,8.0,5.0,2.0,93.0
Fatehgarh Sahib,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,1.0
Fatehgarh Sahib,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,11.0,6.0,14.0,18.0,9.0,9.0,0.0,7.0,5.0,8.0,5.0,2.0,94.0
Fatehgarh Sahib,7.2,Number of MTPs conducted at Private Facilities,TOTAL,77.0,67.0,80.0,70.0,64.0,66.0,48.0,41.0,42.0,37.0,33.0,29.0,654.0
Fatehgarh Sahib,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,170.0,24.0,30.0,5.0,93.0,74.0,20.0,75.0,61.0,115.0,62.0,57.0,786.0
Fatehgarh Sahib,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,143.0,71.0,71.0,32.0,139.0,78.0,52.0,114.0,125.0,131.0,83.0,106.0,1145.0
Fatehgarh Sahib,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,313.0,95.0,101.0,37.0,232.0,152.0,72.0,189.0,186.0,246.0,145.0,163.0,1931.0
Fatehgarh Sahib,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,0.0
Fatehgarh Sahib,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0.0,0.0,0.0,,0.0,2.0,1.0,1.0,,,,,4.0
Fatehgarh Sahib,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,0.0,2.0,1.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,4.0
Fatehgarh Sahib,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,2.0,0.0,4.0,3.0,2.0,1.0,0.0,3.0,0.0,0.0,1.0,1.0,17.0
Fatehgarh Sahib,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Fatehgarh Sahib,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,2.0,2.0,5.0,3.0,2.0,3.0,2.0,4.0,0.0,0.0,1.0,1.0,25.0
Fatehgarh Sahib,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,0.0,0.0,0.0,,0.0,,,,,,,,0.0
Fatehgarh Sahib,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,,0.0,35.0,8.0,36.0,7.0,3.0,3.0,,92.0
Fatehgarh Sahib,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,4.0,21.0,30.0,4.0,5.0,12.0,16.0,14.0,6.0,5.0,6.0,5.0,128.0
Fatehgarh Sahib,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,26.0,2.0,55.0,29.0,16.0,18.0,6.0,22.0,14.0,9.0,7.0,29.0,233.0
Fatehgarh Sahib,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Fatehgarh Sahib,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,30.0,23.0,85.0,33.0,21.0,65.0,30.0,72.0,27.0,17.0,16.0,34.0,453.0
Fatehgarh Sahib,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,0.0,0.0,0.0,,0.0,,,,,,,,0.0
Fatehgarh Sahib,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,,0.0,,,,,,,,0.0
Fatehgarh Sahib,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,0.0,2.0,0.0,6.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,10.0
Fatehgarh Sahib,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,9.0,2.0,13.0,2.0,0.0,0.0,0.0,0.0,4.0,0.0,1.0,,31.0
Fatehgarh Sahib,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Fatehgarh Sahib,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,9.0,4.0,13.0,8.0,0.0,0.0,0.0,0.0,4.0,2.0,1.0,0.0,41.0
Fatehgarh Sahib,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,0.0,0.0,0.0,,0.0,,,,,,,,0.0
Fatehgarh Sahib,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,,0.0,,,,,,,,0.0
Fatehgarh Sahib,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,1.0,0.0,1.0,2.0,9.0,6.0,6.0,2.0,1.0,8.0,3.0,3.0,42.0
Fatehgarh Sahib,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,2.0,0.0,0.0,0.0,0.0,1.0,6.0,9.0,2.0,10.0,3.0,1.0,34.0
Fatehgarh Sahib,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Fatehgarh Sahib,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,3.0,0.0,1.0,2.0,9.0,7.0,12.0,11.0,3.0,18.0,6.0,4.0,76.0
Fatehgarh Sahib,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,1.0,2.0,1.0,2.0,4.0,1.0,4.0,7.0,4.0,2.0,1.0,1.0,30.0
Fatehgarh Sahib,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,243.0,243.0,259.0,297.0,225.0,255.0,253.0,252.0,233.0,222.0,221.0,177.0,2880.0
Fatehgarh Sahib,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,5.0,4.0,5.0,4.0,5.0,4.0,4.0,7.0,4.0,5.0,7.0,6.0,60.0
Fatehgarh Sahib,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,22.0,16.0,21.0,22.0,26.0,28.0,21.0,15.0,25.0,20.0,21.0,20.0,257.0
Fatehgarh Sahib,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,35.0,30.0,36.0,28.0,30.0,29.0,24.0,29.0,23.0,21.0,18.0,22.0,325.0
Fatehgarh Sahib,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Fatehgarh Sahib,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,305.0,293.0,321.0,351.0,286.0,316.0,302.0,303.0,285.0,268.0,267.0,225.0,3522.0
Fatehgarh Sahib,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,2.0,0.0,0.0,3.0,7.0,18.0,8.0,17.0,22.0,18.0,10.0,4.0,109.0
Fatehgarh Sahib,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,3.0,4.0,2.0,2.0,2.0,5.0,3.0,2.0,5.0,,2.0,1.0,31.0
Fatehgarh Sahib,9.06,Number of IUCD removals,TOTAL,88.0,60.0,74.0,54.0,41.0,61.0,69.0,81.0,69.0,62.0,71.0,79.0,809.0
Fatehgarh Sahib,9.07,Number of Oral Pills cycles distributed,TOTAL,1028.0,863.0,2440.0,895.0,835.0,1526.0,1042.0,1110.0,1000.0,955.0,1037.0,964.0,13695.0
Fatehgarh Sahib,9.08,Number of Condom pieces distributed,TOTAL,53538.0,50452.0,42238.0,50197.0,42852.0,49669.0,57669.0,57670.0,54782.0,56339.0,55968.0,53363.0,624737.0
Fatehgarh Sahib,9.09,Number of Centchroman (weekly) pills given,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Fatehgarh Sahib,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,23.0,31.0,71.0,29.0,34.0,64.0,63.0,76.0,68.0,60.0,8.0,25.0,552.0
Fatehgarh Sahib,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Fatehgarh Sahib,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,2.0,0.0,0.0,1.0,1.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,5.0
Fatehgarh Sahib,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Fatehgarh Sahib,9.11.2.b,Number of failures following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Fatehgarh Sahib,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Fatehgarh Sahib,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Fatehgarh Sahib,9.12,Number of Institutions having NSV trained doctors,TOTAL,,,,2.0,2.0,2.0,3.0,3.0,3.0,3.0,3.0,3.0,-1.0
Fatehgarh Sahib,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,518.0,706.0,664.0,771.0,837.0,821.0,801.0,803.0,826.0,804.0,701.0,593.0,8845.0
Fatehgarh Sahib,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,774.0,745.0,622.0,675.0,753.0,819.0,869.0,841.0,799.0,809.0,762.0,378.0,8846.0
Fatehgarh Sahib,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,829.0,762.0,688.0,657.0,674.0,738.0,777.0,865.0,898.0,784.0,730.0,604.0,9006.0
Fatehgarh Sahib,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,894.0,831.0,751.0,751.0,755.0,733.0,772.0,753.0,829.0,794.0,755.0,619.0,9237.0
Fatehgarh Sahib,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,,,,,6.0,323.0,329.0
Fatehgarh Sahib,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,74.0,74.0
Fatehgarh Sahib,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,,,,,0.0,24.0,24.0
Fatehgarh Sahib,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,433.0,419.0,435.0,554.0,645.0,699.0,697.0,662.0,587.0,566.0,500.0,452.0,6649.0
Fatehgarh Sahib,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,774.0,745.0,622.0,675.0,753.0,819.0,869.0,841.0,799.0,809.0,762.0,619.0,9087.0
Fatehgarh Sahib,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,826.0,762.0,688.0,657.0,674.0,738.0,777.0,865.0,898.0,784.0,730.0,662.0,9061.0
Fatehgarh Sahib,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,868.0,831.0,751.0,751.0,755.0,733.0,772.0,753.0,829.0,794.0,755.0,618.0,9210.0
Fatehgarh Sahib,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,332.0,352.0,380.0,548.0,561.0,628.0,594.0,601.0,536.0,503.0,402.0,379.0,5816.0
Fatehgarh Sahib,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,764.0,745.0,622.0,675.0,753.0,819.0,879.0,841.0,799.0,809.0,762.0,383.0,8851.0
Fatehgarh Sahib,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,816.0,762.0,688.0,658.0,673.0,738.0,777.0,865.0,898.0,784.0,730.0,622.0,9011.0
Fatehgarh Sahib,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,855.0,831.0,751.0,751.0,755.0,733.0,772.0,753.0,829.0,794.0,755.0,617.0,9196.0
Fatehgarh Sahib,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,691.0,869.0,825.0,816.0,836.0,816.0,759.0,771.0,667.0,657.0,609.0,504.0,8820.0
Fatehgarh Sahib,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,902.0,930.0,777.0,787.0,763.0,647.0,609.0,701.0,673.0,691.0,772.0,609.0,8861.0
Fatehgarh Sahib,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,0.0,0.0,0.0,0.0,0.0,,,,,,,,0.0
Fatehgarh Sahib,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,366.0,450.0,433.0,430.0,470.0,419.0,414.0,403.0,369.0,357.0,320.0,257.0,4688.0
Fatehgarh Sahib,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,324.0,419.0,387.0,386.0,366.0,397.0,343.0,368.0,298.0,300.0,289.0,247.0,4124.0
Fatehgarh Sahib,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,690.0,869.0,820.0,816.0,836.0,816.0,757.0,771.0,667.0,657.0,609.0,504.0,8812.0
Fatehgarh Sahib,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,902.0,928.0,777.0,787.0,763.0,647.0,609.0,701.0,672.0,691.0,771.0,609.0,8857.0
Fatehgarh Sahib,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,902.0,928.0,777.0,787.0,763.0,647.0,609.0,701.0,672.0,691.0,771.0,609.0,8857.0
Fatehgarh Sahib,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,0.0,0.0,0.0,0.0,0.0,,,,,,0.0,,0.0
Fatehgarh Sahib,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,3.0,0.0,2.0,1.0,1.0,0.0,0.0,2.0,0.0,0.0,2.0,0.0,11.0
Fatehgarh Sahib,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,0.0,0.0,1.0,0.0,1.0,0.0,0.0,1.0,0.0,0.0,3.0,0.0,6.0
Fatehgarh Sahib,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,3.0,0.0,3.0,1.0,2.0,0.0,0.0,3.0,0.0,0.0,5.0,0.0,17.0
Fatehgarh Sahib,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,561.0,968.0,603.0,653.0,830.0,642.0,554.0,733.0,701.0,616.0,578.0,434.0,7873.0
Fatehgarh Sahib,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,410.0,1152.0,398.0,625.0,780.0,521.0,498.0,662.0,577.0,559.0,549.0,324.0,7055.0
Fatehgarh Sahib,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,247.0,454.0,303.0,328.0,344.0,449.0,446.0,409.0,296.0,378.0,379.0,237.0,4270.0
Fatehgarh Sahib,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Fatehgarh Sahib,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Fatehgarh Sahib,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.0,6.0,6.0,1.0,0.0,16.0
Fatehgarh Sahib,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,426.0,413.0,406.0,408.0,410.0,422.0,429.0,440.0,427.0,422.0,432.0,422.0,5057.0
Fatehgarh Sahib,10.4.2,Number of Immunisation sessions held during the month,TOTAL,426.0,413.0,401.0,407.0,406.0,421.0,427.0,423.0,423.0,419.0,424.0,366.0,4956.0
Fatehgarh Sahib,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,323.0,325.0,313.0,310.0,310.0,317.0,321.0,324.0,321.0,323.0,327.0,294.0,3808.0
Fatehgarh Sahib,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,0.0
Fatehgarh Sahib,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,688.0,868.0,840.0,816.0,836.0,794.0,716.0,739.0,665.0,416.0,535.0,492.0,8405.0
Fatehgarh Sahib,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,639.0,467.0,479.0,508.0,628.0,575.0,550.0,627.0,610.0,461.0,451.0,500.0,6495.0
Fatehgarh Sahib,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,608.0,723.0,599.0,627.0,718.0,629.0,537.0,680.0,590.0,448.0,436.0,484.0,7079.0
Fatehgarh Sahib,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Fatehgarh Sahib,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Fatehgarh Sahib,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Fatehgarh Sahib,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Fatehgarh Sahib,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Fatehgarh Sahib,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Fatehgarh Sahib,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,6.0,0.0,0.0,0.0,3.0,9.0
Fatehgarh Sahib,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Fatehgarh Sahib,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Fatehgarh Sahib,13.1,Number of Patients operated for cataract,TOTAL,65.0,90.0,71.0,22.0,154.0,248.0,81.0,108.0,95.0,34.0,55.0,64.0,1087.0
Fatehgarh Sahib,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,65.0,90.0,71.0,22.0,154.0,248.0,81.0,108.0,95.0,34.0,55.0,64.0,1087.0
Fatehgarh Sahib,13.3,Number of School children detected with Refractive errors,TOTAL,29.0,14.0,0.0,43.0,46.0,11.0,78.0,,34.0,7.0,4.0,22.0,288.0
Fatehgarh Sahib,13.4,Number of children provided free glasses,TOTAL,0.0,0.0,0.0,48.0,25.0,11.0,28.0,,113.0,93.0,4.0,,322.0
Fatehgarh Sahib,13.5,Number of eyes collected through eye donation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,0.0
Fatehgarh Sahib,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,0.0
Fatehgarh Sahib,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,,,,6.0,6.0,6.0,6.0,6.0,6.0,6.0,6.0,6.0,-1.0
Fatehgarh Sahib,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,,,,2.0,2.0,2.0,3.0,2.0,2.0,4.0,2.0,3.0,-1.0
Fatehgarh Sahib,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,373.0,393.0,352.0,327.0,319.0,373.0,415.0,361.0,355.0,410.0,366.0,321.0,-1.0
Fatehgarh Sahib,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,3.0,1.0,,6.0,7.0,6.0,6.0,6.0,5.0,6.0,6.0,5.0,-1.0
Fatehgarh Sahib,14.05,Number of RKS meetings held during the month,TOTAL,4.0,5.0,5.0,5.0,2.0,2.0,1.0,0.0,7.0,3.0,7.0,8.0,49.0
Fatehgarh Sahib,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,,,,6.0,6.0,7.0,6.0,6.0,7.0,6.0,6.0,4.0,-1.0
Fatehgarh Sahib,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,0.0,2.0,1.0,5.0,0.0,0.0,,,17.0,,,,25.0
Fatehgarh Sahib,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,,,,2.0,,,,,1.0,1.0,,1.0,-1.0
Fatehgarh Sahib,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,7.0,7.0,7.0,2.0,2.0,3.0,2.0,3.0,4.0,4.0,3.0,3.0,-1.0
Fatehgarh Sahib,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,147.0,138.0,114.0,250.0,551.0,412.0,169.0,397.0,174.0,244.0,145.0,92.0,2833.0
Fatehgarh Sahib,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,409.0,549.0,398.0,516.0,211.0,292.0,431.0,148.0,415.0,345.0,305.0,332.0,4351.0
Fatehgarh Sahib,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,133.0,131.0,106.0,267.0,800.0,568.0,196.0,672.0,160.0,151.0,138.0,80.0,3402.0
Fatehgarh Sahib,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,637.0,895.0,661.0,777.0,316.0,546.0,744.0,228.0,629.0,486.0,600.0,554.0,7073.0
Fatehgarh Sahib,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,280.0,269.0,220.0,517.0,1351.0,980.0,365.0,1069.0,334.0,395.0,283.0,172.0,6235.0
Fatehgarh Sahib,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,1046.0,1444.0,1059.0,1293.0,527.0,838.0,1175.0,376.0,1044.0,831.0,905.0,886.0,11424.0
Fatehgarh Sahib,14.10.2.a,Number of death cases of Inpatient males,TOTAL,1.0,0.0,2.0,4.0,1.0,3.0,1.0,1.0,1.0,4.0,2.0,0.0,20.0
Fatehgarh Sahib,14.10.2.b,Number of death cases of Inpatient females,TOTAL,0.0,0.0,0.0,3.0,0.0,1.0,0.0,1.0,2.0,1.0,1.0,0.0,9.0
Fatehgarh Sahib,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,1.0,0.0,2.0,7.0,1.0,4.0,1.0,2.0,3.0,5.0,3.0,0.0,29.0
Fatehgarh Sahib,14.11,In-Patient Head Count at midnight,TOTAL,9.0,16.0,23.0,34.0,62.0,1372.0,1383.0,922.0,416.0,119.0,2.0,5.0,4363.0
Fatehgarh Sahib,14.12.1,OPD attendance (All),TOTAL,38302.0,38397.0,38505.0,48672.0,54575.0,46171.0,45494.0,45042.0,37809.0,38710.0,40856.0,38579.0,511112.0
Fatehgarh Sahib,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,231.0,158.0,167.0,142.0,192.0,333.0,192.0,267.0,247.0,128.0,142.0,121.0,2320.0
Fatehgarh Sahib,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,0.0,0.0,8.0,0.0,0.0,5.0,,3.0,,0.0,,,16.0
Fatehgarh Sahib,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,402.0,729.0,1122.0,886.0,1065.0,1065.0,511.0,1047.0,576.0,387.0,442.0,232.0,8464.0
Fatehgarh Sahib,14.14.a,Number of patients given AYUSH treatment,TOTAL,8743.0,5907.0,5233.0,8042.0,6664.0,12182.0,10333.0,12872.0,10913.0,6026.0,11125.0,3072.0,101112.0
Fatehgarh Sahib,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,246.0,0.0,98.0,1325.0,1333.0,913.0,299.0,674.0,498.0,434.0,299.0,202.0,6321.0
Fatehgarh Sahib,14.14.c,Number of Adolescents counselled,TOTAL,0.0,12.0,0.0,0.0,0.0,0.0,,18.0,,4.0,,,34.0
Fatehgarh Sahib,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,1952.0,1312.0,1922.0,803.0,1327.0,1540.0,2351.0,3495.0,2377.0,2365.0,2727.0,2456.0,24627.0
Fatehgarh Sahib,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,22.0,12.0,60.0,8.0,13.0,27.0,54.0,35.0,57.0,38.0,69.0,64.0,459.0
Fatehgarh Sahib,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,166.0,0.0,4.0,98.0,218.0,368.0,319.0,464.0,476.0,514.0,229.0,127.0,2983.0
Fatehgarh Sahib,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,0.0,0.0,0.0,0.0,0.0,6.0,2.0,2.0,2.0,3.0,1.0,0.0,16.0
Fatehgarh Sahib,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,77.0,5.0,3.0,59.0,98.0,205.0,168.0,180.0,255.0,327.0,199.0,175.0,1751.0
Fatehgarh Sahib,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,0.0,0.0,0.0,0.0,0.0,5.0,1.0,1.0,0.0,1.0,1.0,3.0,12.0
Fatehgarh Sahib,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,135.0,95.0,256.0,233.0,216.0,467.0,298.0,348.0,330.0,457.0,417.0,278.0,3530.0
Fatehgarh Sahib,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,1.0,2.0
Fatehgarh Sahib,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,378.0,100.0,263.0,390.0,532.0,1040.0,785.0,992.0,1061.0,1298.0,845.0,580.0,8264.0
Fatehgarh Sahib,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,0.0,0.0,0.0,0.0,0.0,11.0,3.0,3.0,2.0,5.0,2.0,4.0,30.0
Fatehgarh Sahib,15.2,Number of Widal tests conducted,Number tested,177.0,38.0,86.0,109.0,141.0,164.0,430.0,248.0,119.0,112.0,344.0,211.0,2179.0
Fatehgarh Sahib,15.3.a,Number of VDRL tests conducted on males,Number tested,48.0,0.0,23.0,12.0,40.0,22.0,39.0,63.0,57.0,45.0,119.0,46.0,514.0
Fatehgarh Sahib,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,59.0,9.0,117.0,18.0,38.0,15.0,47.0,47.0,59.0,116.0,74.0,85.0,684.0
Fatehgarh Sahib,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,234.0,298.0,145.0,213.0,266.0,356.0,344.0,433.0,369.0,608.0,439.0,577.0,4282.0
Fatehgarh Sahib,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,341.0,307.0,285.0,243.0,344.0,393.0,430.0,543.0,485.0,769.0,632.0,708.0,5480.0
Fatehgarh Sahib,15.4.1,Number of blood smears examined for Malaria,TOTAL,1173.0,45.0,451.0,1196.0,344.0,1399.0,1841.0,1796.0,1866.0,1830.0,1684.0,1524.0,15149.0
Fatehgarh Sahib,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Fatehgarh Sahib,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Fatehgarh Sahib,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,1500.0,3000.0,2300.0,5250.0,1500.0,5000.0,5370.0,1500.0,3750.0,,500.0,750.0,30420.0
Fatehgarh Sahib,16.1.1,Stock position of DPT vaccines,2. Stocks Received,5000.0,5000.0,7000.0,,8000.0,3000.0,0.0,6000.0,3000.0,,4000.0,3000.0,44000.0
Fatehgarh Sahib,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,,,,,,,0.0,,,,,,0.0
Fatehgarh Sahib,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,3500.0,5700.0,4050.0,3750.0,4500.0,2630.0,3870.0,3750.0,2250.0,,3750.0,2250.0,40000.0
Fatehgarh Sahib,16.1.1,Stock position of DPT vaccines,5. Total Stock,3000.0,2300.0,5250.0,1500.0,5000.0,5370.0,1500.0,3750.0,4500.0,0.0,750.0,1500.0,34420.0
Fatehgarh Sahib,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,,,,,,,,,,,,7450.0,7450.0
Fatehgarh Sahib,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,,,,,,,,,,,,,
Fatehgarh Sahib,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,,,,,,,,,,,,,
Fatehgarh Sahib,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,,,,,,,,,,,,2300.0,2300.0
Fatehgarh Sahib,16.1.1A,Stock Position of Pentavalent,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,5150.0,5150.0
Fatehgarh Sahib,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,3500.0,1000.0,2500.0,5500.0,500.0,6500.0,2000.0,1500.0,5000.0,,0.0,2500.0,30500.0
Fatehgarh Sahib,16.1.2,Stock position of OPV vaccines,2. Stocks Received,5000.0,10000.0,8000.0,0.0,12000.0,3000.0,6000.0,9000.0,6000.0,,6000.0,5000.0,70000.0
Fatehgarh Sahib,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,,,,0.0,,,0.0,,,,,,0.0
Fatehgarh Sahib,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,7500.0,8500.0,5000.0,5000.0,6000.0,7500.0,6500.0,5500.0,5000.0,,3500.0,2500.0,62500.0
Fatehgarh Sahib,16.1.2,Stock position of OPV vaccines,5. Total Stock,1000.0,2500.0,5500.0,500.0,6500.0,2000.0,1500.0,5000.0,6000.0,0.0,2500.0,5000.0,38000.0
Fatehgarh Sahib,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,4750.0,5750.0,4000.0,5250.0,1000.0,5000.0,5300.0,2950.0,5200.0,,2450.0,2200.0,43850.0
Fatehgarh Sahib,16.1.3,Stock position of TT vaccines,2. Stocks Received,3000.0,5000.0,2000.0,0.0,8000.0,3000.0,0.0,6000.0,2000.0,,3000.0,3000.0,35000.0
Fatehgarh Sahib,16.1.3,Stock position of TT vaccines,3. Unusable Stock,,,,0.0,,,0.0,,,,,,0.0
Fatehgarh Sahib,16.1.3,Stock position of TT vaccines,4. Stock Distributed,2000.0,6750.0,750.0,4250.0,4000.0,2700.0,2350.0,3750.0,1750.0,,3250.0,1200.0,32750.0
Fatehgarh Sahib,16.1.3,Stock position of TT vaccines,5. Total Stock,5750.0,4000.0,5250.0,1000.0,5000.0,5300.0,2950.0,5200.0,5450.0,0.0,2200.0,4000.0,46100.0
Fatehgarh Sahib,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Fatehgarh Sahib,16.1.4,Stock position of DT vaccines,2. Stocks Received,,,,,,,,,,,,,
Fatehgarh Sahib,16.1.4,Stock position of DT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Fatehgarh Sahib,16.1.4,Stock position of DT vaccines,4. Stock Distributed,,,,,,,,,,,,,
Fatehgarh Sahib,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Fatehgarh Sahib,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,5000.0,4000.0,5250.0,4250.0,1750.0,5250.0,5400.0,3250.0,6750.0,,2550.0,2300.0,45750.0
Fatehgarh Sahib,16.1.5,Stock position of BCG vaccines,2. Stocks Received,0.0,4000.0,0.0,0.0,4500.0,3000.0,0.0,6000.0,,,3000.0,2000.0,22500.0
Fatehgarh Sahib,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,,,0.0,0.0,,,0.0,,,,,,0.0
Fatehgarh Sahib,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,1000.0,2750.0,1000.0,2500.0,1000.0,2850.0,2150.0,2500.0,1950.0,,3250.0,1200.0,22150.0
Fatehgarh Sahib,16.1.5,Stock position of BCG vaccines,5. Total Stock,4000.0,5250.0,4250.0,1750.0,5250.0,5400.0,3250.0,6750.0,4800.0,0.0,2300.0,3100.0,46100.0
Fatehgarh Sahib,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,1200.0,1750.0,380.0,2130.0,250.0,3500.0,1310.0,1260.0,1140.0,,0.0,0.0,12920.0
Fatehgarh Sahib,16.1.6,Stock position of Measles vaccines,2. Stocks Received,3000.0,2000.0,3000.0,,5250.0,1000.0,2000.0,3000.0,2000.0,,2000.0,2000.0,25250.0
Fatehgarh Sahib,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,,,,0.0,,,0.0,,,,,,0.0
Fatehgarh Sahib,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,2450.0,3370.0,1250.0,1880.0,2000.0,3190.0,2050.0,3120.0,1140.0,,2000.0,1150.0,23600.0
Fatehgarh Sahib,16.1.6,Stock position of Measles vaccines,5. Total Stock,1750.0,380.0,2130.0,250.0,3500.0,1310.0,1260.0,1140.0,2000.0,0.0,0.0,850.0,14570.0
Fatehgarh Sahib,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Fatehgarh Sahib,16.1.7,Stock position of JE vaccines,2. Stocks Received,,,,,,,,,,,,,
Fatehgarh Sahib,16.1.7,Stock position of JE vaccines,3. Unusable Stock,,,,,,,,,,,,,
Fatehgarh Sahib,16.1.7,Stock position of JE vaccines,4. Stock Distributed,,,,,,,,,,,,,
Fatehgarh Sahib,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Fatehgarh Sahib,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,3000.0,3750.0,2500.0,4750.0,1550.0,5150.0,5010.0,2000.0,4260.0,,1510.0,750.0,34230.0
Fatehgarh Sahib,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,3000.0,4000.0,4000.0,0.0,7000.0,3000.0,0.0,6000.0,3000.0,,3000.0,3000.0,36000.0
Fatehgarh Sahib,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,,,,0.0,,,0.0,,,,,,0.0
Fatehgarh Sahib,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,2250.0,5250.0,1750.0,3200.0,3400.0,3140.0,3010.0,3740.0,2250.0,,3760.0,1700.0,33450.0
Fatehgarh Sahib,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,3750.0,2500.0,4750.0,1550.0,5150.0,5010.0,2000.0,4260.0,5010.0,0.0,750.0,2050.0,36780.0
Fatehgarh Sahib,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Fatehgarh Sahib,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Fatehgarh Sahib,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Fatehgarh Sahib,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Fatehgarh Sahib,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Fatehgarh Sahib,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Fatehgarh Sahib,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Fatehgarh Sahib,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Fatehgarh Sahib,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Fatehgarh Sahib,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Fatehgarh Sahib,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Fatehgarh Sahib,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Fatehgarh Sahib,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Fatehgarh Sahib,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Fatehgarh Sahib,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Fatehgarh Sahib,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Fatehgarh Sahib,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Fatehgarh Sahib,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Fatehgarh Sahib,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Fatehgarh Sahib,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Fatehgarh Sahib,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Fatehgarh Sahib,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Fatehgarh Sahib,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Fatehgarh Sahib,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Fatehgarh Sahib,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Fatehgarh Sahib,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,,,,,,,,,,,,,
Fatehgarh Sahib,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,,,,,,,,,,,,,
Fatehgarh Sahib,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,,,,,,,,,,,,,
Fatehgarh Sahib,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,,,,,,,,,,,,,
Fatehgarh Sahib,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Fatehgarh Sahib,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,,,,,,,,,,,,,
Fatehgarh Sahib,16.3.02,Stock Position of Gloves,2. Stocks Received,,,,,,,,,,,,,
Fatehgarh Sahib,16.3.02,Stock Position of Gloves,3. Unusable Stock,,,,,,,,,,,,,
Fatehgarh Sahib,16.3.02,Stock Position of Gloves,4. Stock Distributed,,,,,,,,,,,,,
Fatehgarh Sahib,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Fatehgarh Sahib,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,,,,,,,,,,,,,
Fatehgarh Sahib,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,,,,,,,,,,,,,
Fatehgarh Sahib,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,,,,,,,,,,,,,
Fatehgarh Sahib,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,,,,,,,,,,,,,
Fatehgarh Sahib,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Fatehgarh Sahib,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
Fatehgarh Sahib,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,,,,,,,,,,,,,
Fatehgarh Sahib,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,,,,,,,,,,,,,
Fatehgarh Sahib,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,,,,,,,,,,,,,
Fatehgarh Sahib,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Fatehgarh Sahib,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,,,,,,,,,,,,,
Fatehgarh Sahib,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,,,,,,,,,,,,,
Fatehgarh Sahib,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,,,,,,,,,,,,,
Fatehgarh Sahib,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,,,,,,,,,,,,,
Fatehgarh Sahib,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Fatehgarh Sahib,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,,,,,,,,,,,,,
Fatehgarh Sahib,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,,,,,,,,,,,,,
Fatehgarh Sahib,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,,,,,,,,,,,,,
Fatehgarh Sahib,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,,,,,,,,,,,,,
Fatehgarh Sahib,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Fatehgarh Sahib,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
Fatehgarh Sahib,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,,,,,,,,,,,,,
Fatehgarh Sahib,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,,,,,,,,,,,,,
Fatehgarh Sahib,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,,,,,,,,,,,,,
Fatehgarh Sahib,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Fatehgarh Sahib,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,,,,,,,,,,,,,
Fatehgarh Sahib,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,,,,,,,,,,,,,
Fatehgarh Sahib,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,,,,,,,,,,,,,
Fatehgarh Sahib,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,,,,,,,,,,,,,
Fatehgarh Sahib,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Fatehgarh Sahib,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,,,,,,,,,,,,,
Fatehgarh Sahib,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,,,,,,,,,,,,,
Fatehgarh Sahib,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,,,,,,,,,,,,,
Fatehgarh Sahib,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,,,,,,,,,,,,,
Fatehgarh Sahib,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Fatehgarh Sahib,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,,,,,,,,,,,,,
Fatehgarh Sahib,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,,,,,,,,,,,,,
Fatehgarh Sahib,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,,,,,,,,,,,,,
Fatehgarh Sahib,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,,,,,,,,,,,,,
Fatehgarh Sahib,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Fatehgarh Sahib,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,,,,,,,,,,,,,
Fatehgarh Sahib,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,,,,,,,,,,,,,
Fatehgarh Sahib,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,,,,,,,,,,,,,
Fatehgarh Sahib,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,,,,,,,,,,,,,
Fatehgarh Sahib,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Fatehgarh Sahib,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,2000.0,1400.0,,0.0,0.0,,3400.0,3400.0,3400.0,,2000.0,0.0,15600.0
Fatehgarh Sahib,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,,,,0.0,0.0,4000.0,0.0,0.0,,,,0.0,4000.0
Fatehgarh Sahib,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,,,,0.0,0.0,,0.0,,,,,0.0,0.0
Fatehgarh Sahib,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,600.0,600.0,,0.0,0.0,600.0,0.0,0.0,1000.0,,2000.0,0.0,4800.0
Fatehgarh Sahib,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,1400.0,800.0,0.0,0.0,0.0,3400.0,3400.0,3400.0,2400.0,0.0,0.0,0.0,14800.0
Fatehgarh Sahib,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,0.0,,0.0,24000.0,0.0,,0.0,0.0,0.0,,40000.0,0.0,64000.0
Fatehgarh Sahib,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,,,60000.0,0.0,0.0,,0.0,0.0,,,,0.0,60000.0
Fatehgarh Sahib,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,,,,0.0,0.0,,0.0,0.0,,,,0.0,0.0
Fatehgarh Sahib,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,,,36000.0,24000.0,0.0,,0.0,0.0,0.0,,40000.0,0.0,100000.0
Fatehgarh Sahib,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,0.0,0.0,24000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,24000.0
Fatehgarh Sahib,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,0.0,,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,,0.0,0.0
Fatehgarh Sahib,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,,,0.0,0.0,0.0,,0.0,0.0,,,,0.0,0.0
Fatehgarh Sahib,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,,,0.0,0.0,0.0,,0.0,0.0,,0.0,,0.0,0.0
Fatehgarh Sahib,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,,,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,,0.0,0.0
Fatehgarh Sahib,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Fatehgarh Sahib,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,,,,,,,,,,,,,
Fatehgarh Sahib,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Fatehgarh Sahib,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Fatehgarh Sahib,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,,,,,,,,,,,,
Fatehgarh Sahib,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Fatehgarh Sahib,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Fatehgarh Sahib,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,,,,,,,,,,,,,
Fatehgarh Sahib,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Fatehgarh Sahib,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,,,,,,,2.0,,,,2.0
Fatehgarh Sahib,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,,,,,,,,,2.0,,,,2.0
Fatehgarh Sahib,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,,,1.0,,,,,3.0,3.0,1.0,,,8.0
Fatehgarh Sahib,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,,,,,,,,,1.0,,1.0,2.0
Fatehgarh Sahib,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,,,1.0,,,,,3.0,3.0,2.0,,1.0,10.0
Fatehgarh Sahib,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,,,,,,,1.0,1.0,1.0,,,3.0
Fatehgarh Sahib,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,,,,,1.0,,,,,1.0
Fatehgarh Sahib,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,,,,,,,,2.0,1.0,1.0,,,4.0
Fatehgarh Sahib,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,1.0,,,,,,,,,1.0
Fatehgarh Sahib,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
Fatehgarh Sahib,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,1.0,,,,,,,,,1.0
Fatehgarh Sahib,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,,,,,,,1.0,,1.0,,2.0
Fatehgarh Sahib,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,,,,,,,,,,
Fatehgarh Sahib,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,,,,,,,,1.0,,1.0,,2.0
Fatehgarh Sahib,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Fatehgarh Sahib,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Fatehgarh Sahib,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Fatehgarh Sahib,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,,,1.0,,,1.0,1.0,,2.0,6.0,3.0,,14.0
Fatehgarh Sahib,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,,2.0,1.0,,,,,1.0,2.0,1.0,,,7.0
Fatehgarh Sahib,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,,2.0,2.0,,,1.0,1.0,1.0,4.0,7.0,3.0,,21.0
Fatehgarh Sahib,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
Fatehgarh Sahib,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,,,,,,,,,
Fatehgarh Sahib,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,,1.0,,,,,,,1.0
Fatehgarh Sahib,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,,,,1.0,,,,,,,1.0
Fatehgarh Sahib,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
Fatehgarh Sahib,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,,,,1.0,2.0,1.0,,,,,1.0,,5.0
Fatehgarh Sahib,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,,,,1.0,,1.0,2.0,,,,1.0,1.0,6.0
Fatehgarh Sahib,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,,,,2.0,2.0,2.0,2.0,,,,2.0,1.0,11.0
Fatehgarh Sahib,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,,,,,,
Fatehgarh Sahib,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,,,,,,1.0,1.0,,,4.0,,1.0,7.0
Fatehgarh Sahib,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,,,,,2.0,1.0,,,1.0,3.0,6.0,5.0,18.0
Fatehgarh Sahib,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,,,,,2.0,2.0,1.0,,1.0,7.0,6.0,6.0,25.0
Fatehgarh Sahib,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
Fatehgarh Sahib,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,,,,,,,,
Fatehgarh Sahib,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
Fatehgarh Sahib,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,,,,,,,,,,
Fatehgarh Sahib,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,,,,,,,,,,
Fatehgarh Sahib,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,,,,,,,1.0,,,,,,1.0
Fatehgarh Sahib,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,,,1.0,,,,,1.0,,1.0,1.0,2.0,6.0
Fatehgarh Sahib,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,,,1.0,,,,1.0,1.0,,1.0,1.0,2.0,7.0
Fatehgarh Sahib,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
Fatehgarh Sahib,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,,,,,,,,,1.0,,1.0
Fatehgarh Sahib,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,1.0,,,,,1.0
Fatehgarh Sahib,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,,,,,,1.0,,,1.0,,2.0
Fatehgarh Sahib,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,1.0,,,,,,,,,1.0
Fatehgarh Sahib,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,,5.0,8.0,6.0,9.0,15.0,12.0,9.0,17.0,16.0,7.0,11.0,115.0
Fatehgarh Sahib,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,,8.0,10.0,18.0,15.0,11.0,22.0,19.0,35.0,36.0,28.0,21.0,223.0
Fatehgarh Sahib,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,,13.0,18.0,25.0,24.0,26.0,34.0,28.0,52.0,52.0,35.0,32.0,339.0
Fatehgarh Sahib,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,,,,,,,
Fatehgarh Sahib,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,,,,,,,,1.0,1.0,,1.0,,3.0
Fatehgarh Sahib,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,,,,,1.0,1.0,,,1.0,1.0,,,4.0
Fatehgarh Sahib,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,,,,,1.0,1.0,,1.0,2.0,1.0,1.0,,7.0
Fatehgarh Sahib,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Fatehgarh Sahib,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
Fatehgarh Sahib,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Fatehgarh Sahib,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
Fatehgarh Sahib,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Fatehgarh Sahib,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,,,,,,,,
Fatehgarh Sahib,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Fatehgarh Sahib,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,,,,,,,,
Fatehgarh Sahib,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Fatehgarh Sahib,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,,,,,,,,,,
Fatehgarh Sahib,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Fatehgarh Sahib,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,,,,,,,,,,,
Fatehgarh Sahib,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Fatehgarh Sahib,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,,,,,,,,,,,
Fatehgarh Sahib,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Fatehgarh Sahib,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,,,,,,,,,,,
Fatehgarh Sahib,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Fatehgarh Sahib,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,1.0,,,,,,,,1.0
Fatehgarh Sahib,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Fatehgarh Sahib,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,1.0,,,,,,,,1.0
Fatehgarh Sahib,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Fatehgarh Sahib,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,,,,,,,,,,1.0,,,1.0
Fatehgarh Sahib,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Fatehgarh Sahib,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,,,,,,,,,,1.0,,,1.0
Fatehgarh Sahib,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,,,1.0,,,,,,,,1.0,2.0
Fatehgarh Sahib,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,,,,,4.0,6.0,14.0,10.0,7.0,10.0,6.0,3.0,60.0
Fatehgarh Sahib,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,,,,,,1.0,3.0,2.0,3.0,3.0,3.0,1.0,16.0
Fatehgarh Sahib,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,,,,1.0,4.0,7.0,17.0,12.0,10.0,13.0,9.0,5.0,78.0
Fatehgarh Sahib,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,,,,,,,,,
Fatehgarh Sahib,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,,,3.0,2.0,1.0,4.0,1.0,2.0,2.0,,1.0,1.0,17.0
Fatehgarh Sahib,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,,,,,,,,,,,,
Fatehgarh Sahib,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,,,3.0,2.0,1.0,4.0,1.0,2.0,2.0,,1.0,1.0,17.0
Fatehgarh Sahib,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,,,,,1.0,,,,,1.0
Fatehgarh Sahib,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,,,,,1.0,1.0,,,,,,2.0
Fatehgarh Sahib,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,,,1.0,,1.0,,,,,,2.0
Fatehgarh Sahib,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,,,,,1.0,1.0,2.0,1.0,,,,,5.0
Fatehgarh Sahib,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,,,,,,,,,,,
Fatehgarh Sahib,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,,,1.0,,,,,,,,,,1.0
Fatehgarh Sahib,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,,,,,,,,,,,,,
Fatehgarh Sahib,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,,,1.0,,,,,,,,,,1.0
Fatehgarh Sahib,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,,,,,,,,,,,,
Fatehgarh Sahib,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,,,,,4.0,3.0,1.0,,5.0,3.0,3.0,4.0,23.0
Fatehgarh Sahib,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,,,,3.0,7.0,2.0,3.0,3.0,6.0,4.0,6.0,11.0,45.0
Fatehgarh Sahib,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,,,,3.0,11.0,5.0,4.0,3.0,11.0,7.0,9.0,15.0,68.0
Fatehgarh Sahib,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,,1.0,,1.0,,,,1.0,1.0,,,1.0,5.0
Fatehgarh Sahib,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,,10.0,12.0,6.0,10.0,21.0,26.0,22.0,25.0,30.0,22.0,22.0,206.0
Fatehgarh Sahib,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,,36.0,30.0,37.0,50.0,59.0,73.0,68.0,115.0,151.0,118.0,66.0,803.0
Fatehgarh Sahib,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,,47.0,42.0,44.0,60.0,80.0,99.0,91.0,141.0,181.0,140.0,89.0,1014.0
Fazilka,1.1,Total number of pregnant women Registered for ANC,TOTAL,1710.0,1742.0,1357.0,1482.0,1483.0,1206.0,1001.0,1144.0,1125.0,1480.0,1628.0,1029.0,16387.0
Fazilka,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,1282.0,1207.0,1003.0,1103.0,1073.0,835.0,703.0,808.0,784.0,1099.0,1228.0,755.0,11880.0
Fazilka,1.2,Number of Pregnant women registered under JSY,TOTAL,781.0,811.0,671.0,776.0,701.0,530.0,450.0,541.0,582.0,739.0,812.0,495.0,7889.0
Fazilka,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,1300.0,1402.0,1340.0,1444.0,1200.0,1315.0,1320.0,1190.0,1101.0,1070.0,1074.0,835.0,14591.0
Fazilka,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,1539.0,1645.0,1240.0,1393.0,1362.0,1105.0,946.0,1054.0,1033.0,1365.0,1492.0,956.0,15130.0
Fazilka,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,1510.0,1589.0,1465.0,1284.0,1389.0,1284.0,1131.0,1047.0,1045.0,1116.0,1264.0,1008.0,15132.0
Fazilka,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,1152.0,1457.0,1368.0,1431.0,1050.0,1142.0,1218.0,1143.0,1132.0,1117.0,1089.0,855.0,14154.0
Fazilka,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,7.0,5.0,6.0,2.0,0.0,4.0,8.0,10.0,3.0,3.0,2.0,2.0,52.0
Fazilka,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Fazilka,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,1229.0,1559.0,1330.0,1298.0,1350.0,1252.0,1127.0,1127.0,1219.0,1387.0,1488.0,892.0,15258.0
Fazilka,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,0.0,0.0,0.0,1.0,0.0,0.0,2.0,0.0,0.0,0.0,0.0,0.0,3.0
Fazilka,1.8,Number of pregnancy test kits used at SC level,TOTAL,198.0,200.0,250.0,246.0,177.0,211.0,211.0,185.0,173.0,213.0,337.0,157.0,2558.0
Fazilka,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,15.0,12.0,6.0,6.0,7.0,6.0,27.0,19.0,14.0,10.0,7.0,4.0,133.0
Fazilka,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,163.0,200.0,177.0,207.0,295.0,237.0,275.0,292.0,245.0,230.0,185.0,168.0,2674.0
Fazilka,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,178.0,212.0,183.0,213.0,302.0,243.0,302.0,311.0,259.0,240.0,192.0,172.0,2807.0
Fazilka,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,146.0,188.0,167.0,189.0,276.0,217.0,277.0,282.0,234.0,200.0,171.0,152.0,2499.0
Fazilka,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,6.0,4.0,3.0,10.0,16.0,11.0,12.0,5.0,4.0,0.0,0.0,0.0,71.0
Fazilka,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,492.0,597.0,646.0,821.0,894.0,965.0,963.0,851.0,760.0,832.0,691.0,644.0,9156.0
Fazilka,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,438.0,523.0,575.0,720.0,773.0,799.0,782.0,685.0,646.0,690.0,596.0,570.0,7797.0
Fazilka,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,236.0,297.0,292.0,416.0,412.0,458.0,494.0,545.0,497.0,439.0,412.0,395.0,4893.0
Fazilka,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Fazilka,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Fazilka,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,95.0,97.0,115.0,51.0,145.0,146.0,128.0,130.0,137.0,155.0,127.0,96.0,1422.0
Fazilka,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,5.0,9.0,8.0,10.0,1.0,7.0,10.0,4.0,6.0,3.0,2.0,0.0,65.0
Fazilka,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Fazilka,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Fazilka,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Fazilka,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Fazilka,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,55.0,65.0,71.0,101.0,121.0,166.0,181.0,166.0,114.0,142.0,95.0,74.0,1351.0
Fazilka,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Fazilka,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,55.0,65.0,71.0,101.0,121.0,166.0,181.0,166.0,114.0,142.0,95.0,74.0,1351.0
Fazilka,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,17.0,18.0,22.0,7.0,23.0,31.0,31.0,34.0,37.0,37.0,36.0,22.0,315.0
Fazilka,4.1.1.a,Number of male live births,TOTAL,426.0,469.0,499.0,565.0,702.0,740.0,734.0,658.0,605.0,641.0,517.0,462.0,7018.0
Fazilka,4.1.1.b,Number of female live births,TOTAL,335.0,419.0,435.0,513.0,629.0,607.0,652.0,618.0,536.0,566.0,478.0,436.0,6224.0
Fazilka,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,761.0,888.0,934.0,1078.0,1331.0,1347.0,1386.0,1276.0,1141.0,1207.0,995.0,898.0,13242.0
Fazilka,4.1.2,Number of still births,TOTAL,15.0,25.0,15.0,17.0,19.0,27.0,27.0,29.0,30.0,29.0,25.0,20.0,278.0
Fazilka,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,29.0,24.0,14.0,16.0,20.0,23.0,6.0,4.0,23.0,27.0,26.0,18.0,230.0
Fazilka,4.2.1,Number of Newborns weighed at birth,TOTAL,653.0,763.0,672.0,984.0,1178.0,1221.0,1269.0,1122.0,1025.0,1205.0,992.0,889.0,11973.0
Fazilka,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,102.0,115.0,216.0,124.0,142.0,127.0,153.0,151.0,147.0,118.0,84.0,63.0,1542.0
Fazilka,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,618.0,753.0,785.0,900.0,1158.0,1129.0,1059.0,1050.0,899.0,1205.0,993.0,894.0,11443.0
Fazilka,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,4.0,0.0,4.0
Fazilka,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,8.0,9.0,1.0,18.0
Fazilka,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,162.0,80.0,82.0,324.0
Fazilka,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Fazilka,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,170.0,93.0,83.0,346.0
Fazilka,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Fazilka,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,15.0,0.0,21.0,34.0,55.0,41.0,52.0,31.0,21.0,76.0,40.0,50.0,436.0
Fazilka,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0,2.0
Fazilka,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,15.0,0.0,21.0,34.0,55.0,41.0,52.0,31.0,21.0,30.0,201.0,70.0,571.0
Fazilka,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,46.0,46.0,20.0,54.0,34.0,89.0,228.0,273.0,202.0,126.0,108.0,96.0,1322.0
Fazilka,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,583.0,706.0,808.0,999.0,1188.0,1174.0,1199.0,1117.0,969.0,1074.0,977.0,836.0,11630.0
Fazilka,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,322.0,351.0,358.0,471.0,659.0,698.0,756.0,676.0,533.0,630.0,505.0,344.0,6303.0
Fazilka,6.3,PNC maternal complications attended,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Fazilka,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,0.0,0.0,25.0,19.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,44.0
Fazilka,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Fazilka,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,0.0,0.0,25.0,19.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,44.0
Fazilka,7.2,Number of MTPs conducted at Private Facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Fazilka,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,10.0,20.0,50.0,27.0,0.0,49.0,12.0,18.0,34.0,9.0,55.0,25.0,309.0
Fazilka,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,82.0,180.0,137.0,140.0,0.0,213.0,102.0,140.0,158.0,165.0,200.0,109.0,1626.0
Fazilka,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,92.0,200.0,187.0,167.0,0.0,262.0,114.0,158.0,192.0,174.0,255.0,134.0,1935.0
Fazilka,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Fazilka,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Fazilka,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,1.0,0.0,0.0,3.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,5.0
Fazilka,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,1.0,2.0,4.0,1.0,0.0,1.0,0.0,0.0,0.0,2.0,1.0,1.0,13.0
Fazilka,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Fazilka,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,2.0,2.0,4.0,4.0,0.0,1.0,0.0,0.0,0.0,2.0,1.0,2.0,18.0
Fazilka,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Fazilka,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Fazilka,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Fazilka,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Fazilka,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Fazilka,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Fazilka,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Fazilka,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Fazilka,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,69.0,79.0,45.0,0.0,9.0,3.0,31.0,3.0,3.0,4.0,2.0,1.0,249.0
Fazilka,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,127.0,228.0,318.0,102.0,34.0,20.0,24.0,18.0,8.0,31.0,92.0,158.0,1160.0
Fazilka,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Fazilka,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,196.0,307.0,363.0,102.0,43.0,23.0,55.0,21.0,11.0,35.0,94.0,159.0,1409.0
Fazilka,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Fazilka,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Fazilka,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Fazilka,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,2.0,1.0,3.0,5.0,13.0,6.0,12.0,16.0,15.0,13.0,13.0,10.0,109.0
Fazilka,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Fazilka,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,2.0,1.0,3.0,5.0,13.0,6.0,12.0,16.0,15.0,13.0,13.0,10.0,109.0
Fazilka,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Fazilka,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,594.0,475.0,512.0,777.0,569.0,557.0,581.0,577.0,498.0,526.0,492.0,298.0,6456.0
Fazilka,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,4.0,0.0,5.0,4.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,13.0
Fazilka,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,32.0,30.0,28.0,26.0,30.0,30.0,28.0,28.0,32.0,29.0,30.0,18.0,341.0
Fazilka,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,86.0,101.0,96.0,120.0,143.0,90.0,79.0,80.0,125.0,77.0,75.0,72.0,1144.0
Fazilka,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Fazilka,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,716.0,606.0,641.0,927.0,742.0,677.0,688.0,685.0,655.0,632.0,597.0,388.0,7954.0
Fazilka,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,7.0,26.0,24.0,24.0,0.0,8.0,0.0,0.0,2.0,0.0,0.0,3.0,94.0
Fazilka,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Fazilka,9.06,Number of IUCD removals,TOTAL,224.0,150.0,145.0,196.0,169.0,177.0,188.0,160.0,162.0,154.0,155.0,104.0,1984.0
Fazilka,9.07,Number of Oral Pills cycles distributed,TOTAL,3242.0,3349.0,2669.0,2935.0,3260.0,4500.0,4476.0,6520.0,4095.0,3759.0,3927.0,3029.0,45761.0
Fazilka,9.08,Number of Condom pieces distributed,TOTAL,66413.0,62255.0,57561.0,56597.0,65213.0,71800.0,76236.0,91748.0,75048.0,74609.0,71915.0,52994.0,822389.0
Fazilka,9.09,Number of Centchroman (weekly) pills given,TOTAL,0.0,43.0,17.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,60.0
Fazilka,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,24.0,12.0,13.0,10.0,18.0,143.0,92.0,82.0,103.0,116.0,96.0,97.0,806.0
Fazilka,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Fazilka,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Fazilka,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Fazilka,9.11.2.b,Number of failures following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Fazilka,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Fazilka,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Fazilka,9.12,Number of Institutions having NSV trained doctors,TOTAL,,1.0,1.0,1.0,2.0,1.0,2.0,1.0,1.0,2.0,2.0,1.0,-1.0
Fazilka,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,1150.0,1043.0,959.0,1194.0,1468.0,1455.0,1442.0,1478.0,1179.0,1163.0,1203.0,687.0,14421.0
Fazilka,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,1362.0,1245.0,1032.0,1158.0,1266.0,1345.0,1489.0,1591.0,1419.0,1270.0,557.0,125.0,13859.0
Fazilka,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,1472.0,1394.0,1138.0,1143.0,1160.0,1222.0,1227.0,1461.0,1454.0,1326.0,1295.0,487.0,14779.0
Fazilka,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,1361.0,1450.0,1240.0,1265.0,1097.0,1103.0,1188.0,1280.0,1366.0,1304.0,1379.0,773.0,14806.0
Fazilka,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,836.0,787.0,1623.0
Fazilka,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,11.0,429.0,440.0
Fazilka,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,6.0,26.0,32.0
Fazilka,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,898.0,802.0,979.0,1177.0,1386.0,1364.0,1371.0,1155.0,1036.0,1031.0,899.0,701.0,12799.0
Fazilka,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,1359.0,1252.0,1027.0,1149.0,1266.0,1342.0,1501.0,1591.0,1413.0,1270.0,1352.0,842.0,15364.0
Fazilka,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,1470.0,1391.0,1133.0,1142.0,1152.0,1215.0,1227.0,1461.0,1444.0,1326.0,1303.0,921.0,15185.0
Fazilka,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,1354.0,1450.0,1232.0,1249.0,1097.0,1095.0,1188.0,1280.0,1363.0,1306.0,1394.0,825.0,14833.0
Fazilka,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,741.0,652.0,831.0,1089.0,1159.0,1201.0,1195.0,998.0,871.0,883.0,770.0,634.0,11024.0
Fazilka,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,1368.0,977.0,1094.0,1157.0,1254.0,1346.0,1485.0,1592.0,1419.0,1269.0,556.0,107.0,13624.0
Fazilka,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,1464.0,1131.0,1186.0,1182.0,1155.0,1216.0,1224.0,1460.0,1446.0,1331.0,1308.0,484.0,14587.0
Fazilka,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,1367.0,1196.0,1282.0,1278.0,1105.0,1116.0,1192.0,1283.0,1366.0,1305.0,1373.0,775.0,14638.0
Fazilka,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,1176.0,1393.0,1167.0,1412.0,1453.0,1390.0,1182.0,1275.0,1079.0,1004.0,943.0,701.0,14175.0
Fazilka,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,1125.0,1162.0,1047.0,1256.0,1091.0,1046.0,854.0,1025.0,955.0,971.0,1096.0,739.0,12367.0
Fazilka,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,3.0,0.0,2.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,5.0
Fazilka,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,616.0,720.0,612.0,730.0,772.0,720.0,599.0,674.0,579.0,526.0,511.0,386.0,7445.0
Fazilka,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,525.0,637.0,514.0,639.0,681.0,631.0,551.0,571.0,485.0,449.0,417.0,310.0,6410.0
Fazilka,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,1141.0,1357.0,1126.0,1369.0,1453.0,1351.0,1150.0,1245.0,1064.0,975.0,928.0,696.0,13855.0
Fazilka,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,1136.0,1181.0,1067.0,1266.0,1100.0,1053.0,889.0,1015.0,948.0,983.0,1096.0,739.0,12473.0
Fazilka,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,1135.0,1171.0,1065.0,1250.0,1100.0,1053.0,889.0,1015.0,948.0,983.0,1096.0,739.0,12444.0
Fazilka,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,0.0,0.0,0.0,0.0,0.0,15.0,0.0,0.0,0.0,0.0,0.0,0.0,15.0
Fazilka,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,20.0,21.0,19.0,20.0,0.0,32.0,36.0,33.0,76.0,15.0,15.0,9.0,296.0
Fazilka,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,15.0,15.0,11.0,21.0,0.0,33.0,31.0,33.0,69.0,13.0,15.0,8.0,264.0
Fazilka,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,35.0,36.0,30.0,41.0,0.0,65.0,67.0,66.0,145.0,28.0,30.0,17.0,560.0
Fazilka,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,743.0,799.0,711.0,933.0,691.0,961.0,915.0,921.0,776.0,725.0,694.0,466.0,9335.0
Fazilka,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,611.0,678.0,579.0,922.0,641.0,881.0,856.0,796.0,680.0,599.0,528.0,408.0,8179.0
Fazilka,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,535.0,554.0,546.0,710.0,566.0,896.0,702.0,671.0,590.0,492.0,445.0,355.0,7062.0
Fazilka,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Fazilka,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Fazilka,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Fazilka,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,704.0,696.0,691.0,709.0,671.0,686.0,689.0,689.0,710.0,703.0,697.0,693.0,8338.0
Fazilka,10.4.2,Number of Immunisation sessions held during the month,TOTAL,684.0,677.0,664.0,695.0,641.0,665.0,675.0,673.0,687.0,673.0,676.0,363.0,7773.0
Fazilka,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,599.0,599.0,590.0,603.0,600.0,593.0,599.0,599.0,614.0,607.0,612.0,315.0,6930.0
Fazilka,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Fazilka,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,1169.0,1387.0,1152.0,1385.0,1330.0,1384.0,1159.0,1263.0,1057.0,913.0,841.0,643.0,13683.0
Fazilka,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,503.0,523.0,539.0,590.0,547.0,586.0,527.0,509.0,645.0,535.0,475.0,323.0,6302.0
Fazilka,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,588.0,583.0,579.0,648.0,533.0,844.0,754.0,775.0,632.0,580.0,575.0,365.0,7456.0
Fazilka,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Fazilka,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Fazilka,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Fazilka,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Fazilka,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Fazilka,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Fazilka,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,5.0,4.0,0.0,0.0,15.0,10.0,4.0,3.0,0.0,2.0,2.0,0.0,45.0
Fazilka,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0
Fazilka,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Fazilka,13.1,Number of Patients operated for cataract,TOTAL,0.0,0.0,0.0,0.0,0.0,31.0,0.0,0.0,0.0,0.0,15.0,24.0,70.0
Fazilka,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,15.0,24.0,39.0
Fazilka,13.3,Number of School children detected with Refractive errors,TOTAL,21.0,108.0,104.0,39.0,0.0,0.0,170.0,23.0,8.0,43.0,20.0,28.0,564.0
Fazilka,13.4,Number of children provided free glasses,TOTAL,0.0,87.0,0.0,0.0,0.0,83.0,86.0,0.0,108.0,27.0,0.0,44.0,435.0
Fazilka,13.5,Number of eyes collected through eye donation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Fazilka,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Fazilka,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,,1.0,,2.0,3.0,3.0,3.0,3.0,3.0,4.0,4.0,4.0,-1.0
Fazilka,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,,,,3.0,2.0,,,2.0,1.0,1.0,1.0,1.0,-1.0
Fazilka,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,361.0,404.0,396.0,404.0,418.0,392.0,422.0,415.0,417.0,412.0,448.0,189.0,-1.0
Fazilka,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,,1.0,2.0,3.0,3.0,3.0,3.0,3.0,3.0,3.0,3.0,3.0,-1.0
Fazilka,14.05,Number of RKS meetings held during the month,TOTAL,0.0,4.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,3.0,0.0,0.0,8.0
Fazilka,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,,,1.0,3.0,3.0,3.0,3.0,3.0,3.0,3.0,3.0,3.0,-1.0
Fazilka,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,9.0,0.0,0.0,0.0,0.0,20.0,11.0,7.0,14.0,16.0,14.0,16.0,107.0
Fazilka,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,,,,1.0,2.0,2.0,2.0,2.0,2.0,2.0,2.0,2.0,-1.0
Fazilka,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,4.0,5.0,4.0,3.0,2.0,1.0,1.0,0.0,0.0,0.0,0.0,0.0,-1.0
Fazilka,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,223.0,279.0,280.0,796.0,434.0,507.0,365.0,435.0,428.0,406.0,247.0,305.0,4705.0
Fazilka,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,567.0,664.0,712.0,777.0,946.0,625.0,589.0,553.0,466.0,437.0,418.0,589.0,7343.0
Fazilka,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,159.0,257.0,240.0,253.0,416.0,447.0,316.0,369.0,760.0,353.0,225.0,312.0,4107.0
Fazilka,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,2426.0,1450.0,1634.0,1015.0,1716.0,1681.0,1566.0,1398.0,760.0,1248.0,921.0,1368.0,17183.0
Fazilka,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,382.0,536.0,520.0,1049.0,850.0,954.0,681.0,804.0,1188.0,759.0,472.0,617.0,8812.0
Fazilka,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,2993.0,2114.0,2346.0,1792.0,2662.0,2306.0,2155.0,1951.0,1226.0,1685.0,1339.0,1957.0,24526.0
Fazilka,14.10.2.a,Number of death cases of Inpatient males,TOTAL,6.0,6.0,8.0,12.0,11.0,17.0,4.0,9.0,10.0,6.0,9.0,16.0,114.0
Fazilka,14.10.2.b,Number of death cases of Inpatient females,TOTAL,5.0,4.0,4.0,4.0,5.0,6.0,7.0,3.0,5.0,2.0,3.0,7.0,55.0
Fazilka,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,11.0,10.0,12.0,16.0,16.0,23.0,11.0,12.0,15.0,8.0,12.0,23.0,169.0
Fazilka,14.11,In-Patient Head Count at midnight,TOTAL,118.0,98.0,84.0,18.0,40.0,156.0,226.0,223.0,148.0,185.0,160.0,150.0,1606.0
Fazilka,14.12.1,OPD attendance (All),TOTAL,40372.0,50502.0,45452.0,49774.0,51156.0,49446.0,41344.0,44895.0,42282.0,40680.0,45030.0,47929.0,548862.0
Fazilka,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,366.0,347.0,203.0,113.0,401.0,245.0,233.0,110.0,188.0,281.0,238.0,275.0,3000.0
Fazilka,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,61.0,79.0,71.0,21.0,60.0,171.0,94.0,0.0,57.0,161.0,103.0,48.0,926.0
Fazilka,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,626.0,683.0,411.0,399.0,90.0,357.0,595.0,319.0,182.0,439.0,514.0,464.0,5079.0
Fazilka,14.14.a,Number of patients given AYUSH treatment,TOTAL,1615.0,2725.0,2487.0,1168.0,2514.0,2321.0,1973.0,1673.0,1783.0,1432.0,1651.0,1650.0,22992.0
Fazilka,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,224.0,268.0,219.0,188.0,213.0,185.0,198.0,181.0,240.0,203.0,190.0,237.0,2546.0
Fazilka,14.14.c,Number of Adolescents counselled,TOTAL,2.0,1.0,0.0,6.0,6.0,5.0,5.0,4.0,4.0,2.0,0.0,5.0,40.0
Fazilka,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,2799.0,3919.0,3449.0,3354.0,3666.0,3120.0,2764.0,2890.0,2929.0,3125.0,3310.0,2113.0,37438.0
Fazilka,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,130.0,212.0,176.0,213.0,209.0,146.0,216.0,189.0,231.0,215.0,220.0,238.0,2395.0
Fazilka,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,138.0,153.0,63.0,156.0,187.0,158.0,159.0,83.0,111.0,109.0,90.0,78.0,1485.0
Fazilka,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,5.0,0.0,1.0,4.0,2.0,3.0,1.0,0.0,1.0,3.0,2.0,3.0,25.0
Fazilka,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,399.0,367.0,81.0,341.0,634.0,367.0,326.0,205.0,191.0,163.0,263.0,190.0,3527.0
Fazilka,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,4.0,0.0,0.0,1.0,1.0,0.0,1.0,0.0,1.0,0.0,0.0,1.0,9.0
Fazilka,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,668.0,711.0,321.0,750.0,792.0,877.0,668.0,714.0,797.0,783.0,758.0,710.0,8549.0
Fazilka,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,0.0,0.0,1.0,1.0,2.0,0.0,0.0,0.0,0.0,1.0,4.0,2.0,11.0
Fazilka,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,1205.0,1231.0,465.0,1247.0,1613.0,1402.0,1153.0,1002.0,1099.0,1055.0,1111.0,978.0,13561.0
Fazilka,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,9.0,0.0,2.0,6.0,5.0,3.0,2.0,0.0,2.0,4.0,6.0,6.0,45.0
Fazilka,15.2,Number of Widal tests conducted,Number tested,158.0,206.0,163.0,157.0,179.0,192.0,131.0,72.0,101.0,126.0,212.0,221.0,1918.0
Fazilka,15.3.a,Number of VDRL tests conducted on males,Number tested,64.0,49.0,52.0,7.0,26.0,14.0,10.0,3.0,3.0,2.0,14.0,6.0,250.0
Fazilka,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,40.0,43.0,50.0,75.0,86.0,81.0,115.0,60.0,116.0,134.0,445.0,22.0,1267.0
Fazilka,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,526.0,723.0,614.0,807.0,834.0,1037.0,744.0,841.0,798.0,844.0,544.0,1004.0,9316.0
Fazilka,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,630.0,815.0,716.0,889.0,946.0,1132.0,869.0,904.0,917.0,980.0,1003.0,1032.0,10833.0
Fazilka,15.4.1,Number of blood smears examined for Malaria,TOTAL,746.0,2086.0,1190.0,2439.0,714.0,1873.0,2737.0,2216.0,1590.0,1493.0,2995.0,774.0,20853.0
Fazilka,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,6.0,0.0,6.0
Fazilka,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Fazilka,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Fazilka,16.1.1,Stock position of DPT vaccines,2. Stocks Received,,,,,,,,,,,,,
Fazilka,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Fazilka,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,,,,,,,,,,,,,
Fazilka,16.1.1,Stock position of DPT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Fazilka,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,,,,,,,,,,,,,
Fazilka,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,,,,,,,,,,,,,
Fazilka,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,,,,,,,,,,,,,
Fazilka,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,,,,,,,,,,,,,
Fazilka,16.1.1A,Stock Position of Pentavalent,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Fazilka,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Fazilka,16.1.2,Stock position of OPV vaccines,2. Stocks Received,,,,,,,,,,,,,
Fazilka,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,,,,,,,,,,,,,
Fazilka,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,,,,,,,,,,,,,
Fazilka,16.1.2,Stock position of OPV vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Fazilka,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Fazilka,16.1.3,Stock position of TT vaccines,2. Stocks Received,,,,,,,,,,,,,
Fazilka,16.1.3,Stock position of TT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Fazilka,16.1.3,Stock position of TT vaccines,4. Stock Distributed,,,,,,,,,,,,,
Fazilka,16.1.3,Stock position of TT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Fazilka,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Fazilka,16.1.4,Stock position of DT vaccines,2. Stocks Received,,,,,,,,,,,,,
Fazilka,16.1.4,Stock position of DT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Fazilka,16.1.4,Stock position of DT vaccines,4. Stock Distributed,,,,,,,,,,,,,
Fazilka,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Fazilka,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Fazilka,16.1.5,Stock position of BCG vaccines,2. Stocks Received,,,,,,,,,,,,,
Fazilka,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,,,,,,,,,,,,,
Fazilka,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,,,,,,,,,,,,,
Fazilka,16.1.5,Stock position of BCG vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Fazilka,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Fazilka,16.1.6,Stock position of Measles vaccines,2. Stocks Received,,,,,,,,,,,,,
Fazilka,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,,,,,,,,,,,,,
Fazilka,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,,,,,,,,,,,,,
Fazilka,16.1.6,Stock position of Measles vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Fazilka,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Fazilka,16.1.7,Stock position of JE vaccines,2. Stocks Received,,,,,,,,,,,,,
Fazilka,16.1.7,Stock position of JE vaccines,3. Unusable Stock,,,,,,,,,,,,,
Fazilka,16.1.7,Stock position of JE vaccines,4. Stock Distributed,,,,,,,,,,,,,
Fazilka,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Fazilka,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Fazilka,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,,,,,,,,,,,,,
Fazilka,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,,,,,,,,,,,,,
Fazilka,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,,,,,,,,,,,,,
Fazilka,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Fazilka,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Fazilka,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Fazilka,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Fazilka,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Fazilka,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Fazilka,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Fazilka,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Fazilka,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Fazilka,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Fazilka,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Fazilka,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Fazilka,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Fazilka,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Fazilka,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Fazilka,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Fazilka,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Fazilka,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Fazilka,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Fazilka,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Fazilka,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Fazilka,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Fazilka,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Fazilka,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Fazilka,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Fazilka,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Fazilka,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,,,,,,,,,,,,,
Fazilka,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,,,,,,,,,,,,,
Fazilka,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,,,,,,,,,,,,,
Fazilka,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,,,,,,,,,,,,,
Fazilka,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Fazilka,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,,,,,,,,,,,,,
Fazilka,16.3.02,Stock Position of Gloves,2. Stocks Received,,,,,,,,,,,,,
Fazilka,16.3.02,Stock Position of Gloves,3. Unusable Stock,,,,,,,,,,,,,
Fazilka,16.3.02,Stock Position of Gloves,4. Stock Distributed,,,,,,,,,,,,,
Fazilka,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Fazilka,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,,,,,,,,,,,,,
Fazilka,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,,,,,,,,,,,,,
Fazilka,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,,,,,,,,,,,,,
Fazilka,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,,,,,,,,,,,,,
Fazilka,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Fazilka,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
Fazilka,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,,,,,,,,,,,,,
Fazilka,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,,,,,,,,,,,,,
Fazilka,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,,,,,,,,,,,,,
Fazilka,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Fazilka,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,,,,,,,,,,,,,
Fazilka,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,,,,,,,,,,,,,
Fazilka,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,,,,,,,,,,,,,
Fazilka,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,,,,,,,,,,,,,
Fazilka,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Fazilka,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,,,,,,,,,,,,,
Fazilka,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,,,,,,,,,,,,,
Fazilka,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,,,,,,,,,,,,,
Fazilka,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,,,,,,,,,,,,,
Fazilka,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Fazilka,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
Fazilka,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,,,,,,,,,,,,,
Fazilka,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,,,,,,,,,,,,,
Fazilka,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,,,,,,,,,,,,,
Fazilka,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Fazilka,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,,,,,,,,,,,,,
Fazilka,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,,,,,,,,,,,,,
Fazilka,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,,,,,,,,,,,,,
Fazilka,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,,,,,,,,,,,,,
Fazilka,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Fazilka,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,,,,,,,,,,,,,
Fazilka,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,,,,,,,,,,,,,
Fazilka,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,,,,,,,,,,,,,
Fazilka,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,,,,,,,,,,,,,
Fazilka,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Fazilka,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,,,,,,,,,,,,,
Fazilka,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,,,,,,,,,,,,,
Fazilka,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,,,,,,,,,,,,,
Fazilka,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,,,,,,,,,,,,,
Fazilka,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Fazilka,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,,,,,,,,,,,,,
Fazilka,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,,,,,,,,,,,,,
Fazilka,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,,,,,,,,,,,,,
Fazilka,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,,,,,,,,,,,,,
Fazilka,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Fazilka,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,,,,,,,,,,,,,
Fazilka,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,,,,,,,,,,,,,
Fazilka,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,,
Fazilka,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,,,,,,,,,,,,,
Fazilka,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Fazilka,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,,,,,,,,,,,,,
Fazilka,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,,,,,,,,,,,,,
Fazilka,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,,
Fazilka,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,,,,,,,,,,,,,
Fazilka,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Fazilka,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,,,,,,,,,,,,,
Fazilka,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,,,,,,,,,,,,,
Fazilka,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,,,,,,,,,,,,,
Fazilka,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,,,,,,,,,,,,,
Fazilka,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Fazilka,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,,,,,,,2.0,,,,,,2.0
Fazilka,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Fazilka,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,1.0,,,,,,1.0
Fazilka,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,,,,,,1.0,,,,,,1.0
Fazilka,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Fazilka,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Fazilka,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,,,,,,,,,,,,,
Fazilka,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,,,,,1.0,,,,,,,,1.0
Fazilka,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Fazilka,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,,,,,1.0,,,,,,,,1.0
Fazilka,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,,,,,,,,1.0,,,1.0,,2.0
Fazilka,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,,,,,1.0,,1.0,,,,,2.0
Fazilka,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,,,,,,1.0,,2.0,,,1.0,,4.0
Fazilka,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,,,,,,1.0,,,,,,1.0
Fazilka,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,,,,,,,,,,
Fazilka,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,,,,,,,1.0,,,,,,1.0
Fazilka,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,,,,,,
Fazilka,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
Fazilka,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,,,,,,,,,
Fazilka,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,,,,1.0,2.0,,,,,3.0,6.0
Fazilka,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,,,,,,,,,,
Fazilka,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,,,,,1.0,2.0,,,,,3.0,6.0
Fazilka,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Fazilka,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Fazilka,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Fazilka,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,,,,,1.0,,,,1.0,1.0,,,3.0
Fazilka,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,,,,,1.0,,1.0,,,,,1.0,3.0
Fazilka,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,,,,,2.0,,1.0,,1.0,1.0,,1.0,6.0
Fazilka,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
Fazilka,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,,,,,,,,,
Fazilka,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,,,,,,,,,
Fazilka,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,,,,,,,,,,,
Fazilka,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
Fazilka,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,,,,,,,2.0,,,,1.0,,3.0
Fazilka,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,,,,,,1.0,,,,,,,1.0
Fazilka,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,,,,,,1.0,2.0,,,,1.0,,4.0
Fazilka,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,,,,,,
Fazilka,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,,,,,,,1.0,,,1.0,,2.0,4.0
Fazilka,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,,,,,,1.0,2.0,,4.0,6.0,,1.0,14.0
Fazilka,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,,,,,,1.0,3.0,,4.0,7.0,,3.0,18.0
Fazilka,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
Fazilka,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,,,,,,,,
Fazilka,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
Fazilka,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,,,,,,,,,,
Fazilka,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,,,,,,,1.0,,,1.0
Fazilka,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,,,,,3.0,,,1.0,,2.0,,3.0,9.0
Fazilka,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,,,,,4.0,,4.0,7.0,1.0,15.0,,5.0,36.0
Fazilka,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,,,,,7.0,,4.0,8.0,1.0,18.0,,8.0,46.0
Fazilka,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
Fazilka,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,,,,,,,,,,,
Fazilka,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,,,,
Fazilka,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,,,,,,,,,,,
Fazilka,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,,,,,,,,,
Fazilka,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,1.0,1.0,,,4.0,6.0,2.0,8.0,6.0,3.0,4.0,5.0,40.0
Fazilka,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,,,,,5.0,2.0,5.0,9.0,5.0,16.0,9.0,11.0,62.0
Fazilka,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,1.0,1.0,,,9.0,8.0,7.0,17.0,11.0,19.0,13.0,16.0,102.0
Fazilka,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,,,,,,,
Fazilka,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,,,,,,,,1.0,1.0,,,,2.0
Fazilka,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,,,,,,,2.0,2.0,,5.0,,2.0,11.0
Fazilka,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,,,,,,,2.0,3.0,1.0,5.0,,2.0,13.0
Fazilka,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Fazilka,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
Fazilka,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Fazilka,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
Fazilka,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Fazilka,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,,,,,,,,
Fazilka,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Fazilka,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,,,,,,,,
Fazilka,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Fazilka,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,,,,,,,,,,
Fazilka,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Fazilka,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,,,,,,,,,,,
Fazilka,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Fazilka,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,,,1.0,,1.0,,,,,,2.0
Fazilka,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Fazilka,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,,,1.0,,1.0,,,,,,2.0
Fazilka,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Fazilka,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,,,,,,,
Fazilka,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Fazilka,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,,,,,,,
Fazilka,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Fazilka,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,,,1.0,2.0,,1.0,,,,,,,4.0
Fazilka,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Fazilka,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,,,1.0,2.0,,1.0,,,,,,,4.0
Fazilka,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,,,,,1.0,,,,,,,1.0
Fazilka,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,,,,,4.0,2.0,2.0,1.0,,4.0,1.0,4.0,18.0
Fazilka,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,,,,,1.0,1.0,1.0,,,,1.0,1.0,5.0
Fazilka,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,,,,,5.0,4.0,3.0,1.0,,4.0,2.0,5.0,24.0
Fazilka,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,,,,,,,,,
Fazilka,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,,,,,,,,3.0,,,,,3.0
Fazilka,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,,,,1.0,,,,,,,,1.0
Fazilka,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,,,,,1.0,,,3.0,,,,,4.0
Fazilka,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,,,,,,,,,,
Fazilka,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,,,,2.0,,,,,,,,2.0
Fazilka,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,,,,,,,,,,,
Fazilka,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,,,,,2.0,,,,,,,,2.0
Fazilka,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,,,,,,,,,,,
Fazilka,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,1.0,,,,,,,2.0,,1.0,,1.0,5.0
Fazilka,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,,,,,2.0,,,2.0,,,,,4.0
Fazilka,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,1.0,,,,2.0,,,4.0,,1.0,,1.0,9.0
Fazilka,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,,,,,,1.0,,,,1.0,,2.0
Fazilka,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,,,,,2.0,3.0,3.0,2.0,3.0,5.0,1.0,3.0,22.0
Fazilka,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,,,,,3.0,1.0,5.0,4.0,1.0,4.0,2.0,2.0,22.0
Fazilka,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,,,,,5.0,4.0,9.0,6.0,4.0,9.0,4.0,5.0,46.0
Fazilka,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,,,,,,,,,1.0,,,,1.0
Fazilka,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,1.0,3.0,,,2.0,9.0,3.0,4.0,5.0,3.0,4.0,,34.0
Fazilka,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,4.0,1.0,,,14.0,15.0,22.0,15.0,23.0,26.0,22.0,20.0,162.0
Fazilka,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,5.0,4.0,,,16.0,24.0,25.0,19.0,29.0,29.0,26.0,20.0,197.0
Firozpur,1.1,Total number of pregnant women Registered for ANC,TOTAL,1766.0,1820.0,1475.0,1614.0,1578.0,1316.0,1211.0,1266.0,1295.0,1603.0,1825.0,1440.0,18209.0
Firozpur,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,1078.0,1073.0,851.0,950.0,911.0,719.0,704.0,708.0,895.0,1074.0,1318.0,897.0,11178.0
Firozpur,1.2,Number of Pregnant women registered under JSY,TOTAL,607.0,573.0,532.0,570.0,591.0,447.0,441.0,420.0,435.0,595.0,737.0,521.0,6469.0
Firozpur,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,1205.0,1456.0,1417.0,1367.0,1465.0,1336.0,1335.0,1330.0,1312.0,1184.0,1122.0,1026.0,15555.0
Firozpur,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,1650.0,1771.0,1409.0,1409.0,1524.0,1310.0,1186.0,1220.0,1217.0,1512.0,1732.0,1308.0,17248.0
Firozpur,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,1621.0,1695.0,1456.0,1280.0,1460.0,1424.0,1288.0,1131.0,1227.0,1348.0,1419.0,1277.0,16626.0
Firozpur,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,1296.0,1579.0,1536.0,1177.0,1381.0,1175.0,983.0,938.0,847.0,1092.0,1009.0,888.0,13901.0
Firozpur,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,5.0,2.0,9.0,6.0,0.0,9.0,0.0,1.0,13.0,2.0,4.0,7.0,58.0
Firozpur,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Firozpur,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,677.0,927.0,746.0,1066.0,997.0,740.0,824.0,738.0,789.0,963.0,1109.0,886.0,10462.0
Firozpur,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,0.0,0.0,0.0,0.0,0.0,1.0,1.0,4.0,1.0,9.0,4.0,3.0,23.0
Firozpur,1.8,Number of pregnancy test kits used at SC level,TOTAL,532.0,580.0,527.0,711.0,644.0,687.0,587.0,601.0,536.0,558.0,651.0,602.0,7216.0
Firozpur,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,22.0,23.0,15.0,16.0,20.0,17.0,20.0,29.0,19.0,16.0,22.0,19.0,238.0
Firozpur,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,170.0,252.0,215.0,271.0,356.0,343.0,356.0,359.0,309.0,242.0,185.0,137.0,3195.0
Firozpur,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,192.0,275.0,230.0,287.0,376.0,360.0,376.0,388.0,328.0,258.0,207.0,156.0,3433.0
Firozpur,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,135.0,194.0,147.0,171.0,185.0,117.0,230.0,234.0,204.0,230.0,199.0,154.0,2200.0
Firozpur,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,0.0,0.0,1.0,5.0,4.0,4.0,5.0,11.0,4.0,10.0,9.0,23.0,76.0
Firozpur,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,229.0,285.0,291.0,477.0,556.0,540.0,449.0,454.0,434.0,476.0,393.0,354.0,4938.0
Firozpur,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,202.0,253.0,222.0,430.0,464.0,420.0,359.0,383.0,371.0,356.0,300.0,268.0,4028.0
Firozpur,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,105.0,136.0,235.0,299.0,315.0,371.0,257.0,334.0,330.0,321.0,321.0,298.0,3322.0
Firozpur,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Firozpur,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Firozpur,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,206.0,218.0,246.0,283.0,372.0,344.0,335.0,356.0,345.0,439.0,372.0,319.0,3835.0
Firozpur,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Firozpur,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Firozpur,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Firozpur,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Firozpur,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Firozpur,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,27.0,32.0,19.0,47.0,76.0,73.0,53.0,52.0,63.0,100.0,92.0,86.0,720.0
Firozpur,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Firozpur,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,27.0,32.0,19.0,47.0,76.0,73.0,53.0,52.0,63.0,100.0,92.0,86.0,720.0
Firozpur,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,113.0,86.0,122.0,133.0,182.0,169.0,119.0,147.0,142.0,155.0,112.0,135.0,1615.0
Firozpur,4.1.1.a,Number of male live births,TOTAL,349.0,393.0,410.0,549.0,703.0,641.0,590.0,680.0,605.0,581.0,535.0,428.0,6464.0
Firozpur,4.1.1.b,Number of female live births,TOTAL,278.0,377.0,347.0,490.0,599.0,596.0,566.0,511.0,490.0,579.0,430.0,397.0,5660.0
Firozpur,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,627.0,770.0,757.0,1039.0,1302.0,1237.0,1156.0,1191.0,1095.0,1160.0,965.0,825.0,12124.0
Firozpur,4.1.2,Number of still births,TOTAL,2.0,17.0,13.0,21.0,12.0,10.0,12.0,9.0,15.0,13.0,9.0,9.0,142.0
Firozpur,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,11.0,15.0,8.0,11.0,10.0,4.0,3.0,6.0,7.0,18.0,27.0,9.0,129.0
Firozpur,4.2.1,Number of Newborns weighed at birth,TOTAL,506.0,655.0,620.0,865.0,1015.0,985.0,868.0,905.0,995.0,1113.0,962.0,813.0,10302.0
Firozpur,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,129.0,125.0,151.0,207.0,141.0,108.0,72.0,40.0,24.0,25.0,19.0,37.0,1078.0
Firozpur,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,471.0,594.0,571.0,851.0,1020.0,977.0,816.0,840.0,739.0,898.0,814.0,661.0,9252.0
Firozpur,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Firozpur,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Firozpur,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,5.0,6.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,11.0
Firozpur,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Firozpur,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,5.0,6.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,11.0
Firozpur,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Firozpur,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,10.0,7.0,0.0,0.0,0.0,0.0,65.0,52.0,0.0,0.0,0.0,0.0,134.0
Firozpur,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,2.0,0.0,0.0,0.0,0.0,0.0,2.0,1.0,0.0,0.0,0.0,0.0,5.0
Firozpur,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,30.0,25.0,0.0,0.0,0.0,0.0,2.0,2.0,0.0,0.0,0.0,0.0,59.0
Firozpur,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,25.0,32.0,23.0,0.0,0.0,0.0,26.0,20.0,47.0,32.0,31.0,28.0,264.0
Firozpur,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,259.0,364.0,355.0,456.0,593.0,430.0,403.0,551.0,580.0,769.0,522.0,459.0,5741.0
Firozpur,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,306.0,372.0,372.0,375.0,690.0,476.0,416.0,466.0,515.0,568.0,495.0,362.0,5413.0
Firozpur,6.3,PNC maternal complications attended,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Firozpur,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,2.0,1.0,5.0
Firozpur,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Firozpur,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,2.0,1.0,5.0
Firozpur,7.2,Number of MTPs conducted at Private Facilities,TOTAL,0.0,0.0,18.0,0.0,0.0,0.0,19.0,15.0,19.0,38.0,43.0,36.0,188.0
Firozpur,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,51.0,64.0,48.0,0.0,0.0,0.0,43.0,50.0,77.0,78.0,58.0,41.0,510.0
Firozpur,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,126.0,84.0,90.0,0.0,0.0,0.0,130.0,138.0,136.0,153.0,141.0,109.0,1107.0
Firozpur,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,177.0,148.0,138.0,0.0,0.0,0.0,173.0,188.0,213.0,231.0,199.0,150.0,1617.0
Firozpur,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,57.0,89.0,33.0,0.0,0.0,0.0,39.0,43.0,50.0,51.0,50.0,45.0,457.0
Firozpur,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Firozpur,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,2.0,0.0,0.0,1.0,0.0,2.0,1.0,6.0,2.0,0.0,0.0,0.0,14.0
Firozpur,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,2.0,0.0,1.0,4.0,1.0,2.0,0.0,3.0,0.0,0.0,1.0,0.0,14.0
Firozpur,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Firozpur,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,4.0,0.0,1.0,5.0,1.0,4.0,1.0,9.0,2.0,0.0,1.0,0.0,28.0
Firozpur,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Firozpur,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Firozpur,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Firozpur,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,83.0,52.0,75.0,56.0,45.0,120.0,51.0,40.0,39.0,23.0,31.0,226.0,841.0
Firozpur,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Firozpur,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,83.0,52.0,75.0,56.0,45.0,120.0,51.0,40.0,39.0,23.0,31.0,226.0,841.0
Firozpur,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Firozpur,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Firozpur,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,29.0,5.0,56.0,24.0,10.0,25.0,31.0,50.0,19.0,14.0,0.0,53.0,316.0
Firozpur,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,45.0,64.0,38.0,33.0,76.0,92.0,26.0,31.0,3.0,16.0,78.0,64.0,566.0
Firozpur,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Firozpur,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,74.0,69.0,94.0,57.0,86.0,117.0,57.0,81.0,22.0,30.0,78.0,117.0,882.0
Firozpur,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,1.0,0.0,2.0,0.0,0.0,1.0,0.0,0.0,4.0
Firozpur,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Firozpur,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Firozpur,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,2.0,7.0,4.0,5.0,9.0,10.0,6.0,12.0,10.0,20.0,16.0,16.0,117.0
Firozpur,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Firozpur,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,2.0,7.0,4.0,5.0,9.0,10.0,6.0,12.0,10.0,20.0,16.0,16.0,117.0
Firozpur,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,4.0,0.0,0.0,4.0
Firozpur,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,503.0,517.0,545.0,698.0,543.0,496.0,498.0,504.0,530.0,477.0,467.0,390.0,6168.0
Firozpur,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,5.0,5.0,0.0,10.0
Firozpur,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Firozpur,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,53.0,41.0,54.0,68.0,68.0,67.0,72.0,71.0,44.0,67.0,63.0,61.0,729.0
Firozpur,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Firozpur,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,556.0,558.0,599.0,766.0,611.0,563.0,570.0,575.0,574.0,549.0,535.0,451.0,6907.0
Firozpur,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,0.0,0.0,4.0,5.0,4.0,0.0,3.0,0.0,4.0,7.0,27.0,2.0,56.0
Firozpur,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,0.0,32.0,0.0,0.0,0.0,0.0,2.0,0.0,26.0,29.0,12.0,7.0,108.0
Firozpur,9.06,Number of IUCD removals,TOTAL,116.0,111.0,128.0,157.0,91.0,107.0,90.0,90.0,88.0,64.0,95.0,72.0,1209.0
Firozpur,9.07,Number of Oral Pills cycles distributed,TOTAL,3507.0,3663.0,4785.0,4514.0,3959.0,4695.0,4255.0,4426.0,5323.0,4485.0,4772.0,4754.0,53138.0
Firozpur,9.08,Number of Condom pieces distributed,TOTAL,56990.0,63061.0,72978.0,70216.0,70850.0,68931.0,71123.0,74847.0,77283.0,73754.0,80214.0,69912.0,850159.0
Firozpur,9.09,Number of Centchroman (weekly) pills given,TOTAL,2.0,17.0,2.0,0.0,10.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,33.0
Firozpur,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,0.0,9.0,10.0,0.0,1.0,0.0,4.0,27.0,35.0,39.0,37.0,23.0,185.0
Firozpur,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Firozpur,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Firozpur,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Firozpur,9.11.2.b,Number of failures following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Firozpur,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Firozpur,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Firozpur,9.12,Number of Institutions having NSV trained doctors,TOTAL,1.0,,,2.0,2.0,1.0,1.0,2.0,2.0,1.0,1.0,1.0,-1.0
Firozpur,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,1233.0,1249.0,1065.0,1160.0,1576.0,1524.0,1457.0,1483.0,1397.0,1413.0,1338.0,971.0,15866.0
Firozpur,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,1484.0,1332.0,1111.0,1151.0,1289.0,1436.0,1524.0,1665.0,1563.0,1404.0,387.0,229.0,14575.0
Firozpur,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,1534.0,1458.0,1241.0,1112.0,1191.0,1261.0,1397.0,1523.0,1507.0,1469.0,1378.0,531.0,15602.0
Firozpur,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,1459.0,1589.0,1302.0,1273.0,1238.0,1193.0,1237.0,1342.0,1389.0,1380.0,1392.0,997.0,15791.0
Firozpur,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1197.0,1095.0,2292.0
Firozpur,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,23.0,666.0,689.0
Firozpur,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,161.0,163.0
Firozpur,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,688.0,750.0,739.0,773.0,1180.0,1021.0,996.0,1031.0,905.0,1039.0,806.0,572.0,10500.0
Firozpur,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,1484.0,1332.0,1111.0,1151.0,1299.0,1436.0,1525.0,1651.0,1563.0,1404.0,1005.0,970.0,15931.0
Firozpur,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,1534.0,1458.0,1241.0,1112.0,1192.0,1264.0,1397.0,1511.0,1506.0,1469.0,1305.0,979.0,15968.0
Firozpur,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,1459.0,1589.0,1302.0,1273.0,1230.0,1186.0,1234.0,1355.0,1406.0,1380.0,1331.0,1000.0,15745.0
Firozpur,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,559.0,646.0,644.0,646.0,935.0,794.0,763.0,752.0,719.0,645.0,673.0,500.0,8276.0
Firozpur,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,1451.0,1326.0,1122.0,1160.0,1299.0,1438.0,1519.0,1668.0,1562.0,1334.0,388.0,239.0,14506.0
Firozpur,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,1530.0,1447.0,1223.0,1103.0,1186.0,1268.0,1395.0,1518.0,1514.0,1419.0,1264.0,518.0,15385.0
Firozpur,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,1439.0,1595.0,1283.0,1266.0,1213.0,1197.0,1232.0,1361.0,1404.0,1330.0,1270.0,984.0,15574.0
Firozpur,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,1295.0,1478.0,1279.0,1364.0,1468.0,1413.0,1386.0,1365.0,1120.0,1124.0,1039.0,873.0,15204.0
Firozpur,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,1481.0,1490.0,1250.0,1232.0,1292.0,1182.0,1111.0,1172.0,1062.0,1117.0,1294.0,997.0,14680.0
Firozpur,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Firozpur,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,692.0,823.0,678.0,741.0,801.0,745.0,752.0,743.0,609.0,630.0,573.0,462.0,8249.0
Firozpur,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,593.0,644.0,596.0,621.0,663.0,664.0,634.0,622.0,504.0,487.0,466.0,411.0,6905.0
Firozpur,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,1285.0,1467.0,1274.0,1362.0,1464.0,1409.0,1386.0,1365.0,1113.0,1117.0,1039.0,873.0,15154.0
Firozpur,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,1481.0,1490.0,1250.0,1232.0,1296.0,1185.0,1104.0,1158.0,1063.0,1117.0,1290.0,996.0,14662.0
Firozpur,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,1481.0,1490.0,1250.0,1232.0,1296.0,1185.0,1103.0,1155.0,1063.0,1117.0,1290.0,996.0,14658.0
Firozpur,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Firozpur,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,4.0,5.0,3.0,0.0,2.0,2.0,0.0,0.0,3.0,4.0,0.0,0.0,23.0
Firozpur,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,6.0,6.0,2.0,2.0,2.0,2.0,0.0,0.0,4.0,3.0,0.0,0.0,27.0
Firozpur,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,10.0,11.0,5.0,2.0,4.0,4.0,0.0,0.0,7.0,7.0,0.0,0.0,50.0
Firozpur,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,1023.0,1092.0,1040.0,1086.0,1222.0,1133.0,1191.0,1112.0,984.0,924.0,975.0,856.0,12638.0
Firozpur,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,932.0,1109.0,898.0,1050.0,1774.0,1061.0,1290.0,1072.0,942.0,860.0,854.0,642.0,12484.0
Firozpur,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,704.0,846.0,790.0,830.0,1001.0,859.0,870.0,919.0,794.0,679.0,700.0,500.0,9492.0
Firozpur,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Firozpur,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Firozpur,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Firozpur,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,630.0,610.0,603.0,606.0,623.0,615.0,617.0,628.0,621.0,626.0,678.0,617.0,7474.0
Firozpur,10.4.2,Number of Immunisation sessions held during the month,TOTAL,610.0,598.0,586.0,589.0,594.0,585.0,591.0,601.0,601.0,588.0,656.0,443.0,7042.0
Firozpur,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,529.0,512.0,504.0,506.0,520.0,511.0,518.0,533.0,523.0,505.0,515.0,376.0,6052.0
Firozpur,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Firozpur,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,1279.0,1411.0,1222.0,1360.0,1424.0,1368.0,1247.0,1208.0,1063.0,1024.0,935.0,637.0,14178.0
Firozpur,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,903.0,899.0,598.0,733.0,574.0,513.0,731.0,683.0,648.0,590.0,576.0,422.0,7870.0
Firozpur,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,971.0,953.0,734.0,739.0,822.0,693.0,948.0,775.0,787.0,746.0,790.0,574.0,9532.0
Firozpur,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Firozpur,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Firozpur,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Firozpur,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Firozpur,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Firozpur,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Firozpur,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Firozpur,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Firozpur,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Firozpur,13.1,Number of Patients operated for cataract,TOTAL,176.0,62.0,14.0,63.0,73.0,201.0,165.0,203.0,116.0,49.0,114.0,304.0,1540.0
Firozpur,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,176.0,62.0,14.0,63.0,73.0,201.0,165.0,203.0,116.0,49.0,114.0,304.0,1540.0
Firozpur,13.3,Number of School children detected with Refractive errors,TOTAL,67.0,190.0,14.0,235.0,200.0,84.0,189.0,74.0,149.0,105.0,142.0,26.0,1475.0
Firozpur,13.4,Number of children provided free glasses,TOTAL,0.0,186.0,0.0,123.0,173.0,182.0,171.0,85.0,99.0,146.0,167.0,52.0,1384.0
Firozpur,13.5,Number of eyes collected through eye donation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Firozpur,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Firozpur,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,4.0,4.0,2.0,5.0,6.0,6.0,6.0,6.0,5.0,6.0,5.0,6.0,-1.0
Firozpur,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,4.0,2.0,4.0,4.0,4.0,6.0,3.0,4.0,3.0,4.0,4.0,2.0,-1.0
Firozpur,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,359.0,329.0,415.0,379.0,336.0,318.0,380.0,375.0,395.0,378.0,430.0,285.0,-1.0
Firozpur,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,3.0,3.0,2.0,5.0,6.0,6.0,6.0,6.0,5.0,6.0,4.0,6.0,-1.0
Firozpur,14.05,Number of RKS meetings held during the month,TOTAL,10.0,9.0,6.0,9.0,8.0,8.0,8.0,10.0,9.0,9.0,8.0,7.0,101.0
Firozpur,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,3.0,5.0,4.0,7.0,8.0,7.0,6.0,7.0,7.0,7.0,7.0,6.0,-1.0
Firozpur,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,6.0,10.0,24.0,35.0,32.0,2.0,18.0,6.0,19.0,9.0,25.0,14.0,200.0
Firozpur,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,1.0,1.0,1.0,2.0,3.0,3.0,3.0,3.0,3.0,3.0,3.0,3.0,-1.0
Firozpur,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,3.0,3.0,3.0,0.0,0.0,0.0,1.0,1.0,1.0,1.0,1.0,1.0,-1.0
Firozpur,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,107.0,96.0,94.0,114.0,132.0,145.0,140.0,168.0,153.0,121.0,162.0,146.0,1578.0
Firozpur,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,456.0,540.0,502.0,570.0,484.0,550.0,376.0,411.0,302.0,458.0,346.0,438.0,5433.0
Firozpur,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,79.0,122.0,98.0,120.0,134.0,121.0,185.0,141.0,174.0,132.0,167.0,154.0,1627.0
Firozpur,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,767.0,824.0,802.0,1012.0,1052.0,1118.0,794.0,821.0,818.0,841.0,724.0,825.0,10398.0
Firozpur,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,186.0,218.0,192.0,234.0,266.0,266.0,325.0,309.0,327.0,253.0,329.0,300.0,3205.0
Firozpur,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,1223.0,1364.0,1304.0,1582.0,1536.0,1668.0,1170.0,1232.0,1120.0,1299.0,1070.0,1263.0,15831.0
Firozpur,14.10.2.a,Number of death cases of Inpatient males,TOTAL,5.0,7.0,9.0,1.0,1.0,6.0,6.0,8.0,7.0,4.0,8.0,8.0,70.0
Firozpur,14.10.2.b,Number of death cases of Inpatient females,TOTAL,4.0,5.0,2.0,0.0,1.0,5.0,4.0,3.0,5.0,3.0,7.0,6.0,45.0
Firozpur,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,9.0,12.0,11.0,1.0,2.0,11.0,10.0,11.0,12.0,7.0,15.0,14.0,115.0
Firozpur,14.11,In-Patient Head Count at midnight,TOTAL,2437.0,3558.0,3396.0,371.0,45.0,185.0,2605.0,2687.0,2515.0,2763.0,3182.0,2965.0,26709.0
Firozpur,14.12.1,OPD attendance (All),TOTAL,34429.0,42902.0,42949.0,28129.0,35257.0,35635.0,35446.0,32969.0,35201.0,33238.0,36788.0,33636.0,426579.0
Firozpur,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,161.0,159.0,105.0,33.0,80.0,3.0,182.0,123.0,123.0,144.0,209.0,416.0,1738.0
Firozpur,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,7.0,3.0,0.0,32.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,42.0
Firozpur,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,802.0,892.0,917.0,129.0,150.0,319.0,529.0,789.0,542.0,488.0,612.0,424.0,6593.0
Firozpur,14.14.a,Number of patients given AYUSH treatment,TOTAL,684.0,924.0,1183.0,1675.0,1142.0,1093.0,995.0,916.0,1152.0,1088.0,1009.0,370.0,12231.0
Firozpur,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,580.0,604.0,704.0,70.0,156.0,593.0,836.0,1041.0,602.0,517.0,643.0,292.0,6638.0
Firozpur,14.14.c,Number of Adolescents counselled,TOTAL,65.0,29.0,22.0,8.0,8.0,8.0,0.0,0.0,0.0,0.0,0.0,0.0,140.0
Firozpur,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,2952.0,3525.0,2630.0,3240.0,1945.0,2641.0,2350.0,2630.0,3347.0,3007.0,3664.0,2747.0,34678.0
Firozpur,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,82.0,99.0,161.0,31.0,57.0,90.0,94.0,90.0,68.0,82.0,65.0,48.0,967.0
Firozpur,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,444.0,431.0,430.0,40.0,43.0,194.0,386.0,301.0,342.0,294.0,221.0,624.0,3750.0
Firozpur,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,16.0,19.0,21.0,1.0,1.0,5.0,11.0,4.0,15.0,11.0,15.0,26.0,145.0
Firozpur,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,387.0,274.0,342.0,59.0,159.0,151.0,291.0,296.0,210.0,255.0,148.0,450.0,3022.0
Firozpur,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,1.0,6.0,5.0,1.0,1.0,5.0,3.0,2.0,2.0,0.0,2.0,11.0,39.0
Firozpur,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,658.0,595.0,564.0,408.0,339.0,324.0,379.0,447.0,528.0,633.0,526.0,392.0,5793.0
Firozpur,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,1.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,2.0,0.0,1.0,0.0,5.0
Firozpur,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,1489.0,1300.0,1336.0,507.0,541.0,669.0,1056.0,1044.0,1080.0,1182.0,895.0,1466.0,12565.0
Firozpur,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,18.0,25.0,26.0,3.0,2.0,10.0,14.0,6.0,19.0,11.0,18.0,37.0,189.0
Firozpur,15.2,Number of Widal tests conducted,Number tested,225.0,159.0,123.0,63.0,122.0,118.0,104.0,83.0,42.0,31.0,222.0,353.0,1645.0
Firozpur,15.3.a,Number of VDRL tests conducted on males,Number tested,68.0,30.0,14.0,15.0,27.0,45.0,31.0,50.0,161.0,169.0,157.0,137.0,904.0
Firozpur,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,63.0,72.0,19.0,20.0,26.0,50.0,82.0,98.0,230.0,83.0,118.0,113.0,974.0
Firozpur,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,522.0,540.0,282.0,413.0,470.0,471.0,249.0,395.0,204.0,442.0,586.0,285.0,4859.0
Firozpur,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,653.0,642.0,315.0,448.0,523.0,566.0,362.0,543.0,595.0,694.0,861.0,535.0,6737.0
Firozpur,15.4.1,Number of blood smears examined for Malaria,TOTAL,1197.0,967.0,1552.0,1287.0,1156.0,1256.0,1375.0,1254.0,1141.0,731.0,1051.0,635.0,13602.0
Firozpur,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Firozpur,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Firozpur,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,16500.0,3500.0,28000.0,14500.0,0.0,9000.0,18500.0,,32500.0,25500.0,19000.0,,167000.0
Firozpur,16.1.1,Stock position of DPT vaccines,2. Stocks Received,0.0,41000.0,0.0,0.0,20000.0,20000.0,21000.0,,0.0,0.0,0.0,,102000.0
Firozpur,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,,0.0
Firozpur,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,13000.0,16500.0,12500.0,14500.0,11000.0,10500.0,9000.0,,7000.0,6500.0,4500.0,,105000.0
Firozpur,16.1.1,Stock position of DPT vaccines,5. Total Stock,3500.0,28000.0,15500.0,0.0,9000.0,18500.0,30500.0,0.0,25500.0,19000.0,14500.0,0.0,164000.0
Firozpur,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,15000.0,14500.0,,29500.0
Firozpur,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,15000.0,0.0,10000.0,,25000.0
Firozpur,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,,0.0
Firozpur,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,500.0,20500.0,,21000.0
Firozpur,16.1.1A,Stock Position of Pentavalent,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,15000.0,14500.0,4000.0,0.0,33500.0
Firozpur,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,43500.0,27500.0,24500.0,11000.0,6000.0,7000.0,0.0,,15500.0,500.0,500.0,,136000.0
Firozpur,16.1.2,Stock position of OPV vaccines,2. Stocks Received,0.0,30000.0,0.0,20000.0,2000.0,5000.0,22000.0,,0.0,0.0,10000.0,,89000.0
Firozpur,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,,0.0
Firozpur,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,16000.0,33000.0,13500.0,25000.0,1000.0,12000.0,16500.0,,15000.0,0.0,6500.0,,138500.0
Firozpur,16.1.2,Stock position of OPV vaccines,5. Total Stock,27500.0,24500.0,11000.0,6000.0,7000.0,0.0,5500.0,0.0,500.0,500.0,4000.0,0.0,86500.0
Firozpur,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,13000.0,2500.0,23500.0,11500.0,4000.0,7500.0,13000.0,,25000.0,19500.0,15000.0,,134500.0
Firozpur,16.1.3,Stock position of TT vaccines,2. Stocks Received,0.0,36000.0,0.0,5000.0,15000.0,16000.0,16000.0,,0.0,0.0,0.0,,88000.0
Firozpur,16.1.3,Stock position of TT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,,0.0
Firozpur,16.1.3,Stock position of TT vaccines,4. Stock Distributed,10500.0,15000.0,12000.0,1250.0,11500.0,10500.0,8500.0,,5500.0,15000.0,3500.0,,93250.0
Firozpur,16.1.3,Stock position of TT vaccines,5. Total Stock,2500.0,23500.0,11500.0,15250.0,7500.0,13000.0,20500.0,0.0,19500.0,4500.0,11500.0,0.0,129250.0
Firozpur,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,,0.0,,0.0
Firozpur,16.1.4,Stock position of DT vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,,0.0,,0.0
Firozpur,16.1.4,Stock position of DT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,,0.0,,0.0
Firozpur,16.1.4,Stock position of DT vaccines,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,,0.0,,0.0
Firozpur,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Firozpur,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,6000.0,1000.0,6000.0,0.0,2000.0,3500.0,4000.0,,5500.0,10000.0,6500.0,,44500.0
Firozpur,16.1.5,Stock position of BCG vaccines,2. Stocks Received,5000.0,16000.0,0.0,10000.0,10000.0,7000.0,6000.0,,10000.0,0.0,5000.0,,69000.0
Firozpur,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,,0.0
Firozpur,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,10000.0,11000.0,6000.0,8000.0,8500.0,6500.0,7000.0,,5500.0,3500.0,2000.0,,68000.0
Firozpur,16.1.5,Stock position of BCG vaccines,5. Total Stock,1000.0,6000.0,0.0,2000.0,3500.0,4000.0,3000.0,0.0,10000.0,6500.0,9500.0,0.0,45500.0
Firozpur,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,7000.0,500.0,17000.0,10500.0,3750.0,10500.0,5250.0,,6750.0,7250.0,4250.0,,72750.0
Firozpur,16.1.6,Stock position of Measles vaccines,2. Stocks Received,0.0,25000.0,0.0,0.0,12000.0,1000.0,0.0,,5000.0,0.0,0.0,,43000.0
Firozpur,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,,0.0
Firozpur,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,6500.0,8500.0,6500.0,6750.0,5250.0,6250.0,4750.0,,4500.0,3000.0,2500.0,,54500.0
Firozpur,16.1.6,Stock position of Measles vaccines,5. Total Stock,500.0,17000.0,10500.0,3750.0,10500.0,5250.0,500.0,0.0,7250.0,4250.0,1750.0,0.0,61250.0
Firozpur,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,,0.0
Firozpur,16.1.7,Stock position of JE vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,,0.0
Firozpur,16.1.7,Stock position of JE vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,,0.0
Firozpur,16.1.7,Stock position of JE vaccines,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,,0.0
Firozpur,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Firozpur,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,9500.0,1000.0,18700.0,2700.0,2700.0,8100.0,2100.0,,10000.0,2500.0,0.0,,57300.0
Firozpur,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,0.0,32000.0,0.0,8000.0,16000.0,4000.0,15000.0,,0.0,0.0,6000.0,,81000.0
Firozpur,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,,0.0
Firozpur,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,8500.0,14300.0,16000.0,8000.0,10600.0,10000.0,11600.0,,7500.0,2500.0,2500.0,,91500.0
Firozpur,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,1000.0,18700.0,2700.0,2700.0,8100.0,2100.0,5500.0,0.0,2500.0,0.0,3500.0,0.0,46800.0
Firozpur,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,2400.0,1200.0,600.0,6580.0,6580.0,4200.0,4200.0,3000.0,3000.0,3000.0,1200.0,600.0,36560.0
Firozpur,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,0.0,0.0,6580.0,1200.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,7780.0
Firozpur,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Firozpur,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,1200.0,600.0,600.0,1200.0,2380.0,0.0,1200.0,0.0,0.0,1800.0,600.0,600.0,10180.0
Firozpur,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,1200.0,600.0,6580.0,6580.0,4200.0,4200.0,3000.0,3000.0,3000.0,1200.0,600.0,0.0,34160.0
Firozpur,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,530160.0,423360.0,201600.0,191520.0,171360.0,370560.0,335840.0,252960.0,252960.0,306560.0,244800.0,213600.0,3495280.0
Firozpur,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,346080.0,0.0,0.0,0.0,53600.0,0.0,0.0,0.0,399680.0
Firozpur,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Firozpur,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,106800.0,221760.0,10080.0,20160.0,146880.0,34720.0,82880.0,0.0,0.0,61760.0,31200.0,106800.0,823040.0
Firozpur,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,423360.0,201600.0,191520.0,171360.0,370560.0,335840.0,252960.0,252960.0,306560.0,244800.0,213600.0,106800.0,3071920.0
Firozpur,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,1200.0,600.0,0.0,0.0,0.0,13200.0,13200.0,7200.0,7200.0,7200.0,5200.0,11700.0,66700.0
Firozpur,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,17300.0,0.0,0.0,0.0,0.0,0.0,8300.0,0.0,25600.0
Firozpur,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Firozpur,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,600.0,600.0,0.0,0.0,4100.0,0.0,6000.0,0.0,0.0,2000.0,1800.0,4800.0,19900.0
Firozpur,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,600.0,0.0,0.0,0.0,13200.0,13200.0,7200.0,7200.0,7200.0,5200.0,11700.0,6900.0,72400.0
Firozpur,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,0.0,0.0,550.0,400.0,400.0,0.0,1650.0,1650.0,1650.0,2000.0,8300.0
Firozpur,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1650.0,0.0,0.0,1050.0,0.0,2700.0
Firozpur,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Firozpur,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,0.0,150.0,0.0,400.0,0.0,0.0,0.0,700.0,1250.0,2500.0
Firozpur,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,400.0,400.0,0.0,1650.0,1650.0,1650.0,2000.0,750.0,8500.0
Firozpur,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,4465.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,4465.0
Firozpur,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Firozpur,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Firozpur,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,4465.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,4465.0
Firozpur,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Firozpur,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,,,,,,,0.0,0.0,0.0,,,,0.0
Firozpur,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,,,,,,,0.0,0.0,0.0,,,,0.0
Firozpur,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,,,,,,,0.0,0.0,0.0,,,,0.0
Firozpur,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,,,,,,,0.0,0.0,0.0,,,,0.0
Firozpur,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Firozpur,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,,,,,,,0.0,0.0,0.0,,,,0.0
Firozpur,16.3.02,Stock Position of Gloves,2. Stocks Received,,,,,,,0.0,,0.0,,,,0.0
Firozpur,16.3.02,Stock Position of Gloves,3. Unusable Stock,,,,,,,0.0,,0.0,,,,0.0
Firozpur,16.3.02,Stock Position of Gloves,4. Stock Distributed,,,,,,,0.0,,0.0,,,,0.0
Firozpur,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Firozpur,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,,,,,,,0.0,0.0,0.0,,,,0.0
Firozpur,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,,,,,,,0.0,0.0,0.0,,,,0.0
Firozpur,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,,,,,,,0.0,0.0,0.0,,,,0.0
Firozpur,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,,,,,,,0.0,0.0,0.0,,,,0.0
Firozpur,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Firozpur,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,,,,,,,0.0,0.0,0.0,,,,0.0
Firozpur,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,,,,,,,0.0,0.0,0.0,,,,0.0
Firozpur,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,,,,,,,0.0,0.0,0.0,,,,0.0
Firozpur,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,,,,,,,0.0,0.0,0.0,,,,0.0
Firozpur,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Firozpur,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,,,,,,,0.0,0.0,0.0,,,,0.0
Firozpur,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,,,,,,,0.0,0.0,0.0,,,,0.0
Firozpur,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,,,,,,,0.0,0.0,0.0,,,,0.0
Firozpur,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,,,,,,,0.0,0.0,0.0,,,,0.0
Firozpur,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Firozpur,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,,,,,,,0.0,0.0,0.0,,,,0.0
Firozpur,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,,,,,,,0.0,0.0,0.0,,,,0.0
Firozpur,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,,,,,,,0.0,0.0,0.0,,,,0.0
Firozpur,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,,,,,,,0.0,0.0,0.0,,,,0.0
Firozpur,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Firozpur,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0
Firozpur,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0
Firozpur,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0
Firozpur,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0
Firozpur,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Firozpur,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,,,,,,,0.0,0.0,0.0,,,,0.0
Firozpur,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,,,,,,,0.0,0.0,0.0,,,,0.0
Firozpur,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,,,,,,,0.0,0.0,0.0,,,,0.0
Firozpur,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,,,,,,,0.0,0.0,0.0,,,,0.0
Firozpur,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Firozpur,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,,,,,,,0.0,0.0,,,,,0.0
Firozpur,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,,,,,,,0.0,0.0,,,,,0.0
Firozpur,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,,,,,,,0.0,0.0,,,,,0.0
Firozpur,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,,,,,,,0.0,0.0,,,,,0.0
Firozpur,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Firozpur,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,,,,,,,0.0,0.0,0.0,,,,0.0
Firozpur,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,,,,,,,0.0,0.0,0.0,,,,0.0
Firozpur,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,,,,,,,0.0,0.0,0.0,,,,0.0
Firozpur,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,,,,,,,0.0,0.0,0.0,,,,0.0
Firozpur,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Firozpur,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,,,,,,,0.0,0.0,,,,,0.0
Firozpur,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,,,,,,,0.0,0.0,,,,,0.0
Firozpur,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,,,,,,,0.0,0.0,,,,,0.0
Firozpur,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,,,,,,,0.0,0.0,,,,,0.0
Firozpur,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Firozpur,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,1200.0,0.0,0.0,0.0,4000.0,0.0,4800.0,,1600.0,0.0,0.0,,11600.0
Firozpur,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,0.0,4000.0,0.0,4000.0,0.0,6000.0,4000.0,,0.0,0.0,4000.0,,22000.0
Firozpur,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,,0.0
Firozpur,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,1200.0,4000.0,0.0,0.0,4000.0,1200.0,4800.0,,1600.0,0.0,0.0,,16800.0
Firozpur,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,0.0,0.0,0.0,4000.0,0.0,4800.0,4000.0,0.0,0.0,0.0,4000.0,0.0,16800.0
Firozpur,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,12000.0,88000.0,76000.0,160000.0,136000.0,100000.0,82000.0,,36000.0,2000.0,6000.0,,698000.0
Firozpur,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,80000.0,40000.0,100000.0,0.0,0.0,0.0,0.0,,0.0,0.0,60000.0,,280000.0
Firozpur,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,,0.0
Firozpur,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,4000.0,52000.0,16000.0,24000.0,36000.0,18000.0,32000.0,,34000.0,0.0,9000.0,,225000.0
Firozpur,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,88000.0,76000.0,160000.0,136000.0,100000.0,82000.0,50000.0,0.0,2000.0,2000.0,57000.0,0.0,753000.0
Firozpur,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,1000.0,400.0,3200.0,1600.0,2700.0,800.0,600.0,,3100.0,2700.0,1500.0,,17600.0
Firozpur,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,0.0,4800.0,1600.0,2400.0,0.0,0.0,4800.0,,0.0,0.0,2400.0,,16000.0
Firozpur,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,,0.0
Firozpur,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,600.0,2000.0,3200.0,1300.0,1900.0,200.0,5200.0,,2900.0,1200.0,1100.0,,19600.0
Firozpur,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,400.0,3200.0,1600.0,2700.0,800.0,600.0,200.0,0.0,200.0,1500.0,2800.0,0.0,14000.0
Firozpur,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,,,,,,,,,,,,,
Firozpur,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Firozpur,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Firozpur,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,,,,,,,,,,,,
Firozpur,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Firozpur,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Firozpur,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,,,,,,,,,,,,,
Firozpur,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,1.0,,,,,,,1.0,,1.0,,,3.0
Firozpur,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,1.0,,,,,,,,,,,,1.0
Firozpur,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,2.0,,,,,,,1.0,,1.0,,,4.0
Firozpur,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,,,,,,,,,1.0,,,,1.0
Firozpur,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Firozpur,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,,,,,,,,,1.0,,,,1.0
Firozpur,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,,1.0,,,,,1.0,3.0,,,,5.0
Firozpur,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,,,,,,1.0,,,,1.0
Firozpur,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,,,1.0,,,,,1.0,4.0,,,,6.0
Firozpur,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,1.0,,,,1.0,,1.0,1.0,,,4.0
Firozpur,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
Firozpur,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,1.0,,,,1.0,,1.0,1.0,,,4.0
Firozpur,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,2.0,,,,1.0,,,1.0,,,,,4.0
Firozpur,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,1.0,,,,,,,,,1.0
Firozpur,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,2.0,,,1.0,1.0,,,1.0,,,,,5.0
Firozpur,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Firozpur,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Firozpur,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Firozpur,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,,,,,,,,,,,,,
Firozpur,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,,,,,,,,,,,,,
Firozpur,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,,,,,,,,,,,,,
Firozpur,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
Firozpur,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,,,,,,,,,
Firozpur,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,,,,,,,,,
Firozpur,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,,,,,,,,,,,
Firozpur,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
Firozpur,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,,,,,,,,,,,,,
Firozpur,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,,,,1.0,,,,,,,,,1.0
Firozpur,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,,,,1.0,,,,,,,,,1.0
Firozpur,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,,,,,,
Firozpur,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,,,,,,,,,,,,,
Firozpur,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,,,,2.0,2.0,,,,,,,,4.0
Firozpur,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,,,,2.0,2.0,,,,,,,,4.0
Firozpur,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
Firozpur,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,,,,,,,,
Firozpur,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
Firozpur,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,,,,,,,,,,
Firozpur,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,,,,,,,,,,
Firozpur,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,,,,,1.0,,,,,,,,1.0
Firozpur,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,,,,,,,,,,,,,
Firozpur,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,,,,,1.0,,,,,,,,1.0
Firozpur,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
Firozpur,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,,,,,,,,1.0,,,1.0
Firozpur,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,,,,
Firozpur,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,,,,,,,,1.0,,,1.0
Firozpur,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,,,,,,,,,
Firozpur,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,,,,3.0,,7.0,4.0,,,,,,14.0
Firozpur,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,1.0,,,6.0,2.0,7.0,3.0,,,,,,19.0
Firozpur,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,1.0,,,9.0,2.0,14.0,7.0,,,,,,33.0
Firozpur,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,,,,,,,
Firozpur,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,,,,,,,1.0,,,,,,1.0
Firozpur,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,,,,1.0,,1.0,,,,,,,2.0
Firozpur,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,,,,1.0,,1.0,1.0,,,,,,3.0
Firozpur,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Firozpur,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
Firozpur,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Firozpur,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
Firozpur,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Firozpur,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,1.0,,,,,,,,1.0
Firozpur,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Firozpur,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,1.0,,,,,,,,1.0
Firozpur,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Firozpur,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,1.0,,,,1.0,,,,,,,,2.0
Firozpur,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Firozpur,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,1.0,,,,1.0,,,,,,,,2.0
Firozpur,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Firozpur,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,,,,,,,1.0,,,,1.0
Firozpur,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Firozpur,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,,,,,,,1.0,,,,1.0
Firozpur,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Firozpur,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,,,,,,,
Firozpur,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Firozpur,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,,,,,,,
Firozpur,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Firozpur,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,,1.0,2.0,1.0,1.0,2.0,,1.0,1.0,,1.0,1.0,11.0
Firozpur,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Firozpur,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,,1.0,2.0,1.0,1.0,2.0,,1.0,1.0,,1.0,1.0,11.0
Firozpur,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,,,,,,,,,,,,
Firozpur,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,,,,1.0,1.0,2.0,1.0,,1.0,,,,6.0
Firozpur,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,,,,,1.0,,1.0,,,1.0,,,3.0
Firozpur,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,,,,1.0,2.0,2.0,2.0,,1.0,1.0,,,9.0
Firozpur,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,,,,,,,,,
Firozpur,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,,,1.0,,1.0,1.0,,,,,,,3.0
Firozpur,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,,,,,,,,,,,,
Firozpur,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,,,1.0,,1.0,1.0,,,,,,,3.0
Firozpur,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,1.0,,1.0,,,,,,,2.0
Firozpur,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,,,,,1.0,,,,,,,1.0
Firozpur,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,,,,,1.0,,,,,,1.0
Firozpur,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,,,,1.0,,2.0,1.0,,,,,,4.0
Firozpur,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,,,,,,,,,,,
Firozpur,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,,,,,,,,,,,,,
Firozpur,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,,,,,,,,,,,,,
Firozpur,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,,,,,,,,,,,,,
Firozpur,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,,,,,1.0,,,,,,,1.0
Firozpur,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,,1.0,,1.0,,3.0,2.0,,,,,,7.0
Firozpur,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,,,,4.0,1.0,4.0,,,,1.0,,,10.0
Firozpur,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,,1.0,,5.0,1.0,8.0,2.0,,,1.0,,,18.0
Firozpur,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,,,,,1.0,1.0,2.0,,,,,,4.0
Firozpur,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,1.0,,2.0,3.0,2.0,3.0,2.0,,2.0,2.0,,,17.0
Firozpur,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,,,,3.0,3.0,18.0,9.0,,,6.0,,,39.0
Firozpur,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,1.0,,2.0,6.0,6.0,22.0,13.0,,2.0,8.0,,,60.0
Gurdaspur,1.1,Total number of pregnant women Registered for ANC,TOTAL,2700.0,3115.0,2587.0,2720.0,2552.0,1948.0,1744.0,1904.0,1869.0,2578.0,2559.0,2578.0,28854.0
Gurdaspur,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,1572.0,1758.0,1638.0,1575.0,1472.0,1138.0,1060.0,1253.0,1257.0,1719.0,1728.0,1643.0,17813.0
Gurdaspur,1.2,Number of Pregnant women registered under JSY,TOTAL,537.0,703.0,662.0,694.0,579.0,475.0,370.0,406.0,430.0,527.0,543.0,464.0,6390.0
Gurdaspur,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,1833.0,2101.0,2201.0,2552.0,2622.0,2418.0,2345.0,2126.0,2087.0,2021.0,1776.0,1788.0,25870.0
Gurdaspur,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,2382.0,2923.0,2401.0,2536.0,2504.0,1810.0,1615.0,1740.0,1769.0,2246.0,2323.0,2289.0,26538.0
Gurdaspur,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,2355.0,2648.0,2797.0,2490.0,2565.0,2221.0,1848.0,1664.0,1667.0,1789.0,2285.0,2155.0,26484.0
Gurdaspur,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,2178.0,2486.0,2166.0,2420.0,2335.0,1901.0,1677.0,1665.0,1636.0,1175.0,1808.0,2027.0,23474.0
Gurdaspur,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,0.0,28.0,28.0,8.0,2.0,1.0,4.0,3.0,2.0,8.0,7.0,1.0,92.0
Gurdaspur,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gurdaspur,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,2362.0,2860.0,2493.0,2747.0,2487.0,1997.0,1893.0,1888.0,1752.0,2434.0,2378.0,2355.0,27646.0
Gurdaspur,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,2.0,1.0,1.0,2.0,1.0,2.0,4.0,1.0,5.0,3.0,4.0,1.0,27.0
Gurdaspur,1.8,Number of pregnancy test kits used at SC level,TOTAL,2045.0,2261.0,1863.0,2180.0,2145.0,1674.0,1560.0,1648.0,1643.0,2164.0,2152.0,2106.0,23441.0
Gurdaspur,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,123.0,152.0,165.0,254.0,261.0,251.0,237.0,206.0,234.0,185.0,192.0,168.0,2428.0
Gurdaspur,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,152.0,154.0,152.0,87.0,86.0,87.0,80.0,77.0,77.0,72.0,49.0,39.0,1112.0
Gurdaspur,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,275.0,306.0,317.0,341.0,347.0,338.0,317.0,283.0,311.0,257.0,241.0,207.0,3540.0
Gurdaspur,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,237.0,250.0,268.0,285.0,296.0,296.0,297.0,255.0,263.0,206.0,228.0,189.0,3070.0
Gurdaspur,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,13.0,41.0,25.0,50.0,43.0,42.0,33.0,26.0,30.0,24.0,21.0,4.0,352.0
Gurdaspur,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,613.0,679.0,742.0,970.0,1112.0,1183.0,1160.0,1020.0,919.0,942.0,757.0,661.0,10758.0
Gurdaspur,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,244.0,284.0,330.0,419.0,496.0,476.0,729.0,660.0,552.0,590.0,458.0,412.0,5650.0
Gurdaspur,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,50.0,242.0,174.0,230.0,317.0,282.0,305.0,230.0,277.0,238.0,229.0,39.0,2613.0
Gurdaspur,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gurdaspur,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gurdaspur,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,529.0,1003.0,996.0,1399.0,1540.0,1174.0,1138.0,1073.0,1006.0,1024.0,771.0,783.0,12436.0
Gurdaspur,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,13.0,4.0,2.0,14.0,15.0,5.0,16.0,10.0,10.0,6.0,2.0,97.0
Gurdaspur,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gurdaspur,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gurdaspur,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gurdaspur,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,64.0,78.0,63.0,103.0,91.0,114.0,112.0,80.0,86.0,89.0,79.0,76.0,1035.0
Gurdaspur,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,141.0,156.0,166.0,222.0,258.0,268.0,280.0,232.0,228.0,228.0,188.0,126.0,2493.0
Gurdaspur,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Gurdaspur,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,205.0,234.0,229.0,325.0,349.0,382.0,392.0,312.0,314.0,317.0,267.0,202.0,3528.0
Gurdaspur,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,353.0,591.0,592.0,901.0,895.0,776.0,684.0,697.0,662.0,709.0,515.0,544.0,7919.0
Gurdaspur,4.1.1.a,Number of male live births,TOTAL,747.0,1072.0,1103.0,1429.0,1515.0,1417.0,1351.0,1261.0,1162.0,1213.0,928.0,909.0,14107.0
Gurdaspur,4.1.1.b,Number of female live births,TOTAL,660.0,898.0,920.0,1249.0,1474.0,1247.0,1231.0,1100.0,1056.0,996.0,838.0,725.0,12394.0
Gurdaspur,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,1407.0,1970.0,2023.0,2678.0,2989.0,2664.0,2582.0,2361.0,2218.0,2209.0,1766.0,1634.0,26501.0
Gurdaspur,4.1.2,Number of still births,TOTAL,27.0,42.0,38.0,43.0,43.0,53.0,45.0,28.0,29.0,26.0,17.0,26.0,417.0
Gurdaspur,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,45.0,70.0,45.0,67.0,70.0,62.0,42.0,35.0,33.0,65.0,63.0,49.0,646.0
Gurdaspur,4.2.1,Number of Newborns weighed at birth,TOTAL,1288.0,1892.0,1768.0,2565.0,2847.0,2530.0,2577.0,2351.0,2216.0,2209.0,1766.0,1633.0,25642.0
Gurdaspur,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,6.0,16.0,22.0,60.0,26.0,37.0,24.0,21.0,16.0,9.0,9.0,7.0,253.0
Gurdaspur,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,882.0,1399.0,1392.0,2016.0,2319.0,1969.0,1970.0,1859.0,1683.0,1583.0,1368.0,1345.0,19785.0
Gurdaspur,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gurdaspur,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,20.0,55.0,77.0,42.0,44.0,35.0,273.0
Gurdaspur,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,78.0,75.0,96.0,129.0,150.0,157.0,165.0,180.0,117.0,152.0,128.0,120.0,1547.0
Gurdaspur,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Gurdaspur,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,78.0,75.0,96.0,129.0,150.0,157.0,185.0,235.0,194.0,194.0,172.0,155.0,1820.0
Gurdaspur,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gurdaspur,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,78.0,75.0,96.0,129.0,150.0,157.0,167.0,204.0,136.0,180.0,157.0,153.0,1682.0
Gurdaspur,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,0.0,2.0,0.0,2.0,2.0,2.0,7.0,13.0,20.0,6.0,8.0,9.0,71.0
Gurdaspur,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,78.0,75.0,96.0,129.0,150.0,91.0,165.0,122.0,148.0,58.0,58.0,60.0,1230.0
Gurdaspur,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,48.0,51.0,50.0,75.0,100.0,97.0,115.0,115.0,69.0,51.0,63.0,17.0,851.0
Gurdaspur,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,646.0,928.0,936.0,1189.0,1326.0,1211.0,1276.0,1107.0,1032.0,975.0,957.0,886.0,12469.0
Gurdaspur,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,725.0,1038.0,1008.0,1428.0,1521.0,1495.0,1502.0,1305.0,1177.0,1255.0,1169.0,1062.0,14685.0
Gurdaspur,6.3,PNC maternal complications attended,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gurdaspur,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,24.0,29.0,7.0,8.0,16.0,4.0,8.0,8.0,9.0,2.0,5.0,3.0,123.0
Gurdaspur,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Gurdaspur,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,24.0,29.0,7.0,9.0,16.0,4.0,8.0,8.0,9.0,2.0,5.0,3.0,124.0
Gurdaspur,7.2,Number of MTPs conducted at Private Facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gurdaspur,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,127.0,119.0,52.0,113.0,118.0,124.0,126.0,94.0,114.0,133.0,222.0,134.0,1476.0
Gurdaspur,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,293.0,319.0,195.0,377.0,346.0,393.0,324.0,339.0,316.0,322.0,300.0,295.0,3819.0
Gurdaspur,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,420.0,438.0,247.0,490.0,464.0,517.0,450.0,433.0,430.0,455.0,522.0,429.0,5295.0
Gurdaspur,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gurdaspur,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,1.0,0.0,0.0,1.0,0.0,1.0,7.0,3.0,0.0,0.0,1.0,0.0,14.0
Gurdaspur,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,6.0,7.0,1.0,3.0,12.0,14.0,9.0,13.0,4.0,9.0,7.0,7.0,92.0
Gurdaspur,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,5.0,2.0,8.0,10.0,21.0,6.0,3.0,4.0,6.0,7.0,0.0,3.0,75.0
Gurdaspur,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Gurdaspur,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,12.0,9.0,9.0,14.0,33.0,21.0,19.0,20.0,10.0,16.0,8.0,10.0,181.0
Gurdaspur,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,0.0,3.0,1.0,3.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,8.0
Gurdaspur,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gurdaspur,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gurdaspur,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,,,,,,,,,,0.0
Gurdaspur,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Gurdaspur,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gurdaspur,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gurdaspur,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,11.0,14.0,2.0,19.0,5.0,4.0,18.0,15.0,6.0,2.0,5.0,8.0,109.0
Gurdaspur,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,100.0,81.0,107.0,75.0,111.0,100.0,56.0,74.0,43.0,22.0,61.0,104.0,934.0
Gurdaspur,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,30.0,32.0,42.0,80.0,35.0,44.0,33.0,38.0,35.0,20.0,20.0,23.0,432.0
Gurdaspur,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Gurdaspur,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,141.0,127.0,151.0,174.0,151.0,148.0,107.0,127.0,84.0,44.0,86.0,135.0,1475.0
Gurdaspur,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,39.0,57.0,62.0,75.0,84.0,67.0,65.0,51.0,53.0,49.0,45.0,31.0,678.0
Gurdaspur,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gurdaspur,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,9.0,12.0,6.0,10.0,16.0,18.0,17.0,6.0,9.0,14.0,11.0,12.0,140.0
Gurdaspur,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,28.0,41.0,26.0,48.0,54.0,34.0,34.0,32.0,19.0,31.0,25.0,29.0,401.0
Gurdaspur,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Gurdaspur,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,37.0,53.0,32.0,58.0,70.0,52.0,51.0,38.0,28.0,45.0,36.0,41.0,541.0
Gurdaspur,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,3.0,6.0,8.0,10.0,8.0,7.0,9.0,5.0,15.0,10.0,5.0,6.0,92.0
Gurdaspur,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,659.0,670.0,719.0,890.0,759.0,602.0,685.0,641.0,629.0,631.0,654.0,576.0,8115.0
Gurdaspur,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,17.0,14.0,0.0,1.0,10.0,4.0,6.0,2.0,5.0,10.0,8.0,11.0,88.0
Gurdaspur,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,17.0,15.0,23.0,37.0,27.0,82.0,73.0,107.0,129.0,128.0,104.0,68.0,810.0
Gurdaspur,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,54.0,64.0,50.0,90.0,90.0,97.0,78.0,74.0,64.0,47.0,32.0,30.0,770.0
Gurdaspur,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Gurdaspur,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,747.0,763.0,792.0,1018.0,886.0,785.0,842.0,824.0,827.0,816.0,798.0,685.0,9783.0
Gurdaspur,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,59.0,69.0,64.0,138.0,121.0,160.0,154.0,223.0,238.0,205.0,156.0,114.0,1701.0
Gurdaspur,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gurdaspur,9.06,Number of IUCD removals,TOTAL,164.0,147.0,95.0,106.0,124.0,100.0,86.0,100.0,113.0,119.0,133.0,122.0,1409.0
Gurdaspur,9.07,Number of Oral Pills cycles distributed,TOTAL,6957.0,7440.0,7164.0,7369.0,7185.0,7112.0,7285.0,7333.0,7127.0,7118.0,7410.0,7073.0,86573.0
Gurdaspur,9.08,Number of Condom pieces distributed,TOTAL,134261.0,150259.0,156958.0,157372.0,156049.0,140453.0,150751.0,144611.0,141256.0,143003.0,150921.0,140848.0,1766742.0
Gurdaspur,9.09,Number of Centchroman (weekly) pills given,TOTAL,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Gurdaspur,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,13.0,38.0,41.0,62.0,69.0,139.0,166.0,168.0,128.0,157.0,235.0,215.0,1431.0
Gurdaspur,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gurdaspur,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gurdaspur,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gurdaspur,9.11.2.b,Number of failures following female sterilization,TOTAL,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Gurdaspur,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gurdaspur,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gurdaspur,9.12,Number of Institutions having NSV trained doctors,TOTAL,1.0,1.0,1.0,2.0,1.0,2.0,3.0,3.0,4.0,3.0,3.0,3.0,-1.0
Gurdaspur,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,1347.0,1917.0,2034.0,2548.0,2939.0,2664.0,2639.0,2405.0,2131.0,2181.0,1799.0,1639.0,26243.0
Gurdaspur,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,1862.0,2063.0,1616.0,1856.0,2246.0,2032.0,2309.0,2827.0,2418.0,2411.0,746.0,42.0,22428.0
Gurdaspur,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,2145.0,2286.0,1846.0,1742.0,1899.0,1868.0,2012.0,2395.0,2665.0,2461.0,2382.0,808.0,24509.0
Gurdaspur,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,2273.0,2558.0,2110.0,2041.0,1879.0,1654.0,1856.0,2091.0,2200.0,2630.0,2336.0,2238.0,25866.0
Gurdaspur,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1495.0,1977.0,3472.0
Gurdaspur,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,4.0,1319.0,1323.0
Gurdaspur,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,4.0,95.0,99.0
Gurdaspur,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,1159.0,1722.0,1822.0,2309.0,2706.0,2356.0,2376.0,2190.0,2005.0,1882.0,1639.0,1413.0,23579.0
Gurdaspur,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,1862.0,2063.0,1616.0,1856.0,2246.0,2032.0,2309.0,2827.0,2418.0,2411.0,1864.0,2019.0,25523.0
Gurdaspur,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,2145.0,2286.0,1846.0,1742.0,1899.0,1868.0,2012.0,2395.0,2665.0,2461.0,2385.0,2127.0,25831.0
Gurdaspur,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,2273.0,2558.0,2110.0,2041.0,1879.0,1654.0,1856.0,2091.0,2200.0,2630.0,2339.0,2333.0,25964.0
Gurdaspur,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,454.0,926.0,1020.0,1276.0,1492.0,1186.0,1148.0,1008.0,888.0,881.0,707.0,588.0,11574.0
Gurdaspur,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,1862.0,2063.0,1616.0,1856.0,2246.0,2032.0,2309.0,2827.0,2418.0,2411.0,746.0,42.0,22428.0
Gurdaspur,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,2145.0,2286.0,1846.0,1742.0,1899.0,1868.0,2012.0,2395.0,2665.0,2461.0,2382.0,808.0,24509.0
Gurdaspur,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,2273.0,2558.0,2110.0,2041.0,1879.0,1654.0,1856.0,2091.0,2200.0,2630.0,2336.0,2238.0,25866.0
Gurdaspur,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,1894.0,2919.0,2614.0,2744.0,3053.0,2303.0,2075.0,2210.0,1661.0,1712.0,1562.0,1675.0,26422.0
Gurdaspur,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,2407.0,2831.0,2349.0,2513.0,2250.0,1836.0,1614.0,1897.0,1929.0,2275.0,2331.0,2379.0,26611.0
Gurdaspur,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gurdaspur,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1068.0,1676.0,1462.0,1542.0,1650.0,1261.0,1151.0,1271.0,906.0,953.0,873.0,931.0,14744.0
Gurdaspur,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,826.0,1243.0,1146.0,1202.0,1393.0,1042.0,924.0,939.0,755.0,759.0,689.0,744.0,11662.0
Gurdaspur,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,1894.0,2919.0,2608.0,2744.0,3043.0,2303.0,2075.0,2210.0,1661.0,1712.0,1562.0,1675.0,26406.0
Gurdaspur,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,2407.0,2785.0,2312.0,2513.0,2250.0,1836.0,1614.0,1897.0,1929.0,2275.0,2331.0,2379.0,26528.0
Gurdaspur,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,2407.0,2785.0,2312.0,2513.0,2250.0,1836.0,1614.0,1897.0,1929.0,2275.0,2331.0,2379.0,26528.0
Gurdaspur,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gurdaspur,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,0.0,9.0,21.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,30.0
Gurdaspur,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gurdaspur,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,0.0,9.0,21.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,30.0
Gurdaspur,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,1517.0,2253.0,1849.0,2292.0,2240.0,1826.0,1840.0,2526.0,1840.0,2120.0,1940.0,1887.0,24130.0
Gurdaspur,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,1288.0,2233.0,1415.0,2404.0,2657.0,1659.0,1510.0,2324.0,1570.0,2060.0,1517.0,1535.0,22172.0
Gurdaspur,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,878.0,1550.0,838.0,1791.0,1883.0,826.0,1243.0,1440.0,1296.0,1719.0,1301.0,763.0,15528.0
Gurdaspur,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,4.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,4.0
Gurdaspur,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gurdaspur,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gurdaspur,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,998.0,1045.0,1041.0,1071.0,1059.0,1024.0,1027.0,1027.0,1037.0,1014.0,1006.0,995.0,12344.0
Gurdaspur,10.4.2,Number of Immunisation sessions held during the month,TOTAL,993.0,1036.0,1028.0,1059.0,1049.0,1016.0,1022.0,1026.0,1027.0,1007.0,998.0,972.0,12233.0
Gurdaspur,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,873.0,883.0,874.0,895.0,869.0,890.0,887.0,892.0,893.0,906.0,907.0,902.0,10671.0
Gurdaspur,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gurdaspur,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,1894.0,2835.0,2609.0,2744.0,3053.0,2303.0,2075.0,2210.0,1661.0,1712.0,1562.0,1675.0,26333.0
Gurdaspur,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,1421.0,1537.0,1440.0,1542.0,1623.0,1422.0,1389.0,1558.0,1408.0,1359.0,1413.0,1337.0,17449.0
Gurdaspur,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,1505.0,2271.0,1852.0,2309.0,2238.0,1813.0,1824.0,2539.0,1848.0,2112.0,1942.0,1877.0,24130.0
Gurdaspur,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gurdaspur,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gurdaspur,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gurdaspur,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gurdaspur,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gurdaspur,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gurdaspur,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,85.0,10.0,14.0,114.0,8.0,9.0,12.0,9.0,12.0,10.0,10.0,9.0,302.0
Gurdaspur,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Gurdaspur,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,5.0,3.0,2.0,75.0,0.0,5.0,4.0,5.0,6.0,6.0,4.0,6.0,121.0
Gurdaspur,13.1,Number of Patients operated for cataract,TOTAL,59.0,46.0,29.0,23.0,32.0,42.0,64.0,300.0,58.0,27.0,30.0,69.0,779.0
Gurdaspur,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,59.0,46.0,29.0,23.0,32.0,42.0,64.0,300.0,58.0,27.0,30.0,69.0,779.0
Gurdaspur,13.3,Number of School children detected with Refractive errors,TOTAL,11.0,188.0,6.0,90.0,137.0,61.0,102.0,92.0,36.0,35.0,38.0,25.0,821.0
Gurdaspur,13.4,Number of children provided free glasses,TOTAL,11.0,138.0,0.0,63.0,29.0,55.0,67.0,74.0,31.0,35.0,12.0,102.0,617.0
Gurdaspur,13.5,Number of eyes collected through eye donation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gurdaspur,13.6,Number of eyes utilised for corneal transplant,TOTAL,3.0,5.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,9.0
Gurdaspur,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,4.0,1.0,4.0,3.0,4.0,3.0,5.0,5.0,6.0,7.0,5.0,5.0,-1.0
Gurdaspur,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,,,4.0,6.0,9.0,8.0,7.0,8.0,6.0,8.0,8.0,6.0,-1.0
Gurdaspur,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,726.0,747.0,749.0,758.0,752.0,755.0,752.0,757.0,753.0,736.0,755.0,737.0,-1.0
Gurdaspur,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,9.0,9.0,5.0,4.0,4.0,3.0,5.0,4.0,3.0,3.0,3.0,3.0,-1.0
Gurdaspur,14.05,Number of RKS meetings held during the month,TOTAL,4.0,6.0,1.0,1.0,3.0,0.0,0.0,0.0,0.0,1.0,1.0,1.0,18.0
Gurdaspur,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,5.0,1.0,7.0,5.0,5.0,4.0,5.0,3.0,4.0,5.0,4.0,3.0,-1.0
Gurdaspur,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,39.0,70.0,49.0,33.0,94.0,81.0,183.0,146.0,112.0,55.0,45.0,47.0,954.0
Gurdaspur,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,2.0,,1.0,1.0,2.0,1.0,1.0,1.0,1.0,2.0,2.0,2.0,-1.0
Gurdaspur,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,9.0,7.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,-1.0
Gurdaspur,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,417.0,397.0,297.0,660.0,565.0,501.0,445.0,409.0,366.0,407.0,204.0,388.0,5056.0
Gurdaspur,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,1349.0,939.0,1193.0,1352.0,1653.0,1479.0,1628.0,1398.0,1320.0,1013.0,562.0,1259.0,15145.0
Gurdaspur,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,376.0,347.0,233.0,572.0,428.0,446.0,479.0,370.0,330.0,371.0,358.0,310.0,4620.0
Gurdaspur,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,1837.0,1684.0,1963.0,2381.0,2632.0,2752.0,2344.0,2276.0,1715.0,1697.0,1152.0,1637.0,24070.0
Gurdaspur,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,793.0,744.0,530.0,1232.0,993.0,947.0,924.0,779.0,696.0,778.0,562.0,698.0,9676.0
Gurdaspur,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,3186.0,2623.0,3156.0,3733.0,4285.0,4231.0,3972.0,3674.0,3035.0,2710.0,1714.0,2896.0,39215.0
Gurdaspur,14.10.2.a,Number of death cases of Inpatient males,TOTAL,25.0,2.0,1.0,19.0,16.0,22.0,10.0,15.0,6.0,5.0,4.0,1.0,126.0
Gurdaspur,14.10.2.b,Number of death cases of Inpatient females,TOTAL,12.0,5.0,4.0,15.0,14.0,9.0,4.0,8.0,3.0,0.0,1.0,1.0,76.0
Gurdaspur,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,37.0,7.0,5.0,34.0,30.0,31.0,14.0,23.0,9.0,5.0,5.0,2.0,202.0
Gurdaspur,14.11,In-Patient Head Count at midnight,TOTAL,996.0,1222.0,1119.0,988.0,923.0,1250.0,877.0,717.0,733.0,745.0,836.0,1007.0,11413.0
Gurdaspur,14.12.1,OPD attendance (All),TOTAL,79424.0,95427.0,86903.0,89336.0,96330.0,93709.0,75328.0,84003.0,72177.0,65506.0,81210.0,81594.0,1000947.0
Gurdaspur,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,350.0,501.0,250.0,533.0,538.0,582.0,633.0,579.0,449.0,491.0,470.0,475.0,5851.0
Gurdaspur,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,5.0,39.0,0.0,62.0,20.0,0.0,0.0,48.0,39.0,39.0,37.0,25.0,314.0
Gurdaspur,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,1110.0,1122.0,919.0,1315.0,1127.0,1226.0,1093.0,1164.0,1010.0,1055.0,956.0,1082.0,13179.0
Gurdaspur,14.14.a,Number of patients given AYUSH treatment,TOTAL,7190.0,8718.0,7615.0,11417.0,12517.0,11557.0,10663.0,10799.0,11007.0,10515.0,11700.0,9204.0,122902.0
Gurdaspur,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,1352.0,1133.0,343.0,1002.0,1111.0,1255.0,981.0,1388.0,1415.0,1261.0,622.0,955.0,12818.0
Gurdaspur,14.14.c,Number of Adolescents counselled,TOTAL,80.0,52.0,67.0,34.0,47.0,43.0,24.0,20.0,22.0,17.0,8.0,0.0,414.0
Gurdaspur,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,7897.0,9728.0,7208.0,9353.0,10313.0,9835.0,7823.0,7655.0,6836.0,6216.0,8169.0,8682.0,99715.0
Gurdaspur,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,258.0,469.0,195.0,534.0,414.0,456.0,335.0,416.0,289.0,299.0,351.0,374.0,4390.0
Gurdaspur,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,585.0,862.0,789.0,935.0,1010.0,1044.0,760.0,753.0,826.0,604.0,673.0,598.0,9439.0
Gurdaspur,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,11.0,18.0,16.0,16.0,15.0,14.0,4.0,7.0,6.0,5.0,9.0,4.0,125.0
Gurdaspur,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,637.0,760.0,943.0,868.0,773.0,670.0,656.0,649.0,551.0,608.0,716.0,688.0,8519.0
Gurdaspur,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,5.0,8.0,10.0,4.0,2.0,7.0,4.0,4.0,1.0,6.0,18.0,1.0,70.0
Gurdaspur,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,1350.0,2133.0,1694.0,2080.0,1918.0,1740.0,1386.0,1382.0,1414.0,1344.0,1380.0,1273.0,19094.0
Gurdaspur,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,6.0,13.0,31.0,0.0,36.0,0.0,0.0,0.0,0.0,19.0,18.0,1.0,124.0
Gurdaspur,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,2572.0,3755.0,3426.0,3883.0,3701.0,3454.0,2802.0,2784.0,2791.0,2556.0,2769.0,2559.0,37052.0
Gurdaspur,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,22.0,39.0,57.0,20.0,53.0,21.0,8.0,11.0,7.0,30.0,45.0,6.0,319.0
Gurdaspur,15.2,Number of Widal tests conducted,Number tested,1483.0,1637.0,1456.0,1566.0,2022.0,1689.0,1110.0,745.0,476.0,396.0,995.0,1228.0,14803.0
Gurdaspur,15.3.a,Number of VDRL tests conducted on males,Number tested,38.0,27.0,25.0,17.0,43.0,13.0,135.0,43.0,14.0,21.0,77.0,34.0,487.0
Gurdaspur,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,85.0,35.0,171.0,28.0,37.0,91.0,66.0,17.0,41.0,103.0,51.0,46.0,771.0
Gurdaspur,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,1418.0,1816.0,1488.0,1514.0,1443.0,1401.0,1053.0,1247.0,1221.0,1253.0,1473.0,1864.0,17191.0
Gurdaspur,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,1541.0,1878.0,1684.0,1559.0,1523.0,1505.0,1254.0,1307.0,1276.0,1377.0,1601.0,1944.0,18449.0
Gurdaspur,15.4.1,Number of blood smears examined for Malaria,TOTAL,7032.0,12006.0,5372.0,9402.0,5954.0,7279.0,6386.0,7487.0,7142.0,4944.0,6533.0,6692.0,86229.0
Gurdaspur,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,1.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0
Gurdaspur,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Gurdaspur,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Gurdaspur,16.1.1,Stock position of DPT vaccines,2. Stocks Received,,,,,,,,,,,,,
Gurdaspur,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Gurdaspur,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,,,,,,,,,,,,,
Gurdaspur,16.1.1,Stock position of DPT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gurdaspur,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,,,,,,,,,,,,,
Gurdaspur,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,,,,,,,,,,,,,
Gurdaspur,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,,,,,,,,,,,,,
Gurdaspur,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,,,,,,,,,,,,,
Gurdaspur,16.1.1A,Stock Position of Pentavalent,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gurdaspur,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Gurdaspur,16.1.2,Stock position of OPV vaccines,2. Stocks Received,,,,,,,,,,,,,
Gurdaspur,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,,,,,,,,,,,,,
Gurdaspur,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,,,,,,,,,,,,,
Gurdaspur,16.1.2,Stock position of OPV vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gurdaspur,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Gurdaspur,16.1.3,Stock position of TT vaccines,2. Stocks Received,,,,,,,,,,,,,
Gurdaspur,16.1.3,Stock position of TT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Gurdaspur,16.1.3,Stock position of TT vaccines,4. Stock Distributed,,,,,,,,,,,,,
Gurdaspur,16.1.3,Stock position of TT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gurdaspur,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Gurdaspur,16.1.4,Stock position of DT vaccines,2. Stocks Received,,,,,,,,,,,,,
Gurdaspur,16.1.4,Stock position of DT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Gurdaspur,16.1.4,Stock position of DT vaccines,4. Stock Distributed,,,,,,,,,,,,,
Gurdaspur,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gurdaspur,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Gurdaspur,16.1.5,Stock position of BCG vaccines,2. Stocks Received,,,,,,,,,,,,,
Gurdaspur,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,,,,,,,,,,,,,
Gurdaspur,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,,,,,,,,,,,,,
Gurdaspur,16.1.5,Stock position of BCG vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gurdaspur,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Gurdaspur,16.1.6,Stock position of Measles vaccines,2. Stocks Received,,,,,,,,,,,,,
Gurdaspur,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,,,,,,,,,,,,,
Gurdaspur,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,,,,,,,,,,,,,
Gurdaspur,16.1.6,Stock position of Measles vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gurdaspur,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Gurdaspur,16.1.7,Stock position of JE vaccines,2. Stocks Received,,,,,,,,,,,,,
Gurdaspur,16.1.7,Stock position of JE vaccines,3. Unusable Stock,,,,,,,,,,,,,
Gurdaspur,16.1.7,Stock position of JE vaccines,4. Stock Distributed,,,,,,,,,,,,,
Gurdaspur,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gurdaspur,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Gurdaspur,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,,,,,,,,,,,,,
Gurdaspur,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,,,,,,,,,,,,,
Gurdaspur,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,,,,,,,,,,,,,
Gurdaspur,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gurdaspur,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Gurdaspur,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Gurdaspur,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Gurdaspur,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Gurdaspur,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gurdaspur,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Gurdaspur,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Gurdaspur,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Gurdaspur,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Gurdaspur,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gurdaspur,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Gurdaspur,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Gurdaspur,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Gurdaspur,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Gurdaspur,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gurdaspur,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Gurdaspur,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Gurdaspur,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Gurdaspur,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Gurdaspur,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gurdaspur,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Gurdaspur,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Gurdaspur,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Gurdaspur,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Gurdaspur,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gurdaspur,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,,,,,,,,,,,,,
Gurdaspur,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,,,,,,,,,,,,,
Gurdaspur,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,,,,,,,,,,,,,
Gurdaspur,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,,,,,,,,,,,,,
Gurdaspur,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gurdaspur,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,,,,,,,,,,,,,
Gurdaspur,16.3.02,Stock Position of Gloves,2. Stocks Received,,,,,,,,,,,,,
Gurdaspur,16.3.02,Stock Position of Gloves,3. Unusable Stock,,,,,,,,,,,,,
Gurdaspur,16.3.02,Stock Position of Gloves,4. Stock Distributed,,,,,,,,,,,,,
Gurdaspur,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gurdaspur,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,,,,,,,,,,,,,
Gurdaspur,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,,,,,,,,,,,,,
Gurdaspur,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,,,,,,,,,,,,,
Gurdaspur,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,,,,,,,,,,,,,
Gurdaspur,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gurdaspur,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
Gurdaspur,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,,,,,,,,,,,,,
Gurdaspur,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,,,,,,,,,,,,,
Gurdaspur,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,,,,,,,,,,,,,
Gurdaspur,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gurdaspur,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,,,,,,,,,,,,,
Gurdaspur,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,,,,,,,,,,,,,
Gurdaspur,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,,,,,,,,,,,,,
Gurdaspur,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,,,,,,,,,,,,,
Gurdaspur,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gurdaspur,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,,,,,,,,,,,,,
Gurdaspur,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,,,,,,,,,,,,,
Gurdaspur,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,,,,,,,,,,,,,
Gurdaspur,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,,,,,,,,,,,,,
Gurdaspur,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gurdaspur,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
Gurdaspur,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,,,,,,,,,,,,,
Gurdaspur,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,,,,,,,,,,,,,
Gurdaspur,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,,,,,,,,,,,,,
Gurdaspur,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gurdaspur,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,,,,,,,,,,,,,
Gurdaspur,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,,,,,,,,,,,,,
Gurdaspur,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,,,,,,,,,,,,,
Gurdaspur,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,,,,,,,,,,,,,
Gurdaspur,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gurdaspur,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,,,,,,,,,,,,,
Gurdaspur,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,,,,,,,,,,,,,
Gurdaspur,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,,,,,,,,,,,,,
Gurdaspur,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,,,,,,,,,,,,,
Gurdaspur,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gurdaspur,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,,,,,,,,,,,,,
Gurdaspur,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,,,,,,,,,,,,,
Gurdaspur,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,,,,,,,,,,,,,
Gurdaspur,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,,,,,,,,,,,,,
Gurdaspur,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gurdaspur,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,,,,,,,,,,,,,
Gurdaspur,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,,,,,,,,,,,,,
Gurdaspur,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,,,,,,,,,,,,,
Gurdaspur,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,,,,,,,,,,,,,
Gurdaspur,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gurdaspur,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,,,,,,,,,,,,,
Gurdaspur,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,,,,,,,,,,,,,
Gurdaspur,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,,
Gurdaspur,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,,,,,,,,,,,,,
Gurdaspur,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gurdaspur,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,,,,,,,,,,,,,
Gurdaspur,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,,,,,,,,,,,,,
Gurdaspur,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,,
Gurdaspur,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,,,,,,,,,,,,,
Gurdaspur,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gurdaspur,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,,,,,,,,,,,,,
Gurdaspur,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,,,,,,,,,,,,,
Gurdaspur,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,,,,,,,,,,,,,
Gurdaspur,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,,,,,,,,,,,,,
Gurdaspur,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gurdaspur,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,,2.0,,,,,,,,,,,2.0
Gurdaspur,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Gurdaspur,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Gurdaspur,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,,,,,,,,,,,,
Gurdaspur,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,,,,,1.0,1.0,2.0,,,,,,4.0
Gurdaspur,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,1.0,,,,,,,,1.0
Gurdaspur,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,,,,,2.0,1.0,2.0,,,,,,5.0
Gurdaspur,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,,,,,,1.0,,1.0,,,,,2.0
Gurdaspur,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Gurdaspur,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,,,,,,1.0,,1.0,,,,,2.0
Gurdaspur,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,1.0,2.0,1.0,1.0,2.0,2.0,,2.0,1.0,1.0,1.0,1.0,15.0
Gurdaspur,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,3.0,3.0,,,,1.0,1.0,1.0,,,,,9.0
Gurdaspur,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,4.0,5.0,1.0,1.0,2.0,3.0,1.0,3.0,1.0,1.0,1.0,1.0,24.0
Gurdaspur,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,2.0,,,,,,,1.0,,1.0,1.0,,5.0
Gurdaspur,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,,,,,1.0,,,,,1.0
Gurdaspur,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,2.0,,,,,,,2.0,,1.0,1.0,,6.0
Gurdaspur,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,1.0,,,,,1.0
Gurdaspur,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
Gurdaspur,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,,,,1.0,,,,,1.0
Gurdaspur,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,1.0,,,1.0,2.0,,,1.0,,,,,5.0
Gurdaspur,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,1.0,,,,,1.0,,,,,2.0
Gurdaspur,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,1.0,,1.0,1.0,2.0,,,2.0,,,,,7.0
Gurdaspur,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Gurdaspur,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Gurdaspur,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Gurdaspur,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,4.0,5.0,1.0,1.0,1.0,,1.0,1.0,1.0,4.0,,,19.0
Gurdaspur,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,1.0,4.0,,2.0,1.0,,1.0,1.0,2.0,4.0,,,16.0
Gurdaspur,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,5.0,9.0,1.0,3.0,2.0,,2.0,2.0,3.0,8.0,,,35.0
Gurdaspur,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
Gurdaspur,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,1.0,,,1.0,1.0,,,,,1.0,,,4.0
Gurdaspur,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,1.0,,1.0,,,,,,,,1.0,2.0,5.0
Gurdaspur,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,2.0,,1.0,1.0,1.0,,,,,1.0,1.0,2.0,9.0
Gurdaspur,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
Gurdaspur,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,4.0,1.0,1.0,6.0,2.0,5.0,1.0,2.0,8.0,3.0,,1.0,34.0
Gurdaspur,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,5.0,2.0,,4.0,2.0,2.0,2.0,2.0,1.0,2.0,,1.0,23.0
Gurdaspur,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,9.0,3.0,1.0,10.0,4.0,7.0,3.0,4.0,9.0,5.0,,2.0,57.0
Gurdaspur,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,,,,,,
Gurdaspur,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,,,1.0,,2.0,,5.0,,2.0,5.0,1.0,1.0,17.0
Gurdaspur,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,1.0,1.0,1.0,1.0,3.0,1.0,2.0,4.0,3.0,2.0,1.0,1.0,21.0
Gurdaspur,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,1.0,1.0,2.0,1.0,5.0,1.0,7.0,4.0,5.0,7.0,2.0,2.0,38.0
Gurdaspur,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
Gurdaspur,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,1.0,,,,,,,,,,,1.0
Gurdaspur,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,2.0,,,,,,,,,,,,2.0
Gurdaspur,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,2.0,1.0,,,,,,,,,,,3.0
Gurdaspur,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,1.0,,,,,,1.0,,,,,2.0
Gurdaspur,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,9.0,9.0,4.0,10.0,11.0,5.0,17.0,15.0,10.0,9.0,4.0,7.0,110.0
Gurdaspur,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,40.0,39.0,13.0,26.0,44.0,11.0,48.0,52.0,57.0,47.0,17.0,24.0,418.0
Gurdaspur,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,49.0,49.0,17.0,36.0,55.0,16.0,65.0,68.0,67.0,56.0,21.0,31.0,530.0
Gurdaspur,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,1.0,,,,,,,,,,,1.0
Gurdaspur,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,2.0,1.0,,,,,,1.0,1.0,,,,5.0
Gurdaspur,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,1.0,,,1.0
Gurdaspur,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,2.0,2.0,,,,,,1.0,1.0,1.0,,,7.0
Gurdaspur,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,2.0,,,,2.0,1.0,2.0,,1.0,,,,8.0
Gurdaspur,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,40.0,54.0,30.0,34.0,51.0,20.0,65.0,53.0,56.0,75.0,32.0,29.0,539.0
Gurdaspur,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,131.0,137.0,77.0,93.0,104.0,55.0,170.0,107.0,160.0,123.0,71.0,69.0,1297.0
Gurdaspur,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,173.0,191.0,107.0,127.0,157.0,76.0,237.0,160.0,217.0,198.0,103.0,98.0,1844.0
Gurdaspur,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,,,,,,,
Gurdaspur,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,,,1.0,,1.0,,1.0,,1.0,,,,4.0
Gurdaspur,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,1.0,2.0,,,,,1.0,1.0,3.0,3.0,,,11.0
Gurdaspur,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,1.0,2.0,1.0,,1.0,,2.0,1.0,4.0,3.0,,,15.0
Gurdaspur,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Gurdaspur,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
Gurdaspur,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Gurdaspur,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
Gurdaspur,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Gurdaspur,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,,,,1.0,,,,1.0
Gurdaspur,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Gurdaspur,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,,,,1.0,,,,1.0
Gurdaspur,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Gurdaspur,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,1.0,,,,,,,,,,,1.0
Gurdaspur,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Gurdaspur,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,1.0,,,,,,,,,,,1.0
Gurdaspur,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Gurdaspur,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,,1.0,,,,,,,,,1.0
Gurdaspur,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Gurdaspur,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,,1.0,,,,,,,,,1.0
Gurdaspur,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Gurdaspur,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,,,,,,,
Gurdaspur,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Gurdaspur,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,,,,,,,
Gurdaspur,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Gurdaspur,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,,,,2.0,,,,,,,1.0,,3.0
Gurdaspur,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Gurdaspur,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,,,,2.0,,,,,,,1.0,,3.0
Gurdaspur,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,1.0,,3.0,3.0,,1.0,,1.0,,,,9.0
Gurdaspur,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,10.0,12.0,2.0,8.0,10.0,6.0,16.0,23.0,22.0,16.0,6.0,6.0,137.0
Gurdaspur,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,6.0,6.0,2.0,6.0,6.0,7.0,2.0,7.0,11.0,2.0,1.0,1.0,57.0
Gurdaspur,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,16.0,19.0,4.0,17.0,19.0,13.0,19.0,30.0,34.0,18.0,7.0,7.0,203.0
Gurdaspur,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,,,,,,1.0,,,1.0
Gurdaspur,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,4.0,2.0,2.0,3.0,2.0,1.0,5.0,1.0,,3.0,,1.0,24.0
Gurdaspur,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,1.0,,,,,1.0,,,,1.0,,1.0,4.0
Gurdaspur,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,5.0,2.0,2.0,3.0,2.0,2.0,5.0,1.0,,5.0,,2.0,29.0
Gurdaspur,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,,,,,,,,,,
Gurdaspur,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,1.0,1.0,,,1.0,2.0,1.0,,,,,6.0
Gurdaspur,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,1.0,,1.0,1.0,1.0,1.0,,1.0,,,,,6.0
Gurdaspur,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,1.0,1.0,2.0,1.0,1.0,2.0,2.0,2.0,,,,,12.0
Gurdaspur,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,,,,,,,,,,,
Gurdaspur,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,1.0,3.0,,1.0,,,3.0,4.0,4.0,1.0,,,17.0
Gurdaspur,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,8.0,,1.0,2.0,,,6.0,4.0,4.0,,2.0,,27.0
Gurdaspur,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,9.0,3.0,1.0,3.0,,,9.0,8.0,8.0,1.0,2.0,,44.0
Gurdaspur,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,1.0,1.0,,,,,,,,,,,2.0
Gurdaspur,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,10.0,8.0,2.0,8.0,13.0,6.0,10.0,12.0,14.0,7.0,8.0,,98.0
Gurdaspur,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,18.0,24.0,4.0,14.0,19.0,12.0,15.0,15.0,14.0,7.0,6.0,3.0,151.0
Gurdaspur,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,29.0,33.0,6.0,22.0,32.0,18.0,25.0,27.0,28.0,14.0,14.0,3.0,251.0
Gurdaspur,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,3.0,1.0,2.0,2.0,4.0,1.0,2.0,3.0,1.0,4.0,1.0,,24.0
Gurdaspur,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,24.0,50.0,34.0,40.0,40.0,47.0,46.0,38.0,57.0,56.0,28.0,39.0,499.0
Gurdaspur,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,139.0,195.0,108.0,117.0,123.0,123.0,198.0,177.0,203.0,210.0,95.0,102.0,1790.0
Gurdaspur,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,166.0,246.0,144.0,159.0,167.0,171.0,246.0,218.0,261.0,270.0,124.0,141.0,2313.0
Hoshiarpur,1.1,Total number of pregnant women Registered for ANC,TOTAL,2787.0,2683.0,2220.0,2176.0,2214.0,1853.0,1579.0,1947.0,1826.0,2520.0,2536.0,2159.0,26500.0
Hoshiarpur,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,1947.0,1816.0,1559.0,1475.0,1442.0,1167.0,1055.0,1415.0,1420.0,1934.0,1993.0,1621.0,18844.0
Hoshiarpur,1.2,Number of Pregnant women registered under JSY,TOTAL,1125.0,1102.0,973.0,974.0,1013.0,881.0,724.0,875.0,894.0,1178.0,1152.0,869.0,11760.0
Hoshiarpur,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,1901.0,1995.0,2044.0,2185.0,2330.0,2280.0,2144.0,2264.0,2018.0,2036.0,1832.0,1630.0,24659.0
Hoshiarpur,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,2636.0,2620.0,2134.0,2128.0,2198.0,1768.0,1529.0,1847.0,1784.0,2395.0,2385.0,2050.0,25474.0
Hoshiarpur,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,2493.0,2632.0,2563.0,2122.0,2111.0,2143.0,1803.0,1534.0,1815.0,1759.0,2258.0,2261.0,25494.0
Hoshiarpur,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,2145.0,2104.0,1873.0,2054.0,1382.0,1111.0,834.0,1156.0,1095.0,1069.0,1090.0,1018.0,16931.0
Hoshiarpur,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,41.0,25.0,22.0,29.0,22.0,23.0,11.0,24.0,18.0,23.0,22.0,14.0,274.0
Hoshiarpur,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,1.0,0.0,0.0,2.0,1.0,2.0,1.0,4.0,2.0,3.0,1.0,1.0,18.0
Hoshiarpur,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,2111.0,2391.0,2244.0,2233.0,1963.0,1961.0,1673.0,1841.0,1906.0,2354.0,2373.0,2034.0,25084.0
Hoshiarpur,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,16.0,23.0,24.0,9.0,12.0,14.0,13.0,10.0,11.0,21.0,11.0,14.0,178.0
Hoshiarpur,1.8,Number of pregnancy test kits used at SC level,TOTAL,1439.0,2094.0,1681.0,1503.0,1574.0,1502.0,1272.0,1405.0,1288.0,1700.0,1557.0,1323.0,18338.0
Hoshiarpur,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,32.0,33.0,40.0,17.0,26.0,22.0,19.0,40.0,39.0,44.0,37.0,19.0,368.0
Hoshiarpur,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,69.0,76.0,58.0,100.0,117.0,90.0,100.0,58.0,61.0,60.0,50.0,69.0,908.0
Hoshiarpur,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,101.0,109.0,98.0,117.0,143.0,112.0,119.0,98.0,100.0,104.0,87.0,88.0,1276.0
Hoshiarpur,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,96.0,107.0,94.0,112.0,135.0,107.0,107.0,97.0,97.0,100.0,86.0,83.0,1221.0
Hoshiarpur,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,39.0,17.0,7.0,14.0,15.0,9.0,12.0,9.0,6.0,2.0,4.0,1.0,135.0
Hoshiarpur,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,653.0,700.0,815.0,1124.0,1280.0,1398.0,1319.0,1173.0,1152.0,1069.0,836.0,790.0,12309.0
Hoshiarpur,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,53.0,51.0,79.0,612.0,633.0,816.0,598.0,232.0,236.0,32.0,37.0,30.0,3409.0
Hoshiarpur,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,310.0,363.0,333.0,410.0,433.0,626.0,512.0,652.0,581.0,656.0,558.0,382.0,5816.0
Hoshiarpur,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,392.0,220.0,249.0,118.0,83.0,105.0,112.0,143.0,251.0,495.0,386.0,97.0,2651.0
Hoshiarpur,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hoshiarpur,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,436.0,515.0,494.0,689.0,792.0,783.0,807.0,841.0,802.0,670.0,586.0,586.0,8001.0
Hoshiarpur,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,4.0,2.0,5.0,3.0,6.0,11.0,7.0,8.0,1.0,1.0,1.0,0.0,49.0
Hoshiarpur,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hoshiarpur,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hoshiarpur,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hoshiarpur,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,28.0,44.0,43.0,55.0,67.0,78.0,76.0,55.0,36.0,42.0,32.0,30.0,586.0
Hoshiarpur,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,165.0,177.0,234.0,339.0,350.0,389.0,339.0,333.0,309.0,333.0,232.0,248.0,3448.0
Hoshiarpur,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Hoshiarpur,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,193.0,221.0,277.0,394.0,417.0,467.0,415.0,388.0,345.0,375.0,264.0,278.0,4034.0
Hoshiarpur,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,211.0,243.0,259.0,380.0,416.0,360.0,423.0,391.0,387.0,317.0,321.0,308.0,4016.0
Hoshiarpur,4.1.1.a,Number of male live births,TOTAL,593.0,696.0,713.0,981.0,1196.0,1214.0,1137.0,1093.0,991.0,918.0,802.0,770.0,11104.0
Hoshiarpur,4.1.1.b,Number of female live births,TOTAL,568.0,628.0,677.0,923.0,1005.0,1053.0,1089.0,997.0,1031.0,889.0,686.0,681.0,10227.0
Hoshiarpur,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,1161.0,1324.0,1390.0,1904.0,2201.0,2267.0,2226.0,2090.0,2022.0,1807.0,1488.0,1451.0,21331.0
Hoshiarpur,4.1.2,Number of still births,TOTAL,34.0,30.0,22.0,42.0,33.0,39.0,34.0,40.0,37.0,42.0,28.0,22.0,403.0
Hoshiarpur,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,106.0,118.0,90.0,97.0,82.0,84.0,42.0,78.0,56.0,95.0,48.0,68.0,964.0
Hoshiarpur,4.2.1,Number of Newborns weighed at birth,TOTAL,1149.0,1316.0,1371.0,1588.0,2042.0,2080.0,2070.0,1916.0,1979.0,1799.0,1488.0,1457.0,20255.0
Hoshiarpur,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,83.0,95.0,107.0,117.0,146.0,111.0,99.0,104.0,95.0,110.0,99.0,80.0,1246.0
Hoshiarpur,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,997.0,1075.0,1035.0,1078.0,1424.0,1480.0,1415.0,1262.0,1340.0,1237.0,961.0,968.0,14272.0
Hoshiarpur,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hoshiarpur,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,26.0,38.0,29.0,13.0,12.0,7.0,10.0,57.0,25.0,36.0,13.0,26.0,292.0
Hoshiarpur,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,86.0,82.0,152.0,198.0,221.0,233.0,232.0,195.0,159.0,146.0,105.0,90.0,1899.0
Hoshiarpur,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Hoshiarpur,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,112.0,120.0,181.0,211.0,233.0,240.0,242.0,252.0,184.0,182.0,118.0,116.0,2191.0
Hoshiarpur,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,137.0,178.0,182.0,242.0,269.0,233.0,1.0,281.0,270.0,239.0,256.0,252.0,2540.0
Hoshiarpur,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,222.0,317.0,330.0,618.0,496.0,455.0,238.0,482.0,408.0,407.0,354.0,353.0,4680.0
Hoshiarpur,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,5.0,8.0,3.0,6.0,4.0,5.0,6.0,9.0,6.0,4.0,1.0,5.0,62.0
Hoshiarpur,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,219.0,298.0,330.0,577.0,467.0,459.0,227.0,476.0,413.0,409.0,347.0,333.0,4555.0
Hoshiarpur,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,65.0,90.0,89.0,107.0,80.0,53.0,171.0,117.0,73.0,99.0,42.0,28.0,1014.0
Hoshiarpur,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,607.0,675.0,789.0,855.0,1150.0,1298.0,1182.0,1183.0,1272.0,1171.0,956.0,720.0,11858.0
Hoshiarpur,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,619.0,586.0,699.0,809.0,988.0,899.0,759.0,1087.0,986.0,961.0,791.0,883.0,10067.0
Hoshiarpur,6.3,PNC maternal complications attended,TOTAL,6.0,8.0,5.0,4.0,2.0,2.0,2.0,12.0,4.0,12.0,2.0,4.0,63.0
Hoshiarpur,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,7.0,18.0,13.0,11.0,33.0,11.0,7.0,7.0,14.0,5.0,10.0,11.0,147.0
Hoshiarpur,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,2.0,2.0,2.0,0.0,7.0
Hoshiarpur,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,7.0,18.0,13.0,11.0,33.0,12.0,7.0,7.0,16.0,7.0,12.0,11.0,154.0
Hoshiarpur,7.2,Number of MTPs conducted at Private Facilities,TOTAL,26.0,33.0,25.0,23.0,22.0,30.0,0.0,32.0,20.0,37.0,19.0,17.0,284.0
Hoshiarpur,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,52.0,82.0,74.0,51.0,64.0,63.0,72.0,44.0,36.0,74.0,86.0,68.0,766.0
Hoshiarpur,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,318.0,419.0,391.0,376.0,479.0,505.0,405.0,393.0,374.0,391.0,400.0,354.0,4805.0
Hoshiarpur,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,370.0,501.0,465.0,427.0,543.0,568.0,477.0,437.0,410.0,465.0,486.0,422.0,5571.0
Hoshiarpur,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hoshiarpur,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,8.0,6.0,2.0,8.0,3.0,16.0,1.0,9.0,4.0,4.0,2.0,0.0,63.0
Hoshiarpur,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,5.0,5.0,4.0,10.0,4.0,5.0,10.0,5.0,0.0,0.0,0.0,1.0,49.0
Hoshiarpur,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,0.0,1.0,0.0,7.0,3.0,2.0,4.0,0.0,1.0,4.0,1.0,1.0,24.0
Hoshiarpur,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Hoshiarpur,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,13.0,12.0,6.0,25.0,10.0,23.0,15.0,14.0,5.0,8.0,3.0,2.0,136.0
Hoshiarpur,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hoshiarpur,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,32.0,93.0,50.0,47.0,38.0,47.0,18.0,44.0,18.0,23.0,9.0,0.0,419.0
Hoshiarpur,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,86.0,68.0,67.0,36.0,49.0,49.0,44.0,61.0,70.0,38.0,27.0,16.0,611.0
Hoshiarpur,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,56.0,36.0,2.0,1.0,34.0,43.0,52.0,40.0,34.0,31.0,53.0,58.0,440.0
Hoshiarpur,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Hoshiarpur,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,174.0,197.0,119.0,84.0,121.0,139.0,114.0,145.0,122.0,92.0,89.0,74.0,1470.0
Hoshiarpur,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,2.0,2.0,1.0,2.0,4.0,2.0,5.0,1.0,5.0,5.0,2.0,0.0,31.0
Hoshiarpur,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0,0.0,0.0,2.0
Hoshiarpur,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,1.0,3.0,9.0,12.0,3.0,4.0,2.0,7.0,5.0,7.0,7.0,2.0,62.0
Hoshiarpur,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,11.0,10.0,23.0,28.0,28.0,31.0,28.0,43.0,46.0,17.0,14.0,20.0,299.0
Hoshiarpur,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Hoshiarpur,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,12.0,13.0,32.0,40.0,31.0,35.0,30.0,50.0,52.0,25.0,21.0,22.0,363.0
Hoshiarpur,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,52.0,63.0,90.0,58.0,87.0,89.0,0.0,73.0,0.0,59.0,0.0,54.0,625.0
Hoshiarpur,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hoshiarpur,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,5.0,3.0,2.0,0.0,0.0,1.0,0.0,11.0
Hoshiarpur,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,39.0,12.0,23.0,28.0,37.0,57.0,34.0,17.0,14.0,29.0,23.0,19.0,332.0
Hoshiarpur,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Hoshiarpur,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,39.0,12.0,23.0,28.0,37.0,62.0,37.0,19.0,14.0,29.0,24.0,19.0,343.0
Hoshiarpur,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,0.0,0.0,0.0,2.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0
Hoshiarpur,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,388.0,380.0,332.0,628.0,415.0,415.0,377.0,408.0,378.0,341.0,328.0,268.0,4658.0
Hoshiarpur,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,9.0,7.0,14.0,14.0,23.0,18.0,13.0,17.0,15.0,6.0,9.0,8.0,153.0
Hoshiarpur,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,3.0,2.0,3.0,7.0,3.0,15.0,16.0,33.0,28.0,20.0,21.0,32.0,183.0
Hoshiarpur,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,6.0,34.0,27.0,26.0,24.0,23.0,26.0,19.0,19.0,36.0,61.0,36.0,337.0
Hoshiarpur,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Hoshiarpur,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,406.0,423.0,376.0,675.0,465.0,471.0,432.0,477.0,440.0,403.0,419.0,344.0,5331.0
Hoshiarpur,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,8.0,40.0,26.0,0.0,18.0,47.0,29.0,66.0,67.0,43.0,66.0,52.0,462.0
Hoshiarpur,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hoshiarpur,9.06,Number of IUCD removals,TOTAL,130.0,104.0,91.0,113.0,97.0,99.0,121.0,108.0,99.0,91.0,108.0,72.0,1233.0
Hoshiarpur,9.07,Number of Oral Pills cycles distributed,TOTAL,5340.0,5324.0,5240.0,5879.0,5565.0,5292.0,5486.0,5350.0,5479.0,5587.0,4923.0,4681.0,64146.0
Hoshiarpur,9.08,Number of Condom pieces distributed,TOTAL,113925.0,119254.0,109829.0,121477.0,122104.0,118979.0,117750.0,115637.0,122770.0,122161.0,111137.0,104543.0,1399566.0
Hoshiarpur,9.09,Number of Centchroman (weekly) pills given,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,9.0,0.0,0.0,9.0
Hoshiarpur,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,49.0,27.0,45.0,45.0,23.0,89.0,82.0,66.0,112.0,74.0,94.0,56.0,762.0
Hoshiarpur,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hoshiarpur,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hoshiarpur,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hoshiarpur,9.11.2.b,Number of failures following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hoshiarpur,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hoshiarpur,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hoshiarpur,9.12,Number of Institutions having NSV trained doctors,TOTAL,1.0,1.0,1.0,4.0,3.0,3.0,3.0,3.0,3.0,3.0,3.0,3.0,-1.0
Hoshiarpur,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,1281.0,1448.0,1541.0,2114.0,2680.0,2689.0,2642.0,2589.0,2389.0,2037.0,1868.0,1710.0,24988.0
Hoshiarpur,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,1706.0,1639.0,1394.0,1516.0,1767.0,2149.0,2278.0,2403.0,2286.0,2278.0,222.0,7.0,19645.0
Hoshiarpur,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,1963.0,1743.0,1569.0,1453.0,1491.0,1674.0,2030.0,2256.0,2354.0,2301.0,2164.0,330.0,21328.0
Hoshiarpur,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,2132.0,1978.0,1713.0,1584.0,1566.0,1483.0,1679.0,2020.0,2169.0,2348.0,2219.0,1939.0,22830.0
Hoshiarpur,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,14.0,1790.0,1753.0,3557.0
Hoshiarpur,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.0,1490.0,1493.0
Hoshiarpur,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,81.0,82.0
Hoshiarpur,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,1099.0,1277.0,1472.0,1806.0,2346.0,2452.0,2459.0,2285.0,2257.0,1884.0,1711.0,1535.0,22583.0
Hoshiarpur,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,1710.0,1642.0,1380.0,1516.0,1767.0,2149.0,2278.0,2395.0,2288.0,2278.0,1720.0,1785.0,22908.0
Hoshiarpur,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,1963.0,1743.0,1566.0,1455.0,1491.0,1674.0,2030.0,2256.0,2354.0,2301.0,2161.0,1861.0,22855.0
Hoshiarpur,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,2130.0,1979.0,1712.0,1584.0,1566.0,1481.0,1680.0,2023.0,2169.0,2348.0,2208.0,1918.0,22798.0
Hoshiarpur,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,516.0,596.0,913.0,1030.0,1281.0,1492.0,1519.0,1449.0,1592.0,1373.0,1313.0,1080.0,14154.0
Hoshiarpur,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,1701.0,1639.0,1390.0,1517.0,1760.0,2149.0,2278.0,2405.0,2287.0,2278.0,426.0,250.0,20080.0
Hoshiarpur,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,1959.0,1741.0,1566.0,1449.0,1488.0,1674.0,2035.0,2256.0,2348.0,2301.0,2175.0,541.0,21533.0
Hoshiarpur,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,2139.0,1980.0,1713.0,1584.0,1572.0,1482.0,1680.0,2017.0,2169.0,2348.0,2195.0,1836.0,22715.0
Hoshiarpur,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,1811.0,2265.0,2124.0,2323.0,2450.0,2212.0,2051.0,1974.0,1608.0,1480.0,1398.0,1336.0,23032.0
Hoshiarpur,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,2127.0,2375.0,2003.0,1976.0,1798.0,1691.0,1466.0,1621.0,1711.0,1969.0,2098.0,1920.0,22755.0
Hoshiarpur,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hoshiarpur,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,984.0,1233.0,1125.0,1207.0,1293.0,1167.0,1085.0,1018.0,847.0,790.0,771.0,723.0,12243.0
Hoshiarpur,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,828.0,1038.0,979.0,1096.0,1128.0,1012.0,966.0,957.0,737.0,688.0,660.0,610.0,10699.0
Hoshiarpur,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,1812.0,2271.0,2104.0,2303.0,2421.0,2179.0,2051.0,1975.0,1584.0,1478.0,1431.0,1333.0,22942.0
Hoshiarpur,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,2095.0,2370.0,1965.0,1934.0,1780.0,1680.0,1440.0,1621.0,1715.0,1969.0,2098.0,1923.0,22590.0
Hoshiarpur,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,2095.0,2370.0,1965.0,1934.0,1780.0,1678.0,1440.0,1621.0,1715.0,2007.0,2098.0,1921.0,22624.0
Hoshiarpur,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,5.0,5.0
Hoshiarpur,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,29.0,31.0,3.0,21.0,18.0,30.0,33.0,63.0,11.0,53.0,39.0,31.0,362.0
Hoshiarpur,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,18.0,31.0,3.0,16.0,12.0,22.0,33.0,59.0,19.0,62.0,29.0,27.0,331.0
Hoshiarpur,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,47.0,62.0,6.0,37.0,30.0,52.0,66.0,122.0,30.0,115.0,68.0,58.0,693.0
Hoshiarpur,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,1500.0,3154.0,1568.0,2186.0,2733.0,1954.0,1880.0,2204.0,1921.0,1814.0,1728.0,1631.0,24273.0
Hoshiarpur,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,1158.0,3559.0,1199.0,2045.0,2709.0,1730.0,1784.0,1709.0,1675.0,1344.0,1448.0,1334.0,21694.0
Hoshiarpur,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,759.0,2411.0,1046.0,1372.0,1782.0,1159.0,1781.0,1427.0,1493.0,1113.0,1313.0,1050.0,16706.0
Hoshiarpur,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hoshiarpur,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hoshiarpur,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hoshiarpur,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,1018.0,1010.0,1005.0,1022.0,1012.0,1007.0,1024.0,1012.0,1015.0,1011.0,1017.0,992.0,12145.0
Hoshiarpur,10.4.2,Number of Immunisation sessions held during the month,TOTAL,1011.0,1001.0,997.0,1013.0,1007.0,997.0,1012.0,1006.0,1004.0,1006.0,1013.0,933.0,12000.0
Hoshiarpur,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,864.0,854.0,853.0,863.0,863.0,858.0,869.0,862.0,869.0,861.0,867.0,802.0,10285.0
Hoshiarpur,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hoshiarpur,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,1638.0,2099.0,2014.0,2239.0,2354.0,2055.0,1897.0,1897.0,1385.0,1505.0,1427.0,1308.0,21818.0
Hoshiarpur,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,1478.0,1233.0,1293.0,1261.0,1450.0,1390.0,1314.0,1218.0,1240.0,1275.0,1492.0,1403.0,16047.0
Hoshiarpur,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,1620.0,2376.0,1597.0,1989.0,2215.0,1838.0,1665.0,1845.0,1685.0,1595.0,1756.0,1773.0,21954.0
Hoshiarpur,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hoshiarpur,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hoshiarpur,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hoshiarpur,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hoshiarpur,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hoshiarpur,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hoshiarpur,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,40.0,70.0,55.0,116.0,36.0,27.0,27.0,16.0,18.0,62.0,57.0,9.0,533.0
Hoshiarpur,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hoshiarpur,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,26.0,28.0,13.0,18.0,24.0,10.0,12.0,11.0,13.0,45.0,23.0,5.0,228.0
Hoshiarpur,13.1,Number of Patients operated for cataract,TOTAL,1036.0,1151.0,1029.0,660.0,823.0,847.0,990.0,1433.0,632.0,654.0,783.0,785.0,10823.0
Hoshiarpur,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,1028.0,1146.0,1023.0,655.0,818.0,837.0,986.0,1432.0,631.0,654.0,783.0,785.0,10778.0
Hoshiarpur,13.3,Number of School children detected with Refractive errors,TOTAL,279.0,557.0,0.0,764.0,562.0,357.0,415.0,456.0,612.0,464.0,765.0,81.0,5312.0
Hoshiarpur,13.4,Number of children provided free glasses,TOTAL,194.0,505.0,0.0,522.0,486.0,387.0,360.0,361.0,589.0,420.0,793.0,101.0,4718.0
Hoshiarpur,13.5,Number of eyes collected through eye donation,TOTAL,0.0,10.0,4.0,2.0,0.0,0.0,0.0,8.0,10.0,9.0,8.0,0.0,51.0
Hoshiarpur,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,12.0,8.0,2.0,0.0,0.0,0.0,8.0,10.0,9.0,8.0,0.0,57.0
Hoshiarpur,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,4.0,4.0,3.0,10.0,9.0,10.0,10.0,11.0,10.0,12.0,12.0,13.0,-1.0
Hoshiarpur,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,11.0,10.0,11.0,9.0,11.0,12.0,10.0,10.0,9.0,9.0,9.0,9.0,-1.0
Hoshiarpur,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,848.0,672.0,855.0,843.0,858.0,828.0,830.0,831.0,826.0,823.0,832.0,785.0,-1.0
Hoshiarpur,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,6.0,7.0,7.0,9.0,9.0,10.0,10.0,9.0,10.0,12.0,12.0,13.0,-1.0
Hoshiarpur,14.05,Number of RKS meetings held during the month,TOTAL,17.0,15.0,16.0,13.0,15.0,18.0,18.0,12.0,20.0,12.0,21.0,18.0,195.0
Hoshiarpur,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,6.0,6.0,5.0,11.0,11.0,12.0,10.0,13.0,9.0,11.0,14.0,13.0,-1.0
Hoshiarpur,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,288.0,340.0,536.0,545.0,609.0,639.0,621.0,578.0,657.0,623.0,490.0,464.0,6390.0
Hoshiarpur,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,2.0,1.0,1.0,5.0,5.0,5.0,5.0,6.0,5.0,7.0,6.0,5.0,-1.0
Hoshiarpur,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,10.0,10.0,8.0,6.0,7.0,5.0,5.0,5.0,5.0,7.0,8.0,6.0,-1.0
Hoshiarpur,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,537.0,661.0,680.0,801.0,949.0,927.0,629.0,734.0,963.0,686.0,525.0,478.0,8570.0
Hoshiarpur,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,1564.0,1793.0,1922.0,1982.0,1900.0,1803.0,1708.0,1457.0,889.0,1225.0,1465.0,1417.0,19125.0
Hoshiarpur,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,440.0,749.0,605.0,718.0,748.0,768.0,702.0,687.0,1188.0,643.0,465.0,465.0,8178.0
Hoshiarpur,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,2305.0,2629.0,2782.0,3088.0,3190.0,3203.0,2890.0,2613.0,1840.0,2355.0,2242.0,2214.0,31351.0
Hoshiarpur,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,977.0,1410.0,1285.0,1519.0,1697.0,1695.0,1331.0,1421.0,2151.0,1329.0,990.0,943.0,16748.0
Hoshiarpur,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,3869.0,4422.0,4704.0,5070.0,5090.0,5006.0,4598.0,4070.0,2729.0,3580.0,3707.0,3631.0,50476.0
Hoshiarpur,14.10.2.a,Number of death cases of Inpatient males,TOTAL,43.0,45.0,36.0,44.0,37.0,48.0,43.0,26.0,47.0,35.0,32.0,48.0,484.0
Hoshiarpur,14.10.2.b,Number of death cases of Inpatient females,TOTAL,14.0,28.0,21.0,19.0,26.0,30.0,29.0,19.0,28.0,18.0,30.0,21.0,283.0
Hoshiarpur,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,57.0,73.0,57.0,63.0,63.0,78.0,72.0,45.0,75.0,53.0,62.0,69.0,767.0
Hoshiarpur,14.11,In-Patient Head Count at midnight,TOTAL,986.0,1275.0,1122.0,1020.0,1072.0,1255.0,1194.0,1043.0,754.0,893.0,902.0,920.0,12436.0
Hoshiarpur,14.12.1,OPD attendance (All),TOTAL,121162.0,126048.0,130806.0,135054.0,133206.0,133252.0,108389.0,117962.0,109293.0,101903.0,114298.0,119250.0,1450623.0
Hoshiarpur,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,683.0,684.0,906.0,1847.0,880.0,990.0,1004.0,971.0,823.0,749.0,718.0,718.0,10973.0
Hoshiarpur,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,115.0,4.0,5.0,163.0,58.0,394.0,385.0,228.0,173.0,240.0,159.0,144.0,2068.0
Hoshiarpur,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,1908.0,3020.0,2856.0,2014.0,2500.0,2791.0,2656.0,2962.0,2242.0,2110.0,2029.0,2633.0,29721.0
Hoshiarpur,14.14.a,Number of patients given AYUSH treatment,TOTAL,10206.0,11790.0,11480.0,12984.0,14179.0,13347.0,12524.0,11975.0,13369.0,13315.0,12652.0,10618.0,148439.0
Hoshiarpur,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,5148.0,4723.0,4633.0,3776.0,3922.0,4366.0,3814.0,4312.0,4497.0,5044.0,4683.0,5798.0,54716.0
Hoshiarpur,14.14.c,Number of Adolescents counselled,TOTAL,38.0,110.0,15.0,16.0,157.0,158.0,160.0,0.0,13.0,12.0,150.0,10.0,839.0
Hoshiarpur,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,8915.0,10070.0,9884.0,9374.0,9630.0,8511.0,8580.0,9186.0,9028.0,8541.0,8766.0,9760.0,110245.0
Hoshiarpur,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,539.0,582.0,676.0,598.0,604.0,573.0,714.0,680.0,595.0,552.0,500.0,619.0,7232.0
Hoshiarpur,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,428.0,463.0,556.0,577.0,653.0,538.0,485.0,591.0,618.0,402.0,417.0,424.0,6152.0
Hoshiarpur,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,7.0,9.0,3.0,9.0,6.0,9.0,5.0,3.0,3.0,8.0,3.0,5.0,70.0
Hoshiarpur,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,279.0,319.0,382.0,312.0,381.0,276.0,458.0,321.0,413.0,241.0,208.0,219.0,3809.0
Hoshiarpur,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,4.0,7.0,5.0,1.0,2.0,4.0,4.0,0.0,6.0,4.0,0.0,1.0,38.0
Hoshiarpur,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,1205.0,1426.0,1373.0,1295.0,1306.0,1347.0,917.0,1197.0,1156.0,1116.0,1316.0,1145.0,14799.0
Hoshiarpur,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,0.0,5.0,2.0,5.0,1.0,1.0,14.0,13.0,2.0,0.0,25.0,0.0,68.0
Hoshiarpur,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,1912.0,2208.0,2311.0,2184.0,2340.0,2161.0,1860.0,2109.0,2187.0,1759.0,1941.0,1788.0,24760.0
Hoshiarpur,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,11.0,21.0,10.0,15.0,9.0,14.0,23.0,16.0,11.0,12.0,28.0,6.0,176.0
Hoshiarpur,15.2,Number of Widal tests conducted,Number tested,646.0,879.0,643.0,872.0,820.0,882.0,581.0,497.0,481.0,416.0,928.0,1092.0,8737.0
Hoshiarpur,15.3.a,Number of VDRL tests conducted on males,Number tested,42.0,41.0,37.0,42.0,100.0,44.0,55.0,31.0,26.0,30.0,39.0,60.0,547.0
Hoshiarpur,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,125.0,147.0,308.0,10.0,13.0,6.0,5.0,263.0,258.0,15.0,305.0,16.0,1471.0
Hoshiarpur,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,1258.0,1915.0,1530.0,1837.0,1443.0,1536.0,1254.0,1102.0,1122.0,1607.0,1489.0,1930.0,18023.0
Hoshiarpur,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,1425.0,2103.0,1875.0,1889.0,1556.0,1586.0,1314.0,1396.0,1406.0,1652.0,1833.0,2006.0,20041.0
Hoshiarpur,15.4.1,Number of blood smears examined for Malaria,TOTAL,12536.0,14344.0,11471.0,11895.0,12010.0,12667.0,10765.0,11523.0,10934.0,8985.0,10298.0,12656.0,140084.0
Hoshiarpur,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Hoshiarpur,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hoshiarpur,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,41500.0,29000.0,212500.0,192500.0,172000.0,163000.0,129500.0,109500.0,80500.0,48000.0,41500.0,35000.0,1254500.0
Hoshiarpur,16.1.1,Stock position of DPT vaccines,2. Stocks Received,0.0,200000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,200000.0
Hoshiarpur,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hoshiarpur,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,12500.0,16500.0,20000.0,20500.0,9000.0,33500.0,20000.0,29000.0,32500.0,6500.0,6500.0,6000.0,212500.0
Hoshiarpur,16.1.1,Stock position of DPT vaccines,5. Total Stock,29000.0,212500.0,192500.0,172000.0,163000.0,129500.0,109500.0,80500.0,48000.0,41500.0,35000.0,29000.0,1242000.0
Hoshiarpur,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,20000.0,15500.0,21500.0,57000.0
Hoshiarpur,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,15000.0,0.0,15000.0
Hoshiarpur,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hoshiarpur,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,4500.0,9000.0,4500.0,18000.0
Hoshiarpur,16.1.1A,Stock Position of Pentavalent,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,15500.0,21500.0,17000.0,54000.0
Hoshiarpur,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,84000.0,70500.0,93000.0,75500.0,56500.0,56500.0,45500.0,31000.0,32000.0,233000.0,15000.0,24000.0,816500.0
Hoshiarpur,16.1.2,Stock position of OPV vaccines,2. Stocks Received,0.0,40000.0,0.0,0.0,15000.0,0.0,0.0,20000.0,240000.0,0.0,242000.0,0.0,557000.0
Hoshiarpur,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hoshiarpur,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,13500.0,17500.0,17500.0,19000.0,15000.0,11000.0,14500.0,19000.0,39000.0,218000.0,233000.0,7500.0,624500.0
Hoshiarpur,16.1.2,Stock position of OPV vaccines,5. Total Stock,70500.0,93000.0,75500.0,56500.0,56500.0,45500.0,31000.0,32000.0,233000.0,15000.0,24000.0,16500.0,749000.0
Hoshiarpur,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,36000.0,27500.0,32000.0,19000.0,8500.0,19500.0,14000.0,4000.0,18500.0,26500.0,17000.0,30000.0,252500.0
Hoshiarpur,16.1.3,Stock position of TT vaccines,2. Stocks Received,0.0,20000.0,0.0,0.0,20000.0,0.0,0.0,30000.0,20000.0,0.0,20000.0,0.0,110000.0
Hoshiarpur,16.1.3,Stock position of TT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hoshiarpur,16.1.3,Stock position of TT vaccines,4. Stock Distributed,8500.0,15500.0,13000.0,10500.0,9000.0,5500.0,10000.0,15500.0,12000.0,9500.0,7000.0,7000.0,123000.0
Hoshiarpur,16.1.3,Stock position of TT vaccines,5. Total Stock,27500.0,32000.0,19000.0,8500.0,19500.0,14000.0,4000.0,18500.0,26500.0,17000.0,30000.0,23000.0,239500.0
Hoshiarpur,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hoshiarpur,16.1.4,Stock position of DT vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hoshiarpur,16.1.4,Stock position of DT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hoshiarpur,16.1.4,Stock position of DT vaccines,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hoshiarpur,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hoshiarpur,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,23500.0,19500.0,20500.0,16500.0,11500.0,19000.0,15000.0,10500.0,20500.0,27000.0,20500.0,27500.0,231500.0
Hoshiarpur,16.1.5,Stock position of BCG vaccines,2. Stocks Received,0.0,6000.0,0.0,0.0,10000.0,0.0,0.0,15000.0,10000.0,0.0,10000.0,0.0,51000.0
Hoshiarpur,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hoshiarpur,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,4000.0,5000.0,4000.0,5000.0,2500.0,4000.0,4500.0,5000.0,3500.0,6500.0,3000.0,3000.0,50000.0
Hoshiarpur,16.1.5,Stock position of BCG vaccines,5. Total Stock,19500.0,20500.0,16500.0,11500.0,19000.0,15000.0,10500.0,20500.0,27000.0,20500.0,27500.0,24500.0,232500.0
Hoshiarpur,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,15500.0,11250.0,14500.0,7500.0,0.0,7500.0,3000.0,0.0,7250.0,11500.0,5500.0,16000.0,99500.0
Hoshiarpur,16.1.6,Stock position of Measles vaccines,2. Stocks Received,0.0,10000.0,0.0,0.0,10000.0,0.0,0.0,15000.0,10000.0,0.0,15000.0,0.0,60000.0
Hoshiarpur,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hoshiarpur,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,4250.0,6750.0,7000.0,7500.0,2500.0,4500.0,3000.0,7750.0,5750.0,6000.0,4500.0,4000.0,63500.0
Hoshiarpur,16.1.6,Stock position of Measles vaccines,5. Total Stock,11250.0,14500.0,7500.0,0.0,7500.0,3000.0,0.0,7250.0,11500.0,5500.0,16000.0,12000.0,96000.0
Hoshiarpur,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hoshiarpur,16.1.7,Stock position of JE vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hoshiarpur,16.1.7,Stock position of JE vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hoshiarpur,16.1.7,Stock position of JE vaccines,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hoshiarpur,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hoshiarpur,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,28300.0,17800.0,26800.0,14200.0,3900.0,12300.0,6800.0,0.0,900.0,16700.0,5700.0,6200.0,139600.0
Hoshiarpur,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,0.0,20000.0,0.0,0.0,15000.0,0.0,0.0,5000.0,25000.0,0.0,10000.0,0.0,75000.0
Hoshiarpur,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hoshiarpur,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,10500.0,11000.0,12600.0,10300.0,6600.0,5500.0,6800.0,4100.0,9200.0,11000.0,9500.0,4000.0,101100.0
Hoshiarpur,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,17800.0,26800.0,14200.0,3900.0,12300.0,6800.0,0.0,900.0,16700.0,5700.0,6200.0,2200.0,113500.0
Hoshiarpur,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,5899.0,5899.0,14849.0,11549.0,11549.0,9049.0,9049.0,9049.0,49.0,49.0,49.0,49.0,77088.0
Hoshiarpur,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,0.0,9000.0,0.0,1200.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,10200.0
Hoshiarpur,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hoshiarpur,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,0.0,50.0,3300.0,1200.0,2500.0,0.0,0.0,9000.0,0.0,0.0,0.0,0.0,16050.0
Hoshiarpur,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,5899.0,14849.0,11549.0,11549.0,9049.0,9049.0,9049.0,49.0,49.0,49.0,49.0,49.0,71238.0
Hoshiarpur,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,922540.0,922540.0,761740.0,651100.0,1115020.0,1016380.0,939820.0,788620.0,37420.0,13420.0,1420.0,1420.0,7171440.0
Hoshiarpur,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,493920.0,0.0,42000.0,0.0,0.0,24000.0,0.0,0.0,0.0,559920.0
Hoshiarpur,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hoshiarpur,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,0.0,160800.0,110640.0,30000.0,98640.0,118560.0,151200.0,751200.0,48000.0,12000.0,0.0,0.0,1481040.0
Hoshiarpur,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,922540.0,761740.0,651100.0,1115020.0,1016380.0,939820.0,788620.0,37420.0,13420.0,1420.0,1420.0,1420.0,6250320.0
Hoshiarpur,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,300.0,300.0,300.0,0.0,19300.0,14100.0,10700.0,10700.0,1100.0,0.0,0.0,3000.0,59800.0
Hoshiarpur,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,19300.0,0.0,0.0,0.0,0.0,0.0,0.0,3000.0,0.0,22300.0
Hoshiarpur,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hoshiarpur,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,0.0,0.0,300.0,0.0,5200.0,3400.0,0.0,9600.0,1100.0,0.0,0.0,1000.0,20600.0
Hoshiarpur,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,300.0,300.0,0.0,19300.0,14100.0,10700.0,10700.0,1100.0,0.0,0.0,3000.0,2000.0,61500.0
Hoshiarpur,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,0.0,1100.0,3200.0,2510.0,2210.0,2210.0,1010.0,260.0,260.0,510.0,13270.0
Hoshiarpur,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,3000.0,0.0,0.0,0.0,0.0,0.0,0.0,250.0,0.0,3250.0
Hoshiarpur,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hoshiarpur,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,900.0,690.0,300.0,0.0,1200.0,750.0,0.0,0.0,0.0,3840.0
Hoshiarpur,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,3200.0,2510.0,2210.0,2210.0,1010.0,260.0,260.0,510.0,510.0,12680.0
Hoshiarpur,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,4255.0,4255.0,8855.0,8855.0,8855.0,8855.0,8855.0,8855.0,8855.0,8855.0,7855.0,7855.0,95060.0
Hoshiarpur,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,0.0,5000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,5000.0
Hoshiarpur,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hoshiarpur,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,0.0,400.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1000.0,0.0,0.0,1400.0
Hoshiarpur,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,4255.0,8855.0,8855.0,8855.0,8855.0,8855.0,8855.0,8855.0,8855.0,7855.0,7855.0,7855.0,98660.0
Hoshiarpur,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,700.0,600.0,600.0,5500.0,5000.0,4500.0,3000.0,2800.0,2700.0,2000.0,800.0,0.0,28200.0
Hoshiarpur,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,0.0,0.0,5400.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,5400.0
Hoshiarpur,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hoshiarpur,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,100.0,0.0,500.0,500.0,500.0,1500.0,200.0,100.0,700.0,1200.0,800.0,0.0,6100.0
Hoshiarpur,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,600.0,600.0,5500.0,5000.0,4500.0,3000.0,2800.0,2700.0,2000.0,800.0,0.0,0.0,27500.0
Hoshiarpur,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,23500.0,62500.0,53500.0,51500.0,50000.0,45000.0,40000.0,38000.0,36000.0,30000.0,19000.0,17000.0,466000.0
Hoshiarpur,16.3.02,Stock Position of Gloves,2. Stocks Received,40000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,40000.0
Hoshiarpur,16.3.02,Stock Position of Gloves,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hoshiarpur,16.3.02,Stock Position of Gloves,4. Stock Distributed,1000.0,9000.0,2000.0,1500.0,5000.0,5000.0,2000.0,2000.0,6000.0,11000.0,2000.0,0.0,46500.0
Hoshiarpur,16.3.02,Stock Position of Gloves,5. Total Stock,62500.0,53500.0,51500.0,50000.0,45000.0,40000.0,38000.0,36000.0,30000.0,19000.0,17000.0,17000.0,459500.0
Hoshiarpur,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hoshiarpur,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hoshiarpur,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hoshiarpur,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hoshiarpur,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hoshiarpur,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,12000.0,12000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,24000.0
Hoshiarpur,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hoshiarpur,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Hoshiarpur,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,0.0,12000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,12000.0
Hoshiarpur,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,12000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,12000.0
Hoshiarpur,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,1575.0,1375.0,700.0,400.0,300.0,250.0,100.0,0.0,,0.0,0.0,0.0,4700.0
Hoshiarpur,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hoshiarpur,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hoshiarpur,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,200.0,675.0,300.0,100.0,50.0,150.0,100.0,0.0,0.0,0.0,0.0,0.0,1575.0
Hoshiarpur,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,1375.0,700.0,400.0,300.0,250.0,100.0,0.0,0.0,0.0,0.0,0.0,0.0,3125.0
Hoshiarpur,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hoshiarpur,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hoshiarpur,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hoshiarpur,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Hoshiarpur,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hoshiarpur,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,140000.0,10000.0,10000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,160000.0
Hoshiarpur,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hoshiarpur,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hoshiarpur,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,130000.0,0.0,10000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,140000.0
Hoshiarpur,16.3.07,Stock Position of IFA Tablets,5. Total Stock,10000.0,10000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,20000.0
Hoshiarpur,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,41500.0,40500.0,30500.0,30500.0,30000.0,20000.0,0.0,0.0,0.0,0.0,0.0,0.0,193000.0
Hoshiarpur,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,10000.0,0.0,10000.0
Hoshiarpur,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hoshiarpur,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,1000.0,10000.0,0.0,500.0,10000.0,20000.0,0.0,0.0,0.0,0.0,1000.0,0.0,42500.0
Hoshiarpur,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,40500.0,30500.0,30500.0,30000.0,20000.0,0.0,0.0,0.0,0.0,0.0,9000.0,0.0,160500.0
Hoshiarpur,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,0.0,0.0,0.0,0.0,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hoshiarpur,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,0.0,0.0,0.0,0.0,,,0.0,0.0,0.0,0.0,2000.0,0.0,2000.0
Hoshiarpur,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,0.0,0.0,0.0,0.0,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hoshiarpur,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,0.0,0.0,0.0,0.0,,,0.0,0.0,0.0,0.0,625.0,0.0,625.0
Hoshiarpur,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1375.0,0.0,1375.0
Hoshiarpur,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,664.0,464.0,464.0,0.0,0.0,0.0,,,0.0,0.0,0.0,0.0,1592.0
Hoshiarpur,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0,0.0,0.0,,0.0
Hoshiarpur,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0,0.0,0.0,0.0,0.0
Hoshiarpur,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,200.0,0.0,464.0,0.0,0.0,0.0,,,,0.0,0.0,0.0,664.0
Hoshiarpur,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,464.0,464.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,928.0
Hoshiarpur,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,3000.0,3000.0,3000.0,0.0,0.0,0.0,,,0.0,0.0,0.0,0.0,9000.0
Hoshiarpur,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0,0.0,0.0,0.0,0.0
Hoshiarpur,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0,0.0,0.0,0.0,0.0
Hoshiarpur,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,0.0,0.0,3000.0,0.0,0.0,0.0,,,0.0,0.0,0.0,0.0,3000.0
Hoshiarpur,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,3000.0,3000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,6000.0
Hoshiarpur,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,5700.0,3700.0,3900.0,2300.0,1300.0,5700.0,3100.0,1700.0,1500.0,2700.0,100.0,100.0,31800.0
Hoshiarpur,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,0.0,2000.0,0.0,0.0,6000.0,0.0,0.0,0.0,4000.0,0.0,0.0,0.0,12000.0
Hoshiarpur,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hoshiarpur,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,2000.0,1800.0,1600.0,1000.0,1600.0,2600.0,1400.0,200.0,2800.0,2600.0,0.0,0.0,17600.0
Hoshiarpur,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,3700.0,3900.0,2300.0,1300.0,5700.0,3100.0,1700.0,1500.0,2700.0,100.0,100.0,100.0,26200.0
Hoshiarpur,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,42000.0,10000.0,10000.0,70000.0,26000.0,6000.0,52000.0,18000.0,18000.0,42000.0,16000.0,14000.0,324000.0
Hoshiarpur,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,0.0,10000.0,100000.0,0.0,0.0,100000.0,0.0,0.0,50000.0,0.0,20000.0,0.0,280000.0
Hoshiarpur,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hoshiarpur,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,32000.0,10000.0,40000.0,44000.0,20000.0,54000.0,34000.0,0.0,26000.0,26000.0,22000.0,10000.0,318000.0
Hoshiarpur,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,10000.0,10000.0,70000.0,26000.0,6000.0,52000.0,18000.0,18000.0,42000.0,16000.0,14000.0,4000.0,286000.0
Hoshiarpur,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,2800.0,1300.0,2500.0,2100.0,300.0,2100.0,700.0,300.0,300.0,2500.0,700.0,1300.0,16900.0
Hoshiarpur,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,0.0,2400.0,0.0,0.0,2400.0,0.0,0.0,0.0,2400.0,0.0,1600.0,0.0,8800.0
Hoshiarpur,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hoshiarpur,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,1500.0,1200.0,400.0,1800.0,600.0,1400.0,400.0,0.0,200.0,1800.0,1000.0,200.0,10500.0
Hoshiarpur,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,1300.0,2500.0,2100.0,300.0,2100.0,700.0,300.0,300.0,2500.0,700.0,1300.0,1100.0,15200.0
Hoshiarpur,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,,7.0,5.0,,,1.0,1.0,,,1.0,,,15.0
Hoshiarpur,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,,,,1.0,2.0,,1.0,3.0,2.0,,2.0,11.0
Hoshiarpur,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Hoshiarpur,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,,,,1.0,2.0,,1.0,3.0,2.0,,2.0,11.0
Hoshiarpur,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,,,1.0,1.0,2.0,,,,,1.0,1.0,2.0,8.0
Hoshiarpur,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,1.0,,,,,,,1.0
Hoshiarpur,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,,,1.0,1.0,2.0,1.0,,,,1.0,1.0,2.0,9.0
Hoshiarpur,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,1.0,,,4.0,4.0,2.0,2.0,2.0,3.0,3.0,,2.0,23.0
Hoshiarpur,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,,,1.0,,,,,1.0,,,2.0
Hoshiarpur,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,1.0,,,4.0,5.0,2.0,2.0,2.0,3.0,4.0,,2.0,25.0
Hoshiarpur,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,4.0,4.0,2.0,2.0,5.0,5.0,8.0,7.0,7.0,4.0,3.0,3.0,54.0
Hoshiarpur,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,1.0,2.0,3.0,,1.0,3.0,1.0,4.0,,1.0,1.0,1.0,18.0
Hoshiarpur,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,5.0,6.0,5.0,2.0,6.0,8.0,9.0,11.0,7.0,5.0,4.0,4.0,72.0
Hoshiarpur,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,1.0,1.0,,,,,1.0,1.0,,,1.0,5.0
Hoshiarpur,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,,,,,,1.0,,2.0,,3.0
Hoshiarpur,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,,1.0,1.0,,,,,1.0,2.0,,2.0,1.0,8.0
Hoshiarpur,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,1.0,,,,,,,,,,,1.0
Hoshiarpur,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,2.0,,,,,,,,1.0,,3.0
Hoshiarpur,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,1.0,2.0,,,,,,,,1.0,,4.0
Hoshiarpur,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,,,2.0,,1.0,1.0,,,1.0,,5.0
Hoshiarpur,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,1.0,3.0,4.0,1.0,,2.0,,,,11.0
Hoshiarpur,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,,,1.0,5.0,4.0,2.0,1.0,2.0,,1.0,,16.0
Hoshiarpur,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Hoshiarpur,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Hoshiarpur,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Hoshiarpur,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,2.0,4.0,3.0,1.0,5.0,2.0,4.0,4.0,3.0,2.0,1.0,4.0,35.0
Hoshiarpur,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,5.0,4.0,1.0,1.0,,6.0,,2.0,4.0,4.0,1.0,2.0,30.0
Hoshiarpur,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,7.0,8.0,4.0,2.0,5.0,8.0,4.0,6.0,7.0,6.0,2.0,6.0,65.0
Hoshiarpur,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,1.0,,,,2.0,,,,3.0
Hoshiarpur,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,,,,,,,,,
Hoshiarpur,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,1.0,1.0,,1.0,,1.0,2.0,,,,,,6.0
Hoshiarpur,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,1.0,1.0,,1.0,1.0,1.0,2.0,,2.0,,,,9.0
Hoshiarpur,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
Hoshiarpur,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,1.0,,2.0,3.0,3.0,4.0,4.0,1.0,,3.0,5.0,3.0,29.0
Hoshiarpur,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,1.0,1.0,2.0,,4.0,1.0,2.0,2.0,1.0,3.0,3.0,3.0,23.0
Hoshiarpur,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,2.0,1.0,4.0,3.0,7.0,5.0,6.0,3.0,1.0,6.0,8.0,6.0,52.0
Hoshiarpur,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,,,,,,
Hoshiarpur,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,,,,6.0,3.0,3.0,5.0,3.0,,4.0,12.0,4.0,40.0
Hoshiarpur,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,,,,6.0,10.0,9.0,7.0,3.0,13.0,23.0,13.0,15.0,99.0
Hoshiarpur,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,,,,12.0,13.0,12.0,12.0,6.0,13.0,27.0,25.0,19.0,139.0
Hoshiarpur,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
Hoshiarpur,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,,,,,,,,
Hoshiarpur,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,1.0,,,,,,,1.0,,,2.0
Hoshiarpur,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,1.0,,,,,,,1.0,,,2.0
Hoshiarpur,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,1.0,,2.0,,1.0,1.0,2.0,1.0,,1.0,1.0,,10.0
Hoshiarpur,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,8.0,19.0,17.0,5.0,2.0,7.0,9.0,3.0,6.0,6.0,9.0,13.0,104.0
Hoshiarpur,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,24.0,34.0,66.0,10.0,14.0,28.0,21.0,23.0,30.0,27.0,27.0,22.0,326.0
Hoshiarpur,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,33.0,53.0,85.0,15.0,17.0,36.0,32.0,27.0,36.0,34.0,37.0,35.0,440.0
Hoshiarpur,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
Hoshiarpur,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,1.0,,,,2.0,,1.0,,,1.0,,,5.0
Hoshiarpur,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,,,,
Hoshiarpur,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,1.0,,,,2.0,,1.0,,,1.0,,,5.0
Hoshiarpur,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,1.0,,,,2.0,,,,,2.0,1.0,1.0,7.0
Hoshiarpur,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,47.0,58.0,63.0,61.0,63.0,58.0,67.0,78.0,55.0,87.0,70.0,97.0,804.0
Hoshiarpur,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,162.0,134.0,194.0,180.0,164.0,157.0,199.0,182.0,192.0,290.0,213.0,201.0,2268.0
Hoshiarpur,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,210.0,192.0,257.0,241.0,229.0,215.0,266.0,260.0,247.0,379.0,284.0,299.0,3079.0
Hoshiarpur,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,1.0,,,,,,,,,1.0
Hoshiarpur,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,2.0,2.0,1.0,4.0,1.0,,2.0,,6.0,1.0,4.0,2.0,25.0
Hoshiarpur,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,6.0,7.0,11.0,4.0,8.0,7.0,5.0,12.0,9.0,4.0,5.0,2.0,80.0
Hoshiarpur,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,8.0,9.0,12.0,9.0,9.0,7.0,7.0,12.0,15.0,5.0,9.0,4.0,106.0
Hoshiarpur,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Hoshiarpur,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
Hoshiarpur,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Hoshiarpur,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
Hoshiarpur,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Hoshiarpur,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,1.0,,,1.0,,,,,,2.0
Hoshiarpur,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Hoshiarpur,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,1.0,,,1.0,,,,,,2.0
Hoshiarpur,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Hoshiarpur,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,1.0,,,,,,,,,,1.0
Hoshiarpur,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Hoshiarpur,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,1.0,,,,,,,,,,1.0
Hoshiarpur,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Hoshiarpur,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,,,,,,1.0,,,,,1.0
Hoshiarpur,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Hoshiarpur,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,,,,,,1.0,,,,,1.0
Hoshiarpur,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Hoshiarpur,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,1.0,,,1.0,,1.0,3.0
Hoshiarpur,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Hoshiarpur,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,1.0,,,1.0,,1.0,3.0
Hoshiarpur,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Hoshiarpur,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,,,,,,,2.0,1.0,,,1.0,1.0,5.0
Hoshiarpur,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Hoshiarpur,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,,,,,,,2.0,1.0,,,1.0,1.0,5.0
Hoshiarpur,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,,,1.0,1.0,,,,,1.0,,,3.0
Hoshiarpur,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,8.0,7.0,,16.0,16.0,17.0,15.0,15.0,14.0,15.0,13.0,9.0,145.0
Hoshiarpur,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,5.0,3.0,,8.0,7.0,5.0,7.0,9.0,3.0,7.0,2.0,7.0,63.0
Hoshiarpur,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,13.0,10.0,,25.0,24.0,22.0,22.0,24.0,17.0,23.0,15.0,16.0,211.0
Hoshiarpur,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,,,,,,,,,
Hoshiarpur,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,6.0,4.0,8.0,5.0,4.0,3.0,5.0,2.0,5.0,3.0,2.0,1.0,48.0
Hoshiarpur,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,2.0,1.0,2.0,,1.0,,1.0,,1.0,2.0,,,10.0
Hoshiarpur,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,8.0,5.0,10.0,5.0,5.0,3.0,6.0,2.0,6.0,5.0,2.0,1.0,58.0
Hoshiarpur,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,,,1.0,,,,,,,1.0
Hoshiarpur,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,,1.0,1.0,3.0,1.0,1.0,,,,,,7.0
Hoshiarpur,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,1.0,,,1.0,,1.0,,,,,,3.0
Hoshiarpur,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,,1.0,1.0,1.0,4.0,2.0,2.0,,,,,,11.0
Hoshiarpur,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,1.0,,,,1.0,1.0,,,,,1.0,4.0
Hoshiarpur,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,1.0,2.0,6.0,3.0,1.0,1.0,4.0,7.0,3.0,6.0,2.0,5.0,41.0
Hoshiarpur,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,3.0,8.0,12.0,11.0,8.0,13.0,8.0,9.0,11.0,6.0,13.0,7.0,109.0
Hoshiarpur,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,4.0,11.0,18.0,14.0,9.0,15.0,13.0,16.0,14.0,12.0,15.0,13.0,154.0
Hoshiarpur,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,1.0,,,,1.0,,,,1.0,,,3.0
Hoshiarpur,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,12.0,9.0,8.0,13.0,22.0,15.0,15.0,13.0,13.0,16.0,13.0,15.0,164.0
Hoshiarpur,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,17.0,24.0,28.0,18.0,33.0,29.0,19.0,27.0,36.0,39.0,29.0,30.0,329.0
Hoshiarpur,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,29.0,34.0,36.0,31.0,55.0,45.0,34.0,40.0,49.0,56.0,42.0,45.0,496.0
Hoshiarpur,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,4.0,2.0,4.0,,2.0,1.0,1.0,3.0,1.0,1.0,,3.0,22.0
Hoshiarpur,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,19.0,34.0,26.0,49.0,45.0,36.0,28.0,33.0,23.0,29.0,39.0,22.0,383.0
Hoshiarpur,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,130.0,142.0,216.0,182.0,169.0,143.0,159.0,224.0,215.0,198.0,171.0,134.0,2083.0
Hoshiarpur,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,153.0,178.0,246.0,231.0,216.0,180.0,188.0,260.0,239.0,228.0,210.0,159.0,2488.0
Jalandhar,1.1,Total number of pregnant women Registered for ANC,TOTAL,3705.0,3684.0,3581.0,3920.0,4220.0,3444.0,2828.0,2997.0,2801.0,2941.0,3036.0,2495.0,39652.0
Jalandhar,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,2397.0,2426.0,2330.0,2501.0,2456.0,2035.0,2050.0,2189.0,2085.0,2446.0,2531.0,2073.0,27519.0
Jalandhar,1.2,Number of Pregnant women registered under JSY,TOTAL,1854.0,1989.0,1637.0,1635.0,1685.0,1377.0,1172.0,1312.0,1224.0,1661.0,1663.0,1292.0,18501.0
Jalandhar,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,3068.0,3126.0,3753.0,4126.0,4212.0,3722.0,3204.0,3039.0,2828.0,2744.0,2820.0,2315.0,38957.0
Jalandhar,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,2970.0,3134.0,2793.0,2877.0,2897.0,2426.0,2252.0,2496.0,2383.0,2717.0,3001.0,2475.0,32421.0
Jalandhar,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,2996.0,3076.0,3172.0,2978.0,2918.0,2850.0,2556.0,2499.0,2543.0,2928.0,3131.0,2569.0,34216.0
Jalandhar,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,3220.0,3118.0,3171.0,2995.0,2874.0,2905.0,2050.0,2276.0,2223.0,2840.0,3172.0,2509.0,33353.0
Jalandhar,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,80.0,209.0,225.0,176.0,268.0,265.0,200.0,174.0,139.0,194.0,214.0,193.0,2337.0
Jalandhar,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,4.0,0.0,2.0,1.0,1.0,1.0,9.0
Jalandhar,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,2122.0,2483.0,2318.0,1808.0,3057.0,2520.0,1987.0,2172.0,2002.0,1942.0,1970.0,1664.0,26045.0
Jalandhar,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,5.0,8.0,14.0
Jalandhar,1.8,Number of pregnancy test kits used at SC level,TOTAL,820.0,836.0,730.0,863.0,678.0,712.0,691.0,821.0,928.0,854.0,881.0,700.0,9514.0
Jalandhar,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,45.0,39.0,127.0,139.0,148.0,154.0,178.0,157.0,140.0,179.0,178.0,155.0,1639.0
Jalandhar,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,179.0,198.0,111.0,130.0,120.0,108.0,96.0,97.0,83.0,13.0,1.0,0.0,1136.0
Jalandhar,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,224.0,237.0,238.0,269.0,268.0,262.0,274.0,254.0,223.0,192.0,179.0,155.0,2775.0
Jalandhar,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,169.0,181.0,204.0,246.0,159.0,238.0,260.0,241.0,221.0,192.0,179.0,154.0,2444.0
Jalandhar,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,0.0,8.0,1.0,20.0,10.0,12.0,8.0,17.0,17.0,11.0,17.0,6.0,127.0
Jalandhar,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,626.0,720.0,714.0,1071.0,1205.0,1212.0,1188.0,1109.0,1084.0,993.0,894.0,776.0,11592.0
Jalandhar,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,376.0,393.0,444.0,538.0,668.0,608.0,556.0,391.0,408.0,84.0,61.0,50.0,4577.0
Jalandhar,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,236.0,239.0,196.0,328.0,427.0,362.0,432.0,648.0,618.0,586.0,479.0,215.0,4766.0
Jalandhar,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,28.0,0.0,0.0,18.0,10.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,56.0
Jalandhar,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jalandhar,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,920.0,979.0,1045.0,1296.0,1569.0,1569.0,1773.0,1574.0,1588.0,1484.0,1172.0,1041.0,16010.0
Jalandhar,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,11.0,15.0,8.0,25.0,24.0,21.0,8.0,40.0,72.0,44.0,25.0,0.0,293.0
Jalandhar,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jalandhar,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jalandhar,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,5.0,9.0,5.0,1.0,5.0,0.0,0.0,0.0,3.0,4.0,3.0,3.0,38.0
Jalandhar,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,12.0,24.0,22.0,9.0,39.0,50.0,54.0,42.0,31.0,27.0,38.0,25.0,373.0
Jalandhar,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,171.0,194.0,202.0,298.0,268.0,284.0,265.0,298.0,306.0,277.0,233.0,205.0,3001.0
Jalandhar,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Jalandhar,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,188.0,227.0,229.0,308.0,312.0,334.0,319.0,340.0,340.0,308.0,274.0,233.0,3412.0
Jalandhar,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,346.0,425.0,471.0,567.0,765.0,726.0,848.0,814.0,830.0,776.0,622.0,518.0,7708.0
Jalandhar,4.1.1.a,Number of male live births,TOTAL,944.0,1056.0,1046.0,1421.0,1656.0,1565.0,1716.0,1527.0,1508.0,1362.0,1136.0,1023.0,15960.0
Jalandhar,4.1.1.b,Number of female live births,TOTAL,815.0,865.0,940.0,1194.0,1362.0,1462.0,1495.0,1388.0,1372.0,1280.0,1089.0,937.0,14199.0
Jalandhar,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,1759.0,1921.0,1986.0,2615.0,3018.0,3027.0,3211.0,2915.0,2880.0,2642.0,2225.0,1960.0,30159.0
Jalandhar,4.1.2,Number of still births,TOTAL,12.0,18.0,12.0,25.0,25.0,21.0,24.0,26.0,18.0,27.0,20.0,18.0,246.0
Jalandhar,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,350.0,270.0,277.0,298.0,221.0,251.0,248.0,237.0,250.0,322.0,287.0,255.0,3266.0
Jalandhar,4.2.1,Number of Newborns weighed at birth,TOTAL,1759.0,1921.0,1986.0,2611.0,3018.0,3025.0,3211.0,2915.0,2880.0,2642.0,2225.0,1960.0,30153.0
Jalandhar,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,12.0,11.0,33.0,43.0,46.0,41.0,43.0,36.0,38.0,39.0,34.0,25.0,401.0
Jalandhar,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,1422.0,1525.0,1504.0,1834.0,1987.0,2104.0,2380.0,2040.0,1998.0,1982.0,1643.0,1472.0,21891.0
Jalandhar,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,18.0,15.0,20.0,16.0,29.0,22.0,28.0,24.0,25.0,4.0,4.0,4.0,209.0
Jalandhar,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,6.0,16.0,17.0,9.0,27.0,29.0,67.0,46.0,35.0,25.0,42.0,61.0,380.0
Jalandhar,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,12.0,9.0,0.0,22.0,20.0,30.0,243.0,248.0,262.0,258.0,387.0,190.0,1681.0
Jalandhar,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Jalandhar,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,36.0,40.0,37.0,47.0,76.0,81.0,338.0,318.0,322.0,287.0,433.0,255.0,2270.0
Jalandhar,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,625.0,436.0,393.0,1454.0
Jalandhar,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,22.0,31.0,29.0,38.0,58.0,67.0,89.0,162.0,296.0,874.0,709.0,584.0,2959.0
Jalandhar,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,2.0,2.0,4.0,7.0,5.0,4.0,11.0,69.0,111.0,111.0,25.0,14.0,365.0
Jalandhar,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,18.0,25.0,25.0,32.0,59.0,57.0,64.0,122.0,271.0,878.0,759.0,584.0,2894.0
Jalandhar,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,2.0,9.0,0.0,8.0,11.0,22.0,122.0,110.0,119.0,66.0,109.0,85.0,663.0
Jalandhar,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,692.0,577.0,887.0,726.0,1073.0,1150.0,2340.0,2155.0,2176.0,2431.0,2067.0,1815.0,18089.0
Jalandhar,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,456.0,375.0,563.0,566.0,769.0,744.0,1334.0,1254.0,1287.0,1476.0,641.0,558.0,10023.0
Jalandhar,6.3,PNC maternal complications attended,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,18.0,12.0,15.0,0.0,5.0,6.0,56.0
Jalandhar,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,23.0,27.0,44.0,9.0,14.0,12.0,16.0,18.0,19.0,25.0,22.0,30.0,259.0
Jalandhar,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,4.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,4.0
Jalandhar,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,27.0,27.0,44.0,9.0,14.0,12.0,16.0,18.0,19.0,25.0,22.0,30.0,263.0
Jalandhar,7.2,Number of MTPs conducted at Private Facilities,TOTAL,323.0,257.0,261.0,253.0,201.0,219.0,228.0,220.0,226.0,298.0,270.0,216.0,2972.0
Jalandhar,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,73.0,176.0,77.0,85.0,98.0,87.0,103.0,109.0,79.0,92.0,210.0,181.0,1370.0
Jalandhar,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,238.0,187.0,244.0,164.0,180.0,143.0,217.0,228.0,207.0,202.0,231.0,118.0,2359.0
Jalandhar,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,311.0,363.0,321.0,249.0,278.0,230.0,320.0,337.0,286.0,294.0,441.0,299.0,3729.0
Jalandhar,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jalandhar,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,3.0,3.0,1.0,4.0,4.0,6.0,2.0,18.0,4.0,2.0,5.0,2.0,54.0
Jalandhar,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,10.0,12.0,30.0,55.0,11.0,33.0,7.0,39.0,7.0,3.0,7.0,3.0,217.0
Jalandhar,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,3.0,5.0,7.0,24.0,21.0,10.0,2.0,56.0,6.0,9.0,11.0,4.0,158.0
Jalandhar,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Jalandhar,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,16.0,20.0,38.0,83.0,36.0,49.0,11.0,113.0,17.0,14.0,23.0,9.0,429.0
Jalandhar,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,0.0,12.0,12.0,14.0,22.0,19.0,13.0,21.0,14.0,19.0,18.0,7.0,171.0
Jalandhar,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,23.0,17.0,64.0,40.0,37.0,63.0,45.0,48.0,22.0,19.0,25.0,15.0,418.0
Jalandhar,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,111.0,105.0,159.0,125.0,112.0,164.0,92.0,52.0,61.0,38.0,75.0,35.0,1129.0
Jalandhar,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,48.0,29.0,79.0,100.0,85.0,65.0,14.0,8.0,25.0,35.0,50.0,33.0,571.0
Jalandhar,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Jalandhar,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,182.0,151.0,302.0,265.0,234.0,292.0,151.0,108.0,108.0,92.0,150.0,83.0,2118.0
Jalandhar,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,322.0,341.0,383.0,369.0,370.0,342.0,227.0,197.0,205.0,170.0,179.0,133.0,3238.0
Jalandhar,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,2.0
Jalandhar,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,0.0,1.0,7.0,9.0,8.0,6.0,0.0,2.0,1.0,0.0,0.0,0.0,34.0
Jalandhar,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,16.0,11.0,0.0,0.0,,,,,,,,1.0,28.0
Jalandhar,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Jalandhar,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,16.0,12.0,7.0,9.0,8.0,6.0,0.0,2.0,1.0,2.0,0.0,1.0,64.0
Jalandhar,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,0.0,0.0,0.0,2.0
Jalandhar,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jalandhar,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,2.0,5.0,0.0,2.0,7.0,0.0,16.0
Jalandhar,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,7.0,17.0,0.0,3.0,,38.0,64.0,48.0,56.0,64.0,47.0,36.0,380.0
Jalandhar,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Jalandhar,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,7.0,17.0,0.0,3.0,0.0,38.0,66.0,53.0,56.0,66.0,54.0,36.0,396.0
Jalandhar,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jalandhar,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,1070.0,1262.0,1308.0,1379.0,1272.0,1221.0,1172.0,1143.0,1119.0,1261.0,1237.0,874.0,14318.0
Jalandhar,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,10.0,10.0,8.0,8.0,8.0,8.0,4.0,3.0,3.0,8.0,12.0,4.0,86.0
Jalandhar,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,11.0,10.0,8.0,9.0,8.0,0.0,6.0,5.0,54.0,4.0,6.0,4.0,125.0
Jalandhar,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,111.0,113.0,112.0,135.0,107.0,117.0,109.0,105.0,90.0,75.0,115.0,109.0,1298.0
Jalandhar,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Jalandhar,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,1202.0,1395.0,1436.0,1531.0,1395.0,1346.0,1291.0,1256.0,1266.0,1348.0,1370.0,991.0,15827.0
Jalandhar,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,1.0,15.0,4.0,41.0,10.0,21.0,26.0,19.0,15.0,19.0,49.0,41.0,261.0
Jalandhar,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jalandhar,9.06,Number of IUCD removals,TOTAL,157.0,199.0,177.0,99.0,40.0,70.0,171.0,171.0,149.0,173.0,180.0,103.0,1689.0
Jalandhar,9.07,Number of Oral Pills cycles distributed,TOTAL,10954.0,10238.0,10526.0,10121.0,10253.0,10032.0,10683.0,10290.0,10127.0,10305.0,10677.0,9184.0,123390.0
Jalandhar,9.08,Number of Condom pieces distributed,TOTAL,249568.0,256649.0,269559.0,260475.0,264067.0,246888.0,260449.0,254114.0,258235.0,267268.0,269957.0,236834.0,3094063.0
Jalandhar,9.09,Number of Centchroman (weekly) pills given,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jalandhar,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jalandhar,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jalandhar,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jalandhar,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jalandhar,9.11.2.b,Number of failures following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jalandhar,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jalandhar,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jalandhar,9.12,Number of Institutions having NSV trained doctors,TOTAL,,,,1.0,,2.0,1.0,1.0,1.0,2.0,3.0,2.0,-1.0
Jalandhar,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,2379.0,2555.0,2513.0,2925.0,3364.0,3400.0,3530.0,3548.0,3259.0,3059.0,2655.0,2288.0,35475.0
Jalandhar,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,2534.0,2633.0,2319.0,2386.0,2559.0,2780.0,2941.0,3137.0,2859.0,2391.0,518.0,164.0,27221.0
Jalandhar,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,2726.0,2780.0,2523.0,2395.0,2410.0,2452.0,2808.0,2991.0,3089.0,2950.0,2404.0,526.0,30054.0
Jalandhar,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,2808.0,2967.0,2660.0,2716.0,2490.0,2449.0,2616.0,2835.0,2920.0,3067.0,2817.0,1702.0,32047.0
Jalandhar,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,880.0,2319.0,1959.0,5158.0
Jalandhar,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,8.0,692.0,1770.0,2470.0
Jalandhar,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,16.0,690.0,708.0
Jalandhar,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,2044.0,2023.0,2041.0,1979.0,2984.0,2798.0,2993.0,2947.0,2748.0,2838.0,2491.0,1802.0,29688.0
Jalandhar,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,2534.0,2633.0,2319.0,2386.0,2559.0,2780.0,2941.0,3137.0,2859.0,3271.0,2837.0,2122.0,32378.0
Jalandhar,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,2726.0,2780.0,2523.0,2395.0,2410.0,2452.0,2808.0,2991.0,3089.0,2958.0,3096.0,2296.0,32524.0
Jalandhar,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,2808.0,2967.0,2660.0,2716.0,2490.0,2449.0,2616.0,2835.0,2920.0,3069.0,2833.0,2391.0,32754.0
Jalandhar,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,1258.0,1425.0,1469.0,1956.0,2141.0,2455.0,2305.0,2442.0,2121.0,2266.0,2002.0,1524.0,23364.0
Jalandhar,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,2479.0,2634.0,2317.0,2401.0,2555.0,2781.0,2949.0,3112.0,2874.0,2411.0,346.0,243.0,27102.0
Jalandhar,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,2703.0,2765.0,2539.0,2392.0,2400.0,2447.0,2817.0,2977.0,3088.0,2933.0,2365.0,650.0,30076.0
Jalandhar,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,2759.0,2996.0,2671.0,2717.0,2480.0,2444.0,2622.0,2837.0,2904.0,3066.0,2806.0,1774.0,32076.0
Jalandhar,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,2328.0,2958.0,2908.0,2861.0,3064.0,2793.0,2601.0,2974.0,2451.0,2387.0,2275.0,1913.0,31513.0
Jalandhar,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,2622.0,2965.0,2486.0,2603.0,2463.0,2415.0,2190.0,2562.0,2422.0,2644.0,2591.0,2102.0,30065.0
Jalandhar,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jalandhar,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1258.0,1567.0,1551.0,1415.0,1557.0,1480.0,1388.0,1588.0,1279.0,1268.0,1200.0,1032.0,16583.0
Jalandhar,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1067.0,1384.0,1343.0,1311.0,1345.0,1303.0,1213.0,1386.0,1165.0,1106.0,1071.0,879.0,14573.0
Jalandhar,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,2325.0,2951.0,2894.0,2726.0,2902.0,2783.0,2601.0,2974.0,2444.0,2374.0,2271.0,1911.0,31156.0
Jalandhar,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,2644.0,2932.0,2569.0,2671.0,2553.0,2360.0,2267.0,2577.0,2389.0,2613.0,2641.0,2061.0,30277.0
Jalandhar,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,2644.0,2932.0,2569.0,2671.0,2553.0,2358.0,2267.0,2577.0,2389.0,2613.0,2641.0,2061.0,30275.0
Jalandhar,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jalandhar,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,147.0,107.0,85.0,185.0,131.0,58.0,0.0,9.0,5.0,1.0,2.0,0.0,730.0
Jalandhar,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,145.0,106.0,73.0,179.0,126.0,54.0,0.0,5.0,4.0,1.0,2.0,0.0,695.0
Jalandhar,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,292.0,213.0,158.0,364.0,257.0,112.0,0.0,14.0,9.0,2.0,4.0,0.0,1425.0
Jalandhar,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,1832.0,2822.0,2080.0,2053.0,2113.0,2105.0,2011.0,2752.0,2061.0,2037.0,2080.0,1659.0,25605.0
Jalandhar,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,1863.0,4747.0,1943.0,2653.0,2677.0,2570.0,2332.0,2977.0,1932.0,1580.0,1900.0,1255.0,28429.0
Jalandhar,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,1080.0,2998.0,1403.0,1903.0,2179.0,2518.0,2065.0,2768.0,1675.0,1261.0,1608.0,972.0,22430.0
Jalandhar,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jalandhar,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jalandhar,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jalandhar,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,1083.0,1104.0,1072.0,1040.0,1020.0,1034.0,1092.0,1087.0,1067.0,1087.0,1074.0,1022.0,12782.0
Jalandhar,10.4.2,Number of Immunisation sessions held during the month,TOTAL,1065.0,1095.0,1064.0,1034.0,1007.0,1018.0,1060.0,1071.0,1054.0,1081.0,1067.0,919.0,12535.0
Jalandhar,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,752.0,779.0,742.0,701.0,681.0,696.0,750.0,742.0,742.0,761.0,770.0,661.0,8777.0
Jalandhar,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jalandhar,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,2269.0,2898.0,2793.0,2671.0,2854.0,2542.0,2396.0,2627.0,2305.0,2297.0,2231.0,1793.0,29676.0
Jalandhar,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,2194.0,2355.0,2050.0,1655.0,1676.0,1878.0,1935.0,1887.0,2064.0,1912.0,2164.0,1732.0,23502.0
Jalandhar,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,1715.0,2395.0,2063.0,1652.0,1450.0,1779.0,1790.0,2133.0,1987.0,1913.0,2063.0,1488.0,22428.0
Jalandhar,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jalandhar,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jalandhar,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jalandhar,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jalandhar,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jalandhar,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jalandhar,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,45.0,57.0,29.0,13.0,129.0,44.0,40.0,31.0,20.0,51.0,36.0,49.0,544.0
Jalandhar,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jalandhar,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jalandhar,13.1,Number of Patients operated for cataract,TOTAL,128.0,70.0,51.0,36.0,98.0,150.0,94.0,163.0,112.0,90.0,158.0,145.0,1295.0
Jalandhar,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,98.0,59.0,29.0,21.0,58.0,87.0,56.0,113.0,64.0,90.0,158.0,145.0,978.0
Jalandhar,13.3,Number of School children detected with Refractive errors,TOTAL,226.0,398.0,8.0,579.0,598.0,281.0,858.0,637.0,233.0,244.0,191.0,242.0,4495.0
Jalandhar,13.4,Number of children provided free glasses,TOTAL,226.0,398.0,8.0,579.0,598.0,281.0,802.0,609.0,356.0,220.0,232.0,247.0,4556.0
Jalandhar,13.5,Number of eyes collected through eye donation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jalandhar,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jalandhar,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,1.0,1.0,1.0,6.0,2.0,4.0,6.0,4.0,4.0,5.0,5.0,4.0,-1.0
Jalandhar,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,,,,5.0,3.0,4.0,5.0,6.0,4.0,5.0,2.0,3.0,-1.0
Jalandhar,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,648.0,605.0,663.0,142.0,369.0,489.0,647.0,641.0,640.0,657.0,719.0,617.0,-1.0
Jalandhar,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,3.0,4.0,8.0,14.0,7.0,7.0,7.0,5.0,5.0,5.0,6.0,4.0,-1.0
Jalandhar,14.05,Number of RKS meetings held during the month,TOTAL,4.0,4.0,9.0,12.0,4.0,6.0,7.0,7.0,5.0,6.0,4.0,2.0,70.0
Jalandhar,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,1.0,1.0,1.0,4.0,4.0,2.0,4.0,2.0,2.0,3.0,2.0,2.0,-1.0
Jalandhar,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,20.0,6.0,22.0,17.0,12.0,14.0,9.0,6.0,0.0,20.0,6.0,1.0,133.0
Jalandhar,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,2.0,2.0,2.0,4.0,3.0,4.0,3.0,2.0,2.0,3.0,3.0,3.0,-1.0
Jalandhar,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,14.0,13.0,14.0,2.0,2.0,2.0,1.0,1.0,1.0,1.0,2.0,1.0,-1.0
Jalandhar,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,525.0,586.0,628.0,771.0,853.0,701.0,775.0,709.0,659.0,619.0,575.0,515.0,7916.0
Jalandhar,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,1551.0,1926.0,1902.0,1845.0,1853.0,1733.0,1665.0,1454.0,1291.0,1183.0,1279.0,1546.0,19228.0
Jalandhar,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,464.0,573.0,534.0,630.0,767.0,713.0,745.0,711.0,584.0,584.0,522.0,499.0,7326.0
Jalandhar,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,2212.0,2563.0,2515.0,2814.0,2883.0,2751.0,2667.0,2303.0,2143.0,1996.0,1962.0,2137.0,28946.0
Jalandhar,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,989.0,1159.0,1162.0,1401.0,1620.0,1414.0,1520.0,1420.0,1243.0,1203.0,1097.0,1014.0,15242.0
Jalandhar,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,3763.0,4489.0,4417.0,4659.0,4736.0,4484.0,4332.0,3757.0,3434.0,3179.0,3241.0,3683.0,48174.0
Jalandhar,14.10.2.a,Number of death cases of Inpatient males,TOTAL,56.0,59.0,87.0,77.0,59.0,50.0,74.0,81.0,73.0,96.0,88.0,79.0,879.0
Jalandhar,14.10.2.b,Number of death cases of Inpatient females,TOTAL,44.0,42.0,43.0,36.0,56.0,43.0,46.0,45.0,44.0,34.0,51.0,49.0,533.0
Jalandhar,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,100.0,101.0,130.0,113.0,115.0,93.0,120.0,126.0,117.0,130.0,139.0,128.0,1412.0
Jalandhar,14.11,In-Patient Head Count at midnight,TOTAL,528.0,772.0,976.0,0.0,973.0,956.0,109.0,660.0,517.0,82.0,26.0,555.0,6154.0
Jalandhar,14.12.1,OPD attendance (All),TOTAL,103958.0,118756.0,112426.0,92716.0,109943.0,115206.0,100468.0,104467.0,103402.0,95606.0,114230.0,119175.0,1290353.0
Jalandhar,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,1142.0,2976.0,905.0,899.0,913.0,950.0,904.0,1018.0,872.0,794.0,812.0,1365.0,13550.0
Jalandhar,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,0.0,0.0,5.0,0.0,3.0,2.0,1.0,2.0,0.0,0.0,4.0,0.0,17.0
Jalandhar,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,3371.0,2891.0,4678.0,4738.0,4116.0,3732.0,4683.0,4398.0,4672.0,4178.0,4044.0,4389.0,49890.0
Jalandhar,14.14.a,Number of patients given AYUSH treatment,TOTAL,3048.0,3861.0,4212.0,2818.0,5507.0,3275.0,4163.0,2964.0,3264.0,3466.0,3537.0,3046.0,43161.0
Jalandhar,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,2311.0,2303.0,1727.0,2461.0,1410.0,1589.0,2142.0,2633.0,2067.0,2248.0,1805.0,1746.0,24442.0
Jalandhar,14.14.c,Number of Adolescents counselled,TOTAL,7.0,6.0,5.0,6.0,6.0,10.0,53.0,25.0,18.0,55.0,18.0,13.0,222.0
Jalandhar,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,9928.0,15177.0,12306.0,9212.0,9482.0,9122.0,10529.0,11395.0,10040.0,12962.0,12796.0,12711.0,135660.0
Jalandhar,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,629.0,714.0,544.0,553.0,575.0,455.0,539.0,563.0,410.0,342.0,362.0,392.0,6078.0
Jalandhar,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,859.0,948.0,933.0,869.0,900.0,794.0,1019.0,936.0,593.0,899.0,1006.0,878.0,10634.0
Jalandhar,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,26.0,38.0,41.0,18.0,28.0,49.0,19.0,19.0,19.0,29.0,29.0,38.0,353.0
Jalandhar,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,463.0,541.0,544.0,495.0,503.0,481.0,566.0,642.0,376.0,1072.0,700.0,477.0,6860.0
Jalandhar,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,32.0,17.0,13.0,15.0,7.0,15.0,13.0,7.0,4.0,1.0,10.0,6.0,140.0
Jalandhar,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,983.0,1104.0,962.0,991.0,979.0,993.0,968.0,1122.0,903.0,1264.0,1130.0,1114.0,12513.0
Jalandhar,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,45.0,10.0,4.0,1.0,1.0,104.0,0.0,1.0,2.0,1.0,2.0,3.0,174.0
Jalandhar,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,2305.0,2593.0,2439.0,2355.0,2382.0,2268.0,2553.0,2700.0,1872.0,3235.0,2836.0,2469.0,30007.0
Jalandhar,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,103.0,65.0,58.0,34.0,36.0,168.0,32.0,27.0,25.0,31.0,41.0,47.0,667.0
Jalandhar,15.2,Number of Widal tests conducted,Number tested,1213.0,1094.0,976.0,1276.0,1349.0,1033.0,693.0,839.0,605.0,1121.0,1474.0,1600.0,13273.0
Jalandhar,15.3.a,Number of VDRL tests conducted on males,Number tested,539.0,214.0,440.0,578.0,563.0,515.0,320.0,512.0,548.0,520.0,634.0,645.0,6028.0
Jalandhar,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,8.0,23.0,559.0,706.0,753.0,645.0,414.0,599.0,707.0,800.0,738.0,738.0,6690.0
Jalandhar,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,1329.0,768.0,486.0,555.0,447.0,430.0,463.0,501.0,493.0,549.0,535.0,652.0,7208.0
Jalandhar,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,1876.0,1005.0,1485.0,1839.0,1763.0,1590.0,1197.0,1612.0,1748.0,1869.0,1907.0,2035.0,19926.0
Jalandhar,15.4.1,Number of blood smears examined for Malaria,TOTAL,6221.0,6924.0,6606.0,1253.0,1694.0,7147.0,7039.0,6369.0,6178.0,6372.0,6981.0,8598.0,71382.0
Jalandhar,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jalandhar,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jalandhar,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,18300.0,20100.0,34850.0,19550.0,6150.0,13550.0,11950.0,18250.0,8450.0,11850.0,,,163000.0
Jalandhar,16.1.1,Stock position of DPT vaccines,2. Stocks Received,20000.0,30000.0,0.0,0.0,20000.0,10000.0,20000.0,0.0,10000.0,20000.0,,,130000.0
Jalandhar,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Jalandhar,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,18200.0,15250.0,15300.0,13400.0,12600.0,11600.0,13700.0,9800.0,6600.0,14500.0,,,130950.0
Jalandhar,16.1.1,Stock position of DPT vaccines,5. Total Stock,20100.0,34850.0,19550.0,6150.0,13550.0,11950.0,18250.0,8450.0,11850.0,17350.0,0.0,0.0,162050.0
Jalandhar,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,,,,,,,,,,0.0,,,0.0
Jalandhar,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,,,,,,,,,,30000.0,,,30000.0
Jalandhar,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,,,,,,,,,,,,,
Jalandhar,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,,,,,,,,,,24000.0,,,24000.0
Jalandhar,16.1.1A,Stock Position of Pentavalent,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,6000.0,0.0,0.0,6000.0
Jalandhar,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,600.0,16200.0,27200.0,30600.0,25100.0,7250.0,10050.0,4650.0,2000.0,3600.0,,,127250.0
Jalandhar,16.1.2,Stock position of OPV vaccines,2. Stocks Received,20000.0,30000.0,34200.0,10000.0,,18000.0,16000.0,20000.0,10000.0,10000.0,,,168200.0
Jalandhar,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,,,,,,,,,,,,,
Jalandhar,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,4400.0,19000.0,30800.0,15500.0,17850.0,15200.0,21400.0,22650.0,8400.0,11800.0,,,167000.0
Jalandhar,16.1.2,Stock position of OPV vaccines,5. Total Stock,16200.0,27200.0,30600.0,25100.0,7250.0,10050.0,4650.0,2000.0,3600.0,1800.0,0.0,0.0,128450.0
Jalandhar,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,4200.0,17100.0,20250.0,7550.0,20750.0,7750.0,10350.0,24250.0,16600.0,25200.0,,,154000.0
Jalandhar,16.1.3,Stock position of TT vaccines,2. Stocks Received,20000.0,20000.0,0.0,20000.0,,10000.0,30000.0,0.0,20000.0,10000.0,,,130000.0
Jalandhar,16.1.3,Stock position of TT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Jalandhar,16.1.3,Stock position of TT vaccines,4. Stock Distributed,7100.0,16850.0,12700.0,6800.0,13000.0,7400.0,16100.0,7650.0,11400.0,9550.0,,,108550.0
Jalandhar,16.1.3,Stock position of TT vaccines,5. Total Stock,17100.0,20250.0,7550.0,20750.0,7750.0,10350.0,24250.0,16600.0,25200.0,25650.0,0.0,0.0,175450.0
Jalandhar,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Jalandhar,16.1.4,Stock position of DT vaccines,2. Stocks Received,,,,,,,,,,,,,
Jalandhar,16.1.4,Stock position of DT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Jalandhar,16.1.4,Stock position of DT vaccines,4. Stock Distributed,,,,,,,,,,,,,
Jalandhar,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jalandhar,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,12600.0,9200.0,8100.0,1250.0,1250.0,0.0,7000.0,15950.0,2700.0,15900.0,,,73950.0
Jalandhar,16.1.5,Stock position of BCG vaccines,2. Stocks Received,5000.0,10000.0,0.0,10000.0,,10000.0,10000.0,10000.0,20000.0,0.0,,,75000.0
Jalandhar,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,,,,,,,,,,,,,
Jalandhar,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,8400.0,11100.0,6850.0,10000.0,1250.0,3000.0,1050.0,23250.0,6800.0,5750.0,,,77450.0
Jalandhar,16.1.5,Stock position of BCG vaccines,5. Total Stock,9200.0,8100.0,1250.0,1250.0,0.0,7000.0,15950.0,2700.0,15900.0,10150.0,0.0,0.0,71500.0
Jalandhar,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,3600.0,7850.0,11850.0,4800.0,7700.0,3950.0,250.0,10100.0,5050.0,12950.0,,,68100.0
Jalandhar,16.1.6,Stock position of Measles vaccines,2. Stocks Received,5000.0,10000.0,0.0,5000.0,,,18000.0,10000.0,15000.0,10000.0,,,73000.0
Jalandhar,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,,,,,,,,,,,,,
Jalandhar,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,750.0,6000.0,7050.0,2100.0,3750.0,3700.0,8150.0,15050.0,7100.0,6650.0,,,60300.0
Jalandhar,16.1.6,Stock position of Measles vaccines,5. Total Stock,7850.0,11850.0,4800.0,7700.0,3950.0,250.0,10100.0,5050.0,12950.0,16300.0,0.0,0.0,80800.0
Jalandhar,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Jalandhar,16.1.7,Stock position of JE vaccines,2. Stocks Received,,,,,,,,,,,,,
Jalandhar,16.1.7,Stock position of JE vaccines,3. Unusable Stock,,,,,,,,,,,,,
Jalandhar,16.1.7,Stock position of JE vaccines,4. Stock Distributed,,,,,,,,,,,,,
Jalandhar,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jalandhar,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,5200.0,16300.0,31850.0,8550.0,20050.0,17450.0,17000.0,12200.0,7700.0,9700.0,,,146000.0
Jalandhar,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,20000.0,30000.0,0.0,20000.0,,,0.0,5000.0,10000.0,5000.0,,,90000.0
Jalandhar,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,,,,,,,,,,,,,
Jalandhar,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,8900.0,14450.0,23300.0,8500.0,2600.0,17450.0,4800.0,9500.0,8000.0,13600.0,,,111100.0
Jalandhar,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,16300.0,31850.0,8550.0,20050.0,17450.0,0.0,12200.0,7700.0,9700.0,1100.0,0.0,0.0,124900.0
Jalandhar,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Jalandhar,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Jalandhar,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Jalandhar,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Jalandhar,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jalandhar,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,0.0,223880.0,,,223880.0
Jalandhar,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,,,,,,,,,250000.0,0.0,,,250000.0
Jalandhar,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Jalandhar,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,,,,,,,,,26120.0,12000.0,,,38120.0
Jalandhar,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,223880.0,211880.0,0.0,0.0,435760.0
Jalandhar,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Jalandhar,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Jalandhar,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Jalandhar,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Jalandhar,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jalandhar,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Jalandhar,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Jalandhar,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Jalandhar,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Jalandhar,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jalandhar,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Jalandhar,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Jalandhar,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Jalandhar,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Jalandhar,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jalandhar,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,,,,,,,,,,,,,
Jalandhar,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,,,,,,,,,,,,,
Jalandhar,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,,,,,,,,,,,,,
Jalandhar,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,,,,,,,,,,,,,
Jalandhar,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jalandhar,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,,,,,,,,,,,,,
Jalandhar,16.3.02,Stock Position of Gloves,2. Stocks Received,,,,,,,,,,,,,
Jalandhar,16.3.02,Stock Position of Gloves,3. Unusable Stock,,,,,,,,,,,,,
Jalandhar,16.3.02,Stock Position of Gloves,4. Stock Distributed,,,,,,,,,,,,,
Jalandhar,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jalandhar,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,,,,,,,,,,,,,
Jalandhar,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,,,,,,,,,,,,,
Jalandhar,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,,,,,,,,,,,,,
Jalandhar,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,,,,,,,,,,,,,
Jalandhar,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jalandhar,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
Jalandhar,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,,,,,,,,,,,,,
Jalandhar,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,,,,,,,,,,,,,
Jalandhar,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,,,,,,,,,,,,,
Jalandhar,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jalandhar,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,,,,,,,,,,,,,
Jalandhar,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,,,,,,,,,,,,,
Jalandhar,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,,,,,,,,,,,,,
Jalandhar,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,,,,,,,,,,,,,
Jalandhar,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jalandhar,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,,,,,,,,,,,,,
Jalandhar,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,,,,,,,,,,,,,
Jalandhar,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,,,,,,,,,,,,,
Jalandhar,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,,,,,,,,,,,,,
Jalandhar,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jalandhar,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
Jalandhar,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,,,,,,,,,,,,,
Jalandhar,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,,,,,,,,,,,,,
Jalandhar,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,,,,,,,,,,,,,
Jalandhar,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jalandhar,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,,,,,,,,,,,,,
Jalandhar,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,,,,,,,,,,,,,
Jalandhar,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,,,,,,,,,,,,,
Jalandhar,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,,,,,,,,,,,,,
Jalandhar,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jalandhar,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,,,,,,,,,,,,,
Jalandhar,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,,,,,,,,,,,,,
Jalandhar,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,,,,,,,,,,,,,
Jalandhar,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,,,,,,,,,,,,,
Jalandhar,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jalandhar,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,,,,,,,,,,,,,
Jalandhar,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,,,,,,,,,,,,,
Jalandhar,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,,,,,,,,,,,,,
Jalandhar,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,,,,,,,,,,,,,
Jalandhar,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jalandhar,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,,,,,,,,,,,,,
Jalandhar,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,,,,,,,,,,,,,
Jalandhar,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,,,,,,,,,,,,,
Jalandhar,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,,,,,,,,,,,,,
Jalandhar,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jalandhar,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,600.0,700.0,2000.0,200.0,4000.0,4400.0,0.0,4900.0,2100.0,,,,18900.0
Jalandhar,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,2000.0,2000.0,0.0,4000.0,2000.0,,8000.0,0.0,0.0,,,,18000.0
Jalandhar,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,,
Jalandhar,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,1900.0,700.0,1800.0,200.0,1600.0,4400.0,3100.0,2800.0,2100.0,,,,18600.0
Jalandhar,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,700.0,2000.0,200.0,4000.0,4400.0,0.0,4900.0,2100.0,0.0,0.0,0.0,0.0,18300.0
Jalandhar,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,198000.0,150000.0,108000.0,58000.0,,130000.0,120000.0,72000.0,56000.0,26000.0,,,918000.0
Jalandhar,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,,0.0,0.0,0.0,150000.0,,0.0,0.0,0.0,50000.0,,,200000.0
Jalandhar,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,,
Jalandhar,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,48000.0,42000.0,50000.0,58000.0,20000.0,10000.0,48000.0,16000.0,30000.0,18000.0,,,340000.0
Jalandhar,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,150000.0,108000.0,58000.0,0.0,130000.0,120000.0,72000.0,56000.0,26000.0,58000.0,0.0,0.0,778000.0
Jalandhar,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,0.0,,0.0,0.0,3600.0,300.0,300.0,7200.0,6000.0,5000.0,,,22400.0
Jalandhar,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,0.0,,0.0,3600.0,,,7200.0,0.0,0.0,2400.0,,,13200.0
Jalandhar,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,,,,,,,,,,,,,
Jalandhar,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,0.0,,0.0,0.0,3300.0,0.0,300.0,1200.0,1000.0,1800.0,,,7600.0
Jalandhar,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,0.0,0.0,0.0,3600.0,300.0,300.0,7200.0,6000.0,5000.0,5600.0,0.0,0.0,28000.0
Jalandhar,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,,,,,,,,,,,,,
Jalandhar,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Jalandhar,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Jalandhar,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,,,,,,,,,,,,
Jalandhar,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Jalandhar,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Jalandhar,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,,,,,,,,,,,,,
Jalandhar,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,,,,,,,,,1.0,,,,1.0
Jalandhar,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Jalandhar,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,,,,,,,,,1.0,,,,1.0
Jalandhar,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,,,,1.0,,1.0,,,,1.0,1.0,,4.0
Jalandhar,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,,,,,,,2.0,,,,,2.0
Jalandhar,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,,,,1.0,,1.0,,2.0,,1.0,1.0,,6.0
Jalandhar,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,,,,,,,,,,,,
Jalandhar,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,,,,,,,,,,
Jalandhar,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,,,,,,,,,,,,,
Jalandhar,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,,,,,,
Jalandhar,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
Jalandhar,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,,,,,,,,,
Jalandhar,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,,,,,,,,,,,
Jalandhar,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,,,1.0,,,1.0,,,,2.0
Jalandhar,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,,,,,1.0,,,1.0,,,,2.0
Jalandhar,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Jalandhar,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Jalandhar,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Jalandhar,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,,,,,,,1.0,,,,,,1.0
Jalandhar,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,,,1.0,,,,1.0,,,1.0,,,3.0
Jalandhar,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,,,1.0,,,,2.0,,,1.0,,,4.0
Jalandhar,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
Jalandhar,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,,,,,,,,,
Jalandhar,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,,,1.0,,,,,,1.0
Jalandhar,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,,,,,1.0,,,,,,1.0
Jalandhar,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
Jalandhar,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,,,,,,1.0,,,,,,,1.0
Jalandhar,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,,,,,,,,,,,,,
Jalandhar,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,,,,,,1.0,,,,,,,1.0
Jalandhar,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,,,,,,
Jalandhar,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,,,,,,,,,,,,,
Jalandhar,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,,,,,,,,,,,1.0,,1.0
Jalandhar,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,,,,,,,,,,,1.0,,1.0
Jalandhar,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
Jalandhar,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,,,,,,,,
Jalandhar,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
Jalandhar,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,,,,,,,,,,
Jalandhar,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,,,,,1.0,,,1.0,,2.0
Jalandhar,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,1.0,,,,,2.0,4.0,6.0,,1.0,3.0,,17.0
Jalandhar,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,,,,,,6.0,14.0,30.0,17.0,7.0,9.0,,83.0
Jalandhar,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,1.0,,,,,8.0,18.0,37.0,17.0,8.0,13.0,,102.0
Jalandhar,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
Jalandhar,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,,,,,,,,,,,
Jalandhar,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,1.0,,,,,,1.0
Jalandhar,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,,,,,1.0,,,,,,1.0
Jalandhar,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,,,,,,,,,
Jalandhar,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,10.0,8.0,10.0,9.0,1.0,29.0,35.0,30.0,38.0,27.0,30.0,3.0,230.0
Jalandhar,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,28.0,6.0,20.0,15.0,10.0,71.0,78.0,76.0,60.0,80.0,70.0,15.0,529.0
Jalandhar,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,38.0,14.0,30.0,24.0,11.0,100.0,113.0,106.0,98.0,107.0,100.0,18.0,759.0
Jalandhar,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,,,,,,,
Jalandhar,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,,,,,,,,,,,,,
Jalandhar,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,,,,,,1.0,,1.0,,1.0,,,3.0
Jalandhar,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,,,,,,1.0,,1.0,,1.0,,,3.0
Jalandhar,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Jalandhar,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
Jalandhar,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Jalandhar,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
Jalandhar,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Jalandhar,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,,,,,,,,
Jalandhar,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Jalandhar,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,,,,,,,,
Jalandhar,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Jalandhar,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,,,,,,,,,,
Jalandhar,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Jalandhar,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,,,,,,,,,,,
Jalandhar,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Jalandhar,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,,,,,,,,,,,
Jalandhar,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Jalandhar,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,,,,,,,,,,,
Jalandhar,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Jalandhar,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,,,,,,,
Jalandhar,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Jalandhar,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,,,,,,,
Jalandhar,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Jalandhar,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,,,,,,,,,,1.0,,,1.0
Jalandhar,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Jalandhar,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,,,,,,,,,,1.0,,,1.0
Jalandhar,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,,,1.0,,1.0,,1.0,,,,,3.0
Jalandhar,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,7.0,,1.0,1.0,2.0,9.0,8.0,12.0,6.0,4.0,8.0,1.0,59.0
Jalandhar,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,2.0,,1.0,1.0,,1.0,4.0,2.0,4.0,,2.0,1.0,18.0
Jalandhar,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,9.0,,2.0,3.0,2.0,11.0,12.0,15.0,10.0,4.0,10.0,2.0,80.0
Jalandhar,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,,,,1.0,,,,,1.0
Jalandhar,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,,,,,1.0,3.0,5.0,2.0,2.0,,1.0,3.0,17.0
Jalandhar,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,,,,,,,,,,,,
Jalandhar,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,,,,,1.0,3.0,5.0,3.0,2.0,,1.0,3.0,18.0
Jalandhar,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,,,,,,,,,,
Jalandhar,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,,,,,,,,,1.0,,,1.0
Jalandhar,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,,,1.0,,,,,,,,1.0
Jalandhar,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,,,,,1.0,,,,,1.0,,,2.0
Jalandhar,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,,,,,,,,,,,
Jalandhar,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,2.0,,3.0,1.0,,2.0,8.0,5.0,5.0,5.0,4.0,2.0,37.0
Jalandhar,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,10.0,1.0,2.0,8.0,5.0,10.0,12.0,14.0,9.0,7.0,4.0,8.0,90.0
Jalandhar,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,12.0,1.0,5.0,9.0,5.0,12.0,20.0,19.0,14.0,12.0,8.0,10.0,127.0
Jalandhar,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,,,,,,,1.0,,,1.0,,2.0
Jalandhar,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,1.0,,1.0,2.0,1.0,5.0,7.0,8.0,7.0,11.0,11.0,12.0,66.0
Jalandhar,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,1.0,,,1.0,,6.0,24.0,9.0,27.0,14.0,13.0,15.0,110.0
Jalandhar,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,2.0,,1.0,3.0,1.0,11.0,31.0,18.0,34.0,25.0,25.0,27.0,178.0
Jalandhar,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,,,,,,,,,,,1.0,,1.0
Jalandhar,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,7.0,1.0,6.0,5.0,5.0,5.0,14.0,15.0,13.0,20.0,16.0,9.0,116.0
Jalandhar,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,30.0,1.0,24.0,25.0,6.0,39.0,43.0,75.0,62.0,70.0,77.0,25.0,477.0
Jalandhar,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,37.0,2.0,30.0,30.0,11.0,44.0,57.0,90.0,75.0,90.0,94.0,34.0,594.0
Kapurthala,1.1,Total number of pregnant women Registered for ANC,TOTAL,1377.0,1470.0,1108.0,1156.0,1192.0,878.0,704.0,893.0,896.0,1161.0,1210.0,1109.0,13154.0
Kapurthala,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,844.0,881.0,702.0,703.0,716.0,492.0,437.0,569.0,610.0,854.0,890.0,785.0,8483.0
Kapurthala,1.2,Number of Pregnant women registered under JSY,TOTAL,726.0,811.0,627.0,632.0,654.0,495.0,429.0,518.0,518.0,738.0,758.0,592.0,7498.0
Kapurthala,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,952.0,1081.0,1007.0,1032.0,1141.0,1048.0,932.0,1009.0,891.0,866.0,864.0,686.0,11509.0
Kapurthala,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,1223.0,1383.0,894.0,1024.0,1070.0,816.0,643.0,711.0,740.0,951.0,1037.0,865.0,11357.0
Kapurthala,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,1163.0,1276.0,1219.0,1021.0,1054.0,1067.0,766.0,680.0,708.0,782.0,883.0,834.0,11453.0
Kapurthala,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,1005.0,1039.0,1019.0,872.0,810.0,717.0,572.0,477.0,465.0,440.0,447.0,415.0,8278.0
Kapurthala,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,19.0,14.0,25.0,21.0,26.0,20.0,12.0,15.0,13.0,9.0,15.0,11.0,200.0
Kapurthala,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,0.0,0.0,0.0,6.0,3.0,2.0,0.0,0.0,0.0,0.0,1.0,1.0,13.0
Kapurthala,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,1259.0,1461.0,1093.0,1153.0,1296.0,952.0,774.0,957.0,940.0,1092.0,1117.0,978.0,13072.0
Kapurthala,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,2.0,2.0,2.0,1.0,2.0,1.0,1.0,2.0,1.0,10.0,5.0,1.0,30.0
Kapurthala,1.8,Number of pregnancy test kits used at SC level,TOTAL,448.0,538.0,436.0,475.0,496.0,368.0,335.0,409.0,388.0,484.0,502.0,480.0,5359.0
Kapurthala,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,1.0,2.0,1.0,0.0,13.0,11.0,28.0
Kapurthala,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,76.0,88.0,72.0,81.0,102.0,97.0,103.0,98.0,95.0,91.0,82.0,41.0,1026.0
Kapurthala,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,76.0,88.0,72.0,81.0,102.0,97.0,104.0,100.0,96.0,91.0,95.0,52.0,1054.0
Kapurthala,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,71.0,81.0,61.0,70.0,86.0,70.0,95.0,82.0,83.0,85.0,86.0,51.0,921.0
Kapurthala,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,0.0,4.0,8.0,13.0,17.0,10.0,5.0,2.0,8.0,7.0,1.0,0.0,75.0
Kapurthala,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,494.0,533.0,640.0,788.0,876.0,875.0,857.0,765.0,691.0,724.0,525.0,503.0,8271.0
Kapurthala,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,293.0,303.0,385.0,442.0,469.0,478.0,491.0,464.0,415.0,448.0,301.0,306.0,4795.0
Kapurthala,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,79.0,217.0,254.0,280.0,281.0,372.0,408.0,362.0,359.0,298.0,351.0,237.0,3498.0
Kapurthala,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kapurthala,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kapurthala,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,269.0,272.0,330.0,400.0,504.0,461.0,509.0,477.0,461.0,414.0,369.0,314.0,4780.0
Kapurthala,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,0.0,0.0,2.0
Kapurthala,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kapurthala,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kapurthala,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kapurthala,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,105.0,95.0,124.0,142.0,157.0,136.0,145.0,130.0,132.0,131.0,105.0,109.0,1511.0
Kapurthala,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,95.0,111.0,115.0,136.0,160.0,193.0,166.0,128.0,113.0,106.0,85.0,68.0,1476.0
Kapurthala,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Kapurthala,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,200.0,206.0,239.0,278.0,317.0,329.0,311.0,258.0,245.0,237.0,190.0,177.0,2987.0
Kapurthala,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,147.0,141.0,186.0,224.0,272.0,227.0,260.0,237.0,245.0,216.0,185.0,189.0,2529.0
Kapurthala,4.1.1.a,Number of male live births,TOTAL,342.0,389.0,446.0,523.0,620.0,607.0,620.0,562.0,524.0,485.0,437.0,357.0,5912.0
Kapurthala,4.1.1.b,Number of female live births,TOTAL,325.0,339.0,390.0,494.0,596.0,572.0,569.0,530.0,481.0,493.0,380.0,333.0,5502.0
Kapurthala,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,667.0,728.0,836.0,1017.0,1216.0,1179.0,1189.0,1092.0,1005.0,978.0,817.0,690.0,11414.0
Kapurthala,4.1.2,Number of still births,TOTAL,5.0,6.0,6.0,15.0,9.0,5.0,12.0,11.0,11.0,11.0,6.0,9.0,106.0
Kapurthala,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,77.0,75.0,82.0,80.0,57.0,54.0,76.0,68.0,72.0,71.0,64.0,63.0,839.0
Kapurthala,4.2.1,Number of Newborns weighed at birth,TOTAL,663.0,727.0,836.0,1009.0,1199.0,1171.0,1178.0,1080.0,985.0,966.0,809.0,686.0,11309.0
Kapurthala,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,43.0,25.0,38.0,35.0,31.0,19.0,20.0,44.0,16.0,15.0,22.0,21.0,329.0
Kapurthala,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,656.0,715.0,827.0,1003.0,1184.0,1050.0,1029.0,963.0,874.0,637.0,534.0,423.0,9895.0
Kapurthala,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,4.0,3.0,0.0,0.0,7.0
Kapurthala,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,1.0,1.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.0
Kapurthala,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,124.0,131.0,140.0,159.0,205.0,225.0,217.0,149.0,136.0,127.0,107.0,86.0,1806.0
Kapurthala,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Kapurthala,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,125.0,132.0,140.0,160.0,205.0,225.0,217.0,149.0,140.0,130.0,107.0,86.0,1816.0
Kapurthala,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,15.0,25.0,20.0,15.0,24.0,30.0,35.0,37.0,45.0,39.0,45.0,35.0,365.0
Kapurthala,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,120.0,156.0,151.0,155.0,208.0,239.0,236.0,179.0,177.0,152.0,149.0,119.0,2041.0
Kapurthala,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,2.0,2.0,4.0,4.0,4.0,3.0,2.0,5.0,4.0,7.0,3.0,1.0,41.0
Kapurthala,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,97.0,138.0,97.0,159.0,131.0,212.0,62.0,113.0,54.0,81.0,65.0,54.0,1263.0
Kapurthala,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,38.0,33.0,24.0,31.0,70.0,46.0,38.0,58.0,39.0,38.0,35.0,60.0,510.0
Kapurthala,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,402.0,480.0,524.0,648.0,725.0,686.0,720.0,714.0,629.0,646.0,581.0,422.0,7177.0
Kapurthala,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,240.0,248.0,308.0,363.0,459.0,476.0,448.0,418.0,440.0,390.0,342.0,302.0,4434.0
Kapurthala,6.3,PNC maternal complications attended,TOTAL,0.0,0.0,0.0,0.0,2.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0
Kapurthala,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,42.0,45.0,49.0,47.0,32.0,35.0,49.0,31.0,37.0,50.0,41.0,48.0,506.0
Kapurthala,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kapurthala,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,42.0,45.0,49.0,47.0,32.0,35.0,49.0,31.0,37.0,50.0,41.0,48.0,506.0
Kapurthala,7.2,Number of MTPs conducted at Private Facilities,TOTAL,48.0,39.0,35.0,38.0,27.0,25.0,40.0,36.0,40.0,38.0,41.0,47.0,454.0
Kapurthala,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,98.0,105.0,143.0,117.0,142.0,131.0,102.0,121.0,121.0,101.0,98.0,118.0,1397.0
Kapurthala,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,308.0,248.0,259.0,242.0,238.0,244.0,215.0,200.0,255.0,226.0,199.0,155.0,2789.0
Kapurthala,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,406.0,353.0,402.0,359.0,380.0,375.0,317.0,321.0,376.0,327.0,297.0,273.0,4186.0
Kapurthala,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0.0,0.0,0.0,0.0,6.0,9.0,4.0,8.0,0.0,0.0,16.0,0.0,43.0
Kapurthala,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kapurthala,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,0.0,1.0,0.0,0.0,2.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.0
Kapurthala,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,9.0,4.0,8.0,4.0,7.0,4.0,4.0,10.0,2.0,4.0,2.0,4.0,62.0
Kapurthala,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Kapurthala,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,9.0,5.0,8.0,4.0,9.0,4.0,4.0,10.0,2.0,4.0,2.0,4.0,65.0
Kapurthala,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,1.0
Kapurthala,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kapurthala,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,0.0,6.0,0.0,2.0,10.0,15.0,11.0,0.0,0.0,2.0,0.0,0.0,46.0
Kapurthala,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,70.0,47.0,89.0,38.0,38.0,71.0,43.0,28.0,22.0,17.0,30.0,33.0,526.0
Kapurthala,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Kapurthala,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,70.0,53.0,89.0,40.0,48.0,86.0,54.0,28.0,22.0,19.0,30.0,33.0,572.0
Kapurthala,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,2.0
Kapurthala,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,0.0,5.0,5.0,5.0,13.0,8.0,4.0,11.0,0.0,0.0,0.0,0.0,51.0
Kapurthala,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,2.0,5.0,2.0,0.0,16.0,0.0,0.0,0.0,0.0,7.0,8.0,0.0,40.0
Kapurthala,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,38.0,22.0,31.0,38.0,27.0,27.0,10.0,51.0,28.0,18.0,36.0,38.0,364.0
Kapurthala,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Kapurthala,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,40.0,32.0,38.0,43.0,56.0,35.0,14.0,62.0,28.0,25.0,44.0,38.0,455.0
Kapurthala,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,9.0,9.0,6.0,4.0,4.0,6.0,3.0,3.0,14.0,20.0,10.0,0.0,88.0
Kapurthala,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kapurthala,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kapurthala,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,4.0,12.0,23.0,10.0,9.0,15.0,10.0,30.0,16.0,4.0,12.0,2.0,147.0
Kapurthala,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Kapurthala,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,4.0,12.0,23.0,10.0,9.0,15.0,10.0,30.0,16.0,4.0,12.0,2.0,147.0
Kapurthala,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0,0.0,0.0,2.0
Kapurthala,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,347.0,312.0,304.0,325.0,358.0,336.0,344.0,326.0,324.0,323.0,327.0,283.0,3909.0
Kapurthala,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kapurthala,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kapurthala,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,136.0,133.0,131.0,152.0,166.0,197.0,172.0,142.0,126.0,148.0,138.0,118.0,1759.0
Kapurthala,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Kapurthala,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,483.0,445.0,435.0,477.0,524.0,533.0,516.0,468.0,450.0,471.0,465.0,401.0,5668.0
Kapurthala,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,13.0,0.0,7.0,16.0,41.0,101.0,60.0,0.0,25.0,36.0,20.0,21.0,340.0
Kapurthala,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kapurthala,9.06,Number of IUCD removals,TOTAL,130.0,116.0,112.0,125.0,125.0,98.0,116.0,95.0,120.0,101.0,98.0,97.0,1333.0
Kapurthala,9.07,Number of Oral Pills cycles distributed,TOTAL,3502.0,4224.0,3859.0,4322.0,4405.0,4183.0,4255.0,3980.0,3905.0,3657.0,3689.0,3376.0,47357.0
Kapurthala,9.08,Number of Condom pieces distributed,TOTAL,84957.0,98264.0,90696.0,88048.0,91510.0,86595.0,89894.0,86430.0,78992.0,75884.0,74693.0,70724.0,1016687.0
Kapurthala,9.09,Number of Centchroman (weekly) pills given,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,2.0
Kapurthala,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,0.0,0.0,2.0,11.0,10.0,4.0,7.0,2.0,8.0,5.0,0.0,0.0,49.0
Kapurthala,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kapurthala,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kapurthala,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kapurthala,9.11.2.b,Number of failures following female sterilization,TOTAL,2.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0
Kapurthala,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kapurthala,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kapurthala,9.12,Number of Institutions having NSV trained doctors,TOTAL,2.0,2.0,2.0,4.0,4.0,5.0,5.0,6.0,5.0,6.0,4.0,3.0,-1.0
Kapurthala,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,715.0,817.0,826.0,1028.0,1357.0,1286.0,1213.0,1190.0,1081.0,1052.0,920.0,755.0,12240.0
Kapurthala,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,959.0,912.0,724.0,888.0,987.0,1051.0,1106.0,1255.0,1160.0,1026.0,81.0,20.0,10169.0
Kapurthala,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,1086.0,1103.0,822.0,846.0,882.0,934.0,958.0,1163.0,1204.0,1146.0,974.0,248.0,11366.0
Kapurthala,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,1025.0,1287.0,940.0,943.0,807.0,848.0,896.0,994.0,1134.0,1190.0,1037.0,752.0,11853.0
Kapurthala,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,86.0,929.0,816.0,1831.0
Kapurthala,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,38.0,657.0,695.0
Kapurthala,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.0,153.0,156.0
Kapurthala,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,442.0,574.0,610.0,779.0,910.0,934.0,901.0,853.0,731.0,779.0,654.0,582.0,8749.0
Kapurthala,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,959.0,912.0,724.0,888.0,987.0,1051.0,1106.0,1255.0,1160.0,1057.0,1010.0,836.0,11945.0
Kapurthala,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,1086.0,1103.0,822.0,846.0,882.0,934.0,958.0,1163.0,1204.0,1146.0,1012.0,905.0,12061.0
Kapurthala,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,1025.0,1287.0,940.0,943.0,807.0,848.0,902.0,994.0,1134.0,1190.0,1040.0,905.0,12015.0
Kapurthala,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,442.0,537.0,593.0,766.0,882.0,888.0,863.0,821.0,705.0,735.0,617.0,511.0,8360.0
Kapurthala,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,959.0,912.0,724.0,888.0,987.0,1050.0,1106.0,1255.0,1160.0,1026.0,81.0,20.0,10168.0
Kapurthala,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,1086.0,1103.0,822.0,846.0,882.0,935.0,958.0,1163.0,1204.0,1146.0,974.0,248.0,11367.0
Kapurthala,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,1025.0,1287.0,940.0,943.0,807.0,848.0,896.0,994.0,1134.0,1190.0,1037.0,752.0,11853.0
Kapurthala,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,887.0,1290.0,1053.0,1272.0,1315.0,1182.0,1012.0,1108.0,832.0,831.0,806.0,699.0,12287.0
Kapurthala,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,1182.0,1284.0,1081.0,1038.0,969.0,866.0,711.0,812.0,810.0,935.0,923.0,929.0,11540.0
Kapurthala,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kapurthala,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,461.0,696.0,545.0,712.0,710.0,659.0,535.0,601.0,441.0,467.0,439.0,362.0,6628.0
Kapurthala,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,426.0,594.0,508.0,560.0,605.0,523.0,477.0,507.0,391.0,364.0,367.0,337.0,5659.0
Kapurthala,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,887.0,1290.0,1053.0,1272.0,1315.0,1182.0,1012.0,1108.0,832.0,831.0,806.0,699.0,12287.0
Kapurthala,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,1182.0,1284.0,1081.0,1038.0,969.0,866.0,712.0,812.0,810.0,935.0,979.0,929.0,11597.0
Kapurthala,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,1182.0,1284.0,1081.0,1038.0,969.0,866.0,712.0,812.0,810.0,935.0,979.0,929.0,11597.0
Kapurthala,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kapurthala,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,84.0,73.0,58.0,77.0,83.0,84.0,58.0,70.0,64.0,76.0,14.0,18.0,759.0
Kapurthala,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,77.0,82.0,44.0,66.0,76.0,71.0,65.0,51.0,68.0,70.0,14.0,9.0,693.0
Kapurthala,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,161.0,155.0,102.0,143.0,159.0,155.0,123.0,121.0,132.0,146.0,28.0,27.0,1452.0
Kapurthala,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,769.0,2060.0,689.0,1039.0,925.0,1203.0,662.0,803.0,624.0,601.0,522.0,558.0,10455.0
Kapurthala,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,548.0,2708.0,533.0,1261.0,909.0,1142.0,581.0,608.0,392.0,350.0,346.0,360.0,9738.0
Kapurthala,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,323.0,1473.0,238.0,901.0,508.0,698.0,355.0,638.0,289.0,224.0,194.0,204.0,6045.0
Kapurthala,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,1.0,2.0
Kapurthala,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kapurthala,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,65.0,53.0,1.0,12.0,1.0,0.0,0.0,0.0,10.0,0.0,11.0,20.0,173.0
Kapurthala,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,471.0,505.0,485.0,535.0,499.0,506.0,499.0,517.0,509.0,506.0,497.0,484.0,6013.0
Kapurthala,10.4.2,Number of Immunisation sessions held during the month,TOTAL,470.0,505.0,484.0,535.0,492.0,505.0,491.0,515.0,508.0,502.0,494.0,402.0,5903.0
Kapurthala,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,391.0,413.0,405.0,416.0,418.0,427.0,417.0,421.0,431.0,430.0,426.0,352.0,4947.0
Kapurthala,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,4.0,0.0,4.0
Kapurthala,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,862.0,1267.0,1053.0,1256.0,1278.0,1129.0,917.0,1029.0,775.0,442.0,515.0,574.0,11097.0
Kapurthala,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,643.0,829.0,697.0,754.0,701.0,641.0,564.0,601.0,669.0,329.0,310.0,407.0,7145.0
Kapurthala,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,729.0,997.0,706.0,754.0,860.0,1033.0,574.0,667.0,670.0,332.0,316.0,510.0,8148.0
Kapurthala,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kapurthala,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kapurthala,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kapurthala,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kapurthala,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kapurthala,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kapurthala,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,0.0,8.0,0.0,6.0,0.0,9.0,12.0,0.0,0.0,0.0,11.0,0.0,46.0
Kapurthala,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kapurthala,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,29.0,0.0,12.0,0.0,0.0,13.0,15.0,10.0,0.0,0.0,3.0,0.0,82.0
Kapurthala,13.1,Number of Patients operated for cataract,TOTAL,269.0,217.0,128.0,126.0,170.0,163.0,332.0,259.0,258.0,113.0,134.0,154.0,2323.0
Kapurthala,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,269.0,213.0,124.0,126.0,170.0,163.0,332.0,259.0,258.0,113.0,134.0,154.0,2315.0
Kapurthala,13.3,Number of School children detected with Refractive errors,TOTAL,137.0,113.0,18.0,139.0,214.0,172.0,245.0,295.0,123.0,65.0,85.0,97.0,1703.0
Kapurthala,13.4,Number of children provided free glasses,TOTAL,77.0,89.0,9.0,130.0,171.0,116.0,164.0,283.0,74.0,67.0,84.0,82.0,1346.0
Kapurthala,13.5,Number of eyes collected through eye donation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kapurthala,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Kapurthala,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,2.0,2.0,2.0,7.0,6.0,6.0,6.0,6.0,6.0,7.0,7.0,7.0,-1.0
Kapurthala,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,,,,2.0,1.0,4.0,1.0,3.0,2.0,3.0,1.0,3.0,-1.0
Kapurthala,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,367.0,395.0,371.0,362.0,375.0,389.0,405.0,408.0,399.0,413.0,427.0,329.0,-1.0
Kapurthala,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,4.0,7.0,3.0,8.0,7.0,7.0,7.0,7.0,7.0,7.0,8.0,7.0,-1.0
Kapurthala,14.05,Number of RKS meetings held during the month,TOTAL,2.0,6.0,7.0,2.0,1.0,4.0,4.0,6.0,8.0,9.0,9.0,9.0,67.0
Kapurthala,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,2.0,3.0,2.0,7.0,7.0,8.0,8.0,8.0,8.0,10.0,9.0,8.0,-1.0
Kapurthala,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,50.0,58.0,24.0,75.0,59.0,77.0,132.0,150.0,149.0,252.0,137.0,109.0,1272.0
Kapurthala,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,2.0,2.0,2.0,3.0,2.0,4.0,3.0,3.0,3.0,3.0,3.0,3.0,-1.0
Kapurthala,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,4.0,4.0,2.0,0.0,1.0,0.0,24.0,1.0,0.0,0.0,0.0,0.0,-1.0
Kapurthala,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,524.0,416.0,522.0,378.0,263.0,418.0,424.0,588.0,346.0,332.0,276.0,300.0,4787.0
Kapurthala,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,834.0,1143.0,928.0,1035.0,1166.0,921.0,888.0,1324.0,693.0,746.0,712.0,699.0,11089.0
Kapurthala,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,496.0,313.0,654.0,401.0,296.0,349.0,426.0,598.0,338.0,316.0,243.0,246.0,4676.0
Kapurthala,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,1241.0,1545.0,1357.0,1636.0,1613.0,1450.0,937.0,2381.0,1002.0,950.0,1022.0,1094.0,16228.0
Kapurthala,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,1020.0,729.0,1176.0,779.0,559.0,767.0,850.0,1186.0,684.0,648.0,519.0,546.0,9463.0
Kapurthala,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,2075.0,2688.0,2285.0,2671.0,2779.0,2371.0,1825.0,3705.0,1695.0,1696.0,1734.0,1793.0,27317.0
Kapurthala,14.10.2.a,Number of death cases of Inpatient males,TOTAL,12.0,23.0,15.0,22.0,22.0,14.0,14.0,16.0,14.0,21.0,18.0,18.0,209.0
Kapurthala,14.10.2.b,Number of death cases of Inpatient females,TOTAL,6.0,18.0,13.0,13.0,25.0,3.0,10.0,8.0,10.0,11.0,7.0,9.0,133.0
Kapurthala,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,18.0,41.0,28.0,35.0,47.0,17.0,24.0,24.0,24.0,32.0,25.0,27.0,342.0
Kapurthala,14.11,In-Patient Head Count at midnight,TOTAL,570.0,488.0,860.0,418.0,579.0,283.0,534.0,554.0,1748.0,515.0,1450.0,1258.0,9257.0
Kapurthala,14.12.1,OPD attendance (All),TOTAL,67642.0,72767.0,68094.0,71049.0,73473.0,69999.0,57358.0,66817.0,56977.0,54965.0,60393.0,64533.0,784067.0
Kapurthala,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,555.0,499.0,531.0,446.0,515.0,591.0,448.0,449.0,370.0,303.0,352.0,373.0,5432.0
Kapurthala,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,1.0,2.0,8.0,10.0,2.0,2.0,2.0,0.0,11.0,10.0,1.0,88.0,137.0
Kapurthala,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,1455.0,1484.0,1629.0,1581.0,1630.0,1648.0,1430.0,1530.0,1290.0,1276.0,1187.0,1357.0,17497.0
Kapurthala,14.14.a,Number of patients given AYUSH treatment,TOTAL,3297.0,3577.0,4904.0,6234.0,7541.0,6787.0,6232.0,8169.0,6446.0,6721.0,6210.0,5553.0,71671.0
Kapurthala,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,771.0,1328.0,930.0,1366.0,1691.0,1590.0,1351.0,1990.0,1374.0,1278.0,1280.0,1195.0,16144.0
Kapurthala,14.14.c,Number of Adolescents counselled,TOTAL,0.0,38.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,38.0
Kapurthala,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,5175.0,5592.0,5987.0,5483.0,5851.0,4962.0,4405.0,4744.0,4574.0,5154.0,5819.0,5004.0,62750.0
Kapurthala,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,109.0,119.0,111.0,108.0,150.0,139.0,82.0,152.0,145.0,135.0,177.0,186.0,1613.0
Kapurthala,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,465.0,476.0,496.0,549.0,533.0,469.0,325.0,610.0,265.0,288.0,260.0,424.0,5160.0
Kapurthala,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,13.0,14.0,17.0,13.0,17.0,15.0,6.0,2.0,10.0,2.0,5.0,10.0,124.0
Kapurthala,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,406.0,361.0,414.0,466.0,398.0,545.0,317.0,227.0,288.0,593.0,454.0,272.0,4741.0
Kapurthala,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,2.0,2.0,1.0,3.0,4.0,1.0,0.0,2.0,1.0,2.0,1.0,1.0,20.0
Kapurthala,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,1006.0,990.0,689.0,796.0,653.0,714.0,536.0,471.0,665.0,582.0,610.0,410.0,8122.0
Kapurthala,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,2.0,0.0,1.0,0.0,1.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,5.0
Kapurthala,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,1877.0,1827.0,1599.0,1811.0,1584.0,1728.0,1178.0,1308.0,1218.0,1463.0,1324.0,1106.0,18023.0
Kapurthala,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,17.0,16.0,19.0,16.0,22.0,16.0,7.0,4.0,11.0,4.0,6.0,11.0,149.0
Kapurthala,15.2,Number of Widal tests conducted,Number tested,1074.0,977.0,1175.0,838.0,1100.0,983.0,625.0,522.0,371.0,320.0,773.0,803.0,9561.0
Kapurthala,15.3.a,Number of VDRL tests conducted on males,Number tested,49.0,58.0,42.0,99.0,36.0,28.0,61.0,39.0,83.0,66.0,76.0,107.0,744.0
Kapurthala,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,70.0,86.0,89.0,47.0,32.0,69.0,23.0,64.0,138.0,134.0,441.0,65.0,1258.0
Kapurthala,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,617.0,684.0,561.0,712.0,552.0,524.0,410.0,526.0,846.0,793.0,467.0,631.0,7323.0
Kapurthala,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,736.0,828.0,692.0,858.0,620.0,621.0,494.0,629.0,1067.0,993.0,984.0,803.0,9325.0
Kapurthala,15.4.1,Number of blood smears examined for Malaria,TOTAL,3863.0,3661.0,3476.0,4083.0,3651.0,3402.0,2324.0,3264.0,3018.0,2479.0,2993.0,2741.0,38955.0
Kapurthala,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Kapurthala,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kapurthala,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,10670.0,3970.0,7870.0,11920.0,5110.0,6710.0,6460.0,10610.0,6100.0,9450.0,2530.0,9030.0,90430.0
Kapurthala,16.1.1,Stock position of DPT vaccines,2. Stocks Received,0.0,12000.0,8000.0,0.0,5000.0,5000.0,8000.0,0.0,8000.0,0.0,8000.0,0.0,54000.0
Kapurthala,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kapurthala,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,6700.0,8100.0,3950.0,7060.0,3400.0,5250.0,3850.0,4510.0,4650.0,6920.0,1500.0,3950.0,59840.0
Kapurthala,16.1.1,Stock position of DPT vaccines,5. Total Stock,3970.0,7870.0,11920.0,4860.0,6710.0,6460.0,10610.0,6100.0,9450.0,2530.0,9030.0,5080.0,84590.0
Kapurthala,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,,,,0.0,0.0,0.0,0.0,0.0,0.0,14000.0,11120.0,14320.0,39440.0
Kapurthala,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,5000.0,0.0,5000.0
Kapurthala,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kapurthala,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,,,,0.0,0.0,0.0,0.0,0.0,0.0,2880.0,1800.0,2010.0,6690.0
Kapurthala,16.1.1A,Stock Position of Pentavalent,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,11120.0,14320.0,12310.0,37750.0
Kapurthala,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,14960.0,7860.0,19560.0,11860.0,2060.0,11740.0,7640.0,12140.0,7960.0,11440.0,1100.0,11300.0,119620.0
Kapurthala,16.1.2,Stock position of OPV vaccines,2. Stocks Received,0.0,20000.0,0.0,0.0,15000.0,5000.0,10000.0,2000.0,12000.0,4000.0,20000.0,0.0,88000.0
Kapurthala,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Kapurthala,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,7100.0,6300.0,7700.0,9800.0,5320.0,9100.0,5500.0,6180.0,8520.0,14340.0,9800.0,7200.0,96860.0
Kapurthala,16.1.2,Stock position of OPV vaccines,5. Total Stock,7860.0,21560.0,11860.0,2060.0,11740.0,7640.0,12140.0,7960.0,11440.0,1100.0,11300.0,4100.0,110760.0
Kapurthala,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,11500.0,5500.0,10150.0,12300.0,6300.0,8150.0,8450.0,10850.0,7700.0,12700.0,7900.0,11500.0,113000.0
Kapurthala,16.1.3,Stock position of TT vaccines,2. Stocks Received,0.0,12000.0,5000.0,0.0,5000.0,5000.0,6000.0,0.0,8000.0,0.0,5000.0,0.0,46000.0
Kapurthala,16.1.3,Stock position of TT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kapurthala,16.1.3,Stock position of TT vaccines,4. Stock Distributed,6000.0,7350.0,2850.0,6000.0,3850.0,4700.0,3600.0,3150.0,3000.0,4800.0,1400.0,2650.0,49350.0
Kapurthala,16.1.3,Stock position of TT vaccines,5. Total Stock,5500.0,10150.0,12300.0,6300.0,7450.0,8450.0,10850.0,7700.0,12700.0,7900.0,11500.0,8850.0,109650.0
Kapurthala,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kapurthala,16.1.4,Stock position of DT vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kapurthala,16.1.4,Stock position of DT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kapurthala,16.1.4,Stock position of DT vaccines,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kapurthala,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kapurthala,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,3170.0,750.0,6650.0,4900.0,2250.0,5950.0,7735.0,7635.0,6350.0,7790.0,5040.0,7090.0,65310.0
Kapurthala,16.1.5,Stock position of BCG vaccines,2. Stocks Received,0.0,8000.0,0.0,0.0,5000.0,5000.0,2000.0,0.0,5000.0,0.0,4000.0,0.0,29000.0
Kapurthala,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kapurthala,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,2420.0,2100.0,2950.0,2650.0,1300.0,3215.0,2100.0,1280.0,3560.0,2750.0,1950.0,1650.0,27925.0
Kapurthala,16.1.5,Stock position of BCG vaccines,5. Total Stock,750.0,6650.0,3700.0,2250.0,5950.0,7735.0,7635.0,6355.0,7790.0,5040.0,7090.0,5440.0,66385.0
Kapurthala,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,2980.0,780.0,5780.0,8430.0,3880.0,4675.0,5125.0,7125.0,5175.0,6375.0,2275.0,3925.0,56525.0
Kapurthala,16.1.6,Stock position of Measles vaccines,2. Stocks Received,0.0,8000.0,5000.0,0.0,2500.0,5000.0,5000.0,0.0,5000.0,0.0,3000.0,0.0,33500.0
Kapurthala,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kapurthala,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,2200.0,3000.0,2350.0,3950.0,1705.0,4550.0,3000.0,1950.0,3800.0,4100.0,1350.0,1900.0,33855.0
Kapurthala,16.1.6,Stock position of Measles vaccines,5. Total Stock,780.0,5780.0,8430.0,4480.0,4675.0,5125.0,7125.0,5175.0,6375.0,2275.0,3925.0,2025.0,56170.0
Kapurthala,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kapurthala,16.1.7,Stock position of JE vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kapurthala,16.1.7,Stock position of JE vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kapurthala,16.1.7,Stock position of JE vaccines,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kapurthala,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kapurthala,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,9340.0,3890.0,9740.0,11190.0,6330.0,8930.0,8530.0,10630.0,7630.0,11130.0,4410.0,8310.0,100060.0
Kapurthala,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,0.0,12000.0,5000.0,0.0,5000.0,5000.0,5000.0,0.0,8000.0,0.0,5000.0,0.0,45000.0
Kapurthala,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kapurthala,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,6150.0,5450.0,3550.0,5110.0,2400.0,5400.0,2900.0,3000.0,4500.0,6720.0,1100.0,2900.0,49180.0
Kapurthala,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,3190.0,10440.0,11190.0,6080.0,8930.0,8530.0,10630.0,7630.0,11130.0,4410.0,8310.0,5410.0,95880.0
Kapurthala,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,0.0,4102.0,4102.0,4102.0,4102.0,4102.0,4102.0,4102.0,4102.0,4102.0,3502.0,3502.0,43922.0
Kapurthala,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kapurthala,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kapurthala,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,600.0,0.0,500.0,1100.0
Kapurthala,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,0.0,4102.0,4102.0,4102.0,4102.0,4102.0,4102.0,4102.0,4102.0,3502.0,3502.0,3002.0,42822.0
Kapurthala,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,0.0,64200.0,64200.0,28200.0,28200.0,24000.0,24000.0,138000.0,84000.0,78000.0,60000.0,40000.0,632800.0
Kapurthala,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,150000.0,0.0,0.0,0.0,0.0,0.0,150000.0
Kapurthala,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kapurthala,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,0.0,0.0,36000.0,0.0,24000.0,0.0,36000.0,54000.0,6000.0,18000.0,20000.0,30000.0,224000.0
Kapurthala,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,0.0,64200.0,28200.0,28200.0,4200.0,24000.0,138000.0,84000.0,78000.0,60000.0,40000.0,10000.0,558800.0
Kapurthala,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,0.0,800.0,800.0,0.0,0.0,9400.0,9400.0,9400.0,5400.0,5000.0,4500.0,4500.0,49200.0
Kapurthala,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,9400.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,9400.0
Kapurthala,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kapurthala,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,0.0,0.0,800.0,0.0,0.0,0.0,0.0,4000.0,400.0,500.0,0.0,300.0,6000.0
Kapurthala,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0.0,800.0,0.0,0.0,9400.0,9400.0,9400.0,5400.0,5000.0,4500.0,4500.0,4200.0,52600.0
Kapurthala,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,,,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Kapurthala,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,,0.0,,,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Kapurthala,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,0.0,0.0,,,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Kapurthala,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,0.0,0.0,,,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Kapurthala,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kapurthala,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,,,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Kapurthala,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,0.0,0.0,,,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Kapurthala,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,0.0,0.0,,,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Kapurthala,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,0.0,0.0,,,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Kapurthala,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kapurthala,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,,0.0,,,,0.0,,0.0,0.0,0.0,0.0,,0.0
Kapurthala,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,,0.0,,,,,,0.0,0.0,0.0,0.0,,0.0
Kapurthala,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,,0.0,,,,,,0.0,0.0,0.0,0.0,,0.0
Kapurthala,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,,0.0,,,,,,0.0,0.0,0.0,0.0,,0.0
Kapurthala,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kapurthala,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,,0.0,,,,,,0.0,0.0,0.0,0.0,,0.0
Kapurthala,16.3.02,Stock Position of Gloves,2. Stocks Received,,0.0,,,,,,0.0,0.0,0.0,0.0,,0.0
Kapurthala,16.3.02,Stock Position of Gloves,3. Unusable Stock,,0.0,,,,,,0.0,0.0,0.0,0.0,,0.0
Kapurthala,16.3.02,Stock Position of Gloves,4. Stock Distributed,,0.0,,,,,,0.0,0.0,0.0,0.0,,0.0
Kapurthala,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kapurthala,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,,0.0,,,,,,0.0,0.0,0.0,0.0,,0.0
Kapurthala,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,,0.0,,,,,,0.0,0.0,0.0,0.0,,0.0
Kapurthala,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,,0.0,,,,,,0.0,0.0,0.0,0.0,,0.0
Kapurthala,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,,0.0,,,,,,0.0,0.0,0.0,0.0,,0.0
Kapurthala,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kapurthala,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,,0.0,,,,,,0.0,0.0,0.0,0.0,,0.0
Kapurthala,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,,0.0,,,,,,0.0,0.0,0.0,0.0,,0.0
Kapurthala,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,,0.0,,,,,,0.0,0.0,0.0,0.0,,0.0
Kapurthala,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,,0.0,,,,,,0.0,0.0,0.0,0.0,,0.0
Kapurthala,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kapurthala,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,,0.0,,,,,,0.0,0.0,0.0,0.0,,0.0
Kapurthala,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,,0.0,,,,,,0.0,0.0,0.0,0.0,,0.0
Kapurthala,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,,0.0,,,,,,0.0,0.0,0.0,0.0,,0.0
Kapurthala,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,,0.0,,,,,,0.0,0.0,0.0,0.0,,0.0
Kapurthala,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kapurthala,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,,0.0,,,,,,0.0,0.0,0.0,0.0,,0.0
Kapurthala,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,,0.0,,,,,,0.0,0.0,0.0,0.0,,0.0
Kapurthala,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,,0.0,,,,,,0.0,0.0,0.0,0.0,,0.0
Kapurthala,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,,0.0,,,,,,0.0,0.0,0.0,0.0,,0.0
Kapurthala,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kapurthala,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,,0.0,,,,,,0.0,0.0,0.0,0.0,,0.0
Kapurthala,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,,0.0,,,,,,0.0,0.0,0.0,0.0,,0.0
Kapurthala,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,,0.0,,,,,,0.0,0.0,0.0,0.0,,0.0
Kapurthala,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,,0.0,,,,,,0.0,0.0,0.0,0.0,,0.0
Kapurthala,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kapurthala,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,,0.0,,,,,,0.0,0.0,0.0,0.0,,0.0
Kapurthala,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,,0.0,,,,,,0.0,,0.0,0.0,,0.0
Kapurthala,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,,0.0,,,,,,0.0,0.0,0.0,0.0,,0.0
Kapurthala,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,,0.0,,,,,,0.0,0.0,0.0,0.0,,0.0
Kapurthala,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kapurthala,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,,0.0,,,,,,0.0,0.0,0.0,0.0,,0.0
Kapurthala,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,,0.0,,,,,,0.0,0.0,0.0,0.0,,0.0
Kapurthala,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,,0.0,,,,,,0.0,0.0,0.0,0.0,,0.0
Kapurthala,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,,0.0,,,,,,0.0,0.0,0.0,0.0,,0.0
Kapurthala,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kapurthala,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,,0.0,,,,,,0.0,0.0,0.0,0.0,,0.0
Kapurthala,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,,0.0,,,,,,0.0,0.0,0.0,0.0,,0.0
Kapurthala,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,,0.0,,,,,,0.0,0.0,0.0,0.0,,0.0
Kapurthala,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,,0.0,,,,,,0.0,0.0,,0.0,,0.0
Kapurthala,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kapurthala,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,,0.0,,,,,,0.0,0.0,0.0,0.0,,0.0
Kapurthala,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,,0.0,,,,,,0.0,0.0,0.0,0.0,,0.0
Kapurthala,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,,0.0,,,,,,0.0,0.0,0.0,0.0,,0.0
Kapurthala,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,,0.0,,,,,,0.0,0.0,0.0,0.0,,0.0
Kapurthala,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kapurthala,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,5700.0,4900.0,2100.0,3350.0,2450.0,2050.0,2050.0,3050.0,3050.0,1450.0,1250.0,850.0,32250.0
Kapurthala,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,0.0,0.0,2000.0,0.0,0.0,2000.0,2000.0,0.0,0.0,0.0,0.0,0.0,6000.0
Kapurthala,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kapurthala,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,1400.0,2800.0,750.0,900.0,400.0,2000.0,1000.0,0.0,1600.0,200.0,400.0,0.0,11450.0
Kapurthala,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,4300.0,2100.0,3350.0,2450.0,2050.0,2050.0,3050.0,3050.0,1450.0,1250.0,850.0,850.0,26800.0
Kapurthala,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,22000.0,20000.0,88000.0,72000.0,62000.0,50000.0,30000.0,30000.0,30000.0,18000.0,18000.0,12000.0,452000.0
Kapurthala,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,0.0,100000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,100000.0
Kapurthala,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kapurthala,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,2000.0,32000.0,16000.0,10000.0,12000.0,20000.0,0.0,0.0,12000.0,0.0,6000.0,0.0,110000.0
Kapurthala,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,20000.0,88000.0,72000.0,62000.0,50000.0,30000.0,30000.0,30000.0,18000.0,18000.0,12000.0,12000.0,442000.0
Kapurthala,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,5150.0,4850.0,2550.0,1850.0,1150.0,750.0,250.0,2650.0,2650.0,1850.0,1850.0,1850.0,27400.0
Kapurthala,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,2400.0,0.0,0.0,0.0,0.0,0.0,2400.0
Kapurthala,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kapurthala,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,300.0,2300.0,700.0,700.0,400.0,500.0,0.0,0.0,800.0,0.0,0.0,0.0,5700.0
Kapurthala,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,4850.0,2550.0,1850.0,1150.0,750.0,250.0,2650.0,2650.0,1850.0,1850.0,1850.0,1850.0,24100.0
Kapurthala,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,,,,,1.0,1.0,1.0,1.0,1.0,,,,5.0
Kapurthala,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Kapurthala,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Kapurthala,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,,,,,,,,,,,,
Kapurthala,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Kapurthala,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Kapurthala,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,,,,,,,,,,,,,
Kapurthala,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,,1.0,,,2.0,,,,,,,,3.0
Kapurthala,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,1.0,,,,,,,,,,,1.0
Kapurthala,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,,2.0,,,2.0,,,,,,,,4.0
Kapurthala,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,4.0,,2.0,6.0,4.0,5.0,7.0,1.0,1.0,10.0,2.0,,42.0
Kapurthala,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,,4.0,1.0,,,1.0,1.0,1.0,,,,8.0
Kapurthala,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,4.0,,6.0,7.0,4.0,5.0,8.0,2.0,2.0,10.0,2.0,,50.0
Kapurthala,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,,1.0,,,,1.0,,,,,,2.0
Kapurthala,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,,,,,,,,,,
Kapurthala,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,,,1.0,,,,1.0,,,,,,2.0
Kapurthala,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,,,,,,
Kapurthala,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,1.0,,,,,,,1.0
Kapurthala,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,,1.0,,,,,,,1.0
Kapurthala,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,,,1.0,,,,,,,,1.0
Kapurthala,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,1.0,,,,,,,,,1.0
Kapurthala,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,,,1.0,1.0,,,,,,,,2.0
Kapurthala,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Kapurthala,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Kapurthala,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Kapurthala,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,2.0,3.0,4.0,1.0,5.0,6.0,6.0,5.0,,5.0,1.0,4.0,42.0
Kapurthala,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,,1.0,,2.0,2.0,,4.0,,3.0,,,,12.0
Kapurthala,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,2.0,4.0,4.0,3.0,7.0,6.0,10.0,5.0,3.0,5.0,1.0,4.0,54.0
Kapurthala,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
Kapurthala,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,1.0,,,,1.0,,,,,,2.0
Kapurthala,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,2.0,,,,,,,,2.0
Kapurthala,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,1.0,,2.0,,1.0,,,,,,4.0
Kapurthala,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
Kapurthala,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,,,1.0,1.0,4.0,1.0,2.0,,1.0,2.0,2.0,,14.0
Kapurthala,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,,,,1.0,,2.0,,,1.0,1.0,,1.0,6.0
Kapurthala,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,,,1.0,2.0,4.0,3.0,2.0,,2.0,3.0,2.0,1.0,20.0
Kapurthala,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,,,,,,
Kapurthala,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,,,1.0,2.0,,1.0,,,,1.0,,,5.0
Kapurthala,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,,,,1.0,4.0,2.0,2.0,,2.0,2.0,3.0,,16.0
Kapurthala,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,,,1.0,3.0,4.0,3.0,2.0,,2.0,3.0,3.0,,21.0
Kapurthala,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
Kapurthala,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,,,,,,,,
Kapurthala,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
Kapurthala,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,,,,,,,,,,
Kapurthala,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,,,,,,,,,,
Kapurthala,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,,,,,,,1.0,,,,,,1.0
Kapurthala,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,,,,,,2.0,4.0,,,,,,6.0
Kapurthala,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,,,,,,2.0,5.0,,,,,,7.0
Kapurthala,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
Kapurthala,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,1.0,,,1.0,,,,2.0,,,4.0
Kapurthala,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,1.0,,,,,,,,,,,1.0
Kapurthala,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,1.0,1.0,,,1.0,,,,2.0,,,5.0
Kapurthala,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,,,,,2.0,,,,2.0
Kapurthala,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,,,,1.0,12.0,13.0,13.0,30.0,23.0,32.0,22.0,17.0,163.0
Kapurthala,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,1.0,,,3.0,31.0,27.0,48.0,70.0,46.0,76.0,56.0,46.0,404.0
Kapurthala,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,1.0,,,4.0,43.0,40.0,61.0,100.0,71.0,108.0,78.0,63.0,569.0
Kapurthala,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,,,,,,,
Kapurthala,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,,,,,,,,1.0,,,,,1.0
Kapurthala,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,,,,,,,,1.0,2.0,3.0,1.0,3.0,10.0
Kapurthala,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,,,,,,,,2.0,2.0,3.0,1.0,3.0,11.0
Kapurthala,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Kapurthala,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
Kapurthala,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Kapurthala,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
Kapurthala,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Kapurthala,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,,,,,,,,
Kapurthala,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Kapurthala,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,,,,,,,,
Kapurthala,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Kapurthala,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,,,,,,,,,,
Kapurthala,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Kapurthala,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,,,,,,,,,,,
Kapurthala,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Kapurthala,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,1.0,,,,,1.0,,,,,2.0
Kapurthala,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Kapurthala,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,1.0,,,,,1.0,,,,,2.0
Kapurthala,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Kapurthala,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,,,,,,,
Kapurthala,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Kapurthala,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,,,,,,,
Kapurthala,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Kapurthala,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,,,,1.0,,1.0,2.0,,,,,,4.0
Kapurthala,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Kapurthala,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,,,,1.0,,1.0,2.0,,,,,,4.0
Kapurthala,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,1.0,,1.0,,,1.0,,1.0,1.0,1.0,,,6.0
Kapurthala,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,3.0,2.0,1.0,3.0,13.0,8.0,8.0,15.0,8.0,5.0,9.0,6.0,81.0
Kapurthala,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,,,,2.0,1.0,4.0,3.0,8.0,1.0,3.0,1.0,3.0,26.0
Kapurthala,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,4.0,2.0,2.0,5.0,14.0,13.0,11.0,24.0,10.0,9.0,10.0,9.0,113.0
Kapurthala,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,,,,,,,,,
Kapurthala,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,,,2.0,,1.0,,1.0,2.0,2.0,1.0,1.0,2.0,12.0
Kapurthala,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,,,,,,,1.0,,1.0,,,2.0
Kapurthala,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,,,2.0,,1.0,,1.0,3.0,2.0,2.0,1.0,2.0,14.0
Kapurthala,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,,,,,1.0,,,,,1.0
Kapurthala,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,,,,1.0,,,,,,,,1.0
Kapurthala,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,,,,,,,,,,,
Kapurthala,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,,,,,1.0,,,1.0,,,,,2.0
Kapurthala,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,,,,,1.0,,,,,,1.0
Kapurthala,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,10.0,9.0,8.0,6.0,10.0,12.0,12.0,23.0,9.0,14.0,13.0,11.0,137.0
Kapurthala,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,16.0,32.0,28.0,32.0,32.0,38.0,22.0,41.0,34.0,36.0,38.0,32.0,381.0
Kapurthala,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,26.0,41.0,36.0,38.0,42.0,50.0,35.0,64.0,43.0,50.0,51.0,43.0,519.0
Kapurthala,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,,,,,,,,,1.0,,,1.0
Kapurthala,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,1.0,2.0,1.0,1.0,7.0,1.0,9.0,16.0,7.0,2.0,4.0,2.0,53.0
Kapurthala,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,4.0,3.0,1.0,4.0,9.0,2.0,5.0,18.0,15.0,8.0,7.0,9.0,85.0
Kapurthala,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,5.0,5.0,2.0,5.0,16.0,3.0,14.0,34.0,22.0,11.0,11.0,11.0,139.0
Kapurthala,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,,,,,,,,1.0,1.0,,1.0,,3.0
Kapurthala,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,,1.0,1.0,,3.0,2.0,2.0,5.0,7.0,5.0,7.0,7.0,40.0
Kapurthala,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,,1.0,,,,10.0,21.0,21.0,19.0,20.0,11.0,8.0,111.0
Kapurthala,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,,2.0,1.0,,3.0,12.0,23.0,27.0,27.0,25.0,19.0,15.0,154.0
Ludhiana,1.1,Total number of pregnant women Registered for ANC,TOTAL,5283.0,5441.0,5000.0,5111.0,5129.0,4676.0,4645.0,4670.0,4752.0,5105.0,5321.0,4830.0,59963.0
Ludhiana,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,4412.0,4201.0,4037.0,3945.0,3984.0,3579.0,3742.0,3709.0,3834.0,4211.0,4366.0,3842.0,47862.0
Ludhiana,1.2,Number of Pregnant women registered under JSY,TOTAL,2371.0,2499.0,2390.0,2294.0,2234.0,2143.0,1950.0,2000.0,2175.0,2536.0,2581.0,2182.0,27355.0
Ludhiana,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,4679.0,4767.0,4674.0,4690.0,4719.0,4622.0,4630.0,4566.0,4586.0,4658.0,4575.0,4128.0,55294.0
Ludhiana,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,5044.0,5185.0,4716.0,4909.0,4870.0,4460.0,4498.0,4440.0,4542.0,4826.0,5102.0,4633.0,57225.0
Ludhiana,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,4940.0,5197.0,4968.0,4868.0,4865.0,4609.0,4493.0,4341.0,4525.0,4444.0,4709.0,4580.0,56539.0
Ludhiana,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,4759.0,5032.0,4842.0,4685.0,4659.0,4553.0,4580.0,4501.0,4313.0,4764.0,4643.0,4323.0,55654.0
Ludhiana,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,88.0,81.0,73.0,85.0,73.0,64.0,75.0,49.0,58.0,73.0,78.0,64.0,861.0
Ludhiana,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,0.0,2.0,0.0,1.0,0.0,0.0,1.0,0.0,1.0,0.0,0.0,0.0,5.0
Ludhiana,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,2654.0,2606.0,2493.0,2643.0,2513.0,2522.0,2297.0,2315.0,2369.0,2870.0,2890.0,2576.0,30748.0
Ludhiana,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,6.0,4.0,8.0,2.0,13.0,3.0,7.0,7.0,8.0,9.0,8.0,8.0,83.0
Ludhiana,1.8,Number of pregnancy test kits used at SC level,TOTAL,1717.0,1493.0,1411.0,1553.0,1483.0,1592.0,1508.0,1560.0,1507.0,1529.0,1454.0,1466.0,18273.0
Ludhiana,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,72.0,71.0,103.0,331.0,456.0,424.0,459.0,512.0,531.0,490.0,550.0,463.0,4462.0
Ludhiana,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,506.0,548.0,501.0,259.0,179.0,236.0,193.0,191.0,151.0,167.0,170.0,141.0,3242.0
Ludhiana,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,578.0,619.0,604.0,590.0,635.0,660.0,652.0,703.0,682.0,657.0,720.0,604.0,7704.0
Ludhiana,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,434.0,541.0,555.0,257.0,292.0,206.0,313.0,318.0,293.0,540.0,493.0,383.0,4625.0
Ludhiana,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,214.0,278.0,218.0,212.0,234.0,267.0,259.0,254.0,234.0,351.0,234.0,154.0,2909.0
Ludhiana,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,1173.0,1389.0,1410.0,1827.0,2068.0,2057.0,1977.0,1724.0,1663.0,1692.0,1403.0,1185.0,19568.0
Ludhiana,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,783.0,1072.0,1021.0,1362.0,1631.0,1534.0,500.0,253.0,210.0,208.0,113.0,66.0,8753.0
Ludhiana,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,934.0,977.0,937.0,1167.0,1353.0,1307.0,1215.0,1222.0,1103.0,1393.0,1152.0,692.0,13452.0
Ludhiana,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ludhiana,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ludhiana,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,1586.0,1815.0,1768.0,1823.0,2434.0,2102.0,2245.0,2156.0,2151.0,2113.0,1907.0,1775.0,23875.0
Ludhiana,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ludhiana,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ludhiana,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ludhiana,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ludhiana,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,52.0,69.0,76.0,77.0,64.0,71.0,74.0,79.0,65.0,68.0,50.0,42.0,787.0
Ludhiana,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,212.0,230.0,231.0,314.0,347.0,371.0,351.0,312.0,327.0,360.0,326.0,282.0,3663.0
Ludhiana,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Ludhiana,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,264.0,299.0,307.0,391.0,411.0,442.0,425.0,391.0,392.0,428.0,376.0,324.0,4450.0
Ludhiana,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,621.0,736.0,684.0,767.0,978.0,845.0,910.0,881.0,825.0,879.0,730.0,504.0,9360.0
Ludhiana,4.1.1.a,Number of male live births,TOTAL,1741.0,1923.0,1885.0,2256.0,2656.0,2567.0,2552.0,2299.0,2405.0,2313.0,2112.0,1781.0,26490.0
Ludhiana,4.1.1.b,Number of female live births,TOTAL,1525.0,1796.0,1782.0,1937.0,2433.0,2301.0,2271.0,2238.0,2074.0,2102.0,1872.0,1730.0,24061.0
Ludhiana,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,3266.0,3719.0,3667.0,4193.0,5089.0,4868.0,4823.0,4537.0,4479.0,4415.0,3984.0,3511.0,50551.0
Ludhiana,4.1.2,Number of still births,TOTAL,50.0,54.0,51.0,55.0,63.0,60.0,63.0,54.0,40.0,60.0,56.0,47.0,653.0
Ludhiana,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,68.0,86.0,89.0,90.0,86.0,76.0,76.0,86.0,83.0,130.0,142.0,77.0,1089.0
Ludhiana,4.2.1,Number of Newborns weighed at birth,TOTAL,3264.0,3706.0,3609.0,4111.0,4997.0,4800.0,4754.0,4502.0,4447.0,4393.0,3968.0,3474.0,50025.0
Ludhiana,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,117.0,269.0,151.0,429.0,331.0,316.0,298.0,316.0,269.0,323.0,287.0,268.0,3374.0
Ludhiana,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,3227.0,3659.0,3624.0,3999.0,4965.0,4677.0,4749.0,3927.0,3834.0,3699.0,3310.0,3096.0,46766.0
Ludhiana,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,5.0,3.0,0.0,0.0,0.0,0.0,1.0,4.0,1.0,14.0,0.0,0.0,28.0
Ludhiana,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,0.0,0.0,0.0,0.0,7.0,0.0,43.0,26.0,69.0,59.0,69.0,41.0,314.0
Ludhiana,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,24.0,44.0,65.0,11.0,210.0,3.0,58.0,37.0,99.0,258.0,187.0,127.0,1123.0
Ludhiana,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Ludhiana,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,29.0,47.0,65.0,11.0,217.0,3.0,102.0,67.0,169.0,331.0,256.0,168.0,1465.0
Ludhiana,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,31.0,2.0,41.0,24.0,21.0,,119.0
Ludhiana,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,27.0,31.0,58.0,0.0,213.0,3.0,75.0,57.0,163.0,307.0,211.0,163.0,1308.0
Ludhiana,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,0.0,1.0,3.0,3.0,10.0,0.0,3.0,4.0,20.0,10.0,14.0,18.0,86.0
Ludhiana,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,27.0,43.0,61.0,0.0,213.0,3.0,70.0,46.0,161.0,215.0,97.0,139.0,1075.0
Ludhiana,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,2.0,26.0,5.0,8.0,40.0,3.0,18.0,5.0,21.0,99.0,9.0,92.0,328.0
Ludhiana,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,2238.0,2200.0,2136.0,2474.0,2892.0,2901.0,3778.0,3761.0,2662.0,3421.0,3139.0,2982.0,34584.0
Ludhiana,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,1678.0,1486.0,1665.0,1826.0,2127.0,2139.0,3586.0,3481.0,2409.0,3111.0,3049.0,2884.0,29441.0
Ludhiana,6.3,PNC maternal complications attended,TOTAL,1.0,4.0,2.0,1.0,2.0,0.0,4.0,2.0,5.0,0.0,0.0,0.0,21.0
Ludhiana,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,42.0,33.0,68.0,42.0,20.0,17.0,19.0,18.0,17.0,19.0,30.0,48.0,373.0
Ludhiana,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,0.0,4.0,1.0,3.0,1.0,0.0,4.0,0.0,0.0,0.0,1.0,1.0,15.0
Ludhiana,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,42.0,37.0,69.0,45.0,21.0,17.0,23.0,18.0,17.0,19.0,31.0,49.0,388.0
Ludhiana,7.2,Number of MTPs conducted at Private Facilities,TOTAL,14.0,10.0,18.0,17.0,16.0,12.0,13.0,10.0,10.0,11.0,16.0,10.0,157.0
Ludhiana,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,91.0,64.0,65.0,61.0,60.0,153.0,114.0,81.0,40.0,86.0,93.0,106.0,1014.0
Ludhiana,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,188.0,202.0,292.0,258.0,170.0,183.0,226.0,291.0,148.0,317.0,227.0,189.0,2691.0
Ludhiana,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,279.0,266.0,357.0,319.0,230.0,336.0,340.0,372.0,188.0,403.0,320.0,295.0,3705.0
Ludhiana,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ludhiana,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,2.0,0.0,0.0,0.0,1.0,0.0,2.0,2.0,0.0,0.0,0.0,1.0,8.0
Ludhiana,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,10.0,6.0,3.0,8.0,14.0,10.0,16.0,33.0,16.0,11.0,19.0,10.0,156.0
Ludhiana,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,14.0,8.0,15.0,11.0,8.0,15.0,13.0,21.0,4.0,5.0,4.0,10.0,128.0
Ludhiana,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Ludhiana,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,26.0,14.0,18.0,19.0,23.0,25.0,31.0,56.0,20.0,16.0,23.0,21.0,292.0
Ludhiana,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,3.0,2.0,7.0,7.0,6.0,9.0,7.0,6.0,6.0,4.0,6.0,3.0,66.0
Ludhiana,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,67.0,25.0,35.0,10.0,14.0,8.0,4.0,40.0,30.0,0.0,20.0,26.0,279.0
Ludhiana,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,181.0,229.0,493.0,142.0,109.0,159.0,118.0,176.0,75.0,89.0,159.0,92.0,2022.0
Ludhiana,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,205.0,159.0,293.0,153.0,120.0,112.0,73.0,117.0,104.0,71.0,146.0,178.0,1731.0
Ludhiana,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Ludhiana,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,453.0,413.0,821.0,305.0,243.0,279.0,195.0,333.0,209.0,160.0,325.0,296.0,4032.0
Ludhiana,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,235.0,301.0,365.0,282.0,229.0,240.0,119.0,86.0,99.0,115.0,118.0,59.0,2248.0
Ludhiana,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ludhiana,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,3.0,0.0,5.0,7.0,5.0,0.0,0.0,7.0,27.0
Ludhiana,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,6.0,2.0,25.0,5.0,3.0,0.0,0.0,1.0,1.0,9.0,13.0,15.0,80.0
Ludhiana,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Ludhiana,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,6.0,2.0,25.0,5.0,6.0,0.0,5.0,8.0,6.0,9.0,13.0,22.0,107.0
Ludhiana,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,2.0,0.0,0.0,0.0,0.0,0.0,15.0,1.0,13.0,4.0,2.0,2.0,39.0
Ludhiana,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ludhiana,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,1.0,5.0,3.0,0.0,0.0,1.0,5.0,1.0,4.0,2.0,5.0,0.0,27.0
Ludhiana,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,19.0,20.0,3.0,35.0,28.0,39.0,53.0,29.0,42.0,28.0,34.0,28.0,358.0
Ludhiana,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Ludhiana,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,20.0,25.0,6.0,35.0,28.0,40.0,58.0,30.0,46.0,30.0,39.0,28.0,385.0
Ludhiana,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,17.0,43.0,29.0,42.0,26.0,29.0,139.0,106.0,150.0,127.0,76.0,32.0,816.0
Ludhiana,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,2299.0,1941.0,2069.0,2354.0,2266.0,2335.0,2333.0,2287.0,2273.0,2262.0,2234.0,1883.0,26536.0
Ludhiana,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,2.0,2.0,2.0,0.0,1.0,1.0,0.0,1.0,2.0,15.0,5.0,28.0,59.0
Ludhiana,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,2.0,3.0,3.0,0.0,22.0,27.0,36.0,15.0,23.0,30.0,34.0,27.0,222.0
Ludhiana,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,322.0,336.0,294.0,331.0,388.0,402.0,382.0,417.0,329.0,356.0,307.0,363.0,4227.0
Ludhiana,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Ludhiana,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,2625.0,2282.0,2368.0,2685.0,2677.0,2765.0,2751.0,2720.0,2627.0,2663.0,2580.0,2301.0,31044.0
Ludhiana,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,47.0,15.0,115.0,82.0,131.0,135.0,120.0,118.0,60.0,114.0,151.0,164.0,1252.0
Ludhiana,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,218.0,250.0,117.0,0.0,103.0,83.0,0.0,30.0,6.0,0.0,,,807.0
Ludhiana,9.06,Number of IUCD removals,TOTAL,537.0,413.0,276.0,285.0,282.0,307.0,289.0,302.0,285.0,350.0,322.0,266.0,3914.0
Ludhiana,9.07,Number of Oral Pills cycles distributed,TOTAL,16350.0,12618.0,12882.0,12494.0,12983.0,12695.0,13119.0,12769.0,13456.0,13315.0,12551.0,12484.0,157716.0
Ludhiana,9.08,Number of Condom pieces distributed,TOTAL,455766.0,412488.0,421335.0,425140.0,428256.0,419626.0,429461.0,416530.0,434238.0,420300.0,417440.0,420672.0,5101252.0
Ludhiana,9.09,Number of Centchroman (weekly) pills given,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ludhiana,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,259.0,260.0,76.0,178.0,130.0,187.0,121.0,117.0,108.0,77.0,84.0,87.0,1684.0
Ludhiana,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ludhiana,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ludhiana,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ludhiana,9.11.2.b,Number of failures following female sterilization,TOTAL,1.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,2.0
Ludhiana,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ludhiana,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ludhiana,9.12,Number of Institutions having NSV trained doctors,TOTAL,1.0,1.0,2.0,3.0,7.0,6.0,5.0,7.0,5.0,5.0,6.0,5.0,-1.0
Ludhiana,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,4040.0,4548.0,4635.0,5027.0,5321.0,5178.0,5477.0,5301.0,5186.0,5143.0,4843.0,4060.0,58759.0
Ludhiana,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,4871.0,4729.0,4555.0,5073.0,4858.0,4913.0,5366.0,5405.0,5341.0,4473.0,1598.0,847.0,52029.0
Ludhiana,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,4977.0,5063.0,4758.0,4958.0,4649.0,4549.0,5032.0,5235.0,5519.0,5078.0,4413.0,2308.0,56539.0
Ludhiana,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,5022.0,5117.0,4922.0,5184.0,4755.0,4529.0,4776.0,4973.0,5280.0,5210.0,4850.0,3955.0,58573.0
Ludhiana,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,0.0,0.0,42.0,0.0,0.0,0.0,0.0,0.0,0.0,1157.0,3635.0,3569.0,8403.0
Ludhiana,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,0.0,0.0,38.0,0.0,0.0,0.0,0.0,0.0,0.0,8.0,448.0,2866.0,3360.0
Ludhiana,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,0.0,0.0,31.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,17.0,621.0,670.0
Ludhiana,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,2112.0,2697.0,2729.0,3774.0,3885.0,3881.0,4020.0,3917.0,3945.0,3868.0,3459.0,2745.0,41032.0
Ludhiana,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,4871.0,4729.0,4595.0,5073.0,4858.0,4913.0,5366.0,5405.0,5341.0,4646.0,3857.0,4395.0,58049.0
Ludhiana,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,4977.0,5063.0,4799.0,4958.0,4649.0,4549.0,5032.0,5235.0,5519.0,5078.0,4415.0,5167.0,59441.0
Ludhiana,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,5022.0,5117.0,4961.0,5184.0,4755.0,4529.0,4776.0,4973.0,5280.0,5210.0,4850.0,4569.0,59226.0
Ludhiana,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,1400.0,1449.0,1797.0,2561.0,2450.0,2614.0,2653.0,2119.0,2149.0,2133.0,1709.0,1469.0,24503.0
Ludhiana,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,4856.0,4743.0,4660.0,5050.0,4991.0,4911.0,5457.0,5511.0,5451.0,4201.0,2106.0,740.0,52677.0
Ludhiana,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,4984.0,5052.0,4774.0,4924.0,4651.0,4550.0,5002.0,5311.0,5486.0,5085.0,4474.0,2277.0,56570.0
Ludhiana,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,5019.0,5108.0,4906.0,5171.0,4808.0,4517.0,4768.0,4971.0,5227.0,5195.0,4767.0,3952.0,58409.0
Ludhiana,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,4384.0,4869.0,4646.0,5078.0,4909.0,4632.0,4810.0,4754.0,4405.0,4228.0,4147.0,4067.0,54929.0
Ludhiana,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,4504.0,4815.0,4392.0,4749.0,4426.0,4125.0,3999.0,4267.0,4299.0,4301.0,4361.0,4265.0,52503.0
Ludhiana,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ludhiana,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,2315.0,2530.0,2419.0,2646.0,2560.0,2411.0,2530.0,2483.0,2322.0,2222.0,2184.0,2125.0,28747.0
Ludhiana,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,2069.0,2339.0,2227.0,2432.0,2349.0,2221.0,2280.0,2271.0,2083.0,2006.0,1963.0,1942.0,26182.0
Ludhiana,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,4384.0,4869.0,4646.0,5078.0,4909.0,4632.0,4810.0,4754.0,4405.0,4228.0,4147.0,4067.0,54929.0
Ludhiana,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,4486.0,4811.0,4500.0,4755.0,4430.0,4140.0,3977.0,4262.0,4299.0,4232.0,4352.0,4290.0,52534.0
Ludhiana,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,4486.0,4811.0,4500.0,4755.0,4430.0,4140.0,3977.0,4262.0,4299.0,4232.0,4352.0,4290.0,52534.0
Ludhiana,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ludhiana,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,323.0,473.0,270.0,112.0,48.0,62.0,24.0,33.0,31.0,27.0,38.0,45.0,1486.0
Ludhiana,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,290.0,486.0,250.0,111.0,41.0,63.0,21.0,31.0,27.0,28.0,29.0,29.0,1406.0
Ludhiana,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,613.0,959.0,520.0,223.0,89.0,125.0,45.0,64.0,58.0,55.0,67.0,74.0,2892.0
Ludhiana,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,3445.0,10142.0,3356.0,4344.0,3748.0,3457.0,2997.0,3064.0,3333.0,2711.0,2628.0,2569.0,45794.0
Ludhiana,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,2936.0,13864.0,2811.0,4269.0,3524.0,3289.0,2573.0,2447.0,2511.0,2097.0,2005.0,1765.0,44091.0
Ludhiana,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,1995.0,10080.0,2028.0,3304.0,2839.0,2852.0,2064.0,2736.0,2157.0,1722.0,1869.0,1409.0,35055.0
Ludhiana,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ludhiana,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ludhiana,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ludhiana,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,1691.0,1489.0,1571.0,1625.0,1550.0,1479.0,1532.0,1515.0,1540.0,1543.0,1471.0,1405.0,18411.0
Ludhiana,10.4.2,Number of Immunisation sessions held during the month,TOTAL,1558.0,1448.0,1536.0,1602.0,1510.0,1407.0,1442.0,1435.0,1495.0,1454.0,1384.0,1226.0,17497.0
Ludhiana,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,1158.0,1101.0,1133.0,1180.0,1118.0,1084.0,1114.0,1101.0,1137.0,1097.0,1062.0,954.0,13239.0
Ludhiana,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ludhiana,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,3822.0,4716.0,4459.0,4811.0,4639.0,4554.0,4576.0,4461.0,4259.0,3971.0,3928.0,3572.0,51768.0
Ludhiana,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,3216.0,4341.0,3389.0,2747.0,3796.0,3986.0,2776.0,2870.0,2869.0,3003.0,2750.0,2437.0,38180.0
Ludhiana,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,3366.0,6421.0,3648.0,3759.0,4280.0,4164.0,3217.0,3121.0,3226.0,2740.0,2764.0,2735.0,43441.0
Ludhiana,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ludhiana,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ludhiana,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ludhiana,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ludhiana,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ludhiana,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ludhiana,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,28.0,39.0,17.0,11.0,10.0,0.0,4.0,0.0,3.0,12.0,9.0,2.0,135.0
Ludhiana,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ludhiana,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,9.0,4.0,15.0,15.0,20.0,9.0,6.0,0.0,6.0,10.0,20.0,11.0,125.0
Ludhiana,13.1,Number of Patients operated for cataract,TOTAL,119.0,66.0,77.0,50.0,46.0,66.0,53.0,102.0,54.0,55.0,56.0,121.0,865.0
Ludhiana,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,119.0,66.0,72.0,50.0,46.0,66.0,53.0,100.0,53.0,55.0,54.0,116.0,850.0
Ludhiana,13.3,Number of School children detected with Refractive errors,TOTAL,356.0,927.0,274.0,579.0,353.0,540.0,1386.0,780.0,476.0,211.0,335.0,240.0,6457.0
Ludhiana,13.4,Number of children provided free glasses,TOTAL,109.0,155.0,17.0,110.0,78.0,483.0,573.0,71.0,47.0,246.0,418.0,70.0,2377.0
Ludhiana,13.5,Number of eyes collected through eye donation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ludhiana,13.6,Number of eyes utilised for corneal transplant,TOTAL,5.0,8.0,5.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,18.0
Ludhiana,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,3.0,2.0,1.0,5.0,5.0,6.0,9.0,6.0,6.0,6.0,5.0,5.0,-1.0
Ludhiana,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,,,,3.0,2.0,2.0,2.0,3.0,2.0,4.0,2.0,2.0,-1.0
Ludhiana,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,897.0,935.0,881.0,926.0,926.0,888.0,919.0,921.0,955.0,929.0,915.0,775.0,-1.0
Ludhiana,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,12.0,13.0,10.0,6.0,5.0,6.0,8.0,6.0,6.0,7.0,6.0,5.0,-1.0
Ludhiana,14.05,Number of RKS meetings held during the month,TOTAL,11.0,16.0,14.0,4.0,4.0,3.0,6.0,4.0,4.0,3.0,5.0,3.0,77.0
Ludhiana,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,3.0,2.0,2.0,6.0,5.0,5.0,8.0,7.0,7.0,5.0,7.0,6.0,-1.0
Ludhiana,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,11.0,32.0,36.0,31.0,25.0,21.0,14.0,23.0,34.0,14.0,23.0,13.0,277.0
Ludhiana,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,,2.0,1.0,4.0,3.0,4.0,6.0,4.0,5.0,3.0,3.0,3.0,-1.0
Ludhiana,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,11.0,13.0,10.0,2.0,1.0,1.0,2.0,2.0,2.0,1.0,1.0,1.0,-1.0
Ludhiana,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,609.0,666.0,666.0,890.0,942.0,964.0,871.0,758.0,643.0,768.0,640.0,591.0,9008.0
Ludhiana,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,1252.0,1505.0,1766.0,1470.0,1662.0,1581.0,1421.0,1363.0,1149.0,1373.0,1447.0,1439.0,17428.0
Ludhiana,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,563.0,608.0,594.0,750.0,863.0,972.0,744.0,740.0,600.0,731.0,631.0,567.0,8363.0
Ludhiana,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,2352.0,2897.0,3393.0,3025.0,3261.0,2991.0,2608.0,2696.0,2478.0,2520.0,2572.0,2623.0,33416.0
Ludhiana,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,1172.0,1274.0,1260.0,1640.0,1805.0,1936.0,1615.0,1498.0,1243.0,1499.0,1271.0,1158.0,17371.0
Ludhiana,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,3604.0,4402.0,5159.0,4495.0,4923.0,4572.0,4029.0,4059.0,3627.0,3893.0,4019.0,4062.0,50844.0
Ludhiana,14.10.2.a,Number of death cases of Inpatient males,TOTAL,54.0,52.0,54.0,60.0,58.0,47.0,52.0,40.0,45.0,49.0,46.0,48.0,605.0
Ludhiana,14.10.2.b,Number of death cases of Inpatient females,TOTAL,22.0,23.0,29.0,16.0,28.0,23.0,30.0,30.0,18.0,20.0,22.0,18.0,279.0
Ludhiana,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,76.0,75.0,83.0,76.0,86.0,70.0,82.0,70.0,63.0,69.0,68.0,66.0,884.0
Ludhiana,14.11,In-Patient Head Count at midnight,TOTAL,332.0,501.0,586.0,522.0,607.0,436.0,579.0,617.0,546.0,548.0,437.0,427.0,6138.0
Ludhiana,14.12.1,OPD attendance (All),TOTAL,115707.0,130355.0,119469.0,135458.0,135017.0,127385.0,118571.0,122817.0,113935.0,109288.0,116165.0,121056.0,1465223.0
Ludhiana,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,632.0,639.0,825.0,499.0,634.0,714.0,432.0,482.0,596.0,592.0,602.0,663.0,7310.0
Ludhiana,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,17.0,39.0,47.0,27.0,59.0,69.0,50.0,58.0,65.0,79.0,54.0,75.0,639.0
Ludhiana,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,2046.0,2583.0,1922.0,2875.0,3687.0,2960.0,1808.0,2010.0,2606.0,2603.0,2389.0,2636.0,30125.0
Ludhiana,14.14.a,Number of patients given AYUSH treatment,TOTAL,17958.0,20414.0,20195.0,22353.0,19628.0,21110.0,19238.0,20551.0,22786.0,19605.0,21988.0,13446.0,239272.0
Ludhiana,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,5749.0,6905.0,6315.0,5381.0,5249.0,3649.0,5159.0,5604.0,5990.0,5927.0,5648.0,3939.0,65515.0
Ludhiana,14.14.c,Number of Adolescents counselled,TOTAL,412.0,331.0,263.0,321.0,247.0,208.0,180.0,187.0,175.0,132.0,209.0,89.0,2754.0
Ludhiana,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,12672.0,15348.0,13770.0,14563.0,11255.0,8582.0,10643.0,11226.0,10323.0,11447.0,12613.0,13032.0,145474.0
Ludhiana,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,266.0,245.0,259.0,213.0,220.0,519.0,255.0,254.0,250.0,280.0,308.0,302.0,3371.0
Ludhiana,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,1398.0,1475.0,1668.0,1774.0,1745.0,1647.0,1548.0,1569.0,1806.0,1445.0,1096.0,1354.0,18525.0
Ludhiana,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,31.0,60.0,42.0,34.0,37.0,29.0,21.0,28.0,32.0,22.0,43.0,25.0,404.0
Ludhiana,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,960.0,1239.0,1538.0,1116.0,1244.0,1167.0,1012.0,1226.0,1119.0,1095.0,1099.0,1031.0,13846.0
Ludhiana,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,19.0,21.0,11.0,19.0,15.0,12.0,11.0,12.0,14.0,7.0,15.0,15.0,171.0
Ludhiana,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,2815.0,3136.0,2716.0,3024.0,2833.0,2590.0,2354.0,2722.0,2798.0,2902.0,2651.0,2515.0,33056.0
Ludhiana,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,5.0,5.0,2.0,4.0,5.0,2.0,2.0,3.0,1.0,3.0,4.0,3.0,39.0
Ludhiana,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,5173.0,5850.0,5922.0,5914.0,5822.0,5404.0,4914.0,5517.0,5723.0,5442.0,4846.0,4900.0,65427.0
Ludhiana,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,55.0,86.0,55.0,57.0,57.0,43.0,34.0,43.0,47.0,32.0,62.0,43.0,614.0
Ludhiana,15.2,Number of Widal tests conducted,Number tested,1514.0,1684.0,1266.0,1431.0,1819.0,1318.0,1124.0,822.0,681.0,657.0,1319.0,1572.0,15207.0
Ludhiana,15.3.a,Number of VDRL tests conducted on males,Number tested,100.0,366.0,305.0,378.0,332.0,243.0,153.0,228.0,302.0,286.0,235.0,95.0,3023.0
Ludhiana,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,86.0,363.0,219.0,159.0,189.0,185.0,143.0,163.0,153.0,205.0,130.0,123.0,2118.0
Ludhiana,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,2135.0,2266.0,2150.0,2409.0,2311.0,1332.0,1761.0,1836.0,1715.0,2317.0,2256.0,2877.0,25365.0
Ludhiana,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,2321.0,2995.0,2674.0,2946.0,2832.0,1760.0,2057.0,2227.0,2170.0,2808.0,2621.0,3095.0,30506.0
Ludhiana,15.4.1,Number of blood smears examined for Malaria,TOTAL,8543.0,10092.0,10127.0,8289.0,8058.0,5820.0,6161.0,6724.0,6765.0,6104.0,6842.0,6353.0,89878.0
Ludhiana,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,1.0
Ludhiana,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ludhiana,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,6400.0,27900.0,15140.0,22350.0,21070.0,20420.0,4010.0,18600.0,8570.0,7860.0,16850.0,19440.0,188610.0
Ludhiana,16.1.1,Stock position of DPT vaccines,2. Stocks Received,36000.0,24000.0,30000.0,30000.0,25000.0,0.0,50000.0,0.0,30000.0,30000.0,20000.0,10000.0,285000.0
Ludhiana,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Ludhiana,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,14500.0,36760.0,22790.0,31280.0,25650.0,16410.0,35410.0,10030.0,30710.0,21010.0,17410.0,8200.0,270160.0
Ludhiana,16.1.1,Stock position of DPT vaccines,5. Total Stock,27900.0,15140.0,22350.0,21070.0,20420.0,4010.0,18600.0,8570.0,7860.0,16850.0,19440.0,21240.0,203450.0
Ludhiana,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,,,,,,,,,,,,23880.0,23880.0
Ludhiana,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,,,,,,,,,,,,,
Ludhiana,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,,,,,,,,,,,,,
Ludhiana,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,,,,,,,,,,,,6980.0,6980.0
Ludhiana,16.1.1A,Stock Position of Pentavalent,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,16900.0,16900.0
Ludhiana,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,15760.0,37480.0,32200.0,34020.0,27500.0,24680.0,2520.0,21600.0,8240.0,3000.0,13680.0,30600.0,251280.0
Ludhiana,16.1.2,Stock position of OPV vaccines,2. Stocks Received,0.0,30000.0,30000.0,30000.0,28000.0,0.0,50000.0,0.0,30000.0,16000.0,30000.0,25000.0,269000.0
Ludhiana,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,,,,,,,,,,,,,
Ludhiana,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,14280.0,35280.0,28180.0,36520.0,30820.0,22160.0,30920.0,13360.0,35240.0,5320.0,13080.0,31180.0,296340.0
Ludhiana,16.1.2,Stock position of OPV vaccines,5. Total Stock,1480.0,32200.0,34020.0,27500.0,24680.0,2520.0,21600.0,8240.0,3000.0,13680.0,30600.0,24420.0,223940.0
Ludhiana,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,12360.0,29240.0,22380.0,27260.0,28750.0,21810.0,8010.0,16170.0,9410.0,13630.0,21630.0,22340.0,232990.0
Ludhiana,16.1.3,Stock position of TT vaccines,2. Stocks Received,30000.0,24000.0,25000.0,25000.0,15000.0,0.0,30000.0,0.0,25000.0,20000.0,15000.0,,209000.0
Ludhiana,16.1.3,Stock position of TT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Ludhiana,16.1.3,Stock position of TT vaccines,4. Stock Distributed,13120.0,30860.0,20120.0,23510.0,21940.0,13800.0,21840.0,6760.0,20780.0,12000.0,14290.0,8020.0,207040.0
Ludhiana,16.1.3,Stock position of TT vaccines,5. Total Stock,29240.0,22380.0,27260.0,28750.0,21810.0,8010.0,16170.0,9410.0,13630.0,21630.0,22340.0,14320.0,234950.0
Ludhiana,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Ludhiana,16.1.4,Stock position of DT vaccines,2. Stocks Received,,,,,,,,,,,,,
Ludhiana,16.1.4,Stock position of DT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Ludhiana,16.1.4,Stock position of DT vaccines,4. Stock Distributed,,,,,,,,,,,,,
Ludhiana,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ludhiana,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,8170.0,11380.0,11520.0,12460.0,11810.0,12900.0,6320.0,10260.0,4410.0,3600.0,14280.0,6630.0,113740.0
Ludhiana,16.1.5,Stock position of BCG vaccines,2. Stocks Received,10000.0,10000.0,10000.0,10000.0,10000.0,0.0,15000.0,0.0,10000.0,16000.0,10000.0,5000.0,106000.0
Ludhiana,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,,,,,,,,,,,,,
Ludhiana,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,6790.0,9860.0,9060.0,10650.0,8910.0,6580.0,11060.0,5850.0,10810.0,5320.0,17650.0,4920.0,107460.0
Ludhiana,16.1.5,Stock position of BCG vaccines,5. Total Stock,11380.0,11520.0,12460.0,11810.0,12900.0,6320.0,10260.0,4410.0,3600.0,14280.0,6630.0,6710.0,112280.0
Ludhiana,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,7290.0,11230.0,9625.0,11000.0,7175.0,9995.0,2050.0,10260.0,6235.0,9490.0,7875.0,6255.0,98480.0
Ludhiana,16.1.6,Stock position of Measles vaccines,2. Stocks Received,10000.0,10000.0,10000.0,10000.0,15000.0,0.0,22000.0,,14000.0,10000.0,10000.0,10000.0,121000.0
Ludhiana,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,,,,,,,,,,,,,
Ludhiana,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,6060.0,11605.0,8625.0,13825.0,12180.0,7945.0,10625.0,4025.0,10745.0,11615.0,11620.0,5220.0,114090.0
Ludhiana,16.1.6,Stock position of Measles vaccines,5. Total Stock,11230.0,9625.0,11000.0,7175.0,9995.0,2050.0,13425.0,6235.0,9490.0,7875.0,6255.0,11035.0,105390.0
Ludhiana,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Ludhiana,16.1.7,Stock position of JE vaccines,2. Stocks Received,,,,,,,,,,,,,
Ludhiana,16.1.7,Stock position of JE vaccines,3. Unusable Stock,,,,,,,,,,,,,
Ludhiana,16.1.7,Stock position of JE vaccines,4. Stock Distributed,,,,,,,,,,,,,
Ludhiana,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ludhiana,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,5410.0,,22380.0,28770.0,25620.0,21260.0,8130.0,15260.0,6420.0,15400.0,8640.0,9200.0,166490.0
Ludhiana,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,25000.0,,25000.0,25000.0,15000.0,0.0,30000.0,0.0,35000.0,5000.0,15000.0,10000.0,185000.0
Ludhiana,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,,,,,,,,,,,,,
Ludhiana,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,9460.0,,18610.0,28150.0,19360.0,13130.0,22870.0,8840.0,26020.0,11760.0,14440.0,6750.0,179390.0
Ludhiana,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,20950.0,0.0,28770.0,25620.0,21260.0,8130.0,15260.0,6420.0,15400.0,8640.0,9200.0,12450.0,172100.0
Ludhiana,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,22400.0,22000.0,20000.0,,33570.0,29770.0,,28520.0,26320.0,,21120.0,,203700.0
Ludhiana,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,,0.0,20070.0,,0.0,,,0.0,,,0.0,,20070.0
Ludhiana,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Ludhiana,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,400.0,2000.0,5900.0,,3800.0,650.0,,2200.0,1900.0,,0.0,,16850.0
Ludhiana,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,22000.0,20000.0,34170.0,0.0,29770.0,29120.0,0.0,26320.0,24420.0,0.0,21120.0,0.0,206920.0
Ludhiana,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,,0.0,0.0,,0.0,,,138000.0,82000.0,,111500.0,,331500.0
Ludhiana,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,,0.0,0.0,,0.0,,,0.0,,,0.0,,0.0
Ludhiana,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Ludhiana,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,,0.0,0.0,,0.0,,,56000.0,30000.0,,6000.0,,92000.0
Ludhiana,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,82000.0,52000.0,0.0,105500.0,0.0,239500.0
Ludhiana,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,7509.0,6609.0,3909.0,,309.0,21909.0,,19209.0,18209.0,,11309.0,,88972.0
Ludhiana,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,,0.0,0.0,,24100.0,,,,,,0.0,,24100.0
Ludhiana,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Ludhiana,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,900.0,2700.0,3200.0,,2500.0,1400.0,,1000.0,2700.0,,0.0,,14400.0
Ludhiana,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,6609.0,3909.0,709.0,0.0,21909.0,20509.0,0.0,18209.0,15509.0,0.0,11309.0,0.0,98672.0
Ludhiana,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,230.0,230.0,50.0,,0.0,410.0,,410.0,410.0,,110.0,,1850.0
Ludhiana,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,,0.0,0.0,,460.0,,,0.0,,,0.0,,460.0
Ludhiana,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Ludhiana,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,,180.0,50.0,,50.0,,,0.0,150.0,,0.0,,430.0
Ludhiana,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,230.0,50.0,0.0,0.0,410.0,410.0,0.0,410.0,260.0,0.0,110.0,0.0,1880.0
Ludhiana,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,8915.0,7215.0,6715.0,,13535.0,11835.0,,11835.0,10335.0,,6835.0,,77220.0
Ludhiana,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,,0.0,10020.0,,0.0,,,0.0,,,0.0,,10020.0
Ludhiana,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Ludhiana,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,1700.0,500.0,3200.0,,1700.0,,,1500.0,2500.0,,,,11100.0
Ludhiana,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,7215.0,6715.0,13535.0,0.0,11835.0,11835.0,0.0,10335.0,7835.0,0.0,6835.0,0.0,76140.0
Ludhiana,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,0.0,0.0,,,0.0,,,0.0,,,0.0,,0.0
Ludhiana,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,,0.0,,,0.0,,,0.0,,,0.0,,0.0
Ludhiana,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,,,,,,,,,,,,,
Ludhiana,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,,0.0,,,0.0,,,0.0,,,0.0,,0.0
Ludhiana,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ludhiana,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,,18676.0,36887.0,,24798.0,15798.0,,2424.0,1112.0,,3500.0,,103195.0
Ludhiana,16.3.02,Stock Position of Gloves,2. Stocks Received,100748.0,0.0,11412.0,,0.0,,,0.0,,,0.0,,112160.0
Ludhiana,16.3.02,Stock Position of Gloves,3. Unusable Stock,,,,,,,,,,,,,
Ludhiana,16.3.02,Stock Position of Gloves,4. Stock Distributed,82072.0,0.0,0.0,,9000.0,11212.0,,1312.0,1112.0,,0.0,,104708.0
Ludhiana,16.3.02,Stock Position of Gloves,5. Total Stock,18676.0,18676.0,48299.0,0.0,15798.0,4586.0,0.0,1112.0,0.0,0.0,3500.0,0.0,110647.0
Ludhiana,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,,,,,,,,,,,,,
Ludhiana,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,,,,,,,,,,,,,
Ludhiana,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,,,,,,,,,,,,,
Ludhiana,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,,,,,,,,,,,,,
Ludhiana,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ludhiana,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,0.0,0.0,0.0,,9200.0,6500.0,,600.0,,,0.0,,16300.0
Ludhiana,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,,0.0,20000.0,,0.0,,,,,,0.0,,20000.0
Ludhiana,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,,,,,,,,,,,,,
Ludhiana,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,,0.0,10800.0,,2700.0,5900.0,,600.0,,,0.0,,20000.0
Ludhiana,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,9200.0,0.0,6500.0,600.0,0.0,0.0,0.0,0.0,0.0,0.0,16300.0
Ludhiana,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,,0.0,,,,,,0.0,,,0.0,,0.0
Ludhiana,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,,0.0,,,,,,0.0,,,0.0,,0.0
Ludhiana,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,,,,,,,,,,,,,
Ludhiana,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,,0.0,,,,,,0.0,,,,,0.0
Ludhiana,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ludhiana,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,8.0,8.0,8.0,,8.0,5.0,,2.0,2.0,,0.0,,41.0
Ludhiana,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,,0.0,0.0,,0.0,,,,,,0.0,,0.0
Ludhiana,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,,,,,,,,,,,,,
Ludhiana,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,,0.0,0.0,,3.0,3.0,,,2.0,,,,8.0
Ludhiana,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,8.0,8.0,8.0,0.0,5.0,2.0,0.0,2.0,0.0,0.0,0.0,0.0,33.0
Ludhiana,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,,0.0,0.0,,16000.0,12500.0,,0.0,,,140000.0,,168500.0
Ludhiana,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,,0.0,180000.0,,0.0,,,,,,0.0,,180000.0
Ludhiana,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,,,,,,,,,,,,,
Ludhiana,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,,0.0,162000.0,,3500.0,9200.0,,,,,11000.0,,185700.0
Ludhiana,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,0.0,18000.0,0.0,12500.0,3300.0,0.0,0.0,0.0,0.0,129000.0,0.0,162800.0
Ludhiana,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,3731.0,3731.0,3731.0,,3251.0,,,,,,0.0,,14444.0
Ludhiana,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,,0.0,0.0,,0.0,,,,,,0.0,,0.0
Ludhiana,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,,,,,,,,,,,,,
Ludhiana,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,,0.0,480.0,,1200.0,,,,,,0.0,,1680.0
Ludhiana,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,3731.0,3731.0,3251.0,0.0,2051.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,12764.0
Ludhiana,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,,,,,,,,,,,,,
Ludhiana,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,,,,,,,,,,,,,
Ludhiana,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,,,,,,,,,,,,,
Ludhiana,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,,,,,,,,,,,,,
Ludhiana,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ludhiana,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,3.0,3.0,,,,,,98.0,,,,,104.0
Ludhiana,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,,0.0,,,,,,0.0,,,,,0.0
Ludhiana,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,,,,,,,,,,,,,
Ludhiana,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,,0.0,,,,,,25.0,,,,,25.0
Ludhiana,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,3.0,3.0,0.0,0.0,0.0,0.0,0.0,73.0,0.0,0.0,0.0,0.0,79.0
Ludhiana,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,,,,,,,,,,,,,
Ludhiana,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,,,,,,,,,,,,,
Ludhiana,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,,,,,,,,,,,,,
Ludhiana,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,,,,,,,,,,,,,
Ludhiana,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ludhiana,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,14150.0,9100.0,7900.0,7300.0,14000.0,9600.0,6200.0,12900.0,11200.0,7200.0,1600.0,1500.0,102650.0
Ludhiana,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,0.0,4000.0,4000.0,11000.0,0.0,0.0,12000.0,,2000.0,,1000.0,12000.0,46000.0
Ludhiana,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,,
Ludhiana,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,5050.0,5200.0,4600.0,4300.0,4400.0,3400.0,5300.0,1700.0,6000.0,5600.0,1100.0,2600.0,49250.0
Ludhiana,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,9100.0,7900.0,7300.0,14000.0,9600.0,6200.0,12900.0,11200.0,7200.0,1600.0,1500.0,10900.0,99400.0
Ludhiana,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,57000.0,88400.0,26600.0,45600.0,85600.0,95600.0,41200.0,19000.0,6600.0,106600.0,29600.0,47200.0,649000.0
Ludhiana,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,100000.0,,40000.0,100000.0,100000.0,0.0,,,150000.0,,35600.0,80000.0,605600.0
Ludhiana,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,,
Ludhiana,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,68600.0,58800.0,45600.0,60000.0,90000.0,54400.0,22200.0,12400.0,50000.0,77000.0,18000.0,36400.0,593400.0
Ludhiana,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,88400.0,29600.0,21000.0,85600.0,95600.0,41200.0,19000.0,6600.0,106600.0,29600.0,47200.0,90800.0,661200.0
Ludhiana,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,4100.0,3100.0,3050.0,4650.0,6000.0,4700.0,3300.0,12200.0,11300.0,8700.0,6500.0,5500.0,73100.0
Ludhiana,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,0.0,2400.0,2800.0,4800.0,0.0,0.0,12000.0,,,,,2400.0,24400.0
Ludhiana,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,,,,,,,,,,,,,
Ludhiana,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,1000.0,2450.0,1200.0,3450.0,1300.0,1400.0,3100.0,900.0,2600.0,2200.0,1000.0,1000.0,21600.0
Ludhiana,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,3100.0,3050.0,4650.0,6000.0,4700.0,3300.0,12200.0,11300.0,8700.0,6500.0,5500.0,6900.0,75900.0
Ludhiana,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,,,,,,,2.0,2.0,2.0,1.0,,,7.0
Ludhiana,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,,,1.0,3.0,,,,,,,,4.0
Ludhiana,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,1.0,,1.0,,,,,,2.0
Ludhiana,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,,,1.0,4.0,,1.0,,,,,,6.0
Ludhiana,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,,,,,1.0,,1.0,1.0,,,,,3.0
Ludhiana,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,1.0,,,,,,1.0
Ludhiana,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,,,,,1.0,,2.0,1.0,,,,,4.0
Ludhiana,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,,,,,,2.0,,,,,,,2.0
Ludhiana,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Ludhiana,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,,,,,,2.0,,,,,,,2.0
Ludhiana,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,,,,,3.0,3.0,1.0,2.0,3.0,1.0,1.0,,14.0
Ludhiana,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,,,,,,,1.0,,,1.0,,2.0
Ludhiana,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,,,,,3.0,3.0,1.0,3.0,3.0,1.0,2.0,,16.0
Ludhiana,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,,,,,1.0,1.0,,3.0,3.0,3.0,,11.0
Ludhiana,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,,,,,,,2.0,1.0,1.0,4.0
Ludhiana,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,,,,,,1.0,1.0,,3.0,5.0,4.0,1.0,15.0
Ludhiana,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,,,,,,
Ludhiana,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,1.0,,1.0,,1.0,,3.0
Ludhiana,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,,,1.0,,1.0,,1.0,,3.0
Ludhiana,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,,,,,,,,1.0,1.0,,2.0
Ludhiana,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,,1.0,1.0,,,2.0,1.0,,,5.0
Ludhiana,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,,,,1.0,1.0,,,2.0,2.0,1.0,,7.0
Ludhiana,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Ludhiana,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Ludhiana,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Ludhiana,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,,,,,,,1.0,2.0,3.0,1.0,5.0,,12.0
Ludhiana,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,,,,1.0,1.0,2.0,2.0,1.0,1.0,1.0,,2.0,11.0
Ludhiana,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,,,,1.0,1.0,2.0,3.0,3.0,4.0,2.0,5.0,2.0,23.0
Ludhiana,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
Ludhiana,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,,,,1.0,,,,,1.0
Ludhiana,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,,,,,,,,,
Ludhiana,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,,,,,,1.0,,,,,1.0
Ludhiana,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
Ludhiana,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,,,,2.0,1.0,4.0,3.0,6.0,6.0,,6.0,2.0,30.0
Ludhiana,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,,,,2.0,,1.0,3.0,2.0,3.0,1.0,3.0,4.0,19.0
Ludhiana,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,,,,4.0,1.0,5.0,6.0,8.0,9.0,1.0,9.0,6.0,49.0
Ludhiana,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,,,,,,
Ludhiana,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,,,,,,2.0,2.0,5.0,,2.0,6.0,4.0,21.0
Ludhiana,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,,,,,,2.0,1.0,4.0,9.0,15.0,9.0,7.0,47.0
Ludhiana,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,,,,,,4.0,3.0,9.0,9.0,17.0,15.0,11.0,68.0
Ludhiana,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
Ludhiana,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,,,,,,,,
Ludhiana,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
Ludhiana,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,,,,,,,,,,
Ludhiana,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,,,,,1.0,,,,,1.0
Ludhiana,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,,,,,2.0,4.0,4.0,1.0,2.0,2.0,1.0,,16.0
Ludhiana,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,,,,,10.0,16.0,13.0,8.0,2.0,1.0,5.0,3.0,58.0
Ludhiana,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,,,,,12.0,20.0,17.0,10.0,4.0,3.0,6.0,3.0,75.0
Ludhiana,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,1.0,,,,,,,1.0
Ludhiana,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,,,,,,1.0,,,1.0,1.0,3.0
Ludhiana,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,,,,
Ludhiana,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,,,,1.0,,1.0,,,1.0,1.0,4.0
Ludhiana,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,4.0,1.0,2.0,1.0,,,,1.0,9.0
Ludhiana,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,8.0,6.0,11.0,23.0,30.0,44.0,50.0,61.0,54.0,56.0,54.0,45.0,442.0
Ludhiana,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,16.0,11.0,21.0,17.0,59.0,63.0,91.0,94.0,115.0,128.0,110.0,70.0,795.0
Ludhiana,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,24.0,17.0,32.0,40.0,93.0,108.0,143.0,156.0,169.0,184.0,164.0,116.0,1246.0
Ludhiana,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,,,,,1.0,,1.0
Ludhiana,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,,,,,,,3.0,,,,,1.0,4.0
Ludhiana,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,,,,,,2.0,2.0,1.0,2.0,,1.0,5.0,13.0
Ludhiana,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,,,,,,2.0,5.0,1.0,2.0,,2.0,6.0,18.0
Ludhiana,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Ludhiana,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
Ludhiana,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Ludhiana,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
Ludhiana,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Ludhiana,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,,,,,,,,
Ludhiana,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Ludhiana,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,,,,,,,,
Ludhiana,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Ludhiana,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,,,,,,,,,,
Ludhiana,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Ludhiana,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,,,,,,,,,,,
Ludhiana,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Ludhiana,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,,,,,,1.0,,,,,1.0
Ludhiana,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Ludhiana,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,,,,,,1.0,,,,,1.0
Ludhiana,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Ludhiana,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,,,,,,,
Ludhiana,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Ludhiana,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,,,,,,,
Ludhiana,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Ludhiana,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,,,,,,4.0,3.0,1.0,,1.0,6.0,2.0,17.0
Ludhiana,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Ludhiana,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,,,,,,4.0,3.0,1.0,,1.0,6.0,2.0,17.0
Ludhiana,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,,,,1.0,,2.0,,1.0,2.0,,,6.0
Ludhiana,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,5.0,1.0,2.0,10.0,15.0,20.0,33.0,16.0,21.0,14.0,17.0,22.0,176.0
Ludhiana,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,1.0,,2.0,1.0,3.0,7.0,12.0,9.0,2.0,6.0,6.0,14.0,63.0
Ludhiana,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,6.0,1.0,4.0,11.0,19.0,27.0,47.0,25.0,24.0,22.0,23.0,36.0,245.0
Ludhiana,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,1.0,,,,,,,,1.0
Ludhiana,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,,,,,4.0,9.0,4.0,4.0,5.0,5.0,7.0,3.0,41.0
Ludhiana,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,,,,,,2.0,1.0,1.0,,,2.0,6.0
Ludhiana,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,,,,,5.0,9.0,6.0,5.0,6.0,5.0,7.0,5.0,48.0
Ludhiana,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,,,,,,,,,,
Ludhiana,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,,,,,1.0,,,1.0,,,,2.0
Ludhiana,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,,,,1.0,1.0,,,,,,2.0
Ludhiana,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,,,,,,2.0,1.0,,1.0,,,,4.0
Ludhiana,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,,,1.0,,2.0,,,,,1.0,4.0
Ludhiana,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,1.0,1.0,,1.0,5.0,10.0,5.0,4.0,9.0,6.0,8.0,5.0,55.0
Ludhiana,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,3.0,3.0,1.0,1.0,12.0,21.0,32.0,15.0,24.0,29.0,17.0,17.0,175.0
Ludhiana,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,4.0,4.0,1.0,2.0,18.0,31.0,39.0,19.0,33.0,35.0,25.0,23.0,234.0
Ludhiana,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,,,,,,,,1.0,,,1.0,2.0
Ludhiana,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,2.0,,4.0,5.0,15.0,9.0,22.0,21.0,21.0,24.0,15.0,21.0,159.0
Ludhiana,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,7.0,6.0,8.0,,22.0,31.0,39.0,35.0,31.0,29.0,38.0,43.0,289.0
Ludhiana,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,9.0,6.0,12.0,5.0,37.0,40.0,61.0,56.0,53.0,53.0,53.0,65.0,450.0
Ludhiana,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,,,1.0,,,1.0,1.0,2.0,,,4.0,1.0,10.0
Ludhiana,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,4.0,5.0,7.0,24.0,44.0,32.0,56.0,47.0,48.0,38.0,43.0,38.0,386.0
Ludhiana,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,41.0,25.0,66.0,108.0,134.0,209.0,231.0,189.0,303.0,321.0,226.0,192.0,2045.0
Ludhiana,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,45.0,30.0,74.0,132.0,178.0,242.0,288.0,238.0,351.0,359.0,273.0,231.0,2441.0
Mansa,1.1,Total number of pregnant women Registered for ANC,TOTAL,1198.0,1360.0,1040.0,1146.0,1101.0,916.0,753.0,941.0,950.0,1200.0,1206.0,953.0,12764.0
Mansa,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,1042.0,1089.0,862.0,910.0,884.0,729.0,587.0,767.0,738.0,983.0,999.0,812.0,10402.0
Mansa,1.2,Number of Pregnant women registered under JSY,TOTAL,562.0,581.0,442.0,447.0,458.0,417.0,323.0,412.0,385.0,498.0,503.0,375.0,5403.0
Mansa,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,1062.0,1117.0,983.0,988.0,1001.0,910.0,878.0,954.0,858.0,814.0,920.0,737.0,11222.0
Mansa,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,1044.0,1160.0,883.0,1013.0,1034.0,788.0,670.0,821.0,720.0,944.0,1009.0,738.0,10824.0
Mansa,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,1110.0,1134.0,975.0,943.0,980.0,895.0,828.0,753.0,847.0,788.0,1002.0,718.0,10973.0
Mansa,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,1156.0,1258.0,1181.0,1236.0,1162.0,987.0,901.0,973.0,922.0,951.0,1046.0,783.0,12556.0
Mansa,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,27.0,21.0,10.0,9.0,16.0,5.0,24.0,10.0,2.0,5.0,7.0,5.0,141.0
Mansa,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mansa,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,649.0,1153.0,777.0,925.0,982.0,742.0,697.0,870.0,814.0,920.0,1055.0,700.0,10284.0
Mansa,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,18.0,6.0,3.0,12.0,2.0,5.0,4.0,9.0,14.0,6.0,5.0,1.0,85.0
Mansa,1.8,Number of pregnancy test kits used at SC level,TOTAL,0.0,172.0,158.0,206.0,225.0,0.0,9.0,0.0,0.0,0.0,0.0,0.0,770.0
Mansa,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,4.0,6.0,7.0,4.0,5.0,0.0,6.0,6.0,5.0,8.0,2.0,8.0,61.0
Mansa,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,14.0,31.0,14.0,23.0,21.0,31.0,35.0,21.0,15.0,20.0,21.0,6.0,252.0
Mansa,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,18.0,37.0,21.0,27.0,26.0,31.0,41.0,27.0,20.0,28.0,23.0,14.0,313.0
Mansa,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,13.0,32.0,15.0,23.0,25.0,31.0,41.0,25.0,18.0,11.0,23.0,8.0,265.0
Mansa,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,6.0,3.0,2.0,2.0,0.0,2.0,3.0,1.0,1.0,0.0,0.0,1.0,21.0
Mansa,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,435.0,469.0,438.0,609.0,647.0,679.0,626.0,575.0,591.0,630.0,497.0,452.0,6648.0
Mansa,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,207.0,337.0,174.0,236.0,329.0,298.0,271.0,257.0,238.0,412.0,254.0,237.0,3250.0
Mansa,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,238.0,307.0,228.0,278.0,245.0,224.0,219.0,220.0,262.0,267.0,267.0,158.0,2913.0
Mansa,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,0.0,7.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,7.0
Mansa,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mansa,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,226.0,286.0,233.0,357.0,371.0,413.0,384.0,360.0,342.0,365.0,285.0,260.0,3882.0
Mansa,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mansa,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mansa,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mansa,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mansa,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,21.0,26.0,22.0,27.0,27.0,32.0,34.0,38.0,16.0,29.0,32.0,22.0,326.0
Mansa,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,46.0,64.0,44.0,76.0,72.0,65.0,73.0,61.0,84.0,76.0,54.0,56.0,771.0
Mansa,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Mansa,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,67.0,90.0,66.0,103.0,99.0,97.0,107.0,99.0,100.0,105.0,86.0,78.0,1097.0
Mansa,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,7.0,0.0,0.0,0.0,0.0,17.0,17.0,20.0,11.0,9.0,10.0,7.0,98.0
Mansa,4.1.1.a,Number of male live births,TOTAL,255.0,430.0,389.0,528.0,546.0,609.0,496.0,495.0,522.0,531.0,441.0,474.0,5716.0
Mansa,4.1.1.b,Number of female live births,TOTAL,229.0,356.0,299.0,463.0,493.0,511.0,547.0,463.0,427.0,491.0,365.0,252.0,4896.0
Mansa,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,484.0,786.0,688.0,991.0,1039.0,1120.0,1043.0,958.0,949.0,1022.0,806.0,726.0,10612.0
Mansa,4.1.2,Number of still births,TOTAL,9.0,7.0,7.0,9.0,6.0,8.0,10.0,9.0,7.0,7.0,5.0,3.0,87.0
Mansa,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,22.0,21.0,26.0,34.0,23.0,31.0,14.0,19.0,17.0,21.0,39.0,30.0,297.0
Mansa,4.2.1,Number of Newborns weighed at birth,TOTAL,476.0,768.0,681.0,713.0,775.0,1120.0,1041.0,955.0,940.0,1006.0,798.0,723.0,9996.0
Mansa,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,178.0,3.0,0.0,3.0,4.0,63.0,16.0,12.0,33.0,47.0,45.0,19.0,423.0
Mansa,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,476.0,769.0,685.0,713.0,775.0,1114.0,1041.0,955.0,937.0,925.0,788.0,712.0,9890.0
Mansa,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,,0.0,,0.0
Mansa,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,0.0,14.0,11.0,18.0,21.0,26.0,23.0,27.0,13.0,20.0,24.0,14.0,211.0
Mansa,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,,64.0,44.0,76.0,72.0,65.0,73.0,61.0,84.0,76.0,54.0,56.0,725.0
Mansa,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Mansa,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,0.0,78.0,55.0,94.0,93.0,91.0,96.0,88.0,97.0,96.0,78.0,70.0,936.0
Mansa,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,0.0,0.0,0.0,0.0,,0.0,0.0,,,,,,0.0
Mansa,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,58.0,78.0,16.0,94.0,97.0,94.0,96.0,88.0,97.0,96.0,78.0,70.0,962.0
Mansa,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,0.0,0.0,44.0,0.0,2.0,3.0,0.0,2.0,0.0,0.0,1.0,1.0,53.0
Mansa,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,58.0,163.0,35.0,94.0,97.0,93.0,96.0,88.0,97.0,96.0,78.0,70.0,1065.0
Mansa,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,18.0,21.0,0.0,23.0,10.0,20.0,5.0,21.0,16.0,20.0,15.0,23.0,192.0
Mansa,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,562.0,659.0,454.0,723.0,781.0,1118.0,1047.0,958.0,943.0,1006.0,798.0,779.0,9828.0
Mansa,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,525.0,687.0,476.0,728.0,767.0,1118.0,1045.0,956.0,949.0,1015.0,820.0,762.0,9848.0
Mansa,6.3,PNC maternal complications attended,TOTAL,0.0,1.0,2.0,1.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,5.0
Mansa,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,12.0,9.0,9.0,9.0,5.0,7.0,3.0,6.0,3.0,3.0,8.0,7.0,81.0
Mansa,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,1.0,3.0,3.0,1.0,5.0,0.0,5.0,1.0,3.0,1.0,0.0,9.0,32.0
Mansa,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,13.0,12.0,12.0,10.0,10.0,7.0,8.0,7.0,6.0,4.0,8.0,16.0,113.0
Mansa,7.2,Number of MTPs conducted at Private Facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mansa,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,1.0,10.0,20.0,0.0,3.0,49.0,39.0,34.0,42.0,37.0,36.0,42.0,313.0
Mansa,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,9.0,141.0,139.0,6.0,21.0,146.0,160.0,155.0,173.0,153.0,110.0,112.0,1325.0
Mansa,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,10.0,151.0,159.0,6.0,24.0,195.0,199.0,189.0,215.0,190.0,146.0,154.0,1638.0
Mansa,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,,,,0.0
Mansa,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,,,,0.0,,,,0.0
Mansa,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,3.0,1.0,2.0,1.0,0.0,0.0,0.0,1.0,0.0,1.0,0.0,0.0,9.0
Mansa,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,,3.0,3.0,6.0,3.0,4.0,1.0,1.0,,,1.0,,22.0
Mansa,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Mansa,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,3.0,4.0,5.0,7.0,3.0,4.0,1.0,2.0,0.0,1.0,1.0,0.0,31.0
Mansa,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,,,,,,,,,0.0
Mansa,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,,,,,,,,0.0
Mansa,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,87.0,238.0,296.0,196.0,79.0,14.0,0.0,29.0,22.0,21.0,15.0,27.0,1024.0
Mansa,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,1.0,0.0,0.0,0.0,0.0,0.0,0.0,,48.0,24.0,49.0,,122.0
Mansa,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Mansa,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,88.0,238.0,296.0,196.0,79.0,14.0,0.0,29.0,70.0,45.0,64.0,27.0,1146.0
Mansa,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,,,,,,,,,0.0
Mansa,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,,,,,,,,0.0
Mansa,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,0.0,11.0,78.0,36.0,39.0,14.0,12.0,12.0,17.0,14.0,61.0,49.0,343.0
Mansa,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,14.0,127.0,189.0,47.0,13.0,14.0,7.0,16.0,21.0,6.0,23.0,16.0,493.0
Mansa,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Mansa,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,14.0,138.0,267.0,83.0,52.0,28.0,19.0,28.0,38.0,20.0,84.0,65.0,836.0
Mansa,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,,,,,,,,,0.0
Mansa,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,,,,,,,,0.0
Mansa,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,0.0,3.0,0.0,6.0,0.0,0.0,0.0,0.0,0.0,0.0,,,9.0
Mansa,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,,4.0,4.0,77.0,0.0,11.0,10.0,,15.0,6.0,5.0,4.0,136.0
Mansa,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Mansa,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,0.0,7.0,4.0,83.0,0.0,11.0,10.0,0.0,15.0,6.0,5.0,4.0,145.0
Mansa,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,,,,,,,,,0.0
Mansa,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,311.0,343.0,335.0,504.0,366.0,343.0,362.0,356.0,302.0,313.0,357.0,267.0,4159.0
Mansa,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,0.0,10.0,4.0,16.0,0.0,7.0,7.0,8.0,13.0,8.0,10.0,9.0,92.0
Mansa,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,38.0,43.0,63.0,38.0,49.0,48.0,58.0,58.0,96.0,109.0,85.0,31.0,716.0
Mansa,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,94.0,85.0,75.0,90.0,65.0,104.0,85.0,105.0,104.0,125.0,99.0,58.0,1089.0
Mansa,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Mansa,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,443.0,481.0,477.0,648.0,480.0,502.0,512.0,527.0,515.0,555.0,551.0,365.0,6056.0
Mansa,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,9.0,12.0,18.0,12.0,13.0,74.0,41.0,107.0,134.0,177.0,137.0,54.0,788.0
Mansa,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,,,,,,,,,0.0
Mansa,9.06,Number of IUCD removals,TOTAL,194.0,203.0,124.0,135.0,147.0,170.0,273.0,180.0,129.0,124.0,120.0,93.0,1892.0
Mansa,9.07,Number of Oral Pills cycles distributed,TOTAL,4262.0,5318.0,4769.0,3944.0,3393.0,3426.0,5049.0,4131.0,3307.0,3922.0,3391.0,3022.0,47934.0
Mansa,9.08,Number of Condom pieces distributed,TOTAL,67212.0,72303.0,74950.0,71501.0,69496.0,71523.0,76974.0,73905.0,73033.0,71967.0,75647.0,65941.0,864452.0
Mansa,9.09,Number of Centchroman (weekly) pills given,TOTAL,0.0,20.0,6.0,8.0,9.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,44.0
Mansa,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,6.0,10.0,9.0,9.0,18.0,33.0,8.0,16.0,2.0,0.0,7.0,13.0,131.0
Mansa,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,,,0.0,0.0
Mansa,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0.0,0.0,1.0,0.0,0.0,0.0,0.0,,0.0,,,0.0,1.0
Mansa,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,0.0,0.0
Mansa,9.11.2.b,Number of failures following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,0.0,0.0
Mansa,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,0.0,0.0
Mansa,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,0.0,0.0
Mansa,9.12,Number of Institutions having NSV trained doctors,TOTAL,1.0,,,1.0,1.0,1.0,,,1.0,,,,-1.0
Mansa,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,884.0,971.0,904.0,1089.0,1219.0,1394.0,1415.0,1336.0,1253.0,1139.0,1070.0,831.0,13505.0
Mansa,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,956.0,993.0,710.0,813.0,899.0,945.0,1061.0,1216.0,1001.0,467.0,105.0,112.0,9278.0
Mansa,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,996.0,1114.0,836.0,857.0,822.0,819.0,895.0,1097.0,1063.0,931.0,526.0,262.0,10218.0
Mansa,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,931.0,1239.0,929.0,1000.0,867.0,795.0,825.0,921.0,990.0,1040.0,934.0,481.0,10952.0
Mansa,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,8.0,28.0,27.0,20.0,2.0,0.0,5.0,0.0,0.0,594.0,960.0,535.0,2179.0
Mansa,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,11.0,20.0,23.0,27.0,3.0,0.0,27.0,0.0,0.0,20.0,445.0,450.0,1026.0
Mansa,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,24.0,12.0,30.0,23.0,20.0,16.0,24.0,0.0,0.0,1.0,51.0,227.0,428.0
Mansa,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,724.0,827.0,708.0,827.0,940.0,996.0,1127.0,1110.0,865.0,740.0,575.0,551.0,9990.0
Mansa,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,950.0,960.0,710.0,813.0,899.0,942.0,1061.0,1218.0,1001.0,856.0,971.0,592.0,10973.0
Mansa,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,979.0,1095.0,836.0,859.0,822.0,821.0,900.0,1089.0,1063.0,935.0,909.0,656.0,10964.0
Mansa,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,955.0,1231.0,932.0,1002.0,867.0,797.0,828.0,932.0,990.0,1041.0,987.0,686.0,11248.0
Mansa,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,574.0,631.0,629.0,615.0,715.0,678.0,920.0,814.0,991.0,829.0,662.0,566.0,8624.0
Mansa,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,950.0,959.0,710.0,813.0,899.0,949.0,1064.0,1218.0,1001.0,458.0,237.0,112.0,9370.0
Mansa,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,981.0,1094.0,835.0,857.0,815.0,821.0,903.0,1091.0,1063.0,931.0,535.0,258.0,10184.0
Mansa,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,942.0,1228.0,929.0,996.0,864.0,765.0,827.0,923.0,990.0,1040.0,934.0,484.0,10922.0
Mansa,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,852.0,1225.0,984.0,1147.0,1110.0,1059.0,1012.0,1018.0,864.0,794.0,870.0,654.0,11589.0
Mansa,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,659.0,865.0,635.0,751.0,649.0,538.0,513.0,841.0,838.0,849.0,1040.0,717.0,8895.0
Mansa,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mansa,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,477.0,637.0,529.0,619.0,573.0,536.0,543.0,565.0,457.0,435.0,474.0,365.0,6210.0
Mansa,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,407.0,583.0,438.0,520.0,492.0,495.0,459.0,459.0,407.0,359.0,386.0,276.0,5281.0
Mansa,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,884.0,1220.0,967.0,1139.0,1065.0,1031.0,1002.0,1024.0,864.0,794.0,860.0,641.0,11491.0
Mansa,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,978.0,1149.0,906.0,1000.0,889.0,756.0,724.0,863.0,838.0,849.0,1014.0,730.0,10696.0
Mansa,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,971.0,1148.0,906.0,1057.0,943.0,754.0,724.0,860.0,838.0,849.0,1014.0,732.0,10796.0
Mansa,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,716.0,610.0,260.0,375.0,432.0,401.0,396.0,0.0,0.0,19.0,3.0,17.0,3229.0
Mansa,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,366.0,440.0,332.0,429.0,401.0,335.0,322.0,380.0,360.0,350.0,408.0,315.0,4438.0
Mansa,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,343.0,341.0,284.0,350.0,320.0,291.0,290.0,318.0,285.0,304.0,362.0,270.0,3758.0
Mansa,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,709.0,781.0,616.0,779.0,721.0,626.0,612.0,698.0,645.0,654.0,770.0,585.0,8196.0
Mansa,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,522.0,758.0,501.0,725.0,936.0,677.0,668.0,593.0,501.0,430.0,525.0,398.0,7234.0
Mansa,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,314.0,941.0,286.0,877.0,1273.0,533.0,568.0,515.0,341.0,198.0,328.0,172.0,6346.0
Mansa,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,160.0,513.0,148.0,526.0,1035.0,464.0,373.0,344.0,210.0,133.0,228.0,111.0,4245.0
Mansa,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Mansa,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mansa,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mansa,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,373.0,437.0,389.0,298.0,287.0,298.0,412.0,424.0,445.0,436.0,434.0,432.0,4665.0
Mansa,10.4.2,Number of Immunisation sessions held during the month,TOTAL,364.0,438.0,373.0,292.0,278.0,293.0,402.0,415.0,438.0,425.0,424.0,307.0,4449.0
Mansa,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,349.0,400.0,344.0,239.0,225.0,251.0,358.0,374.0,392.0,374.0,388.0,286.0,3980.0
Mansa,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,,0.0,0.0,0.0
Mansa,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,844.0,1149.0,975.0,1026.0,1072.0,1003.0,1003.0,1014.0,824.0,778.0,866.0,641.0,11195.0
Mansa,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,1091.0,1125.0,852.0,745.0,834.0,993.0,1088.0,1179.0,1351.0,1251.0,1272.0,916.0,12697.0
Mansa,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,1029.0,1159.0,614.0,575.0,807.0,1268.0,1371.0,1369.0,1221.0,1044.0,1167.0,787.0,12411.0
Mansa,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,0.0
Mansa,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,0.0
Mansa,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,0.0
Mansa,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,0.0
Mansa,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,0.0
Mansa,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mansa,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,4.0,35.0,0.0,0.0,27.0,3.0,0.0,6.0,6.0,8.0,7.0,0.0,96.0
Mansa,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,5.0,0.0,0.0,0.0,0.0,0.0,0.0,5.0
Mansa,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,0.0
Mansa,13.1,Number of Patients operated for cataract,TOTAL,109.0,52.0,51.0,0.0,64.0,60.0,51.0,66.0,72.0,28.0,64.0,108.0,725.0
Mansa,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,139.0,51.0,51.0,0.0,62.0,62.0,50.0,64.0,70.0,28.0,64.0,108.0,749.0
Mansa,13.3,Number of School children detected with Refractive errors,TOTAL,18.0,60.0,0.0,0.0,41.0,41.0,84.0,482.0,80.0,42.0,17.0,95.0,960.0
Mansa,13.4,Number of children provided free glasses,TOTAL,77.0,0.0,0.0,0.0,0.0,0.0,85.0,35.0,0.0,0.0,0.0,95.0,292.0
Mansa,13.5,Number of eyes collected through eye donation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mansa,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mansa,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,1.0,,,,1.0,2.0,2.0,1.0,1.0,1.0,1.0,1.0,-1.0
Mansa,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,,,,,,,1.0,3.0,,,,,-1.0
Mansa,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,230.0,254.0,140.0,238.0,258.0,255.0,257.0,261.0,264.0,260.0,272.0,164.0,-1.0
Mansa,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,1.0,,1.0,3.0,1.0,2.0,1.0,1.0,1.0,1.0,1.0,,-1.0
Mansa,14.05,Number of RKS meetings held during the month,TOTAL,0.0,0.0,4.0,1.0,0.0,0.0,,0.0,,,1.0,0.0,6.0
Mansa,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,1.0,,1.0,2.0,1.0,2.0,1.0,2.0,1.0,1.0,1.0,,-1.0
Mansa,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,0.0,0.0,3.0,1.0,36.0,36.0,,23.0,,28.0,39.0,32.0,198.0
Mansa,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,1.0,,,,,1.0,1.0,1.0,,,,,-1.0
Mansa,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,0.0,,0.0,,0.0,0.0,,,,,1.0,,-1.0
Mansa,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,144.0,590.0,313.0,174.0,285.0,324.0,288.0,328.0,205.0,222.0,192.0,187.0,3252.0
Mansa,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,327.0,1097.0,859.0,612.0,409.0,613.0,491.0,628.0,485.0,347.0,566.0,491.0,6925.0
Mansa,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,107.0,282.0,318.0,119.0,247.0,298.0,348.0,279.0,165.0,187.0,170.0,148.0,2668.0
Mansa,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,607.0,1079.0,731.0,694.0,549.0,896.0,860.0,989.0,1023.0,665.0,922.0,941.0,9956.0
Mansa,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,251.0,872.0,631.0,293.0,532.0,622.0,636.0,607.0,370.0,409.0,362.0,335.0,5920.0
Mansa,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,934.0,2176.0,1590.0,1306.0,958.0,1509.0,1351.0,1617.0,1508.0,1012.0,1488.0,1432.0,16881.0
Mansa,14.10.2.a,Number of death cases of Inpatient males,TOTAL,0.0,1.0,6.0,0.0,3.0,5.0,2.0,6.0,6.0,,,,29.0
Mansa,14.10.2.b,Number of death cases of Inpatient females,TOTAL,0.0,3.0,3.0,0.0,2.0,1.0,2.0,6.0,1.0,,,,18.0
Mansa,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,0.0,4.0,9.0,0.0,5.0,6.0,4.0,12.0,7.0,,,,47.0
Mansa,14.11,In-Patient Head Count at midnight,TOTAL,38.0,2514.0,2634.0,0.0,2155.0,2549.0,2778.0,3091.0,3209.0,19.0,,30.0,19017.0
Mansa,14.12.1,OPD attendance (All),TOTAL,23362.0,41491.0,37959.0,47252.0,36655.0,40089.0,34234.0,35881.0,29568.0,32864.0,37365.0,31865.0,428585.0
Mansa,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,118.0,342.0,235.0,236.0,182.0,116.0,380.0,342.0,258.0,255.0,305.0,305.0,3074.0
Mansa,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,0.0,5.0,32.0,0.0,0.0,0.0,5.0,0.0,0.0,0.0,0.0,0.0,42.0
Mansa,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,23.0,686.0,435.0,449.0,333.0,207.0,483.0,453.0,560.0,577.0,706.0,523.0,5435.0
Mansa,14.14.a,Number of patients given AYUSH treatment,TOTAL,767.0,1843.0,1645.0,1994.0,992.0,4291.0,3207.0,2848.0,3101.0,3518.0,4554.0,3668.0,32428.0
Mansa,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,0.0,334.0,962.0,0.0,564.0,311.0,307.0,306.0,303.0,307.0,325.0,,3719.0
Mansa,14.14.c,Number of Adolescents counselled,TOTAL,0.0,20.0,23.0,0.0,34.0,28.0,35.0,29.0,24.0,0.0,56.0,17.0,266.0
Mansa,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,7642.0,6359.0,5725.0,5405.0,3163.0,4575.0,3768.0,3594.0,4974.0,4613.0,4458.0,2925.0,57201.0
Mansa,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,93.0,357.0,253.0,335.0,42.0,341.0,317.0,299.0,359.0,453.0,348.0,323.0,3520.0
Mansa,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,59.0,182.0,241.0,191.0,58.0,255.0,180.0,77.0,237.0,139.0,150.0,128.0,1897.0
Mansa,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,0.0,2.0,1.0,4.0,0.0,4.0,0.0,0.0,1.0,2.0,0.0,2.0,16.0
Mansa,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,28.0,278.0,343.0,255.0,214.0,297.0,261.0,29.0,421.0,278.0,227.0,164.0,2795.0
Mansa,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,0.0,3.0,1.0,2.0,0.0,0.0,1.0,0.0,1.0,1.0,0.0,32.0,41.0
Mansa,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,438.0,1005.0,699.0,635.0,158.0,857.0,828.0,399.0,700.0,580.0,530.0,418.0,7247.0
Mansa,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,1.0,0.0,2.0,0.0,0.0,1.0,0.0,0.0,1.0,0.0,0.0,1.0,6.0
Mansa,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,525.0,1465.0,1283.0,1081.0,430.0,1409.0,1269.0,505.0,1358.0,997.0,907.0,710.0,11939.0
Mansa,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,1.0,5.0,4.0,6.0,0.0,5.0,1.0,0.0,3.0,3.0,0.0,35.0,63.0
Mansa,15.2,Number of Widal tests conducted,Number tested,279.0,273.0,433.0,326.0,165.0,378.0,744.0,704.0,89.0,118.0,236.0,218.0,3963.0
Mansa,15.3.a,Number of VDRL tests conducted on males,Number tested,4.0,15.0,35.0,26.0,5.0,51.0,40.0,34.0,43.0,36.0,39.0,39.0,367.0
Mansa,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,15.0,125.0,126.0,113.0,52.0,147.0,150.0,140.0,168.0,142.0,108.0,98.0,1384.0
Mansa,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,168.0,478.0,554.0,529.0,256.0,478.0,427.0,722.0,573.0,480.0,621.0,406.0,5692.0
Mansa,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,187.0,618.0,715.0,668.0,313.0,676.0,617.0,896.0,784.0,658.0,768.0,543.0,7443.0
Mansa,15.4.1,Number of blood smears examined for Malaria,TOTAL,2865.0,3818.0,1565.0,242.0,136.0,3620.0,2799.0,422.0,3195.0,305.0,3096.0,3876.0,25939.0
Mansa,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,249.0,19.0,4.0,0.0,0.0,40.0,12.0,,1.0,0.0,2.0,1.0,328.0
Mansa,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Mansa,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,2500.0,500.0,1500.0,10000.0,3500.0,,,,,,,,18000.0
Mansa,16.1.1,Stock position of DPT vaccines,2. Stocks Received,0.0,10000.0,10000.0,0.0,0.0,,,,,,,,20000.0
Mansa,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,,,,,,,,0.0
Mansa,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,2000.0,9000.0,1500.0,6500.0,3000.0,,,,,,,,22000.0
Mansa,16.1.1,Stock position of DPT vaccines,5. Total Stock,500.0,1500.0,10000.0,3500.0,500.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,16000.0
Mansa,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,0.0,,,0.0,0.0,,,,,,,,0.0
Mansa,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,0.0,,,0.0,0.0,,,,,,,,0.0
Mansa,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,0.0,,,0.0,0.0,,,,,,,,0.0
Mansa,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,0.0,,,0.0,0.0,,,,,,,,0.0
Mansa,16.1.1A,Stock Position of Pentavalent,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mansa,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,18000.0,16500.0,8000.0,12000.0,4000.0,,,,,,,,58500.0
Mansa,16.1.2,Stock position of OPV vaccines,2. Stocks Received,0.0,0.0,5000.0,0.0,0.0,,,,,,,,5000.0
Mansa,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,1500.0,0.0,0.0,0.0,0.0,,,,,,,,1500.0
Mansa,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,0.0,8500.0,1000.0,8000.0,4000.0,,,,,,,,21500.0
Mansa,16.1.2,Stock position of OPV vaccines,5. Total Stock,16500.0,8000.0,12000.0,4000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,40500.0
Mansa,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,5000.0,4500.0,5500.0,7500.0,3000.0,,,,,,,,25500.0
Mansa,16.1.3,Stock position of TT vaccines,2. Stocks Received,,6000.0,5000.0,0.0,0.0,,,,,,,,11000.0
Mansa,16.1.3,Stock position of TT vaccines,3. Unusable Stock,500.0,0.0,0.0,0.0,0.0,,,,,,,,500.0
Mansa,16.1.3,Stock position of TT vaccines,4. Stock Distributed,0.0,5000.0,3000.0,4500.0,3000.0,,,,,,,,15500.0
Mansa,16.1.3,Stock position of TT vaccines,5. Total Stock,4500.0,5500.0,7500.0,3000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,20500.0
Mansa,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,,,,,,,,0.0
Mansa,16.1.4,Stock position of DT vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,,,,,,,,0.0
Mansa,16.1.4,Stock position of DT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,,,,,,,,0.0
Mansa,16.1.4,Stock position of DT vaccines,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,,,,,,,,0.0
Mansa,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mansa,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,1500.0,500.0,500.0,5500.0,3000.0,,,,,,,,11000.0
Mansa,16.1.5,Stock position of BCG vaccines,2. Stocks Received,0.0,5000.0,5000.0,0.0,0.0,,,,,,,,10000.0
Mansa,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,1000.0,0.0,0.0,0.0,0.0,,,,,,,,1000.0
Mansa,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,0.0,5000.0,0.0,2500.0,3000.0,,,,,,,,10500.0
Mansa,16.1.5,Stock position of BCG vaccines,5. Total Stock,500.0,500.0,5500.0,3000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,9500.0
Mansa,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,2500.0,1500.0,1750.0,3500.0,1500.0,,,,,,,,10750.0
Mansa,16.1.6,Stock position of Measles vaccines,2. Stocks Received,0.0,4000.0,5000.0,0.0,0.0,,,,,,,,9000.0
Mansa,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,1000.0,0.0,0.0,0.0,0.0,,,,,,,,1000.0
Mansa,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,0.0,5500.0,3250.0,3500.0,1500.0,,,,,,,,13750.0
Mansa,16.1.6,Stock position of Measles vaccines,5. Total Stock,1500.0,0.0,3500.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,5000.0
Mansa,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,,,,,,,,0.0
Mansa,16.1.7,Stock position of JE vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,,,,,,,,0.0
Mansa,16.1.7,Stock position of JE vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,,,,,,,,0.0
Mansa,16.1.7,Stock position of JE vaccines,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,,,,,,,,0.0
Mansa,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mansa,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,4000.0,3000.0,4800.0,8700.0,,,,,,,,,20500.0
Mansa,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,0.0,8000.0,6000.0,0.0,,,,,,,,,14000.0
Mansa,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,1000.0,0.0,0.0,0.0,,,,,,,,,1000.0
Mansa,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,,6200.0,2100.0,3000.0,,,,,,,,,11300.0
Mansa,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,3000.0,4800.0,8700.0,5700.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,22200.0
Mansa,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,,0.0,0.0,,,,,,,,,,0.0
Mansa,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,,0.0,0.0,,,,,,,,,,0.0
Mansa,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,,0.0,0.0,,,,,,,,,,0.0
Mansa,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,,0.0,0.0,,,,,,,,,,0.0
Mansa,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mansa,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,,0.0,0.0,,,,,,,,,,0.0
Mansa,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,,0.0,0.0,,,,,,,,,,0.0
Mansa,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,,0.0,0.0,,,,,,,,,,0.0
Mansa,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,,0.0,0.0,,,,,,,,,,0.0
Mansa,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mansa,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,0.0,0.0,,,,,,,,,,0.0
Mansa,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,,0.0,0.0,,,,,,,,,,0.0
Mansa,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,,0.0,0.0,,,,,,,,,,0.0
Mansa,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,,0.0,0.0,,,,,,,,,,0.0
Mansa,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mansa,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,0.0,0.0,,,,,,,,,,0.0
Mansa,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,,0.0,0.0,,,,,,,,,,0.0
Mansa,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,,0.0,0.0,,,,,,,,,,0.0
Mansa,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,,0.0,0.0,,,,,,,,,,0.0
Mansa,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mansa,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,,0.0,0.0,,,,,,,,,,0.0
Mansa,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,,0.0,0.0,,,,,,,,,,0.0
Mansa,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,,0.0,0.0,,,,,,,,,,0.0
Mansa,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,,0.0,0.0,,,,,,,,,,0.0
Mansa,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mansa,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,,0.0,0.0,,,,,,,,,,0.0
Mansa,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,,0.0,0.0,,,,,,,,,,0.0
Mansa,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,,0.0,0.0,,,,,,,,,,0.0
Mansa,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,,0.0,0.0,,,,,,,,,,0.0
Mansa,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mansa,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,,0.0,0.0,,,,,,,,,,0.0
Mansa,16.3.02,Stock Position of Gloves,2. Stocks Received,,0.0,0.0,,,,,,,,,,0.0
Mansa,16.3.02,Stock Position of Gloves,3. Unusable Stock,,0.0,0.0,,,,,,,,,,0.0
Mansa,16.3.02,Stock Position of Gloves,4. Stock Distributed,,0.0,0.0,,,,,,,,,,0.0
Mansa,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mansa,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,,0.0,0.0,,,,,,,,,,0.0
Mansa,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,,0.0,0.0,,,,,,,,,,0.0
Mansa,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,,0.0,0.0,,,,,,,,,,0.0
Mansa,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,,0.0,0.0,,,,,,,,,,0.0
Mansa,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mansa,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,,0.0,0.0,,,,,,,,,,0.0
Mansa,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,,0.0,0.0,,,,,,,,,,0.0
Mansa,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,,0.0,0.0,,,,,,,,,,0.0
Mansa,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,,0.0,0.0,,,,,,,,,,0.0
Mansa,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mansa,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,,0.0,0.0,,,,,,,,,,0.0
Mansa,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,,0.0,0.0,,,,,,,,,,0.0
Mansa,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,,0.0,0.0,,,,,,,,,,0.0
Mansa,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,,0.0,0.0,,,,,,,,,,0.0
Mansa,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mansa,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,,0.0,0.0,,,,,,,,,,0.0
Mansa,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,,0.0,0.0,,,,,,,,,,0.0
Mansa,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,,0.0,0.0,,,,,,,,,,0.0
Mansa,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,,0.0,0.0,,,,,,,,,,0.0
Mansa,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mansa,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,,0.0,0.0,,,,,,,,,,0.0
Mansa,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,,0.0,0.0,,,,,,,,,,0.0
Mansa,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,,0.0,0.0,,,,,,,,,,0.0
Mansa,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,,0.0,0.0,,,,,,,,,,0.0
Mansa,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mansa,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,,0.0,0.0,,,,,,,,,,0.0
Mansa,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,,0.0,0.0,,,,,,,,,,0.0
Mansa,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,,0.0,0.0,,,,,,,,,,0.0
Mansa,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,,0.0,0.0,,,,,,,,,,0.0
Mansa,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mansa,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,,0.0,0.0,,,,,,,,,,0.0
Mansa,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,,0.0,0.0,,,,,,,,,,0.0
Mansa,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,,0.0,0.0,,,,,,,,,,0.0
Mansa,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,,0.0,0.0,,,,,,,,,,0.0
Mansa,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mansa,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,,0.0,0.0,,,,,,,,,,0.0
Mansa,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,,0.0,0.0,,,,,,,,,,0.0
Mansa,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,,0.0,0.0,,,,,,,,,,0.0
Mansa,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,,0.0,0.0,,,,,,,,,,0.0
Mansa,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mansa,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,,0.0,0.0,,,,,,,,,,0.0
Mansa,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,,0.0,0.0,,,,,,,,,,0.0
Mansa,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,,0.0,0.0,,,,,,,,,,0.0
Mansa,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,,0.0,0.0,,,,,,,,,,0.0
Mansa,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mansa,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,2000.0,2000.0,2000.0,3000.0,3000.0,,,,,,,,12000.0
Mansa,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,0.0,2000.0,2000.0,0.0,0.0,,,,,,,,4000.0
Mansa,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,,,,,,,,0.0
Mansa,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,0.0,2000.0,1000.0,0.0,0.0,,,,,,,,3000.0
Mansa,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,2000.0,2000.0,3000.0,3000.0,3000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,13000.0
Mansa,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,,,,,,,,0.0
Mansa,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,0.0,50000.0,0.0,0.0,0.0,,,,,,,,50000.0
Mansa,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,,,,,,,,0.0
Mansa,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,0.0,50000.0,0.0,0.0,0.0,,,,,,,,50000.0
Mansa,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mansa,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,0.0,0.0,1800.0,3000.0,2400.0,,,,,,,,7200.0
Mansa,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,0.0,2400.0,2400.0,0.0,0.0,,,,,,,,4800.0
Mansa,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,,,,,,,,0.0
Mansa,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,0.0,600.0,1200.0,600.0,0.0,,,,,,,,2400.0
Mansa,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,0.0,1800.0,3000.0,2400.0,2400.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,9600.0
Mansa,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,,,,,,,,,,,,,
Mansa,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Mansa,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Mansa,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,,,,,,,,,,,,
Mansa,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Mansa,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Mansa,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,,,,,,,,,,,,,
Mansa,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,,,,,,,1.0,,,,,,1.0
Mansa,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Mansa,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,,,,,,,1.0,,,,,,1.0
Mansa,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Mansa,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Mansa,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,,,,,,,,,,,,,
Mansa,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,,,,,,,,,,,,
Mansa,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,,,,,,,,,,
Mansa,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,,,,,,,,,,,,,
Mansa,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,,,,,,
Mansa,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
Mansa,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,,,,,,,,,
Mansa,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,,,,,,,,,,,
Mansa,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,,,,,,,,,,
Mansa,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,,,,,,,,,,,,
Mansa,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Mansa,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Mansa,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Mansa,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,,,,,,,,,,,,,
Mansa,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,,,,,,,,,,,,,
Mansa,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,,,,,,,,,,,,,
Mansa,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
Mansa,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,,,,,,,,,
Mansa,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,,,,,,,,,
Mansa,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,,,,,,,,,,,
Mansa,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
Mansa,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,,,,,,,,,,,,,
Mansa,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,,,,,,,,,,,,,
Mansa,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,,,,,,,,,,,,,
Mansa,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,,,,,,
Mansa,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,,,,,,,1.0,1.0,,,,,2.0
Mansa,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,,,,,,,,,,,,,
Mansa,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,,,,,,,1.0,1.0,,,,,2.0
Mansa,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
Mansa,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,,,,,,,,
Mansa,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
Mansa,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,,,,,,,,,,
Mansa,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,,,,,,,,,,
Mansa,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,,,,,,,,,,,,,
Mansa,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,,,,,,,,,,,,,
Mansa,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,,,,,,,,,,,,,
Mansa,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
Mansa,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,,,,,,,,,,,
Mansa,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,,,,
Mansa,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,,,,,,,,,,,
Mansa,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,,,,,,,,,
Mansa,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,,,,,,,2.0,1.0,,,,,3.0
Mansa,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,,,,,,,5.0,1.0,,,,,6.0
Mansa,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,,,,,,,7.0,2.0,,,,,9.0
Mansa,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,,,,,,,
Mansa,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,,,,,,,,,,,,,
Mansa,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,,,,,,,,,,,,,
Mansa,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,,,,,,,,,,,,,
Mansa,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Mansa,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
Mansa,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Mansa,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
Mansa,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Mansa,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,,,,,,,,
Mansa,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Mansa,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,,,,,,,,
Mansa,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Mansa,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,,,,,,,,,,
Mansa,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Mansa,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,,,,,,,,,,,
Mansa,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Mansa,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,,,,,,,,,,,
Mansa,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Mansa,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,,,,,,,,,,,
Mansa,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Mansa,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,,,,,,,
Mansa,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Mansa,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,,,,,,,
Mansa,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Mansa,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,,,,,,,,,,,,,
Mansa,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Mansa,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,,,,,,,,,,,,,
Mansa,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,,,,,,,,,,,,
Mansa,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,,,,,,,,,,,,,
Mansa,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,,,,,,,,,,,,,
Mansa,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,,,,,,,,,,,,,
Mansa,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,,,,,,,,,
Mansa,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,,,,,,,1.0,,,,,,1.0
Mansa,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,,,,,,,,,,,,
Mansa,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,,,,,,,1.0,,,,,,1.0
Mansa,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,,,,,,,,,,
Mansa,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,,,,,,,,,,,,
Mansa,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,,,,,,,,,,,
Mansa,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,,,,,,,,,,,,,
Mansa,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,,,,,,,,,,,
Mansa,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,,,,,,,,,,,,,
Mansa,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,,,,,,,1.0,,,,,,1.0
Mansa,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,,,,,,,1.0,,,,,,1.0
Mansa,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,,,,,,,,,,,,
Mansa,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,,,,,,,2.0,,,,,,2.0
Mansa,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,,,,,,,1.0,1.0,,,,,2.0
Mansa,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,,,,,,,3.0,1.0,,,,,4.0
Mansa,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,,,,,,,,,,,,,
Mansa,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,,,,,,,1.0,,,,,,1.0
Mansa,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,,,,,,,5.0,3.0,,,,,8.0
Mansa,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,,,,,,,6.0,3.0,,,,,9.0
Moga,1.1,Total number of pregnant women Registered for ANC,TOTAL,1688.0,1799.0,1474.0,1410.0,1470.0,1133.0,990.0,1166.0,1135.0,1521.0,1526.0,1222.0,16534.0
Moga,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,1146.0,1228.0,976.0,896.0,932.0,710.0,651.0,788.0,798.0,1138.0,1153.0,812.0,11228.0
Moga,1.2,Number of Pregnant women registered under JSY,TOTAL,907.0,971.0,792.0,793.0,850.0,685.0,587.0,705.0,714.0,933.0,944.0,748.0,9629.0
Moga,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,1324.0,1288.0,1330.0,1409.0,1375.0,1378.0,1289.0,1228.0,1168.0,1122.0,1051.0,895.0,14857.0
Moga,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,1651.0,1682.0,1410.0,1317.0,1403.0,1094.0,979.0,1104.0,1083.0,1384.0,1423.0,1094.0,15624.0
Moga,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,1632.0,1581.0,1589.0,1324.0,1375.0,1403.0,1157.0,1040.0,1104.0,1155.0,1412.0,1124.0,15896.0
Moga,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,1374.0,1545.0,1566.0,1616.0,1466.0,1168.0,920.0,687.0,441.0,595.0,675.0,682.0,12735.0
Moga,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,44.0,27.0,30.0,29.0,55.0,57.0,0.0,43.0,80.0,29.0,29.0,5.0,428.0
Moga,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,25.0,24.0,22.0,21.0,14.0,16.0,16.0,29.0,32.0,37.0,17.0,16.0,269.0
Moga,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,1625.0,1664.0,1385.0,1477.0,1431.0,1201.0,997.0,1151.0,1169.0,1423.0,1402.0,1102.0,16027.0
Moga,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,4.0,1.0,5.0,1.0,0.0,2.0,2.0,3.0,5.0,28.0,27.0,10.0,88.0
Moga,1.8,Number of pregnancy test kits used at SC level,TOTAL,853.0,991.0,952.0,835.0,844.0,673.0,594.0,726.0,746.0,909.0,968.0,669.0,9760.0
Moga,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,69.0,33.0,29.0,46.0,53.0,43.0,43.0,40.0,31.0,46.0,47.0,17.0,497.0
Moga,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,12.0,62.0,59.0,64.0,90.0,69.0,97.0,76.0,54.0,52.0,53.0,41.0,729.0
Moga,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,81.0,95.0,88.0,110.0,143.0,112.0,140.0,116.0,85.0,98.0,100.0,58.0,1226.0
Moga,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,57.0,74.0,85.0,94.0,140.0,112.0,140.0,114.0,79.0,80.0,96.0,52.0,1123.0
Moga,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,0.0,4.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,2.0,2.0,0.0,9.0
Moga,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,537.0,601.0,719.0,925.0,997.0,969.0,956.0,856.0,856.0,823.0,649.0,638.0,9526.0
Moga,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,391.0,440.0,522.0,682.0,787.0,719.0,736.0,649.0,566.0,563.0,459.0,491.0,7005.0
Moga,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,236.0,305.0,311.0,502.0,540.0,522.0,393.0,352.0,416.0,446.0,416.0,338.0,4777.0
Moga,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Moga,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Moga,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,253.0,331.0,314.0,492.0,590.0,542.0,570.0,462.0,525.0,472.0,434.0,358.0,5343.0
Moga,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,53.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,53.0
Moga,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Moga,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Moga,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Moga,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,2.0,1.0,3.0,7.0,4.0,8.0,3.0,2.0,5.0,3.0,3.0,4.0,45.0
Moga,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,144.0,151.0,180.0,228.0,210.0,226.0,220.0,190.0,199.0,242.0,180.0,147.0,2317.0
Moga,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Moga,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,146.0,152.0,183.0,235.0,214.0,234.0,223.0,192.0,204.0,245.0,183.0,151.0,2362.0
Moga,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,85.0,135.0,80.0,169.0,165.0,174.0,176.0,123.0,132.0,139.0,130.0,98.0,1606.0
Moga,4.1.1.a,Number of male live births,TOTAL,426.0,544.0,460.0,835.0,915.0,841.0,864.0,744.0,772.0,677.0,642.0,538.0,8258.0
Moga,4.1.1.b,Number of female live births,TOTAL,431.0,474.0,410.0,678.0,809.0,774.0,799.0,687.0,686.0,710.0,545.0,509.0,7512.0
Moga,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,857.0,1018.0,870.0,1513.0,1724.0,1615.0,1663.0,1431.0,1458.0,1387.0,1187.0,1047.0,15770.0
Moga,4.1.2,Number of still births,TOTAL,18.0,15.0,30.0,31.0,22.0,24.0,13.0,11.0,9.0,17.0,11.0,13.0,214.0
Moga,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,96.0,128.0,96.0,77.0,66.0,78.0,58.0,66.0,56.0,72.0,89.0,53.0,935.0
Moga,4.2.1,Number of Newborns weighed at birth,TOTAL,855.0,1010.0,865.0,1505.0,1708.0,1607.0,1658.0,1420.0,1457.0,1380.0,1187.0,1047.0,15699.0
Moga,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,12.0,45.0,23.0,31.0,41.0,37.0,67.0,152.0,206.0,281.0,186.0,102.0,1183.0
Moga,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,764.0,706.0,689.0,844.0,1339.0,1195.0,1264.0,1047.0,1099.0,1005.0,865.0,897.0,11714.0
Moga,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Moga,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,2.0,1.0,3.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,0.0,0.0,8.0
Moga,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,0.0,160.0,180.0,147.0,123.0,285.0,381.0,247.0,213.0,296.0,253.0,242.0,2527.0
Moga,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Moga,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,2.0,162.0,183.0,147.0,123.0,285.0,381.0,249.0,213.0,296.0,253.0,242.0,2536.0
Moga,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,3.0,5.0
Moga,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,180.0,159.0,348.0,646.0,471.0,616.0,282.0,247.0,199.0,20.0,250.0,162.0,3580.0
Moga,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,25.0,19.0,22.0,22.0,14.0,16.0,16.0,120.0,100.0,34.0,16.0,16.0,420.0
Moga,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,190.0,239.0,692.0,637.0,588.0,775.0,381.0,102.0,204.0,14.0,248.0,55.0,4125.0
Moga,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,30.0,36.0,10.0,9.0,24.0,6.0,10.0,18.0,21.0,28.0,27.0,42.0,261.0
Moga,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,648.0,283.0,342.0,437.0,544.0,462.0,589.0,506.0,696.0,651.0,522.0,277.0,5957.0
Moga,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,669.0,635.0,612.0,756.0,951.0,851.0,928.0,870.0,939.0,808.0,877.0,537.0,9433.0
Moga,6.3,PNC maternal complications attended,TOTAL,54.0,56.0,10.0,2.0,12.0,25.0,25.0,0.0,0.0,120.0,50.0,2.0,356.0
Moga,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,3.0,28.0,39.0,1.0,2.0,2.0,1.0,22.0,0.0,0.0,0.0,0.0,98.0
Moga,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,3.0,2.0,13.0,0.0,0.0,0.0,0.0,4.0,1.0,1.0,2.0,3.0,29.0
Moga,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,6.0,30.0,52.0,1.0,2.0,2.0,1.0,26.0,1.0,1.0,2.0,3.0,127.0
Moga,7.2,Number of MTPs conducted at Private Facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,5.0,0.0,6.0,5.0,0.0,2.0,0.0,18.0
Moga,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,19.0,21.0,21.0,18.0,27.0,28.0,18.0,19.0,15.0,22.0,11.0,61.0,280.0
Moga,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,61.0,46.0,124.0,87.0,75.0,36.0,71.0,129.0,118.0,114.0,71.0,102.0,1034.0
Moga,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,80.0,67.0,145.0,105.0,102.0,64.0,89.0,148.0,133.0,136.0,82.0,163.0,1314.0
Moga,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Moga,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Moga,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,1.0,4.0,3.0,3.0,3.0,1.0,1.0,1.0,1.0,0.0,1.0,0.0,19.0
Moga,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,1.0,4.0,4.0,5.0,6.0,4.0,2.0,27.0,2.0,6.0,1.0,5.0,67.0
Moga,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Moga,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,2.0,8.0,7.0,8.0,9.0,5.0,3.0,28.0,3.0,6.0,2.0,5.0,86.0
Moga,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Moga,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Moga,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,14.0,32.0,65.0,23.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,134.0
Moga,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Moga,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Moga,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,14.0,32.0,65.0,23.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,134.0
Moga,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Moga,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Moga,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,83.0,115.0,195.0,176.0,195.0,124.0,42.0,59.0,50.0,49.0,65.0,135.0,1288.0
Moga,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,43.0,29.0,34.0,44.0,29.0,23.0,58.0,37.0,33.0,52.0,34.0,32.0,448.0
Moga,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Moga,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,126.0,144.0,229.0,220.0,224.0,147.0,100.0,96.0,83.0,101.0,99.0,167.0,1736.0
Moga,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,1.0,3.0,3.0,7.0,0.0,0.0,5.0,6.0,0.0,0.0,5.0,3.0,33.0
Moga,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Moga,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,1.0,0.0,2.0,0.0,0.0,0.0,18.0,0.0,0.0,0.0,0.0,0.0,21.0
Moga,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,11.0,34.0,97.0,34.0,54.0,42.0,24.0,12.0,12.0,4.0,21.0,28.0,373.0
Moga,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Moga,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,12.0,34.0,99.0,34.0,54.0,42.0,42.0,12.0,12.0,4.0,21.0,28.0,394.0
Moga,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,5.0,5.0,0.0,0.0,4.0,0.0,0.0,0.0,14.0
Moga,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,645.0,638.0,620.0,659.0,593.0,638.0,614.0,632.0,600.0,585.0,599.0,421.0,7244.0
Moga,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Moga,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,0.0,0.0,0.0,5.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,5.0
Moga,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,54.0,42.0,46.0,67.0,168.0,38.0,124.0,134.0,134.0,101.0,131.0,86.0,1125.0
Moga,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Moga,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,699.0,680.0,666.0,731.0,761.0,676.0,738.0,766.0,734.0,686.0,730.0,507.0,8374.0
Moga,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,0.0,0.0,1.0,22.0,64.0,0.0,96.0,104.0,24.0,31.0,21.0,29.0,392.0
Moga,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,17.0,23.0,17.0,29.0,26.0,17.0,13.0,16.0,10.0,57.0,22.0,21.0,268.0
Moga,9.06,Number of IUCD removals,TOTAL,159.0,131.0,169.0,168.0,148.0,167.0,142.0,142.0,144.0,160.0,192.0,105.0,1827.0
Moga,9.07,Number of Oral Pills cycles distributed,TOTAL,3484.0,3069.0,3389.0,2905.0,2881.0,3586.0,3609.0,3650.0,3478.0,3139.0,2935.0,2778.0,38903.0
Moga,9.08,Number of Condom pieces distributed,TOTAL,64622.0,68553.0,68156.0,67426.0,70685.0,80433.0,78060.0,79437.0,76951.0,73543.0,69906.0,54797.0,852569.0
Moga,9.09,Number of Centchroman (weekly) pills given,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Moga,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,5.0,4.0,4.0,10.0,25.0,47.0,69.0,97.0,88.0,51.0,4.0,31.0,435.0
Moga,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Moga,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,2.0,2.0,0.0,2.0,1.0,1.0,8.0
Moga,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Moga,9.11.2.b,Number of failures following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Moga,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Moga,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Moga,9.12,Number of Institutions having NSV trained doctors,TOTAL,,,,1.0,,,,,,,,,-1.0
Moga,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,1230.0,1251.0,1191.0,1425.0,1830.0,1730.0,1742.0,1710.0,1575.0,1419.0,1377.0,1020.0,17500.0
Moga,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,1282.0,1288.0,1019.0,1231.0,1503.0,1423.0,1547.0,1589.0,1356.0,1328.0,610.0,111.0,14287.0
Moga,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,1499.0,1370.0,1225.0,1124.0,1232.0,1275.0,1453.0,1483.0,1470.0,1300.0,1282.0,499.0,15212.0
Moga,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,1395.0,1510.0,1350.0,1181.0,1243.0,1228.0,1437.0,1406.0,1388.0,1438.0,1324.0,921.0,15821.0
Moga,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,841.0,802.0,1643.0
Moga,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,22.0,557.0,579.0
Moga,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.0,66.0,69.0
Moga,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,824.0,894.0,1082.0,1376.0,1664.0,1456.0,1537.0,1333.0,1410.0,1148.0,1108.0,1001.0,14833.0
Moga,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,1282.0,1288.0,1019.0,1231.0,1503.0,1423.0,1547.0,1589.0,1356.0,1328.0,1032.0,746.0,15344.0
Moga,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,1499.0,1370.0,1225.0,1124.0,1232.0,1275.0,1453.0,1483.0,1470.0,1300.0,1297.0,980.0,15708.0
Moga,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,1395.0,1509.0,1350.0,1181.0,1243.0,1228.0,1437.0,1406.0,1388.0,1438.0,1327.0,966.0,15868.0
Moga,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,781.0,797.0,1007.0,1268.0,1440.0,1337.0,1441.0,1238.0,1357.0,1098.0,1058.0,978.0,13800.0
Moga,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,1282.0,1288.0,1019.0,1231.0,1503.0,1423.0,1547.0,1589.0,1356.0,1328.0,610.0,111.0,14287.0
Moga,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,1499.0,1370.0,1225.0,1124.0,1232.0,1275.0,1453.0,1483.0,1470.0,1300.0,1282.0,499.0,15212.0
Moga,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,1395.0,1509.0,1350.0,1181.0,1243.0,1228.0,1437.0,1406.0,1388.0,1438.0,1324.0,921.0,15820.0
Moga,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,1256.0,1520.0,1414.0,1426.0,1601.0,1394.0,1398.0,1534.0,1109.0,1128.0,1060.0,927.0,15767.0
Moga,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,1382.0,1448.0,1269.0,1254.0,1340.0,1095.0,1057.0,1210.0,1107.0,1138.0,1259.0,1055.0,14614.0
Moga,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,0.0,0.0,6.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,6.0
Moga,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,661.0,797.0,757.0,591.0,849.0,743.0,744.0,806.0,626.0,579.0,561.0,483.0,8197.0
Moga,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,595.0,708.0,640.0,546.0,752.0,651.0,654.0,728.0,483.0,549.0,499.0,444.0,7249.0
Moga,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,1256.0,1505.0,1397.0,1137.0,1601.0,1394.0,1398.0,1534.0,1109.0,1128.0,1060.0,927.0,15446.0
Moga,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,1375.0,1441.0,1239.0,1257.0,1339.0,1088.0,1084.0,1210.0,1107.0,1138.0,1267.0,1055.0,14600.0
Moga,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,1375.0,1441.0,1239.0,1257.0,1339.0,1088.0,1084.0,1210.0,1107.0,1138.0,1267.0,1055.0,14600.0
Moga,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Moga,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,709.0,383.0,254.0,269.0,262.0,276.0,238.0,240.0,232.0,225.0,236.0,208.0,3532.0
Moga,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,686.0,335.0,257.0,244.0,248.0,237.0,213.0,211.0,194.0,207.0,219.0,192.0,3243.0
Moga,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,1395.0,718.0,511.0,513.0,510.0,513.0,451.0,451.0,426.0,432.0,455.0,400.0,6775.0
Moga,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,694.0,4514.0,1056.0,1034.0,939.0,807.0,1068.0,713.0,594.0,729.0,575.0,444.0,13167.0
Moga,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,910.0,7915.0,616.0,1060.0,1038.0,945.0,842.0,582.0,372.0,328.0,355.0,164.0,15127.0
Moga,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,1099.0,5760.0,385.0,745.0,821.0,919.0,987.0,445.0,257.0,233.0,254.0,295.0,12200.0
Moga,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Moga,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Moga,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Moga,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,615.0,613.0,611.0,601.0,610.0,606.0,594.0,594.0,600.0,603.0,598.0,483.0,7128.0
Moga,10.4.2,Number of Immunisation sessions held during the month,TOTAL,595.0,608.0,594.0,596.0,604.0,597.0,585.0,587.0,587.0,582.0,579.0,425.0,6939.0
Moga,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,557.0,567.0,551.0,554.0,553.0,545.0,549.0,546.0,547.0,547.0,543.0,376.0,6435.0
Moga,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Moga,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,1164.0,1420.0,1309.0,1336.0,1424.0,1244.0,1248.0,1342.0,944.0,878.0,787.0,747.0,13843.0
Moga,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,946.0,956.0,861.0,946.0,901.0,916.0,895.0,899.0,954.0,758.0,677.0,549.0,10258.0
Moga,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,879.0,1783.0,1060.0,1019.0,1048.0,965.0,807.0,966.0,815.0,686.0,679.0,513.0,11220.0
Moga,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Moga,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Moga,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Moga,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Moga,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Moga,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Moga,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,93.0,385.0,309.0,24.0,250.0,19.0,12.0,4.0,3.0,0.0,2.0,0.0,1101.0
Moga,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,17.0,0.0,0.0,14.0,0.0,0.0,6.0,4.0,4.0,6.0,6.0,0.0,57.0
Moga,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,2.0,50.0,415.0,115.0,350.0,9.0,5.0,0.0,4.0,14.0,7.0,0.0,971.0
Moga,13.1,Number of Patients operated for cataract,TOTAL,0.0,0.0,4.0,9.0,8.0,10.0,30.0,22.0,0.0,11.0,30.0,42.0,166.0
Moga,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,0.0,7.0,4.0,0.0,8.0,10.0,30.0,22.0,263.0,10.0,30.0,42.0,426.0
Moga,13.3,Number of School children detected with Refractive errors,TOTAL,22.0,42.0,10.0,0.0,46.0,21.0,94.0,555.0,11.0,177.0,31.0,4.0,1013.0
Moga,13.4,Number of children provided free glasses,TOTAL,107.0,0.0,0.0,0.0,25.0,19.0,56.0,11.0,147.0,165.0,352.0,0.0,882.0
Moga,13.5,Number of eyes collected through eye donation,TOTAL,0.0,0.0,0.0,0.0,4.0,0.0,0.0,0.0,2.0,0.0,0.0,0.0,6.0
Moga,13.6,Number of eyes utilised for corneal transplant,TOTAL,1.0,2.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,4.0
Moga,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,3.0,2.0,1.0,4.0,4.0,3.0,2.0,2.0,5.0,4.0,4.0,5.0,-1.0
Moga,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,1.0,,,7.0,9.0,8.0,4.0,4.0,11.0,5.0,4.0,6.0,-1.0
Moga,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,272.0,278.0,330.0,286.0,282.0,272.0,277.0,283.0,290.0,309.0,283.0,215.0,-1.0
Moga,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,5.0,4.0,4.0,5.0,5.0,3.0,3.0,3.0,6.0,4.0,3.0,4.0,-1.0
Moga,14.05,Number of RKS meetings held during the month,TOTAL,10.0,10.0,8.0,7.0,8.0,9.0,7.0,7.0,7.0,6.0,6.0,6.0,91.0
Moga,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,4.0,3.0,3.0,6.0,6.0,5.0,4.0,4.0,11.0,5.0,4.0,5.0,-1.0
Moga,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,15.0,8.0,21.0,30.0,34.0,6.0,18.0,13.0,10.0,8.0,4.0,3.0,170.0
Moga,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,3.0,2.0,1.0,1.0,2.0,1.0,1.0,1.0,2.0,2.0,2.0,2.0,-1.0
Moga,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,2.0,2.0,1.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,-1.0
Moga,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,271.0,541.0,412.0,499.0,543.0,566.0,515.0,490.0,492.0,428.0,914.0,122.0,5793.0
Moga,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,429.0,670.0,492.0,540.0,488.0,422.0,490.0,544.0,334.0,278.0,3735.0,171.0,8593.0
Moga,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,270.0,885.0,332.0,377.0,465.0,499.0,517.0,438.0,443.0,413.0,936.0,204.0,5779.0
Moga,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,1081.0,497.0,1428.0,1579.0,1767.0,1671.0,1478.0,1366.0,1391.0,1194.0,6481.0,450.0,20383.0
Moga,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,541.0,1426.0,744.0,876.0,1008.0,1065.0,1032.0,928.0,935.0,841.0,1850.0,326.0,11572.0
Moga,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,1510.0,1167.0,1920.0,2119.0,2255.0,2093.0,1968.0,1910.0,1725.0,1472.0,10216.0,621.0,28976.0
Moga,14.10.2.a,Number of death cases of Inpatient males,TOTAL,9.0,2.0,5.0,10.0,5.0,5.0,7.0,3.0,7.0,5.0,13.0,11.0,82.0
Moga,14.10.2.b,Number of death cases of Inpatient females,TOTAL,3.0,7.0,4.0,10.0,3.0,2.0,4.0,4.0,4.0,7.0,8.0,6.0,62.0
Moga,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,12.0,9.0,9.0,20.0,8.0,7.0,11.0,7.0,11.0,12.0,21.0,17.0,144.0
Moga,14.11,In-Patient Head Count at midnight,TOTAL,83.0,153.0,370.0,310.0,301.0,300.0,229.0,363.0,97.0,247.0,193.0,259.0,2905.0
Moga,14.12.1,OPD attendance (All),TOTAL,37166.0,40011.0,41630.0,45998.0,43246.0,47533.0,35895.0,41289.0,37272.0,32246.0,41894.0,43752.0,487932.0
Moga,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,252.0,286.0,330.0,366.0,318.0,334.0,315.0,311.0,304.0,315.0,281.0,4.0,3416.0
Moga,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,16.0,24.0,23.0,37.0,20.0,20.0,20.0,17.0,32.0,36.0,16.0,0.0,261.0
Moga,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,207.0,370.0,666.0,125.0,308.0,139.0,145.0,218.0,97.0,147.0,186.0,163.0,2771.0
Moga,14.14.a,Number of patients given AYUSH treatment,TOTAL,1879.0,2056.0,2088.0,1877.0,721.0,2290.0,1631.0,1797.0,1893.0,1572.0,1766.0,809.0,20379.0
Moga,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,1655.0,1411.0,1462.0,1527.0,1389.0,1609.0,1238.0,1483.0,1249.0,1146.0,1354.0,1473.0,16996.0
Moga,14.14.c,Number of Adolescents counselled,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,6.0,6.0,0.0,0.0,0.0,12.0
Moga,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,3400.0,4002.0,4164.0,3487.0,3795.0,3518.0,2897.0,3059.0,2884.0,2763.0,3156.0,2439.0,39564.0
Moga,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,267.0,157.0,128.0,126.0,152.0,170.0,43.0,102.0,127.0,109.0,59.0,97.0,1537.0
Moga,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,186.0,64.0,321.0,319.0,354.0,222.0,143.0,214.0,147.0,161.0,170.0,180.0,2481.0
Moga,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,3.0,2.0,7.0,7.0,9.0,9.0,4.0,6.0,6.0,7.0,2.0,13.0,75.0
Moga,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,224.0,95.0,383.0,297.0,356.0,266.0,150.0,226.0,167.0,181.0,175.0,174.0,2694.0
Moga,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,2.0,0.0,7.0,3.0,5.0,6.0,0.0,2.0,1.0,2.0,0.0,0.0,28.0
Moga,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,889.0,1115.0,773.0,855.0,749.0,832.0,717.0,777.0,586.0,613.0,746.0,628.0,9280.0
Moga,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,0.0,0.0,2.0,1.0,4.0,1.0,2.0,0.0,2.0,1.0,1.0,7.0,21.0
Moga,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,1299.0,1274.0,1477.0,1471.0,1459.0,1320.0,1010.0,1217.0,900.0,955.0,1091.0,982.0,14455.0
Moga,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,5.0,2.0,16.0,11.0,18.0,16.0,6.0,8.0,9.0,10.0,3.0,20.0,124.0
Moga,15.2,Number of Widal tests conducted,Number tested,211.0,259.0,249.0,159.0,266.0,243.0,138.0,337.0,73.0,54.0,130.0,52.0,2171.0
Moga,15.3.a,Number of VDRL tests conducted on males,Number tested,26.0,18.0,22.0,30.0,44.0,29.0,0.0,9.0,29.0,25.0,21.0,3.0,256.0
Moga,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,36.0,43.0,65.0,50.0,79.0,255.0,14.0,16.0,59.0,35.0,41.0,3.0,696.0
Moga,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,958.0,1027.0,982.0,968.0,930.0,720.0,925.0,820.0,595.0,576.0,812.0,292.0,9605.0
Moga,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,1020.0,1088.0,1069.0,1048.0,1053.0,1004.0,939.0,845.0,683.0,636.0,874.0,298.0,10557.0
Moga,15.4.1,Number of blood smears examined for Malaria,TOTAL,4514.0,3191.0,3516.0,4540.0,3773.0,3724.0,3345.0,4055.0,3540.0,2405.0,3144.0,1656.0,41403.0
Moga,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0
Moga,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Moga,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,,,,,,,6500.0,15500.0,6500.0,,7500.0,9000.0,45000.0
Moga,16.1.1,Stock position of DPT vaccines,2. Stocks Received,,,,,,,15000.0,0.0,10000.0,,5000.0,2000.0,32000.0
Moga,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,,,,,,,,0.0,0.0,,0.0,0.0,0.0
Moga,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,,,,,,,9000.0,10000.0,5000.0,,3500.0,4500.0,32000.0
Moga,16.1.1,Stock position of DPT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,12500.0,5500.0,11500.0,0.0,9000.0,6500.0,45000.0
Moga,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,,,,,,,,0.0,0.0,,15000.0,13500.0,28500.0
Moga,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,,,,,,,,0.0,15000.0,,5000.0,0.0,20000.0
Moga,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,,,,,,,,0.0,0.0,,0.0,0.0,0.0
Moga,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,,,,,,,,0.0,0.0,,6500.0,3000.0,9500.0
Moga,16.1.1A,Stock Position of Pentavalent,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,15000.0,0.0,13500.0,10500.0,39000.0
Moga,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,,,,,,,3000.0,6500.0,16000.0,,5500.0,11000.0,42000.0
Moga,16.1.2,Stock position of OPV vaccines,2. Stocks Received,,,,,,,12000.0,22000.0,10000.0,,10000.0,6000.0,60000.0
Moga,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,,,,,,,,0.0,0.0,,0.0,0.0,0.0
Moga,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,,,,,,,11500.0,17500.0,14000.0,,4500.0,9500.0,57000.0
Moga,16.1.2,Stock position of OPV vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,3500.0,11000.0,12000.0,0.0,11000.0,7500.0,45000.0
Moga,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,,,,,,,4500.0,12500.0,5000.0,,8500.0,9500.0,40000.0
Moga,16.1.3,Stock position of TT vaccines,2. Stocks Received,,,,,,,15000.0,0.0,10000.0,,5000.0,2000.0,32000.0
Moga,16.1.3,Stock position of TT vaccines,3. Unusable Stock,,,,,,,,0.0,0.0,,0.0,0.0,0.0
Moga,16.1.3,Stock position of TT vaccines,4. Stock Distributed,,,,,,,10000.0,8000.0,3500.0,,4000.0,4500.0,30000.0
Moga,16.1.3,Stock position of TT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,9500.0,4500.0,11500.0,0.0,9500.0,7000.0,42000.0
Moga,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,,,,,,,,0.0,0.0,,0.0,0.0,0.0
Moga,16.1.4,Stock position of DT vaccines,2. Stocks Received,,,,,,,,0.0,0.0,,0.0,0.0,0.0
Moga,16.1.4,Stock position of DT vaccines,3. Unusable Stock,,,,,,,,0.0,0.0,,0.0,0.0,0.0
Moga,16.1.4,Stock position of DT vaccines,4. Stock Distributed,,,,,,,,0.0,0.0,,0.0,0.0,0.0
Moga,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Moga,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,,,,,,,3000.0,6000.0,3500.0,,7000.0,10000.0,29500.0
Moga,16.1.5,Stock position of BCG vaccines,2. Stocks Received,,,,,,,6000.0,2000.0,11000.0,,5000.0,0.0,24000.0
Moga,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,,,,,,,,0.0,0.0,,0.0,0.0,0.0
Moga,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,,,,,,,4000.0,5500.0,5000.0,,2000.0,2500.0,19000.0
Moga,16.1.5,Stock position of BCG vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,5000.0,2500.0,9500.0,0.0,10000.0,7500.0,34500.0
Moga,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,,,,,,,1250.0,1750.0,2750.0,,6250.0,4000.0,16000.0
Moga,16.1.6,Stock position of Measles vaccines,2. Stocks Received,,,,,,,3500.0,6000.0,12000.0,,0.0,2000.0,23500.0
Moga,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,,,,,,,,0.0,0.0,,0.0,0.0,0.0
Moga,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,,,,,,,4000.0,6000.0,5000.0,,2250.0,1500.0,18750.0
Moga,16.1.6,Stock position of Measles vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,750.0,1750.0,9750.0,0.0,4000.0,4500.0,20750.0
Moga,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,,,,,,,,0.0,0.0,,0.0,0.0,0.0
Moga,16.1.7,Stock position of JE vaccines,2. Stocks Received,,,,,,,,0.0,0.0,,0.0,0.0,0.0
Moga,16.1.7,Stock position of JE vaccines,3. Unusable Stock,,,,,,,,0.0,0.0,,0.0,0.0,0.0
Moga,16.1.7,Stock position of JE vaccines,4. Stock Distributed,,,,,,,,0.0,0.0,,0.0,0.0,0.0
Moga,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Moga,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,,,,,,,1000.0,5000.0,1000.0,,2700.0,4000.0,13700.0
Moga,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,,,,,,,8000.0,3000.0,15000.0,,6000.0,6000.0,38000.0
Moga,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,,,,,,,,0.0,0.0,,0.0,0.0,0.0
Moga,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,,,,,,,6000.0,7800.0,6300.0,,4700.0,3500.0,28300.0
Moga,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,3000.0,200.0,9700.0,0.0,4000.0,6500.0,23400.0
Moga,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,,,,,,,0.0,0.0,0.0,,0.0,0.0,0.0
Moga,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,,,,,,,0.0,0.0,0.0,,0.0,0.0,0.0
Moga,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,,,,,,,0.0,0.0,0.0,,0.0,0.0,0.0
Moga,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,,,,,,,0.0,0.0,0.0,,0.0,0.0,0.0
Moga,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Moga,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,,,,,,,300960.0,6000.0,6000.0,35500.0,35500.0,35500.0,419460.0
Moga,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,,,,,,,0.0,0.0,29500.0,0.0,0.0,66000.0,95500.0
Moga,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,,,,,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Moga,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,,,,,,,89280.0,0.0,0.0,,35500.0,54000.0,178780.0
Moga,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,211680.0,6000.0,35500.0,35500.0,0.0,47500.0,336180.0
Moga,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,3900.0,300.0,0.0,,0.0,3500.0,7700.0
Moga,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,0.0,0.0,0.0,,4600.0,0.0,4600.0
Moga,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,0.0,0.0,0.0,,0.0,0.0,0.0
Moga,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,2700.0,300.0,0.0,,0.0,2800.0,5800.0
Moga,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,1200.0,0.0,0.0,0.0,4600.0,700.0,6500.0
Moga,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,360.0,0.0,0.0,,0.0,150.0,510.0
Moga,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,0.0,0.0,0.0,,250.0,0.0,250.0
Moga,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,0.0,0.0,0.0,,0.0,0.0,0.0
Moga,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,240.0,0.0,0.0,,0.0,120.0,360.0
Moga,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,120.0,0.0,0.0,0.0,250.0,30.0,400.0
Moga,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,,,,,,,100.0,100.0,100.0,100.0,100.0,100.0,600.0
Moga,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,,,,,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Moga,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,,,,,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Moga,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,,,,,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Moga,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,100.0,100.0,100.0,100.0,100.0,100.0,600.0
Moga,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,,,,,,,,,,,,,
Moga,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,,,,,,,,,,,,,
Moga,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,,,,,,,,,,,,,
Moga,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,,,,,,,,,,,,,
Moga,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Moga,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,,,,,,,,,,,,,
Moga,16.3.02,Stock Position of Gloves,2. Stocks Received,,,,,,,,,,,,,
Moga,16.3.02,Stock Position of Gloves,3. Unusable Stock,,,,,,,,,,,,,
Moga,16.3.02,Stock Position of Gloves,4. Stock Distributed,,,,,,,,,,,,,
Moga,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Moga,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,,,,,,,,,,,,,
Moga,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,,,,,,,,,,,,,
Moga,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,,,,,,,,,,,,,
Moga,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,,,,,,,,,,,,,
Moga,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Moga,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
Moga,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,,,,,,,,,,,,,
Moga,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,,,,,,,,,,,,,
Moga,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,,,,,,,,,,,,,
Moga,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Moga,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,,,,,,,,,,,,,
Moga,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,,,,,,,,,,,,,
Moga,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,,,,,,,,,,,,,
Moga,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,,,,,,,,,,,,,
Moga,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Moga,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,,,,,,,,,,,,,
Moga,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,,,,,,,,,,,,,
Moga,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,,,,,,,,,,,,,
Moga,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,,,,,,,,,,,,,
Moga,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Moga,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,,,,,,,0.0,,,,,,0.0
Moga,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,,,,,,,0.0,,,,,,0.0
Moga,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,,,,,,,0.0,,,,,,0.0
Moga,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,,,,,,,0.0,,,,,,0.0
Moga,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Moga,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,,,,,,,,0.0,6300.0,,0.0,46800.0,53100.0
Moga,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,,,,,,,,40000.0,0.0,,46800.0,,86800.0
Moga,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,,,,,,,,0.0,0.0,,0.0,,0.0
Moga,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,,,,,,,,33700.0,0.0,,0.0,35500.0,69200.0
Moga,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,6300.0,6300.0,0.0,46800.0,11300.0,70700.0
Moga,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,,,,,,,,,,,,,
Moga,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,,,,,,,,,,,,,
Moga,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,,,,,,,,,,,,,
Moga,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,,,,,,,,,,,,,
Moga,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Moga,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,,,,,,,,,,,,,
Moga,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,,,,,,,,,,,,,
Moga,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,,,,,,,,,,,,,
Moga,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,,,,,,,,,,,,,
Moga,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Moga,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,,,,,,,,,,,,,
Moga,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,,,,,,,,,,,,,
Moga,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,,,,,,,,,,,,,
Moga,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,,,,,,,,,,,,,
Moga,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Moga,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,,,,,,,2000.0,3600.0,2400.0,,2400.0,1600.0,12000.0
Moga,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,,,,,,,2000.0,0.0,2000.0,,0.0,2000.0,6000.0
Moga,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,,,,,,,,0.0,0.0,,0.0,0.0,0.0
Moga,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,,,,,,,400.0,1600.0,600.0,,800.0,1000.0,4400.0
Moga,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,3600.0,2000.0,3800.0,0.0,1600.0,2600.0,13600.0
Moga,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,,,,,,,8000.0,0.0,8000.0,,4000.0,2000.0,22000.0
Moga,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,,,,,,,0.0,0.0,0.0,,0.0,2000.0,2000.0
Moga,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,,,,,,,,0.0,0.0,,0.0,0.0,0.0
Moga,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,,,,,,,0.0,0.0,2000.0,,2000.0,1400.0,5400.0
Moga,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,8000.0,0.0,6000.0,0.0,2000.0,2600.0,18600.0
Moga,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,,,,,,,3100.0,4900.0,4500.0,,6500.0,6300.0,25300.0
Moga,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,,,,,,,2400.0,0.0,2400.0,,0.0,0.0,4800.0
Moga,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,,,,,,,,0.0,0.0,,0.0,0.0,0.0
Moga,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,,,,,,,600.0,600.0,400.0,,200.0,1200.0,3000.0
Moga,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,4900.0,4300.0,6500.0,0.0,6300.0,5100.0,27100.0
Moga,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,,,,,,,,,,,,,
Moga,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Moga,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Moga,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,,,,,,,,,,,,
Moga,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Moga,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Moga,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,,,,,,,,,,,,,
Moga,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Moga,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Moga,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,,,,,,,,,,,,,
Moga,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,,,,,,,,,3.0,,,,3.0
Moga,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,,,,,,1.0,,1.0,,,,2.0
Moga,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,,,,,,,1.0,,4.0,,,,5.0
Moga,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,,,,,,,,,,,,
Moga,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,,,,,,,,,,
Moga,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,,,,,,,,,,,,,
Moga,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,,,,,,
Moga,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
Moga,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,,,,,,,,,
Moga,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,,,,,,,,,1.0,,1.0
Moga,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,,,,,,,,,,
Moga,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,,,,,,,,,,1.0,,1.0
Moga,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Moga,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Moga,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Moga,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,,,,,,,,,,1.0,,,1.0
Moga,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,,,,,,,,,,,,,
Moga,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,,,,,,,,,,1.0,,,1.0
Moga,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
Moga,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,,,,,,,,,
Moga,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,,,,,,,,,
Moga,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,,,,,,,,,,,
Moga,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
Moga,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,,,,,,,,,,,,,
Moga,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,,,,,,,,,,,,,
Moga,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,,,,,,,,,,,,,
Moga,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,,,,,,
Moga,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,,,,,,,,,,,,,
Moga,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,,,,,,,,,,,,,
Moga,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,,,,,,,,,,,,,
Moga,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
Moga,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,,,,,,,,
Moga,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
Moga,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,,,,,,,,,,
Moga,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,,,,,,,,,,
Moga,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,,,,,,,,,,,,,
Moga,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,,,,,,,,,,,,,
Moga,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,,,,,,,,,,,,,
Moga,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
Moga,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,,,,,,,,,,,
Moga,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,,,,
Moga,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,,,,,,,,,,,
Moga,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,,,,,,,,,
Moga,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,,,,,,,,,,,,,
Moga,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,,,,,,,,1.0,,,,,1.0
Moga,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,,,,,,,,1.0,,,,,1.0
Moga,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,,,,,,,
Moga,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,,,,,,,,,,,,,
Moga,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,,,,,,,,,,,,,
Moga,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,,,,,,,,,,,,,
Moga,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Moga,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
Moga,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Moga,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
Moga,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Moga,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,,,,,,,,
Moga,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Moga,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,,,,,,,,
Moga,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Moga,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,,,,,,,,,,
Moga,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Moga,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,,,,,,,,,,,
Moga,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Moga,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,,,,,,,,,,,
Moga,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Moga,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,,,,,,,,,,,
Moga,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Moga,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,,,,,,,
Moga,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Moga,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,,,,,,,
Moga,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Moga,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,,,,,,,,,,,,,
Moga,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Moga,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,,,,,,,,,,,,,
Moga,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,,,,,,,,,,,,
Moga,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,,,,,,,,,,,,,
Moga,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,,,,,,,,,,,,,
Moga,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,,,,,,,,,,,,,
Moga,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,,,,,,,,,
Moga,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,,,,,,,,,,,,,
Moga,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,,,,,,,,,,,,
Moga,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,,,,,,,,,,,,,
Moga,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,,,,,,,,,,
Moga,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,,,,,,,,,,,,
Moga,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,,,,,,,,,,,
Moga,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,,,,,,,,,,,,,
Moga,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,,,,,,,,,,,
Moga,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,,,,,,,,,,,,,
Moga,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,,,,,,,,,,,,,
Moga,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,,,,,,,,,,,,,
Moga,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,,,,,,,,,,,,
Moga,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,,,,,,,,,,,,,
Moga,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,,,,,,,,,,,,,
Moga,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,,,,,,,,,,,,,
Moga,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,,,,,,,,,,,,,
Moga,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,,,,2.0,,1.0,2.0,1.0,,,,,6.0
Moga,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,,,,,,,,,,,,,
Moga,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,,,,2.0,,1.0,2.0,1.0,,,,,6.0
Mohali SAS Nagar,1.1,Total number of pregnant women Registered for ANC,TOTAL,2183.0,2234.0,1751.0,1912.0,1921.0,1677.0,1145.0,1398.0,1283.0,1438.0,1632.0,1789.0,20363.0
Mohali SAS Nagar,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,1448.0,1656.0,1271.0,1433.0,1370.0,1181.0,853.0,1115.0,1025.0,1103.0,1224.0,1227.0,14906.0
Mohali SAS Nagar,1.2,Number of Pregnant women registered under JSY,TOTAL,324.0,341.0,262.0,302.0,301.0,229.0,196.0,274.0,222.0,267.0,274.0,238.0,3230.0
Mohali SAS Nagar,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,1674.0,1720.0,1739.0,1793.0,1674.0,1626.0,1720.0,1460.0,1276.0,1285.0,1255.0,1315.0,18537.0
Mohali SAS Nagar,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,1709.0,1841.0,1403.0,1512.0,1617.0,1351.0,980.0,1198.0,1100.0,1221.0,1294.0,1298.0,16524.0
Mohali SAS Nagar,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,1650.0,1926.0,1731.0,1492.0,1633.0,1554.0,1265.0,1115.0,1232.0,1163.0,1198.0,1383.0,17342.0
Mohali SAS Nagar,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,1776.0,1837.0,1824.0,1769.0,1934.0,1641.0,1699.0,1353.0,1322.0,1443.0,1267.0,1302.0,19167.0
Mohali SAS Nagar,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,18.0,18.0,11.0,12.0,6.0,2.0,2.0,3.0,7.0,26.0,26.0,15.0,146.0
Mohali SAS Nagar,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0
Mohali SAS Nagar,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,835.0,673.0,520.0,686.0,700.0,676.0,563.0,586.0,596.0,498.0,706.0,687.0,7726.0
Mohali SAS Nagar,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,4.0,2.0,2.0,2.0,1.0,1.0,0.0,1.0,10.0,0.0,,14.0,37.0
Mohali SAS Nagar,1.8,Number of pregnancy test kits used at SC level,TOTAL,206.0,204.0,15.0,131.0,112.0,124.0,93.0,51.0,112.0,32.0,18.0,23.0,1121.0
Mohali SAS Nagar,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,23.0,21.0,27.0,12.0,9.0,28.0,63.0,13.0,18.0,8.0,26.0,10.0,258.0
Mohali SAS Nagar,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,42.0,43.0,36.0,32.0,59.0,54.0,17.0,69.0,46.0,54.0,46.0,59.0,557.0
Mohali SAS Nagar,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,65.0,64.0,63.0,44.0,68.0,82.0,80.0,82.0,64.0,62.0,72.0,69.0,815.0
Mohali SAS Nagar,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,57.0,55.0,43.0,42.0,62.0,70.0,76.0,75.0,62.0,50.0,54.0,58.0,704.0
Mohali SAS Nagar,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,4.0,0.0,1.0,0.0,0.0,,2.0,,,0.0,1.0,0.0,8.0
Mohali SAS Nagar,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,345.0,342.0,395.0,487.0,649.0,620.0,615.0,557.0,488.0,527.0,434.0,373.0,5832.0
Mohali SAS Nagar,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,278.0,215.0,236.0,219.0,450.0,408.0,402.0,333.0,306.0,146.0,115.0,85.0,3193.0
Mohali SAS Nagar,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,118.0,139.0,153.0,135.0,229.0,201.0,245.0,169.0,116.0,174.0,133.0,82.0,1894.0
Mohali SAS Nagar,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,,0.0,0.0
Mohali SAS Nagar,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,,0.0,0.0
Mohali SAS Nagar,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,331.0,344.0,414.0,454.0,484.0,413.0,379.0,470.0,518.0,368.0,237.0,208.0,4620.0
Mohali SAS Nagar,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,7.0,5.0,7.0,,4.0,1.0,8.0,,,13.0,,,45.0
Mohali SAS Nagar,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,0.0,,,,,,,,,,0.0
Mohali SAS Nagar,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,,,,,,,,,,0.0
Mohali SAS Nagar,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0.0,0.0,0.0,0.0,,0.0,,,,,,,0.0
Mohali SAS Nagar,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,23.0,20.0,15.0,17.0,23.0,21.0,24.0,25.0,20.0,19.0,17.0,18.0,242.0
Mohali SAS Nagar,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,44.0,46.0,59.0,81.0,103.0,100.0,97.0,110.0,88.0,106.0,82.0,82.0,998.0
Mohali SAS Nagar,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Mohali SAS Nagar,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,67.0,66.0,74.0,98.0,126.0,121.0,121.0,135.0,108.0,125.0,99.0,100.0,1240.0
Mohali SAS Nagar,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,123.0,131.0,190.0,125.0,227.0,201.0,188.0,212.0,201.0,171.0,114.0,80.0,1963.0
Mohali SAS Nagar,4.1.1.a,Number of male live births,TOTAL,419.0,375.0,398.0,518.0,605.0,570.0,563.0,562.0,559.0,456.0,411.0,336.0,5772.0
Mohali SAS Nagar,4.1.1.b,Number of female live births,TOTAL,325.0,377.0,473.0,468.0,596.0,546.0,512.0,547.0,518.0,501.0,333.0,316.0,5512.0
Mohali SAS Nagar,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,744.0,752.0,871.0,986.0,1201.0,1116.0,1075.0,1109.0,1077.0,957.0,744.0,652.0,11284.0
Mohali SAS Nagar,4.1.2,Number of still births,TOTAL,2.0,0.0,3.0,2.0,2.0,3.0,3.0,5.0,1.0,3.0,0.0,1.0,25.0
Mohali SAS Nagar,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,54.0,85.0,56.0,159.0,132.0,132.0,104.0,113.0,55.0,66.0,45.0,99.0,1100.0
Mohali SAS Nagar,4.2.1,Number of Newborns weighed at birth,TOTAL,706.0,723.0,853.0,968.0,1201.0,1116.0,1075.0,1107.0,1076.0,950.0,741.0,648.0,11164.0
Mohali SAS Nagar,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,3.0,2.0,3.0,24.0,39.0,23.0,12.0,31.0,86.0,17.0,20.0,14.0,274.0
Mohali SAS Nagar,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,744.0,752.0,865.0,907.0,847.0,880.0,882.0,937.0,825.0,748.0,598.0,572.0,9557.0
Mohali SAS Nagar,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,0.0,0.0,0.0,1.0,,,,,,,,,1.0
Mohali SAS Nagar,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,0.0,0.0,1.0,,0.0,0.0,0.0,,,0.0,32.0,0.0,33.0
Mohali SAS Nagar,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,53.0,46.0,48.0,50.0,49.0,70.0,75.0,91.0,71.0,114.0,97.0,87.0,851.0
Mohali SAS Nagar,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Mohali SAS Nagar,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,53.0,46.0,49.0,51.0,49.0,70.0,75.0,91.0,71.0,114.0,129.0,87.0,885.0
Mohali SAS Nagar,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,0.0,0.0,0.0,,34.0,32.0,147.0,156.0,190.0,2.0,,,561.0
Mohali SAS Nagar,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,24.0,40.0,28.0,44.0,83.0,86.0,208.0,224.0,245.0,73.0,76.0,45.0,1176.0
Mohali SAS Nagar,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,1.0,2.0,4.0,0.0,0.0,0.0,0.0,,,0.0,,2.0,9.0
Mohali SAS Nagar,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,19.0,28.0,34.0,32.0,72.0,76.0,198.0,215.0,232.0,61.0,72.0,35.0,1074.0
Mohali SAS Nagar,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,7.0,18.0,11.0,10.0,5.0,11.0,17.0,24.0,18.0,14.0,20.0,15.0,170.0
Mohali SAS Nagar,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,669.0,709.0,794.0,864.0,891.0,824.0,799.0,755.0,682.0,626.0,483.0,611.0,8707.0
Mohali SAS Nagar,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,452.0,432.0,625.0,335.0,448.0,422.0,310.0,349.0,390.0,416.0,241.0,326.0,4746.0
Mohali SAS Nagar,6.3,PNC maternal complications attended,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,1.0,2.0,,0.0,,2.0,5.0
Mohali SAS Nagar,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,42.0,24.0,20.0,12.0,21.0,26.0,25.0,35.0,20.0,18.0,19.0,4.0,266.0
Mohali SAS Nagar,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,0.0,0.0,2.0,0.0,0.0,0.0,,,,0.0,,0.0,2.0
Mohali SAS Nagar,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,42.0,24.0,22.0,12.0,21.0,26.0,25.0,35.0,20.0,18.0,19.0,4.0,268.0
Mohali SAS Nagar,7.2,Number of MTPs conducted at Private Facilities,TOTAL,92.0,123.0,98.0,98.0,65.0,77.0,55.0,45.0,6.0,125.0,74.0,66.0,924.0
Mohali SAS Nagar,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,113.0,40.0,119.0,131.0,114.0,127.0,109.0,103.0,58.0,118.0,112.0,44.0,1188.0
Mohali SAS Nagar,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,348.0,81.0,128.0,177.0,79.0,174.0,145.0,130.0,179.0,153.0,179.0,64.0,1837.0
Mohali SAS Nagar,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,461.0,121.0,247.0,308.0,193.0,301.0,254.0,233.0,237.0,271.0,291.0,108.0,3025.0
Mohali SAS Nagar,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0.0,0.0,0.0,0.0,0.0,,,,,5.0,,0.0,5.0
Mohali SAS Nagar,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0.0,0.0,0.0,,,,,,,,,,0.0
Mohali SAS Nagar,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,4.0,4.0,1.0,6.0,4.0,2.0,0.0,4.0,1.0,1.0,1.0,1.0,29.0
Mohali SAS Nagar,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,3.0,6.0,3.0,1.0,1.0,1.0,,9.0,6.0,2.0,,1.0,33.0
Mohali SAS Nagar,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Mohali SAS Nagar,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,7.0,10.0,4.0,7.0,5.0,3.0,0.0,13.0,7.0,3.0,1.0,2.0,62.0
Mohali SAS Nagar,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,0.0,3.0,2.0,,1.0,,,1.0,,,,,7.0
Mohali SAS Nagar,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,,,,,,,,,,0.0
Mohali SAS Nagar,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,70.0,54.0,107.0,33.0,18.0,34.0,43.0,33.0,16.0,20.0,9.0,8.0,445.0
Mohali SAS Nagar,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,56.0,53.0,125.0,7.0,24.0,37.0,41.0,,,6.0,19.0,4.0,372.0
Mohali SAS Nagar,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Mohali SAS Nagar,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,126.0,107.0,232.0,40.0,42.0,71.0,84.0,33.0,16.0,26.0,28.0,12.0,817.0
Mohali SAS Nagar,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,11.0,8.0,0.0,,3.0,13.0,18.0,6.0,7.0,,,,66.0
Mohali SAS Nagar,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,,,,,,,,,,0.0
Mohali SAS Nagar,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,15.0,16.0,15.0,6.0,0.0,,,,,0.0,,,52.0
Mohali SAS Nagar,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,22.0,13.0,43.0,61.0,5.0,6.0,6.0,70.0,43.0,17.0,15.0,22.0,323.0
Mohali SAS Nagar,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Mohali SAS Nagar,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,37.0,29.0,58.0,67.0,5.0,6.0,6.0,70.0,43.0,17.0,15.0,22.0,375.0
Mohali SAS Nagar,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,6.0,19.0,14.0,26.0,27.0,14.0,3.0,2.0,1.0,1.0,3.0,2.0,118.0
Mohali SAS Nagar,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,,,,,,,,,,0.0
Mohali SAS Nagar,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,0.0,0.0,,,0.0,,,,,0.0,,,0.0
Mohali SAS Nagar,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,0.0,1.0,0.0,2.0,3.0,11.0,3.0,2.0,1.0,5.0,2.0,4.0,34.0
Mohali SAS Nagar,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Mohali SAS Nagar,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,0.0,1.0,0.0,2.0,3.0,11.0,3.0,2.0,1.0,5.0,2.0,4.0,34.0
Mohali SAS Nagar,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,0.0,0.0,0.0,,0.0,,,,,,,,0.0
Mohali SAS Nagar,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,494.0,561.0,489.0,659.0,507.0,480.0,431.0,461.0,418.0,510.0,373.0,330.0,5713.0
Mohali SAS Nagar,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,32.0,20.0,20.0,55.0,34.0,36.0,30.0,23.0,27.0,30.0,21.0,25.0,353.0
Mohali SAS Nagar,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,155.0,91.0,162.0,105.0,288.0,427.0,234.0,191.0,161.0,89.0,12.0,19.0,1934.0
Mohali SAS Nagar,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,86.0,94.0,107.0,123.0,161.0,142.0,140.0,70.0,140.0,91.0,118.0,66.0,1338.0
Mohali SAS Nagar,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Mohali SAS Nagar,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,767.0,766.0,778.0,942.0,990.0,1085.0,835.0,745.0,746.0,720.0,524.0,440.0,9338.0
Mohali SAS Nagar,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,193.0,183.0,95.0,7.0,301.0,262.0,245.0,97.0,128.0,5.0,16.0,3.0,1535.0
Mohali SAS Nagar,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,10.0,9.0,4.0,5.0,12.0,7.0,5.0,12.0,12.0,10.0,4.0,,90.0
Mohali SAS Nagar,9.06,Number of IUCD removals,TOTAL,138.0,84.0,68.0,64.0,71.0,73.0,46.0,66.0,61.0,68.0,73.0,69.0,881.0
Mohali SAS Nagar,9.07,Number of Oral Pills cycles distributed,TOTAL,3906.0,3055.0,3226.0,3152.0,3233.0,3198.0,3106.0,3045.0,3130.0,3110.0,2937.0,2708.0,37806.0
Mohali SAS Nagar,9.08,Number of Condom pieces distributed,TOTAL,92796.0,92430.0,93431.0,97042.0,95900.0,96035.0,98467.0,92539.0,93196.0,96246.0,91217.0,88228.0,1127527.0
Mohali SAS Nagar,9.09,Number of Centchroman (weekly) pills given,TOTAL,5.0,0.0,0.0,2.0,1.0,0.0,0.0,,,5.0,152.0,5.0,170.0
Mohali SAS Nagar,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,21.0,29.0,17.0,20.0,21.0,18.0,17.0,24.0,16.0,26.0,38.0,52.0,299.0
Mohali SAS Nagar,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0,,0.0,0.0
Mohali SAS Nagar,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0.0,2.0,0.0,1.0,1.0,0.0,0.0,3.0,2.0,0.0,4.0,0.0,13.0
Mohali SAS Nagar,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0,,0.0,0.0
Mohali SAS Nagar,9.11.2.b,Number of failures following female sterilization,TOTAL,0.0,0.0,0.0,0.0,1.0,0.0,,,,0.0,,0.0,1.0
Mohali SAS Nagar,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0,,0.0,0.0
Mohali SAS Nagar,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0,,0.0,0.0
Mohali SAS Nagar,9.12,Number of Institutions having NSV trained doctors,TOTAL,,,2.0,,1.0,2.0,1.0,2.0,,2.0,,,-1.0
Mohali SAS Nagar,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,1143.0,1161.0,955.0,1350.0,1758.0,1651.0,1520.0,1408.0,957.0,985.0,905.0,755.0,14548.0
Mohali SAS Nagar,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,1549.0,1426.0,1187.0,1245.0,1545.0,1426.0,1402.0,1798.0,1618.0,871.0,269.0,63.0,14399.0
Mohali SAS Nagar,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,1539.0,1522.0,1319.0,1221.0,1396.0,1313.0,1349.0,1533.0,1728.0,1527.0,944.0,278.0,15669.0
Mohali SAS Nagar,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,1625.0,1607.0,1457.0,1327.0,1424.0,1301.0,1199.0,1362.0,1543.0,1624.0,1300.0,758.0,16527.0
Mohali SAS Nagar,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,879.0,1095.0,1259.0,3233.0
Mohali SAS Nagar,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,28.0,535.0,1084.0,1647.0
Mohali SAS Nagar,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,15.0,64.0,680.0,759.0
Mohali SAS Nagar,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,1114.0,1152.0,948.0,1350.0,1737.0,1651.0,1520.0,1601.0,945.0,985.0,900.0,753.0,14656.0
Mohali SAS Nagar,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,1549.0,1426.0,1187.0,1245.0,1545.0,1426.0,1402.0,1798.0,1618.0,1750.0,1364.0,1322.0,17632.0
Mohali SAS Nagar,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,1539.0,1522.0,1319.0,1221.0,1396.0,1313.0,1349.0,1533.0,1728.0,1555.0,1479.0,1364.0,17318.0
Mohali SAS Nagar,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,1625.0,1607.0,1457.0,1327.0,1424.0,1301.0,1199.0,1362.0,1543.0,1639.0,1364.0,1438.0,17286.0
Mohali SAS Nagar,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,577.0,547.0,375.0,698.0,866.0,852.0,787.0,806.0,705.0,621.0,491.0,390.0,7715.0
Mohali SAS Nagar,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,1511.0,1410.0,1189.0,1238.0,1508.0,1407.0,1402.0,1776.0,1618.0,857.0,197.0,47.0,14160.0
Mohali SAS Nagar,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,1501.0,1501.0,1316.0,1221.0,1358.0,1289.0,1349.0,1533.0,1728.0,1488.0,842.0,248.0,15374.0
Mohali SAS Nagar,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,1570.0,1597.0,1456.0,1329.0,1405.0,1273.0,1207.0,1364.0,1491.0,1614.0,1220.0,711.0,16237.0
Mohali SAS Nagar,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,1487.0,1788.0,1572.0,1718.0,1853.0,1601.0,1339.0,1643.0,1331.0,1265.0,1028.0,1168.0,17793.0
Mohali SAS Nagar,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,1602.0,1577.0,1320.0,1404.0,1270.0,1212.0,940.0,1378.0,1254.0,964.0,940.0,1077.0,14938.0
Mohali SAS Nagar,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mohali SAS Nagar,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,794.0,835.0,853.0,948.0,977.0,816.0,664.0,884.0,680.0,624.0,529.0,606.0,9210.0
Mohali SAS Nagar,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,693.0,677.0,719.0,767.0,759.0,722.0,573.0,710.0,626.0,544.0,466.0,499.0,7755.0
Mohali SAS Nagar,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,1487.0,1512.0,1572.0,1715.0,1736.0,1538.0,1237.0,1594.0,1306.0,1168.0,995.0,1105.0,16965.0
Mohali SAS Nagar,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,1604.0,1582.0,1315.0,1406.0,1282.0,1228.0,954.0,1378.0,1257.0,1321.0,1243.0,1460.0,16030.0
Mohali SAS Nagar,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,1604.0,1582.0,1315.0,1404.0,1282.0,1228.0,954.0,1378.0,1257.0,1321.0,1234.0,1348.0,15907.0
Mohali SAS Nagar,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0
Mohali SAS Nagar,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,0.0,0.0,2.0,7.0,2.0,0.0,0.0,,3.0,183.0,193.0,168.0,558.0
Mohali SAS Nagar,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,0.0,0.0,2.0,7.0,2.0,0.0,0.0,11.0,3.0,146.0,153.0,151.0,475.0
Mohali SAS Nagar,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,0.0,0.0,4.0,14.0,4.0,0.0,0.0,11.0,6.0,329.0,346.0,319.0,1033.0
Mohali SAS Nagar,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,1126.0,2359.0,1062.0,1099.0,1317.0,1025.0,805.0,1361.0,2100.0,1029.0,1019.0,845.0,15147.0
Mohali SAS Nagar,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,644.0,1987.0,721.0,878.0,938.0,810.0,557.0,1075.0,1959.0,752.0,762.0,626.0,11709.0
Mohali SAS Nagar,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,326.0,1329.0,428.0,383.0,586.0,518.0,366.0,975.0,1854.0,683.0,413.0,382.0,8243.0
Mohali SAS Nagar,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0,,0.0,0.0
Mohali SAS Nagar,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0,,0.0,0.0
Mohali SAS Nagar,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0,,0.0,0.0
Mohali SAS Nagar,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,596.0,595.0,553.0,586.0,579.0,570.0,566.0,551.0,548.0,566.0,509.0,518.0,6737.0
Mohali SAS Nagar,10.4.2,Number of Immunisation sessions held during the month,TOTAL,606.0,589.0,553.0,589.0,577.0,560.0,563.0,548.0,545.0,554.0,510.0,474.0,6668.0
Mohali SAS Nagar,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,486.0,479.0,438.0,484.0,456.0,452.0,451.0,457.0,451.0,448.0,421.0,379.0,5402.0
Mohali SAS Nagar,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0,,0.0,0.0
Mohali SAS Nagar,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,1536.0,1726.0,1544.0,1681.0,1827.0,1558.0,1306.0,1606.0,1204.0,589.0,693.0,1073.0,16343.0
Mohali SAS Nagar,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,1080.0,1012.0,827.0,876.0,920.0,853.0,746.0,836.0,859.0,339.0,378.0,823.0,9549.0
Mohali SAS Nagar,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,1234.0,1568.0,1118.0,1142.0,1190.0,988.0,852.0,1197.0,1175.0,565.0,446.0,791.0,12266.0
Mohali SAS Nagar,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,,0.0,,,0.0,,,0.0
Mohali SAS Nagar,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,,0.0,,,0.0,,,0.0
Mohali SAS Nagar,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,,0.0,,,0.0,,,0.0
Mohali SAS Nagar,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,,0.0,,,0.0,,,0.0
Mohali SAS Nagar,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,,0.0,,,0.0,,,0.0
Mohali SAS Nagar,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0,,0.0,0.0
Mohali SAS Nagar,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,17.0,19.0,15.0,19.0,15.0,20.0,11.0,,,37.0,48.0,0.0,201.0
Mohali SAS Nagar,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,1.0,0.0,,0.0,,,0.0,,0.0,1.0
Mohali SAS Nagar,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,23.0,15.0,19.0,26.0,36.0,30.0,27.0,,,37.0,43.0,,256.0
Mohali SAS Nagar,13.1,Number of Patients operated for cataract,TOTAL,173.0,93.0,135.0,77.0,101.0,104.0,216.0,85.0,131.0,71.0,72.0,136.0,1394.0
Mohali SAS Nagar,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,173.0,93.0,102.0,56.0,56.0,104.0,203.0,85.0,103.0,71.0,72.0,127.0,1245.0
Mohali SAS Nagar,13.3,Number of School children detected with Refractive errors,TOTAL,106.0,68.0,45.0,400.0,126.0,112.0,405.0,153.0,268.0,225.0,42.0,71.0,2021.0
Mohali SAS Nagar,13.4,Number of children provided free glasses,TOTAL,89.0,57.0,35.0,0.0,80.0,57.0,72.0,31.0,184.0,128.0,32.0,48.0,813.0
Mohali SAS Nagar,13.5,Number of eyes collected through eye donation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0,,0.0,0.0
Mohali SAS Nagar,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0,,0.0,0.0
Mohali SAS Nagar,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,,,4.0,4.0,6.0,7.0,5.0,5.0,2.0,4.0,3.0,2.0,-1.0
Mohali SAS Nagar,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,,,,2.0,,,,,,,,,-1.0
Mohali SAS Nagar,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,324.0,301.0,280.0,312.0,313.0,313.0,315.0,309.0,288.0,310.0,247.0,223.0,-1.0
Mohali SAS Nagar,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,1.0,2.0,6.0,5.0,6.0,6.0,4.0,5.0,5.0,4.0,2.0,3.0,-1.0
Mohali SAS Nagar,14.05,Number of RKS meetings held during the month,TOTAL,3.0,5.0,5.0,9.0,4.0,3.0,4.0,4.0,4.0,3.0,4.0,2.0,50.0
Mohali SAS Nagar,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,,,5.0,6.0,5.0,8.0,5.0,8.0,6.0,2.0,3.0,3.0,-1.0
Mohali SAS Nagar,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,177.0,41.0,42.0,60.0,191.0,112.0,124.0,81.0,48.0,24.0,14.0,108.0,1022.0
Mohali SAS Nagar,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,,,2.0,2.0,4.0,6.0,4.0,4.0,3.0,1.0,1.0,1.0,-1.0
Mohali SAS Nagar,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,7.0,8.0,2.0,1.0,2.0,3.0,2.0,3.0,3.0,,1.0,,-1.0
Mohali SAS Nagar,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,155.0,153.0,183.0,165.0,303.0,731.0,805.0,472.0,318.0,453.0,183.0,162.0,4083.0
Mohali SAS Nagar,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,420.0,427.0,519.0,579.0,1766.0,710.0,724.0,1064.0,763.0,401.0,511.0,589.0,8473.0
Mohali SAS Nagar,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,141.0,119.0,165.0,103.0,250.0,838.0,652.0,595.0,301.0,507.0,174.0,108.0,3953.0
Mohali SAS Nagar,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,865.0,881.0,677.0,895.0,1998.0,1261.0,1409.0,1321.0,1133.0,642.0,709.0,603.0,12394.0
Mohali SAS Nagar,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,296.0,272.0,348.0,268.0,553.0,1569.0,1457.0,1067.0,619.0,960.0,357.0,270.0,8036.0
Mohali SAS Nagar,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,1285.0,1308.0,1196.0,1474.0,3764.0,1971.0,2133.0,2385.0,1896.0,1043.0,1220.0,1192.0,20867.0
Mohali SAS Nagar,14.10.2.a,Number of death cases of Inpatient males,TOTAL,2.0,0.0,5.0,3.0,24.0,16.0,10.0,10.0,4.0,3.0,1.0,2.0,80.0
Mohali SAS Nagar,14.10.2.b,Number of death cases of Inpatient females,TOTAL,0.0,0.0,0.0,1.0,14.0,9.0,12.0,15.0,3.0,2.0,0.0,0.0,56.0
Mohali SAS Nagar,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,2.0,0.0,5.0,4.0,38.0,25.0,22.0,25.0,7.0,5.0,1.0,2.0,136.0
Mohali SAS Nagar,14.11,In-Patient Head Count at midnight,TOTAL,195.0,67.0,73.0,123.0,8730.0,108.0,63.0,59.0,92.0,64.0,79.0,82.0,9735.0
Mohali SAS Nagar,14.12.1,OPD attendance (All),TOTAL,52665.0,60943.0,61573.0,88480.0,109647.0,91403.0,79539.0,83978.0,79264.0,75295.0,68088.0,68183.0,919058.0
Mohali SAS Nagar,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,305.0,606.0,411.0,326.0,1232.0,876.0,353.0,746.0,349.0,327.0,241.0,277.0,6049.0
Mohali SAS Nagar,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,26.0,46.0,12.0,0.0,0.0,,0.0,0.0,0.0,0.0,2.0,1.0,87.0
Mohali SAS Nagar,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,699.0,446.0,86.0,783.0,791.0,581.0,474.0,676.0,658.0,762.0,747.0,487.0,7190.0
Mohali SAS Nagar,14.14.a,Number of patients given AYUSH treatment,TOTAL,5597.0,4496.0,1908.0,4447.0,7899.0,9768.0,10225.0,11490.0,11932.0,9872.0,5609.0,5742.0,88985.0
Mohali SAS Nagar,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,1872.0,1968.0,761.0,2420.0,3273.0,1727.0,1851.0,1905.0,1507.0,1977.0,870.0,1485.0,21616.0
Mohali SAS Nagar,14.14.c,Number of Adolescents counselled,TOTAL,230.0,207.0,67.0,194.0,156.0,445.0,200.0,170.0,122.0,157.0,128.0,118.0,2194.0
Mohali SAS Nagar,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,4485.0,4379.0,5865.0,6049.0,12945.0,8809.0,9063.0,9195.0,5206.0,4907.0,2672.0,4921.0,78496.0
Mohali SAS Nagar,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,61.0,14.0,31.0,36.0,72.0,356.0,56.0,337.0,300.0,311.0,497.0,52.0,2123.0
Mohali SAS Nagar,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,554.0,590.0,559.0,624.0,858.0,449.0,656.0,662.0,710.0,605.0,494.0,426.0,7187.0
Mohali SAS Nagar,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,3.0,1.0,3.0,8.0,3.0,2.0,0.0,1.0,0.0,8.0,2.0,3.0,34.0
Mohali SAS Nagar,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,567.0,655.0,689.0,569.0,3210.0,1907.0,2244.0,2242.0,1462.0,1082.0,1143.0,1050.0,16820.0
Mohali SAS Nagar,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,2.0,2.0,3.0,3.0,4.0,2.0,0.0,0.0,0.0,0.0,0.0,1.0,17.0
Mohali SAS Nagar,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,832.0,1063.0,939.0,395.0,120.0,229.0,133.0,193.0,215.0,227.0,190.0,144.0,4680.0
Mohali SAS Nagar,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,0.0,0.0,1.0,2.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.0
Mohali SAS Nagar,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,1953.0,2308.0,2187.0,1588.0,4188.0,2585.0,3033.0,3097.0,2387.0,1914.0,1827.0,1620.0,28687.0
Mohali SAS Nagar,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,5.0,3.0,7.0,13.0,7.0,4.0,0.0,1.0,0.0,8.0,2.0,4.0,54.0
Mohali SAS Nagar,15.2,Number of Widal tests conducted,Number tested,406.0,385.0,323.0,689.0,771.0,760.0,638.0,457.0,1208.0,450.0,476.0,623.0,7186.0
Mohali SAS Nagar,15.3.a,Number of VDRL tests conducted on males,Number tested,115.0,102.0,314.0,365.0,109.0,96.0,65.0,120.0,68.0,85.0,64.0,101.0,1604.0
Mohali SAS Nagar,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,56.0,82.0,30.0,31.0,2688.0,1601.0,1626.0,2146.0,932.0,843.0,890.0,906.0,11831.0
Mohali SAS Nagar,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,1047.0,1150.0,694.0,316.0,158.0,209.0,150.0,163.0,214.0,229.0,200.0,305.0,4835.0
Mohali SAS Nagar,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,1218.0,1334.0,1038.0,712.0,2955.0,1906.0,1841.0,2429.0,1214.0,1157.0,1154.0,1312.0,18270.0
Mohali SAS Nagar,15.4.1,Number of blood smears examined for Malaria,TOTAL,2919.0,2231.0,1297.0,2181.0,2070.0,1810.0,1675.0,1857.0,2535.0,2649.0,2471.0,2986.0,26681.0
Mohali SAS Nagar,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,0.0,0.0,2.0,2.0,2.0,2.0,,,,1.0,,0.0,9.0
Mohali SAS Nagar,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,0.0,0.0,0.0,0.0,0.0,,,,,0.0,,0.0,0.0
Mohali SAS Nagar,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,2950.0,500.0,250.0,450.0,2750.0,600.0,2600.0,5000.0,10800.0,5800.0,100.0,5300.0,37100.0
Mohali SAS Nagar,16.1.1,Stock position of DPT vaccines,2. Stocks Received,8000.0,9000.0,7000.0,7000.0,8000.0,8000.0,8000.0,10000.0,0.0,,10000.0,5000.0,80000.0
Mohali SAS Nagar,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Mohali SAS Nagar,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,10450.0,9250.0,6800.0,4700.0,10150.0,6000.0,5600.0,4200.0,5000.0,5700.0,4800.0,6200.0,78850.0
Mohali SAS Nagar,16.1.1,Stock position of DPT vaccines,5. Total Stock,500.0,250.0,450.0,2750.0,600.0,2600.0,5000.0,10800.0,5800.0,100.0,5300.0,4100.0,38250.0
Mohali SAS Nagar,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,,,,,,,,,,,500.0,9500.0,10000.0
Mohali SAS Nagar,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,,,,,,,,,,13000.0,13000.0,,26000.0
Mohali SAS Nagar,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,,,,,,,,,,,,,
Mohali SAS Nagar,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,,,,,,,,,,12500.0,4000.0,5300.0,21800.0
Mohali SAS Nagar,16.1.1A,Stock Position of Pentavalent,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,500.0,9500.0,4200.0,14200.0
Mohali SAS Nagar,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,7780.0,4380.0,3880.0,3280.0,3960.0,960.0,1460.0,600.0,3900.0,6400.0,1100.0,9000.0,46700.0
Mohali SAS Nagar,16.1.2,Stock position of OPV vaccines,2. Stocks Received,5000.0,7500.0,7000.0,7000.0,8000.0,8000.0,8000.0,10000.0,10000.0,,15000.0,4000.0,89500.0
Mohali SAS Nagar,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,,,,,,,,,,,,,
Mohali SAS Nagar,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,8400.0,8000.0,7600.0,6320.0,11000.0,7500.0,8860.0,6700.0,7500.0,5300.0,7100.0,7160.0,91440.0
Mohali SAS Nagar,16.1.2,Stock position of OPV vaccines,5. Total Stock,4380.0,3880.0,3280.0,3960.0,960.0,1460.0,600.0,3900.0,6400.0,1100.0,9000.0,5840.0,44760.0
Mohali SAS Nagar,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,6010.0,4610.0,6000.0,3880.0,7330.0,1000.0,3100.0,4330.0,5230.0,7030.0,2030.0,8630.0,59180.0
Mohali SAS Nagar,16.1.3,Stock position of TT vaccines,2. Stocks Received,8000.0,8000.0,4000.0,7500.0,4000.0,6000.0,8000.0,5000.0,5000.0,,10000.0,,65500.0
Mohali SAS Nagar,16.1.3,Stock position of TT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Mohali SAS Nagar,16.1.3,Stock position of TT vaccines,4. Stock Distributed,9400.0,6610.0,6120.0,4050.0,10330.0,3900.0,6770.0,4100.0,3200.0,5000.0,3400.0,6280.0,69160.0
Mohali SAS Nagar,16.1.3,Stock position of TT vaccines,5. Total Stock,4610.0,6000.0,3880.0,7330.0,1000.0,3100.0,4330.0,5230.0,7030.0,2030.0,8630.0,2350.0,55520.0
Mohali SAS Nagar,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Mohali SAS Nagar,16.1.4,Stock position of DT vaccines,2. Stocks Received,,,,,,,,,,,,,
Mohali SAS Nagar,16.1.4,Stock position of DT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Mohali SAS Nagar,16.1.4,Stock position of DT vaccines,4. Stock Distributed,,,,,,,,,,,,,
Mohali SAS Nagar,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mohali SAS Nagar,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,3670.0,2740.0,3570.0,2670.0,4320.0,3000.0,410.0,1700.0,3000.0,4920.0,2470.0,6370.0,38840.0
Mohali SAS Nagar,16.1.5,Stock position of BCG vaccines,2. Stocks Received,3000.0,4000.0,2000.0,3000.0,3000.0,910.0,4290.0,3000.0,4000.0,,6000.0,2000.0,35200.0
Mohali SAS Nagar,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,,,,,,,,,,,,,
Mohali SAS Nagar,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,3930.0,3170.0,2900.0,1350.0,4320.0,3500.0,3000.0,1700.0,2080.0,2450.0,2100.0,3200.0,33700.0
Mohali SAS Nagar,16.1.5,Stock position of BCG vaccines,5. Total Stock,2740.0,3570.0,2670.0,4320.0,3000.0,410.0,1700.0,3000.0,4920.0,2470.0,6370.0,5170.0,40340.0
Mohali SAS Nagar,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,2880.0,2080.0,2780.0,1360.0,3110.0,3000.0,1700.0,150.0,800.0,3330.0,2580.0,6430.0,30200.0
Mohali SAS Nagar,16.1.6,Stock position of Measles vaccines,2. Stocks Received,3000.0,3500.0,3000.0,3000.0,3000.0,2000.0,1710.0,3000.0,5000.0,,6000.0,3000.0,36210.0
Mohali SAS Nagar,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,,,,,,,,,,,,,
Mohali SAS Nagar,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,3800.0,2800.0,4420.0,1250.0,3110.0,3300.0,3260.0,2350.0,2470.0,750.0,2150.0,5005.0,34665.0
Mohali SAS Nagar,16.1.6,Stock position of Measles vaccines,5. Total Stock,2080.0,2780.0,1360.0,3110.0,3000.0,1700.0,150.0,800.0,3330.0,2580.0,6430.0,4425.0,31745.0
Mohali SAS Nagar,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Mohali SAS Nagar,16.1.7,Stock position of JE vaccines,2. Stocks Received,,,,,,,,,,,,,
Mohali SAS Nagar,16.1.7,Stock position of JE vaccines,3. Unusable Stock,,,,,,,,,,,,,
Mohali SAS Nagar,16.1.7,Stock position of JE vaccines,4. Stock Distributed,,,,,,,,,,,,,
Mohali SAS Nagar,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mohali SAS Nagar,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,6050.0,5700.0,5500.0,5040.0,7390.0,6000.0,4000.0,5600.0,2000.0,5300.0,0.0,5000.0,57580.0
Mohali SAS Nagar,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,8000.0,5500.0,5000.0,5000.0,6000.0,3000.0,6000.0,,7000.0,,6000.0,2000.0,53500.0
Mohali SAS Nagar,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,,,,,,,,,,,,,
Mohali SAS Nagar,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,8350.0,5700.0,5460.0,2650.0,7390.0,5000.0,4400.0,3600.0,3700.0,5300.0,1000.0,4800.0,57350.0
Mohali SAS Nagar,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,5700.0,5500.0,5040.0,7390.0,6000.0,4000.0,5600.0,2000.0,5300.0,0.0,5000.0,2200.0,53730.0
Mohali SAS Nagar,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Mohali SAS Nagar,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Mohali SAS Nagar,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Mohali SAS Nagar,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Mohali SAS Nagar,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mohali SAS Nagar,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Mohali SAS Nagar,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Mohali SAS Nagar,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Mohali SAS Nagar,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Mohali SAS Nagar,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mohali SAS Nagar,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Mohali SAS Nagar,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Mohali SAS Nagar,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Mohali SAS Nagar,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Mohali SAS Nagar,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mohali SAS Nagar,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Mohali SAS Nagar,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Mohali SAS Nagar,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Mohali SAS Nagar,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Mohali SAS Nagar,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mohali SAS Nagar,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Mohali SAS Nagar,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Mohali SAS Nagar,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Mohali SAS Nagar,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Mohali SAS Nagar,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mohali SAS Nagar,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,,,,,,,,,,,,,
Mohali SAS Nagar,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,,,,,,,,,,,,,
Mohali SAS Nagar,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,,,,,,,,,,,,,
Mohali SAS Nagar,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,,,,,,,,,,,,,
Mohali SAS Nagar,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mohali SAS Nagar,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,,,,,,,,,,,,,
Mohali SAS Nagar,16.3.02,Stock Position of Gloves,2. Stocks Received,,,,,,,,,,,,,
Mohali SAS Nagar,16.3.02,Stock Position of Gloves,3. Unusable Stock,,,,,,,,,,,,,
Mohali SAS Nagar,16.3.02,Stock Position of Gloves,4. Stock Distributed,,,,,,,,,,,,,
Mohali SAS Nagar,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mohali SAS Nagar,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,,,,,,,,,,,,,
Mohali SAS Nagar,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,,,,,,,,,,,,,
Mohali SAS Nagar,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,,,,,,,,,,,,,
Mohali SAS Nagar,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,,,,,,,,,,,,,
Mohali SAS Nagar,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mohali SAS Nagar,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
Mohali SAS Nagar,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,,,,,,,,,,,,,
Mohali SAS Nagar,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,,,,,,,,,,,,,
Mohali SAS Nagar,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,,,,,,,,,,,,,
Mohali SAS Nagar,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mohali SAS Nagar,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,,,,,,,,,,,,,
Mohali SAS Nagar,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,,,,,,,,,,,,,
Mohali SAS Nagar,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,,,,,,,,,,,,,
Mohali SAS Nagar,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,,,,,,,,,,,,,
Mohali SAS Nagar,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mohali SAS Nagar,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,,,,,,,,,,,,,
Mohali SAS Nagar,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,,,,,,,,,,,,,
Mohali SAS Nagar,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,,,,,,,,,,,,,
Mohali SAS Nagar,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,,,,,,,,,,,,,
Mohali SAS Nagar,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mohali SAS Nagar,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
Mohali SAS Nagar,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,,,,,,,,,,,,,
Mohali SAS Nagar,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,,,,,,,,,,,,,
Mohali SAS Nagar,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,,,,,,,,,,,,,
Mohali SAS Nagar,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mohali SAS Nagar,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,,,,,,,,,,,,,
Mohali SAS Nagar,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,,,,,,,,,,,,,
Mohali SAS Nagar,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,,,,,,,,,,,,,
Mohali SAS Nagar,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,,,,,,,,,,,,,
Mohali SAS Nagar,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mohali SAS Nagar,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,,,,,,,,,,,,,
Mohali SAS Nagar,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,,,,,,,,,,,,,
Mohali SAS Nagar,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,,,,,,,,,,,,,
Mohali SAS Nagar,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,,,,,,,,,,,,,
Mohali SAS Nagar,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mohali SAS Nagar,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,,,,,,,,,,,,,
Mohali SAS Nagar,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,,,,,,,,,,,,,
Mohali SAS Nagar,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,,,,,,,,,,,,,
Mohali SAS Nagar,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,,,,,,,,,,,,,
Mohali SAS Nagar,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mohali SAS Nagar,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,,,,,,,,,,,,,
Mohali SAS Nagar,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,,,,,,,,,,,,,
Mohali SAS Nagar,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,,,,,,,,,,,,,
Mohali SAS Nagar,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,,,,,,,,,,,,,
Mohali SAS Nagar,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mohali SAS Nagar,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,100.0,0.0,100.0,100.0,100.0,0.0,2000.0,200.0,200.0,700.0,700.0,0.0,4200.0
Mohali SAS Nagar,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,2000.0,4400.0,,,,2000.0,,,1800.0,,,4000.0,14200.0
Mohali SAS Nagar,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,,
Mohali SAS Nagar,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,2100.0,4300.0,,,100.0,,1800.0,,1300.0,,700.0,3600.0,13900.0
Mohali SAS Nagar,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,0.0,100.0,100.0,100.0,0.0,2000.0,200.0,200.0,700.0,700.0,0.0,400.0,4500.0
Mohali SAS Nagar,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,1000.0,1000.0,2000.0,,,,,,,,,,4000.0
Mohali SAS Nagar,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,,150000.0,,,,,,,,,,100000.0,250000.0
Mohali SAS Nagar,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,,
Mohali SAS Nagar,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,,149000.0,2000.0,,,,,,,,,96000.0,247000.0
Mohali SAS Nagar,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,1000.0,2000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,4000.0,7000.0
Mohali SAS Nagar,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,100.0,0.0,2400.0,2000.0,1000.0,,2400.0,600.0,600.0,300.0,100.0,100.0,9600.0
Mohali SAS Nagar,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,,2400.0,,,,2400.0,,,,,,2400.0,7200.0
Mohali SAS Nagar,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,,,,,,,,,,,,,
Mohali SAS Nagar,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,100.0,0.0,400.0,1000.0,1000.0,,1800.0,,300.0,200.0,,2100.0,6900.0
Mohali SAS Nagar,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,0.0,2400.0,2000.0,1000.0,0.0,2400.0,600.0,600.0,300.0,100.0,100.0,400.0,9900.0
Mohali SAS Nagar,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,,2.0,,,1.0,,,,,,,,3.0
Mohali SAS Nagar,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Mohali SAS Nagar,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Mohali SAS Nagar,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,,,,,,,,,,,,
Mohali SAS Nagar,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,2.0,,,,2.0,,,,,,,,4.0
Mohali SAS Nagar,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Mohali SAS Nagar,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,2.0,,,,2.0,,,,,,,,4.0
Mohali SAS Nagar,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,2.0,2.0,,,,,,,,,,,4.0
Mohali SAS Nagar,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Mohali SAS Nagar,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,2.0,2.0,,,,,,,,,,,4.0
Mohali SAS Nagar,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,4.0,,1.0,,1.0,,1.0,1.0,,,4.0,,12.0
Mohali SAS Nagar,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,1.0,1.0
Mohali SAS Nagar,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,4.0,,1.0,,1.0,,1.0,1.0,,,4.0,1.0,13.0
Mohali SAS Nagar,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,,,,,,,,,1.0,,,1.0
Mohali SAS Nagar,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,,,,,,,,,,
Mohali SAS Nagar,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,,,,,,,,,,1.0,,,1.0
Mohali SAS Nagar,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,1.0,,,1.0,,,,,,,,2.0
Mohali SAS Nagar,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,1.0,,,,,,,,,,,1.0
Mohali SAS Nagar,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,2.0,,,1.0,,,,,,,,3.0
Mohali SAS Nagar,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,4.0,1.0,1.0,,,,1.0,,,,,,7.0
Mohali SAS Nagar,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,,,,,,,,1.0,,1.0
Mohali SAS Nagar,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,4.0,1.0,1.0,,,,1.0,,,,1.0,,8.0
Mohali SAS Nagar,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Mohali SAS Nagar,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Mohali SAS Nagar,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Mohali SAS Nagar,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,,2.0,,,2.0,1.0,,,,,,,5.0
Mohali SAS Nagar,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,,1.0,,,,,,,,,,1.0,2.0
Mohali SAS Nagar,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,,3.0,,,2.0,1.0,,,,,,1.0,7.0
Mohali SAS Nagar,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
Mohali SAS Nagar,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,,,,,,1.0,,,1.0
Mohali SAS Nagar,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,,,,,,,,,
Mohali SAS Nagar,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,,,,,,,,1.0,,,1.0
Mohali SAS Nagar,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
Mohali SAS Nagar,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,,,2.0,,1.0,,,1.0,,1.0,,,5.0
Mohali SAS Nagar,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,,1.0,,,,,,,1.0,,,,2.0
Mohali SAS Nagar,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,,1.0,2.0,,1.0,,,1.0,1.0,1.0,,,7.0
Mohali SAS Nagar,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,,,,,,
Mohali SAS Nagar,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,,,,1.0,,,,,,,,,1.0
Mohali SAS Nagar,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,,,,,1.0,,,,,2.0,,,3.0
Mohali SAS Nagar,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,,,,1.0,1.0,,,,,2.0,,,4.0
Mohali SAS Nagar,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,1.0,,,,1.0
Mohali SAS Nagar,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,,,1.0,,,,,1.0
Mohali SAS Nagar,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
Mohali SAS Nagar,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,,,,,1.0,1.0,,,,2.0
Mohali SAS Nagar,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,,,,,,,,,,
Mohali SAS Nagar,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,,,,,1.0,1.0,2.0,1.0,1.0,,,,6.0
Mohali SAS Nagar,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,,7.0,,,,,5.0,,,,,,12.0
Mohali SAS Nagar,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,,7.0,,,1.0,1.0,7.0,1.0,1.0,,,,18.0
Mohali SAS Nagar,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
Mohali SAS Nagar,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,,,,,,,,,,,
Mohali SAS Nagar,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,,,,
Mohali SAS Nagar,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,,,,,,,,,,,
Mohali SAS Nagar,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,,,,,,,,,
Mohali SAS Nagar,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,1.0,3.0,1.0,1.0,3.0,2.0,4.0,3.0,6.0,5.0,3.0,4.0,36.0
Mohali SAS Nagar,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,3.0,10.0,8.0,1.0,7.0,11.0,7.0,7.0,26.0,9.0,15.0,13.0,117.0
Mohali SAS Nagar,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,4.0,13.0,9.0,2.0,10.0,13.0,11.0,10.0,32.0,14.0,18.0,17.0,153.0
Mohali SAS Nagar,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,,,,,,,
Mohali SAS Nagar,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,,,,,1.0,,,,,,,,1.0
Mohali SAS Nagar,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,,,,,,,,,,,,,
Mohali SAS Nagar,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,,,,,1.0,,,,,,,,1.0
Mohali SAS Nagar,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Mohali SAS Nagar,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
Mohali SAS Nagar,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Mohali SAS Nagar,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
Mohali SAS Nagar,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Mohali SAS Nagar,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,,,,,,,,
Mohali SAS Nagar,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Mohali SAS Nagar,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,,,,,,,,
Mohali SAS Nagar,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Mohali SAS Nagar,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,,,,,,,,,,
Mohali SAS Nagar,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Mohali SAS Nagar,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,,,,,,,,,,,
Mohali SAS Nagar,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Mohali SAS Nagar,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,,,,,,,,,,,
Mohali SAS Nagar,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Mohali SAS Nagar,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,,,,,,,,,,,
Mohali SAS Nagar,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Mohali SAS Nagar,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,1.0,,,1.0,,,1.0,,,3.0
Mohali SAS Nagar,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Mohali SAS Nagar,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,1.0,,,1.0,,,1.0,,,3.0
Mohali SAS Nagar,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Mohali SAS Nagar,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,,,,,,,,,,,,,
Mohali SAS Nagar,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Mohali SAS Nagar,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,,,,,,,,,,,,,
Mohali SAS Nagar,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,,,,,,,,,,,,
Mohali SAS Nagar,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,,,,1.0,3.0,3.0,1.0,2.0,3.0,7.0,,1.0,21.0
Mohali SAS Nagar,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,,,,,,1.0,1.0,1.0,1.0,,,,4.0
Mohali SAS Nagar,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,,,,1.0,3.0,4.0,2.0,3.0,4.0,7.0,,1.0,25.0
Mohali SAS Nagar,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,,,,,,,,,
Mohali SAS Nagar,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,,,,,2.0,,1.0,,1.0,,,1.0,5.0
Mohali SAS Nagar,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,,,,,,,,,,,,
Mohali SAS Nagar,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,,,,,2.0,,1.0,,1.0,,,1.0,5.0
Mohali SAS Nagar,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,,,,,,,,,,
Mohali SAS Nagar,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,,,,,,,,,,,,
Mohali SAS Nagar,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,,,,,,,,,,,
Mohali SAS Nagar,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,,,,,,,,,,,,,
Mohali SAS Nagar,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,,,,,,,,,,,
Mohali SAS Nagar,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,,,,,2.0,,,,,,,,2.0
Mohali SAS Nagar,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,,,,,1.0,,,,,,,,1.0
Mohali SAS Nagar,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,,,,,3.0,,,,,,,,3.0
Mohali SAS Nagar,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,,,,,,,,,,,,
Mohali SAS Nagar,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,,,,,,,,,,,,,
Mohali SAS Nagar,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,,,1.0,,2.0,,1.0,,,1.0,,,5.0
Mohali SAS Nagar,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,,,1.0,,2.0,,1.0,,,1.0,,,5.0
Mohali SAS Nagar,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,,,,,,,,,,,,,
Mohali SAS Nagar,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,,4.0,,,,10.0,5.0,7.0,13.0,2.0,4.0,3.0,48.0
Mohali SAS Nagar,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,3.0,19.0,14.0,3.0,9.0,11.0,14.0,25.0,46.0,23.0,20.0,13.0,200.0
Mohali SAS Nagar,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,3.0,23.0,14.0,3.0,9.0,21.0,19.0,32.0,59.0,25.0,24.0,16.0,248.0
Muktsar,1.1,Total number of pregnant women Registered for ANC,TOTAL,1633.0,1657.0,1359.0,1468.0,1488.0,1201.0,1030.0,1263.0,1193.0,1500.0,1474.0,1297.0,16563.0
Muktsar,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,1011.0,1019.0,885.0,993.0,997.0,802.0,739.0,886.0,877.0,1195.0,1118.0,1010.0,11532.0
Muktsar,1.2,Number of Pregnant women registered under JSY,TOTAL,831.0,831.0,698.0,692.0,714.0,577.0,486.0,613.0,609.0,774.0,794.0,644.0,8263.0
Muktsar,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,1286.0,1495.0,1430.0,1376.0,1373.0,1289.0,1265.0,1218.0,1130.0,1156.0,1131.0,1107.0,15256.0
Muktsar,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,1606.0,1587.0,1357.0,1408.0,1431.0,1161.0,994.0,1207.0,1164.0,1412.0,1430.0,1243.0,16000.0
Muktsar,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,1536.0,1565.0,1466.0,1389.0,1330.0,1395.0,1178.0,1066.0,1095.0,1123.0,1253.0,1212.0,15608.0
Muktsar,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,1456.0,1497.0,1356.0,1473.0,1290.0,1277.0,1314.0,1356.0,1278.0,1321.0,1270.0,1252.0,16140.0
Muktsar,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,10.0,16.0,17.0,31.0,36.0,61.0,10.0,6.0,2.0,14.0,15.0,22.0,240.0
Muktsar,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,2.0
Muktsar,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,1436.0,1548.0,1399.0,1429.0,1431.0,1106.0,1164.0,1042.0,1106.0,1318.0,1482.0,1249.0,15710.0
Muktsar,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,4.0,10.0,6.0,4.0,1.0,2.0,3.0,3.0,2.0,1.0,3.0,0.0,39.0
Muktsar,1.8,Number of pregnancy test kits used at SC level,TOTAL,632.0,633.0,583.0,563.0,567.0,541.0,423.0,427.0,422.0,416.0,383.0,254.0,5844.0
Muktsar,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,1.0,6.0,6.0,9.0,17.0,26.0,17.0,18.0,10.0,19.0,13.0,23.0,165.0
Muktsar,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,55.0,51.0,49.0,57.0,72.0,57.0,67.0,53.0,52.0,63.0,36.0,43.0,655.0
Muktsar,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,56.0,57.0,55.0,66.0,89.0,83.0,84.0,71.0,62.0,82.0,49.0,66.0,820.0
Muktsar,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,11.0,34.0,28.0,38.0,57.0,45.0,58.0,47.0,49.0,63.0,37.0,41.0,508.0
Muktsar,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,1.0
Muktsar,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,409.0,453.0,504.0,643.0,722.0,719.0,626.0,618.0,576.0,605.0,506.0,450.0,6831.0
Muktsar,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,282.0,275.0,318.0,427.0,364.0,303.0,366.0,357.0,221.0,425.0,397.0,343.0,4078.0
Muktsar,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,327.0,316.0,276.0,330.0,446.0,463.0,368.0,354.0,402.0,367.0,347.0,323.0,4319.0
Muktsar,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Muktsar,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Muktsar,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,398.0,461.0,501.0,544.0,723.0,682.0,651.0,695.0,610.0,658.0,510.0,535.0,6968.0
Muktsar,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Muktsar,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Muktsar,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Muktsar,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Muktsar,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,5.0,1.0,2.0,8.0,8.0,4.0,4.0,10.0,3.0,5.0,5.0,6.0,61.0
Muktsar,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,37.0,52.0,45.0,49.0,60.0,51.0,44.0,38.0,48.0,36.0,21.0,41.0,522.0
Muktsar,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Muktsar,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,42.0,53.0,47.0,57.0,68.0,55.0,48.0,48.0,51.0,41.0,26.0,47.0,583.0
Muktsar,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,102.0,108.0,150.0,153.0,198.0,182.0,206.0,168.0,205.0,202.0,125.0,138.0,1937.0
Muktsar,4.1.1.a,Number of male live births,TOTAL,447.0,490.0,539.0,683.0,784.0,773.0,711.0,747.0,647.0,701.0,573.0,532.0,7627.0
Muktsar,4.1.1.b,Number of female live births,TOTAL,405.0,467.0,510.0,553.0,733.0,703.0,648.0,632.0,586.0,627.0,487.0,508.0,6859.0
Muktsar,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,852.0,957.0,1049.0,1236.0,1517.0,1476.0,1359.0,1379.0,1233.0,1328.0,1060.0,1040.0,14486.0
Muktsar,4.1.2,Number of still births,TOTAL,17.0,19.0,17.0,23.0,27.0,22.0,18.0,25.0,24.0,25.0,13.0,15.0,245.0
Muktsar,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,103.0,97.0,86.0,95.0,94.0,86.0,63.0,86.0,85.0,102.0,109.0,92.0,1098.0
Muktsar,4.2.1,Number of Newborns weighed at birth,TOTAL,851.0,949.0,1049.0,1227.0,1421.0,1476.0,1358.0,1374.0,1233.0,1326.0,1059.0,1037.0,14360.0
Muktsar,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,68.0,101.0,69.0,80.0,79.0,42.0,40.0,38.0,67.0,145.0,34.0,44.0,807.0
Muktsar,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,772.0,849.0,958.0,830.0,1308.0,1382.0,1298.0,1324.0,1196.0,1246.0,977.0,897.0,13037.0
Muktsar,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,3.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,4.0
Muktsar,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,37.0,37.0,38.0,43.0,40.0,42.0,43.0,39.0,5.0,24.0,25.0,0.0,373.0
Muktsar,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,34.0,54.0,49.0,47.0,48.0,58.0,73.0,63.0,47.0,82.0,36.0,42.0,633.0
Muktsar,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Muktsar,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,74.0,91.0,87.0,90.0,88.0,100.0,116.0,103.0,52.0,106.0,61.0,42.0,1010.0
Muktsar,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,45.0,79.0,115.0,114.0,120.0,473.0
Muktsar,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,73.0,91.0,87.0,83.0,88.0,100.0,116.0,148.0,131.0,221.0,175.0,162.0,1475.0
Muktsar,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Muktsar,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,71.0,91.0,87.0,90.0,88.0,100.0,116.0,147.0,131.0,221.0,175.0,162.0,1479.0
Muktsar,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,13.0,37.0,28.0,30.0,57.0,39.0,34.0,56.0,39.0,41.0,23.0,41.0,438.0
Muktsar,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,635.0,670.0,755.0,957.0,1143.0,1234.0,1169.0,1202.0,1049.0,1002.0,891.0,940.0,11647.0
Muktsar,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,508.0,580.0,614.0,778.0,946.0,998.0,1133.0,1153.0,878.0,857.0,742.0,903.0,10090.0
Muktsar,6.3,PNC maternal complications attended,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Muktsar,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,18.0,11.0,8.0,11.0,16.0,12.0,7.0,4.0,2.0,8.0,6.0,0.0,103.0
Muktsar,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Muktsar,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,18.0,11.0,8.0,11.0,16.0,12.0,7.0,4.0,2.0,8.0,6.0,0.0,103.0
Muktsar,7.2,Number of MTPs conducted at Private Facilities,TOTAL,80.0,81.0,57.0,65.0,67.0,60.0,43.0,71.0,65.0,91.0,101.0,75.0,856.0
Muktsar,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,68.0,60.0,60.0,57.0,88.0,65.0,50.0,54.0,38.0,54.0,76.0,59.0,729.0
Muktsar,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,186.0,173.0,165.0,102.0,171.0,172.0,123.0,195.0,108.0,160.0,146.0,165.0,1866.0
Muktsar,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,254.0,233.0,225.0,159.0,259.0,237.0,173.0,249.0,146.0,214.0,222.0,224.0,2595.0
Muktsar,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Muktsar,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Muktsar,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,2.0,2.0,1.0,10.0,2.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,17.0
Muktsar,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,0.0,6.0,6.0,14.0,3.0,2.0,0.0,10.0,2.0,1.0,9.0,8.0,61.0
Muktsar,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Muktsar,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,2.0,8.0,7.0,24.0,5.0,2.0,0.0,10.0,2.0,1.0,9.0,8.0,78.0
Muktsar,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0
Muktsar,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Muktsar,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Muktsar,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Muktsar,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Muktsar,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Muktsar,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Muktsar,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,5.0,12.0,6.0,25.0,4.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,52.0
Muktsar,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,72.0,159.0,190.0,180.0,90.0,19.0,6.0,8.0,6.0,15.0,37.0,56.0,838.0
Muktsar,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,115.0,150.0,246.0,137.0,83.0,76.0,37.0,25.0,19.0,21.0,129.0,149.0,1187.0
Muktsar,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Muktsar,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,192.0,321.0,442.0,342.0,177.0,95.0,43.0,33.0,25.0,36.0,166.0,205.0,2077.0
Muktsar,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,3.0,1.0,1.0,2.0,0.0,2.0,0.0,0.0,1.0,0.0,0.0,19.0,29.0
Muktsar,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Muktsar,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Muktsar,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,6.0,6.0,5.0,3.0,7.0,9.0,9.0,2.0,0.0,2.0,3.0,0.0,52.0
Muktsar,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Muktsar,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,6.0,6.0,5.0,3.0,7.0,9.0,9.0,2.0,0.0,2.0,3.0,0.0,52.0
Muktsar,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,1.0,0.0,0.0,2.0
Muktsar,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,553.0,534.0,574.0,755.0,533.0,593.0,520.0,517.0,451.0,477.0,504.0,401.0,6412.0
Muktsar,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,1.0,2.0,2.0,2.0,1.0,2.0,1.0,2.0,0.0,4.0,4.0,0.0,21.0
Muktsar,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,1.0,0.0,0.0,0.0,4.0,5.0,3.0,3.0,4.0,1.0,3.0,1.0,25.0
Muktsar,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,151.0,145.0,153.0,337.0,144.0,140.0,135.0,135.0,142.0,149.0,137.0,135.0,1903.0
Muktsar,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Muktsar,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,706.0,681.0,729.0,1094.0,682.0,740.0,659.0,657.0,597.0,631.0,648.0,537.0,8361.0
Muktsar,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,7.0,5.0,1.0,3.0,10.0,0.0,1.0,5.0,1.0,2.0,11.0,8.0,54.0
Muktsar,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,134.0,98.0,108.0,96.0,89.0,71.0,76.0,120.0,70.0,65.0,100.0,91.0,1118.0
Muktsar,9.06,Number of IUCD removals,TOTAL,206.0,209.0,186.0,194.0,156.0,184.0,155.0,170.0,171.0,151.0,149.0,149.0,2080.0
Muktsar,9.07,Number of Oral Pills cycles distributed,TOTAL,3350.0,3889.0,3517.0,3832.0,3387.0,3828.0,3042.0,3384.0,3596.0,3601.0,3766.0,4161.0,43353.0
Muktsar,9.08,Number of Condom pieces distributed,TOTAL,81903.0,73814.0,85813.0,86003.0,79557.0,83869.0,78793.0,73385.0,73001.0,87790.0,83089.0,69207.0,956224.0
Muktsar,9.09,Number of Centchroman (weekly) pills given,TOTAL,19.0,10.0,0.0,0.0,16.0,8.0,84.0,112.0,53.0,23.0,9.0,35.0,369.0
Muktsar,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,193.0,175.0,161.0,156.0,130.0,92.0,151.0,169.0,71.0,141.0,103.0,64.0,1606.0
Muktsar,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Muktsar,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Muktsar,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Muktsar,9.11.2.b,Number of failures following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Muktsar,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Muktsar,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Muktsar,9.12,Number of Institutions having NSV trained doctors,TOTAL,,,,2.0,4.0,4.0,2.0,3.0,3.0,4.0,2.0,2.0,-1.0
Muktsar,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,1120.0,1072.0,1051.0,1187.0,1482.0,1511.0,1401.0,1568.0,1221.0,1292.0,1342.0,991.0,15238.0
Muktsar,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,1200.0,1188.0,998.0,1126.0,1121.0,1174.0,1332.0,1450.0,1208.0,1129.0,350.0,92.0,12368.0
Muktsar,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,1350.0,1297.0,1173.0,1116.0,1096.0,1096.0,1163.0,1301.0,1314.0,1195.0,1151.0,477.0,13729.0
Muktsar,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,1289.0,1347.0,1265.0,1242.0,1094.0,1130.0,1116.0,1148.0,1255.0,1325.0,1148.0,992.0,14351.0
Muktsar,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1126.0,988.0,2114.0
Muktsar,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,802.0,802.0
Muktsar,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,6.0,6.0
Muktsar,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,709.0,780.0,801.0,982.0,1269.0,1238.0,1177.0,1165.0,975.0,1162.0,1064.0,693.0,12015.0
Muktsar,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,1200.0,1188.0,998.0,1126.0,1121.0,1174.0,1332.0,1450.0,1208.0,1129.0,1476.0,1080.0,14482.0
Muktsar,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,1350.0,1297.0,1173.0,1116.0,1096.0,1096.0,1163.0,1301.0,1314.0,1195.0,1151.0,1269.0,14521.0
Muktsar,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,1289.0,1347.0,1265.0,1242.0,1094.0,1130.0,1116.0,1148.0,1255.0,1325.0,1148.0,998.0,14357.0
Muktsar,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,465.0,579.0,556.0,691.0,722.0,887.0,813.0,801.0,689.0,763.0,723.0,456.0,8145.0
Muktsar,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,1200.0,1188.0,998.0,1126.0,1121.0,1174.0,1332.0,1450.0,1208.0,1129.0,350.0,97.0,12373.0
Muktsar,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,1350.0,1297.0,1173.0,1116.0,1096.0,1096.0,1163.0,1301.0,1314.0,1195.0,1151.0,498.0,13750.0
Muktsar,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,1289.0,1347.0,1265.0,1242.0,1094.0,1130.0,1116.0,1148.0,1255.0,1325.0,1148.0,982.0,14341.0
Muktsar,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,1177.0,1418.0,1233.0,1240.0,1236.0,1346.0,1216.0,1134.0,1042.0,1017.0,991.0,935.0,13985.0
Muktsar,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,1097.0,1188.0,1128.0,1160.0,1112.0,1045.0,937.0,981.0,891.0,1022.0,1164.0,960.0,12685.0
Muktsar,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Muktsar,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,614.0,728.0,618.0,627.0,623.0,704.0,607.0,567.0,518.0,487.0,495.0,454.0,7042.0
Muktsar,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,494.0,610.0,536.0,539.0,537.0,599.0,550.0,511.0,453.0,456.0,444.0,385.0,6114.0
Muktsar,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,1108.0,1338.0,1154.0,1166.0,1160.0,1303.0,1157.0,1078.0,971.0,943.0,939.0,839.0,13156.0
Muktsar,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,1087.0,1211.0,1085.0,1169.0,1121.0,975.0,933.0,936.0,892.0,1017.0,1151.0,976.0,12553.0
Muktsar,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,1087.0,1211.0,1085.0,1169.0,1121.0,975.0,933.0,936.0,892.0,1017.0,1151.0,976.0,12553.0
Muktsar,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Muktsar,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,37.0,43.0,43.0,46.0,35.0,24.0,30.0,35.0,38.0,38.0,31.0,55.0,455.0
Muktsar,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,32.0,37.0,36.0,28.0,41.0,19.0,29.0,21.0,33.0,36.0,21.0,41.0,374.0
Muktsar,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,69.0,80.0,79.0,74.0,76.0,43.0,59.0,56.0,71.0,74.0,52.0,96.0,829.0
Muktsar,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,484.0,679.0,617.0,524.0,652.0,677.0,728.0,734.0,633.0,369.0,557.0,488.0,7142.0
Muktsar,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,331.0,700.0,344.0,462.0,998.0,786.0,587.0,664.0,458.0,209.0,419.0,223.0,6181.0
Muktsar,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,234.0,421.0,226.0,343.0,546.0,481.0,522.0,411.0,305.0,129.0,405.0,188.0,4211.0
Muktsar,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Muktsar,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Muktsar,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Muktsar,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,537.0,531.0,523.0,535.0,516.0,518.0,523.0,511.0,514.0,506.0,529.0,516.0,6259.0
Muktsar,10.4.2,Number of Immunisation sessions held during the month,TOTAL,536.0,529.0,523.0,534.0,497.0,512.0,523.0,509.0,506.0,505.0,512.0,431.0,6117.0
Muktsar,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,427.0,418.0,420.0,425.0,414.0,420.0,431.0,421.0,419.0,422.0,451.0,360.0,5028.0
Muktsar,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Muktsar,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,1177.0,1418.0,1233.0,1240.0,1115.0,1324.0,1201.0,1106.0,1031.0,974.0,935.0,835.0,13589.0
Muktsar,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,833.0,727.0,682.0,959.0,749.0,856.0,874.0,797.0,738.0,824.0,756.0,688.0,9483.0
Muktsar,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,739.0,586.0,780.0,858.0,709.0,792.0,994.0,870.0,671.0,716.0,934.0,677.0,9326.0
Muktsar,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Muktsar,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Muktsar,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Muktsar,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Muktsar,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Muktsar,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Muktsar,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,63.0,57.0,63.0,22.0,25.0,22.0,21.0,15.0,20.0,9.0,5.0,9.0,331.0
Muktsar,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,1.0
Muktsar,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Muktsar,13.1,Number of Patients operated for cataract,TOTAL,470.0,401.0,278.0,221.0,231.0,481.0,342.0,705.0,270.0,174.0,347.0,801.0,4721.0
Muktsar,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,470.0,399.0,278.0,221.0,230.0,480.0,338.0,705.0,270.0,173.0,346.0,800.0,4710.0
Muktsar,13.3,Number of School children detected with Refractive errors,TOTAL,21.0,24.0,55.0,57.0,78.0,40.0,383.0,184.0,115.0,71.0,38.0,28.0,1094.0
Muktsar,13.4,Number of children provided free glasses,TOTAL,21.0,24.0,55.0,57.0,78.0,40.0,383.0,184.0,115.0,71.0,38.0,28.0,1094.0
Muktsar,13.5,Number of eyes collected through eye donation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Muktsar,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Muktsar,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,,,,6.0,6.0,7.0,6.0,7.0,6.0,6.0,8.0,8.0,-1.0
Muktsar,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,,,,8.0,8.0,7.0,6.0,7.0,5.0,4.0,5.0,6.0,-1.0
Muktsar,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,249.0,259.0,254.0,267.0,275.0,267.0,273.0,264.0,275.0,263.0,266.0,230.0,-1.0
Muktsar,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,5.0,5.0,5.0,6.0,6.0,7.0,6.0,6.0,7.0,6.0,6.0,7.0,-1.0
Muktsar,14.05,Number of RKS meetings held during the month,TOTAL,1.0,0.0,1.0,4.0,3.0,4.0,2.0,2.0,6.0,1.0,4.0,3.0,31.0
Muktsar,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,,1.0,,5.0,4.0,5.0,4.0,5.0,4.0,4.0,5.0,6.0,-1.0
Muktsar,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,9.0,7.0,10.0,5.0,5.0,9.0,12.0,2.0,3.0,3.0,2.0,2.0,69.0
Muktsar,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,,,,2.0,2.0,1.0,,1.0,,,1.0,1.0,-1.0
Muktsar,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,5.0,5.0,5.0,1.0,0.0,0.0,0.0,0.0,1.0,1.0,0.0,0.0,-1.0
Muktsar,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,225.0,121.0,304.0,137.0,196.0,266.0,235.0,235.0,694.0,237.0,190.0,184.0,3024.0
Muktsar,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,448.0,451.0,589.0,583.0,501.0,412.0,398.0,412.0,469.0,313.0,358.0,528.0,5462.0
Muktsar,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,173.0,107.0,355.0,135.0,216.0,263.0,245.0,178.0,705.0,225.0,178.0,180.0,2960.0
Muktsar,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,1055.0,1121.0,1610.0,951.0,1188.0,930.0,871.0,1065.0,854.0,855.0,1014.0,1164.0,12678.0
Muktsar,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,398.0,228.0,659.0,272.0,412.0,529.0,480.0,413.0,1399.0,462.0,368.0,364.0,5984.0
Muktsar,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,1503.0,1572.0,2199.0,1534.0,1689.0,1342.0,1269.0,1477.0,1323.0,1168.0,1372.0,1692.0,18140.0
Muktsar,14.10.2.a,Number of death cases of Inpatient males,TOTAL,3.0,3.0,2.0,3.0,0.0,4.0,3.0,7.0,1.0,5.0,5.0,0.0,36.0
Muktsar,14.10.2.b,Number of death cases of Inpatient females,TOTAL,1.0,1.0,0.0,0.0,1.0,4.0,4.0,3.0,1.0,0.0,3.0,1.0,19.0
Muktsar,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,4.0,4.0,2.0,3.0,1.0,8.0,7.0,10.0,2.0,5.0,8.0,1.0,55.0
Muktsar,14.11,In-Patient Head Count at midnight,TOTAL,463.0,594.0,423.0,674.0,309.0,425.0,378.0,316.0,386.0,299.0,329.0,342.0,4938.0
Muktsar,14.12.1,OPD attendance (All),TOTAL,47122.0,43248.0,54900.0,54581.0,43519.0,49079.0,41453.0,45250.0,39853.0,38992.0,44766.0,47488.0,550251.0
Muktsar,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,220.0,140.0,269.0,80.0,398.0,450.0,375.0,323.0,274.0,217.0,214.0,535.0,3495.0
Muktsar,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,5.0,1.0,2.0,14.0,4.0,5.0,1.0,1.0,3.0,148.0,140.0,181.0,505.0
Muktsar,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,406.0,606.0,746.0,553.0,260.0,439.0,617.0,510.0,514.0,228.0,199.0,380.0,5458.0
Muktsar,14.14.a,Number of patients given AYUSH treatment,TOTAL,1847.0,1529.0,2230.0,2005.0,1715.0,2379.0,1484.0,1556.0,1701.0,2158.0,2573.0,1486.0,22663.0
Muktsar,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,297.0,592.0,477.0,469.0,507.0,605.0,208.0,355.0,361.0,516.0,505.0,609.0,5501.0
Muktsar,14.14.c,Number of Adolescents counselled,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Muktsar,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,5525.0,6296.0,5807.0,6093.0,6133.0,5383.0,3915.0,4004.0,4050.0,3626.0,5085.0,3978.0,59895.0
Muktsar,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,174.0,207.0,250.0,223.0,230.0,266.0,204.0,280.0,163.0,229.0,179.0,149.0,2554.0
Muktsar,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,303.0,257.0,408.0,461.0,522.0,316.0,253.0,371.0,330.0,322.0,339.0,467.0,4349.0
Muktsar,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,2.0,1.0,4.0,1.0,0.0,1.0,4.0,2.0,1.0,0.0,6.0,0.0,22.0
Muktsar,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,298.0,374.0,360.0,340.0,310.0,218.0,165.0,294.0,225.0,272.0,551.0,336.0,3743.0
Muktsar,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,0.0,2.0,4.0,5.0,3.0,1.0,1.0,0.0,1.0,0.0,3.0,0.0,20.0
Muktsar,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,762.0,757.0,852.0,932.0,742.0,652.0,634.0,709.0,675.0,900.0,786.0,984.0,9385.0
Muktsar,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,1.0,2.0,1.0,2.0,0.0,1.0,2.0,3.0,0.0,0.0,0.0,0.0,12.0
Muktsar,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,1363.0,1388.0,1620.0,1733.0,1574.0,1186.0,1052.0,1374.0,1230.0,1494.0,1676.0,1787.0,17477.0
Muktsar,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,3.0,5.0,9.0,8.0,3.0,3.0,7.0,5.0,2.0,0.0,9.0,0.0,54.0
Muktsar,15.2,Number of Widal tests conducted,Number tested,231.0,359.0,273.0,320.0,623.0,280.0,104.0,147.0,98.0,206.0,502.0,357.0,3500.0
Muktsar,15.3.a,Number of VDRL tests conducted on males,Number tested,71.0,61.0,28.0,18.0,74.0,85.0,57.0,198.0,109.0,100.0,134.0,140.0,1075.0
Muktsar,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,60.0,75.0,40.0,37.0,92.0,43.0,0.0,53.0,72.0,92.0,46.0,134.0,744.0
Muktsar,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,613.0,792.0,484.0,663.0,493.0,511.0,183.0,501.0,527.0,593.0,896.0,730.0,6986.0
Muktsar,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,744.0,928.0,552.0,718.0,659.0,639.0,240.0,752.0,708.0,785.0,1076.0,1004.0,8805.0
Muktsar,15.4.1,Number of blood smears examined for Malaria,TOTAL,3074.0,3886.0,4931.0,7103.0,4297.0,4949.0,3317.0,3550.0,2570.0,3104.0,3593.0,3665.0,48039.0
Muktsar,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,0.0,3.0,22.0,46.0,44.0,7.0,3.0,2.0,0.0,0.0,1.0,0.0,128.0
Muktsar,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Muktsar,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,14000.0,6000.0,2500.0,10500.0,3500.0,15500.0,,5500.0,250.0,13250.0,11500.0,16000.0,98500.0
Muktsar,16.1.1,Stock position of DPT vaccines,2. Stocks Received,0.0,0.0,15000.0,0.0,15000.0,0.0,,0.0,20000.0,0.0,10000.0,0.0,60000.0
Muktsar,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Muktsar,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,8000.0,3500.0,7000.0,7000.0,3000.0,7000.0,,5250.0,7000.0,2000.0,5500.0,4500.0,59750.0
Muktsar,16.1.1,Stock position of DPT vaccines,5. Total Stock,6000.0,2500.0,10500.0,3500.0,15500.0,8500.0,0.0,250.0,13250.0,11250.0,16000.0,11500.0,98750.0
Muktsar,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,,,,0.0,0.0,0.0,,0.0,0.0,16000.0,12000.0,9500.0,37500.0
Muktsar,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,,,,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Muktsar,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,,,,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Muktsar,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,,,,0.0,0.0,0.0,,0.0,0.0,4000.0,2500.0,1500.0,8000.0
Muktsar,16.1.1A,Stock Position of Pentavalent,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,12000.0,9500.0,8000.0,29500.0
Muktsar,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,17500.0,25500.0,23000.0,21000.0,8500.0,15000.0,,6500.0,0.0,13000.0,4500.0,15000.0,149500.0
Muktsar,16.1.2,Stock position of OPV vaccines,2. Stocks Received,8000.0,0.0,10000.0,0.0,15000.0,0.0,,0.0,25000.0,0.0,170000.0,0.0,228000.0
Muktsar,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Muktsar,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,0.0,2500.0,12000.0,12500.0,8500.0,12000.0,,6500.0,12000.0,8500.0,159500.0,3500.0,237500.0
Muktsar,16.1.2,Stock position of OPV vaccines,5. Total Stock,25500.0,23000.0,21000.0,8500.0,15000.0,3000.0,0.0,0.0,13000.0,4500.0,15000.0,11500.0,140000.0
Muktsar,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,14500.0,8000.0,5500.0,14000.0,7000.0,17000.0,,6000.0,1500.0,11000.0,10000.0,15500.0,110000.0
Muktsar,16.1.3,Stock position of TT vaccines,2. Stocks Received,0.0,0.0,15000.0,0.0,15000.0,0.0,,0.0,15000.0,0.0,10000.0,0.0,55000.0
Muktsar,16.1.3,Stock position of TT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Muktsar,16.1.3,Stock position of TT vaccines,4. Stock Distributed,6500.0,2500.0,6500.0,7000.0,5000.0,8000.0,,4500.0,5500.0,1000.0,4500.0,2000.0,53000.0
Muktsar,16.1.3,Stock position of TT vaccines,5. Total Stock,8000.0,5500.0,14000.0,7000.0,17000.0,9000.0,0.0,1500.0,11000.0,10000.0,15500.0,13500.0,112000.0
Muktsar,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Muktsar,16.1.4,Stock position of DT vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Muktsar,16.1.4,Stock position of DT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Muktsar,16.1.4,Stock position of DT vaccines,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Muktsar,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Muktsar,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,32000.0,7000.0,4500.0,0.0,0.0,6000.0,,3750.0,500.0,7500.0,5500.0,11500.0,78250.0
Muktsar,16.1.5,Stock position of BCG vaccines,2. Stocks Received,0.0,0.0,4600.0,0.0,10000.0,0.0,,0.0,12000.0,0.0,10000.0,0.0,36600.0
Muktsar,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Muktsar,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,25000.0,2500.0,4600.0,0.0,4000.0,5500.0,,3250.0,5000.0,2000.0,4000.0,3000.0,58850.0
Muktsar,16.1.5,Stock position of BCG vaccines,5. Total Stock,7000.0,4500.0,4500.0,0.0,6000.0,500.0,0.0,500.0,7500.0,5500.0,11500.0,8500.0,56000.0
Muktsar,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,3400.0,1500.0,0.0,1750.0,0.0,5750.0,,2250.0,0.0,5000.0,3500.0,9750.0,32900.0
Muktsar,16.1.6,Stock position of Measles vaccines,2. Stocks Received,0.0,0.0,4000.0,0.0,10000.0,0.0,,0.0,7000.0,0.0,10000.0,0.0,31000.0
Muktsar,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Muktsar,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,1900.0,1500.0,2250.0,1750.0,4250.0,3750.0,,2250.0,2000.0,1500.0,3750.0,2500.0,27400.0
Muktsar,16.1.6,Stock position of Measles vaccines,5. Total Stock,1500.0,0.0,1750.0,0.0,5750.0,2000.0,0.0,0.0,5000.0,3500.0,9750.0,7250.0,36500.0
Muktsar,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Muktsar,16.1.7,Stock position of JE vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Muktsar,16.1.7,Stock position of JE vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Muktsar,16.1.7,Stock position of JE vaccines,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Muktsar,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Muktsar,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,16000.0,9000.0,6000.0,7400.0,1100.0,10200.0,,5000.0,250.0,9250.0,8000.0,8500.0,80700.0
Muktsar,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,0.0,0.0,8000.0,0.0,12000.0,0.0,,0.0,15000.0,0.0,7000.0,0.0,42000.0
Muktsar,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Muktsar,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,7000.0,3000.0,6600.0,6300.0,2900.0,7000.0,,4750.0,6000.0,1250.0,6500.0,1500.0,52800.0
Muktsar,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,9000.0,6000.0,7400.0,1100.0,10200.0,3200.0,0.0,250.0,9250.0,8000.0,8500.0,7000.0,69900.0
Muktsar,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,2500.0,2500.0,2500.0,2500.0,12400.0,0.0,,0.0,0.0,0.0,0.0,0.0,22400.0
Muktsar,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,9900.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,9900.0
Muktsar,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Muktsar,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Muktsar,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,2500.0,2500.0,2500.0,12400.0,12400.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,32300.0
Muktsar,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Muktsar,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,72000.0,,0.0,0.0,0.0,0.0,0.0,72000.0
Muktsar,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Muktsar,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,72000.0,,0.0,0.0,0.0,0.0,0.0,72000.0
Muktsar,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Muktsar,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Muktsar,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,100.0,,0.0,0.0,0.0,0.0,0.0,100.0
Muktsar,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Muktsar,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,100.0,,0.0,0.0,0.0,0.0,0.0,100.0
Muktsar,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Muktsar,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Muktsar,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,300.0,0.0,7200.0,,0.0,0.0,0.0,0.0,0.0,7500.0
Muktsar,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Muktsar,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,7200.0,,0.0,0.0,0.0,0.0,0.0,7200.0
Muktsar,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,300.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,300.0
Muktsar,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Muktsar,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Muktsar,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Muktsar,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Muktsar,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Muktsar,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Muktsar,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Muktsar,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Muktsar,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Muktsar,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Muktsar,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,0.0,0.0,0.0,0.0,114246.0,0.0,,0.0,0.0,0.0,0.0,0.0,114246.0
Muktsar,16.3.02,Stock Position of Gloves,2. Stocks Received,0.0,0.0,0.0,124246.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,124246.0
Muktsar,16.3.02,Stock Position of Gloves,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Muktsar,16.3.02,Stock Position of Gloves,4. Stock Distributed,0.0,0.0,0.0,10000.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,10000.0
Muktsar,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,0.0,0.0,114246.0,114246.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,228492.0
Muktsar,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Muktsar,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Muktsar,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Muktsar,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Muktsar,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Muktsar,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Muktsar,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Muktsar,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Muktsar,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Muktsar,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Muktsar,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Muktsar,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Muktsar,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Muktsar,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Muktsar,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Muktsar,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Muktsar,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Muktsar,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Muktsar,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Muktsar,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Muktsar,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Muktsar,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Muktsar,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Muktsar,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Muktsar,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Muktsar,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Muktsar,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Muktsar,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Muktsar,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Muktsar,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Muktsar,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Muktsar,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Muktsar,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Muktsar,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Muktsar,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Muktsar,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Muktsar,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Muktsar,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Muktsar,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Muktsar,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Muktsar,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Muktsar,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Muktsar,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Muktsar,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Muktsar,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Muktsar,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,2800.0,,1200.0,0.0,2000.0,600.0,0.0,6600.0
Muktsar,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,0.0,0.0,0.0,0.0,6000.0,0.0,,0.0,2000.0,0.0,0.0,4000.0,12000.0
Muktsar,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Muktsar,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,0.0,0.0,0.0,0.0,3200.0,1600.0,,1200.0,0.0,1400.0,600.0,600.0,8600.0
Muktsar,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,0.0,0.0,0.0,0.0,2800.0,1200.0,0.0,0.0,2000.0,600.0,0.0,3400.0,10000.0
Muktsar,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,56000.0,44000.0,26000.0,16000.0,14000.0,0.0,,92000.0,84000.0,70000.0,58000.0,26000.0,486000.0
Muktsar,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,100000.0,,0.0,0.0,0.0,0.0,12000.0,112000.0
Muktsar,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Muktsar,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,12000.0,18000.0,10000.0,2000.0,14000.0,4000.0,,8000.0,14000.0,12000.0,32000.0,0.0,126000.0
Muktsar,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,44000.0,26000.0,16000.0,14000.0,0.0,96000.0,0.0,84000.0,70000.0,58000.0,26000.0,38000.0,472000.0
Muktsar,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,200.0,200.0,200.0,0.0,0.0,1000.0,,400.0,0.0,2400.0,1400.0,9500.0,15300.0
Muktsar,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,0.0,0.0,0.0,0.0,2400.0,0.0,,0.0,2400.0,0.0,0.0,0.0,4800.0
Muktsar,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Muktsar,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,0.0,0.0,200.0,0.0,1400.0,400.0,,400.0,0.0,1000.0,1000.0,1500.0,5900.0
Muktsar,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,200.0,200.0,0.0,0.0,1000.0,600.0,0.0,0.0,2400.0,1400.0,400.0,8000.0,14200.0
Muktsar,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,1.0,1.0,,,,,,,,,,,2.0
Muktsar,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,1.0,,,,,,,,,,,,1.0
Muktsar,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Muktsar,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,1.0,,,,,,,,,,,,1.0
Muktsar,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Muktsar,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Muktsar,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,,,,,,,,,,,,,
Muktsar,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,1.0,,,,,,2.0,,,,,,3.0
Muktsar,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Muktsar,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,1.0,,,,,,2.0,,,,,,3.0
Muktsar,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,,,,1.0,,1.0,,1.0,1.0,,,,4.0
Muktsar,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,1.0,,,2.0,,,,,,,,,3.0
Muktsar,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,1.0,,,3.0,,1.0,,1.0,1.0,,,,7.0
Muktsar,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,,,,,,,,2.0,2.0,2.0,2.0,8.0
Muktsar,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,,,,,,,,,,
Muktsar,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,,,,,,,,,2.0,2.0,2.0,2.0,8.0
Muktsar,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,,,,,,
Muktsar,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
Muktsar,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,,,,,,,,,
Muktsar,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,,,,,,,2.0,,,1.0,3.0
Muktsar,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,,,,,,,,1.0,1.0,2.0
Muktsar,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,,,,,,,,2.0,,1.0,2.0,5.0
Muktsar,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Muktsar,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,1.0,,,,,,,,,,,,1.0
Muktsar,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,1.0,,,,,,,,,,,,1.0
Muktsar,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,2.0,,,1.0,1.0,1.0,1.0,,3.0,2.0,,,11.0
Muktsar,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,2.0,2.0,1.0,,1.0,1.0,2.0,,2.0,,,,11.0
Muktsar,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,4.0,2.0,1.0,1.0,2.0,2.0,3.0,,5.0,2.0,,,22.0
Muktsar,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
Muktsar,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,,,,,,,,,
Muktsar,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,,,,,,,,,
Muktsar,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,,,,,,,,,,,
Muktsar,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,1.0,,,,,,1.0
Muktsar,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,3.0,,1.0,2.0,2.0,1.0,5.0,4.0,1.0,1.0,2.0,5.0,27.0
Muktsar,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,1.0,1.0,2.0,4.0,1.0,,1.0,1.0,,1.0,1.0,1.0,14.0
Muktsar,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,4.0,1.0,3.0,6.0,3.0,1.0,7.0,5.0,1.0,2.0,3.0,6.0,42.0
Muktsar,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,,,,,,
Muktsar,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,,,,,,,,,,1.0,1.0,,2.0
Muktsar,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,,,,2.0,,,1.0,2.0,6.0,4.0,5.0,,20.0
Muktsar,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,,,,2.0,,,1.0,2.0,6.0,5.0,6.0,,22.0
Muktsar,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
Muktsar,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,,,,,,,,
Muktsar,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,1.0,1.0,,,,,,,,,,,2.0
Muktsar,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,1.0,1.0,,,,,,,,,,,2.0
Muktsar,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,,1.0,,,,,,,,1.0
Muktsar,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,,1.0,,,3.0,1.0,1.0,1.0,,1.0,1.0,1.0,10.0
Muktsar,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,1.0,1.0,,,1.0,1.0,2.0,,,,,,6.0
Muktsar,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,1.0,2.0,,,5.0,2.0,3.0,1.0,,1.0,1.0,1.0,17.0
Muktsar,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
Muktsar,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,1.0,,,,,,1.0,,,,,2.0
Muktsar,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,,,,
Muktsar,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,1.0,,,,,,1.0,,,,,2.0
Muktsar,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,1.0,,,,,,,1.0,,2.0,,4.0
Muktsar,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,17.0,14.0,4.0,21.0,35.0,24.0,34.0,23.0,24.0,37.0,32.0,36.0,301.0
Muktsar,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,50.0,16.0,14.0,60.0,59.0,41.0,33.0,42.0,57.0,68.0,51.0,68.0,559.0
Muktsar,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,67.0,31.0,18.0,81.0,94.0,65.0,67.0,65.0,82.0,105.0,85.0,104.0,864.0
Muktsar,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,1.0,,,,,,,,,,,,1.0
Muktsar,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,,2.0,,1.0,,1.0,1.0,,1.0,,,1.0,7.0
Muktsar,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,3.0,4.0,,2.0,,2.0,,1.0,2.0,,,1.0,15.0
Muktsar,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,4.0,6.0,,3.0,,3.0,1.0,1.0,3.0,,,2.0,23.0
Muktsar,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Muktsar,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
Muktsar,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Muktsar,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
Muktsar,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Muktsar,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,,,,,,,,
Muktsar,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Muktsar,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,,,,,,,,
Muktsar,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Muktsar,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,,,1.0,,,,,,,1.0
Muktsar,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Muktsar,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,,,,1.0,,,,,,,1.0
Muktsar,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Muktsar,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,,,,,,,,,,,
Muktsar,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Muktsar,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,,,,,,,,,,,
Muktsar,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Muktsar,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,,,,,,,
Muktsar,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Muktsar,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,,,,,,,
Muktsar,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Muktsar,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,,,,3.0,1.0,,,4.0,1.0,1.0,,3.0,13.0
Muktsar,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Muktsar,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,,,,3.0,1.0,,,4.0,1.0,1.0,,3.0,13.0
Muktsar,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,,,,,1.0,1.0,,1.0,1.0,,,4.0
Muktsar,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,8.0,8.0,,6.0,11.0,11.0,6.0,11.0,6.0,4.0,9.0,5.0,85.0
Muktsar,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,1.0,4.0,,2.0,5.0,3.0,1.0,1.0,1.0,,4.0,3.0,25.0
Muktsar,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,9.0,12.0,,8.0,16.0,15.0,8.0,12.0,8.0,5.0,13.0,8.0,114.0
Muktsar,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,,,1.0,,,,,,1.0
Muktsar,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,3.0,,1.0,1.0,2.0,,5.0,1.0,,1.0,1.0,1.0,16.0
Muktsar,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,1.0,,1.0,,1.0,,,,,,,3.0
Muktsar,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,3.0,1.0,1.0,2.0,2.0,1.0,6.0,1.0,,1.0,1.0,1.0,20.0
Muktsar,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,,,,,,,,,,
Muktsar,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,1.0,2.0,1.0,1.0,1.0,,,,,,1.0,1.0,8.0
Muktsar,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,,1.0,,1.0,,,,,,1.0,3.0
Muktsar,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,1.0,2.0,1.0,2.0,1.0,1.0,,,,,1.0,2.0,11.0
Muktsar,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,,,,,,,,,,,
Muktsar,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,,1.0,,,,,,,,,,,1.0
Muktsar,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,,1.0,,,,,,,,1.0,,,2.0
Muktsar,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,,2.0,,,,,,,,1.0,,,3.0
Muktsar,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,1.0,,1.0,,1.0,,1.0,,,,,4.0
Muktsar,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,3.0,8.0,3.0,4.0,4.0,7.0,5.0,5.0,4.0,3.0,1.0,3.0,50.0
Muktsar,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,8.0,12.0,4.0,3.0,2.0,4.0,4.0,2.0,6.0,1.0,4.0,2.0,52.0
Muktsar,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,11.0,21.0,7.0,8.0,6.0,12.0,9.0,8.0,10.0,4.0,5.0,5.0,106.0
Muktsar,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,1.0,,,,3.0,2.0,1.0,3.0,2.0,,3.0,1.0,16.0
Muktsar,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,19.0,8.0,1.0,45.0,26.0,41.0,33.0,40.0,46.0,44.0,24.0,21.0,348.0
Muktsar,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,92.0,48.0,,151.0,143.0,132.0,156.0,168.0,159.0,205.0,127.0,112.0,1493.0
Muktsar,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,112.0,56.0,1.0,196.0,172.0,175.0,190.0,211.0,207.0,249.0,154.0,134.0,1857.0
Nawanshahr,1.1,Total number of pregnant women Registered for ANC,TOTAL,1127.0,1092.0,838.0,802.0,738.0,670.0,544.0,668.0,613.0,874.0,907.0,823.0,9696.0
Nawanshahr,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,836.0,823.0,628.0,578.0,523.0,453.0,393.0,477.0,494.0,678.0,684.0,618.0,7185.0
Nawanshahr,1.2,Number of Pregnant women registered under JSY,TOTAL,459.0,530.0,366.0,334.0,298.0,284.0,241.0,276.0,309.0,410.0,407.0,378.0,4292.0
Nawanshahr,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,712.0,803.0,817.0,853.0,848.0,864.0,704.0,750.0,634.0,645.0,599.0,596.0,8825.0
Nawanshahr,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,1083.0,1049.0,837.0,783.0,728.0,662.0,502.0,605.0,598.0,812.0,829.0,790.0,9278.0
Nawanshahr,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,986.0,1036.0,1009.0,853.0,734.0,723.0,604.0,517.0,603.0,583.0,761.0,785.0,9194.0
Nawanshahr,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,817.0,921.0,854.0,815.0,711.0,619.0,544.0,563.0,506.0,536.0,532.0,547.0,7965.0
Nawanshahr,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,16.0,8.0,18.0,7.0,8.0,7.0,3.0,9.0,7.0,8.0,8.0,3.0,102.0
Nawanshahr,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,0.0,1.0,0.0,1.0,2.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,4.0
Nawanshahr,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,964.0,943.0,712.0,633.0,670.0,648.0,487.0,593.0,528.0,762.0,802.0,680.0,8422.0
Nawanshahr,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,3.0,1.0,2.0,0.0,2.0,1.0,0.0,5.0,3.0,5.0,1.0,0.0,23.0
Nawanshahr,1.8,Number of pregnancy test kits used at SC level,TOTAL,999.0,991.0,864.0,749.0,740.0,688.0,526.0,660.0,805.0,908.0,974.0,778.0,9682.0
Nawanshahr,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,8.0,6.0,12.0,10.0,13.0,11.0,14.0,13.0,19.0,6.0,8.0,6.0,126.0
Nawanshahr,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,24.0,28.0,13.0,27.0,28.0,30.0,34.0,23.0,13.0,26.0,15.0,12.0,273.0
Nawanshahr,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,32.0,34.0,25.0,37.0,41.0,41.0,48.0,36.0,32.0,32.0,23.0,18.0,399.0
Nawanshahr,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,22.0,28.0,18.0,24.0,19.0,35.0,37.0,32.0,25.0,32.0,15.0,10.0,297.0
Nawanshahr,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,5.0,2.0,2.0,5.0,4.0,8.0,5.0,2.0,3.0,2.0,3.0,0.0,41.0
Nawanshahr,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,109.0,151.0,151.0,223.0,282.0,296.0,320.0,354.0,317.0,273.0,224.0,211.0,2911.0
Nawanshahr,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,90.0,132.0,135.0,206.0,222.0,248.0,241.0,285.0,225.0,165.0,175.0,164.0,2288.0
Nawanshahr,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,100.0,69.0,65.0,98.0,132.0,143.0,185.0,149.0,216.0,120.0,159.0,49.0,1485.0
Nawanshahr,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nawanshahr,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nawanshahr,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,309.0,312.0,338.0,440.0,472.0,488.0,560.0,464.0,446.0,425.0,303.0,303.0,4860.0
Nawanshahr,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,13.0,12.0,13.0,19.0,14.0,26.0,22.0,16.0,23.0,12.0,14.0,3.0,187.0
Nawanshahr,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nawanshahr,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nawanshahr,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nawanshahr,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,1.0,11.0,14.0,7.0,12.0,18.0,12.0,11.0,18.0,6.0,9.0,10.0,129.0
Nawanshahr,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,0.0,6.0,0.0,8.0,30.0,22.0,44.0,50.0,60.0,41.0,33.0,36.0,330.0
Nawanshahr,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Nawanshahr,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,1.0,17.0,14.0,15.0,42.0,40.0,56.0,61.0,78.0,47.0,42.0,46.0,459.0
Nawanshahr,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,190.0,212.0,207.0,282.0,314.0,285.0,347.0,280.0,276.0,279.0,189.0,194.0,3055.0
Nawanshahr,4.1.1.a,Number of male live births,TOTAL,238.0,263.0,277.0,360.0,416.0,436.0,497.0,432.0,410.0,366.0,282.0,269.0,4246.0
Nawanshahr,4.1.1.b,Number of female live births,TOTAL,206.0,231.0,240.0,341.0,387.0,380.0,426.0,424.0,377.0,361.0,262.0,263.0,3898.0
Nawanshahr,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,444.0,494.0,517.0,701.0,803.0,816.0,923.0,856.0,787.0,727.0,544.0,532.0,8144.0
Nawanshahr,4.1.2,Number of still births,TOTAL,8.0,7.0,4.0,8.0,7.0,18.0,17.0,7.0,12.0,9.0,8.0,5.0,110.0
Nawanshahr,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,44.0,63.0,74.0,36.0,53.0,38.0,56.0,56.0,77.0,79.0,56.0,62.0,694.0
Nawanshahr,4.2.1,Number of Newborns weighed at birth,TOTAL,442.0,492.0,514.0,641.0,790.0,813.0,921.0,854.0,784.0,722.0,540.0,531.0,8044.0
Nawanshahr,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,28.0,72.0,52.0,54.0,94.0,60.0,98.0,105.0,78.0,94.0,69.0,60.0,864.0
Nawanshahr,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,379.0,421.0,424.0,505.0,629.0,707.0,731.0,695.0,644.0,581.0,476.0,445.0,6637.0
Nawanshahr,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,1.0,1.0,0.0,8.0,4.0,8.0,8.0,1.0,3.0,3.0,2.0,4.0,43.0
Nawanshahr,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,1.0,11.0,14.0,7.0,12.0,19.0,12.0,13.0,18.0,12.0,9.0,10.0,138.0
Nawanshahr,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,0.0,16.0,0.0,8.0,62.0,0.0,15.0,54.0,64.0,45.0,27.0,40.0,331.0
Nawanshahr,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Nawanshahr,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,2.0,28.0,14.0,23.0,78.0,27.0,35.0,68.0,85.0,60.0,38.0,54.0,512.0
Nawanshahr,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,3.0,3.0,12.0,1.0,3.0,3.0,4.0,3.0,5.0,7.0,4.0,2.0,50.0
Nawanshahr,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,1.0,18.0,14.0,15.0,41.0,19.0,31.0,63.0,80.0,56.0,36.0,46.0,420.0
Nawanshahr,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,2.0,3.0,3.0,2.0,3.0,3.0,4.0,4.0,4.0,3.0,2.0,4.0,37.0
Nawanshahr,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,1.0,17.0,14.0,16.0,74.0,5.0,24.0,54.0,62.0,55.0,36.0,46.0,404.0
Nawanshahr,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,1.0,19.0,9.0,3.0,19.0,7.0,25.0,38.0,59.0,34.0,21.0,18.0,253.0
Nawanshahr,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,184.0,278.0,286.0,382.0,452.0,463.0,503.0,542.0,480.0,404.0,333.0,357.0,4664.0
Nawanshahr,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,224.0,356.0,370.0,444.0,509.0,580.0,592.0,614.0,564.0,556.0,485.0,390.0,5684.0
Nawanshahr,6.3,PNC maternal complications attended,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nawanshahr,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,7.0,8.0,9.0,3.0,17.0,5.0,0.0,1.0,16.0,8.0,6.0,6.0,86.0
Nawanshahr,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nawanshahr,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,7.0,8.0,9.0,3.0,17.0,5.0,0.0,1.0,16.0,8.0,6.0,6.0,86.0
Nawanshahr,7.2,Number of MTPs conducted at Private Facilities,TOTAL,7.0,34.0,31.0,17.0,26.0,18.0,37.0,40.0,41.0,44.0,37.0,49.0,381.0
Nawanshahr,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,25.0,28.0,27.0,24.0,95.0,28.0,19.0,33.0,34.0,66.0,70.0,80.0,529.0
Nawanshahr,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,136.0,171.0,210.0,150.0,146.0,199.0,208.0,218.0,219.0,258.0,234.0,262.0,2411.0
Nawanshahr,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,161.0,199.0,237.0,174.0,241.0,227.0,227.0,251.0,253.0,324.0,304.0,342.0,2940.0
Nawanshahr,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nawanshahr,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nawanshahr,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,1.0,1.0,2.0,3.0,3.0,2.0,1.0,0.0,0.0,1.0,0.0,0.0,14.0
Nawanshahr,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,2.0,3.0,1.0,1.0,0.0,3.0,0.0,0.0,0.0,0.0,0.0,0.0,10.0
Nawanshahr,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Nawanshahr,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,3.0,4.0,3.0,4.0,3.0,5.0,1.0,0.0,0.0,1.0,0.0,0.0,24.0
Nawanshahr,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,1.0
Nawanshahr,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nawanshahr,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,0.0,0.0,29.0,20.0,22.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,71.0
Nawanshahr,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,38.0,45.0,29.0,15.0,32.0,35.0,1.0,0.0,0.0,0.0,0.0,0.0,195.0
Nawanshahr,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Nawanshahr,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,38.0,45.0,58.0,35.0,54.0,35.0,1.0,0.0,0.0,0.0,0.0,0.0,266.0
Nawanshahr,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,56.0,57.0,57.0,60.0,48.0,15.0,15.0,10.0,10.0,4.0,11.0,3.0,346.0
Nawanshahr,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nawanshahr,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,3.0,4.0,26.0,3.0,9.0,13.0,1.0,5.0,3.0,0.0,7.0,1.0,75.0
Nawanshahr,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,7.0,3.0,5.0,3.0,2.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,20.0
Nawanshahr,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Nawanshahr,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,10.0,7.0,31.0,6.0,11.0,13.0,1.0,5.0,3.0,0.0,7.0,1.0,95.0
Nawanshahr,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,0.0,0.0,0.0,3.0,2.0,29.0,14.0,19.0,6.0,9.0,12.0,10.0,104.0
Nawanshahr,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nawanshahr,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,1.0,0.0,0.0,0.0,1.0,1.0,1.0,1.0,0.0,5.0
Nawanshahr,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Nawanshahr,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Nawanshahr,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,1.0,0.0,0.0,1.0,0.0,0.0,0.0,1.0,1.0,1.0,1.0,0.0,6.0
Nawanshahr,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,2.0,1.0,1.0,4.0,9.0,12.0,6.0,14.0,11.0,19.0,7.0,12.0,98.0
Nawanshahr,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,217.0,236.0,216.0,339.0,211.0,201.0,194.0,170.0,162.0,173.0,148.0,108.0,2375.0
Nawanshahr,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,0.0,0.0,0.0,1.0,0.0,0.0,2.0,0.0,0.0,0.0,0.0,0.0,3.0
Nawanshahr,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,32.0,26.0,43.0,37.0,21.0,28.0,31.0,36.0,42.0,39.0,31.0,31.0,397.0
Nawanshahr,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,18.0,21.0,21.0,30.0,19.0,44.0,63.0,79.0,134.0,136.0,8.0,35.0,608.0
Nawanshahr,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Nawanshahr,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,267.0,283.0,280.0,407.0,251.0,273.0,290.0,285.0,338.0,348.0,187.0,174.0,3383.0
Nawanshahr,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,17.0,17.0,16.0,17.0,3.0,31.0,65.0,80.0,149.0,146.0,18.0,58.0,617.0
Nawanshahr,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nawanshahr,9.06,Number of IUCD removals,TOTAL,64.0,87.0,52.0,62.0,52.0,68.0,69.0,51.0,59.0,60.0,67.0,29.0,720.0
Nawanshahr,9.07,Number of Oral Pills cycles distributed,TOTAL,2063.0,2203.0,2090.0,1590.0,2009.0,2050.0,1996.0,2091.0,2176.0,2101.0,1715.0,1881.0,23965.0
Nawanshahr,9.08,Number of Condom pieces distributed,TOTAL,80504.0,77260.0,73587.0,57435.0,71029.0,70952.0,75419.0,75297.0,75518.0,59155.0,48400.0,55140.0,819696.0
Nawanshahr,9.09,Number of Centchroman (weekly) pills given,TOTAL,2.0,10.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,2.0,0.0,15.0
Nawanshahr,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,75.0,81.0,65.0,45.0,45.0,21.0,57.0,58.0,43.0,44.0,43.0,14.0,591.0
Nawanshahr,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nawanshahr,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nawanshahr,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nawanshahr,9.11.2.b,Number of failures following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nawanshahr,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nawanshahr,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nawanshahr,9.12,Number of Institutions having NSV trained doctors,TOTAL,3.0,3.0,3.0,3.0,3.0,3.0,2.0,2.0,2.0,2.0,1.0,1.0,-1.0
Nawanshahr,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,664.0,609.0,584.0,740.0,858.0,959.0,1017.0,1025.0,880.0,802.0,611.0,605.0,9354.0
Nawanshahr,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,738.0,706.0,519.0,651.0,729.0,803.0,906.0,1028.0,991.0,685.0,28.0,9.0,7793.0
Nawanshahr,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,972.0,764.0,667.0,609.0,579.0,689.0,792.0,888.0,1056.0,925.0,660.0,89.0,8690.0
Nawanshahr,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,947.0,954.0,747.0,706.0,626.0,595.0,692.0,799.0,862.0,984.0,863.0,610.0,9385.0
Nawanshahr,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,392.0,740.0,660.0,1792.0
Nawanshahr,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.0,279.0,612.0,894.0
Nawanshahr,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,3.0,192.0,196.0
Nawanshahr,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,509.0,464.0,483.0,671.0,765.0,787.0,857.0,822.0,804.0,671.0,524.0,468.0,7825.0
Nawanshahr,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,738.0,706.0,519.0,651.0,729.0,803.0,906.0,1028.0,991.0,880.0,741.0,641.0,9333.0
Nawanshahr,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,972.0,764.0,667.0,609.0,579.0,689.0,792.0,888.0,1056.0,927.0,892.0,660.0,9495.0
Nawanshahr,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,947.0,954.0,747.0,706.0,626.0,595.0,692.0,799.0,862.0,984.0,865.0,693.0,9470.0
Nawanshahr,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,359.0,320.0,400.0,507.0,578.0,648.0,650.0,716.0,655.0,554.0,386.0,412.0,6185.0
Nawanshahr,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,738.0,706.0,519.0,651.0,729.0,803.0,906.0,1028.0,991.0,685.0,30.0,6.0,7792.0
Nawanshahr,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,972.0,764.0,667.0,609.0,579.0,689.0,792.0,888.0,1056.0,933.0,652.0,86.0,8687.0
Nawanshahr,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,947.0,957.0,747.0,706.0,626.0,595.0,692.0,799.0,862.0,989.0,846.0,599.0,9365.0
Nawanshahr,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,826.0,945.0,867.0,997.0,940.0,848.0,768.0,853.0,575.0,610.0,496.0,515.0,9240.0
Nawanshahr,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,911.0,885.0,725.0,764.0,775.0,620.0,532.0,686.0,704.0,804.0,719.0,695.0,8820.0
Nawanshahr,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nawanshahr,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,419.0,507.0,453.0,523.0,484.0,445.0,397.0,463.0,314.0,336.0,265.0,268.0,4874.0
Nawanshahr,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,407.0,438.0,414.0,474.0,456.0,403.0,371.0,390.0,261.0,274.0,231.0,247.0,4366.0
Nawanshahr,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,826.0,945.0,867.0,997.0,940.0,848.0,768.0,853.0,575.0,610.0,496.0,515.0,9240.0
Nawanshahr,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,911.0,885.0,725.0,764.0,775.0,620.0,542.0,686.0,704.0,808.0,717.0,695.0,8832.0
Nawanshahr,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,911.0,885.0,725.0,764.0,775.0,620.0,542.0,686.0,704.0,808.0,717.0,695.0,8832.0
Nawanshahr,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nawanshahr,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1.0,0.0,0.0,0.0,0.0,6.0,0.0,0.0,1.0,0.0,2.0,0.0,10.0
Nawanshahr,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1.0,0.0,1.0,0.0,0.0,3.0,0.0,0.0,1.0,0.0,4.0,0.0,10.0
Nawanshahr,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,2.0,0.0,1.0,0.0,0.0,9.0,0.0,0.0,2.0,0.0,6.0,0.0,20.0
Nawanshahr,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,667.0,2537.0,712.0,1123.0,895.0,785.0,532.0,560.0,505.0,595.0,440.0,448.0,9799.0
Nawanshahr,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,654.0,3516.0,512.0,1191.0,916.0,765.0,357.0,538.0,274.0,477.0,287.0,373.0,9860.0
Nawanshahr,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,404.0,3138.0,308.0,1075.0,925.0,641.0,374.0,375.0,271.0,230.0,278.0,492.0,8511.0
Nawanshahr,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nawanshahr,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nawanshahr,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nawanshahr,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,445.0,444.0,457.0,480.0,450.0,457.0,477.0,444.0,468.0,441.0,435.0,409.0,5407.0
Nawanshahr,10.4.2,Number of Immunisation sessions held during the month,TOTAL,444.0,443.0,455.0,479.0,444.0,454.0,476.0,442.0,465.0,437.0,431.0,325.0,5295.0
Nawanshahr,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,413.0,398.0,401.0,443.0,408.0,415.0,434.0,404.0,419.0,390.0,393.0,310.0,4828.0
Nawanshahr,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nawanshahr,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,744.0,946.0,849.0,985.0,940.0,817.0,719.0,800.0,520.0,368.0,265.0,233.0,8186.0
Nawanshahr,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,440.0,676.0,579.0,556.0,585.0,543.0,473.0,539.0,492.0,297.0,240.0,185.0,5605.0
Nawanshahr,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,544.0,1378.0,661.0,884.0,758.0,614.0,501.0,583.0,542.0,330.0,222.0,211.0,7228.0
Nawanshahr,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nawanshahr,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nawanshahr,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nawanshahr,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nawanshahr,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nawanshahr,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nawanshahr,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,4.0,12.0,21.0,27.0,25.0,15.0,15.0,9.0,2.0,4.0,1.0,4.0,139.0
Nawanshahr,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nawanshahr,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,0.0,5.0,43.0,40.0,30.0,21.0,40.0,19.0,19.0,57.0,25.0,41.0,340.0
Nawanshahr,13.1,Number of Patients operated for cataract,TOTAL,228.0,115.0,151.0,81.0,92.0,120.0,115.0,652.0,135.0,150.0,294.0,335.0,2468.0
Nawanshahr,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,223.0,112.0,148.0,77.0,87.0,118.0,110.0,525.0,129.0,135.0,287.0,325.0,2276.0
Nawanshahr,13.3,Number of School children detected with Refractive errors,TOTAL,45.0,107.0,13.0,71.0,83.0,49.0,311.0,27.0,52.0,52.0,55.0,15.0,880.0
Nawanshahr,13.4,Number of children provided free glasses,TOTAL,14.0,41.0,0.0,126.0,54.0,37.0,36.0,60.0,209.0,23.0,41.0,3.0,644.0
Nawanshahr,13.5,Number of eyes collected through eye donation,TOTAL,4.0,2.0,2.0,0.0,0.0,0.0,2.0,2.0,12.0,12.0,6.0,12.0,54.0
Nawanshahr,13.6,Number of eyes utilised for corneal transplant,TOTAL,4.0,2.0,2.0,0.0,0.0,0.0,2.0,2.0,12.0,12.0,6.0,12.0,54.0
Nawanshahr,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,5.0,5.0,5.0,5.0,5.0,5.0,5.0,5.0,5.0,5.0,5.0,5.0,-1.0
Nawanshahr,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,7.0,7.0,7.0,8.0,8.0,8.0,8.0,8.0,8.0,8.0,8.0,8.0,-1.0
Nawanshahr,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,433.0,431.0,433.0,439.0,436.0,434.0,431.0,419.0,419.0,417.0,418.0,331.0,-1.0
Nawanshahr,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,5.0,5.0,5.0,5.0,5.0,5.0,5.0,5.0,5.0,5.0,5.0,5.0,-1.0
Nawanshahr,14.05,Number of RKS meetings held during the month,TOTAL,2.0,0.0,3.0,3.0,2.0,2.0,2.0,3.0,3.0,2.0,2.0,0.0,24.0
Nawanshahr,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,5.0,5.0,5.0,5.0,5.0,5.0,5.0,5.0,5.0,5.0,5.0,5.0,-1.0
Nawanshahr,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,59.0,51.0,53.0,78.0,56.0,68.0,43.0,57.0,50.0,86.0,80.0,94.0,775.0
Nawanshahr,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,,,1.0,1.0,,,1.0,1.0,,,,1.0,-1.0
Nawanshahr,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,4.0,4.0,4.0,4.0,4.0,4.0,4.0,4.0,4.0,4.0,4.0,4.0,-1.0
Nawanshahr,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,59.0,100.0,92.0,124.0,116.0,167.0,263.0,169.0,167.0,147.0,110.0,117.0,1631.0
Nawanshahr,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,314.0,455.0,314.0,379.0,319.0,387.0,378.0,371.0,313.0,357.0,475.0,476.0,4538.0
Nawanshahr,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,44.0,88.0,61.0,130.0,101.0,141.0,138.0,184.0,148.0,153.0,112.0,104.0,1404.0
Nawanshahr,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,335.0,608.0,492.0,685.0,590.0,756.0,677.0,723.0,623.0,609.0,602.0,594.0,7294.0
Nawanshahr,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,103.0,188.0,153.0,254.0,217.0,308.0,401.0,353.0,315.0,300.0,222.0,221.0,3035.0
Nawanshahr,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,649.0,1063.0,806.0,1064.0,909.0,1143.0,1055.0,1094.0,936.0,966.0,1077.0,1070.0,11832.0
Nawanshahr,14.10.2.a,Number of death cases of Inpatient males,TOTAL,8.0,7.0,6.0,2.0,3.0,8.0,6.0,9.0,4.0,6.0,13.0,10.0,82.0
Nawanshahr,14.10.2.b,Number of death cases of Inpatient females,TOTAL,2.0,3.0,4.0,6.0,5.0,1.0,5.0,2.0,7.0,8.0,4.0,3.0,50.0
Nawanshahr,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,10.0,10.0,10.0,8.0,8.0,9.0,11.0,11.0,11.0,14.0,17.0,13.0,132.0
Nawanshahr,14.11,In-Patient Head Count at midnight,TOTAL,2543.0,2408.0,2517.0,2538.0,3155.0,3201.0,3162.0,3827.0,3486.0,3233.0,3461.0,3348.0,36879.0
Nawanshahr,14.12.1,OPD attendance (All),TOTAL,39486.0,42479.0,41211.0,42991.0,44816.0,38941.0,33477.0,36042.0,32558.0,32366.0,36868.0,40038.0,461273.0
Nawanshahr,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,104.0,133.0,280.0,91.0,121.0,100.0,141.0,160.0,119.0,153.0,108.0,242.0,1752.0
Nawanshahr,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,1.0,5.0,11.0,1.0,0.0,1.0,0.0,2.0,1.0,9.0,5.0,0.0,36.0
Nawanshahr,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,400.0,367.0,369.0,288.0,482.0,399.0,347.0,357.0,468.0,365.0,299.0,440.0,4581.0
Nawanshahr,14.14.a,Number of patients given AYUSH treatment,TOTAL,3245.0,3727.0,4520.0,6056.0,5771.0,4391.0,4996.0,3564.0,2886.0,2318.0,3238.0,2632.0,47344.0
Nawanshahr,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,3165.0,3026.0,3556.0,3350.0,3535.0,3337.0,2616.0,3243.0,2975.0,2621.0,2820.0,3052.0,37296.0
Nawanshahr,14.14.c,Number of Adolescents counselled,TOTAL,10.0,11.0,0.0,1.0,10.0,6.0,14.0,0.0,10.0,10.0,10.0,0.0,82.0
Nawanshahr,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,3834.0,4733.0,4156.0,3895.0,4139.0,3625.0,3207.0,3544.0,3454.0,3358.0,3989.0,3868.0,45802.0
Nawanshahr,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,65.0,74.0,51.0,63.0,80.0,43.0,61.0,76.0,82.0,67.0,79.0,80.0,821.0
Nawanshahr,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,308.0,308.0,321.0,265.0,317.0,219.0,214.0,243.0,249.0,223.0,221.0,286.0,3174.0
Nawanshahr,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,6.0,10.0,6.0,2.0,3.0,7.0,7.0,11.0,6.0,8.0,9.0,14.0,89.0
Nawanshahr,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,133.0,152.0,123.0,120.0,141.0,87.0,168.0,153.0,237.0,150.0,128.0,167.0,1759.0
Nawanshahr,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,1.0,0.0,0.0,2.0,0.0,4.0,1.0,2.0,1.0,1.0,0.0,3.0,15.0
Nawanshahr,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,609.0,630.0,284.0,398.0,481.0,348.0,288.0,379.0,465.0,501.0,343.0,388.0,5114.0
Nawanshahr,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,0.0,4.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,2.0,0.0,0.0,7.0
Nawanshahr,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,1050.0,1090.0,728.0,783.0,939.0,654.0,670.0,775.0,951.0,874.0,692.0,841.0,10047.0
Nawanshahr,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,7.0,14.0,6.0,4.0,3.0,11.0,8.0,13.0,8.0,11.0,9.0,17.0,111.0
Nawanshahr,15.2,Number of Widal tests conducted,Number tested,763.0,788.0,544.0,656.0,967.0,693.0,528.0,467.0,360.0,342.0,620.0,690.0,7418.0
Nawanshahr,15.3.a,Number of VDRL tests conducted on males,Number tested,52.0,73.0,115.0,64.0,43.0,42.0,39.0,61.0,110.0,52.0,55.0,48.0,754.0
Nawanshahr,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,26.0,52.0,61.0,65.0,65.0,38.0,53.0,82.0,109.0,80.0,56.0,64.0,751.0
Nawanshahr,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,709.0,805.0,576.0,574.0,576.0,618.0,457.0,536.0,650.0,693.0,706.0,722.0,7622.0
Nawanshahr,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,787.0,930.0,752.0,703.0,684.0,698.0,549.0,679.0,869.0,825.0,817.0,834.0,9127.0
Nawanshahr,15.4.1,Number of blood smears examined for Malaria,TOTAL,2622.0,3316.0,3663.0,3192.0,2411.0,2158.0,1585.0,2729.0,3357.0,2721.0,3178.0,3613.0,34545.0
Nawanshahr,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,0.0,1.0,0.0,2.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.0
Nawanshahr,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Nawanshahr,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,1000.0,0.0,2500.0,2500.0,0.0,5500.0,5000.0,1750.0,3750.0,5250.0,1500.0,3500.0,32250.0
Nawanshahr,16.1.1,Stock position of DPT vaccines,2. Stocks Received,6000.0,5000.0,5000.0,0.0,10000.0,0.0,0.0,5000.0,4000.0,0.0,5000.0,0.0,40000.0
Nawanshahr,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nawanshahr,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,7000.0,2500.0,5000.0,2500.0,4500.0,500.0,3250.0,3000.0,2500.0,3750.0,3000.0,1500.0,39000.0
Nawanshahr,16.1.1,Stock position of DPT vaccines,5. Total Stock,0.0,2500.0,2500.0,0.0,5500.0,5000.0,1750.0,3750.0,5250.0,1500.0,3500.0,2000.0,33250.0
Nawanshahr,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,0.0,,,,,0.0,0.0,0.0,,0.0,0.0,0.0,0.0
Nawanshahr,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,0.0,,,,,0.0,0.0,0.0,,10000.0,0.0,3000.0,13000.0
Nawanshahr,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,0.0,,,,,0.0,0.0,0.0,,0.0,0.0,0.0,0.0
Nawanshahr,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,0.0,,,,,0.0,0.0,0.0,,7000.0,0.0,500.0,7500.0
Nawanshahr,16.1.1A,Stock Position of Pentavalent,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3000.0,0.0,2500.0,5500.0
Nawanshahr,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,24400.0,16400.0,8900.0,8900.0,3900.0,8500.0,7500.0,1700.0,200.0,6400.0,19400.0,23400.0,129600.0
Nawanshahr,16.1.2,Stock position of OPV vaccines,2. Stocks Received,0.0,0.0,5000.0,0.0,10000.0,0.0,0.0,3000.0,10000.0,100000.0,90000.0,0.0,218000.0
Nawanshahr,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nawanshahr,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,8000.0,7500.0,5000.0,5000.0,5400.0,1000.0,5800.0,4500.0,3800.0,87000.0,86000.0,2500.0,221500.0
Nawanshahr,16.1.2,Stock position of OPV vaccines,5. Total Stock,16400.0,8900.0,8900.0,3900.0,8500.0,7500.0,1700.0,200.0,6400.0,19400.0,23400.0,20900.0,126100.0
Nawanshahr,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,2500.0,1500.0,3500.0,2500.0,250.0,4750.0,4500.0,1050.0,3600.0,5100.0,4100.0,6600.0,39950.0
Nawanshahr,16.1.3,Stock position of TT vaccines,2. Stocks Received,6000.0,5000.0,5000.0,0.0,10000.0,0.0,0.0,5000.0,4000.0,0.0,5000.0,0.0,40000.0
Nawanshahr,16.1.3,Stock position of TT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nawanshahr,16.1.3,Stock position of TT vaccines,4. Stock Distributed,7000.0,3000.0,6000.0,2250.0,5500.0,250.0,3450.0,2450.0,2500.0,1000.0,2500.0,1000.0,36900.0
Nawanshahr,16.1.3,Stock position of TT vaccines,5. Total Stock,1500.0,3500.0,2500.0,250.0,4750.0,4500.0,1050.0,3600.0,5100.0,4100.0,6600.0,5600.0,43050.0
Nawanshahr,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nawanshahr,16.1.4,Stock position of DT vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nawanshahr,16.1.4,Stock position of DT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nawanshahr,16.1.4,Stock position of DT vaccines,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nawanshahr,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nawanshahr,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,3050.0,3050.0,4050.0,3050.0,1050.0,4050.0,3550.0,2050.0,2950.0,950.0,4100.0,5600.0,37500.0
Nawanshahr,16.1.5,Stock position of BCG vaccines,2. Stocks Received,4000.0,4000.0,3000.0,0.0,5000.0,0.0,0.0,3000.0,0.0,4000.0,5000.0,0.0,28000.0
Nawanshahr,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nawanshahr,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,4000.0,3000.0,4000.0,2000.0,2000.0,500.0,1500.0,2100.0,2000.0,850.0,3500.0,1000.0,26450.0
Nawanshahr,16.1.5,Stock position of BCG vaccines,5. Total Stock,3050.0,4050.0,3050.0,1050.0,4050.0,3550.0,2050.0,2950.0,950.0,4100.0,5600.0,4600.0,39050.0
Nawanshahr,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,5500.0,2250.0,4250.0,5250.0,3750.0,6750.0,6250.0,4000.0,5250.0,3500.0,7000.0,9750.0,63500.0
Nawanshahr,16.1.6,Stock position of Measles vaccines,2. Stocks Received,0.0,4000.0,3000.0,0.0,5000.0,0.0,0.0,3000.0,0.0,5000.0,5000.0,0.0,25000.0
Nawanshahr,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nawanshahr,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,3250.0,2000.0,2000.0,1500.0,2000.0,500.0,2250.0,1750.0,1750.0,1500.0,2250.0,1000.0,21750.0
Nawanshahr,16.1.6,Stock position of Measles vaccines,5. Total Stock,2250.0,4250.0,5250.0,3750.0,6750.0,6250.0,4000.0,5250.0,3500.0,7000.0,9750.0,8750.0,66750.0
Nawanshahr,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nawanshahr,16.1.7,Stock position of JE vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nawanshahr,16.1.7,Stock position of JE vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nawanshahr,16.1.7,Stock position of JE vaccines,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nawanshahr,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nawanshahr,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,4000.0,2200.0,4400.0,3400.0,1300.0,6300.0,6000.0,3200.0,3200.0,700.0,0.0,3500.0,38200.0
Nawanshahr,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,4000.0,5000.0,3000.0,0.0,10000.0,0.0,0.0,2000.0,0.0,2000.0,5000.0,0.0,31000.0
Nawanshahr,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nawanshahr,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,5800.0,2800.0,4000.0,2100.0,5000.0,300.0,2800.0,2000.0,2500.0,2700.0,1500.0,2000.0,33500.0
Nawanshahr,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,2200.0,4400.0,3400.0,1300.0,6300.0,6000.0,3200.0,3200.0,700.0,0.0,3500.0,1500.0,35700.0
Nawanshahr,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nawanshahr,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nawanshahr,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nawanshahr,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nawanshahr,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nawanshahr,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,89500.0,89500.0
Nawanshahr,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,89500.0,0.0,89500.0
Nawanshahr,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nawanshahr,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,72000.0,72000.0
Nawanshahr,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,89500.0,17500.0,107000.0
Nawanshahr,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nawanshahr,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3700.0,0.0,3700.0
Nawanshahr,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nawanshahr,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3700.0,0.0,3700.0
Nawanshahr,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nawanshahr,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nawanshahr,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,500.0,0.0,500.0
Nawanshahr,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nawanshahr,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,500.0,0.0,500.0
Nawanshahr,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nawanshahr,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,700.0,700.0
Nawanshahr,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,700.0,0.0,700.0
Nawanshahr,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nawanshahr,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,700.0,700.0
Nawanshahr,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,700.0,0.0,700.0
Nawanshahr,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nawanshahr,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nawanshahr,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nawanshahr,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nawanshahr,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nawanshahr,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nawanshahr,16.3.02,Stock Position of Gloves,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nawanshahr,16.3.02,Stock Position of Gloves,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nawanshahr,16.3.02,Stock Position of Gloves,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nawanshahr,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nawanshahr,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nawanshahr,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nawanshahr,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nawanshahr,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nawanshahr,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nawanshahr,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nawanshahr,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nawanshahr,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nawanshahr,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nawanshahr,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nawanshahr,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nawanshahr,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nawanshahr,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nawanshahr,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nawanshahr,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nawanshahr,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nawanshahr,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nawanshahr,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nawanshahr,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nawanshahr,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nawanshahr,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nawanshahr,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nawanshahr,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nawanshahr,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nawanshahr,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nawanshahr,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nawanshahr,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nawanshahr,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nawanshahr,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nawanshahr,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nawanshahr,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nawanshahr,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nawanshahr,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nawanshahr,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nawanshahr,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nawanshahr,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,0.0,0.0,0.0,,,0.0,0.0,0.0,,0.0,0.0,0.0,0.0
Nawanshahr,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,0.0,0.0,0.0,,,0.0,0.0,0.0,,0.0,0.0,0.0,0.0
Nawanshahr,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,0.0,0.0,0.0,,,0.0,0.0,0.0,,0.0,0.0,0.0,0.0
Nawanshahr,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,0.0,0.0,0.0,,,0.0,0.0,0.0,,0.0,0.0,0.0,0.0
Nawanshahr,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nawanshahr,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nawanshahr,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nawanshahr,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nawanshahr,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nawanshahr,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nawanshahr,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,1100.0,1100.0,1100.0,0.0,0.0,1400.0,800.0,800.0,800.0,800.0,800.0,2400.0,11100.0
Nawanshahr,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,0.0,0.0,0.0,0.0,2000.0,2000.0,0.0,0.0,0.0,0.0,2000.0,0.0,6000.0
Nawanshahr,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nawanshahr,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,0.0,0.0,1100.0,0.0,600.0,2600.0,0.0,0.0,0.0,0.0,400.0,1600.0,6300.0
Nawanshahr,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,1100.0,1100.0,0.0,0.0,1400.0,800.0,800.0,800.0,800.0,800.0,2400.0,800.0,10800.0
Nawanshahr,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,30000.0,14000.0,14000.0,14000.0,6000.0,6000.0,6000.0,90000.0
Nawanshahr,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,0.0,0.0,0.0,0.0,60000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,60000.0
Nawanshahr,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nawanshahr,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,0.0,0.0,0.0,0.0,30000.0,16000.0,0.0,0.0,8000.0,0.0,0.0,4000.0,58000.0
Nawanshahr,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,0.0,0.0,0.0,0.0,30000.0,14000.0,14000.0,14000.0,6000.0,6000.0,6000.0,2000.0,92000.0
Nawanshahr,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,0.0,0.0,0.0,3100.0,3100.0,200.0,0.0,2000.0,1900.0,1900.0,1900.0,0.0,14100.0
Nawanshahr,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,0.0,0.0,4800.0,0.0,2000.0,2000.0,2000.0,0.0,0.0,0.0,0.0,0.0,10800.0
Nawanshahr,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Nawanshahr,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,0.0,0.0,1700.0,0.0,4900.0,2200.0,100.0,0.0,0.0,0.0,1900.0,0.0,10800.0
Nawanshahr,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,0.0,0.0,3100.0,3100.0,200.0,0.0,1900.0,2000.0,1900.0,1900.0,0.0,0.0,14100.0
Nawanshahr,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,,2.0,4.0,,,,,,,,,,6.0
Nawanshahr,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Nawanshahr,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Nawanshahr,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,,,,,,,,,,,,
Nawanshahr,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Nawanshahr,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Nawanshahr,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,,,,,,,,,,,,,
Nawanshahr,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,,,,,,,,2.0,,,,,2.0
Nawanshahr,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,1.0,,,,,,,,,,,1.0
Nawanshahr,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,,1.0,,,,,,2.0,,,,,3.0
Nawanshahr,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,1.0,4.0,2.0,7.0,1.0,3.0,2.0,8.0,3.0,3.0,,2.0,36.0
Nawanshahr,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,3.0,,,,1.0,4.0,3.0,3.0,4.0,2.0,4.0,,24.0
Nawanshahr,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,4.0,4.0,2.0,7.0,2.0,7.0,5.0,11.0,7.0,5.0,4.0,2.0,60.0
Nawanshahr,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,1.0,,,,1.0,,,,,3.0,,,5.0
Nawanshahr,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,,,2.0,,,,1.0,,,3.0
Nawanshahr,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,1.0,,,,1.0,2.0,,,,4.0,,,8.0
Nawanshahr,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,,1.0,,,,1.0
Nawanshahr,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
Nawanshahr,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,,,,,1.0,,,,1.0
Nawanshahr,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,,,,,,,,1.0,,,1.0
Nawanshahr,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,1.0,,,,,,,,,1.0
Nawanshahr,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,,,1.0,,,,,,1.0,,,2.0
Nawanshahr,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Nawanshahr,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Nawanshahr,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Nawanshahr,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,1.0,2.0,1.0,,3.0,8.0,5.0,3.0,5.0,6.0,,,34.0
Nawanshahr,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,,,2.0,1.0,3.0,,2.0,1.0,1.0,1.0,4.0,2.0,17.0
Nawanshahr,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,1.0,2.0,3.0,1.0,6.0,8.0,7.0,4.0,6.0,7.0,4.0,2.0,51.0
Nawanshahr,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
Nawanshahr,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,1.0,,1.0,,,,,,2.0
Nawanshahr,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,1.0,,1.0,,,,,,,2.0
Nawanshahr,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,,1.0,1.0,1.0,1.0,,,,,,4.0
Nawanshahr,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,1.0,,,,1.0
Nawanshahr,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,2.0,2.0,,4.0,4.0,1.0,2.0,1.0,,2.0,3.0,2.0,23.0
Nawanshahr,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,5.0,2.0,1.0,5.0,,2.0,1.0,4.0,4.0,1.0,2.0,3.0,30.0
Nawanshahr,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,7.0,4.0,1.0,9.0,4.0,3.0,3.0,5.0,5.0,3.0,5.0,5.0,54.0
Nawanshahr,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,1.0,,,,,1.0,,2.0
Nawanshahr,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,,,,,3.0,,,,1.0,1.0,7.0,5.0,17.0
Nawanshahr,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,,,1.0,2.0,5.0,3.0,4.0,10.0,7.0,5.0,17.0,4.0,58.0
Nawanshahr,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,,,1.0,2.0,8.0,4.0,4.0,10.0,8.0,6.0,25.0,9.0,77.0
Nawanshahr,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
Nawanshahr,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,,,,,,,,
Nawanshahr,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
Nawanshahr,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,,,,,,,,,,
Nawanshahr,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,1.0,,1.0,,,,1.0,,,,,,3.0
Nawanshahr,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,,,,1.0,4.0,,4.0,1.0,2.0,4.0,2.0,,18.0
Nawanshahr,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,3.0,5.0,2.0,2.0,9.0,7.0,14.0,7.0,5.0,12.0,6.0,1.0,73.0
Nawanshahr,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,4.0,5.0,3.0,3.0,13.0,7.0,19.0,8.0,7.0,16.0,8.0,1.0,94.0
Nawanshahr,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
Nawanshahr,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,1.0,1.0,,,,,1.0,1.0,,,1.0,,5.0
Nawanshahr,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,2.0,,,,,,,1.0,,,,,3.0
Nawanshahr,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,3.0,1.0,,,,,1.0,2.0,,,1.0,,8.0
Nawanshahr,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,1.0,,,,,1.0,1.0,1.0,1.0,,,5.0
Nawanshahr,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,43.0,49.0,34.0,39.0,33.0,49.0,41.0,32.0,55.0,52.0,43.0,40.0,510.0
Nawanshahr,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,99.0,128.0,102.0,104.0,110.0,125.0,103.0,99.0,148.0,177.0,133.0,87.0,1415.0
Nawanshahr,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,142.0,178.0,136.0,143.0,143.0,174.0,145.0,132.0,204.0,230.0,176.0,127.0,1930.0
Nawanshahr,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,1.0,,,,,,,1.0
Nawanshahr,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,,1.0,,,2.0,,,2.0,,,,,5.0
Nawanshahr,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,,,1.0,1.0,1.0,1.0,1.0,1.0,1.0,,2.0,,9.0
Nawanshahr,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,,1.0,1.0,1.0,3.0,2.0,1.0,3.0,1.0,,2.0,,15.0
Nawanshahr,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Nawanshahr,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
Nawanshahr,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Nawanshahr,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
Nawanshahr,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Nawanshahr,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,,,,,,,,
Nawanshahr,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Nawanshahr,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,,,,,,,,
Nawanshahr,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Nawanshahr,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,,,,,,,,,,
Nawanshahr,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Nawanshahr,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,,,,,,,,,,,
Nawanshahr,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Nawanshahr,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,1.0,1.0,,,,,,,,,,2.0
Nawanshahr,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Nawanshahr,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,1.0,1.0,,,,,,,,,,2.0
Nawanshahr,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Nawanshahr,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,,,,,,,
Nawanshahr,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Nawanshahr,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,,,,,,,
Nawanshahr,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Nawanshahr,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,,,,,,,,,,,,,
Nawanshahr,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Nawanshahr,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,,,,,,,,,,,,,
Nawanshahr,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,,,,2.0,,,,2.0,1.0,1.0,1.0,7.0
Nawanshahr,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,,1.0,,6.0,11.0,8.0,12.0,14.0,15.0,16.0,4.0,8.0,95.0
Nawanshahr,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,,,1.0,3.0,6.0,9.0,6.0,4.0,5.0,7.0,6.0,1.0,48.0
Nawanshahr,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,,1.0,1.0,9.0,19.0,17.0,18.0,18.0,22.0,24.0,11.0,10.0,150.0
Nawanshahr,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,,,,,,,,,
Nawanshahr,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,7.0,1.0,5.0,4.0,3.0,5.0,1.0,1.0,2.0,2.0,4.0,7.0,42.0
Nawanshahr,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,1.0,1.0,,3.0,,,,1.0,,2.0,,8.0
Nawanshahr,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,7.0,2.0,6.0,4.0,6.0,5.0,1.0,1.0,3.0,2.0,6.0,7.0,50.0
Nawanshahr,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,,,,,,,,,,
Nawanshahr,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,,,,3.0,,1.0,,,1.0,,,5.0
Nawanshahr,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,1.0,,1.0,,,1.0,,,,,,3.0
Nawanshahr,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,,1.0,,1.0,3.0,,2.0,,,1.0,,,8.0
Nawanshahr,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,1.0,,,,,,,,,,1.0
Nawanshahr,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,1.0,4.0,1.0,2.0,4.0,1.0,1.0,1.0,3.0,1.0,,,19.0
Nawanshahr,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,11.0,3.0,1.0,3.0,2.0,1.0,1.0,3.0,1.0,4.0,3.0,1.0,34.0
Nawanshahr,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,12.0,7.0,3.0,5.0,6.0,2.0,2.0,4.0,4.0,5.0,3.0,1.0,54.0
Nawanshahr,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,,,,,1.0,,2.0,2.0,,,,5.0
Nawanshahr,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,2.0,10.0,9.0,12.0,10.0,10.0,16.0,7.0,12.0,15.0,7.0,4.0,114.0
Nawanshahr,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,16.0,17.0,11.0,20.0,27.0,20.0,20.0,21.0,37.0,25.0,21.0,4.0,239.0
Nawanshahr,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,18.0,27.0,20.0,32.0,37.0,31.0,36.0,30.0,51.0,40.0,28.0,8.0,358.0
Nawanshahr,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,2.0,,1.0,3.0,2.0,,1.0,,4.0,4.0,,2.0,19.0
Nawanshahr,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,7.0,22.0,21.0,19.0,13.0,32.0,26.0,17.0,15.0,13.0,18.0,11.0,214.0
Nawanshahr,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,64.0,101.0,96.0,108.0,102.0,78.0,94.0,106.0,129.0,140.0,94.0,69.0,1181.0
Nawanshahr,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,73.0,123.0,118.0,130.0,117.0,110.0,121.0,123.0,148.0,157.0,112.0,82.0,1414.0
Pathankot,1.1,Total number of pregnant women Registered for ANC,TOTAL,906.0,946.0,757.0,870.0,859.0,634.0,616.0,709.0,668.0,793.0,877.0,819.0,9454.0
Pathankot,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,576.0,565.0,483.0,500.0,499.0,393.0,369.0,400.0,422.0,530.0,569.0,504.0,5810.0
Pathankot,1.2,Number of Pregnant women registered under JSY,TOTAL,213.0,302.0,284.0,279.0,302.0,232.0,219.0,265.0,244.0,272.0,290.0,305.0,3207.0
Pathankot,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,637.0,680.0,658.0,795.0,884.0,853.0,801.0,766.0,729.0,730.0,644.0,645.0,8822.0
Pathankot,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,891.0,928.0,796.0,853.0,922.0,687.0,669.0,679.0,576.0,710.0,806.0,746.0,9263.0
Pathankot,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,949.0,891.0,884.0,849.0,898.0,791.0,747.0,649.0,621.0,613.0,681.0,655.0,9228.0
Pathankot,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,759.0,780.0,619.0,650.0,676.0,623.0,861.0,621.0,523.0,243.0,268.0,322.0,6945.0
Pathankot,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,22.0,31.0,11.0,16.0,3.0,1.0,1.0,16.0,1.0,3.0,1.0,5.0,111.0
Pathankot,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Pathankot,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,722.0,796.0,631.0,679.0,663.0,473.0,502.0,566.0,556.0,621.0,721.0,650.0,7580.0
Pathankot,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,5.0,0.0,0.0,0.0,0.0,5.0
Pathankot,1.8,Number of pregnancy test kits used at SC level,TOTAL,864.0,815.0,673.0,745.0,550.0,542.0,533.0,609.0,565.0,661.0,777.0,669.0,8003.0
Pathankot,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,53.0,56.0,40.0,24.0,15.0,13.0,16.0,12.0,14.0,17.0,15.0,11.0,286.0
Pathankot,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,85.0,98.0,83.0,116.0,130.0,105.0,102.0,107.0,81.0,97.0,66.0,68.0,1138.0
Pathankot,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,138.0,154.0,123.0,140.0,145.0,118.0,118.0,119.0,95.0,114.0,81.0,79.0,1424.0
Pathankot,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,113.0,127.0,104.0,123.0,116.0,102.0,104.0,112.0,91.0,110.0,79.0,75.0,1256.0
Pathankot,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,0.0,1.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0
Pathankot,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,141.0,161.0,171.0,225.0,295.0,353.0,350.0,316.0,290.0,317.0,241.0,250.0,3110.0
Pathankot,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,105.0,108.0,97.0,73.0,215.0,233.0,248.0,213.0,173.0,199.0,142.0,140.0,1946.0
Pathankot,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,79.0,63.0,60.0,70.0,76.0,131.0,122.0,145.0,63.0,93.0,146.0,53.0,1101.0
Pathankot,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Pathankot,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Pathankot,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,441.0,453.0,427.0,519.0,661.0,659.0,611.0,699.0,557.0,541.0,478.0,455.0,6501.0
Pathankot,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,1.0
Pathankot,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Pathankot,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Pathankot,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Pathankot,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,8.0,7.0,5.0,7.0,10.0,16.0,7.0,9.0,10.0,14.0,8.0,11.0,112.0
Pathankot,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,36.0,45.0,46.0,78.0,70.0,100.0,95.0,91.0,107.0,104.0,91.0,99.0,962.0
Pathankot,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Pathankot,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,44.0,52.0,51.0,85.0,80.0,116.0,102.0,100.0,117.0,118.0,99.0,110.0,1074.0
Pathankot,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,207.0,231.0,225.0,329.0,322.0,356.0,359.0,304.0,291.0,293.0,236.0,245.0,3398.0
Pathankot,4.1.1.a,Number of male live births,TOTAL,387.0,403.0,400.0,482.0,564.0,563.0,552.0,596.0,506.0,495.0,436.0,416.0,5800.0
Pathankot,4.1.1.b,Number of female live births,TOTAL,330.0,360.0,321.0,401.0,531.0,567.0,528.0,528.0,436.0,468.0,360.0,366.0,5196.0
Pathankot,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,717.0,763.0,721.0,883.0,1095.0,1130.0,1080.0,1124.0,942.0,963.0,796.0,782.0,10996.0
Pathankot,4.1.2,Number of still births,TOTAL,5.0,8.0,3.0,1.0,11.0,7.0,9.0,17.0,10.0,8.0,8.0,7.0,94.0
Pathankot,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,18.0,24.0,11.0,23.0,28.0,14.0,15.0,15.0,15.0,21.0,14.0,7.0,205.0
Pathankot,4.2.1,Number of Newborns weighed at birth,TOTAL,662.0,726.0,676.0,822.0,959.0,1062.0,1017.0,1119.0,936.0,686.0,799.0,781.0,10245.0
Pathankot,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,11.0,14.0,17.0,12.0,9.0,13.0,10.0,17.0,17.0,8.0,9.0,6.0,143.0
Pathankot,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,613.0,658.0,603.0,716.0,887.0,935.0,899.0,726.0,542.0,456.0,476.0,539.0,8050.0
Pathankot,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Pathankot,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Pathankot,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Pathankot,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Pathankot,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Pathankot,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Pathankot,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Pathankot,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Pathankot,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Pathankot,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Pathankot,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,454.0,468.0,385.0,437.0,749.0,667.0,622.0,745.0,554.0,476.0,636.0,435.0,6628.0
Pathankot,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,388.0,444.0,344.0,590.0,782.0,714.0,683.0,653.0,564.0,466.0,486.0,517.0,6631.0
Pathankot,6.3,PNC maternal complications attended,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Pathankot,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,4.0,11.0,5.0,10.0,9.0,4.0,3.0,13.0,10.0,14.0,15.0,7.0,105.0
Pathankot,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Pathankot,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,4.0,11.0,5.0,10.0,9.0,4.0,3.0,13.0,10.0,14.0,15.0,7.0,105.0
Pathankot,7.2,Number of MTPs conducted at Private Facilities,TOTAL,4.0,3.0,2.0,2.0,2.0,3.0,2.0,3.0,1.0,3.0,3.0,2.0,30.0
Pathankot,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,2.0,0.0,0.0,3.0,3.0,0.0,0.0,2.0,0.0,0.0,0.0,0.0,10.0
Pathankot,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,29.0,0.0,0.0,18.0,18.0,0.0,8.0,11.0,17.0,10.0,0.0,0.0,111.0
Pathankot,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,31.0,0.0,0.0,21.0,21.0,0.0,8.0,13.0,17.0,10.0,0.0,0.0,121.0
Pathankot,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Pathankot,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,4.0,1.0,1.0,0.0,0.0,0.0,6.0
Pathankot,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,2.0,5.0,9.0
Pathankot,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,0.0,0.0,1.0,0.0,3.0,0.0,0.0,1.0,0.0,0.0,0.0,1.0,6.0
Pathankot,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Pathankot,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,0.0,0.0,1.0,0.0,3.0,0.0,4.0,2.0,3.0,0.0,2.0,6.0,21.0
Pathankot,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,6.0,7.0,1.0,3.0,3.0,12.0,6.0,6.0,2.0,1.0,2.0,6.0,55.0
Pathankot,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Pathankot,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Pathankot,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Pathankot,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Pathankot,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Pathankot,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,15.0,0.0,15.0
Pathankot,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,2.0,0.0,3.0,0.0,0.0,3.0,6.0,44.0,11.0,6.0,4.0,0.0,79.0
Pathankot,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,14.0,1.0,7.0,7.0,8.0,18.0,6.0,34.0,26.0,13.0,40.0,30.0,204.0
Pathankot,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,12.0,15.0,14.0,21.0,8.0,14.0,21.0,22.0,29.0,20.0,16.0,15.0,207.0
Pathankot,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Pathankot,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,28.0,16.0,24.0,28.0,16.0,35.0,33.0,100.0,66.0,39.0,60.0,45.0,490.0
Pathankot,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,24.0,30.0,36.0,52.0,33.0,58.0,42.0,35.0,30.0,20.0,15.0,31.0,406.0
Pathankot,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Pathankot,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Pathankot,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Pathankot,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Pathankot,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Pathankot,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,10.0,9.0,5.0,0.0,17.0,13.0,14.0,10.0,8.0,4.0,9.0,9.0,108.0
Pathankot,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,251.0,259.0,208.0,285.0,237.0,218.0,247.0,243.0,230.0,280.0,378.0,250.0,3086.0
Pathankot,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,3.0,3.0,2.0,2.0,2.0,0.0,3.0,0.0,0.0,2.0,0.0,0.0,17.0
Pathankot,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,7.0,7.0
Pathankot,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,0.0,6.0,4.0,7.0,4.0,0.0,6.0,24.0,41.0,42.0,28.0,31.0,193.0
Pathankot,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Pathankot,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,254.0,268.0,214.0,294.0,243.0,218.0,256.0,267.0,271.0,324.0,406.0,288.0,3303.0
Pathankot,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,0.0,0.0,0.0,0.0,0.0,6.0,1.0,18.0,32.0,39.0,26.0,35.0,157.0
Pathankot,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Pathankot,9.06,Number of IUCD removals,TOTAL,74.0,71.0,56.0,78.0,77.0,69.0,64.0,68.0,61.0,90.0,97.0,65.0,870.0
Pathankot,9.07,Number of Oral Pills cycles distributed,TOTAL,2530.0,2493.0,2170.0,2623.0,2568.0,2587.0,2460.0,2438.0,2622.0,2870.0,2768.0,2254.0,30383.0
Pathankot,9.08,Number of Condom pieces distributed,TOTAL,64590.0,63840.0,62824.0,64382.0,66876.0,68370.0,64232.0,65543.0,66178.0,65547.0,78026.0,67466.0,797874.0
Pathankot,9.09,Number of Centchroman (weekly) pills given,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Pathankot,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,32.0,42.0,46.0,12.0,6.0,0.0,28.0,16.0,21.0,5.0,2.0,8.0,218.0
Pathankot,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Pathankot,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Pathankot,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Pathankot,9.11.2.b,Number of failures following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Pathankot,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Pathankot,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Pathankot,9.12,Number of Institutions having NSV trained doctors,TOTAL,,1.0,1.0,3.0,2.0,1.0,2.0,4.0,3.0,,2.0,3.0,-1.0
Pathankot,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,732.0,768.0,673.0,814.0,1186.0,1033.0,1162.0,1112.0,982.0,948.0,854.0,827.0,11091.0
Pathankot,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,792.0,774.0,567.0,627.0,794.0,764.0,926.0,1130.0,909.0,844.0,119.0,25.0,8271.0
Pathankot,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,865.0,831.0,631.0,660.0,675.0,643.0,765.0,889.0,1035.0,934.0,678.0,182.0,8788.0
Pathankot,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,863.0,926.0,701.0,714.0,740.0,610.0,681.0,747.0,789.0,1039.0,831.0,613.0,9254.0
Pathankot,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,78.0,717.0,682.0,1477.0
Pathankot,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,224.0,573.0,797.0
Pathankot,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,200.0,200.0
Pathankot,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,560.0,572.0,527.0,601.0,837.0,819.0,898.0,833.0,769.0,714.0,659.0,672.0,8461.0
Pathankot,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,792.0,774.0,567.0,627.0,794.0,764.0,926.0,1130.0,909.0,844.0,836.0,707.0,9670.0
Pathankot,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,865.0,831.0,631.0,660.0,675.0,643.0,765.0,889.0,1035.0,934.0,902.0,755.0,9585.0
Pathankot,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,863.0,926.0,701.0,714.0,740.0,610.0,681.0,747.0,789.0,1039.0,829.0,814.0,9453.0
Pathankot,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,323.0,330.0,285.0,346.0,437.0,420.0,518.0,443.0,455.0,406.0,394.0,457.0,4814.0
Pathankot,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,792.0,774.0,567.0,627.0,794.0,764.0,926.0,1130.0,909.0,844.0,119.0,25.0,8271.0
Pathankot,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,865.0,831.0,631.0,660.0,675.0,643.0,765.0,889.0,1035.0,934.0,678.0,182.0,8788.0
Pathankot,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,863.0,926.0,701.0,714.0,740.0,610.0,681.0,747.0,789.0,1039.0,831.0,613.0,9254.0
Pathankot,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,711.0,957.0,780.0,980.0,1041.0,731.0,764.0,880.0,692.0,671.0,584.0,552.0,9343.0
Pathankot,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,867.0,995.0,693.0,888.0,875.0,627.0,573.0,715.0,644.0,745.0,757.0,738.0,9117.0
Pathankot,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Pathankot,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,427.0,543.0,467.0,513.0,579.0,400.0,423.0,470.0,354.0,377.0,318.0,306.0,5177.0
Pathankot,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,284.0,414.0,313.0,467.0,462.0,331.0,341.0,410.0,338.0,294.0,266.0,246.0,4166.0
Pathankot,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,711.0,957.0,780.0,980.0,1041.0,731.0,764.0,880.0,692.0,671.0,584.0,552.0,9343.0
Pathankot,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,867.0,995.0,693.0,888.0,875.0,627.0,573.0,715.0,644.0,745.0,757.0,738.0,9117.0
Pathankot,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,867.0,995.0,693.0,888.0,875.0,627.0,573.0,715.0,644.0,745.0,757.0,738.0,9117.0
Pathankot,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Pathankot,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,5.0,9.0,0.0,0.0,3.0,1.0,0.0,0.0,52.0,50.0,67.0,63.0,250.0
Pathankot,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1.0,0.0,0.0,1.0,2.0,0.0,0.0,0.0,46.0,44.0,58.0,42.0,194.0
Pathankot,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,6.0,9.0,0.0,1.0,5.0,1.0,0.0,0.0,98.0,94.0,125.0,105.0,444.0
Pathankot,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,581.0,786.0,555.0,685.0,753.0,715.0,637.0,710.0,709.0,624.0,640.0,556.0,7951.0
Pathankot,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,467.0,726.0,439.0,1101.0,560.0,575.0,652.0,548.0,545.0,436.0,442.0,409.0,6900.0
Pathankot,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,201.0,528.0,210.0,555.0,531.0,311.0,504.0,263.0,250.0,194.0,381.0,186.0,4114.0
Pathankot,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,8.0,4.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,12.0
Pathankot,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Pathankot,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Pathankot,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,342.0,340.0,332.0,346.0,350.0,329.0,346.0,335.0,336.0,363.0,354.0,362.0,4135.0
Pathankot,10.4.2,Number of Immunisation sessions held during the month,TOTAL,342.0,339.0,332.0,346.0,350.0,325.0,344.0,335.0,336.0,360.0,354.0,342.0,4105.0
Pathankot,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,281.0,278.0,263.0,289.0,289.0,268.0,280.0,278.0,278.0,279.0,279.0,269.0,3331.0
Pathankot,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Pathankot,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,678.0,877.0,643.0,939.0,975.0,671.0,688.0,793.0,608.0,364.0,307.0,260.0,7803.0
Pathankot,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,492.0,497.0,426.0,591.0,497.0,436.0,409.0,441.0,421.0,313.0,264.0,228.0,5015.0
Pathankot,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,564.0,656.0,550.0,657.0,677.0,596.0,550.0,611.0,583.0,340.0,247.0,211.0,6242.0
Pathankot,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Pathankot,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Pathankot,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Pathankot,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Pathankot,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Pathankot,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Pathankot,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,81.0,73.0,25.0,9.0,10.0,4.0,0.0,0.0,0.0,2.0,0.0,0.0,204.0
Pathankot,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Pathankot,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Pathankot,13.1,Number of Patients operated for cataract,TOTAL,0.0,15.0,4.0,12.0,0.0,12.0,17.0,105.0,0.0,0.0,1.0,0.0,166.0
Pathankot,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,0.0,15.0,4.0,12.0,0.0,12.0,17.0,0.0,0.0,0.0,1.0,0.0,61.0
Pathankot,13.3,Number of School children detected with Refractive errors,TOTAL,10.0,8.0,10.0,25.0,17.0,21.0,95.0,137.0,66.0,53.0,48.0,33.0,523.0
Pathankot,13.4,Number of children provided free glasses,TOTAL,10.0,8.0,10.0,25.0,17.0,21.0,34.0,130.0,66.0,53.0,48.0,33.0,455.0
Pathankot,13.5,Number of eyes collected through eye donation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Pathankot,13.6,Number of eyes utilised for corneal transplant,TOTAL,2.0,1.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,4.0
Pathankot,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,2.0,1.0,1.0,6.0,5.0,7.0,6.0,6.0,6.0,6.0,7.0,6.0,-1.0
Pathankot,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,2.0,,1.0,4.0,1.0,3.0,4.0,4.0,4.0,4.0,5.0,3.0,-1.0
Pathankot,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,268.0,259.0,232.0,264.0,263.0,251.0,238.0,257.0,264.0,258.0,263.0,263.0,-1.0
Pathankot,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,3.0,3.0,3.0,7.0,4.0,5.0,6.0,6.0,5.0,6.0,7.0,6.0,-1.0
Pathankot,14.05,Number of RKS meetings held during the month,TOTAL,2.0,2.0,3.0,2.0,2.0,0.0,0.0,1.0,1.0,0.0,0.0,0.0,13.0
Pathankot,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,3.0,1.0,2.0,4.0,5.0,3.0,4.0,7.0,7.0,7.0,6.0,6.0,-1.0
Pathankot,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,5.0,4.0,5.0,5.0,5.0,2.0,2.0,2.0,0.0,0.0,0.0,1.0,31.0
Pathankot,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,1.0,1.0,1.0,2.0,4.0,1.0,3.0,2.0,2.0,,,,-1.0
Pathankot,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,5.0,26.0,21.0,1.0,1.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,-1.0
Pathankot,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,37.0,50.0,40.0,40.0,79.0,60.0,52.0,68.0,81.0,64.0,52.0,116.0,739.0
Pathankot,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,426.0,510.0,674.0,757.0,640.0,712.0,463.0,517.0,388.0,397.0,426.0,424.0,6334.0
Pathankot,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,35.0,39.0,43.0,39.0,57.0,54.0,63.0,52.0,62.0,53.0,40.0,90.0,627.0
Pathankot,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,669.0,798.0,830.0,930.0,1099.0,995.0,1003.0,843.0,775.0,698.0,677.0,743.0,10060.0
Pathankot,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,72.0,89.0,83.0,79.0,136.0,114.0,115.0,120.0,143.0,117.0,92.0,206.0,1366.0
Pathankot,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,1095.0,1308.0,1504.0,1687.0,1739.0,1707.0,1466.0,1360.0,1163.0,1095.0,1103.0,1167.0,16394.0
Pathankot,14.10.2.a,Number of death cases of Inpatient males,TOTAL,0.0,7.0,19.0,10.0,11.0,13.0,10.0,9.0,5.0,14.0,8.0,11.0,117.0
Pathankot,14.10.2.b,Number of death cases of Inpatient females,TOTAL,0.0,4.0,16.0,10.0,3.0,1.0,9.0,5.0,6.0,4.0,4.0,7.0,69.0
Pathankot,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,0.0,11.0,35.0,20.0,14.0,14.0,19.0,14.0,11.0,18.0,12.0,18.0,186.0
Pathankot,14.11,In-Patient Head Count at midnight,TOTAL,214.0,202.0,255.0,232.0,411.0,307.0,314.0,312.0,229.0,168.0,270.0,348.0,3262.0
Pathankot,14.12.1,OPD attendance (All),TOTAL,29152.0,30347.0,29134.0,35745.0,29729.0,29382.0,23680.0,28883.0,26162.0,23637.0,30681.0,26628.0,343160.0
Pathankot,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,177.0,178.0,231.0,290.0,167.0,256.0,205.0,278.0,282.0,237.0,215.0,282.0,2798.0
Pathankot,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,23.0,31.0,24.0,26.0,20.0,2.0,0.0,3.0,0.0,31.0,32.0,0.0,192.0
Pathankot,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,183.0,132.0,451.0,449.0,201.0,361.0,409.0,547.0,123.0,225.0,216.0,432.0,3729.0
Pathankot,14.14.a,Number of patients given AYUSH treatment,TOTAL,3422.0,3121.0,2854.0,3890.0,3854.0,3601.0,2631.0,2501.0,3275.0,3310.0,3711.0,1990.0,38160.0
Pathankot,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,593.0,591.0,465.0,674.0,580.0,661.0,845.0,994.0,924.0,635.0,295.0,770.0,8027.0
Pathankot,14.14.c,Number of Adolescents counselled,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Pathankot,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,2719.0,3274.0,2480.0,3707.0,3189.0,3508.0,2785.0,2884.0,2552.0,3122.0,3486.0,3425.0,37131.0
Pathankot,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,95.0,124.0,88.0,145.0,141.0,205.0,165.0,159.0,120.0,417.0,421.0,329.0,2409.0
Pathankot,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,228.0,231.0,263.0,250.0,349.0,279.0,158.0,259.0,258.0,231.0,180.0,285.0,2971.0
Pathankot,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,4.0,7.0,10.0,9.0,8.0,4.0,4.0,0.0,0.0,4.0,2.0,2.0,54.0
Pathankot,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,204.0,274.0,217.0,209.0,287.0,247.0,258.0,271.0,275.0,224.0,119.0,304.0,2889.0
Pathankot,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,4.0,2.0,8.0,1.0,2.0,3.0,2.0,0.0,1.0,1.0,4.0,4.0,32.0
Pathankot,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,401.0,412.0,632.0,622.0,467.0,630.0,344.0,494.0,449.0,548.0,426.0,302.0,5727.0
Pathankot,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,0.0,0.0,0.0,0.0,0.0,0.0,0.0,4.0,0.0,1.0,0.0,2.0,7.0
Pathankot,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,833.0,917.0,1112.0,1081.0,1103.0,1156.0,760.0,1024.0,982.0,1003.0,725.0,891.0,11587.0
Pathankot,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,8.0,9.0,18.0,10.0,10.0,7.0,6.0,4.0,1.0,6.0,6.0,8.0,93.0
Pathankot,15.2,Number of Widal tests conducted,Number tested,385.0,718.0,570.0,558.0,877.0,688.0,426.0,404.0,229.0,218.0,485.0,836.0,6394.0
Pathankot,15.3.a,Number of VDRL tests conducted on males,Number tested,95.0,30.0,1.0,204.0,191.0,212.0,168.0,25.0,31.0,27.0,34.0,178.0,1196.0
Pathankot,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,68.0,75.0,9.0,55.0,88.0,72.0,66.0,104.0,49.0,57.0,80.0,183.0,906.0
Pathankot,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,90.0,187.0,224.0,388.0,263.0,332.0,249.0,246.0,291.0,239.0,279.0,350.0,3138.0
Pathankot,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,253.0,292.0,234.0,647.0,542.0,616.0,483.0,375.0,371.0,323.0,393.0,711.0,5240.0
Pathankot,15.4.1,Number of blood smears examined for Malaria,TOTAL,1016.0,1457.0,1736.0,1599.0,2064.0,2004.0,1469.0,1927.0,1685.0,1383.0,1698.0,1803.0,19841.0
Pathankot,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,0.0,0.0,0.0,0.0,2.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0
Pathankot,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Pathankot,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Pathankot,16.1.1,Stock position of DPT vaccines,2. Stocks Received,,,,,,,,,,,,,
Pathankot,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Pathankot,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,,,,,,,,,,,,,
Pathankot,16.1.1,Stock position of DPT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Pathankot,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,,,,,,,,,,,,,
Pathankot,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,,,,,,,,,,,,,
Pathankot,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,,,,,,,,,,,,,
Pathankot,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,,,,,,,,,,,,,
Pathankot,16.1.1A,Stock Position of Pentavalent,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Pathankot,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Pathankot,16.1.2,Stock position of OPV vaccines,2. Stocks Received,,,,,,,,,,,,,
Pathankot,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,,,,,,,,,,,,,
Pathankot,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,,,,,,,,,,,,,
Pathankot,16.1.2,Stock position of OPV vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Pathankot,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Pathankot,16.1.3,Stock position of TT vaccines,2. Stocks Received,,,,,,,,,,,,,
Pathankot,16.1.3,Stock position of TT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Pathankot,16.1.3,Stock position of TT vaccines,4. Stock Distributed,,,,,,,,,,,,,
Pathankot,16.1.3,Stock position of TT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Pathankot,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Pathankot,16.1.4,Stock position of DT vaccines,2. Stocks Received,,,,,,,,,,,,,
Pathankot,16.1.4,Stock position of DT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Pathankot,16.1.4,Stock position of DT vaccines,4. Stock Distributed,,,,,,,,,,,,,
Pathankot,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Pathankot,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Pathankot,16.1.5,Stock position of BCG vaccines,2. Stocks Received,,,,,,,,,,,,,
Pathankot,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,,,,,,,,,,,,,
Pathankot,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,,,,,,,,,,,,,
Pathankot,16.1.5,Stock position of BCG vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Pathankot,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Pathankot,16.1.6,Stock position of Measles vaccines,2. Stocks Received,,,,,,,,,,,,,
Pathankot,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,,,,,,,,,,,,,
Pathankot,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,,,,,,,,,,,,,
Pathankot,16.1.6,Stock position of Measles vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Pathankot,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Pathankot,16.1.7,Stock position of JE vaccines,2. Stocks Received,,,,,,,,,,,,,
Pathankot,16.1.7,Stock position of JE vaccines,3. Unusable Stock,,,,,,,,,,,,,
Pathankot,16.1.7,Stock position of JE vaccines,4. Stock Distributed,,,,,,,,,,,,,
Pathankot,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Pathankot,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Pathankot,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,,,,,,,,,,,,,
Pathankot,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,,,,,,,,,,,,,
Pathankot,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,,,,,,,,,,,,,
Pathankot,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Pathankot,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Pathankot,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Pathankot,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Pathankot,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Pathankot,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Pathankot,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Pathankot,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Pathankot,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Pathankot,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Pathankot,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Pathankot,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Pathankot,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Pathankot,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Pathankot,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Pathankot,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Pathankot,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Pathankot,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Pathankot,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Pathankot,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Pathankot,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Pathankot,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Pathankot,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Pathankot,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Pathankot,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Pathankot,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Pathankot,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,,,,,,,,,,,,,
Pathankot,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,,,,,,,,,,,,,
Pathankot,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,,,,,,,,,,,,,
Pathankot,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,,,,,,,,,,,,,
Pathankot,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Pathankot,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,,,,,,,,,,,,,
Pathankot,16.3.02,Stock Position of Gloves,2. Stocks Received,,,,,,,,,,,,,
Pathankot,16.3.02,Stock Position of Gloves,3. Unusable Stock,,,,,,,,,,,,,
Pathankot,16.3.02,Stock Position of Gloves,4. Stock Distributed,,,,,,,,,,,,,
Pathankot,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Pathankot,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,,,,,,,,,,,,,
Pathankot,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,,,,,,,,,,,,,
Pathankot,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,,,,,,,,,,,,,
Pathankot,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,,,,,,,,,,,,,
Pathankot,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Pathankot,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
Pathankot,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,,,,,,,,,,,,,
Pathankot,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,,,,,,,,,,,,,
Pathankot,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,,,,,,,,,,,,,
Pathankot,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Pathankot,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,,,,,,,,,,,,,
Pathankot,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,,,,,,,,,,,,,
Pathankot,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,,,,,,,,,,,,,
Pathankot,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,,,,,,,,,,,,,
Pathankot,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Pathankot,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,,,,,,,,,,,,,
Pathankot,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,,,,,,,,,,,,,
Pathankot,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,,,,,,,,,,,,,
Pathankot,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,,,,,,,,,,,,,
Pathankot,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Pathankot,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
Pathankot,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,,,,,,,,,,,,,
Pathankot,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,,,,,,,,,,,,,
Pathankot,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,,,,,,,,,,,,,
Pathankot,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Pathankot,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,,,,,,,,,,,,,
Pathankot,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,,,,,,,,,,,,,
Pathankot,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,,,,,,,,,,,,,
Pathankot,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,,,,,,,,,,,,,
Pathankot,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Pathankot,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,,,,,,,,,,,,,
Pathankot,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,,,,,,,,,,,,,
Pathankot,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,,,,,,,,,,,,,
Pathankot,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,,,,,,,,,,,,,
Pathankot,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Pathankot,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,,,,,,,,,,,,,
Pathankot,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,,,,,,,,,,,,,
Pathankot,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,,,,,,,,,,,,,
Pathankot,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,,,,,,,,,,,,,
Pathankot,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Pathankot,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,,,,,,,,,,,,,
Pathankot,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,,,,,,,,,,,,,
Pathankot,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,,,,,,,,,,,,,
Pathankot,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,,,,,,,,,,,,,
Pathankot,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Pathankot,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,,,,,,,,,,,,,
Pathankot,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,,,,,,,,,,,,,
Pathankot,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,,
Pathankot,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,,,,,,,,,,,,,
Pathankot,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Pathankot,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,,,,,,,,,,,,,
Pathankot,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,,,,,,,,,,,,,
Pathankot,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,,
Pathankot,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,,,,,,,,,,,,,
Pathankot,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Pathankot,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,,,,,,,,,,,,,
Pathankot,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,,,,,,,,,,,,,
Pathankot,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,,,,,,,,,,,,,
Pathankot,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,,,,,,,,,,,,,
Pathankot,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Pathankot,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,,,,,1.0,,,,,,,,1.0
Pathankot,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Pathankot,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Pathankot,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,,,,,,,,,,,,
Pathankot,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,,,,,1.0,1.0,,2.0,,,,,4.0
Pathankot,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Pathankot,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,,,,,1.0,1.0,,2.0,,,,,4.0
Pathankot,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,,,,1.0,1.0,2.0,1.0,1.0,,1.0,1.0,,8.0
Pathankot,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Pathankot,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,,,,1.0,1.0,2.0,1.0,1.0,,1.0,1.0,,8.0
Pathankot,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,,,,3.0,1.0,,4.0,1.0,2.0,3.0,1.0,2.0,17.0
Pathankot,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,,,1.0,1.0,,1.0,1.0,2.0,,1.0,2.0,9.0
Pathankot,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,,,,4.0,2.0,,5.0,2.0,4.0,3.0,2.0,4.0,26.0
Pathankot,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,,,,,,,1.0,,2.0,,,3.0
Pathankot,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,,,,,,,,,,
Pathankot,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,,,,,,,,1.0,,2.0,,,3.0
Pathankot,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,3.0,,,,,,,,,3.0
Pathankot,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
Pathankot,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,3.0,,,,,,,,,3.0
Pathankot,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,,1.0,,,,,1.0,,,,2.0
Pathankot,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,,,,,,,,,1.0,1.0
Pathankot,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,,,1.0,,,,,1.0,,,1.0,3.0
Pathankot,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Pathankot,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Pathankot,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Pathankot,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,,,,3.0,2.0,1.0,2.0,,3.0,,1.0,,12.0
Pathankot,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,,,,2.0,1.0,,,,2.0,,,,5.0
Pathankot,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,,,,5.0,3.0,1.0,2.0,,5.0,,1.0,,17.0
Pathankot,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
Pathankot,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,,,,,,1.0,,,1.0
Pathankot,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,1.0,,,1.0,,,,,,2.0
Pathankot,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,,1.0,,,1.0,,,1.0,,,3.0
Pathankot,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
Pathankot,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,,1.0,,4.0,1.0,2.0,5.0,1.0,3.0,,1.0,3.0,21.0
Pathankot,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,,,,1.0,4.0,3.0,1.0,3.0,1.0,3.0,1.0,1.0,18.0
Pathankot,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,,1.0,,5.0,5.0,5.0,6.0,4.0,4.0,3.0,2.0,4.0,39.0
Pathankot,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,,,,,,
Pathankot,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,,,,,,2.0,,,1.0,,1.0,,4.0
Pathankot,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,,,,3.0,1.0,2.0,2.0,,2.0,3.0,2.0,4.0,19.0
Pathankot,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,,,,3.0,1.0,4.0,2.0,,3.0,3.0,3.0,4.0,23.0
Pathankot,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
Pathankot,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,,,,,,,,
Pathankot,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
Pathankot,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,,,,,,,,,,
Pathankot,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,,,1.0,,,,,,,1.0
Pathankot,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,,,,7.0,3.0,5.0,7.0,11.0,6.0,8.0,4.0,8.0,59.0
Pathankot,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,,,,26.0,23.0,26.0,27.0,22.0,32.0,28.0,22.0,22.0,228.0
Pathankot,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,,,,33.0,26.0,32.0,34.0,33.0,38.0,36.0,26.0,30.0,288.0
Pathankot,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
Pathankot,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,,,,,,,,,,,
Pathankot,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,,,,
Pathankot,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,,,,,,,,,,,
Pathankot,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,1.0,,,1.0,,,,,2.0
Pathankot,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,,,,20.0,20.0,18.0,10.0,9.0,18.0,9.0,18.0,8.0,130.0
Pathankot,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,1.0,3.0,1.0,26.0,29.0,25.0,31.0,30.0,41.0,40.0,40.0,32.0,299.0
Pathankot,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,1.0,3.0,1.0,46.0,50.0,43.0,41.0,40.0,59.0,49.0,58.0,40.0,431.0
Pathankot,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,,,,,,1.0,1.0
Pathankot,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,,,,,,,,,,,1.0,,1.0
Pathankot,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,,,,1.0,2.0,,1.0,,,,,,4.0
Pathankot,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,,,,1.0,2.0,,1.0,,,,1.0,1.0,6.0
Pathankot,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Pathankot,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
Pathankot,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Pathankot,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
Pathankot,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Pathankot,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,,,,,,,,
Pathankot,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Pathankot,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,,,,,,,,
Pathankot,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Pathankot,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,,,,,,,,,,
Pathankot,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Pathankot,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,,,,,,,,,,,
Pathankot,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Pathankot,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,,,,,,,,,,1.0,1.0
Pathankot,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Pathankot,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,,,,,,,,,,1.0,1.0
Pathankot,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Pathankot,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,2.0,,,,,1.0,,,3.0
Pathankot,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Pathankot,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,2.0,,,,,1.0,,,3.0
Pathankot,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Pathankot,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,,,,,1.0,,1.0,3.0,,,2.0,,7.0
Pathankot,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Pathankot,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,,,,,1.0,,1.0,3.0,,,2.0,,7.0
Pathankot,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,,,1.0,1.0,1.0,,,1.0,,1.0,,5.0
Pathankot,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,,,,6.0,19.0,4.0,7.0,6.0,6.0,5.0,6.0,5.0,64.0
Pathankot,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,,,,3.0,2.0,3.0,,4.0,2.0,2.0,2.0,2.0,20.0
Pathankot,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,,,,10.0,22.0,8.0,7.0,10.0,9.0,7.0,9.0,7.0,89.0
Pathankot,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,,,,,,,,,
Pathankot,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,,,,1.0,2.0,1.0,1.0,,1.0,1.0,1.0,,8.0
Pathankot,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,,,,,,,1.0,,,,,1.0
Pathankot,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,,,,1.0,2.0,1.0,1.0,1.0,1.0,1.0,1.0,,9.0
Pathankot,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,,,,,,,,,,
Pathankot,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,,,1.0,2.0,1.0,,,,,,,4.0
Pathankot,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,,,1.0,,,,,,,,1.0
Pathankot,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,,,,1.0,3.0,1.0,,,,,,,5.0
Pathankot,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,,,,,,,,,,,
Pathankot,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,,1.0,,1.0,1.0,2.0,2.0,1.0,,,1.0,,9.0
Pathankot,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,,,,1.0,3.0,1.0,,1.0,,1.0,1.0,,8.0
Pathankot,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,,1.0,,2.0,4.0,3.0,2.0,2.0,,1.0,2.0,,17.0
Pathankot,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,,,1.0,,,,,,,,,1.0
Pathankot,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,,1.0,,8.0,9.0,2.0,3.0,4.0,11.0,12.0,6.0,6.0,62.0
Pathankot,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,1.0,1.0,1.0,17.0,22.0,21.0,8.0,18.0,18.0,18.0,15.0,10.0,150.0
Pathankot,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,1.0,2.0,1.0,26.0,31.0,23.0,11.0,22.0,29.0,30.0,21.0,16.0,213.0
Pathankot,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,,,,,,,,,,,,,
Pathankot,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,,,,6.0,6.0,2.0,9.0,2.0,6.0,7.0,3.0,8.0,49.0
Pathankot,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,,,1.0,37.0,45.0,24.0,31.0,44.0,61.0,39.0,54.0,34.0,370.0
Pathankot,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,,,1.0,43.0,51.0,26.0,40.0,46.0,67.0,46.0,57.0,42.0,419.0
Patiala,1.1,Total number of pregnant women Registered for ANC,TOTAL,3351.0,3517.0,2843.0,3134.0,3179.0,2668.0,2375.0,2570.0,3431.0,3031.0,3328.0,3007.0,36434.0
Patiala,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,2666.0,2336.0,1906.0,2058.0,2161.0,1737.0,1531.0,1718.0,1751.0,2381.0,2479.0,2121.0,24845.0
Patiala,1.2,Number of Pregnant women registered under JSY,TOTAL,1358.0,1545.0,1247.0,1424.0,1396.0,1087.0,1005.0,1074.0,1006.0,1401.0,1581.0,1271.0,15395.0
Patiala,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,3109.0,3213.0,2979.0,3388.0,3347.0,3112.0,2624.0,2864.0,2668.0,2889.0,3119.0,3089.0,36401.0
Patiala,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,2296.0,2687.0,2187.0,2275.0,2337.0,2106.0,1886.0,1886.0,1752.0,2211.0,2396.0,2190.0,26209.0
Patiala,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,2958.0,2959.0,2928.0,3018.0,2938.0,2813.0,2634.0,2490.0,3320.0,3130.0,3176.0,2853.0,35217.0
Patiala,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,2926.0,3278.0,3245.0,3537.0,3484.0,2826.0,2701.0,2499.0,2761.0,3112.0,3322.0,2879.0,36570.0
Patiala,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,59.0,80.0,57.0,79.0,88.0,81.0,66.0,65.0,78.0,76.0,107.0,65.0,901.0
Patiala,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,8.0,15.0,18.0,7.0,7.0,10.0,24.0,13.0,20.0,13.0,11.0,9.0,155.0
Patiala,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,1787.0,2239.0,1902.0,2026.0,2075.0,2036.0,1775.0,2042.0,2169.0,2664.0,2805.0,2478.0,25998.0
Patiala,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,37.0,23.0,17.0,11.0,26.0,29.0,16.0,32.0,24.0,36.0,30.0,29.0,310.0
Patiala,1.8,Number of pregnancy test kits used at SC level,TOTAL,698.0,756.0,616.0,731.0,741.0,851.0,789.0,943.0,980.0,1003.0,831.0,730.0,9669.0
Patiala,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,12.0,21.0,5.0,18.0,15.0,27.0,25.0,17.0,18.0,12.0,26.0,9.0,205.0
Patiala,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,21.0,15.0,23.0,17.0,21.0,26.0,23.0,20.0,23.0,30.0,23.0,13.0,255.0
Patiala,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,33.0,36.0,28.0,35.0,36.0,53.0,48.0,37.0,41.0,42.0,49.0,22.0,460.0
Patiala,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,27.0,26.0,24.0,33.0,36.0,51.0,47.0,34.0,40.0,36.0,48.0,13.0,415.0
Patiala,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,18.0,12.0,4.0,10.0,12.0,3.0,12.0,18.0,7.0,7.0,10.0,7.0,120.0
Patiala,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,989.0,1004.0,1047.0,1392.0,1638.0,1628.0,1564.0,1502.0,1388.0,1349.0,1140.0,1144.0,15785.0
Patiala,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,403.0,340.0,547.0,436.0,710.0,968.0,786.0,680.0,800.0,702.0,571.0,623.0,7566.0
Patiala,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,537.0,618.0,495.0,589.0,568.0,634.0,438.0,610.0,778.0,692.0,448.0,498.0,6905.0
Patiala,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Patiala,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Patiala,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,910.0,955.0,1162.0,1318.0,1536.0,1589.0,1445.0,1360.0,1304.0,1369.0,1138.0,973.0,15059.0
Patiala,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Patiala,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Patiala,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Patiala,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Patiala,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,18.0,24.0,23.0,30.0,34.0,34.0,15.0,19.0,19.0,28.0,16.0,19.0,279.0
Patiala,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,264.0,248.0,270.0,366.0,422.0,384.0,398.0,379.0,375.0,366.0,321.0,328.0,4121.0
Patiala,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Patiala,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,282.0,272.0,293.0,396.0,456.0,418.0,413.0,398.0,394.0,394.0,337.0,347.0,4400.0
Patiala,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,266.0,273.0,343.0,400.0,468.0,447.0,454.0,416.0,394.0,439.0,365.0,302.0,4567.0
Patiala,4.1.1.a,Number of male live births,TOTAL,1082.0,1091.0,1183.0,1478.0,1757.0,1808.0,1621.0,1554.0,1486.0,1469.0,1197.0,1114.0,16840.0
Patiala,4.1.1.b,Number of female live births,TOTAL,844.0,889.0,1042.0,1251.0,1441.0,1427.0,1425.0,1332.0,1220.0,1270.0,1105.0,1013.0,14259.0
Patiala,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,1926.0,1980.0,2225.0,2729.0,3198.0,3235.0,3046.0,2886.0,2706.0,2739.0,2302.0,2127.0,31099.0
Patiala,4.1.2,Number of still births,TOTAL,30.0,37.0,36.0,38.0,43.0,49.0,44.0,38.0,46.0,40.0,40.0,21.0,462.0
Patiala,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,180.0,167.0,192.0,138.0,169.0,113.0,101.0,198.0,194.0,280.0,182.0,151.0,2065.0
Patiala,4.2.1,Number of Newborns weighed at birth,TOTAL,1919.0,1974.0,2159.0,2721.0,3189.0,3256.0,3037.0,2766.0,2701.0,2687.0,2290.0,2120.0,30819.0
Patiala,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,19.0,269.0,254.0,241.0,231.0,218.0,225.0,209.0,165.0,175.0,141.0,164.0,2311.0
Patiala,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,1809.0,1482.0,1657.0,1922.0,2289.0,2373.0,2234.0,1967.0,1872.0,1870.0,1555.0,1561.0,22591.0
Patiala,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,1.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0
Patiala,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,14.0,26.0,29.0,36.0,38.0,61.0,54.0,27.0,21.0,34.0,19.0,6.0,365.0
Patiala,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,299.0,387.0,454.0,442.0,477.0,418.0,437.0,441.0,417.0,436.0,391.0,369.0,4968.0
Patiala,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Patiala,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,314.0,413.0,483.0,479.0,515.0,479.0,491.0,468.0,438.0,470.0,410.0,375.0,5335.0
Patiala,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,240.0,257.0,360.0,457.0,490.0,435.0,471.0,338.0,410.0,455.0,371.0,344.0,4628.0
Patiala,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,548.0,665.0,824.0,906.0,985.0,836.0,918.0,771.0,682.0,734.0,628.0,582.0,9079.0
Patiala,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,8.0,15.0,20.0,14.0,9.0,3.0,22.0,8.0,18.0,28.0,23.0,11.0,179.0
Patiala,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,522.0,555.0,654.0,736.0,714.0,616.0,757.0,483.0,514.0,466.0,417.0,398.0,6832.0
Patiala,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,64.0,92.0,97.0,126.0,129.0,124.0,119.0,100.0,120.0,110.0,180.0,158.0,1419.0
Patiala,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,1932.0,1989.0,2105.0,2488.0,2680.0,2774.0,2731.0,2449.0,2487.0,2567.0,2073.0,2013.0,28288.0
Patiala,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,1210.0,1267.0,1455.0,1684.0,2035.0,2133.0,1975.0,1935.0,1858.0,1887.0,1828.0,1520.0,20787.0
Patiala,6.3,PNC maternal complications attended,TOTAL,1.0,0.0,0.0,47.0,51.0,39.0,36.0,45.0,39.0,12.0,27.0,33.0,330.0
Patiala,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,60.0,55.0,53.0,47.0,41.0,38.0,19.0,90.0,32.0,28.0,41.0,47.0,551.0
Patiala,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,4.0,6.0,0.0,0.0,0.0,0.0,10.0
Patiala,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,60.0,55.0,53.0,47.0,41.0,38.0,23.0,96.0,32.0,28.0,41.0,47.0,561.0
Patiala,7.2,Number of MTPs conducted at Private Facilities,TOTAL,69.0,55.0,59.0,40.0,72.0,43.0,37.0,53.0,113.0,197.0,59.0,57.0,854.0
Patiala,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,40.0,21.0,43.0,28.0,27.0,40.0,36.0,27.0,43.0,43.0,37.0,53.0,438.0
Patiala,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,305.0,221.0,354.0,352.0,289.0,322.0,316.0,440.0,406.0,435.0,399.0,417.0,4256.0
Patiala,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,345.0,242.0,397.0,380.0,316.0,362.0,352.0,467.0,449.0,478.0,436.0,470.0,4694.0
Patiala,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Patiala,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,1.0,0.0,2.0,2.0,1.0,1.0,2.0,2.0,0.0,0.0,0.0,1.0,12.0
Patiala,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,6.0,5.0,14.0,5.0,15.0,7.0,6.0,21.0,5.0,6.0,6.0,5.0,101.0
Patiala,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,2.0,4.0,1.0,2.0,5.0,6.0,0.0,6.0,2.0,1.0,0.0,0.0,29.0
Patiala,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Patiala,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,9.0,9.0,17.0,9.0,21.0,14.0,8.0,29.0,7.0,7.0,6.0,6.0,142.0
Patiala,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Patiala,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,32.0,53.0,70.0,23.0,26.0,22.0,24.0,26.0,23.0,2.0,5.0,31.0,337.0
Patiala,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,191.0,294.0,418.0,131.0,151.0,156.0,67.0,185.0,112.0,98.0,160.0,139.0,2102.0
Patiala,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,74.0,120.0,144.0,108.0,49.0,66.0,45.0,59.0,37.0,22.0,42.0,63.0,829.0
Patiala,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Patiala,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,297.0,467.0,632.0,262.0,226.0,244.0,136.0,270.0,172.0,122.0,207.0,233.0,3268.0
Patiala,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,0.0,2.0,5.0,10.0,3.0,1.0,5.0,6.0,6.0,224.0,76.0,68.0,406.0
Patiala,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Patiala,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,1.0,0.0,0.0,3.0,3.0,0.0,1.0,3.0,1.0,7.0,2.0,2.0,23.0
Patiala,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,26.0,3.0,33.0,0.0,0.0,0.0,0.0,0.0,18.0,10.0,12.0,10.0,112.0
Patiala,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Patiala,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,27.0,3.0,33.0,3.0,3.0,0.0,1.0,3.0,19.0,17.0,14.0,12.0,135.0
Patiala,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Patiala,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Patiala,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,0.0,4.0,3.0,4.0,5.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,17.0
Patiala,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,40.0,40.0,42.0,43.0,59.0,43.0,52.0,56.0,39.0,39.0,40.0,37.0,530.0
Patiala,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Patiala,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,40.0,44.0,45.0,47.0,64.0,44.0,52.0,56.0,39.0,39.0,40.0,37.0,547.0
Patiala,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,100.0,96.0,196.0
Patiala,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,1109.0,1129.0,1080.0,1190.0,1104.0,1145.0,1106.0,1055.0,1046.0,1045.0,1034.0,845.0,12888.0
Patiala,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Patiala,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,10.0,16.0,0.0,14.0,13.0,15.0,10.0,0.0,10.0,12.0,13.0,14.0,127.0
Patiala,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,231.0,217.0,309.0,248.0,291.0,232.0,233.0,227.0,259.0,231.0,271.0,201.0,2950.0
Patiala,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Patiala,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,1350.0,1362.0,1389.0,1452.0,1408.0,1392.0,1349.0,1282.0,1315.0,1288.0,1318.0,1060.0,15965.0
Patiala,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,46.0,30.0,51.0,81.0,120.0,58.0,85.0,77.0,113.0,88.0,108.0,82.0,939.0
Patiala,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,325.0,355.0,227.0,253.0,262.0,299.0,276.0,117.0,13.0,2.0,4.0,2.0,2135.0
Patiala,9.06,Number of IUCD removals,TOTAL,274.0,227.0,238.0,217.0,202.0,175.0,214.0,186.0,187.0,207.0,221.0,189.0,2537.0
Patiala,9.07,Number of Oral Pills cycles distributed,TOTAL,8169.0,8119.0,8499.0,8398.0,8733.0,9814.0,10150.0,9398.0,8529.0,8632.0,9412.0,8417.0,106270.0
Patiala,9.08,Number of Condom pieces distributed,TOTAL,170146.0,136354.0,149269.0,173499.0,190474.0,198336.0,202059.0,171300.0,142451.0,147279.0,147846.0,129332.0,1958345.0
Patiala,9.09,Number of Centchroman (weekly) pills given,TOTAL,0.0,11.0,0.0,0.0,0.0,12.0,11.0,8.0,0.0,0.0,0.0,13.0,55.0
Patiala,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,20.0,4.0,8.0,36.0,29.0,22.0,49.0,25.0,44.0,17.0,15.0,21.0,290.0
Patiala,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Patiala,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Patiala,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Patiala,9.11.2.b,Number of failures following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Patiala,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Patiala,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Patiala,9.12,Number of Institutions having NSV trained doctors,TOTAL,5.0,1.0,4.0,4.0,5.0,5.0,5.0,5.0,6.0,5.0,5.0,5.0,-1.0
Patiala,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,2231.0,3033.0,2562.0,3034.0,3673.0,3401.0,3239.0,3189.0,2860.0,2969.0,2578.0,2473.0,35242.0
Patiala,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,2087.0,2264.0,1891.0,2211.0,2250.0,2441.0,2588.0,2892.0,2612.0,1906.0,232.0,106.0,23480.0
Patiala,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,2269.0,2388.0,2040.0,2019.0,2196.0,2071.0,2350.0,2624.0,2714.0,2490.0,1950.0,524.0,25635.0
Patiala,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,2354.0,2776.0,2464.0,2584.0,2535.0,2499.0,2517.0,2793.0,2922.0,3104.0,2985.0,1640.0,31173.0
Patiala,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,996.0,2231.0,2101.0,5328.0
Patiala,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,6.0,781.0,1818.0,2605.0
Patiala,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.0,72.0,896.0,971.0
Patiala,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,1720.0,1866.0,1766.0,2227.0,2709.0,2667.0,2753.0,2669.0,2389.0,2527.0,2108.0,2055.0,27456.0
Patiala,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,2087.0,2264.0,1891.0,2211.0,2250.0,2441.0,2588.0,2892.0,2612.0,2364.0,2055.0,2207.0,27862.0
Patiala,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,2269.0,2388.0,2040.0,2019.0,2196.0,2071.0,2350.0,2624.0,2714.0,2492.0,2510.0,2342.0,28015.0
Patiala,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,2354.0,2776.0,2464.0,2584.0,2535.0,2499.0,2517.0,2793.0,2922.0,3104.0,3017.0,2525.0,32090.0
Patiala,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,1429.0,1601.0,1568.0,1991.0,2405.0,2340.0,2360.0,2354.0,2116.0,2232.0,1601.0,1195.0,23192.0
Patiala,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,2087.0,2264.0,1891.0,2211.0,2250.0,2441.0,2588.0,2892.0,2612.0,1906.0,232.0,106.0,23480.0
Patiala,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,2269.0,2388.0,2040.0,2019.0,2196.0,2071.0,2350.0,2624.0,2714.0,2490.0,1948.0,524.0,25633.0
Patiala,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,2354.0,2776.0,2464.0,2584.0,2535.0,2499.0,2517.0,2793.0,2922.0,3104.0,2985.0,1640.0,31173.0
Patiala,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,2192.0,2800.0,2785.0,3046.0,3177.0,3165.0,2337.0,2521.0,2314.0,2140.0,2118.0,1921.0,30516.0
Patiala,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,2348.0,2668.0,2346.0,2405.0,2234.0,2177.0,1919.0,2156.0,2090.0,2119.0,2468.0,2282.0,27212.0
Patiala,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Patiala,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1169.0,1481.0,1471.0,1618.0,1671.0,1685.0,1281.0,1351.0,1202.0,1161.0,1164.0,1028.0,16282.0
Patiala,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1023.0,1311.0,1312.0,1422.0,1504.0,1477.0,1053.0,1165.0,1106.0,975.0,955.0,893.0,14196.0
Patiala,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,2192.0,2792.0,2783.0,3040.0,3175.0,3162.0,2334.0,2516.0,2308.0,2136.0,2119.0,1921.0,30478.0
Patiala,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,2370.0,2670.0,2340.0,2421.0,2253.0,2176.0,1945.0,2196.0,2097.0,2115.0,2488.0,2278.0,27349.0
Patiala,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,2370.0,2670.0,2340.0,2421.0,2253.0,2176.0,1945.0,2196.0,2095.0,2115.0,2488.0,2278.0,27347.0
Patiala,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,6.0,5.0,0.0,0.0,0.0,0.0,11.0
Patiala,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,0.0,2.0,2.0,3.0,1.0,2.0,1.0,1.0,3.0,2.0,0.0,0.0,17.0
Patiala,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,0.0,6.0,0.0,3.0,1.0,1.0,2.0,2.0,3.0,2.0,0.0,0.0,20.0
Patiala,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,0.0,8.0,2.0,6.0,2.0,3.0,3.0,3.0,6.0,4.0,0.0,0.0,37.0
Patiala,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,2114.0,3301.0,2217.0,2734.0,2507.0,2497.0,2316.0,2585.0,2304.0,2353.0,2222.0,2082.0,29232.0
Patiala,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,1689.0,4191.0,1933.0,2677.0,2811.0,2587.0,2424.0,2309.0,2027.0,2162.0,1919.0,1684.0,28413.0
Patiala,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,1347.0,2690.0,1575.0,2560.0,2840.0,1918.0,2336.0,2258.0,1804.0,2074.0,2023.0,1461.0,24886.0
Patiala,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Patiala,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Patiala,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Patiala,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,943.0,967.0,945.0,945.0,964.0,951.0,971.0,999.0,1001.0,986.0,998.0,973.0,11643.0
Patiala,10.4.2,Number of Immunisation sessions held during the month,TOTAL,944.0,968.0,943.0,937.0,959.0,941.0,969.0,996.0,998.0,984.0,997.0,802.0,11438.0
Patiala,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,740.0,739.0,736.0,731.0,742.0,738.0,780.0,788.0,783.0,780.0,782.0,609.0,8948.0
Patiala,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Patiala,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,2076.0,2671.0,2650.0,2926.0,3077.0,2997.0,2096.0,2110.0,1961.0,1904.0,1866.0,1718.0,28052.0
Patiala,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,1837.0,1827.0,1439.0,1429.0,1444.0,1521.0,1413.0,1514.0,1346.0,1393.0,1423.0,1496.0,18082.0
Patiala,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,2047.0,2714.0,2023.0,2413.0,2247.0,2209.0,2120.0,2138.0,1806.0,1908.0,1865.0,1590.0,25080.0
Patiala,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Patiala,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Patiala,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Patiala,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Patiala,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Patiala,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Patiala,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,463.0,495.0,95.0,455.0,683.0,841.0,365.0,347.0,163.0,510.0,412.0,655.0,5484.0
Patiala,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Patiala,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,67.0,129.0,246.0,451.0,471.0,525.0,545.0,518.0,375.0,994.0,203.0,50.0,4574.0
Patiala,13.1,Number of Patients operated for cataract,TOTAL,473.0,348.0,326.0,296.0,260.0,396.0,354.0,1015.0,327.0,280.0,335.0,495.0,4905.0
Patiala,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,459.0,339.0,326.0,289.0,250.0,396.0,346.0,1014.0,327.0,280.0,335.0,484.0,4845.0
Patiala,13.3,Number of School children detected with Refractive errors,TOTAL,343.0,562.0,0.0,449.0,265.0,137.0,764.0,811.0,442.0,462.0,247.0,114.0,4596.0
Patiala,13.4,Number of children provided free glasses,TOTAL,151.0,57.0,0.0,408.0,180.0,175.0,254.0,476.0,1079.0,667.0,203.0,309.0,3959.0
Patiala,13.5,Number of eyes collected through eye donation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Patiala,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Patiala,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,13.0,9.0,11.0,12.0,10.0,10.0,12.0,10.0,11.0,11.0,11.0,11.0,-1.0
Patiala,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,,6.0,8.0,6.0,7.0,5.0,5.0,5.0,7.0,5.0,5.0,5.0,-1.0
Patiala,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,737.0,737.0,759.0,748.0,754.0,760.0,786.0,789.0,795.0,793.0,794.0,661.0,-1.0
Patiala,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,12.0,9.0,11.0,11.0,9.0,9.0,11.0,9.0,9.0,9.0,9.0,10.0,-1.0
Patiala,14.05,Number of RKS meetings held during the month,TOTAL,2.0,1.0,2.0,3.0,3.0,3.0,5.0,5.0,3.0,2.0,5.0,5.0,39.0
Patiala,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,9.0,8.0,10.0,12.0,10.0,10.0,12.0,10.0,10.0,9.0,11.0,12.0,-1.0
Patiala,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,43.0,83.0,91.0,77.0,128.0,174.0,133.0,74.0,55.0,40.0,42.0,66.0,1006.0
Patiala,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,7.0,3.0,6.0,9.0,9.0,8.0,11.0,10.0,9.0,9.0,9.0,9.0,-1.0
Patiala,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,6.0,9.0,7.0,7.0,7.0,7.0,7.0,7.0,7.0,6.0,6.0,6.0,-1.0
Patiala,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,672.0,764.0,733.0,739.0,809.0,1039.0,785.0,762.0,692.0,705.0,736.0,351.0,8787.0
Patiala,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,1811.0,1354.0,1498.0,2290.0,1743.0,1309.0,968.0,993.0,793.0,838.0,1297.0,1596.0,16490.0
Patiala,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,480.0,657.0,617.0,589.0,684.0,770.0,805.0,686.0,643.0,602.0,619.0,925.0,8077.0
Patiala,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,3335.0,4195.0,4539.0,5083.0,4731.0,4499.0,3932.0,3919.0,3726.0,3461.0,3859.0,3342.0,48621.0
Patiala,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,1152.0,1421.0,1350.0,1328.0,1493.0,1809.0,1590.0,1448.0,1335.0,1307.0,1355.0,1276.0,16864.0
Patiala,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,5146.0,5549.0,6037.0,7373.0,6474.0,5808.0,4900.0,4912.0,4519.0,4299.0,5156.0,4938.0,65111.0
Patiala,14.10.2.a,Number of death cases of Inpatient males,TOTAL,4.0,3.0,8.0,6.0,6.0,2.0,2.0,6.0,5.0,3.0,6.0,6.0,57.0
Patiala,14.10.2.b,Number of death cases of Inpatient females,TOTAL,4.0,1.0,6.0,5.0,2.0,2.0,3.0,2.0,3.0,2.0,4.0,2.0,36.0
Patiala,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,8.0,4.0,14.0,11.0,8.0,4.0,5.0,8.0,8.0,5.0,10.0,8.0,93.0
Patiala,14.11,In-Patient Head Count at midnight,TOTAL,1581.0,391.0,670.0,1816.0,1682.0,1399.0,1097.0,1406.0,1135.0,1053.0,1572.0,1521.0,15323.0
Patiala,14.12.1,OPD attendance (All),TOTAL,131127.0,142408.0,147772.0,142543.0,147717.0,132951.0,118306.0,123769.0,119365.0,115524.0,133515.0,146703.0,1601700.0
Patiala,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,965.0,1018.0,1071.0,1182.0,1309.0,1153.0,1122.0,1109.0,1092.0,911.0,981.0,1034.0,12947.0
Patiala,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,4.0,13.0,0.0,0.0,14.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,31.0
Patiala,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,2244.0,2665.0,2409.0,2520.0,2577.0,2604.0,2339.0,2533.0,1974.0,2254.0,2189.0,2489.0,28797.0
Patiala,14.14.a,Number of patients given AYUSH treatment,TOTAL,8394.0,7740.0,9202.0,8963.0,12160.0,13338.0,11366.0,12932.0,13130.0,13881.0,11195.0,11155.0,133456.0
Patiala,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,3514.0,4778.0,5563.0,2624.0,3611.0,4766.0,4519.0,4491.0,4122.0,4378.0,4421.0,4100.0,50887.0
Patiala,14.14.c,Number of Adolescents counselled,TOTAL,463.0,699.0,638.0,406.0,575.0,528.0,573.0,550.0,571.0,595.0,683.0,465.0,6746.0
Patiala,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,9950.0,12198.0,14978.0,13167.0,12954.0,12822.0,18173.0,9263.0,8750.0,8129.0,8839.0,9903.0,139126.0
Patiala,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,122.0,123.0,835.0,605.0,565.0,705.0,123.0,117.0,114.0,182.0,86.0,152.0,3729.0
Patiala,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,459.0,514.0,323.0,438.0,548.0,525.0,486.0,499.0,817.0,438.0,351.0,416.0,5814.0
Patiala,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,5.0,12.0,7.0,6.0,12.0,14.0,5.0,10.0,8.0,8.0,7.0,7.0,101.0
Patiala,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,493.0,631.0,559.0,557.0,528.0,487.0,340.0,555.0,454.0,582.0,425.0,506.0,6117.0
Patiala,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,2.0,8.0,2.0,5.0,7.0,8.0,3.0,5.0,2.0,3.0,2.0,1.0,48.0
Patiala,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,1703.0,1895.0,1296.0,1551.0,1542.0,1374.0,1055.0,1425.0,1187.0,1440.0,1552.0,1599.0,17619.0
Patiala,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,1.0,2.0,2.0,2.0,22.0,19.0,15.0,17.0,1.0,0.0,15.0,2.0,98.0
Patiala,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,2655.0,3040.0,2178.0,2546.0,2618.0,2386.0,1881.0,2479.0,2458.0,2460.0,2328.0,2521.0,29550.0
Patiala,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,8.0,22.0,11.0,13.0,41.0,41.0,23.0,32.0,11.0,11.0,24.0,10.0,247.0
Patiala,15.2,Number of Widal tests conducted,Number tested,623.0,864.0,462.0,466.0,762.0,733.0,454.0,457.0,591.0,374.0,512.0,967.0,7265.0
Patiala,15.3.a,Number of VDRL tests conducted on males,Number tested,30.0,49.0,47.0,191.0,133.0,118.0,90.0,173.0,124.0,143.0,171.0,186.0,1455.0
Patiala,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,56.0,103.0,50.0,134.0,62.0,62.0,36.0,232.0,221.0,218.0,195.0,316.0,1685.0
Patiala,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,1075.0,1061.0,842.0,962.0,949.0,1036.0,590.0,1181.0,1142.0,1186.0,1280.0,1783.0,13087.0
Patiala,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,1161.0,1213.0,939.0,1287.0,1144.0,1216.0,716.0,1586.0,1487.0,1547.0,1646.0,2285.0,16227.0
Patiala,15.4.1,Number of blood smears examined for Malaria,TOTAL,8109.0,8617.0,5357.0,6784.0,7573.0,7083.0,6529.0,9050.0,8817.0,7422.0,8945.0,9633.0,93919.0
Patiala,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,0.0,4.0,2.0,3.0,5.0,4.0,1.0,1.0,1.0,1.0,0.0,0.0,22.0
Patiala,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Patiala,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,470.0,23770.0,24910.0,35550.0,20200.0,22150.0,20710.0,18820.0,11090.0,19950.0,9850.0,16080.0,223550.0
Patiala,16.1.1,Stock position of DPT vaccines,2. Stocks Received,35000.0,20000.0,20000.0,0.0,10000.0,16000.0,10000.0,8000.0,20000.0,0.0,15000.0,0.0,154000.0
Patiala,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Patiala,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,11700.0,18860.0,9360.0,15350.0,8050.0,17440.0,11890.0,15730.0,11140.0,10100.0,8770.0,6990.0,145380.0
Patiala,16.1.1,Stock position of DPT vaccines,5. Total Stock,23770.0,24910.0,35550.0,20200.0,22150.0,20710.0,18820.0,11090.0,19950.0,9850.0,16080.0,9090.0,232170.0
Patiala,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,17130.0,17130.0
Patiala,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,30000.0,,30000.0
Patiala,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Patiala,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,12870.0,4730.0,17600.0
Patiala,16.1.1A,Stock Position of Pentavalent,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,17130.0,12400.0,29530.0
Patiala,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,30700.0,22160.0,19460.0,27740.0,8720.0,16200.0,7080.0,12540.0,1320.0,3680.0,3400.0,0.0,153000.0
Patiala,16.1.2,Stock position of OPV vaccines,2. Stocks Received,5000.0,20000.0,20000.0,0.0,20000.0,10000.0,24000.0,3000.0,20000.0,10000.0,0.0,29840.0,161840.0
Patiala,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Patiala,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,13540.0,22700.0,11720.0,19020.0,12520.0,19120.0,18540.0,14220.0,17640.0,10280.0,3400.0,10640.0,173340.0
Patiala,16.1.2,Stock position of OPV vaccines,5. Total Stock,22160.0,19460.0,27740.0,8720.0,16200.0,7080.0,12540.0,1320.0,3680.0,3400.0,0.0,19200.0,141500.0
Patiala,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,7400.0,36290.0,19930.0,21540.0,6710.0,17390.0,19340.0,30340.0,28100.0,23380.0,15050.0,12350.0,237820.0
Patiala,16.1.3,Stock position of TT vaccines,2. Stocks Received,35000.0,0.0,10000.0,0.0,20000.0,20000.0,20000.0,10000.0,5000.0,0.0,5000.0,10000.0,135000.0
Patiala,16.1.3,Stock position of TT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Patiala,16.1.3,Stock position of TT vaccines,4. Stock Distributed,6110.0,16360.0,8390.0,14830.0,9320.0,18050.0,9000.0,12240.0,9720.0,8330.0,7700.0,5690.0,125740.0
Patiala,16.1.3,Stock position of TT vaccines,5. Total Stock,36290.0,19930.0,21540.0,6710.0,17390.0,19340.0,30340.0,28100.0,23380.0,15050.0,12350.0,16660.0,247080.0
Patiala,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Patiala,16.1.4,Stock position of DT vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Patiala,16.1.4,Stock position of DT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Patiala,16.1.4,Stock position of DT vaccines,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Patiala,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Patiala,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,140.0,1070.0,5490.0,9210.0,1340.0,5910.0,8710.0,15360.0,18060.0,14970.0,9180.0,8340.0,97780.0
Patiala,16.1.5,Stock position of BCG vaccines,2. Stocks Received,6000.0,10000.0,8000.0,0.0,10000.0,10000.0,15000.0,10000.0,4000.0,0.0,5000.0,5000.0,83000.0
Patiala,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Patiala,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,5070.0,5580.0,4280.0,7870.0,5430.0,7200.0,8350.0,7300.0,7090.0,5790.0,5840.0,4540.0,74340.0
Patiala,16.1.5,Stock position of BCG vaccines,5. Total Stock,1070.0,5490.0,9210.0,1340.0,5910.0,8710.0,15360.0,18060.0,14970.0,9180.0,8340.0,8800.0,106440.0
Patiala,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,4980.0,14820.0,11090.0,10320.0,4170.0,4785.0,665.0,4215.0,6585.0,12085.0,6230.0,5390.0,85335.0
Patiala,16.1.6,Stock position of Measles vaccines,2. Stocks Received,15000.0,5000.0,5000.0,0.0,5000.0,1000.0,8000.0,10000.0,12000.0,0.0,5000.0,5000.0,71000.0
Patiala,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Patiala,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,5160.0,8730.0,5770.0,6150.0,4385.0,5120.0,4450.0,7630.0,6500.0,5855.0,5840.0,4380.0,69970.0
Patiala,16.1.6,Stock position of Measles vaccines,5. Total Stock,14820.0,11090.0,10320.0,4170.0,4785.0,665.0,4215.0,6585.0,12085.0,6230.0,5390.0,6010.0,86365.0
Patiala,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Patiala,16.1.7,Stock position of JE vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Patiala,16.1.7,Stock position of JE vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Patiala,16.1.7,Stock position of JE vaccines,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Patiala,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Patiala,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,2240.0,8430.0,3460.0,13690.0,1290.0,13000.0,4280.0,3690.0,530.0,10660.0,2870.0,2610.0,66750.0
Patiala,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,15000.0,10000.0,15000.0,0.0,20000.0,5000.0,10000.0,5000.0,20000.0,2000.0,7000.0,5000.0,114000.0
Patiala,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Patiala,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,8810.0,14970.0,4770.0,12400.0,8290.0,13720.0,10590.0,8160.0,9870.0,9790.0,7260.0,4690.0,113320.0
Patiala,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,8430.0,3460.0,13690.0,1290.0,13000.0,4280.0,3690.0,530.0,10660.0,2870.0,2610.0,2920.0,67430.0
Patiala,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,5400.0,5350.0,18188.0,18188.0,18088.0,18000.0,17050.0,17050.0,15800.0,13900.0,11600.0,6200.0,164814.0
Patiala,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,0.0,13788.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,13788.0
Patiala,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Patiala,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,50.0,950.0,0.0,100.0,88.0,950.0,0.0,1250.0,1900.0,2300.0,5400.0,2400.0,15388.0
Patiala,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,5350.0,18188.0,18188.0,18088.0,18000.0,17050.0,17050.0,15800.0,13900.0,11600.0,6200.0,3800.0,163214.0
Patiala,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,4000.0,2000.0,0.0,0.0,0.0,0.0,94000.0,77000.0,30000.0,86000.0,30000.0,5000.0,328000.0
Patiala,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,126000.0,0.0,0.0,78000.0,0.0,0.0,0.0,204000.0
Patiala,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Patiala,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,2000.0,2000.0,0.0,0.0,0.0,32000.0,17000.0,47000.0,22000.0,56000.0,25000.0,5000.0,208000.0
Patiala,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,2000.0,0.0,0.0,0.0,0.0,94000.0,77000.0,30000.0,86000.0,30000.0,5000.0,0.0,324000.0
Patiala,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,7500.0,5500.0,100.0,0.0,0.0,13800.0,10800.0,8800.0,5100.0,4400.0,0.0,11500.0,67500.0
Patiala,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,16100.0,0.0,0.0,0.0,0.0,0.0,13900.0,0.0,30000.0
Patiala,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Patiala,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,2000.0,5400.0,100.0,0.0,2300.0,3000.0,2000.0,3700.0,700.0,4400.0,2400.0,3800.0,29800.0
Patiala,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,5500.0,100.0,0.0,0.0,13800.0,10800.0,8800.0,5100.0,4400.0,0.0,11500.0,7700.0,67700.0
Patiala,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,300.0,300.0,300.0,240.0,240.0,330.0,0.0,0.0,280.0,220.0,0.0,250.0,2460.0
Patiala,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,150.0,0.0,0.0,330.0,0.0,0.0,250.0,0.0,730.0
Patiala,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Patiala,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,0.0,0.0,60.0,0.0,60.0,330.0,0.0,50.0,60.0,220.0,0.0,100.0,880.0
Patiala,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,300.0,300.0,240.0,240.0,330.0,0.0,0.0,280.0,220.0,0.0,250.0,150.0,2310.0
Patiala,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Patiala,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Patiala,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Patiala,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Patiala,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Patiala,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Patiala,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Patiala,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Patiala,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Patiala,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Patiala,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Patiala,16.3.02,Stock Position of Gloves,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Patiala,16.3.02,Stock Position of Gloves,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Patiala,16.3.02,Stock Position of Gloves,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Patiala,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Patiala,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Patiala,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Patiala,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Patiala,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Patiala,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Patiala,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Patiala,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Patiala,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Patiala,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Patiala,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Patiala,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Patiala,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Patiala,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Patiala,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Patiala,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Patiala,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Patiala,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Patiala,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Patiala,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Patiala,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Patiala,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Patiala,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Patiala,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Patiala,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Patiala,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Patiala,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Patiala,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Patiala,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Patiala,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Patiala,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Patiala,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Patiala,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Patiala,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Patiala,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Patiala,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Patiala,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Patiala,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Patiala,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Patiala,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Patiala,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Patiala,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Patiala,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Patiala,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Patiala,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Patiala,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Patiala,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,3160.0,2760.0,0.0,2025.0,0.0,2300.0,1550.0,3050.0,200.0,3200.0,150.0,0.0,18395.0
Patiala,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,2000.0,0.0,4000.0,0.0,4000.0,2000.0,4000.0,0.0,4000.0,0.0,0.0,6000.0,26000.0
Patiala,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Patiala,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,2400.0,2760.0,1975.0,2025.0,1700.0,2750.0,2500.0,2850.0,1000.0,3050.0,150.0,3180.0,26340.0
Patiala,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,2760.0,0.0,2025.0,0.0,2300.0,1550.0,3050.0,200.0,3200.0,150.0,0.0,2820.0,18055.0
Patiala,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,57800.0,42800.0,68000.0,98600.0,71600.0,66800.0,104800.0,66000.0,34400.0,22800.0,78000.0,71000.0,782600.0
Patiala,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,0.0,70000.0,50000.0,0.0,0.0,60000.0,0.0,0.0,0.0,100000.0,0.0,0.0,280000.0
Patiala,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Patiala,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,15000.0,44800.0,19400.0,27000.0,4800.0,22000.0,38800.0,31600.0,11600.0,44800.0,7000.0,19400.0,286200.0
Patiala,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,42800.0,68000.0,98600.0,71600.0,66800.0,104800.0,66000.0,34400.0,22800.0,78000.0,71000.0,51600.0,776400.0
Patiala,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,1700.0,900.0,0.0,2100.0,1100.0,2800.0,850.0,4350.0,2650.0,3050.0,3520.0,1870.0,24890.0
Patiala,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,0.0,0.0,2400.0,0.0,2400.0,0.0,4800.0,0.0,2400.0,2400.0,0.0,2400.0,16800.0
Patiala,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Patiala,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,800.0,900.0,300.0,1000.0,700.0,1950.0,1300.0,1700.0,2000.0,1930.0,1650.0,1000.0,15230.0
Patiala,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,900.0,0.0,2100.0,1100.0,2800.0,850.0,4350.0,2650.0,3050.0,3520.0,1870.0,3270.0,26460.0
Patiala,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,1.0,,,1.0,,,,,,,,,2.0
Patiala,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Patiala,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Patiala,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,,,,,,,,,,,,
Patiala,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Patiala,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Patiala,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,,,,,,,,,,,,,
Patiala,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,,,1.0,,,,,,,,1.0,,2.0
Patiala,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Patiala,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,,,1.0,,,,,,,,1.0,,2.0
Patiala,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,2.0,,,,1.0,,,2.0,2.0,1.0,1.0,,9.0
Patiala,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,1.0,,,1.0,,,1.0,,1.0,,,4.0
Patiala,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,2.0,1.0,,,2.0,,,3.0,2.0,2.0,1.0,,13.0
Patiala,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,1.0,,,,,,,,1.0,,,,2.0
Patiala,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,,,,,,,,1.0,,1.0
Patiala,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,1.0,,,,,,,,1.0,,1.0,,3.0
Patiala,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,,,,,,
Patiala,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,1.0,,,1.0,,,,,,,,2.0
Patiala,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,1.0,,,1.0,,,,,,,,2.0
Patiala,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,,,,1.0,,1.0,,,,1.0,3.0
Patiala,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,,,1.0,,,,,,,1.0
Patiala,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,,,,,2.0,,1.0,,,,1.0,4.0
Patiala,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Patiala,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Patiala,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Patiala,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,4.0,2.0,2.0,,,,,3.0,3.0,,,,14.0
Patiala,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,7.0,3.0,1.0,1.0,1.0,,,,1.0,1.0,,1.0,16.0
Patiala,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,11.0,5.0,3.0,1.0,1.0,,,3.0,4.0,1.0,,1.0,30.0
Patiala,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
Patiala,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,,,,,,,,,
Patiala,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,,,,,,,,,
Patiala,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,,,,,,,,,,,
Patiala,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
Patiala,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,1.0,4.0,3.0,,1.0,1.0,1.0,3.0,,6.0,4.0,1.0,25.0
Patiala,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,,,1.0,3.0,2.0,1.0,1.0,3.0,1.0,,,2.0,14.0
Patiala,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,1.0,4.0,4.0,3.0,3.0,2.0,2.0,6.0,1.0,6.0,4.0,3.0,39.0
Patiala,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,,,,,,
Patiala,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,,1.0,2.0,3.0,2.0,2.0,2.0,1.0,4.0,4.0,,1.0,22.0
Patiala,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,,2.0,1.0,1.0,3.0,5.0,,3.0,2.0,1.0,4.0,6.0,28.0
Patiala,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,,3.0,3.0,4.0,5.0,7.0,2.0,4.0,6.0,5.0,4.0,7.0,50.0
Patiala,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
Patiala,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,,,,,,,,
Patiala,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
Patiala,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,,,,,,,,,,
Patiala,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,,,,2.0,,1.0,,,,3.0
Patiala,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,1.0,2.0,,,4.0,1.0,1.0,4.0,3.0,3.0,3.0,,22.0
Patiala,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,1.0,6.0,2.0,,2.0,,,5.0,4.0,8.0,5.0,,33.0
Patiala,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,2.0,8.0,2.0,,6.0,1.0,3.0,9.0,8.0,11.0,8.0,,58.0
Patiala,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
Patiala,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,1.0,,,,1.0,,,,2.0,,4.0
Patiala,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,,,,
Patiala,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,1.0,,,,1.0,,,,2.0,,4.0
Patiala,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,1.0,,,,1.0,,,,2.0
Patiala,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,23.0,33.0,20.0,23.0,34.0,18.0,19.0,32.0,26.0,25.0,25.0,22.0,300.0
Patiala,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,37.0,44.0,36.0,41.0,31.0,25.0,36.0,42.0,35.0,42.0,35.0,20.0,424.0
Patiala,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,60.0,77.0,56.0,64.0,66.0,43.0,55.0,74.0,62.0,67.0,60.0,42.0,726.0
Patiala,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,1.0,,,,,,,,,,,1.0
Patiala,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,1.0,2.0,4.0,4.0,2.0,1.0,,4.0,4.0,3.0,3.0,,28.0
Patiala,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,3.0,2.0,3.0,2.0,5.0,1.0,,4.0,3.0,3.0,9.0,,35.0
Patiala,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,4.0,5.0,7.0,6.0,7.0,2.0,,8.0,7.0,6.0,12.0,,64.0
Patiala,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Patiala,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
Patiala,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Patiala,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
Patiala,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Patiala,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,,,,,,,,
Patiala,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Patiala,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,,,,,,,,
Patiala,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Patiala,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,,,,,,,,,,
Patiala,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Patiala,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,,,,,,,,,,,
Patiala,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Patiala,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,,,,,,1.0,,,,,1.0
Patiala,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Patiala,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,,,,,,1.0,,,,,1.0
Patiala,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Patiala,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,1.0,,,,1.0,1.0,,1.0,,,4.0
Patiala,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Patiala,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,1.0,,,,1.0,1.0,,1.0,,,4.0
Patiala,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Patiala,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,3.0,3.0,4.0,1.0,2.0,9.0,3.0,2.0,1.0,3.0,1.0,1.0,33.0
Patiala,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Patiala,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,3.0,3.0,4.0,1.0,2.0,9.0,3.0,2.0,1.0,3.0,1.0,1.0,33.0
Patiala,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,,1.0,,3.0,,1.0,1.0,1.0,,1.0,1.0,9.0
Patiala,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,3.0,19.0,9.0,19.0,19.0,16.0,16.0,19.0,13.0,14.0,8.0,7.0,162.0
Patiala,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,2.0,4.0,5.0,3.0,2.0,2.0,4.0,11.0,5.0,2.0,1.0,3.0,44.0
Patiala,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,5.0,23.0,15.0,22.0,24.0,18.0,21.0,31.0,19.0,16.0,10.0,11.0,215.0
Patiala,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,,,,,,,,,
Patiala,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,2.0,5.0,3.0,8.0,2.0,,2.0,2.0,3.0,3.0,3.0,4.0,37.0
Patiala,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,1.0,,,,1.0,1.0,,1.0,,,,,4.0
Patiala,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,3.0,5.0,3.0,8.0,3.0,1.0,2.0,3.0,3.0,3.0,3.0,4.0,41.0
Patiala,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,,1.0,,,,,,,,1.0
Patiala,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,1.0,1.0,1.0,,1.0,2.0,1.0,1.0,,1.0,,9.0
Patiala,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,,,1.0,,1.0,,,,,,2.0
Patiala,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,,1.0,1.0,1.0,2.0,1.0,3.0,1.0,1.0,,1.0,,12.0
Patiala,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,1.0,,,1.0,,,,,,,,,2.0
Patiala,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,8.0,4.0,5.0,8.0,7.0,3.0,5.0,7.0,14.0,4.0,4.0,10.0,79.0
Patiala,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,9.0,21.0,17.0,10.0,13.0,3.0,8.0,18.0,12.0,12.0,7.0,7.0,137.0
Patiala,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,18.0,25.0,22.0,19.0,20.0,6.0,13.0,25.0,26.0,16.0,11.0,17.0,218.0
Patiala,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,,,,1.0,,,,,,1.0,,2.0
Patiala,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,14.0,6.0,12.0,20.0,17.0,10.0,9.0,16.0,19.0,18.0,5.0,12.0,158.0
Patiala,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,43.0,21.0,22.0,16.0,37.0,28.0,21.0,39.0,21.0,20.0,17.0,13.0,298.0
Patiala,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,57.0,27.0,34.0,36.0,55.0,38.0,30.0,55.0,40.0,38.0,23.0,25.0,458.0
Patiala,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,3.0,1.0,3.0,1.0,1.0,2.0,3.0,1.0,1.0,,,1.0,17.0
Patiala,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,25.0,30.0,41.0,34.0,37.0,24.0,47.0,49.0,27.0,30.0,20.0,19.0,383.0
Patiala,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,109.0,127.0,130.0,155.0,110.0,104.0,112.0,173.0,112.0,183.0,101.0,77.0,1493.0
Patiala,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,137.0,158.0,174.0,190.0,148.0,130.0,162.0,223.0,140.0,213.0,121.0,97.0,1893.0
Rupnagar,1.1,Total number of pregnant women Registered for ANC,TOTAL,1163.0,1273.0,1021.0,1022.0,1046.0,861.0,808.0,901.0,912.0,1107.0,1090.0,989.0,12193.0
Rupnagar,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,867.0,941.0,730.0,738.0,746.0,592.0,572.0,665.0,678.0,815.0,830.0,733.0,8907.0
Rupnagar,1.2,Number of Pregnant women registered under JSY,TOTAL,448.0,537.0,455.0,424.0,455.0,403.0,370.0,398.0,390.0,497.0,493.0,435.0,5305.0
Rupnagar,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,1044.0,1087.0,1005.0,1086.0,1022.0,940.0,950.0,974.0,928.0,1034.0,984.0,926.0,11980.0
Rupnagar,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,1122.0,1225.0,944.0,1019.0,1029.0,828.0,801.0,870.0,893.0,1086.0,1052.0,922.0,11791.0
Rupnagar,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,1067.0,1147.0,1118.0,1004.0,1022.0,1022.0,852.0,797.0,911.0,973.0,1013.0,980.0,11906.0
Rupnagar,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,1112.0,1174.0,1029.0,1079.0,1045.0,987.0,936.0,829.0,920.0,1067.0,1030.0,1011.0,12219.0
Rupnagar,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,25.0,14.0,27.0,20.0,18.0,6.0,9.0,5.0,8.0,11.0,19.0,6.0,168.0
Rupnagar,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rupnagar,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,751.0,1114.0,957.0,976.0,944.0,742.0,704.0,887.0,945.0,1249.0,1145.0,1028.0,11442.0
Rupnagar,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,19.0,31.0,26.0,41.0,48.0,32.0,40.0,41.0,43.0,24.0,29.0,3.0,377.0
Rupnagar,1.8,Number of pregnancy test kits used at SC level,TOTAL,849.0,920.0,630.0,685.0,636.0,536.0,452.0,533.0,584.0,753.0,734.0,663.0,7975.0
Rupnagar,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,5.0,1.0,7.0,1.0,1.0,1.0,0.0,0.0,0.0,0.0,1.0,0.0,17.0
Rupnagar,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,32.0,26.0,20.0,21.0,33.0,33.0,39.0,11.0,11.0,15.0,7.0,16.0,264.0
Rupnagar,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,37.0,27.0,27.0,22.0,34.0,34.0,39.0,11.0,11.0,15.0,8.0,16.0,281.0
Rupnagar,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,37.0,27.0,8.0,19.0,29.0,32.0,35.0,10.0,11.0,12.0,7.0,15.0,242.0
Rupnagar,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,4.0,11.0,10.0,9.0,4.0,12.0,4.0,5.0,4.0,4.0,5.0,0.0,72.0
Rupnagar,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,356.0,409.0,415.0,559.0,673.0,601.0,537.0,548.0,477.0,525.0,418.0,364.0,5882.0
Rupnagar,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,154.0,167.0,219.0,190.0,222.0,183.0,153.0,149.0,166.0,134.0,119.0,68.0,1924.0
Rupnagar,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,180.0,247.0,238.0,347.0,325.0,412.0,266.0,340.0,286.0,241.0,223.0,99.0,3204.0
Rupnagar,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rupnagar,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rupnagar,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,238.0,270.0,343.0,357.0,453.0,509.0,492.0,481.0,459.0,436.0,357.0,351.0,4746.0
Rupnagar,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,22.0,18.0,21.0,18.0,29.0,29.0,50.0,18.0,45.0,30.0,34.0,24.0,338.0
Rupnagar,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rupnagar,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rupnagar,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rupnagar,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,22.0,17.0,22.0,16.0,14.0,11.0,8.0,6.0,7.0,6.0,3.0,1.0,133.0
Rupnagar,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,56.0,78.0,71.0,89.0,110.0,101.0,73.0,93.0,62.0,90.0,68.0,61.0,952.0
Rupnagar,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Rupnagar,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,78.0,95.0,93.0,105.0,124.0,112.0,81.0,99.0,69.0,96.0,71.0,62.0,1085.0
Rupnagar,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,73.0,78.0,118.0,134.0,144.0,161.0,163.0,154.0,173.0,143.0,140.0,126.0,1607.0
Rupnagar,4.1.1.a,Number of male live births,TOTAL,336.0,376.0,408.0,491.0,631.0,634.0,521.0,519.0,481.0,501.0,424.0,370.0,5692.0
Rupnagar,4.1.1.b,Number of female live births,TOTAL,293.0,322.0,373.0,440.0,519.0,509.0,550.0,515.0,459.0,473.0,354.0,357.0,5164.0
Rupnagar,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,629.0,698.0,781.0,931.0,1150.0,1143.0,1071.0,1034.0,940.0,974.0,778.0,727.0,10856.0
Rupnagar,4.1.2,Number of still births,TOTAL,5.0,9.0,13.0,9.0,16.0,9.0,12.0,11.0,13.0,5.0,6.0,7.0,115.0
Rupnagar,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,53.0,69.0,43.0,52.0,51.0,42.0,37.0,40.0,45.0,30.0,34.0,54.0,550.0
Rupnagar,4.2.1,Number of Newborns weighed at birth,TOTAL,629.0,698.0,780.0,931.0,1148.0,1143.0,1062.0,1024.0,940.0,973.0,777.0,726.0,10831.0
Rupnagar,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,26.0,33.0,36.0,32.0,30.0,43.0,44.0,41.0,34.0,45.0,41.0,30.0,435.0
Rupnagar,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,624.0,644.0,775.0,886.0,1045.0,1031.0,995.0,936.0,870.0,861.0,692.0,672.0,10031.0
Rupnagar,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.0,3.0,6.0
Rupnagar,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,22.0,24.0,22.0,16.0,9.0,13.0,8.0,9.0,20.0,16.0,9.0,1.0,169.0
Rupnagar,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,56.0,81.0,71.0,89.0,110.0,101.0,73.0,145.0,116.0,113.0,125.0,83.0,1163.0
Rupnagar,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Rupnagar,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,78.0,105.0,93.0,105.0,119.0,114.0,81.0,154.0,136.0,129.0,137.0,87.0,1338.0
Rupnagar,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,65.0,67.0,109.0,119.0,129.0,139.0,149.0,138.0,148.0,128.0,121.0,112.0,1424.0
Rupnagar,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,41.0,51.0,54.0,62.0,58.0,64.0,44.0,78.0,64.0,61.0,70.0,40.0,687.0
Rupnagar,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,4.0,3.0,3.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,10.0
Rupnagar,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,25.0,32.0,25.0,34.0,44.0,29.0,28.0,37.0,30.0,38.0,44.0,18.0,384.0
Rupnagar,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,8.0,16.0,14.0,9.0,17.0,21.0,9.0,39.0,42.0,40.0,23.0,39.0,277.0
Rupnagar,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,299.0,348.0,414.0,550.0,837.0,717.0,703.0,484.0,725.0,884.0,757.0,725.0,7443.0
Rupnagar,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,332.0,602.0,504.0,561.0,654.0,756.0,683.0,699.0,588.0,635.0,498.0,510.0,7022.0
Rupnagar,6.3,PNC maternal complications attended,TOTAL,0.0,2.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0,1.0,0.0,0.0,5.0
Rupnagar,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,14.0,13.0,6.0,8.0,10.0,10.0,1.0,0.0,7.0,13.0,4.0,4.0,90.0
Rupnagar,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rupnagar,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,14.0,13.0,6.0,8.0,10.0,10.0,1.0,0.0,7.0,13.0,4.0,4.0,90.0
Rupnagar,7.2,Number of MTPs conducted at Private Facilities,TOTAL,35.0,34.0,55.0,34.0,25.0,25.0,31.0,20.0,29.0,31.0,35.0,44.0,398.0
Rupnagar,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,46.0,31.0,51.0,41.0,97.0,54.0,82.0,58.0,44.0,67.0,128.0,49.0,748.0
Rupnagar,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,154.0,258.0,306.0,256.0,370.0,346.0,231.0,203.0,210.0,241.0,221.0,187.0,2983.0
Rupnagar,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,200.0,289.0,357.0,297.0,467.0,400.0,313.0,261.0,254.0,308.0,349.0,236.0,3731.0
Rupnagar,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rupnagar,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0.0,0.0,0.0,2.0,0.0,0.0,1.0,1.0,0.0,1.0,0.0,0.0,5.0
Rupnagar,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,1.0,0.0,5.0,0.0,2.0,1.0,0.0,7.0,1.0,1.0,1.0,0.0,19.0
Rupnagar,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,0.0,0.0,3.0,2.0,0.0,0.0,0.0,1.0,0.0,1.0,1.0,1.0,9.0
Rupnagar,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Rupnagar,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,1.0,0.0,8.0,4.0,2.0,1.0,1.0,9.0,1.0,3.0,2.0,1.0,33.0
Rupnagar,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rupnagar,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rupnagar,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,12.0,26.0,31.0,5.0,5.0,20.0,0.0,9.0,3.0,2.0,2.0,0.0,115.0
Rupnagar,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rupnagar,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Rupnagar,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,12.0,26.0,31.0,5.0,5.0,20.0,0.0,9.0,3.0,2.0,2.0,0.0,115.0
Rupnagar,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,3.0,2.0,3.0,3.0,9.0,12.0,5.0,4.0,5.0,4.0,3.0,0.0,53.0
Rupnagar,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,37.0,36.0,57.0,85.0,32.0,28.0,46.0,39.0,43.0,16.0,33.0,68.0,520.0
Rupnagar,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,7.0,27.0,19.0,12.0,6.0,3.0,9.0,28.0,15.0,7.0,6.0,20.0,159.0
Rupnagar,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,10.0,17.0,24.0,19.0,12.0,16.0,17.0,23.0,16.0,23.0,17.0,11.0,205.0
Rupnagar,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Rupnagar,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,54.0,80.0,100.0,116.0,50.0,47.0,72.0,90.0,74.0,46.0,56.0,99.0,884.0
Rupnagar,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,22.0,16.0,10.0,20.0,18.0,20.0,10.0,10.0,39.0,23.0,13.0,7.0,208.0
Rupnagar,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rupnagar,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,0.0,2.0,4.0,1.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,8.0
Rupnagar,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0
Rupnagar,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Rupnagar,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,0.0,2.0,4.0,1.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,9.0
Rupnagar,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rupnagar,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,322.0,379.0,369.0,709.0,345.0,187.0,179.0,143.0,156.0,131.0,154.0,150.0,3224.0
Rupnagar,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rupnagar,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,10.0,7.0,10.0,9.0,4.0,12.0,12.0,11.0,15.0,12.0,16.0,25.0,143.0
Rupnagar,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,56.0,61.0,62.0,118.0,131.0,29.0,31.0,32.0,42.0,59.0,151.0,101.0,873.0
Rupnagar,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Rupnagar,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,388.0,447.0,441.0,836.0,480.0,228.0,222.0,186.0,213.0,202.0,321.0,276.0,4240.0
Rupnagar,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,7.0,13.0,14.0,58.0,91.0,13.0,25.0,17.0,31.0,48.0,150.0,108.0,575.0
Rupnagar,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rupnagar,9.06,Number of IUCD removals,TOTAL,100.0,114.0,120.0,171.0,135.0,93.0,80.0,79.0,72.0,73.0,70.0,85.0,1192.0
Rupnagar,9.07,Number of Oral Pills cycles distributed,TOTAL,2487.0,2752.0,2434.0,2816.0,2253.0,2412.0,2163.0,2187.0,2341.0,2318.0,2386.0,2150.0,28699.0
Rupnagar,9.08,Number of Condom pieces distributed,TOTAL,71924.0,76253.0,63793.0,72023.0,72785.0,64425.0,61870.0,58051.0,56241.0,60825.0,56110.0,55338.0,769638.0
Rupnagar,9.09,Number of Centchroman (weekly) pills given,TOTAL,0.0,0.0,1.0,0.0,0.0,2.0,0.0,0.0,2.0,2.0,0.0,5.0,12.0
Rupnagar,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,18.0,16.0,13.0,12.0,13.0,10.0,19.0,16.0,12.0,12.0,18.0,8.0,167.0
Rupnagar,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rupnagar,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Rupnagar,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rupnagar,9.11.2.b,Number of failures following female sterilization,TOTAL,0.0,1.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0
Rupnagar,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rupnagar,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rupnagar,9.12,Number of Institutions having NSV trained doctors,TOTAL,1.0,1.0,1.0,2.0,1.0,2.0,2.0,1.0,1.0,1.0,1.0,,-1.0
Rupnagar,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,634.0,718.0,833.0,981.0,1147.0,1117.0,1068.0,1005.0,978.0,1024.0,992.0,790.0,11287.0
Rupnagar,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,896.0,934.0,828.0,872.0,998.0,1108.0,1111.0,1160.0,1084.0,1140.0,492.0,67.0,10690.0
Rupnagar,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,952.0,955.0,883.0,882.0,905.0,952.0,1024.0,1124.0,1187.0,1010.0,1041.0,393.0,11308.0
Rupnagar,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,1030.0,1008.0,932.0,970.0,938.0,899.0,909.0,995.0,1131.0,1146.0,1015.0,872.0,11845.0
Rupnagar,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,477.0,804.0,1281.0
Rupnagar,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,8.0,505.0,513.0
Rupnagar,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,130.0,130.0
Rupnagar,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,641.0,718.0,795.0,921.0,1110.0,1117.0,1047.0,947.0,915.0,1048.0,960.0,763.0,10982.0
Rupnagar,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,896.0,932.0,828.0,872.0,998.0,1101.0,1111.0,1160.0,1084.0,1132.0,969.0,871.0,11954.0
Rupnagar,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,952.0,955.0,883.0,882.0,905.0,952.0,1024.0,1124.0,1187.0,1010.0,1047.0,897.0,11818.0
Rupnagar,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,1030.0,1008.0,932.0,970.0,938.0,899.0,909.0,995.0,1131.0,1146.0,1015.0,1002.0,11975.0
Rupnagar,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,320.0,390.0,361.0,479.0,545.0,532.0,475.0,485.0,461.0,500.0,427.0,346.0,5321.0
Rupnagar,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,896.0,934.0,828.0,872.0,998.0,1108.0,1111.0,1160.0,1084.0,1140.0,492.0,81.0,10704.0
Rupnagar,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,952.0,955.0,883.0,882.0,905.0,952.0,1024.0,1124.0,1193.0,1010.0,1041.0,393.0,11314.0
Rupnagar,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,1030.0,1008.0,932.0,970.0,938.0,899.0,909.0,995.0,1131.0,1146.0,1015.0,872.0,11845.0
Rupnagar,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,879.0,1189.0,1025.0,1104.0,1148.0,1074.0,872.0,1041.0,860.0,858.0,782.0,776.0,11608.0
Rupnagar,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,969.0,1178.0,874.0,959.0,902.0,837.0,742.0,897.0,843.0,1032.0,938.0,907.0,11078.0
Rupnagar,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rupnagar,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,469.0,658.0,564.0,541.0,638.0,555.0,463.0,553.0,457.0,445.0,424.0,419.0,6186.0
Rupnagar,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,410.0,531.0,461.0,563.0,510.0,519.0,409.0,488.0,403.0,413.0,358.0,357.0,5422.0
Rupnagar,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,879.0,1189.0,1025.0,1104.0,1148.0,1074.0,872.0,1041.0,860.0,858.0,782.0,776.0,11608.0
Rupnagar,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,971.0,1178.0,874.0,949.0,906.0,837.0,746.0,896.0,841.0,1039.0,938.0,907.0,11082.0
Rupnagar,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,971.0,1178.0,874.0,949.0,906.0,837.0,746.0,896.0,841.0,1039.0,938.0,907.0,11082.0
Rupnagar,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rupnagar,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,8.0,11.0,8.0,8.0,8.0,8.0,5.0,9.0,4.0,10.0,5.0,7.0,91.0
Rupnagar,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,7.0,11.0,9.0,10.0,6.0,5.0,6.0,6.0,10.0,6.0,5.0,5.0,86.0
Rupnagar,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,15.0,22.0,17.0,18.0,14.0,13.0,11.0,15.0,14.0,16.0,10.0,12.0,177.0
Rupnagar,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,489.0,6066.0,438.0,1123.0,589.0,486.0,344.0,381.0,367.0,388.0,311.0,358.0,11340.0
Rupnagar,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,299.0,6654.0,240.0,981.0,365.0,402.0,218.0,232.0,145.0,184.0,143.0,237.0,10100.0
Rupnagar,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,232.0,6288.0,100.0,1050.0,296.0,388.0,208.0,302.0,84.0,144.0,86.0,166.0,9344.0
Rupnagar,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,2.0,0.0,0.0,2.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,4.0
Rupnagar,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rupnagar,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,4.0,1.0,3.0,6.0,0.0,5.0,5.0,2.0,4.0,4.0,5.0,3.0,42.0
Rupnagar,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,425.0,447.0,411.0,449.0,429.0,442.0,425.0,426.0,427.0,434.0,425.0,430.0,5170.0
Rupnagar,10.4.2,Number of Immunisation sessions held during the month,TOTAL,424.0,442.0,411.0,446.0,427.0,440.0,421.0,426.0,427.0,432.0,421.0,316.0,5033.0
Rupnagar,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,356.0,375.0,366.0,382.0,361.0,361.0,353.0,354.0,363.0,362.0,360.0,256.0,4249.0
Rupnagar,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rupnagar,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,870.0,1185.0,1019.0,1100.0,1146.0,1070.0,872.0,979.0,856.0,854.0,782.0,771.0,11504.0
Rupnagar,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,946.0,1050.0,922.0,949.0,941.0,896.0,828.0,779.0,729.0,883.0,928.0,801.0,10652.0
Rupnagar,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,945.0,1011.0,1025.0,1005.0,949.0,973.0,820.0,746.0,758.0,908.0,917.0,884.0,10941.0
Rupnagar,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rupnagar,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rupnagar,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rupnagar,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rupnagar,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rupnagar,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,1.0
Rupnagar,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,20.0,113.0,93.0,82.0,95.0,42.0,35.0,39.0,49.0,63.0,67.0,63.0,761.0
Rupnagar,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rupnagar,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,2.0,5.0,1.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,9.0
Rupnagar,13.1,Number of Patients operated for cataract,TOTAL,129.0,64.0,37.0,35.0,31.0,43.0,39.0,45.0,26.0,27.0,36.0,37.0,549.0
Rupnagar,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,129.0,64.0,37.0,35.0,31.0,43.0,39.0,45.0,26.0,27.0,33.0,37.0,546.0
Rupnagar,13.3,Number of School children detected with Refractive errors,TOTAL,66.0,42.0,10.0,115.0,184.0,103.0,201.0,140.0,82.0,47.0,76.0,49.0,1115.0
Rupnagar,13.4,Number of children provided free glasses,TOTAL,0.0,0.0,0.0,0.0,205.0,145.0,124.0,107.0,0.0,188.0,64.0,54.0,887.0
Rupnagar,13.5,Number of eyes collected through eye donation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rupnagar,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rupnagar,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,5.0,5.0,5.0,5.0,5.0,5.0,5.0,5.0,5.0,5.0,5.0,5.0,-1.0
Rupnagar,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,7.0,7.0,7.0,7.0,7.0,7.0,7.0,7.0,7.0,7.0,7.0,7.0,-1.0
Rupnagar,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,575.0,533.0,531.0,558.0,559.0,567.0,563.0,538.0,598.0,584.0,567.0,514.0,-1.0
Rupnagar,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,5.0,5.0,5.0,5.0,5.0,5.0,5.0,5.0,5.0,5.0,5.0,5.0,-1.0
Rupnagar,14.05,Number of RKS meetings held during the month,TOTAL,5.0,8.0,5.0,4.0,5.0,4.0,4.0,5.0,6.0,7.0,5.0,5.0,63.0
Rupnagar,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,6.0,6.0,6.0,6.0,7.0,7.0,7.0,7.0,6.0,6.0,6.0,6.0,-1.0
Rupnagar,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,190.0,126.0,223.0,289.0,230.0,280.0,305.0,275.0,236.0,197.0,241.0,157.0,2749.0
Rupnagar,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,3.0,3.0,3.0,3.0,3.0,3.0,3.0,3.0,3.0,4.0,4.0,3.0,-1.0
Rupnagar,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,-1.0
Rupnagar,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,246.0,301.0,318.0,310.0,414.0,395.0,320.0,320.0,303.0,319.0,284.0,213.0,3743.0
Rupnagar,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,661.0,821.0,865.0,745.0,790.0,775.0,828.0,673.0,479.0,588.0,628.0,617.0,8470.0
Rupnagar,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,207.0,234.0,270.0,285.0,375.0,290.0,300.0,308.0,282.0,308.0,240.0,212.0,3311.0
Rupnagar,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,1147.0,1324.0,1452.0,1263.0,1508.0,1547.0,1401.0,1172.0,1044.0,1105.0,992.0,1038.0,14993.0
Rupnagar,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,453.0,535.0,588.0,595.0,789.0,685.0,620.0,628.0,585.0,627.0,524.0,425.0,7054.0
Rupnagar,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,1808.0,2145.0,2317.0,2008.0,2298.0,2322.0,2229.0,1845.0,1523.0,1693.0,1620.0,1655.0,23463.0
Rupnagar,14.10.2.a,Number of death cases of Inpatient males,TOTAL,11.0,11.0,8.0,9.0,6.0,13.0,9.0,13.0,5.0,7.0,11.0,12.0,115.0
Rupnagar,14.10.2.b,Number of death cases of Inpatient females,TOTAL,7.0,6.0,4.0,3.0,1.0,3.0,8.0,9.0,9.0,8.0,5.0,7.0,70.0
Rupnagar,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,18.0,17.0,12.0,12.0,7.0,16.0,17.0,22.0,14.0,15.0,16.0,19.0,185.0
Rupnagar,14.11,In-Patient Head Count at midnight,TOTAL,216.0,184.0,214.0,294.0,245.0,254.0,255.0,182.0,177.0,260.0,164.0,238.0,2683.0
Rupnagar,14.12.1,OPD attendance (All),TOTAL,51385.0,56461.0,56990.0,57422.0,60874.0,55670.0,48154.0,50976.0,48669.0,50929.0,57060.0,57559.0,652149.0
Rupnagar,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,239.0,284.0,241.0,234.0,266.0,236.0,188.0,235.0,168.0,206.0,167.0,159.0,2623.0
Rupnagar,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,35.0,57.0,16.0,12.0,15.0,2.0,8.0,53.0,20.0,14.0,10.0,12.0,254.0
Rupnagar,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,788.0,788.0,970.0,830.0,741.0,736.0,538.0,588.0,701.0,797.0,733.0,782.0,8992.0
Rupnagar,14.14.a,Number of patients given AYUSH treatment,TOTAL,2023.0,2616.0,2556.0,3316.0,4242.0,3571.0,2468.0,3049.0,3461.0,3804.0,4218.0,2497.0,37821.0
Rupnagar,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,595.0,846.0,213.0,1025.0,1766.0,539.0,675.0,1204.0,702.0,1051.0,1041.0,876.0,10533.0
Rupnagar,14.14.c,Number of Adolescents counselled,TOTAL,7.0,24.0,10.0,8.0,0.0,0.0,2.0,6.0,2.0,0.0,0.0,2.0,61.0
Rupnagar,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,4220.0,5154.0,5191.0,4812.0,4771.0,4852.0,3829.0,4467.0,4036.0,4361.0,5226.0,6084.0,57003.0
Rupnagar,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,105.0,73.0,68.0,142.0,92.0,101.0,104.0,53.0,48.0,52.0,83.0,70.0,991.0
Rupnagar,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,335.0,301.0,431.0,451.0,403.0,415.0,355.0,375.0,373.0,348.0,322.0,317.0,4426.0
Rupnagar,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,6.0,3.0,3.0,6.0,5.0,4.0,4.0,5.0,3.0,3.0,3.0,2.0,47.0
Rupnagar,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,282.0,330.0,463.0,434.0,459.0,415.0,248.0,310.0,300.0,282.0,282.0,345.0,4150.0
Rupnagar,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,1.0,1.0,2.0,1.0,1.0,1.0,1.0,2.0,1.0,2.0,0.0,0.0,13.0
Rupnagar,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,882.0,960.0,793.0,789.0,738.0,684.0,499.0,676.0,645.0,701.0,661.0,873.0,8901.0
Rupnagar,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,2.0,0.0,4.0,0.0,0.0,3.0,0.0,0.0,0.0,0.0,1.0,0.0,10.0
Rupnagar,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,1499.0,1591.0,1687.0,1674.0,1600.0,1514.0,1102.0,1361.0,1318.0,1331.0,1265.0,1535.0,17477.0
Rupnagar,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,9.0,4.0,9.0,7.0,6.0,8.0,5.0,7.0,4.0,5.0,4.0,2.0,70.0
Rupnagar,15.2,Number of Widal tests conducted,Number tested,440.0,520.0,346.0,497.0,639.0,490.0,417.0,311.0,163.0,169.0,448.0,388.0,4828.0
Rupnagar,15.3.a,Number of VDRL tests conducted on males,Number tested,3.0,7.0,3.0,3.0,6.0,3.0,3.0,18.0,32.0,51.0,34.0,18.0,181.0
Rupnagar,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,6.0,15.0,11.0,7.0,4.0,8.0,5.0,88.0,79.0,130.0,74.0,97.0,524.0
Rupnagar,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,481.0,604.0,490.0,474.0,509.0,496.0,503.0,692.0,622.0,685.0,537.0,805.0,6898.0
Rupnagar,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,490.0,626.0,504.0,484.0,519.0,507.0,511.0,798.0,733.0,866.0,645.0,920.0,7603.0
Rupnagar,15.4.1,Number of blood smears examined for Malaria,TOTAL,5790.0,6386.0,6109.0,6171.0,7397.0,6200.0,5343.0,5879.0,5941.0,5013.0,5972.0,6263.0,72464.0
Rupnagar,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Rupnagar,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rupnagar,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,7300.0,0.0,8500.0,2500.0,5500.0,6500.0,1000.0,4000.0,5500.0,250.0,7750.0,8250.0,57050.0
Rupnagar,16.1.1,Stock position of DPT vaccines,2. Stocks Received,0.0,20000.0,0.0,8000.0,6000.0,0.0,8000.0,4000.0,0.0,10000.0,5000.0,0.0,61000.0
Rupnagar,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rupnagar,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,7300.0,11500.0,6000.0,5000.0,5000.0,5500.0,5000.0,2500.0,5250.0,2500.0,4500.0,3500.0,63550.0
Rupnagar,16.1.1,Stock position of DPT vaccines,5. Total Stock,0.0,8500.0,2500.0,5500.0,6500.0,1000.0,4000.0,5500.0,250.0,7750.0,8250.0,4750.0,54500.0
Rupnagar,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,,,,0.0,0.0,,,,,0.0,5000.0,2500.0,7500.0
Rupnagar,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,,,,0.0,0.0,,,,,5000.0,0.0,3000.0,8000.0
Rupnagar,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,,,,0.0,0.0,,,,,0.0,0.0,0.0,0.0
Rupnagar,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,,,,0.0,0.0,,,,,0.0,2500.0,2200.0,4700.0
Rupnagar,16.1.1A,Stock Position of Pentavalent,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,5000.0,2500.0,3300.0,10800.0
Rupnagar,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,16500.0,10500.0,2000.0,3500.0,6500.0,6500.0,3000.0,4000.0,2500.0,5000.0,5500.0,5500.0,71000.0
Rupnagar,16.1.2,Stock position of OPV vaccines,2. Stocks Received,0.0,0.0,10000.0,10000.0,10000.0,5000.0,12000.0,5000.0,10000.0,5000.0,5000.0,5000.0,77000.0
Rupnagar,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rupnagar,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,6000.0,8500.0,8500.0,7000.0,10000.0,8500.0,11000.0,6500.0,7500.0,4500.0,5000.0,4000.0,87000.0
Rupnagar,16.1.2,Stock position of OPV vaccines,5. Total Stock,10500.0,2000.0,3500.0,6500.0,6500.0,3000.0,4000.0,2500.0,5000.0,5500.0,5500.0,6500.0,61000.0
Rupnagar,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,7480.0,0.0,9000.0,5000.0,4000.0,10000.0,5000.0,8000.0,5000.0,5500.0,9500.0,10500.0,78980.0
Rupnagar,16.1.3,Stock position of TT vaccines,2. Stocks Received,0.0,20000.0,0.0,5000.0,10000.0,0.0,5000.0,5000.0,4000.0,5000.0,5000.0,5000.0,64000.0
Rupnagar,16.1.3,Stock position of TT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rupnagar,16.1.3,Stock position of TT vaccines,4. Stock Distributed,7480.0,11000.0,4000.0,6000.0,4000.0,5000.0,2000.0,8000.0,3500.0,1000.0,4000.0,8000.0,63980.0
Rupnagar,16.1.3,Stock position of TT vaccines,5. Total Stock,0.0,9000.0,5000.0,4000.0,10000.0,5000.0,8000.0,5000.0,5500.0,9500.0,10500.0,7500.0,79000.0
Rupnagar,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Rupnagar,16.1.4,Stock position of DT vaccines,2. Stocks Received,,,,,,,,,,,,,
Rupnagar,16.1.4,Stock position of DT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Rupnagar,16.1.4,Stock position of DT vaccines,4. Stock Distributed,,,,,,,,,,,,,
Rupnagar,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rupnagar,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,4150.0,1800.0,4500.0,1500.0,1500.0,3000.0,3500.0,3500.0,1500.0,2000.0,5500.0,3500.0,35950.0
Rupnagar,16.1.5,Stock position of BCG vaccines,2. Stocks Received,0.0,5000.0,0.0,3000.0,5000.0,3000.0,3000.0,0.0,3000.0,5000.0,0.0,0.0,27000.0
Rupnagar,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rupnagar,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,2350.0,2300.0,3000.0,3000.0,3500.0,2500.0,3000.0,2000.0,2500.0,1500.0,2000.0,,27650.0
Rupnagar,16.1.5,Stock position of BCG vaccines,5. Total Stock,1800.0,4500.0,1500.0,1500.0,3000.0,3500.0,3500.0,1500.0,2000.0,5500.0,3500.0,3500.0,35300.0
Rupnagar,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,5650.0,3500.0,250.0,3500.0,3000.0,900.0,100.0,1150.0,3500.0,0.0,,,21550.0
Rupnagar,16.1.6,Stock position of Measles vaccines,2. Stocks Received,0.0,0.0,6000.0,2000.0,0.0,1000.0,4000.0,5000.0,0.0,,,,18000.0
Rupnagar,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0
Rupnagar,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,2150.0,3250.0,2750.0,2500.0,2100.0,1800.0,2950.0,2650.0,3500.0,,,,23650.0
Rupnagar,16.1.6,Stock position of Measles vaccines,5. Total Stock,3500.0,250.0,3500.0,3000.0,900.0,100.0,1150.0,3500.0,0.0,0.0,0.0,0.0,15900.0
Rupnagar,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Rupnagar,16.1.7,Stock position of JE vaccines,2. Stocks Received,,,,,,,,,,,,,
Rupnagar,16.1.7,Stock position of JE vaccines,3. Unusable Stock,,,,,,,,,,,,,
Rupnagar,16.1.7,Stock position of JE vaccines,4. Stock Distributed,,,,,,,,,,,,,
Rupnagar,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rupnagar,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,6000.0,1000.0,7000.0,7700.0,3700.0,2700.0,1900.0,2500.0,4500.0,5000.0,4000.0,500.0,46500.0
Rupnagar,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,0.0,10000.0,4000.0,0.0,3000.0,3000.0,5000.0,5000.0,5000.0,2000.0,0.0,5000.0,42000.0
Rupnagar,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rupnagar,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,5000.0,4000.0,3300.0,4000.0,4000.0,3800.0,4400.0,3000.0,4500.0,3000.0,3500.0,2500.0,45000.0
Rupnagar,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,1000.0,7000.0,7700.0,3700.0,2700.0,1900.0,2500.0,4500.0,5000.0,4000.0,500.0,3000.0,43500.0
Rupnagar,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Rupnagar,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Rupnagar,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Rupnagar,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Rupnagar,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rupnagar,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Rupnagar,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Rupnagar,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Rupnagar,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Rupnagar,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rupnagar,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Rupnagar,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Rupnagar,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Rupnagar,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Rupnagar,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rupnagar,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Rupnagar,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Rupnagar,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Rupnagar,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Rupnagar,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rupnagar,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Rupnagar,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Rupnagar,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Rupnagar,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Rupnagar,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rupnagar,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,,,,,,,,,,,,,
Rupnagar,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,,,,,,,,,,,,,
Rupnagar,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,,,,,,,,,,,,,
Rupnagar,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,,,,,,,,,,,,,
Rupnagar,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rupnagar,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,,,,,,,,,,,,,
Rupnagar,16.3.02,Stock Position of Gloves,2. Stocks Received,,,,,,,,,,,,,
Rupnagar,16.3.02,Stock Position of Gloves,3. Unusable Stock,,,,,,,,,,,,,
Rupnagar,16.3.02,Stock Position of Gloves,4. Stock Distributed,,,,,,,,,,,,,
Rupnagar,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rupnagar,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,,,,,,,,,,,,,
Rupnagar,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,,,,,,,,,,,,,
Rupnagar,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,,,,,,,,,,,,,
Rupnagar,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,,,,,,,,,,,,,
Rupnagar,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rupnagar,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
Rupnagar,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,,,,,,,,,,,,,
Rupnagar,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,,,,,,,,,,,,,
Rupnagar,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,,,,,,,,,,,,,
Rupnagar,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rupnagar,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,,,,,,,,,,,,,
Rupnagar,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,,,,,,,,,,,,,
Rupnagar,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,,,,,,,,,,,,,
Rupnagar,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,,,,,,,,,,,,,
Rupnagar,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rupnagar,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,,,,,,,,,,,,,
Rupnagar,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,,,,,,,,,,,,,
Rupnagar,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,,,,,,,,,,,,,
Rupnagar,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,,,,,,,,,,,,,
Rupnagar,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rupnagar,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
Rupnagar,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,,,,,,,,,,,,,
Rupnagar,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,,,,,,,,,,,,,
Rupnagar,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,,,,,,,,,,,,,
Rupnagar,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rupnagar,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,,,,,,,,,,,,,
Rupnagar,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,,,,,,,,,,,,,
Rupnagar,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,,,,,,,,,,,,,
Rupnagar,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,,,,,,,,,,,,,
Rupnagar,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rupnagar,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,,,,,,,,,,,,,
Rupnagar,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,,,,,,,,,,,,,
Rupnagar,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,,,,,,,,,,,,,
Rupnagar,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,,,,,,,,,,,,,
Rupnagar,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rupnagar,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,,,,,,,,,,,,,
Rupnagar,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,,,,,,,,,,,,,
Rupnagar,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,,,,,,,,,,,,,
Rupnagar,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,,,,,,,,,,,,,
Rupnagar,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rupnagar,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,,,,,,,,,,,,,
Rupnagar,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,,,,,,,,,,,,,
Rupnagar,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,,,,,,,,,,,,,
Rupnagar,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,,,,,,,,,,,,,
Rupnagar,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rupnagar,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,600.0,800.0,1800.0,1000.0,2000.0,600.0,1000.0,400.0,2000.0,1000.0,200.0,1600.0,13000.0
Rupnagar,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,2000.0,2000.0,0.0,2000.0,0.0,2000.0,0.0,4000.0,0.0,0.0,2000.0,0.0,14000.0
Rupnagar,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rupnagar,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,1800.0,1000.0,800.0,1000.0,1400.0,1600.0,600.0,2400.0,1000.0,800.0,600.0,1000.0,14000.0
Rupnagar,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,800.0,1800.0,1000.0,2000.0,600.0,1000.0,400.0,2000.0,1000.0,200.0,1600.0,600.0,13000.0
Rupnagar,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,4000.0,34000.0,4000.0,2000.0,2000.0,2000.0,26000.0,12000.0,2000.0,2000.0,2000.0,2000.0,94000.0
Rupnagar,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,100000.0,0.0,0.0,0.0,0.0,100000.0,0.0,0.0,0.0,0.0,0.0,80000.0,280000.0
Rupnagar,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rupnagar,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,70000.0,30000.0,2000.0,0.0,0.0,76000.0,14000.0,10000.0,0.0,0.0,0.0,56000.0,258000.0
Rupnagar,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,34000.0,4000.0,2000.0,2000.0,2000.0,26000.0,12000.0,2000.0,2000.0,2000.0,2000.0,26000.0,116000.0
Rupnagar,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,1100.0,1400.0,400.0,0.0,2000.0,400.0,2200.0,1600.0,1600.0,1000.0,800.0,2000.0,14500.0
Rupnagar,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,2400.0,0.0,0.0,2400.0,0.0,2400.0,0.0,2400.0,0.0,0.0,2400.0,0.0,12000.0
Rupnagar,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rupnagar,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,2100.0,1000.0,400.0,400.0,1600.0,600.0,600.0,2400.0,600.0,200.0,1200.0,600.0,11700.0
Rupnagar,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,1400.0,400.0,0.0,2000.0,400.0,2200.0,1600.0,1600.0,1000.0,800.0,2000.0,1400.0,14800.0
Rupnagar,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,,,,,,,,,,,,,
Rupnagar,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Rupnagar,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Rupnagar,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,,,,,,,,,,,,
Rupnagar,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Rupnagar,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Rupnagar,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,,,,,,,,,,,,,
Rupnagar,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,,,,,,1.0,,,,,,,1.0
Rupnagar,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Rupnagar,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,,,,,,1.0,,,,,,,1.0
Rupnagar,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,2.0,2.0,,,,2.0,1.0,1.0,4.0,,,,12.0
Rupnagar,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Rupnagar,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,2.0,2.0,,,,2.0,1.0,1.0,4.0,,,,12.0
Rupnagar,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,,,,,,,,,,,,
Rupnagar,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,,,,,,,,,,
Rupnagar,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,,,,,,,,,,,,,
Rupnagar,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,,,,,,
Rupnagar,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
Rupnagar,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,,,,,,,,,
Rupnagar,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,,,,,,,,,,,
Rupnagar,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,,,,,,,,,,
Rupnagar,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,,,,,,,,,,,,
Rupnagar,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Rupnagar,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Rupnagar,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Rupnagar,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,2.0,1.0,1.0,,,,1.0,,1.0,,,,6.0
Rupnagar,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,1.0,1.0,,,,,,,,,,,2.0
Rupnagar,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,3.0,2.0,1.0,,,,1.0,,1.0,,,,8.0
Rupnagar,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
Rupnagar,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,,,,,,,,,
Rupnagar,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,,,,,,,,,
Rupnagar,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,,,,,,,,,,,
Rupnagar,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
Rupnagar,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,,,,,,1.0,1.0,,2.0,1.0,1.0,,6.0
Rupnagar,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,4.0,1.0,,,,,,,,,,,5.0
Rupnagar,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,4.0,1.0,,,,1.0,1.0,,2.0,1.0,1.0,,11.0
Rupnagar,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,,,,,,
Rupnagar,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,,,,,,2.0,,2.0,1.0,1.0,1.0,,7.0
Rupnagar,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,,,,,4.0,8.0,3.0,2.0,9.0,5.0,11.0,2.0,44.0
Rupnagar,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,,,,,4.0,10.0,3.0,4.0,10.0,6.0,12.0,2.0,51.0
Rupnagar,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
Rupnagar,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,,,,,,,,
Rupnagar,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
Rupnagar,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,,,,,,,,,,
Rupnagar,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,1.0,,1.0,,,,,,1.0,,,,3.0
Rupnagar,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,,1.0,2.0,1.0,,1.0,,,4.0,,,,9.0
Rupnagar,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,,2.0,17.0,,2.0,1.0,1.0,1.0,5.0,,,,29.0
Rupnagar,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,1.0,3.0,20.0,1.0,2.0,2.0,1.0,1.0,10.0,,,,41.0
Rupnagar,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,1.0,,,,1.0
Rupnagar,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,,,,1.0,,,1.0,1.0,,,3.0
Rupnagar,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,,,,
Rupnagar,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,,,,1.0,,,2.0,1.0,,,4.0
Rupnagar,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,,,,1.0,,,,,1.0
Rupnagar,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,8.0,13.0,9.0,4.0,17.0,18.0,14.0,16.0,21.0,18.0,16.0,7.0,161.0
Rupnagar,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,24.0,29.0,30.0,5.0,25.0,34.0,44.0,35.0,53.0,41.0,43.0,19.0,382.0
Rupnagar,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,32.0,42.0,39.0,9.0,42.0,52.0,58.0,52.0,74.0,59.0,59.0,26.0,544.0
Rupnagar,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,,1.0,,,1.0,,2.0
Rupnagar,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,,1.0,,1.0,,,,,,,,,2.0
Rupnagar,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,2.0,1.0,,1.0,,,,,,,1.0,,5.0
Rupnagar,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,2.0,2.0,,2.0,,,,1.0,,,2.0,,9.0
Rupnagar,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Rupnagar,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
Rupnagar,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Rupnagar,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
Rupnagar,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Rupnagar,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,,,,,,,,
Rupnagar,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Rupnagar,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,,,,,,,,
Rupnagar,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Rupnagar,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,,,,,,,,,,
Rupnagar,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Rupnagar,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,,,,,,,,,,,
Rupnagar,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Rupnagar,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,,,,,,,,,,,
Rupnagar,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Rupnagar,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,,,,,,,,,,,
Rupnagar,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Rupnagar,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,,,,,,,
Rupnagar,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Rupnagar,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,,,,,,,
Rupnagar,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Rupnagar,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,,,,,,,,1.0,1.0,1.0,,2.0,5.0
Rupnagar,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Rupnagar,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,,,,,,,,1.0,1.0,1.0,,2.0,5.0
Rupnagar,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,,,,1.0,,,2.0,1.0,,1.0,1.0,6.0
Rupnagar,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,,,,3.0,6.0,15.0,21.0,3.0,3.0,6.0,8.0,2.0,67.0
Rupnagar,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,,,,1.0,4.0,,6.0,1.0,2.0,3.0,2.0,,19.0
Rupnagar,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,,,,4.0,11.0,15.0,27.0,6.0,6.0,9.0,11.0,3.0,92.0
Rupnagar,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,,,,,,,,,
Rupnagar,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,2.0,4.0,,,2.0,3.0,4.0,2.0,,2.0,4.0,1.0,24.0
Rupnagar,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,1.0,1.0,,,1.0,1.0,,,,,1.0,,5.0
Rupnagar,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,3.0,5.0,,,3.0,4.0,4.0,2.0,,2.0,5.0,1.0,29.0
Rupnagar,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,,,,,,,,,,
Rupnagar,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,,,1.0,1.0,1.0,2.0,,,,,,5.0
Rupnagar,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,,,,,2.0,,,,,,2.0
Rupnagar,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,,,,1.0,1.0,1.0,4.0,,,,,,7.0
Rupnagar,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,1.0,,,,,,,,,,,1.0
Rupnagar,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,,5.0,,,,,,,1.0,6.0,6.0,,18.0
Rupnagar,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,4.0,15.0,,,,,,2.0,4.0,9.0,9.0,1.0,44.0
Rupnagar,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,4.0,21.0,,,,,,2.0,5.0,15.0,15.0,1.0,63.0
Rupnagar,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,1.0,,,,,,,,,,,,1.0
Rupnagar,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,5.0,3.0,2.0,1.0,7.0,14.0,11.0,9.0,5.0,3.0,11.0,,71.0
Rupnagar,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,21.0,5.0,5.0,1.0,17.0,25.0,20.0,24.0,17.0,11.0,13.0,13.0,172.0
Rupnagar,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,27.0,8.0,7.0,2.0,24.0,39.0,31.0,33.0,22.0,14.0,24.0,13.0,244.0
Rupnagar,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,,,,,1.0,,,,,,,,1.0
Rupnagar,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,5.0,15.0,8.0,4.0,5.0,3.0,10.0,11.0,9.0,11.0,10.0,3.0,94.0
Rupnagar,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,55.0,59.0,53.0,14.0,40.0,53.0,78.0,77.0,90.0,86.0,98.0,48.0,751.0
Rupnagar,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,60.0,74.0,61.0,18.0,46.0,56.0,88.0,88.0,99.0,97.0,108.0,51.0,846.0
Sangrur,1.1,Total number of pregnant women Registered for ANC,TOTAL,2349.0,2663.0,2113.0,2157.0,2074.0,1794.0,1630.0,1795.0,1816.0,2186.0,2340.0,2034.0,24951.0
Sangrur,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,1756.0,1892.0,1519.0,1521.0,1428.0,1228.0,1142.0,1239.0,1319.0,1544.0,1690.0,1482.0,17760.0
Sangrur,1.2,Number of Pregnant women registered under JSY,TOTAL,837.0,936.0,805.0,790.0,769.0,659.0,622.0,696.0,718.0,868.0,937.0,753.0,9390.0
Sangrur,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,1786.0,2071.0,1951.0,2072.0,1942.0,1904.0,1796.0,1707.0,1738.0,1635.0,1614.0,1542.0,21758.0
Sangrur,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,2195.0,2418.0,1986.0,2047.0,1951.0,1746.0,1553.0,1691.0,1686.0,1930.0,2029.0,1909.0,23141.0
Sangrur,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,2181.0,2285.0,2138.0,1986.0,1998.0,1812.0,1731.0,1606.0,1646.0,1781.0,1792.0,1832.0,22788.0
Sangrur,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,1994.0,2237.0,2155.0,2212.0,2021.0,2025.0,1931.0,1860.0,1796.0,1884.0,1689.0,1609.0,23413.0
Sangrur,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,10.0,25.0,54.0,20.0,26.0,37.0,6.0,4.0,3.0,58.0,13.0,7.0,263.0
Sangrur,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,0.0,0.0,0.0,0.0,0.0,4.0,0.0,0.0,0.0,2.0,0.0,0.0,6.0
Sangrur,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,1215.0,1258.0,1043.0,1161.0,1208.0,919.0,965.0,1012.0,1217.0,1134.0,1278.0,1007.0,13417.0
Sangrur,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,9.0,21.0,13.0,12.0,13.0,12.0,17.0,19.0,4.0,24.0,15.0,5.0,164.0
Sangrur,1.8,Number of pregnancy test kits used at SC level,TOTAL,388.0,438.0,230.0,316.0,263.0,252.0,213.0,220.0,287.0,427.0,405.0,415.0,3854.0
Sangrur,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,105.0,120.0,96.0,131.0,124.0,144.0,147.0,141.0,116.0,148.0,118.0,82.0,1472.0
Sangrur,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,16.0,13.0,21.0,14.0,24.0,10.0,15.0,17.0,20.0,19.0,19.0,10.0,198.0
Sangrur,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,121.0,133.0,117.0,145.0,148.0,154.0,162.0,158.0,136.0,167.0,137.0,92.0,1670.0
Sangrur,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,121.0,133.0,117.0,145.0,148.0,154.0,162.0,158.0,136.0,166.0,138.0,92.0,1670.0
Sangrur,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,54.0,65.0,47.0,53.0,35.0,44.0,39.0,33.0,50.0,24.0,55.0,36.0,535.0
Sangrur,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,767.0,768.0,835.0,1241.0,1441.0,1434.0,1275.0,1180.0,1257.0,1183.0,901.0,878.0,13160.0
Sangrur,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,562.0,546.0,594.0,920.0,1026.0,1003.0,934.0,807.0,863.0,802.0,563.0,596.0,9216.0
Sangrur,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,309.0,552.0,460.0,525.0,512.0,551.0,469.0,569.0,643.0,572.0,569.0,693.0,6424.0
Sangrur,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sangrur,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sangrur,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,484.0,525.0,529.0,657.0,762.0,822.0,781.0,732.0,686.0,729.0,579.0,522.0,7808.0
Sangrur,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sangrur,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sangrur,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sangrur,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sangrur,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,18.0,14.0,18.0,24.0,49.0,38.0,29.0,33.0,30.0,33.0,16.0,13.0,315.0
Sangrur,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,187.0,208.0,223.0,297.0,366.0,393.0,312.0,340.0,364.0,348.0,322.0,268.0,3628.0
Sangrur,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Sangrur,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,205.0,222.0,241.0,321.0,415.0,431.0,341.0,373.0,394.0,381.0,338.0,281.0,3943.0
Sangrur,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,90.0,104.0,121.0,131.0,157.0,179.0,178.0,161.0,134.0,150.0,96.0,129.0,1630.0
Sangrur,4.1.1.a,Number of male live births,TOTAL,761.0,770.0,806.0,1080.0,1242.0,1284.0,1177.0,1125.0,1111.0,1091.0,851.0,808.0,12106.0
Sangrur,4.1.1.b,Number of female live births,TOTAL,604.0,646.0,667.0,970.0,1101.0,1123.0,1036.0,933.0,958.0,973.0,766.0,688.0,10465.0
Sangrur,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,1365.0,1416.0,1473.0,2050.0,2343.0,2407.0,2213.0,2058.0,2069.0,2064.0,1617.0,1496.0,22571.0
Sangrur,4.1.2,Number of still births,TOTAL,18.0,26.0,21.0,23.0,20.0,22.0,20.0,23.0,26.0,29.0,12.0,8.0,248.0
Sangrur,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,116.0,49.0,89.0,132.0,124.0,70.0,48.0,61.0,49.0,58.0,64.0,60.0,920.0
Sangrur,4.2.1,Number of Newborns weighed at birth,TOTAL,1365.0,1416.0,1473.0,2050.0,2343.0,2407.0,2213.0,2058.0,2069.0,2064.0,1617.0,1478.0,22553.0
Sangrur,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,116.0,118.0,100.0,114.0,118.0,134.0,214.0,171.0,161.0,106.0,281.0,247.0,1880.0
Sangrur,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,1365.0,1416.0,1473.0,2049.0,2343.0,2407.0,2213.0,1556.0,1584.0,1509.0,1181.0,1095.0,20191.0
Sangrur,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sangrur,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sangrur,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,52.0,73.0,62.0,66.0,95.0,54.0,58.0,78.0,45.0,0.0,22.0,49.0,654.0
Sangrur,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Sangrur,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,52.0,73.0,62.0,66.0,95.0,54.0,58.0,78.0,45.0,0.0,22.0,49.0,654.0
Sangrur,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,73.0,0.0,0.0,10.0,5.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,88.0
Sangrur,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,286.0,29.0,180.0,20.0,322.0,50.0,364.0,290.0,290.0,117.0,63.0,36.0,2047.0
Sangrur,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,16.0,48.0,21.0,2.0,20.0,63.0,39.0,36.0,35.0,30.0,27.0,0.0,337.0
Sangrur,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,285.0,30.0,314.0,14.0,609.0,55.0,538.0,484.0,489.0,103.0,79.0,40.0,3040.0
Sangrur,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,35.0,45.0,26.0,70.0,56.0,92.0,5.0,29.0,65.0,48.0,41.0,7.0,519.0
Sangrur,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,1372.0,1379.0,1481.0,2043.0,2351.0,2410.0,2218.0,2070.0,2117.0,2079.0,1617.0,1410.0,22547.0
Sangrur,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,1352.0,1414.0,1516.0,2031.0,2395.0,2405.0,2223.0,2092.0,2144.0,2109.0,1389.0,1195.0,22265.0
Sangrur,6.3,PNC maternal complications attended,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sangrur,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,55.0,65.0,60.0,55.0,56.0,49.0,22.0,37.0,34.0,32.0,42.0,37.0,544.0
Sangrur,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,0.0,0.0,0.0,0.0,0.0,3.0,0.0,4.0,0.0,0.0,2.0,5.0,14.0
Sangrur,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,55.0,65.0,60.0,55.0,56.0,52.0,22.0,41.0,34.0,32.0,44.0,42.0,558.0
Sangrur,7.2,Number of MTPs conducted at Private Facilities,TOTAL,21.0,44.0,29.0,38.0,26.0,10.0,7.0,12.0,12.0,31.0,9.0,0.0,239.0
Sangrur,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,68.0,102.0,115.0,0.0,27.0,93.0,41.0,85.0,128.0,85.0,100.0,71.0,915.0
Sangrur,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,93.0,433.0,319.0,72.0,61.0,460.0,36.0,96.0,438.0,390.0,400.0,426.0,3224.0
Sangrur,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,161.0,535.0,434.0,72.0,88.0,553.0,77.0,181.0,566.0,475.0,500.0,497.0,4139.0
Sangrur,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sangrur,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sangrur,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,0.0,2.0,0.0,3.0,2.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,8.0
Sangrur,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,1.0,4.0,3.0,6.0,3.0,4.0,2.0,3.0,2.0,9.0,2.0,4.0,43.0
Sangrur,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Sangrur,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,1.0,6.0,3.0,9.0,5.0,5.0,2.0,3.0,2.0,9.0,2.0,4.0,51.0
Sangrur,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sangrur,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,0.0,51.0,34.0,26.0,25.0,11.0,40.0,14.0,24.0,11.0,43.0,11.0,290.0
Sangrur,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,73.0,135.0,180.0,102.0,125.0,70.0,32.0,81.0,44.0,12.0,34.0,65.0,953.0
Sangrur,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,37.0,82.0,137.0,79.0,52.0,36.0,13.0,25.0,24.0,5.0,23.0,49.0,562.0
Sangrur,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Sangrur,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,110.0,268.0,351.0,207.0,202.0,117.0,85.0,120.0,92.0,28.0,100.0,125.0,1805.0
Sangrur,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sangrur,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sangrur,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,8.0,18.0,28.0,22.0,5.0,10.0,0.0,4.0,0.0,1.0,6.0,5.0,107.0
Sangrur,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,37.0,79.0,132.0,41.0,43.0,25.0,10.0,35.0,14.0,15.0,31.0,54.0,516.0
Sangrur,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Sangrur,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,45.0,97.0,160.0,63.0,48.0,35.0,10.0,39.0,14.0,16.0,37.0,59.0,623.0
Sangrur,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sangrur,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sangrur,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sangrur,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,13.0,20.0,25.0,5.0,33.0,37.0,32.0,26.0,10.0,26.0,33.0,17.0,277.0
Sangrur,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Sangrur,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,13.0,20.0,25.0,5.0,33.0,37.0,32.0,26.0,10.0,26.0,33.0,17.0,277.0
Sangrur,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sangrur,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,844.0,870.0,803.0,875.0,820.0,840.0,713.0,640.0,603.0,553.0,658.0,516.0,8735.0
Sangrur,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,5.0,6.0,4.0,3.0,3.0,4.0,3.0,3.0,4.0,3.0,4.0,2.0,44.0
Sangrur,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,25.0,35.0,28.0,45.0,31.0,35.0,25.0,21.0,18.0,25.0,16.0,35.0,339.0
Sangrur,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,148.0,146.0,143.0,206.0,176.0,151.0,194.0,186.0,218.0,210.0,215.0,203.0,2196.0
Sangrur,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Sangrur,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,1022.0,1057.0,978.0,1129.0,1030.0,1030.0,935.0,850.0,843.0,791.0,893.0,756.0,11314.0
Sangrur,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,28.0,20.0,38.0,23.0,0.0,16.0,9.0,26.0,0.0,27.0,41.0,45.0,273.0
Sangrur,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sangrur,9.06,Number of IUCD removals,TOTAL,414.0,200.0,173.0,161.0,152.0,241.0,209.0,144.0,154.0,136.0,152.0,141.0,2277.0
Sangrur,9.07,Number of Oral Pills cycles distributed,TOTAL,6072.0,5933.0,6017.0,5381.0,5097.0,5330.0,5748.0,5656.0,4685.0,5321.0,5604.0,5113.0,65957.0
Sangrur,9.08,Number of Condom pieces distributed,TOTAL,114858.0,101031.0,116070.0,98409.0,117447.0,119066.0,132648.0,132991.0,115325.0,132824.0,131915.0,122456.0,1435040.0
Sangrur,9.09,Number of Centchroman (weekly) pills given,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,4.0,4.0
Sangrur,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sangrur,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,0.0,2.0
Sangrur,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sangrur,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sangrur,9.11.2.b,Number of failures following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sangrur,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sangrur,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sangrur,9.12,Number of Institutions having NSV trained doctors,TOTAL,2.0,,2.0,1.0,1.0,1.0,1.0,,1.0,,2.0,2.0,-1.0
Sangrur,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,1687.0,1812.0,1598.0,1900.0,2268.0,2263.0,2428.0,2350.0,2061.0,2100.0,1990.0,1649.0,24106.0
Sangrur,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,1808.0,1992.0,1548.0,1684.0,1924.0,2017.0,2230.0,2341.0,2020.0,2170.0,335.0,292.0,20361.0
Sangrur,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,1955.0,1855.0,1745.0,1687.0,1667.0,1763.0,1955.0,2178.0,2179.0,2079.0,1911.0,661.0,21635.0
Sangrur,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,2172.0,2172.0,1721.0,1882.0,1661.0,1685.0,1795.0,2002.0,2073.0,2174.0,1931.0,1564.0,22832.0
Sangrur,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1691.0,1489.0,3180.0
Sangrur,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,32.0,1088.0,1120.0
Sangrur,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,6.0,173.0,179.0
Sangrur,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,1098.0,1009.0,1145.0,1572.0,1759.0,1188.0,1587.0,1457.0,1571.0,1526.0,1292.0,1192.0,16396.0
Sangrur,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,1808.0,1992.0,1548.0,1684.0,1926.0,2017.0,2230.0,2341.0,2020.0,2170.0,1574.0,1773.0,23083.0
Sangrur,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,1955.0,1855.0,1745.0,1687.0,1667.0,1763.0,1955.0,2178.0,2179.0,2079.0,1925.0,1749.0,22737.0
Sangrur,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,2172.0,2172.0,1721.0,1882.0,1661.0,1685.0,1795.0,2002.0,2073.0,2174.0,1933.0,1736.0,23006.0
Sangrur,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,1002.0,910.0,1069.0,1442.0,1690.0,1125.0,1554.0,1359.0,1552.0,1526.0,1235.0,1140.0,15604.0
Sangrur,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,1807.0,1992.0,1548.0,1684.0,1926.0,2017.0,2230.0,2341.0,2020.0,2170.0,343.0,292.0,20370.0
Sangrur,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,1953.0,1858.0,1745.0,1687.0,1667.0,1763.0,1955.0,2178.0,2179.0,2079.0,1911.0,661.0,21636.0
Sangrur,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,2169.0,2172.0,1723.0,1882.0,1661.0,1685.0,1795.0,2002.0,2073.0,2174.0,1931.0,1564.0,22831.0
Sangrur,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,1797.0,2220.0,2071.0,2178.0,2192.0,2058.0,1875.0,2022.0,1608.0,1738.0,1618.0,1467.0,22844.0
Sangrur,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,2059.0,2209.0,1803.0,1858.0,1769.0,1560.0,1486.0,1811.0,1631.0,1813.0,1864.0,1759.0,21622.0
Sangrur,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sangrur,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,976.0,1208.0,1129.0,1193.0,1221.0,1115.0,1027.0,1079.0,872.0,961.0,871.0,767.0,12419.0
Sangrur,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,821.0,1012.0,939.0,985.0,971.0,943.0,848.0,943.0,736.0,777.0,747.0,670.0,10392.0
Sangrur,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,1797.0,2220.0,2068.0,2178.0,2192.0,2058.0,1875.0,2022.0,1608.0,1738.0,1618.0,1437.0,22811.0
Sangrur,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,2059.0,2209.0,1801.0,1858.0,1769.0,1599.0,1488.0,1811.0,1649.0,1825.0,1876.0,1759.0,21703.0
Sangrur,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,2059.0,2209.0,1801.0,1858.0,1769.0,1599.0,1488.0,1811.0,1649.0,1825.0,1876.0,1759.0,21703.0
Sangrur,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sangrur,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,15.0,15.0
Sangrur,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,0.0,0.0,3.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,15.0,18.0
Sangrur,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,0.0,0.0,3.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,30.0,33.0
Sangrur,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,1306.0,2438.0,1283.0,2037.0,2123.0,1879.0,1688.0,1936.0,1499.0,1272.0,1170.0,1589.0,20220.0
Sangrur,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,1099.0,3468.0,988.0,1716.0,2446.0,2027.0,1856.0,1837.0,1345.0,975.0,887.0,1398.0,20042.0
Sangrur,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,738.0,2878.0,643.0,1254.0,2247.0,1696.0,1452.0,1382.0,1262.0,778.0,828.0,1152.0,16310.0
Sangrur,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sangrur,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sangrur,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sangrur,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,904.0,896.0,929.0,926.0,906.0,900.0,908.0,904.0,891.0,907.0,899.0,871.0,10841.0
Sangrur,10.4.2,Number of Immunisation sessions held during the month,TOTAL,887.0,891.0,923.0,915.0,888.0,877.0,891.0,894.0,876.0,893.0,881.0,730.0,10546.0
Sangrur,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,751.0,754.0,766.0,770.0,760.0,753.0,754.0,743.0,745.0,752.0,752.0,630.0,8930.0
Sangrur,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sangrur,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,1797.0,2220.0,2057.0,2199.0,2122.0,2061.0,1961.0,2005.0,1655.0,1675.0,1314.0,1095.0,22161.0
Sangrur,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,1559.0,2036.0,1671.0,1448.0,1454.0,1751.0,1885.0,1535.0,1466.0,1262.0,1282.0,1060.0,18409.0
Sangrur,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,1475.0,2375.0,1885.0,1546.0,1525.0,1715.0,1827.0,1773.0,1514.0,1206.0,1229.0,1014.0,19084.0
Sangrur,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sangrur,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sangrur,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sangrur,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sangrur,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sangrur,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,1.0,2.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,1.0,14.0,19.0
Sangrur,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,25.0,126.0,21.0,11.0,3.0,9.0,9.0,4.0,10.0,4.0,18.0,6.0,246.0
Sangrur,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,427.0,0.0,427.0
Sangrur,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,15.0,18.0,1.0,5.0,2.0,5.0,4.0,4.0,3.0,3.0,12.0,1.0,73.0
Sangrur,13.1,Number of Patients operated for cataract,TOTAL,652.0,444.0,325.0,284.0,465.0,1011.0,1041.0,2184.0,826.0,378.0,661.0,1053.0,9324.0
Sangrur,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,650.0,442.0,323.0,281.0,460.0,1007.0,1038.0,2181.0,824.0,376.0,661.0,1053.0,9296.0
Sangrur,13.3,Number of School children detected with Refractive errors,TOTAL,12.0,15.0,18.0,288.0,163.0,150.0,503.0,245.0,105.0,375.0,23.0,0.0,1897.0
Sangrur,13.4,Number of children provided free glasses,TOTAL,0.0,0.0,28.0,36.0,385.0,197.0,85.0,621.0,261.0,261.0,20.0,0.0,1894.0
Sangrur,13.5,Number of eyes collected through eye donation,TOTAL,0.0,0.0,2.0,6.0,6.0,2.0,2.0,19.0,6.0,2.0,0.0,1.0,46.0
Sangrur,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sangrur,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,2.0,1.0,3.0,4.0,5.0,4.0,3.0,4.0,4.0,4.0,5.0,4.0,-1.0
Sangrur,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,2.0,,5.0,7.0,7.0,6.0,6.0,7.0,7.0,6.0,4.0,8.0,-1.0
Sangrur,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,604.0,584.0,598.0,583.0,598.0,604.0,606.0,603.0,611.0,602.0,581.0,448.0,-1.0
Sangrur,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,6.0,4.0,4.0,6.0,5.0,4.0,3.0,4.0,6.0,6.0,6.0,7.0,-1.0
Sangrur,14.05,Number of RKS meetings held during the month,TOTAL,12.0,12.0,11.0,8.0,8.0,7.0,10.0,9.0,10.0,7.0,9.0,10.0,113.0
Sangrur,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,1.0,1.0,4.0,5.0,3.0,2.0,2.0,4.0,4.0,4.0,5.0,5.0,-1.0
Sangrur,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,89.0,75.0,116.0,86.0,142.0,62.0,46.0,29.0,118.0,73.0,58.0,63.0,957.0
Sangrur,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,,,1.0,1.0,1.0,1.0,1.0,,1.0,,2.0,3.0,-1.0
Sangrur,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,9.0,5.0,1.0,2.0,2.0,1.0,2.0,4.0,4.0,1.0,4.0,45.0,-1.0
Sangrur,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,418.0,398.0,242.0,461.0,972.0,648.0,342.0,599.0,549.0,519.0,284.0,372.0,5804.0
Sangrur,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,958.0,1229.0,777.0,1382.0,766.0,1438.0,700.0,1065.0,1005.0,1031.0,1429.0,1169.0,12949.0
Sangrur,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,318.0,318.0,300.0,470.0,1244.0,518.0,296.0,701.0,521.0,404.0,330.0,332.0,5752.0
Sangrur,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,2137.0,2102.0,1820.0,2987.0,2398.0,3180.0,2133.0,2605.0,2782.0,2270.0,2170.0,2269.0,28853.0
Sangrur,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,736.0,716.0,542.0,931.0,2216.0,1166.0,638.0,1300.0,1070.0,923.0,614.0,704.0,11556.0
Sangrur,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,3095.0,3331.0,2597.0,4369.0,3164.0,4618.0,2833.0,3670.0,3787.0,3301.0,3599.0,3438.0,41802.0
Sangrur,14.10.2.a,Number of death cases of Inpatient males,TOTAL,9.0,14.0,2.0,10.0,5.0,7.0,3.0,18.0,23.0,11.0,5.0,22.0,129.0
Sangrur,14.10.2.b,Number of death cases of Inpatient females,TOTAL,7.0,8.0,4.0,5.0,3.0,7.0,4.0,8.0,12.0,8.0,1.0,11.0,78.0
Sangrur,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,16.0,22.0,6.0,15.0,8.0,14.0,7.0,26.0,35.0,19.0,6.0,33.0,207.0
Sangrur,14.11,In-Patient Head Count at midnight,TOTAL,749.0,52.0,42.0,106.0,253.0,51.0,72.0,791.0,863.0,32.0,266.0,41.0,3318.0
Sangrur,14.12.1,OPD attendance (All),TOTAL,107536.0,81636.0,83964.0,105520.0,110288.0,104811.0,76979.0,98786.0,93578.0,82101.0,106249.0,113373.0,1164821.0
Sangrur,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,706.0,539.0,510.0,645.0,773.0,847.0,351.0,771.0,1022.0,659.0,753.0,745.0,8321.0
Sangrur,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,4.0,2.0,8.0,24.0,39.0
Sangrur,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,1857.0,1171.0,1261.0,2074.0,1894.0,2363.0,1120.0,1947.0,1901.0,1727.0,1675.0,1843.0,20833.0
Sangrur,14.14.a,Number of patients given AYUSH treatment,TOTAL,7730.0,9942.0,9169.0,9058.0,10099.0,9895.0,8891.0,9933.0,11156.0,10955.0,10952.0,7296.0,115076.0
Sangrur,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,1676.0,994.0,1685.0,1495.0,1705.0,1605.0,1674.0,1911.0,1414.0,1370.0,1586.0,2140.0,19255.0
Sangrur,14.14.c,Number of Adolescents counselled,TOTAL,16.0,0.0,0.0,0.0,3.0,2.0,1.0,2.0,4.0,0.0,31.0,41.0,100.0
Sangrur,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,7404.0,9690.0,8282.0,6723.0,6878.0,6246.0,6091.0,5528.0,9112.0,6445.0,8505.0,8689.0,89593.0
Sangrur,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,182.0,225.0,116.0,62.0,83.0,31.0,229.0,80.0,180.0,73.0,167.0,167.0,1595.0
Sangrur,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,506.0,647.0,300.0,418.0,531.0,614.0,452.0,621.0,531.0,423.0,114.0,418.0,5575.0
Sangrur,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,7.0,4.0,5.0,3.0,5.0,4.0,4.0,9.0,3.0,3.0,67.0,0.0,114.0
Sangrur,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,641.0,939.0,433.0,489.0,620.0,637.0,383.0,606.0,734.0,507.0,122.0,754.0,6865.0
Sangrur,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,4.0,3.0,1.0,1.0,1.0,116.0,2.0,4.0,1.0,3.0,80.0,5.0,221.0
Sangrur,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,1286.0,1551.0,947.0,1038.0,1352.0,1188.0,913.0,1363.0,1300.0,1241.0,534.0,1343.0,14056.0
Sangrur,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,6.0,2.0,0.0,0.0,0.0,1.0,94.0,102.0,99.0,1.0,295.0,0.0,600.0
Sangrur,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,2433.0,3137.0,1680.0,1945.0,2503.0,2439.0,1748.0,2590.0,2565.0,2171.0,770.0,2515.0,26496.0
Sangrur,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,17.0,9.0,6.0,4.0,6.0,121.0,100.0,115.0,103.0,7.0,442.0,5.0,935.0
Sangrur,15.2,Number of Widal tests conducted,Number tested,596.0,464.0,463.0,350.0,511.0,465.0,548.0,561.0,367.0,255.0,765.0,1353.0,6698.0
Sangrur,15.3.a,Number of VDRL tests conducted on males,Number tested,245.0,124.0,14.0,78.0,57.0,81.0,67.0,122.0,90.0,56.0,23.0,82.0,1039.0
Sangrur,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,255.0,242.0,22.0,269.0,190.0,350.0,163.0,257.0,282.0,171.0,18.0,322.0,2541.0
Sangrur,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,1126.0,1863.0,1390.0,1047.0,1361.0,1226.0,1436.0,1741.0,1992.0,1095.0,1439.0,2069.0,17785.0
Sangrur,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,1626.0,2229.0,1426.0,1394.0,1608.0,1657.0,1666.0,2120.0,2364.0,1322.0,1480.0,2473.0,21365.0
Sangrur,15.4.1,Number of blood smears examined for Malaria,TOTAL,7462.0,10661.0,6180.0,5468.0,6381.0,6920.0,8074.0,7018.0,6278.0,5569.0,6451.0,6802.0,83264.0
Sangrur,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,1.0,1.0,0.0,2.0,3.0,1.0,1.0,0.0,0.0,0.0,0.0,0.0,9.0
Sangrur,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sangrur,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,9500.0,6500.0,13000.0,11000.0,20500.0,20500.0,10500.0,27500.0,16500.0,11000.0,12000.0,11000.0,169500.0
Sangrur,16.1.1,Stock position of DPT vaccines,2. Stocks Received,10000.0,14000.0,8000.0,25000.0,5000.0,6000.0,24000.0,0.0,4000.0,8000.0,7000.0,8000.0,119000.0
Sangrur,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sangrur,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,13000.0,7500.0,10000.0,15500.0,10500.0,10500.0,7000.0,11000.0,9500.0,7000.0,8000.0,9000.0,118500.0
Sangrur,16.1.1,Stock position of DPT vaccines,5. Total Stock,6500.0,13000.0,11000.0,20500.0,15000.0,16000.0,27500.0,16500.0,11000.0,12000.0,11000.0,10000.0,170000.0
Sangrur,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,,,0.0,0.0,0.0,0.0,0.0,,,0.0,8000.0,6720.0,14720.0
Sangrur,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,,,0.0,0.0,0.0,0.0,0.0,,,8000.0,3000.0,6000.0,17000.0
Sangrur,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,,,0.0,0.0,0.0,0.0,0.0,,,0.0,0.0,0.0,0.0
Sangrur,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,,,0.0,0.0,0.0,0.0,0.0,,,0.0,4280.0,4520.0,8800.0
Sangrur,16.1.1A,Stock Position of Pentavalent,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,8000.0,6720.0,8200.0,22920.0
Sangrur,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,29000.0,17000.0,13500.0,17000.0,13500.0,14500.0,12500.0,16500.0,16000.0,247500.0,19700.0,17500.0,434200.0
Sangrur,16.1.2,Stock position of OPV vaccines,2. Stocks Received,0.0,5000.0,16000.0,15000.0,16000.0,16000.0,13000.0,13000.0,248000.0,11000.0,238000.0,4000.0,595000.0
Sangrur,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sangrur,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,12000.0,8500.0,12500.0,18500.0,15000.0,18000.0,9000.0,13500.0,16500.0,238800.0,240200.0,3000.0,605500.0
Sangrur,16.1.2,Stock position of OPV vaccines,5. Total Stock,17000.0,13500.0,17000.0,13500.0,14500.0,12500.0,16500.0,16000.0,247500.0,19700.0,17500.0,18500.0,423700.0
Sangrur,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,9300.0,8500.0,12300.0,10000.0,20000.0,20000.0,12000.0,16000.0,12000.0,12000.0,12500.0,12500.0,157100.0
Sangrur,16.1.3,Stock position of TT vaccines,2. Stocks Received,8000.0,12000.0,6000.0,25000.0,6000.0,7000.0,11000.0,4000.0,8000.0,8000.0,6000.0,5000.0,106000.0
Sangrur,16.1.3,Stock position of TT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sangrur,16.1.3,Stock position of TT vaccines,4. Stock Distributed,8800.0,8200.0,8300.0,15000.0,11500.0,11500.0,7000.0,8000.0,8000.0,7500.0,6000.0,7000.0,106800.0
Sangrur,16.1.3,Stock position of TT vaccines,5. Total Stock,8500.0,12300.0,10000.0,20000.0,14500.0,15500.0,16000.0,12000.0,12000.0,12500.0,12500.0,10500.0,156300.0
Sangrur,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,,,0.0,0.0,0.0,,0.0,,,,,,0.0
Sangrur,16.1.4,Stock position of DT vaccines,2. Stocks Received,,,0.0,0.0,0.0,,0.0,,,,,,0.0
Sangrur,16.1.4,Stock position of DT vaccines,3. Unusable Stock,,,0.0,0.0,0.0,,0.0,,,,,,0.0
Sangrur,16.1.4,Stock position of DT vaccines,4. Stock Distributed,,,0.0,0.0,0.0,,0.0,,,,,,0.0
Sangrur,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sangrur,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,7500.0,5250.0,6500.0,6500.0,4500.0,6000.0,4500.0,7000.0,6000.0,6000.0,7000.0,7000.0,73750.0
Sangrur,16.1.5,Stock position of BCG vaccines,2. Stocks Received,4000.0,5000.0,4000.0,5000.0,5000.0,5000.0,7000.0,5000.0,6000.0,5000.0,5000.0,4000.0,60000.0
Sangrur,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sangrur,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,6250.0,3750.0,4000.0,7000.0,3500.0,5500.0,4500.0,6000.0,6000.0,4000.0,5000.0,5000.0,60500.0
Sangrur,16.1.5,Stock position of BCG vaccines,5. Total Stock,5250.0,6500.0,6500.0,4500.0,6000.0,5500.0,7000.0,6000.0,6000.0,7000.0,7000.0,6000.0,73250.0
Sangrur,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,5750.0,4750.0,6250.0,6500.0,5500.0,5500.0,2500.0,6250.0,3750.0,8000.0,7250.0,7250.0,69250.0
Sangrur,16.1.6,Stock position of Measles vaccines,2. Stocks Received,4000.0,6000.0,5000.0,6000.0,5000.0,5000.0,6000.0,2000.0,8000.0,5000.0,6000.0,5000.0,63000.0
Sangrur,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sangrur,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,5000.0,4500.0,4750.0,7000.0,5000.0,5000.0,2250.0,4500.0,3750.0,5750.0,6000.0,5500.0,59000.0
Sangrur,16.1.6,Stock position of Measles vaccines,5. Total Stock,4750.0,6250.0,6500.0,5500.0,5500.0,5500.0,6250.0,3750.0,8000.0,7250.0,7250.0,6750.0,73250.0
Sangrur,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,0.0,,0.0,0.0,0.0,,0.0,,,,,,0.0
Sangrur,16.1.7,Stock position of JE vaccines,2. Stocks Received,0.0,,0.0,0.0,0.0,,0.0,,,,,,0.0
Sangrur,16.1.7,Stock position of JE vaccines,3. Unusable Stock,0.0,,0.0,0.0,0.0,,0.0,,,,,,0.0
Sangrur,16.1.7,Stock position of JE vaccines,4. Stock Distributed,0.0,,0.0,0.0,0.0,,0.0,,,,,,0.0
Sangrur,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sangrur,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,10500.0,9700.0,13000.0,12100.0,11500.0,14500.0,9500.0,15000.0,11000.0,11500.0,5000.0,11500.0,134800.0
Sangrur,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,11000.0,11000.0,7000.0,12000.0,10000.0,10000.0,12000.0,5000.0,10000.0,1000.0,16000.0,5000.0,110000.0
Sangrur,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sangrur,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,11800.0,7700.0,7900.0,12600.0,7000.0,9000.0,6500.0,9000.0,9500.0,7500.0,9500.0,7000.0,105000.0
Sangrur,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,9700.0,13000.0,12100.0,11500.0,14500.0,15500.0,15000.0,11000.0,11500.0,5000.0,11500.0,9500.0,139800.0
Sangrur,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,13206.0,13206.0,32382.0,10782.0,13206.0,10782.0,9582.0,9582.0,9582.0,9260.0,9260.0,6860.0,147690.0
Sangrur,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,0.0,19176.0,0.0,0.0,19176.0,0.0,,,0.0,0.0,0.0,0.0,38352.0
Sangrur,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0,0.0,0.0,0.0,0.0
Sangrur,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,0.0,0.0,21600.0,0.0,22800.0,1200.0,,,322.0,0.0,2400.0,0.0,48322.0
Sangrur,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,13206.0,32382.0,10782.0,10782.0,9582.0,9582.0,9582.0,9582.0,9260.0,9260.0,6860.0,6860.0,137720.0
Sangrur,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,0.0,,,,0.0,0.0,,,0.0,54220.0,8860.0,0.0,63080.0
Sangrur,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,0.0,,,,0.0,143600.0,,,89500.0,0.0,0.0,0.0,233100.0
Sangrur,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,0.0,,,,0.0,0.0,,,0.0,0.0,0.0,0.0,0.0
Sangrur,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,0.0,,,,0.0,143600.0,,,35280.0,45360.0,8860.0,0.0,233100.0
Sangrur,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,54220.0,8860.0,0.0,0.0,63080.0
Sangrur,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,0.0,,,,0.0,0.0,,,,,0.0,2300.0,2300.0
Sangrur,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,,,,0.0,10700.0,,,,,9300.0,0.0,20000.0
Sangrur,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,0.0,,,,0.0,0.0,,,,,0.0,0.0,0.0
Sangrur,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,0.0,,,,0.0,10700.0,,,,,7000.0,2300.0,20000.0
Sangrur,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2300.0,0.0,2300.0
Sangrur,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,0.0,,,,0.0,0.0,,,,,0.0,0.0,0.0
Sangrur,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,,,,0.0,50.0,,,,,64.0,0.0,114.0
Sangrur,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,0.0,,,,0.0,0.0,,,,,0.0,0.0,0.0
Sangrur,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,0.0,,,,0.0,50.0,,,,,64.0,0.0,114.0
Sangrur,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sangrur,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,400.0,400.0,400.0,6000.0,6000.0,6000.0,6000.0,6000.0,6000.0,6000.0,6000.0,5600.0,54800.0
Sangrur,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,0.0,0.0,5600.0,0.0,8000.0,,,,,,0.0,0.0,13600.0
Sangrur,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,,,,,,0.0,0.0,0.0
Sangrur,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,0.0,2400.0,0.0,,,,,400.0,0.0,2800.0
Sangrur,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,400.0,400.0,6000.0,6000.0,11600.0,6000.0,6000.0,6000.0,6000.0,6000.0,5600.0,5600.0,65600.0
Sangrur,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,,,,,,0.0,,,,,,,0.0
Sangrur,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,,,,,,,,,,,,,
Sangrur,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,,,,,,,,,,,,,
Sangrur,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,,,,,,,,,,,,,
Sangrur,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sangrur,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,,,,,,,,,,,,,
Sangrur,16.3.02,Stock Position of Gloves,2. Stocks Received,,,,,,,,,,,,,
Sangrur,16.3.02,Stock Position of Gloves,3. Unusable Stock,,,,,,,,,,,,,
Sangrur,16.3.02,Stock Position of Gloves,4. Stock Distributed,,,,,,,,,,,,,
Sangrur,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sangrur,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,,,,,,,,,,,,,
Sangrur,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,,,,,,,,,,,,,
Sangrur,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,,,,,,,,,,,,,
Sangrur,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,,,,,,,,,,,,,
Sangrur,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sangrur,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
Sangrur,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,,,,,,,,,,,,,
Sangrur,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,,,,,,,,,,,,,
Sangrur,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,,,,,,,,,,,,,
Sangrur,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sangrur,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,,,,,,,,,,,,,
Sangrur,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,,,,,,,,,,,,,
Sangrur,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,,,,,,,,,,,,,
Sangrur,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,,,,,,,,,,,,,
Sangrur,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sangrur,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,,,,,,,,,,,,,
Sangrur,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,,,,,,,,,,,,,
Sangrur,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,,,,,,,,,,,,,
Sangrur,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,,,,,,,,,,,,,
Sangrur,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sangrur,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
Sangrur,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,,,,,,,,,,,,,
Sangrur,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,,,,,,,,,,,,,
Sangrur,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,,,,,,,,,,,,,
Sangrur,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sangrur,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,,,,,,,,,,,,,
Sangrur,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,,,,,,,,,,,,,
Sangrur,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,,,,,,,,,,,,,
Sangrur,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,,,,,,,,,,,,,
Sangrur,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sangrur,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,,,,,,,,,,,,,
Sangrur,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,,,,,,,,,,,,,
Sangrur,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,,,,,,,,,,,,,
Sangrur,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,,,,,,,,,,,,,
Sangrur,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sangrur,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,,,,,,,,,,,,,
Sangrur,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,,,,,,,,,,,,,
Sangrur,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,,,,,,,,,,,,,
Sangrur,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,,,,,,,,,,,,,
Sangrur,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sangrur,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,,,,,,,,,,,,,
Sangrur,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,,,,,,,,,,,,,
Sangrur,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,,,,,,,,,,,,,
Sangrur,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,,,,,,,,,,,,,
Sangrur,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sangrur,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,3000.0,1400.0,1800.0,2200.0,3400.0,3400.0,3000.0,7800.0,5400.0,3400.0,2000.0,6700.0,43500.0
Sangrur,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,2000.0,2000.0,2000.0,4000.0,2000.0,2000.0,6000.0,0.0,0.0,0.0,6000.0,0.0,26000.0
Sangrur,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sangrur,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,3600.0,1600.0,1600.0,2800.0,2000.0,2400.0,1200.0,2400.0,2000.0,1400.0,1300.0,3100.0,25400.0
Sangrur,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,1400.0,1800.0,2200.0,3400.0,3400.0,3000.0,7800.0,5400.0,3400.0,2000.0,6700.0,3600.0,44100.0
Sangrur,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,16000.0,12000.0,800.0,32000.0,80000.0,80000.0,28000.0,102000.0,78000.0,58000.0,60000.0,42000.0,588800.0
Sangrur,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,10000.0,0.0,50000.0,90000.0,0.0,16000.0,90000.0,0.0,0.0,10000.0,0.0,20000.0,286000.0
Sangrur,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sangrur,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,14000.0,11200.0,18800.0,42000.0,44000.0,44000.0,16000.0,24000.0,20000.0,8000.0,18000.0,22000.0,282000.0
Sangrur,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,12000.0,800.0,32000.0,80000.0,36000.0,52000.0,102000.0,78000.0,58000.0,60000.0,42000.0,40000.0,592800.0
Sangrur,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,200.0,2100.0,3200.0,2000.0,2500.0,3700.0,1800.0,5700.0,4000.0,2400.0,1600.0,3000.0,32200.0
Sangrur,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,2400.0,2400.0,0.0,2400.0,2400.0,2400.0,4800.0,0.0,0.0,0.0,2400.0,0.0,19200.0
Sangrur,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sangrur,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,500.0,1300.0,1200.0,1900.0,1200.0,1900.0,900.0,1700.0,1600.0,800.0,1000.0,2000.0,16000.0
Sangrur,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,2100.0,3200.0,2000.0,2500.0,3700.0,4200.0,5700.0,4000.0,2400.0,1600.0,3000.0,1000.0,35400.0
Sangrur,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,1.0,,,,,,,,,,,,1.0
Sangrur,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Sangrur,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Sangrur,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,,,,,,,,,,,,
Sangrur,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Sangrur,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Sangrur,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,,,,,,,,,,,,,
Sangrur,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Sangrur,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Sangrur,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,,,,,,,,,,,,,
Sangrur,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,1.0,,,,,,,,,,,,1.0
Sangrur,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,3.0,,,,,,,,,,,,3.0
Sangrur,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,4.0,,,,,,,,,,,,4.0
Sangrur,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,,,,,,,,,,,,
Sangrur,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,,,,,,,,,,
Sangrur,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,,,,,,,,,,,,,
Sangrur,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,,,,,,
Sangrur,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
Sangrur,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,,,,,,,,,
Sangrur,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,,,,,,,,,,,
Sangrur,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,,,,,,,,,,
Sangrur,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,,,,,,,,,,,,
Sangrur,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Sangrur,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Sangrur,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Sangrur,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,1.0,,,,,,,,,,,,1.0
Sangrur,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,2.0,3.0,,,,,,,,1.0,,,6.0
Sangrur,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,3.0,3.0,,,,,,,,1.0,,,7.0
Sangrur,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
Sangrur,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,,,,,,,,,
Sangrur,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,,,,,,,,,
Sangrur,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,,,,,,,,,,,
Sangrur,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,1.0,,,,,,,,,,,,1.0
Sangrur,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,,,1.0,,,,1.0,1.0,1.0,1.0,,,5.0
Sangrur,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,1.0,,,,,,,,,1.0,,,2.0
Sangrur,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,2.0,,1.0,,,,1.0,1.0,1.0,2.0,,,8.0
Sangrur,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,,,,,,
Sangrur,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,,,,1.0,,1.0,,,,,,,2.0
Sangrur,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,,,,,,,,,,,,1.0,1.0
Sangrur,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,,,,1.0,,1.0,,,,,,1.0,3.0
Sangrur,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
Sangrur,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,,,,,,,,
Sangrur,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
Sangrur,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,,,,,,,,,,
Sangrur,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,,,,,,,,,,
Sangrur,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,2.0,,,,,,,,,,1.0,,3.0
Sangrur,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,,,,,,,1.0,,,,,,1.0
Sangrur,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,2.0,,,,,,1.0,,,,1.0,,4.0
Sangrur,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
Sangrur,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,,,,,,,,,,,
Sangrur,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,,,,
Sangrur,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,,,,,,,,,,,
Sangrur,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,1.0,,,1.0,,,,,1.0,,3.0
Sangrur,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,20.0,3.0,1.0,2.0,3.0,4.0,3.0,7.0,7.0,13.0,6.0,8.0,77.0
Sangrur,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,19.0,4.0,6.0,1.0,6.0,5.0,10.0,9.0,22.0,4.0,12.0,7.0,105.0
Sangrur,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,39.0,7.0,8.0,3.0,9.0,10.0,13.0,16.0,29.0,17.0,19.0,15.0,185.0
Sangrur,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,,,,,,,
Sangrur,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,,,,,,,,,,1.0,1.0,,2.0
Sangrur,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,,,,,,,,,,,1.0,,1.0
Sangrur,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,,,,,,,,,,1.0,2.0,,3.0
Sangrur,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Sangrur,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
Sangrur,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Sangrur,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
Sangrur,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Sangrur,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,,,,,,,,
Sangrur,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Sangrur,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,,,,,,,,
Sangrur,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Sangrur,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,,,,,,,,,,
Sangrur,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Sangrur,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,,,,,,,,,,,
Sangrur,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Sangrur,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,,,,,,,,,,,
Sangrur,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Sangrur,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,,,,,,,,,,,
Sangrur,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Sangrur,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,,,,,,,
Sangrur,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Sangrur,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,,,,,,,
Sangrur,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Sangrur,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,,,,,,,,,,,,,
Sangrur,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Sangrur,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,,,,,,,,,,,,,
Sangrur,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,,,,,,,,,,,,
Sangrur,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,5.0,,2.0,4.0,1.0,1.0,3.0,4.0,,,3.0,6.0,29.0
Sangrur,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,3.0,,,,,2.0,,,,,,1.0,6.0
Sangrur,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,8.0,,2.0,4.0,1.0,3.0,3.0,4.0,,,3.0,7.0,35.0
Sangrur,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,,,,,,,,,
Sangrur,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,3.0,,1.0,1.0,,,,,3.0,2.0,3.0,1.0,14.0
Sangrur,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,1.0,,,,,,,,1.0,,,,2.0
Sangrur,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,4.0,,1.0,1.0,,,,,4.0,2.0,3.0,1.0,16.0
Sangrur,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,,,,,,,,,,
Sangrur,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,,,,,1.0,1.0,,,,,,2.0
Sangrur,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,,,,,,,,,,,
Sangrur,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,,,,,,1.0,1.0,,,,,,2.0
Sangrur,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,,,,1.0,,,,,,,1.0
Sangrur,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,4.0,,1.0,1.0,,2.0,,5.0,7.0,1.0,2.0,1.0,24.0
Sangrur,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,8.0,,5.0,3.0,1.0,2.0,3.0,2.0,1.0,4.0,9.0,6.0,44.0
Sangrur,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,12.0,,6.0,4.0,1.0,5.0,3.0,7.0,8.0,5.0,11.0,7.0,69.0
Sangrur,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,,,,,,,,,,,,
Sangrur,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,6.0,,,,2.0,2.0,2.0,1.0,4.0,4.0,2.0,2.0,25.0
Sangrur,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,14.0,1.0,2.0,3.0,3.0,1.0,,6.0,,4.0,6.0,,40.0
Sangrur,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,20.0,1.0,2.0,3.0,5.0,3.0,2.0,7.0,4.0,8.0,8.0,2.0,65.0
Sangrur,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,,1.0,,,,,,,,,,,1.0
Sangrur,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,22.0,7.0,1.0,3.0,4.0,,4.0,1.0,4.0,6.0,5.0,2.0,59.0
Sangrur,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,97.0,37.0,19.0,19.0,17.0,17.0,33.0,32.0,55.0,66.0,38.0,14.0,444.0
Sangrur,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,119.0,45.0,20.0,22.0,21.0,17.0,37.0,33.0,59.0,72.0,43.0,16.0,504.0
Tarn Taran,1.1,Total number of pregnant women Registered for ANC,TOTAL,2124.0,2201.0,1625.0,1824.0,1487.0,1195.0,1326.0,1252.0,1371.0,1894.0,1948.0,1786.0,20033.0
Tarn Taran,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,1675.0,1696.0,1251.0,1336.0,1105.0,873.0,969.0,969.0,1089.0,1504.0,1565.0,1434.0,15466.0
Tarn Taran,1.2,Number of Pregnant women registered under JSY,TOTAL,1045.0,1043.0,819.0,850.0,738.0,603.0,644.0,631.0,722.0,988.0,993.0,861.0,9937.0
Tarn Taran,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,1309.0,1522.0,1577.0,1781.0,1731.0,1580.0,1587.0,1421.0,1362.0,1339.0,1214.0,1235.0,17658.0
Tarn Taran,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,1939.0,2027.0,1486.0,1408.0,1166.0,1071.0,1061.0,981.0,1063.0,1526.0,1591.0,1460.0,16779.0
Tarn Taran,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,1868.0,1986.0,1874.0,1531.0,1424.0,1178.0,1149.0,1069.0,1113.0,1206.0,1458.0,1573.0,17429.0
Tarn Taran,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,1314.0,1565.0,1387.0,1335.0,1036.0,592.0,417.0,238.0,170.0,247.0,475.0,541.0,9317.0
Tarn Taran,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,56.0,59.0,65.0,68.0,71.0,66.0,50.0,53.0,36.0,52.0,42.0,38.0,656.0
Tarn Taran,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tarn Taran,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,1897.0,1983.0,1415.0,1666.0,1384.0,1083.0,1264.0,1173.0,1285.0,1750.0,1868.0,1645.0,18413.0
Tarn Taran,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,13.0,20.0,23.0,23.0,19.0,38.0,16.0,13.0,15.0,27.0,26.0,10.0,243.0
Tarn Taran,1.8,Number of pregnancy test kits used at SC level,TOTAL,1199.0,1178.0,1315.0,1293.0,1217.0,1047.0,1154.0,1017.0,938.0,1029.0,1416.0,1114.0,13917.0
Tarn Taran,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,77.0,81.0,104.0,119.0,145.0,133.0,148.0,112.0,114.0,134.0,113.0,89.0,1369.0
Tarn Taran,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,121.0,126.0,131.0,194.0,181.0,197.0,180.0,155.0,163.0,170.0,127.0,126.0,1871.0
Tarn Taran,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,198.0,207.0,235.0,313.0,326.0,330.0,328.0,267.0,277.0,304.0,240.0,215.0,3240.0
Tarn Taran,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,136.0,133.0,135.0,179.0,183.0,177.0,221.0,183.0,181.0,210.0,159.0,149.0,2046.0
Tarn Taran,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,7.0,11.0,7.0,9.0,10.0,12.0,8.0,7.0,6.0,13.0,3.0,4.0,97.0
Tarn Taran,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,434.0,466.0,540.0,747.0,873.0,916.0,839.0,705.0,682.0,669.0,537.0,488.0,7896.0
Tarn Taran,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,348.0,384.0,412.0,578.0,613.0,669.0,658.0,551.0,527.0,509.0,416.0,373.0,6038.0
Tarn Taran,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,265.0,309.0,343.0,439.0,548.0,566.0,610.0,510.0,633.0,478.0,398.0,285.0,5384.0
Tarn Taran,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tarn Taran,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tarn Taran,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,318.0,315.0,327.0,440.0,492.0,518.0,620.0,544.0,464.0,460.0,348.0,313.0,5159.0
Tarn Taran,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,2.0,9.0,8.0,11.0,16.0,13.0,15.0,17.0,11.0,8.0,11.0,2.0,123.0
Tarn Taran,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tarn Taran,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tarn Taran,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tarn Taran,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tarn Taran,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,71.0,73.0,67.0,91.0,133.0,137.0,118.0,109.0,113.0,122.0,76.0,103.0,1213.0
Tarn Taran,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Tarn Taran,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,71.0,73.0,67.0,91.0,133.0,137.0,118.0,109.0,113.0,122.0,76.0,103.0,1213.0
Tarn Taran,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,104.0,140.0,126.0,177.0,206.0,229.0,236.0,235.0,192.0,217.0,163.0,112.0,2137.0
Tarn Taran,4.1.1.a,Number of male live births,TOTAL,506.0,528.0,583.0,773.0,902.0,877.0,899.0,796.0,759.0,789.0,553.0,508.0,8473.0
Tarn Taran,4.1.1.b,Number of female live births,TOTAL,423.0,436.0,485.0,677.0,740.0,850.0,845.0,681.0,642.0,619.0,534.0,475.0,7407.0
Tarn Taran,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,929.0,964.0,1068.0,1450.0,1642.0,1727.0,1744.0,1477.0,1401.0,1408.0,1087.0,983.0,15880.0
Tarn Taran,4.1.2,Number of still births,TOTAL,26.0,31.0,42.0,56.0,60.0,49.0,52.0,48.0,34.0,34.0,42.0,25.0,499.0
Tarn Taran,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,67.0,84.0,85.0,83.0,64.0,77.0,72.0,45.0,45.0,54.0,72.0,38.0,786.0
Tarn Taran,4.2.1,Number of Newborns weighed at birth,TOTAL,929.0,964.0,1068.0,1450.0,1642.0,1727.0,1744.0,1477.0,1401.0,1408.0,1087.0,1037.0,15934.0
Tarn Taran,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,28.0,25.0,20.0,20.0,24.0,25.0,18.0,23.0,26.0,20.0,17.0,18.0,264.0
Tarn Taran,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,772.0,768.0,888.0,1197.0,1336.0,1427.0,1422.0,1160.0,1135.0,1182.0,897.0,830.0,13014.0
Tarn Taran,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tarn Taran,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,0.0,2.0,15.0,11.0,0.0,0.0,0.0,0.0,8.0,0.0,7.0,0.0,43.0
Tarn Taran,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,71.0,73.0,67.0,89.0,124.0,124.0,110.0,98.0,184.0,132.0,177.0,144.0,1393.0
Tarn Taran,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Tarn Taran,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,71.0,75.0,82.0,100.0,124.0,124.0,110.0,98.0,192.0,132.0,184.0,144.0,1436.0
Tarn Taran,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,15.0,21.0,15.0,13.0,20.0,33.0,34.0,24.0,20.0,24.0,25.0,13.0,257.0
Tarn Taran,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,71.0,71.0,41.0,67.0,82.0,100.0,86.0,60.0,121.0,102.0,96.0,102.0,999.0
Tarn Taran,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tarn Taran,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tarn Taran,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,15.0,25.0,56.0,46.0,62.0,57.0,58.0,62.0,91.0,54.0,113.0,55.0,694.0
Tarn Taran,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,705.0,793.0,878.0,1201.0,1340.0,1452.0,1422.0,1210.0,1117.0,1164.0,878.0,795.0,12955.0
Tarn Taran,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,457.0,510.0,656.0,831.0,909.0,916.0,892.0,804.0,797.0,741.0,599.0,533.0,8645.0
Tarn Taran,6.3,PNC maternal complications attended,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,2.0
Tarn Taran,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,18.0,22.0,17.0,15.0,13.0,9.0,4.0,2.0,5.0,14.0,9.0,0.0,128.0
Tarn Taran,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tarn Taran,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,18.0,22.0,17.0,15.0,13.0,9.0,4.0,2.0,5.0,14.0,9.0,0.0,128.0
Tarn Taran,7.2,Number of MTPs conducted at Private Facilities,TOTAL,35.0,43.0,17.0,36.0,28.0,26.0,37.0,36.0,44.0,56.0,54.0,57.0,469.0
Tarn Taran,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,68.0,114.0,94.0,102.0,79.0,84.0,83.0,127.0,86.0,65.0,63.0,30.0,995.0
Tarn Taran,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,243.0,314.0,284.0,295.0,380.0,350.0,237.0,298.0,251.0,175.0,219.0,35.0,3081.0
Tarn Taran,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,311.0,428.0,378.0,397.0,459.0,434.0,320.0,425.0,337.0,240.0,282.0,65.0,4076.0
Tarn Taran,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tarn Taran,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,6.0,3.0,3.0,3.0,9.0,12.0,6.0,14.0,10.0,1.0,3.0,1.0,71.0
Tarn Taran,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,6.0,4.0,7.0,13.0,18.0,18.0,4.0,17.0,5.0,6.0,5.0,9.0,112.0
Tarn Taran,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,5.0,6.0,3.0,5.0,6.0,4.0,1.0,110.0,2.0,4.0,0.0,2.0,148.0
Tarn Taran,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Tarn Taran,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,17.0,13.0,13.0,21.0,33.0,34.0,11.0,141.0,17.0,11.0,8.0,12.0,331.0
Tarn Taran,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tarn Taran,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tarn Taran,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tarn Taran,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,0.0,10.0,38.0,47.0,21.0,48.0,19.0,21.0,5.0,5.0,17.0,18.0,249.0
Tarn Taran,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Tarn Taran,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,0.0,10.0,38.0,47.0,21.0,48.0,19.0,21.0,5.0,5.0,17.0,18.0,249.0
Tarn Taran,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tarn Taran,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,13.0,37.0,42.0,38.0,63.0,31.0,7.0,12.0,4.0,0.0,14.0,28.0,289.0
Tarn Taran,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,121.0,89.0,117.0,90.0,115.0,54.0,34.0,33.0,16.0,17.0,46.0,118.0,850.0
Tarn Taran,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,33.0,26.0,38.0,38.0,29.0,16.0,9.0,7.0,2.0,10.0,7.0,9.0,224.0
Tarn Taran,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Tarn Taran,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,167.0,152.0,197.0,166.0,207.0,101.0,50.0,52.0,22.0,27.0,67.0,155.0,1363.0
Tarn Taran,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,1.0,1.0,1.0,0.0,2.0,2.0,2.0,5.0,1.0,0.0,1.0,0.0,16.0
Tarn Taran,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tarn Taran,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tarn Taran,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,13.0,10.0,8.0,21.0,25.0,23.0,17.0,13.0,17.0,17.0,11.0,23.0,198.0
Tarn Taran,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Tarn Taran,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,13.0,10.0,8.0,21.0,25.0,23.0,17.0,13.0,17.0,17.0,11.0,23.0,198.0
Tarn Taran,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tarn Taran,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,574.0,563.0,577.0,865.0,609.0,619.0,644.0,598.0,598.0,601.0,598.0,537.0,7383.0
Tarn Taran,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tarn Taran,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tarn Taran,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,62.0,73.0,68.0,84.0,102.0,127.0,131.0,97.0,124.0,176.0,129.0,109.0,1282.0
Tarn Taran,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Tarn Taran,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,636.0,636.0,645.0,949.0,711.0,746.0,775.0,695.0,722.0,777.0,727.0,646.0,8665.0
Tarn Taran,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,0.0,22.0,28.0,29.0,49.0,55.0,68.0,40.0,61.0,115.0,72.0,46.0,585.0
Tarn Taran,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tarn Taran,9.06,Number of IUCD removals,TOTAL,168.0,167.0,210.0,217.0,186.0,172.0,192.0,165.0,180.0,202.0,201.0,176.0,2236.0
Tarn Taran,9.07,Number of Oral Pills cycles distributed,TOTAL,4631.0,4717.0,4631.0,4742.0,4536.0,4897.0,4942.0,4840.0,4779.0,4796.0,4528.0,4724.0,56763.0
Tarn Taran,9.08,Number of Condom pieces distributed,TOTAL,86146.0,86982.0,84356.0,83724.0,78272.0,81079.0,83254.0,80537.0,80513.0,79467.0,84995.0,76182.0,985507.0
Tarn Taran,9.09,Number of Centchroman (weekly) pills given,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tarn Taran,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,87.0,92.0,50.0,52.0,43.0,36.0,30.0,46.0,43.0,20.0,24.0,10.0,533.0
Tarn Taran,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tarn Taran,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tarn Taran,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tarn Taran,9.11.2.b,Number of failures following female sterilization,TOTAL,0.0,4.0,0.0,5.0,1.0,1.0,0.0,0.0,0.0,1.0,0.0,0.0,12.0
Tarn Taran,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tarn Taran,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tarn Taran,9.12,Number of Institutions having NSV trained doctors,TOTAL,7.0,7.0,7.0,7.0,7.0,7.0,7.0,7.0,7.0,7.0,7.0,5.0,-1.0
Tarn Taran,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,980.0,1165.0,1097.0,1453.0,1749.0,1831.0,1959.0,1780.0,1566.0,1626.0,1275.0,969.0,17450.0
Tarn Taran,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,1249.0,1236.0,1038.0,1152.0,1321.0,1445.0,1826.0,1872.0,1644.0,1528.0,90.0,34.0,14435.0
Tarn Taran,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,1422.0,1364.0,1173.0,1157.0,1092.0,1215.0,1495.0,1669.0,1860.0,1641.0,1511.0,360.0,15959.0
Tarn Taran,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,1550.0,1566.0,1270.0,1318.0,1143.0,1063.0,1274.0,1339.0,1663.0,1786.0,1617.0,1238.0,16827.0
Tarn Taran,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1507.0,1211.0,2718.0
Tarn Taran,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,1067.0,1069.0
Tarn Taran,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,148.0,148.0
Tarn Taran,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,694.0,809.0,867.0,1080.0,1356.0,1335.0,1553.0,1341.0,1307.0,1128.0,958.0,700.0,13128.0
Tarn Taran,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,1249.0,1236.0,1038.0,1152.0,1321.0,1445.0,1826.0,1872.0,1644.0,1528.0,1589.0,1220.0,17120.0
Tarn Taran,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,1422.0,1364.0,1173.0,1157.0,1092.0,1215.0,1495.0,1669.0,1860.0,1641.0,1511.0,1371.0,16970.0
Tarn Taran,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,1550.0,1566.0,1270.0,1318.0,1143.0,1063.0,1274.0,1339.0,1663.0,1786.0,1617.0,1213.0,16802.0
Tarn Taran,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,375.0,444.0,528.0,646.0,707.0,880.0,820.0,626.0,631.0,564.0,435.0,337.0,6993.0
Tarn Taran,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,1249.0,1236.0,1038.0,1152.0,1321.0,1445.0,1826.0,1872.0,1644.0,1528.0,107.0,33.0,14451.0
Tarn Taran,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,1422.0,1364.0,1173.0,1157.0,1092.0,1215.0,1495.0,1669.0,1860.0,1641.0,1511.0,394.0,15993.0
Tarn Taran,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,1550.0,1566.0,1270.0,1318.0,1143.0,1063.0,1274.0,1339.0,1663.0,1786.0,1617.0,1255.0,16844.0
Tarn Taran,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,1319.0,1788.0,1667.0,1760.0,1675.0,1541.0,1522.0,1363.0,1224.0,1113.0,1076.0,1040.0,17088.0
Tarn Taran,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,1533.0,1626.0,1424.0,1508.0,1250.0,1047.0,1200.0,1253.0,1375.0,1431.0,1559.0,1376.0,16582.0
Tarn Taran,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tarn Taran,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,711.0,983.0,908.0,1002.0,899.0,803.0,815.0,723.0,683.0,611.0,606.0,574.0,9318.0
Tarn Taran,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,608.0,805.0,759.0,758.0,776.0,738.0,707.0,640.0,541.0,502.0,470.0,472.0,7776.0
Tarn Taran,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,1319.0,1788.0,1667.0,1760.0,1675.0,1541.0,1522.0,1363.0,1224.0,1113.0,1076.0,1046.0,17094.0
Tarn Taran,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,1533.0,1626.0,1424.0,1508.0,1250.0,1047.0,1200.0,1253.0,1375.0,1431.0,1559.0,1372.0,16578.0
Tarn Taran,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,1533.0,1626.0,1424.0,1508.0,1250.0,1047.0,1200.0,1253.0,1375.0,1431.0,1559.0,1372.0,16578.0
Tarn Taran,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tarn Taran,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tarn Taran,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tarn Taran,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tarn Taran,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,893.0,943.0,973.0,1169.0,1182.0,975.0,953.0,1004.0,996.0,966.0,1039.0,901.0,11994.0
Tarn Taran,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,780.0,887.0,771.0,1170.0,1703.0,1209.0,775.0,757.0,811.0,695.0,798.0,719.0,11075.0
Tarn Taran,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,523.0,526.0,511.0,753.0,1082.0,1240.0,805.0,583.0,587.0,575.0,645.0,447.0,8277.0
Tarn Taran,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tarn Taran,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tarn Taran,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tarn Taran,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,709.0,658.0,654.0,787.0,674.0,657.0,766.0,670.0,782.0,665.0,657.0,645.0,8324.0
Tarn Taran,10.4.2,Number of Immunisation sessions held during the month,TOTAL,677.0,657.0,654.0,759.0,660.0,649.0,729.0,668.0,751.0,655.0,647.0,588.0,8094.0
Tarn Taran,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,644.0,621.0,613.0,715.0,612.0,594.0,680.0,620.0,701.0,611.0,606.0,556.0,7573.0
Tarn Taran,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tarn Taran,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,1265.0,1697.0,1602.0,1668.0,1576.0,1447.0,1351.0,1127.0,967.0,639.0,545.0,587.0,14471.0
Tarn Taran,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,1178.0,1134.0,1083.0,1173.0,1061.0,1190.0,1128.0,1088.0,965.0,633.0,725.0,639.0,11997.0
Tarn Taran,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,901.0,857.0,941.0,992.0,913.0,804.0,802.0,799.0,827.0,544.0,546.0,442.0,9368.0
Tarn Taran,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tarn Taran,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tarn Taran,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tarn Taran,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tarn Taran,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tarn Taran,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tarn Taran,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,0.0,12.0,0.0,0.0,76.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,89.0
Tarn Taran,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tarn Taran,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Tarn Taran,13.1,Number of Patients operated for cataract,TOTAL,748.0,603.0,383.0,351.0,440.0,290.0,386.0,414.0,815.0,821.0,1287.0,22.0,6560.0
Tarn Taran,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,726.0,583.0,368.0,341.0,500.0,290.0,366.0,392.0,800.0,801.0,1257.0,22.0,6446.0
Tarn Taran,13.3,Number of School children detected with Refractive errors,TOTAL,39.0,288.0,0.0,362.0,273.0,357.0,205.0,222.0,201.0,242.0,212.0,18.0,2419.0
Tarn Taran,13.4,Number of children provided free glasses,TOTAL,0.0,200.0,150.0,150.0,250.0,225.0,225.0,200.0,180.0,220.0,200.0,8.0,2008.0
Tarn Taran,13.5,Number of eyes collected through eye donation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tarn Taran,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tarn Taran,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,10.0,10.0,10.0,10.0,10.0,10.0,10.0,10.0,10.0,10.0,10.0,10.0,-1.0
Tarn Taran,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,9.0,9.0,9.0,8.0,8.0,8.0,9.0,7.0,8.0,7.0,8.0,6.0,-1.0
Tarn Taran,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,569.0,560.0,569.0,588.0,529.0,519.0,555.0,529.0,595.0,523.0,513.0,464.0,-1.0
Tarn Taran,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,8.0,6.0,6.0,6.0,8.0,6.0,6.0,5.0,5.0,6.0,6.0,5.0,-1.0
Tarn Taran,14.05,Number of RKS meetings held during the month,TOTAL,3.0,3.0,3.0,2.0,1.0,2.0,1.0,2.0,2.0,1.0,1.0,2.0,23.0
Tarn Taran,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,8.0,8.0,8.0,8.0,9.0,8.0,8.0,9.0,9.0,8.0,9.0,8.0,-1.0
Tarn Taran,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,12.0,18.0,16.0,10.0,15.0,39.0,15.0,32.0,31.0,36.0,19.0,10.0,253.0
Tarn Taran,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,,,,,1.0,,,,,,,,-1.0
Tarn Taran,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,-1.0
Tarn Taran,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,241.0,160.0,122.0,243.0,239.0,345.0,245.0,203.0,238.0,234.0,176.0,186.0,2632.0
Tarn Taran,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,440.0,757.0,806.0,787.0,772.0,675.0,625.0,498.0,437.0,503.0,444.0,552.0,7296.0
Tarn Taran,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,260.0,135.0,155.0,204.0,176.0,330.0,199.0,192.0,216.0,205.0,228.0,199.0,2499.0
Tarn Taran,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,933.0,1111.0,1389.0,1420.0,1600.0,1242.0,1194.0,1167.0,1025.0,892.0,919.0,1004.0,13896.0
Tarn Taran,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,501.0,295.0,277.0,447.0,415.0,675.0,444.0,395.0,454.0,439.0,404.0,385.0,5131.0
Tarn Taran,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,1373.0,1868.0,2195.0,2207.0,2372.0,1917.0,1819.0,1665.0,1462.0,1395.0,1363.0,1556.0,21192.0
Tarn Taran,14.10.2.a,Number of death cases of Inpatient males,TOTAL,7.0,9.0,9.0,6.0,10.0,4.0,9.0,7.0,15.0,14.0,9.0,12.0,111.0
Tarn Taran,14.10.2.b,Number of death cases of Inpatient females,TOTAL,2.0,10.0,14.0,5.0,10.0,5.0,9.0,6.0,4.0,3.0,6.0,10.0,84.0
Tarn Taran,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,9.0,19.0,23.0,11.0,20.0,9.0,18.0,13.0,19.0,17.0,15.0,22.0,195.0
Tarn Taran,14.11,In-Patient Head Count at midnight,TOTAL,822.0,1065.0,1391.0,1401.0,1566.0,1284.0,4592.0,3125.0,2964.0,1317.0,439.0,394.0,20360.0
Tarn Taran,14.12.1,OPD attendance (All),TOTAL,80567.0,86728.0,86657.0,367540.0,88365.0,74818.0,64479.0,69679.0,59815.0,61964.0,71768.0,75875.0,1188255.0
Tarn Taran,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,370.0,582.0,338.0,387.0,406.0,270.0,232.0,374.0,278.0,225.0,275.0,284.0,4021.0
Tarn Taran,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,11.0,7.0,18.0,11.0,38.0,18.0,11.0,8.0,4.0,5.0,14.0,1.0,146.0
Tarn Taran,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,571.0,1286.0,761.0,698.0,770.0,754.0,629.0,713.0,468.0,445.0,407.0,545.0,8047.0
Tarn Taran,14.14.a,Number of patients given AYUSH treatment,TOTAL,5812.0,7655.0,7240.0,6394.0,7378.0,7959.0,7124.0,6814.0,4186.0,5826.0,6488.0,6598.0,79474.0
Tarn Taran,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,1082.0,1759.0,1638.0,1141.0,1022.0,1530.0,1182.0,1703.0,1021.0,1567.0,1447.0,928.0,16020.0
Tarn Taran,14.14.c,Number of Adolescents counselled,TOTAL,7.0,13.0,18.0,11.0,10.0,4.0,0.0,0.0,0.0,0.0,0.0,0.0,63.0
Tarn Taran,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,5120.0,5925.0,5576.0,5452.0,6099.0,5083.0,4444.0,4511.0,4178.0,4343.0,5035.0,5366.0,61132.0
Tarn Taran,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,133.0,135.0,161.0,181.0,186.0,207.0,179.0,191.0,192.0,177.0,159.0,185.0,2086.0
Tarn Taran,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,345.0,507.0,535.0,540.0,508.0,432.0,385.0,430.0,332.0,314.0,243.0,408.0,4979.0
Tarn Taran,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,9.0,16.0,23.0,14.0,6.0,4.0,3.0,7.0,9.0,11.0,10.0,11.0,123.0
Tarn Taran,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,292.0,275.0,398.0,325.0,518.0,256.0,216.0,193.0,171.0,164.0,167.0,247.0,3222.0
Tarn Taran,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,2.0,17.0,6.0,5.0,3.0,0.0,3.0,1.0,5.0,3.0,2.0,6.0,53.0
Tarn Taran,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,804.0,1434.0,1079.0,1375.0,1323.0,758.0,756.0,685.0,735.0,954.0,714.0,810.0,11427.0
Tarn Taran,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,35.0,4.0,16.0,2.0,1.0,0.0,1.0,0.0,1.0,2.0,2.0,1.0,65.0
Tarn Taran,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,1441.0,2216.0,2012.0,2240.0,2349.0,1446.0,1357.0,1308.0,1238.0,1432.0,1124.0,1465.0,19628.0
Tarn Taran,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,46.0,37.0,45.0,21.0,10.0,4.0,7.0,8.0,15.0,16.0,14.0,18.0,241.0
Tarn Taran,15.2,Number of Widal tests conducted,Number tested,1046.0,1210.0,1062.0,1112.0,1271.0,1081.0,937.0,770.0,604.0,597.0,896.0,1118.0,11704.0
Tarn Taran,15.3.a,Number of VDRL tests conducted on males,Number tested,93.0,111.0,117.0,76.0,87.0,75.0,47.0,78.0,53.0,28.0,31.0,42.0,838.0
Tarn Taran,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,311.0,266.0,231.0,121.0,387.0,272.0,109.0,171.0,189.0,116.0,160.0,229.0,2562.0
Tarn Taran,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,1106.0,1208.0,1165.0,1180.0,1161.0,765.0,831.0,813.0,908.0,789.0,823.0,984.0,11733.0
Tarn Taran,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,1510.0,1585.0,1513.0,1377.0,1635.0,1112.0,987.0,1062.0,1150.0,933.0,1014.0,1255.0,15133.0
Tarn Taran,15.4.1,Number of blood smears examined for Malaria,TOTAL,2545.0,3153.0,3102.0,2160.0,2892.0,2905.0,1863.0,2206.0,3241.0,2471.0,2373.0,2821.0,31732.0
Tarn Taran,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,0.0,0.0,0.0,7.0,15.0,13.0,3.0,1.0,0.0,0.0,0.0,0.0,39.0
Tarn Taran,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tarn Taran,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,5000.0,12300.0,3600.0,13200.0,3900.0,,12400.0,,,,,,50400.0
Tarn Taran,16.1.1,Stock position of DPT vaccines,2. Stocks Received,15000.0,0.0,15000.0,0.0,10000.0,,10000.0,,,,,,50000.0
Tarn Taran,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,,,,,,,,0.0
Tarn Taran,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,7700.0,8700.0,5400.0,9300.0,5200.0,,7000.0,,,,,,43300.0
Tarn Taran,16.1.1,Stock position of DPT vaccines,5. Total Stock,12300.0,3600.0,13200.0,3900.0,8700.0,0.0,15400.0,0.0,0.0,0.0,0.0,0.0,57100.0
Tarn Taran,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,,,,,,,,,,,,,
Tarn Taran,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,,,,,,,,,,,,,
Tarn Taran,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,,,,,,,,,,,,,
Tarn Taran,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,,,,,,,,,,,,,
Tarn Taran,16.1.1A,Stock Position of Pentavalent,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tarn Taran,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,28600.0,25700.0,17500.0,18100.0,5600.0,,7000.0,,,,,,102500.0
Tarn Taran,16.1.2,Stock position of OPV vaccines,2. Stocks Received,0.0,0.0,5000.0,0.0,10000.0,,14000.0,,,,,,29000.0
Tarn Taran,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,,,,,,,,0.0
Tarn Taran,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,2900.0,8200.0,4400.0,12500.0,5200.0,,10500.0,,,,,,43700.0
Tarn Taran,16.1.2,Stock position of OPV vaccines,5. Total Stock,25700.0,17500.0,18100.0,5600.0,10400.0,0.0,10500.0,0.0,0.0,0.0,0.0,0.0,87800.0
Tarn Taran,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,5800.0,14800.0,7900.0,13400.0,6400.0,,10600.0,,,,,,58900.0
Tarn Taran,16.1.3,Stock position of TT vaccines,2. Stocks Received,15000.0,0.0,10000.0,0.0,5000.0,,10000.0,,,,,,40000.0
Tarn Taran,16.1.3,Stock position of TT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,,,,,,,,0.0
Tarn Taran,16.1.3,Stock position of TT vaccines,4. Stock Distributed,6000.0,6900.0,4500.0,7000.0,4500.0,,4800.0,,,,,,33700.0
Tarn Taran,16.1.3,Stock position of TT vaccines,5. Total Stock,14800.0,7900.0,13400.0,6400.0,6900.0,0.0,15800.0,0.0,0.0,0.0,0.0,0.0,65200.0
Tarn Taran,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Tarn Taran,16.1.4,Stock position of DT vaccines,2. Stocks Received,,,,,,,,,,,,,
Tarn Taran,16.1.4,Stock position of DT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Tarn Taran,16.1.4,Stock position of DT vaccines,4. Stock Distributed,,,,,,,,,,,,,
Tarn Taran,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tarn Taran,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,8550.0,8900.0,5800.0,5300.0,2000.0,,6800.0,,,,,,37350.0
Tarn Taran,16.1.5,Stock position of BCG vaccines,2. Stocks Received,3000.0,0.0,2000.0,0.0,5000.0,,8000.0,,,,,,18000.0
Tarn Taran,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,,,,,,,,0.0
Tarn Taran,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,2650.0,3100.0,2500.0,3300.0,2300.0,,4000.0,,,,,,17850.0
Tarn Taran,16.1.5,Stock position of BCG vaccines,5. Total Stock,8900.0,5800.0,5300.0,2000.0,4700.0,0.0,10800.0,0.0,0.0,0.0,0.0,0.0,37500.0
Tarn Taran,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,4500.0,9750.0,5000.0,6000.0,1000.0,,1650.0,,,,,,27900.0
Tarn Taran,16.1.6,Stock position of Measles vaccines,2. Stocks Received,8000.0,0.0,5000.0,0.0,5000.0,,4000.0,,,,,,22000.0
Tarn Taran,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,,,,,,,,0.0
Tarn Taran,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,2750.0,4750.0,4000.0,5000.0,2750.0,,3800.0,,,,,,23050.0
Tarn Taran,16.1.6,Stock position of Measles vaccines,5. Total Stock,9750.0,5000.0,6000.0,1000.0,3250.0,0.0,1850.0,0.0,0.0,0.0,0.0,0.0,26850.0
Tarn Taran,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Tarn Taran,16.1.7,Stock position of JE vaccines,2. Stocks Received,,,,,,,,,,,,,
Tarn Taran,16.1.7,Stock position of JE vaccines,3. Unusable Stock,,,,,,,,,,,,,
Tarn Taran,16.1.7,Stock position of JE vaccines,4. Stock Distributed,,,,,,,,,,,,,
Tarn Taran,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tarn Taran,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,6300.0,16000.0,9200.0,14300.0,6300.0,,8900.0,,,,,,61000.0
Tarn Taran,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,15000.0,0.0,10000.0,0.0,5000.0,,9000.0,,,,,,39000.0
Tarn Taran,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,,,,,,,,0.0
Tarn Taran,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,5300.0,6800.0,4900.0,8000.0,3300.0,,6600.0,,,,,,34900.0
Tarn Taran,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,16000.0,9200.0,14300.0,6300.0,8000.0,0.0,11300.0,0.0,0.0,0.0,0.0,0.0,65100.0
Tarn Taran,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,0.0,3228.0,428.0,,0.0,,,,,,3656.0
Tarn Taran,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,0.0,0.0,3228.0,0.0,0.0,,0.0,,,,,,3228.0
Tarn Taran,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,,0.0,,,,,,0.0
Tarn Taran,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,0.0,0.0,,2800.0,200.0,,0.0,,,,,,3000.0
Tarn Taran,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,0.0,0.0,3228.0,428.0,228.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3884.0
Tarn Taran,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,598760.0,308760.0,58760.0,0.0,0.0,,318800.0,,,,,,1285080.0
Tarn Taran,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,480800.0,,0.0,,,,,,480800.0
Tarn Taran,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,,0.0,,,,,,0.0
Tarn Taran,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,290000.0,250000.0,0.0,0.0,20000.0,,120000.0,,,,,,680000.0
Tarn Taran,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,308760.0,58760.0,58760.0,0.0,460800.0,0.0,198800.0,0.0,0.0,0.0,0.0,0.0,1085880.0
Tarn Taran,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,,7300.0,,,,,,7300.0
Tarn Taran,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,16300.0,,0.0,,,,,,16300.0
Tarn Taran,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,,0.0,,,,,,0.0
Tarn Taran,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,0.0,2000.0,,7300.0,,,,,,9300.0
Tarn Taran,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,14300.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,14300.0
Tarn Taran,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,0.0,75.0,0.0,,105.0,,,,,,180.0
Tarn Taran,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,0.0,75.0,0.0,225.0,,0.0,,,,,,300.0
Tarn Taran,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,,0.0,,,,,,0.0
Tarn Taran,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,75.0,30.0,,105.0,,,,,,210.0
Tarn Taran,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,75.0,0.0,195.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,270.0
Tarn Taran,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,1200.0,0.0,0.0,3000.0,2000.0,,600.0,,,,,,6800.0
Tarn Taran,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,0.0,0.0,3000.0,0.0,0.0,,0.0,,,,,,3000.0
Tarn Taran,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,,0.0,,,,,,0.0
Tarn Taran,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,1200.0,0.0,0.0,1000.0,1400.0,,0.0,,,,,,3600.0
Tarn Taran,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0.0,0.0,3000.0,2000.0,600.0,0.0,600.0,0.0,0.0,0.0,0.0,0.0,6200.0
Tarn Taran,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,,0.0,,,,,,0.0
Tarn Taran,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,,0.0,,,,,,0.0
Tarn Taran,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,,0.0,,,,,,0.0
Tarn Taran,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,,0.0,,,,,,0.0
Tarn Taran,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tarn Taran,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,,0.0,,,,,,0.0
Tarn Taran,16.3.02,Stock Position of Gloves,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,,0.0,,,,,,0.0
Tarn Taran,16.3.02,Stock Position of Gloves,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,,0.0,,,,,,0.0
Tarn Taran,16.3.02,Stock Position of Gloves,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,,0.0,,,,,,0.0
Tarn Taran,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tarn Taran,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,,0.0,,,,,,0.0
Tarn Taran,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,,0.0,,,,,,0.0
Tarn Taran,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,,0.0,,,,,,0.0
Tarn Taran,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,,0.0,,,,,,0.0
Tarn Taran,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tarn Taran,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,,0.0,,,,,,0.0
Tarn Taran,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,,0.0,,,,,,0.0
Tarn Taran,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,,0.0,,,,,,0.0
Tarn Taran,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,,0.0,,,,,,0.0
Tarn Taran,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tarn Taran,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,,0.0,,,,,,0.0
Tarn Taran,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,,0.0,,,,,,0.0
Tarn Taran,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,,0.0,,,,,,0.0
Tarn Taran,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,,0.0,,,,,,0.0
Tarn Taran,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tarn Taran,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,,0.0,,,,,,0.0
Tarn Taran,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,,0.0,,,,,,0.0
Tarn Taran,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,,0.0,,,,,,0.0
Tarn Taran,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,,0.0,,,,,,0.0
Tarn Taran,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tarn Taran,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,489500.0,325000.0,0.0,0.0,0.0,,0.0,,,,,,814500.0
Tarn Taran,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,,0.0,,,,,,0.0
Tarn Taran,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,,0.0,,,,,,0.0
Tarn Taran,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,164500.0,325000.0,0.0,0.0,0.0,,0.0,,,,,,489500.0
Tarn Taran,16.3.07,Stock Position of IFA Tablets,5. Total Stock,325000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,325000.0
Tarn Taran,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,,0.0,,,,,,0.0
Tarn Taran,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,,0.0,,,,,,0.0
Tarn Taran,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,,0.0,,,,,,0.0
Tarn Taran,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,,0.0,,,,,,0.0
Tarn Taran,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tarn Taran,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,,0.0,,,,,,0.0
Tarn Taran,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,,0.0,,,,,,0.0
Tarn Taran,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,,0.0,,,,,,0.0
Tarn Taran,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,,0.0,,,,,,0.0
Tarn Taran,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tarn Taran,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,,0.0,,,,,,0.0
Tarn Taran,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,,0.0,,,,,,0.0
Tarn Taran,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,,0.0,,,,,,0.0
Tarn Taran,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,,0.0,,,,,,0.0
Tarn Taran,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tarn Taran,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,,0.0,,,,,,0.0
Tarn Taran,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,,0.0,,,,,,0.0
Tarn Taran,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,,0.0,,,,,,0.0
Tarn Taran,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,,0.0,,,,,,0.0
Tarn Taran,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tarn Taran,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,0.0,800.0,400.0,100.0,100.0,,700.0,,,,,,2100.0
Tarn Taran,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,2000.0,0.0,0.0,0.0,4000.0,,4000.0,,,,,,10000.0
Tarn Taran,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,,0.0,,,,,,0.0
Tarn Taran,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,1200.0,400.0,300.0,0.0,1700.0,,1200.0,,,,,,4800.0
Tarn Taran,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,800.0,400.0,100.0,100.0,2400.0,0.0,3500.0,0.0,0.0,0.0,0.0,0.0,7300.0
Tarn Taran,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,20000.0,100000.0,48000.0,30000.0,20000.0,,58000.0,,,,,,276000.0
Tarn Taran,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,100000.0,0.0,0.0,0.0,100000.0,,0.0,,,,,,200000.0
Tarn Taran,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,,0.0,,,,,,0.0
Tarn Taran,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,20000.0,52000.0,18000.0,10000.0,10000.0,,6000.0,,,,,,116000.0
Tarn Taran,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,100000.0,48000.0,30000.0,20000.0,110000.0,0.0,52000.0,0.0,0.0,0.0,0.0,0.0,360000.0
Tarn Taran,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,400.0,400.0,0.0,0.0,0.0,,800.0,,,,,,1600.0
Tarn Taran,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,0.0,0.0,0.0,0.0,2400.0,,4800.0,,,,,,7200.0
Tarn Taran,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,,0.0,,,,,,0.0
Tarn Taran,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,0.0,400.0,0.0,0.0,200.0,,600.0,,,,,,1200.0
Tarn Taran,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,400.0,0.0,0.0,0.0,2200.0,0.0,5000.0,0.0,0.0,0.0,0.0,0.0,7600.0
Tarn Taran,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,4.0,1.0,2.0,,,2.0,1.0,,,,,,10.0
Tarn Taran,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,,1.0,,,,,,,,,,1.0
Tarn Taran,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Tarn Taran,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,,1.0,,,,,,,,,,1.0
Tarn Taran,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,,,2.0,,3.0,,1.0,1.0,,1.0,1.0,,9.0
Tarn Taran,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,1.0,,,,,,,,,,,1.0
Tarn Taran,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,,1.0,2.0,,3.0,,1.0,1.0,,1.0,1.0,,10.0
Tarn Taran,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,1.0,2.0,,,2.0,,3.0,,,1.0,,1.0,10.0
Tarn Taran,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,1.0,1.0,,,,,,,,,,2.0
Tarn Taran,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,1.0,3.0,1.0,,2.0,,3.0,,,1.0,,1.0,12.0
Tarn Taran,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,3.0,4.0,2.0,4.0,14.0,4.0,9.0,10.0,4.0,2.0,9.0,2.0,67.0
Tarn Taran,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,3.0,2.0,1.0,,,2.0,2.0,1.0,3.0,,,,14.0
Tarn Taran,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,6.0,6.0,3.0,4.0,14.0,6.0,11.0,11.0,7.0,2.0,9.0,2.0,81.0
Tarn Taran,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,,,,,1.0,1.0,,3.0,3.0,,1.0,9.0
Tarn Taran,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,,,1.0,,1.0,3.0,,,,5.0
Tarn Taran,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,,,,,,2.0,1.0,1.0,6.0,3.0,,1.0,14.0
Tarn Taran,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,1.0,1.0,,,1.0,1.0,,,,,4.0
Tarn Taran,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,1.0,1.0,,,,,,,,,,2.0
Tarn Taran,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,1.0,2.0,1.0,,,1.0,1.0,,,,,6.0
Tarn Taran,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,8.0,1.0,1.0,2.0,1.0,1.0,1.0,3.0,,,18.0
Tarn Taran,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,,,3.0,,,,,,,3.0
Tarn Taran,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,,8.0,1.0,1.0,5.0,1.0,1.0,1.0,3.0,,,21.0
Tarn Taran,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Tarn Taran,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Tarn Taran,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Tarn Taran,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,5.0,4.0,1.0,3.0,3.0,9.0,5.0,6.0,9.0,3.0,6.0,3.0,57.0
Tarn Taran,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,3.0,3.0,,2.0,1.0,1.0,5.0,6.0,3.0,2.0,3.0,3.0,32.0
Tarn Taran,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,8.0,7.0,1.0,5.0,4.0,10.0,10.0,12.0,12.0,5.0,9.0,6.0,89.0
Tarn Taran,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,1.0,,,1.0
Tarn Taran,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,2.0,2.0,,1.0,,1.0,,1.0,,1.0,8.0
Tarn Taran,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,2.0,3.0,,,,1.0,,1.0,2.0,,9.0
Tarn Taran,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,4.0,5.0,,1.0,,2.0,,3.0,2.0,1.0,18.0
Tarn Taran,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,1.0,1.0,,,,,,,,,2.0
Tarn Taran,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,1.0,4.0,,3.0,1.0,,1.0,3.0,4.0,3.0,10.0,,30.0
Tarn Taran,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,1.0,,1.0,1.0,3.0,,1.0,,2.0,3.0,1.0,,13.0
Tarn Taran,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,2.0,4.0,2.0,5.0,4.0,,2.0,3.0,6.0,6.0,11.0,,45.0
Tarn Taran,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,,,,1.0,,1.0
Tarn Taran,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,,,1.0,2.0,3.0,2.0,1.0,1.0,1.0,6.0,2.0,1.0,20.0
Tarn Taran,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,,1.0,7.0,2.0,6.0,5.0,4.0,2.0,1.0,5.0,3.0,,36.0
Tarn Taran,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,,1.0,8.0,4.0,9.0,7.0,5.0,3.0,2.0,11.0,6.0,1.0,57.0
Tarn Taran,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
Tarn Taran,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,2.0,,,,,,,,,,,,2.0
Tarn Taran,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,1.0,,,,,,,,1.0
Tarn Taran,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,2.0,,,,1.0,,,,,,,,3.0
Tarn Taran,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,2.0,,,2.0,,2.0,,1.0,,,,7.0
Tarn Taran,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,5.0,13.0,7.0,6.0,9.0,6.0,7.0,8.0,7.0,6.0,6.0,,80.0
Tarn Taran,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,14.0,26.0,20.0,16.0,11.0,13.0,12.0,18.0,22.0,22.0,11.0,,185.0
Tarn Taran,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,19.0,41.0,27.0,22.0,22.0,19.0,21.0,26.0,30.0,28.0,17.0,,272.0
Tarn Taran,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,2.0,,,,,,,,2.0
Tarn Taran,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,2.0,3.0,,1.0,2.0,2.0,4.0,2.0,,1.0,1.0,,18.0
Tarn Taran,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,2.0,,,1.0,,,,,,1.0,,4.0
Tarn Taran,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,2.0,5.0,,1.0,5.0,2.0,4.0,2.0,,1.0,2.0,,24.0
Tarn Taran,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,1.0,,,,1.0,1.0,,2.0,,3.0,1.0,1.0,10.0
Tarn Taran,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,75.0,90.0,91.0,119.0,85.0,93.0,101.0,94.0,121.0,140.0,105.0,39.0,1153.0
Tarn Taran,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,178.0,197.0,235.0,203.0,150.0,171.0,221.0,207.0,290.0,316.0,240.0,80.0,2488.0
Tarn Taran,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,254.0,287.0,326.0,322.0,236.0,265.0,322.0,303.0,411.0,459.0,346.0,120.0,3651.0
Tarn Taran,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,,1.0,,,,,1.0
Tarn Taran,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,1.0,3.0,4.0,4.0,6.0,1.0,2.0,3.0,,7.0,7.0,,38.0
Tarn Taran,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,4.0,8.0,4.0,7.0,8.0,4.0,6.0,5.0,12.0,9.0,7.0,,74.0
Tarn Taran,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,5.0,11.0,8.0,11.0,14.0,5.0,8.0,9.0,12.0,16.0,14.0,,113.0
Tarn Taran,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Tarn Taran,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
Tarn Taran,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Tarn Taran,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
Tarn Taran,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Tarn Taran,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,,,,,,,,
Tarn Taran,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Tarn Taran,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,,,,,,,,
Tarn Taran,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Tarn Taran,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,,,,,,,,,,
Tarn Taran,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Tarn Taran,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,,,,,,,,,,,
Tarn Taran,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Tarn Taran,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,1.0,,,,,,,,,,,1.0
Tarn Taran,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Tarn Taran,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,1.0,,,,,,,,,,,1.0
Tarn Taran,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Tarn Taran,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,1.0,1.0,,1.0,,,,,,3.0
Tarn Taran,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Tarn Taran,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,1.0,1.0,,1.0,,,,,,3.0
Tarn Taran,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Tarn Taran,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,,3.0,1.0,,4.0,1.0,,,1.0,,,,10.0
Tarn Taran,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Tarn Taran,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,,3.0,1.0,,4.0,1.0,,,1.0,,,,10.0
Tarn Taran,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,,1.0,4.0,2.0,2.0,1.0,4.0,1.0,2.0,1.0,,18.0
Tarn Taran,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,,5.0,25.0,23.0,31.0,31.0,35.0,32.0,32.0,19.0,19.0,6.0,258.0
Tarn Taran,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,,,10.0,9.0,5.0,7.0,9.0,3.0,10.0,4.0,9.0,5.0,71.0
Tarn Taran,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,,5.0,36.0,36.0,38.0,40.0,45.0,39.0,43.0,25.0,29.0,11.0,347.0
Tarn Taran,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,,1.0,1.0,,,,,,2.0
Tarn Taran,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,4.0,6.0,5.0,8.0,3.0,8.0,6.0,5.0,4.0,4.0,6.0,1.0,60.0
Tarn Taran,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,,,,,1.0,,,,,,1.0,2.0
Tarn Taran,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,4.0,6.0,5.0,8.0,3.0,10.0,7.0,5.0,4.0,4.0,6.0,2.0,64.0
Tarn Taran,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,1.0,,,1.0,1.0,,,,,,,3.0
Tarn Taran,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,2.0,1.0,3.0,2.0,5.0,1.0,2.0,3.0,1.0,,,,20.0
Tarn Taran,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,1.0,1.0,3.0,,2.0,1.0,,1.0,1.0,,10.0
Tarn Taran,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,2.0,2.0,4.0,3.0,9.0,2.0,4.0,4.0,1.0,1.0,1.0,,33.0
Tarn Taran,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,,,,,,1.0,1.0,,,,2.0
Tarn Taran,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,3.0,5.0,14.0,5.0,5.0,4.0,3.0,9.0,12.0,5.0,8.0,1.0,74.0
Tarn Taran,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,5.0,5.0,4.0,10.0,6.0,4.0,7.0,7.0,19.0,22.0,11.0,4.0,104.0
Tarn Taran,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,8.0,10.0,18.0,15.0,11.0,8.0,10.0,17.0,32.0,27.0,19.0,5.0,180.0
Tarn Taran,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,,1.0,1.0,,,,,,,1.0,,3.0
Tarn Taran,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,15.0,19.0,23.0,19.0,24.0,16.0,27.0,23.0,25.0,27.0,35.0,8.0,261.0
Tarn Taran,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,30.0,28.0,42.0,33.0,36.0,33.0,48.0,42.0,58.0,53.0,50.0,10.0,463.0
Tarn Taran,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,45.0,47.0,66.0,53.0,60.0,49.0,75.0,65.0,83.0,80.0,86.0,18.0,727.0
Tarn Taran,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,2.0,2.0,2.0,1.0,1.0,2.0,2.0,1.0,2.0,1.0,1.0,,17.0
Tarn Taran,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,24.0,25.0,42.0,28.0,32.0,24.0,42.0,37.0,31.0,25.0,25.0,8.0,343.0
Tarn Taran,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,72.0,94.0,100.0,77.0,72.0,66.0,83.0,96.0,88.0,93.0,59.0,26.0,926.0
Tarn Taran,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,98.0,121.0,144.0,106.0,105.0,92.0,127.0,134.0,121.0,119.0,85.0,34.0,1286.0
